data_2bjx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2bjx _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.235 0.541 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.2 t -86.26 170.53 12.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.277 -0.889 . . . . 0.0 110.3 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.8 m -104.13 105.03 15.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.105 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 17.8 mt -79.65 129.24 71.99 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.9 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 49.1 Cg_endo -72.85 -44.84 0.56 Allowed 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.421 1.222 . . . . 0.0 110.39 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.415 ' OD2' ' CB ' ' A' ' 127' ' ' ALA . 0.9 OUTLIER -157.44 -169.3 2.85 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.325 -0.86 . . . . 0.0 110.572 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.44 -23.4 60.28 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.415 ' CB ' ' OD2' ' A' ' 125' ' ' ASP . . . -57.24 -29.7 64.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.263 -1.139 . . . . 0.0 110.25 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.428 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -88.26 -31.15 19.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 110.035 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.3 -30.7 68.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -0.901 . . . . 0.0 110.002 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -87.88 -37.99 16.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.343 -0.848 . . . . 0.0 110.09 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 10.1 p -73.95 -29.65 62.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 110.106 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.425 ' CD2' HG12 ' A' ' 141' ' ' ILE . 15.1 tp -61.9 -55.55 28.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.212 -0.93 . . . . 0.0 110.082 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.424 ' CG2' ' HB3' ' A' ' 189' ' ' PHE . 55.5 t -55.37 -25.87 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.895 . . . . 0.0 110.155 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -83.33 -29.21 28.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.319 -0.863 . . . . 0.0 110.422 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.5 m -61.05 -31.2 70.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.236 -0.915 . . . . 0.0 110.312 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 95.8 p -146.34 159.21 43.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.219 -0.925 . . . . 0.0 110.25 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.426 ' HG3' ' CG2' ' A' ' 138' ' ' VAL . 12.7 pt-20 -64.38 -40.65 96.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.879 . . . . 0.0 110.155 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.426 ' CG2' ' HG3' ' A' ' 137' ' ' GLU . 95.1 t -113.24 128.32 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.477 -0.764 . . . . 0.0 110.194 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -158.11 145.31 18.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.859 . . . . 0.0 109.839 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.481 HG12 ' CE2' ' A' ' 167' ' ' PHE . 7.5 p -124.63 151.29 29.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.125 -0.985 . . . . 0.0 110.298 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.425 HG12 ' CD2' ' A' ' 132' ' ' LEU . 66.7 mt -143.11 119.52 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.441 -0.787 . . . . 0.0 109.576 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -90.62 164.95 30.67 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.473 ' CE2' HG13 ' A' ' 175' ' ' VAL . 46.7 m-85 -130.72 69.09 1.46 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.52 -0.988 . . . . 0.0 109.375 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -89.03 132.63 34.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.139 -0.975 . . . . 0.0 111.379 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.3 -28.52 59.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.582 -0.699 . . . . 0.0 110.077 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -127.38 73.87 1.47 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.392 -0.817 . . . . 0.0 109.923 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.428 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 24.0 m -53.21 -21.8 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.348 -0.845 . . . . 0.0 110.611 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.49 13.39 8.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.134 -0.979 . . . . 0.0 110.801 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 85.3 p -98.6 -163.53 1.05 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.04 -1.038 . . . . 0.0 110.131 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.43 -43.67 14.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.114 -0.991 . . . . 0.0 110.293 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 85.6 p -52.74 -27.65 18.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -0.928 . . . . 0.0 110.25 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.428 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -85.48 -35.17 21.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 110.057 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.6 mmmt -54.28 -50.04 68.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 110.216 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -57.74 -38.9 76.16 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.261 -0.899 . . . . 0.0 110.085 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . 0.477 ' CE1' HG13 ' A' ' 186' ' ' VAL . 4.1 t80 -52.41 -63.24 1.2 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 0.0 110.278 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.4 mt -53.86 -52.13 61.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.346 -0.846 . . . . 0.0 110.205 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -52.01 -50.44 61.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.369 -0.832 . . . . 0.0 110.12 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.428 ' CA ' ' HG3' ' A' ' 205' ' ' LYS . . . -66.15 -29.13 69.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.127 -0.983 . . . . 0.0 109.738 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.454 ' HB3' ' CD2' ' A' ' 167' ' ' PHE . . . -73.12 -34.3 66.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.389 -0.819 . . . . 0.0 109.995 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -57.11 -22.84 42.79 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.296 -0.877 . . . . 0.0 110.125 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.13 -51.47 69.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.896 . . . . 0.0 110.134 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.449 HD11 HG22 ' A' ' 162' ' ' ILE . 76.8 mt -100.96 139.76 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.32 -0.862 . . . . 0.0 110.246 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -117.51 -21.87 8.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 0.0 110.47 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -74.17 -11.0 60.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.184 -0.947 . . . . 0.0 110.729 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.429 HD11 HG21 ' A' ' 165' ' ' ILE . 49.4 mm -100.02 130.96 25.11 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 120.995 -1.066 . . . . 0.0 110.107 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -75.88 78.38 3.15 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.409 1.216 . . . . 0.0 110.683 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.481 ' CE2' HG12 ' A' ' 140' ' ' VAL . 5.8 m-85 -68.87 138.78 54.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.212 -0.93 . . . . 0.0 109.813 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -133.02 150.34 19.77 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 14.6 tt -149.67 137.81 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -1.191 . . . . 0.0 110.693 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.6 t -150.88 157.37 42.83 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.092 0.948 . . . . 0.0 110.774 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 79.7 p -118.78 0.78 11.5 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.581 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.48 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 43.3 t30 -53.56 -177.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.216 -0.928 . . . . 0.0 110.136 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 18.3 m -106.8 -35.96 6.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.137 -0.977 . . . . 0.0 110.077 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -57.91 -31.52 66.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -0.914 . . . . 0.0 109.819 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.473 HG13 ' CE2' ' A' ' 143' ' ' PHE . 40.2 t -76.42 -30.03 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.282 -0.886 . . . . 0.0 109.562 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 172' ' ' ASN . 11.4 m-85 -77.33 -57.36 3.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 109.613 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.2 m -53.2 -23.58 8.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.342 -0.849 . . . . 0.0 110.052 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -58.69 -57.91 10.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.873 . . . . 0.0 110.288 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -89.98 17.41 6.87 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.237 -0.914 . . . . 0.0 110.445 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 53.84 65.53 1.49 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.045 -1.035 . . . . 0.0 110.347 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 83.3 mt -108.29 100.79 10.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.316 -0.865 . . . . 0.0 110.194 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.97 -26.12 46.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 109.978 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -144.3 -165.5 2.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.362 -0.837 . . . . 0.0 110.122 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -68.89 163.56 24.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.171 -0.956 . . . . 0.0 110.233 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 175.81 144.75 5.21 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.477 HG13 ' CE1' ' A' ' 155' ' ' PHE . 11.5 m -114.32 128.47 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -1.131 . . . . 0.0 110.283 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 94.8 t -132.75 163.3 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.389 -0.819 . . . . 0.0 109.326 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.453 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 6.6 tt -110.79 161.55 15.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.939 -1.101 . . . . 0.0 109.907 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.424 ' HB3' ' CG2' ' A' ' 133' ' ' VAL . 52.6 m-85 -128.53 124.85 37.05 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.989 -1.07 . . . . 0.0 110.418 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.408 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -138.14 161.24 37.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.265 -0.897 . . . . 0.0 110.378 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -90.87 -27.89 18.5 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.342 -0.849 . . . . 0.0 110.552 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.408 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.8 OUTLIER -90.75 -176.39 4.68 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.435 -0.79 . . . . 0.0 110.873 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 48.02 -154.52 0.08 Allowed 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.718 0.77 . . . . 0.0 110.587 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.04 -55.6 22.51 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.72 -0.613 . . . . 0.0 110.243 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 121.52 -25.69 6.85 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -134.89 161.56 34.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.268 -1.137 . . . . 0.0 110.203 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ASN . . . . . 0.462 ' N ' ' ND2' ' A' ' 197' ' ' ASN . 0.6 OUTLIER -133.34 -153.57 0.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.151 -0.968 . . . . 0.0 109.998 -179.481 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -174.57 88.3 0.05 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.446 -0.784 . . . . 0.0 110.217 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.468 ' CE1' ' O ' ' A' ' 200' ' ' GLU . 29.3 t80 -60.75 139.97 57.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.334 -0.854 . . . . 0.0 110.398 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.468 ' O ' ' CE1' ' A' ' 199' ' ' PHE . 55.7 mt-10 -130.0 -151.33 0.47 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.141 -0.974 . . . . 0.0 109.679 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 51.34 -146.66 10.96 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.08 158.45 16.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -1.157 . . . . 0.0 110.016 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 73.2 t -89.13 114.69 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.255 -0.903 . . . . 0.0 110.251 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 38.8 p -150.27 147.78 28.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.329 -0.857 . . . . 0.0 110.165 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.428 ' HG3' ' CA ' ' A' ' 158' ' ' ALA . 13.2 tttm -46.78 -50.26 18.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.25 -0.906 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . 0.423 ' HG3' ' N ' ' A' ' 207' ' ' ASN . 17.7 pt-20 -56.77 -39.36 73.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 110.191 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.423 ' N ' ' HG3' ' A' ' 206' ' ' GLU . 54.8 m-20 -72.33 -45.63 59.1 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.315 -0.865 . . . . 0.0 110.165 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 89.7 mt -54.52 -54.54 39.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 110.285 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 1.4 mt -52.69 -29.09 24.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 0.0 110.002 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -77.72 -48.18 17.31 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.34 -0.85 . . . . 0.0 109.651 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.428 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 18.3 t80 -52.22 -56.04 17.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.865 . . . . 0.0 109.763 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 36.9 mm -51.24 -65.4 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.319 -0.863 . . . . 0.0 110.001 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -50.86 -25.31 4.38 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.755 -0.591 . . . . 0.0 110.452 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -89.57 -14.77 34.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.176 -0.952 . . . . 0.0 110.565 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 1.7 m-80 -89.06 -81.99 0.26 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.074 -1.016 . . . . 0.0 110.27 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 . . . . . 0 N--CA 1.487 1.379 0 O-C-N 121.157 -0.965 . . . . 0.0 110.164 -179.943 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.263 0.554 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.8 t -99.38 169.95 8.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.124 -0.985 . . . . 0.0 110.318 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 92.8 m -108.18 121.12 44.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.288 -0.882 . . . . 0.0 110.119 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.1 mt -100.06 136.49 20.12 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.241 -0.912 . . . . 0.0 110.08 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.88 -51.76 0.14 Allowed 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.509 1.268 . . . . 0.0 110.44 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.08 -170.42 3.48 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.224 -0.922 . . . . 0.0 110.788 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -58.86 -28.8 63.81 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -51.2 -36.69 42.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.176 -1.191 . . . . 0.0 110.472 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.68 -29.19 27.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.145 -0.972 . . . . 0.0 110.03 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.2 -27.3 68.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.131 -0.98 . . . . 0.0 109.95 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -89.07 -49.74 6.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.893 . . . . 0.0 109.971 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.3 t -58.7 -32.22 68.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.893 . . . . 0.0 110.197 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 27.0 tp -59.91 -52.52 65.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.321 -0.862 . . . . 0.0 110.011 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.498 HG23 ' CD2' ' A' ' 189' ' ' PHE . 47.7 t -58.56 -37.62 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.295 -0.878 . . . . 0.0 110.033 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -74.13 -5.69 43.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.32 -0.862 . . . . 0.0 110.909 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.35 -21.98 25.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.903 -1.123 . . . . 0.0 110.615 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.08 162.24 40.79 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.196 -0.94 . . . . 0.0 110.571 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.06 -17.39 62.01 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.314 -0.866 . . . . 0.0 109.912 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 99.2 t -135.13 139.6 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.976 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.431 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -173.13 146.9 1.51 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 0.0 110.121 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.489 HG12 ' CE2' ' A' ' 167' ' ' PHE . 7.7 p -129.13 152.74 37.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.089 -1.007 . . . . 0.0 109.919 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.477 ' O ' ' CE1' ' A' ' 143' ' ' PHE . 62.5 mt -139.47 117.68 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.209 -0.932 . . . . 0.0 110.204 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -81.85 139.68 20.2 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.477 ' CE1' ' O ' ' A' ' 141' ' ' ILE . 70.9 m-85 -114.07 79.38 1.25 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.154 -1.204 . . . . 0.0 109.971 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -107.15 148.35 28.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.109 -0.994 . . . . 0.0 110.842 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.32 -28.59 18.65 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.3 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.69 82.88 1.95 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -0.837 . . . . 0.0 109.638 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 87.6 t -52.87 -21.93 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.366 -0.833 . . . . 0.0 110.76 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.81 18.39 6.59 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.218 -0.926 . . . . 0.0 110.563 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 10.3 p -90.8 -162.84 0.95 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.139 -0.976 . . . . 0.0 110.245 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -90.27 -47.94 7.46 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.267 -0.896 . . . . 0.0 110.489 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 62.5 m -52.35 -29.97 26.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.167 -0.958 . . . . 0.0 110.245 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.53 -29.08 41.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 109.975 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.1 -54.36 45.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -0.907 . . . . 0.0 109.865 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -58.21 -37.91 75.74 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.309 -0.87 . . . . 0.0 109.864 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -50.22 -59.84 3.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.315 -0.866 . . . . 0.0 110.32 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 17.4 mt -50.44 -50.23 52.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.328 -0.858 . . . . 0.0 110.39 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -52.83 -54.76 29.61 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.392 -0.818 . . . . 0.0 110.113 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.58 -40.94 93.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.051 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.452 ' CB ' ' CD2' ' A' ' 167' ' ' PHE . . . -67.46 -25.67 66.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.307 -0.87 . . . . 0.0 110.158 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -82.94 -31.19 27.82 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.304 -0.873 . . . . 0.0 110.214 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.77 -38.64 64.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 0.0 110.195 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.8 tt -96.37 156.36 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.914 . . . . 0.0 110.339 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -133.93 16.01 3.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.93 . . . . 0.0 110.481 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -123.68 10.43 9.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.08 -1.013 . . . . 0.0 110.716 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.424 HG21 HD11 ' A' ' 165' ' ' ILE . 50.0 mm -126.67 136.52 28.85 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.0 -1.062 . . . . 0.0 110.189 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.431 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 49.9 Cg_endo -77.13 91.94 1.15 Allowed 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.499 1.262 . . . . 0.0 110.915 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.489 ' CE2' HG12 ' A' ' 140' ' ' VAL . 4.1 m-85 -86.66 130.75 34.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.288 -0.882 . . . . 0.0 109.823 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -133.56 156.06 22.07 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 12.6 tt -150.84 150.78 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.094 -1.239 . . . . 0.0 110.418 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.3 t -157.65 157.78 34.24 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.06 0.933 . . . . 0.0 110.819 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.2 t -120.13 -0.18 10.57 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.389 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.429 ' ND2' ' HB2' ' A' ' 174' ' ' ASP . 23.8 t30 -61.55 129.47 41.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.096 -1.002 . . . . 0.0 110.24 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.6 t -58.83 -29.36 66.85 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.261 -0.9 . . . . 0.0 110.448 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.429 ' HB2' ' ND2' ' A' ' 172' ' ' ASN . 1.0 OUTLIER -56.36 -33.66 65.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.125 -0.984 . . . . 0.0 110.206 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 42.3 t -80.03 -25.29 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.913 . . . . 0.0 109.947 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 176' ' ' PHE . 11.9 m-85 -80.39 -53.06 6.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.304 -0.873 . . . . 0.0 109.777 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 14.2 m -54.45 -23.19 15.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.886 . . . . 0.0 109.932 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.71 -50.28 45.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.361 -0.837 . . . . 0.0 110.025 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -89.84 8.21 33.21 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.319 -0.863 . . . . 0.0 110.735 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 52.51 57.94 5.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.991 -1.068 . . . . 0.0 110.4 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 83.7 mt -99.45 100.27 11.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.197 -0.939 . . . . 0.0 110.351 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 3.7 m-20 -54.07 -26.74 28.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.96 . . . . 0.0 110.198 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -146.94 -165.29 2.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.217 -0.927 . . . . 0.0 109.914 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -64.1 162.49 14.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.14 -0.975 . . . . 0.0 109.91 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -170.57 140.3 5.92 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.466 -1.35 . . . . 0.0 110.064 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.405 ' HB ' ' HB3' ' A' ' 199' ' ' PHE . 53.3 t -109.46 90.32 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.423 -1.045 . . . . 0.0 109.448 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.427 HG11 ' N ' ' A' ' 188' ' ' LEU . 94.0 t -102.55 147.75 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.338 -0.851 . . . . 0.0 110.277 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.463 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 7.7 tt -107.46 158.98 16.75 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.292 -0.88 . . . . 0.0 109.306 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.498 ' CD2' HG23 ' A' ' 133' ' ' VAL . 71.2 m-85 -123.86 139.76 53.65 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.995 -1.066 . . . . 0.0 110.707 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.91 166.16 26.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.399 -0.813 . . . . 0.0 109.796 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -84.4 -36.55 22.35 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.138 -0.976 . . . . 0.0 110.409 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.07 -170.98 2.83 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.743 0.782 . . . . 0.0 110.782 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 53.54 -160.58 0.13 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.666 0.746 . . . . 0.0 110.575 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -60.79 -29.59 69.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.668 -0.645 . . . . 0.0 110.241 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 105.38 -21.87 34.05 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.71 172.84 12.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.083 -1.245 . . . . 0.0 110.616 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ASN . . . . . 0.463 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.8 m-80 -134.65 -148.9 0.33 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.585 -0.697 . . . . 0.0 109.48 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -173.73 81.25 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.228 -0.92 . . . . 0.0 110.393 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.414 ' CD1' ' C ' ' A' ' 199' ' ' PHE . 12.1 t80 -69.64 123.55 21.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.372 -0.83 . . . . 0.0 109.96 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -138.26 122.0 17.55 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.214 -0.929 . . . . 0.0 109.949 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 144.01 -145.2 14.61 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.53 112.92 19.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -1.132 . . . . 0.0 110.333 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 83.6 t -74.72 109.57 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.103 -0.998 . . . . 0.0 110.03 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 71.9 p -147.95 151.67 36.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.315 -0.865 . . . . 0.0 110.47 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 12.5 tttm -46.84 -55.14 8.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.468 -0.77 . . . . 0.0 110.928 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -54.65 -28.14 44.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.357 -0.839 . . . . 0.0 110.479 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 24.8 m-20 -86.18 -44.38 12.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 0.0 110.396 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 80.4 mt -57.28 -55.02 40.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.938 . . . . 0.0 110.695 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 8.0 mp -50.99 -50.32 58.61 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.116 -0.99 . . . . 0.0 110.653 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.01 -37.16 76.26 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.251 -0.906 . . . . 0.0 110.497 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.417 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 8.9 t80 -64.36 -60.46 3.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.145 -0.972 . . . . 0.0 110.472 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 8.9 mt -53.77 -47.37 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.337 -0.852 . . . . 0.0 110.697 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.6 mmtt -50.79 -23.21 2.57 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.235 -0.916 . . . . 0.0 110.863 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -96.69 -16.13 21.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.167 -0.958 . . . . 0.0 110.862 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 77.6 m-20 -94.66 -40.04 10.01 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.108 -0.995 . . . . 0.0 111.33 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 . . . . . 0 N--CA 1.493 1.715 0 O-C-N 120.897 -1.127 . . . . 0.0 110.662 -179.674 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.183 0.515 . . . . 0.0 110.301 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.3 t -74.66 169.23 18.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.288 -0.883 . . . . 0.0 110.093 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.4 m -101.66 121.32 41.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.262 -0.899 . . . . 0.0 110.548 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.3 mt -102.34 118.33 59.12 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.336 -0.853 . . . . 0.0 109.619 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.411 ' O ' ' ND2' ' A' ' 172' ' ' ASN . 46.1 Cg_endo -71.0 -18.34 31.27 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.453 1.239 . . . . 0.0 110.848 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 179.4 -170.03 0.12 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.088 -1.007 . . . . 0.0 111.466 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.96 -29.43 70.72 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -53.47 -29.9 38.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -1.12 . . . . 0.0 110.159 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.75 -35.17 15.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.906 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.59 -39.16 79.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.327 -0.858 . . . . 0.0 109.996 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.49 -51.11 12.38 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.249 -0.907 . . . . 0.0 110.253 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.0 m -57.27 -20.46 28.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.35 -0.844 . . . . 0.0 110.408 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.9 tp -79.15 -48.14 14.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 110.381 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.444 ' CG2' ' HB3' ' A' ' 189' ' ' PHE . 90.9 t -60.02 -31.39 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.142 -0.974 . . . . 0.0 110.38 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -85.79 -23.69 27.12 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.238 -0.913 . . . . 0.0 109.582 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.12 -63.41 1.19 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.143 -0.973 . . . . 0.0 110.12 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.4 p -115.7 -176.63 2.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.927 . . . . 0.0 110.259 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.5 -35.56 58.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.872 . . . . 0.0 110.248 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.5 t -120.86 149.29 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.247 -0.908 . . . . 0.0 110.261 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -175.27 130.45 0.29 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.316 -0.865 . . . . 0.0 109.907 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.455 HG12 ' CZ ' ' A' ' 167' ' ' PHE . 9.6 p -119.13 147.99 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.142 -0.974 . . . . 0.0 110.329 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.432 ' N ' HG21 ' A' ' 140' ' ' VAL . 3.2 mt -134.83 113.92 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.342 -0.849 . . . . 0.0 109.945 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -80.98 128.23 8.33 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 143' ' ' PHE . 32.0 m-85 -94.89 76.57 3.6 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.235 -1.156 . . . . 0.0 109.904 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -96.63 139.21 33.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 110.965 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.39 -26.89 26.16 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.425 -0.797 . . . . 0.0 109.576 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -137.96 78.39 1.68 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.51 -0.744 . . . . 0.0 109.508 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 27.3 m -50.36 -23.86 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.349 -0.844 . . . . 0.0 110.717 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -84.66 10.59 10.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 110.892 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 11.2 p -88.11 -161.65 0.75 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.963 -1.085 . . . . 0.0 110.187 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.05 -42.81 10.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.262 -0.899 . . . . 0.0 110.344 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.0 m -59.4 -28.66 67.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.158 -0.964 . . . . 0.0 110.355 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.8 -31.26 45.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.309 -0.87 . . . . 0.0 110.174 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -58.94 -25.43 63.48 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.21 -0.931 . . . . 0.0 109.96 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -75.37 -46.31 33.84 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.394 -0.816 . . . . 0.0 110.133 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -49.97 -56.56 10.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 110.476 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 64.9 mt -49.36 -52.29 29.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.42 -0.8 . . . . 0.0 110.584 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -51.82 -46.49 64.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.422 -0.799 . . . . 0.0 110.36 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.4 -39.81 74.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 110.261 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.25 -27.61 69.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 110.298 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -60.42 -47.44 86.1 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.208 -0.932 . . . . 0.0 110.38 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.76 -35.65 56.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.165 -0.959 . . . . 0.0 110.342 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.7 mm -89.8 112.26 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 109.89 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -114.0 13.9 18.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 110.446 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -124.32 17.35 9.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.086 -1.009 . . . . 0.0 110.366 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 42.2 mm -128.22 141.03 40.01 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.162 -0.961 . . . . 0.0 110.057 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -75.32 73.68 4.42 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.533 1.281 . . . . 0.0 110.409 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.455 ' CZ ' HG12 ' A' ' 140' ' ' VAL . 2.6 m-85 -66.32 132.67 48.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.23 -0.919 . . . . 0.0 110.09 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -123.99 154.08 17.59 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 16.9 tt -149.2 138.96 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -1.14 . . . . 0.0 110.283 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.3 t -159.46 157.35 29.96 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.113 0.958 . . . . 0.0 110.753 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.2 t -122.79 2.15 9.43 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.495 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 124' ' ' PRO . 60.8 t30 -57.08 123.77 16.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.135 -0.978 . . . . 0.0 110.277 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 77.2 p -49.65 -33.18 14.86 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.253 -0.905 . . . . 0.0 110.504 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -54.1 -32.61 55.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 109.887 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 41.4 t -78.83 -24.45 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -0.872 . . . . 0.0 109.861 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 176' ' ' PHE . 20.6 m-85 -86.64 -44.91 11.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -0.871 . . . . 0.0 109.891 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 5.6 m -70.83 -7.22 43.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -0.844 . . . . 0.0 110.777 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 45.7 tttp -88.09 -47.49 8.46 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.058 -1.026 . . . . 0.0 109.563 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -90.06 12.19 18.47 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.371 -0.831 . . . . 0.0 110.385 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.93 68.6 0.78 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.054 -1.028 . . . . 0.0 110.483 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 62.2 mt -116.23 103.35 10.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 110.143 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -51.57 -26.14 8.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.27 -0.894 . . . . 0.0 110.226 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -149.93 -169.0 3.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 110.023 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -63.43 162.94 11.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.202 -0.936 . . . . 0.0 110.137 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -169.18 166.73 39.93 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.421 ' O ' ' CG2' ' A' ' 186' ' ' VAL . 21.4 m -135.19 114.68 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.247 -1.149 . . . . 0.0 110.11 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.419 ' CG2' ' HA ' ' A' ' 198' ' ' ASN . 99.5 t -127.29 153.67 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.924 . . . . 0.0 110.082 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.478 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 6.1 tt -109.27 137.96 46.36 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.285 -0.884 . . . . 0.0 108.668 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.444 ' HB3' ' CG2' ' A' ' 133' ' ' VAL . 62.4 m-85 -111.28 135.87 51.2 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.726 -1.234 . . . . 0.0 111.19 -178.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.487 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -150.16 159.76 44.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.453 -0.779 . . . . 0.0 109.967 179.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -83.97 -22.18 31.51 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.242 -0.911 . . . . 0.0 110.491 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.487 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 2.4 p90 -90.7 -178.91 5.4 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.284 -0.885 . . . . 0.0 110.633 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 48.79 -159.17 0.05 Allowed 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.659 0.742 . . . . 0.0 110.509 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -60.61 -31.05 70.24 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.583 -0.698 . . . . 0.0 110.293 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 114.58 -42.74 1.85 Allowed Glycine 0 N--CA 1.483 1.822 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.09 177.95 5.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.147 -1.208 . . . . 0.0 110.462 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ASN . . . . . 0.478 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 2.5 m-80 -134.47 -37.3 0.85 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 0.0 110.55 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.419 ' HA ' ' CG2' ' A' ' 187' ' ' VAL . 4.0 m-80 57.73 83.29 0.11 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.171 -0.955 . . . . 0.0 109.991 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.406 ' HB3' ' CG2' ' A' ' 186' ' ' VAL . 84.3 t80 -66.61 115.27 6.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.396 -0.815 . . . . 0.0 110.433 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -115.6 80.16 1.4 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.368 -0.832 . . . . 0.0 110.12 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -169.12 -157.6 11.92 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -79.36 122.47 26.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -1.154 . . . . 0.0 110.305 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 70.6 t -71.87 101.36 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 110.076 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 57.9 p -150.27 152.08 33.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.388 -0.82 . . . . 0.0 110.268 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.419 ' HG2' ' CD1' ' A' ' 209' ' ' LEU . 3.9 tttm -49.49 -48.54 47.82 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.321 -0.862 . . . . 0.0 110.426 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -57.1 -39.81 75.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.342 -0.849 . . . . 0.0 110.283 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -80.03 -48.48 13.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.231 -0.918 . . . . 0.0 110.368 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 98.8 mt -54.19 -55.44 27.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.935 . . . . 0.0 110.257 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.419 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 8.2 mt -54.35 -29.88 49.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.283 -0.885 . . . . 0.0 110.221 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -76.42 -45.88 29.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.911 . . . . 0.0 110.065 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 197' ' ' ASN . 6.9 t80 -56.46 -62.79 1.48 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.411 -0.806 . . . . 0.0 110.462 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 5.8 mt -52.42 -42.56 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.0 110.593 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -56.15 -19.74 14.73 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.218 -0.926 . . . . 0.0 110.786 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -110.92 11.64 22.27 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.198 -0.939 . . . . 0.0 110.755 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.431 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 1.3 m120 -91.89 -64.41 1.12 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.946 -1.096 . . . . 0.0 110.611 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' GLN . . . . . 0.483 ' HA ' ' CZ ' ' A' ' 192' ' ' PHE . 5.9 pt20 . . . . . 0 C--N 1.303 -1.427 0 O-C-N 121.289 -0.882 . . . . 0.0 111.002 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.289 0.566 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.429 ' CG2' ' HA2' ' A' ' 168' ' ' GLY . 8.9 t -97.87 166.89 11.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.182 -0.949 . . . . 0.0 110.15 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.8 m -115.02 103.92 11.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.942 . . . . 0.0 110.346 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.3 mt -77.85 126.2 84.43 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.299 -0.876 . . . . 0.0 110.015 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.27 -40.25 2.47 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.418 1.22 . . . . 0.0 110.508 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -153.82 -170.59 3.62 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.308 -0.87 . . . . 0.0 110.813 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.02 -29.93 72.19 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -52.15 -30.36 26.29 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.157 -1.202 . . . . 0.0 110.371 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.79 -38.7 13.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.947 . . . . 0.0 110.032 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.451 ' HB3' ' HH ' ' A' ' 179' ' ' TYR . . . -54.53 -25.22 24.5 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.283 -0.885 . . . . 0.0 110.036 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -86.62 -54.49 4.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.353 -0.842 . . . . 0.0 110.115 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.07 -18.31 33.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.912 . . . . 0.0 110.291 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.3 tt -73.25 -59.35 2.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 0.0 109.747 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.429 ' CG2' ' HB3' ' A' ' 189' ' ' PHE . 49.8 t -53.01 -37.21 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.414 -0.803 . . . . 0.0 110.257 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -73.16 -25.58 60.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.274 -0.891 . . . . 0.0 110.313 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.81 -48.82 69.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 110.28 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 78.0 p -135.65 173.86 11.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.224 -0.922 . . . . 0.0 110.338 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.91 -41.22 91.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -0.862 . . . . 0.0 110.309 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 95.7 t -112.97 151.02 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.283 -0.886 . . . . 0.0 110.371 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -174.4 137.79 0.52 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.854 . . . . 0.0 109.845 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.469 HG12 ' CE2' ' A' ' 167' ' ' PHE . 9.1 p -123.38 147.09 27.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.203 -0.936 . . . . 0.0 110.302 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.47 HG23 ' CE1' ' A' ' 143' ' ' PHE . 3.4 mt -135.79 115.82 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.265 -0.897 . . . . 0.0 109.666 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -79.82 134.25 13.39 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.511 ' CE2' ' CG1' ' A' ' 175' ' ' VAL . 11.5 m-85 -103.48 71.25 1.08 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.181 -1.188 . . . . 0.0 109.615 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -91.74 137.45 32.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.026 -1.046 . . . . 0.0 110.992 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.464 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -91.19 -31.94 15.98 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 121.614 0.721 . . . . 0.0 109.846 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.464 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 1.7 t70 -89.5 -41.49 12.01 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.534 0.683 . . . . 0.0 110.166 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.432 ' CB ' ' O ' ' A' ' 146' ' ' ASP . 2.5 t 72.97 -51.08 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.859 -0.526 . . . . 0.0 110.714 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -90.72 8.87 32.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.093 -1.005 . . . . 0.0 110.551 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 19.8 p -70.34 -164.68 0.09 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.863 -1.148 . . . . 0.0 109.971 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.41 -31.18 16.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.895 . . . . 0.0 110.277 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.5 p -68.49 -25.6 65.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.906 . . . . 0.0 110.123 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.39 -34.01 25.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.9 . . . . 0.0 110.173 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -53.2 -44.77 68.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.355 -0.841 . . . . 0.0 110.4 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -66.89 -36.83 83.17 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.221 -0.925 . . . . 0.0 110.316 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -51.58 -58.22 6.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.392 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.6 mt -50.52 -54.25 23.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.4 -0.813 . . . . 0.0 110.45 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -50.88 -29.93 13.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.258 -0.901 . . . . 0.0 110.342 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -75.63 -56.47 4.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.338 -0.852 . . . . 0.0 110.006 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.404 ' CB ' ' CD2' ' A' ' 167' ' ' PHE . . . -54.86 -33.58 62.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 110.059 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -66.69 -28.7 68.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.331 -0.856 . . . . 0.0 110.226 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -64.67 -42.88 95.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.285 -0.884 . . . . 0.0 110.231 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 4.1 tt -93.12 164.42 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.254 -0.904 . . . . 0.0 110.209 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 163' ' ' ASP . 17.1 p-10 -145.23 19.2 1.57 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.101 -0.999 . . . . 0.0 110.467 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -125.57 8.82 7.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.196 -0.94 . . . . 0.0 110.652 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.463 HD11 HG22 ' A' ' 165' ' ' ILE . 45.8 mm -125.53 137.21 29.46 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.04 -1.037 . . . . 0.0 109.798 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.69 78.97 2.33 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.568 1.299 . . . . 0.0 110.724 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.469 ' CE2' HG12 ' A' ' 140' ' ' VAL . 2.9 m-85 -71.4 125.64 27.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.186 -0.946 . . . . 0.0 109.694 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.429 ' HA2' ' CG2' ' A' ' 121' ' ' THR . . . -123.33 156.15 17.59 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.134 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 14.7 tt -150.17 142.95 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.459 -1.024 . . . . 0.0 109.912 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.4 t -164.98 157.57 16.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.117 -0.989 . . . . 0.0 110.892 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 91.2 p -122.97 3.58 9.38 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.375 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -54.98 122.05 10.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.158 -0.964 . . . . 0.0 110.306 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 83.9 p -51.52 -31.85 25.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.321 -0.862 . . . . 0.0 110.477 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -54.32 -33.8 59.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.142 -0.974 . . . . 0.0 109.809 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.511 ' CG1' ' CE2' ' A' ' 143' ' ' PHE . 41.0 t -79.78 -24.46 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.44 -0.788 . . . . 0.0 109.642 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 176' ' ' PHE . 10.8 m-85 -79.44 -54.96 5.41 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.441 -0.787 . . . . 0.0 109.907 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 29.9 t -66.53 -14.27 62.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.366 -0.834 . . . . 0.0 110.562 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 11.3 tttt -82.01 -44.94 15.99 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.086 -1.009 . . . . 0.0 110.034 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.451 ' HH ' ' HB3' ' A' ' 129' ' ' ALA . 49.6 m-85 -90.7 8.08 36.25 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.15 -0.969 . . . . 0.0 110.674 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.69 67.81 0.87 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.05 -1.032 . . . . 0.0 110.676 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.434 ' CD1' ' CD2' ' A' ' 143' ' ' PHE . 3.4 mt -109.06 124.43 50.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.226 -0.921 . . . . 0.0 110.137 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -62.08 -15.83 47.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.108 -0.995 . . . . 0.0 110.012 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -175.26 -157.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.233 -0.917 . . . . 0.0 109.551 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -71.57 160.45 32.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.087 -1.008 . . . . 0.0 109.945 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -177.33 172.97 45.82 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 74.9 t -126.5 107.54 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.385 -1.068 . . . . 0.0 110.006 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.428 HG11 ' N ' ' A' ' 188' ' ' LEU . 75.0 t -111.57 148.22 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.339 -0.851 . . . . 0.0 109.94 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.466 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 6.3 tt -108.16 143.74 36.54 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.008 -1.057 . . . . 0.0 109.421 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.429 ' HB3' ' CG2' ' A' ' 133' ' ' VAL . 59.9 m-85 -115.62 118.6 33.56 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.017 -1.052 . . . . 0.0 110.874 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.445 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -130.55 164.02 25.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.279 -0.888 . . . . 0.0 109.996 179.513 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -88.86 -24.9 22.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.165 -0.959 . . . . 0.0 110.148 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.445 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 1.6 p90 -91.01 -176.17 4.55 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.46 -0.775 . . . . 0.0 110.741 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 46.22 -159.13 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.605 0.717 . . . . 0.0 110.966 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -50.9 -56.33 12.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.66 -0.65 . . . . 0.0 110.284 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 125.17 -21.71 6.43 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.4 mtm180 -143.63 156.91 44.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.132 -1.216 . . . . 0.0 110.571 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ASN . . . . . 0.466 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.1 m-80 -131.46 -167.35 1.84 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.36 -0.837 . . . . 0.0 109.84 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -156.82 80.69 0.94 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.442 -0.787 . . . . 0.0 109.892 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.471 ' CE2' HG23 ' A' ' 203' ' ' VAL . 84.7 t80 -51.3 121.87 6.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.138 -0.976 . . . . 0.0 110.484 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.03 91.72 3.49 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.344 -0.847 . . . . 0.0 110.271 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 165.34 177.41 37.71 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -55.96 107.52 0.36 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.25 -1.147 . . . . 0.0 110.237 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.471 HG23 ' CE2' ' A' ' 199' ' ' PHE . 93.1 t -64.84 113.66 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -0.879 . . . . 0.0 110.071 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 12.5 p -150.33 157.36 42.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.87 . . . . 0.0 110.475 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.424 ' HG2' ' CD1' ' A' ' 209' ' ' LEU . 11.4 tttt -50.09 -52.25 36.26 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.196 -0.94 . . . . 0.0 110.597 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . 0.431 ' HG3' ' N ' ' A' ' 207' ' ' ASN . 12.3 pt-20 -55.91 -40.04 72.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.221 -0.924 . . . . 0.0 110.329 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.431 ' N ' ' HG3' ' A' ' 206' ' ' GLU . 87.6 m-20 -78.12 -48.01 16.93 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.271 -0.893 . . . . 0.0 110.253 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 68.2 mt -53.53 -57.99 8.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.221 -0.924 . . . . 0.0 110.346 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.424 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 0.4 OUTLIER -53.54 -22.83 9.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.293 -0.88 . . . . 0.0 110.467 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -81.76 -49.62 10.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.099 -1.001 . . . . 0.0 110.093 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -58.97 -56.92 16.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.317 -0.864 . . . . 0.0 110.428 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 6.9 mt -55.22 -49.03 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.267 -0.896 . . . . 0.0 110.621 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -50.33 -27.35 6.04 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.173 -0.954 . . . . 0.0 110.598 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -88.0 -24.67 23.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -0.925 . . . . 0.0 110.412 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -89.58 -33.59 16.65 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.263 -0.898 . . . . 0.0 110.753 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 O-C-N 121.13 -0.981 . . . . 0.0 110.63 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.209 0.528 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.432 ' N ' ' O ' ' A' ' 167' ' ' PHE . 28.6 m -97.53 95.7 7.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 110.172 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 95.9 m -61.34 104.24 0.38 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -0.9 . . . . 0.0 109.88 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.98 137.1 43.5 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.124 -0.985 . . . . 0.0 110.169 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 48.9 Cg_endo -73.33 -39.62 2.0 Allowed 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.532 1.28 . . . . 0.0 110.206 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.06 -169.11 2.84 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.992 0.901 . . . . 0.0 111.085 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.4 -31.7 79.66 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -53.21 -27.14 20.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.233 -1.157 . . . . 0.0 110.119 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.428 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -88.2 -32.75 18.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.87 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.85 -41.54 78.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.349 -0.844 . . . . 0.0 109.946 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.77 -52.79 11.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.331 -0.856 . . . . 0.0 110.086 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.96 -40.31 63.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.333 -0.854 . . . . 0.0 110.099 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.443 ' CD2' HG12 ' A' ' 141' ' ' ILE . 21.3 tp -53.55 -50.72 64.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.247 -0.908 . . . . 0.0 109.961 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.428 HG23 ' CD2' ' A' ' 189' ' ' PHE . 39.9 t -53.63 -32.71 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.459 -0.775 . . . . 0.0 110.186 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -87.54 -32.11 19.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.186 -0.946 . . . . 0.0 110.377 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 59.7 p -52.0 -46.29 64.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.193 -0.942 . . . . 0.0 110.382 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.2 p -132.29 163.94 27.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.145 -0.972 . . . . 0.0 110.109 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -63.4 -43.66 96.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.902 . . . . 0.0 110.166 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 28.1 m -117.63 147.99 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.215 -0.928 . . . . 0.0 110.422 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -175.27 126.34 0.26 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.364 -0.835 . . . . 0.0 110.031 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.446 ' CG1' ' HA ' ' A' ' 167' ' ' PHE . 13.7 p -97.91 147.96 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 121.119 -0.988 . . . . 0.0 110.535 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.443 HG12 ' CD2' ' A' ' 132' ' ' LEU . 44.7 mt -141.43 107.71 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.91 . . . . 0.0 109.734 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -84.36 163.15 38.89 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 143' ' ' PHE . 26.2 m-85 -126.72 70.42 1.27 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.632 -0.923 . . . . 0.0 109.647 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -97.21 146.02 25.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 111.071 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.61 -28.22 18.57 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.145 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.89 84.17 1.94 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -0.833 . . . . 0.0 109.94 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.9 t -66.89 -12.45 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.345 -0.847 . . . . 0.0 110.8 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -99.07 4.03 46.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.009 -1.057 . . . . 0.0 110.805 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 38.7 p -85.97 -159.52 0.47 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.824 -1.173 . . . . 0.0 110.27 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -88.82 -35.34 16.66 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.232 -0.918 . . . . 0.0 110.135 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.1 t -54.89 -33.24 61.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.34 -0.85 . . . . 0.0 110.226 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.49 -33.51 28.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.917 . . . . 0.0 110.203 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -53.46 -50.48 65.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.879 . . . . 0.0 110.128 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -57.34 -41.96 81.02 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.369 -0.832 . . . . 0.0 110.124 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -52.22 -57.31 10.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 110.1 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.65 -55.13 24.68 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.42 -0.8 . . . . 0.0 110.207 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -47.64 -48.58 28.7 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.414 -0.804 . . . . 0.0 110.551 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.418 ' N ' ' HG3' ' A' ' 205' ' ' LYS . . . -64.84 -43.6 92.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 109.766 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.05 -35.28 74.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.372 -0.83 . . . . 0.0 109.862 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -68.16 -29.09 67.89 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.319 -0.863 . . . . 0.0 110.301 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.32 -61.61 2.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.197 -0.939 . . . . 0.0 110.171 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.437 HG22 HD11 ' A' ' 162' ' ' ILE . 73.6 mt -89.67 149.28 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.928 . . . . 0.0 109.95 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.47 -31.06 4.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.205 -0.934 . . . . 0.0 110.375 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -68.74 -14.51 63.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.22 -0.925 . . . . 0.0 110.698 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.531 ' CG2' ' CE1' ' A' ' 167' ' ' PHE . 37.1 mm -98.46 123.98 48.31 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.08 -1.013 . . . . 0.0 110.263 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -83.38 107.6 1.44 Allowed 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.471 1.248 . . . . 0.0 110.064 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.531 ' CE1' ' CG2' ' A' ' 165' ' ' ILE . 0.4 OUTLIER -99.25 154.46 18.15 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.12 -0.988 . . . . 0.0 109.969 -179.489 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -137.71 145.03 16.57 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 16.8 tt -143.27 126.31 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.269 -1.136 . . . . 0.0 110.231 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.8 t -143.77 157.96 44.01 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.146 0.974 . . . . 0.0 111.131 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.7 t -127.09 5.37 6.46 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.181 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.405 ' ND2' ' HB2' ' A' ' 174' ' ' ASP . 43.4 t30 -62.0 128.32 35.58 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.182 -0.949 . . . . 0.0 110.231 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 9.0 t -52.23 -33.88 43.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.187 -0.946 . . . . 0.0 110.323 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.405 ' HB2' ' ND2' ' A' ' 172' ' ' ASN . 0.3 OUTLIER -54.67 -34.23 61.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.949 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 57.3 t -78.35 -27.19 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.537 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.401 ' N ' ' CD1' ' A' ' 176' ' ' PHE . 12.5 m-85 -81.54 -42.45 20.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.424 -0.798 . . . . 0.0 109.805 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.03 -7.47 46.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.343 -0.848 . . . . 0.0 110.629 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.86 -45.11 9.98 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.901 -1.124 . . . . 0.0 109.304 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -89.59 5.07 47.25 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.742 -0.599 . . . . 0.0 110.555 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.42 ' CG ' ' O ' ' A' ' 180' ' ' GLN . 0.0 OUTLIER 51.81 58.81 5.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.1 -1.0 . . . . 0.0 110.722 179.587 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.4 mt -98.66 130.35 45.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.063 -1.023 . . . . 0.0 109.824 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -87.06 12.22 11.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.1 -1.0 . . . . 0.0 110.295 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 13.8 pttp 179.13 -163.34 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.227 -0.921 . . . . 0.0 109.618 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -87.47 156.63 19.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.287 -0.883 . . . . 0.0 110.133 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -177.54 152.09 11.58 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.434 HG12 ' CD2' ' A' ' 208' ' ' LEU . 88.2 t -103.65 128.4 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.317 -1.108 . . . . 0.0 110.468 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.412 HG11 ' N ' ' A' ' 188' ' ' LEU . 83.1 t -134.56 151.48 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.363 -0.836 . . . . 0.0 109.655 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.461 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 7.8 tt -113.21 158.67 20.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.996 -1.065 . . . . 0.0 109.915 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.428 ' CD2' HG23 ' A' ' 133' ' ' VAL . 52.6 m-85 -128.67 130.03 46.63 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.078 -1.014 . . . . 0.0 110.459 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.21 166.61 23.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.877 . . . . 0.0 110.069 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.01 -33.73 18.27 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.199 -0.938 . . . . 0.0 110.128 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -90.91 -173.4 3.68 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.443 -0.786 . . . . 0.0 110.647 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 51.95 -159.73 0.11 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.434 -0.792 . . . . 0.0 110.458 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -54.93 -54.17 46.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.634 -0.666 . . . . 0.0 110.271 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 128.65 -38.49 2.04 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.18 165.31 21.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -1.166 . . . . 0.0 110.359 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ASN . . . . . 0.461 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.8 m-80 -128.72 -151.31 0.47 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.3 -0.875 . . . . 0.0 109.865 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -174.37 78.37 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.279 -0.888 . . . . 0.0 110.381 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.417 ' CB ' ' O ' ' A' ' 186' ' ' VAL . 28.3 t80 -57.95 118.7 5.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 109.838 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -125.53 38.8 4.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.302 -0.874 . . . . 0.0 110.413 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -128.83 -149.24 6.86 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -90.71 97.38 11.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.149 -1.206 . . . . 0.0 109.928 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.409 ' O ' ' CG1' ' A' ' 203' ' ' VAL . 7.4 p -51.33 102.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.212 -0.93 . . . . 0.0 110.373 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 26.2 p -140.93 150.59 43.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.357 -0.84 . . . . 0.0 110.323 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.418 ' HG3' ' N ' ' A' ' 158' ' ' ALA . 3.7 tttp -47.21 -31.31 3.56 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.359 -0.838 . . . . 0.0 110.946 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -79.42 -33.06 42.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.178 -0.951 . . . . 0.0 110.316 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 59.9 m-20 -83.57 -47.06 11.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 110.289 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.434 ' CD2' HG12 ' A' ' 186' ' ' VAL . 65.6 mt -52.87 -48.65 66.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 110.33 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 13.6 mt -59.26 -29.13 67.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 110.095 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.47 -34.42 41.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 0.0 110.144 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.412 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 7.1 t80 -62.88 -62.98 1.35 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.306 -0.871 . . . . 0.0 110.192 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 7.0 mt -51.03 -49.75 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.391 -0.818 . . . . 0.0 110.473 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -48.7 -25.08 1.62 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.364 -0.835 . . . . 0.0 110.868 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.75 -14.77 21.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.125 -0.984 . . . . 0.0 110.815 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.412 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 73.4 m-80 -102.27 -24.29 13.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.078 -1.014 . . . . 0.0 110.767 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.066 -1.021 . . . . 0.0 110.736 179.895 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.33 0.586 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 167' ' ' PHE . 3.9 m -119.92 112.69 19.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.348 -0.845 . . . . 0.0 109.729 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.5 m -68.57 144.04 54.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 110.047 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 20.5 mt -125.3 143.98 46.17 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.0 110.106 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.06 -40.33 2.58 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.705 1.371 . . . . 0.0 110.293 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.415 ' OD1' ' CB ' ' A' ' 127' ' ' ALA . 0.2 OUTLIER -170.5 -169.93 0.87 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.346 -0.846 . . . . 0.0 110.636 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -54.74 -27.77 44.35 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.415 ' CB ' ' OD1' ' A' ' 125' ' ' ASP . . . -52.88 -31.51 39.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.194 -1.18 . . . . 0.0 110.434 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.77 -37.5 14.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.177 -0.952 . . . . 0.0 109.912 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.0 -33.19 68.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.332 -0.855 . . . . 0.0 110.004 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -74.28 -51.2 15.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.06 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.14 -30.71 71.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.307 -0.871 . . . . 0.0 110.07 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.1 tp -59.74 -48.68 80.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.207 -0.933 . . . . 0.0 109.961 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.5 t -56.05 -52.13 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 110.07 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -65.59 -20.21 66.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.234 -0.916 . . . . 0.0 110.243 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.2 t -52.49 -51.43 59.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.146 -0.971 . . . . 0.0 110.351 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 53.7 p -137.31 -171.88 3.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.252 -0.905 . . . . 0.0 110.313 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -75.57 -39.74 57.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -0.878 . . . . 0.0 110.169 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 87.1 t -119.43 147.29 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.25 -0.906 . . . . 0.0 110.175 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.408 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -170.89 121.94 0.57 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.201 -0.937 . . . . 0.0 110.203 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.442 ' CG1' ' HA ' ' A' ' 167' ' ' PHE . 14.8 p -104.41 148.78 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.311 -0.868 . . . . 0.0 110.361 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.491 HG23 ' CE1' ' A' ' 143' ' ' PHE . 51.1 mt -133.79 107.71 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.258 -0.902 . . . . 0.0 109.992 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.49 122.81 6.91 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.491 ' CE1' HG23 ' A' ' 141' ' ' ILE . 93.0 m-85 -101.63 67.48 1.12 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.273 -1.134 . . . . 0.0 109.961 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -95.48 146.34 24.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.091 -1.006 . . . . 0.0 110.418 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.449 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -91.08 -32.5 15.85 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.586 -0.696 . . . . 0.0 109.585 179.083 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.449 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 88.5 m-20 -122.32 69.7 0.97 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.517 -0.739 . . . . 0.0 109.862 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.445 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 26.4 m -53.8 -21.31 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.206 -0.934 . . . . 0.0 110.51 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -79.74 4.32 16.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.09 -1.006 . . . . 0.0 111.008 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 32.9 p -87.34 -163.72 0.97 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.904 -1.122 . . . . 0.0 110.284 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.87 -40.83 12.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.0 110.103 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.83 -28.99 59.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.187 -0.946 . . . . 0.0 109.807 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.445 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -79.68 -35.26 39.44 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.332 -0.855 . . . . 0.0 109.849 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -51.32 -44.99 62.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.277 -0.89 . . . . 0.0 110.192 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -54.7 -47.36 73.78 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.156 -0.965 . . . . 0.0 109.514 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -52.48 -56.44 15.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 0.0 109.831 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.426 ' CD1' ' O ' ' A' ' 152' ' ' ALA . 2.6 mp -51.44 -58.27 6.71 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.362 -0.836 . . . . 0.0 110.095 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -49.61 -41.79 43.12 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.343 -0.848 . . . . 0.0 110.313 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.61 -26.88 60.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.995 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.2 -29.03 42.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 0.0 110.067 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -63.4 -37.82 88.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 110.111 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.97 -29.82 69.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.358 -0.838 . . . . 0.0 109.961 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.441 ' CG2' ' HB ' ' A' ' 165' ' ' ILE . 18.2 mm -90.1 122.48 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.423 -0.798 . . . . 0.0 109.634 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -123.88 2.07 8.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.243 -0.91 . . . . 0.0 110.727 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -109.36 -19.85 13.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.952 -1.092 . . . . 0.0 110.252 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.452 ' CG2' ' HD2' ' A' ' 166' ' ' PRO . 41.4 mm -91.4 146.1 32.69 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.146 -0.971 . . . . 0.0 110.182 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.452 ' HD2' ' CG2' ' A' ' 165' ' ' ILE . 44.9 Cg_endo -84.25 79.26 2.64 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.807 1.425 . . . . 0.0 110.089 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.442 ' HA ' ' CG1' ' A' ' 140' ' ' VAL . 3.6 m-85 -71.92 126.94 31.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.406 -0.809 . . . . 0.0 110.589 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.404 ' HA2' ' HB ' ' A' ' 121' ' ' THR . . . -118.69 157.24 15.33 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 6.3 tt -150.42 141.96 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.255 -1.144 . . . . 0.0 110.618 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.2 t -158.25 155.52 29.07 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.004 0.907 . . . . 0.0 110.463 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 78.8 p -127.47 7.83 6.41 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.38 179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -67.39 119.84 12.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.073 -1.017 . . . . 0.0 110.383 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.5 p -49.02 -28.17 3.76 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.211 -0.93 . . . . 0.0 110.535 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -54.8 -41.09 70.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.115 -0.991 . . . . 0.0 109.734 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 45.1 t -78.77 -23.68 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.381 -0.824 . . . . 0.0 109.691 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -72.43 -51.81 18.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.394 -0.816 . . . . 0.0 109.531 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 33.9 t -70.58 -17.06 62.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.482 -0.761 . . . . 0.0 110.366 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 23.9 tttm -73.52 -52.43 13.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.137 -0.977 . . . . 0.0 109.96 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -90.53 22.55 3.4 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.221 -0.924 . . . . 0.0 110.53 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 54.56 56.96 6.19 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.129 -0.982 . . . . 0.0 110.176 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 86.1 mt -113.13 96.63 6.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 110.181 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -63.18 -19.15 64.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.291 -0.881 . . . . 0.0 110.427 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.51 -159.74 1.05 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.194 -0.941 . . . . 0.0 110.152 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -53.52 152.31 5.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.182 -0.949 . . . . 0.0 109.896 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -153.4 136.74 5.44 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.59 -1.29 . . . . 0.0 110.008 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 59.0 t -121.53 84.43 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.367 -1.079 . . . . 0.0 109.479 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.424 ' CG2' ' HA ' ' A' ' 198' ' ' ASN . 98.2 t -111.55 150.11 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.111 -0.993 . . . . 0.0 110.352 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.466 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 6.0 tt -106.55 150.88 25.7 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.182 -0.949 . . . . 0.0 108.833 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -120.64 116.58 25.6 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.863 -1.148 . . . . 0.0 110.438 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.511 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -124.6 170.62 10.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.0 110.153 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.26 -24.12 19.1 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.316 -0.865 . . . . 0.0 110.339 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.511 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.4 OUTLIER -91.25 -171.71 3.05 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.881 179.666 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 47.23 -154.67 0.06 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.699 0.761 . . . . 0.0 110.502 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.45 -44.45 91.1 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.619 -0.675 . . . . 0.0 110.191 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 131.19 -39.88 1.72 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -116.65 175.55 5.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.16 -1.2 . . . . 0.0 110.248 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ASN . . . . . 0.466 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 2.7 m-80 -134.93 -44.99 0.72 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.271 -0.893 . . . . 0.0 110.952 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.424 ' HA ' ' CG2' ' A' ' 187' ' ' VAL . 0.9 OUTLIER 65.46 89.04 0.1 Allowed 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.27 -0.894 . . . . 0.0 110.196 -179.251 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.401 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 45.5 t80 -56.62 123.79 16.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.464 -0.772 . . . . 0.0 110.501 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -120.65 101.37 7.69 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.212 -0.93 . . . . 0.0 110.269 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 152.99 -159.32 28.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -81.51 118.66 22.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -1.1 . . . . 0.0 110.357 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 78.2 t -68.07 103.5 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.93 . . . . 0.0 110.056 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 14.0 p -138.68 149.03 44.69 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.444 -0.785 . . . . 0.0 109.858 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -51.05 -39.19 55.37 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.223 -0.923 . . . . 0.0 110.321 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . 0.412 ' CG ' ' N ' ' A' ' 207' ' ' ASN . 11.5 pt-20 -66.11 -40.32 90.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.295 -0.878 . . . . 0.0 110.001 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.412 ' N ' ' CG ' ' A' ' 206' ' ' GLU . 79.3 m-20 -78.33 -30.83 48.38 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.384 -0.822 . . . . 0.0 109.923 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 64.0 mt -65.5 -55.84 15.62 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.459 -0.776 . . . . 0.0 110.272 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 5.9 mt -56.03 -25.65 45.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 110.289 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -80.49 -48.58 12.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.324 -0.86 . . . . 0.0 110.029 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.421 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 10.8 t80 -51.55 -57.67 8.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.341 -0.849 . . . . 0.0 110.468 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.408 ' N ' HD11 ' A' ' 212' ' ' ILE . 6.9 mm -53.32 -52.37 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.329 -0.857 . . . . 0.0 110.133 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.404 ' HA ' ' NE2' ' A' ' 216' ' ' GLN . 3.7 tmtt? -52.99 -31.51 41.29 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.624 -0.673 . . . . 0.0 110.586 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -77.44 -15.6 59.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.884 . . . . 0.0 110.702 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.421 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 74.3 m-20 -105.8 -40.31 5.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.119 -0.988 . . . . 0.0 110.55 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' GLN . . . . . 0.404 ' NE2' ' HA ' ' A' ' 213' ' ' LYS . 10.2 pt20 . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.095 -1.003 . . . . 0.0 110.133 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.289 0.566 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.8 m -104.91 116.82 32.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.291 -0.88 . . . . 0.0 109.833 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.6 m -78.86 118.49 20.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.302 -0.874 . . . . 0.0 110.221 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.433 HD21 ' CB ' ' A' ' 128' ' ' ALA . 0.9 OUTLIER -101.84 128.8 27.93 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.171 -0.956 . . . . 0.0 110.027 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 47.7 Cg_endo -73.22 -27.87 13.18 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.447 1.235 . . . . 0.0 110.107 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.93 -170.49 1.97 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.063 0.935 . . . . 0.0 111.077 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.405 ' HA3' ' CE ' ' A' ' 178' ' ' LYS . . . -64.53 -25.93 70.49 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.401 ' O ' ' HG2' ' A' ' 130' ' ' GLU . . . -58.72 -30.56 67.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.298 -1.119 . . . . 0.0 110.183 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.433 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -84.45 -20.92 30.98 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.004 -1.06 . . . . 0.0 109.625 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.36 -23.98 37.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.426 -0.796 . . . . 0.0 110.266 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 127' ' ' ALA . 13.9 pt-20 -84.78 -36.47 21.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.94 . . . . 0.0 110.171 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 135' ' ' SER . 0.6 OUTLIER -77.57 -32.45 53.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.334 -0.854 . . . . 0.0 110.552 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.427 HD21 ' CG1' ' A' ' 141' ' ' ILE . 6.3 tp -59.05 -52.97 63.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.058 -1.026 . . . . 0.0 110.045 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.456 ' CG2' ' CB ' ' A' ' 189' ' ' PHE . 87.9 t -55.49 -37.04 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 110.085 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -83.93 -22.04 31.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.391 -0.818 . . . . 0.0 110.192 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 131' ' ' SER . 0.7 OUTLIER -66.29 -54.34 25.99 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.376 -0.828 . . . . 0.0 110.199 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.9 p -115.77 157.9 23.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -0.91 . . . . 0.0 110.259 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -59.47 -45.75 90.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.169 -0.957 . . . . 0.0 110.196 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.5 t -119.71 123.77 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 110.262 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -152.2 120.24 6.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 109.599 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.436 ' CG1' ' HA ' ' A' ' 167' ' ' PHE . 11.6 p -98.51 143.05 13.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.093 -1.005 . . . . 0.0 110.664 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.427 ' CG1' HD21 ' A' ' 132' ' ' LEU . 77.2 mt -133.84 115.13 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.463 -0.773 . . . . 0.0 109.446 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -82.97 163.45 41.72 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.132 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 143' ' ' PHE . 30.3 m-85 -127.7 63.18 1.38 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.723 -0.869 . . . . 0.0 109.421 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.522 ' CE1' ' CB ' ' A' ' 151' ' ' SER . 12.4 m-85 -81.34 133.3 35.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 111.311 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.96 -26.69 43.47 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.729 0.776 . . . . 0.0 109.582 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.45 98.79 5.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.73 -0.606 . . . . 0.0 109.624 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.4 t -63.67 -12.82 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.0 110.903 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -103.01 14.83 31.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.968 -1.083 . . . . 0.0 110.776 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 21.9 p -83.29 -164.89 0.96 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.054 -1.029 . . . . 0.0 110.165 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -90.33 -18.2 25.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 110.317 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.522 ' CB ' ' CE1' ' A' ' 144' ' ' PHE . 6.1 m -83.36 -26.13 30.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 110.326 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.63 -32.75 36.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -0.915 . . . . 0.0 110.089 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.83 -49.85 75.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 109.993 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -57.69 -41.66 82.09 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.37 -0.831 . . . . 0.0 110.278 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -50.68 -55.68 15.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.181 -0.949 . . . . 0.0 110.523 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 16.4 mt -51.01 -55.85 15.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.167 -0.958 . . . . 0.0 110.427 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -53.09 -49.24 66.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.26 -0.9 . . . . 0.0 110.007 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.87 -48.11 80.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 109.977 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.466 ' HB3' ' CD2' ' A' ' 167' ' ' PHE . . . -63.66 -27.09 68.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 110.011 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -75.15 -27.37 59.69 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.367 -0.833 . . . . 0.0 110.297 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.87 -47.84 73.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.902 . . . . 0.0 110.254 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.428 HG23 HD11 ' A' ' 162' ' ' ILE . 68.4 mt -98.38 150.25 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -0.899 . . . . 0.0 110.133 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -125.0 -12.57 6.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.253 -0.904 . . . . 0.0 111.105 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -86.99 5.81 35.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.861 -1.149 . . . . 0.0 110.843 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.536 ' CG2' ' CE1' ' A' ' 167' ' ' PHE . 32.6 mm -128.31 126.04 23.47 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.857 -1.152 . . . . 0.0 110.186 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -81.32 110.65 2.27 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.428 1.225 . . . . 0.0 110.585 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.536 ' CE1' ' CG2' ' A' ' 165' ' ' ILE . 1.1 m-85 -102.63 126.49 49.73 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.218 -0.926 . . . . 0.0 109.49 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -106.85 155.52 16.4 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 9.5 tt -149.49 133.04 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.374 -1.074 . . . . 0.0 110.378 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.6 t -152.82 157.24 40.47 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 122.003 0.906 . . . . 0.0 110.889 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.6 t -125.51 2.68 7.64 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -64.42 129.21 39.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 0.0 110.3 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.4 m -53.42 -28.06 27.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.301 -0.875 . . . . 0.0 110.225 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -54.89 -39.96 69.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.887 . . . . 0.0 110.024 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 34.0 t -77.15 -24.92 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.81 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -77.54 -49.69 14.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.201 -0.937 . . . . 0.0 109.942 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.88 -34.21 40.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.278 -0.889 . . . . 0.0 110.023 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.405 ' CE ' ' HA3' ' A' ' 126' ' ' GLY . 0.2 OUTLIER -55.34 -55.68 28.71 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.359 -0.838 . . . . 0.0 110.202 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -92.88 6.84 46.28 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.15 -0.969 . . . . 0.0 110.629 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 49.59 65.24 1.46 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.02 -1.05 . . . . 0.0 110.495 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 92.6 mt -101.84 124.33 47.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.263 -0.898 . . . . 0.0 110.282 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.68 0.13 31.64 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.2 -0.937 . . . . 0.0 110.665 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -171.09 -174.67 1.54 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.094 -1.004 . . . . 0.0 109.827 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 21.4 p30 -54.61 156.95 3.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.17 -0.956 . . . . 0.0 110.247 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -172.94 118.78 0.73 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 96.4 t -95.18 128.99 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -1.154 . . . . 0.0 110.152 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 98.7 t -138.06 149.28 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 110.148 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.49 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 9.3 tt -109.75 139.25 45.03 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.105 -0.997 . . . . 0.0 108.437 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.456 ' CB ' ' CG2' ' A' ' 133' ' ' VAL . 50.7 m-85 -112.66 126.18 55.1 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.768 -1.207 . . . . 0.0 110.866 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.9 166.1 23.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.338 -0.851 . . . . 0.0 110.211 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -89.29 -31.4 17.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.913 . . . . 0.0 110.422 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -90.56 -173.32 3.72 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.443 -0.786 . . . . 0.0 110.729 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 51.93 -159.43 0.11 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.431 -0.793 . . . . 0.0 110.456 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.06 -48.9 78.17 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.633 -0.667 . . . . 0.0 110.238 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 136.58 -58.94 0.65 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 17.6 mtm-85 -108.7 175.21 5.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.183 -1.187 . . . . 0.0 110.329 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ASN . . . . . 0.49 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.8 m-80 -132.49 -34.7 1.18 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.263 -0.898 . . . . 0.0 110.996 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.89 87.81 0.09 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.162 -0.961 . . . . 0.0 110.021 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.467 ' HA ' ' CE1' ' A' ' 211' ' ' PHE . 28.6 t80 -57.83 124.11 18.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.379 -0.826 . . . . 0.0 110.265 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -118.15 103.37 9.8 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.318 -0.864 . . . . 0.0 110.337 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 147.52 -148.72 20.54 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -97.66 123.74 41.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -1.147 . . . . 0.0 110.129 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 79.2 t -70.6 113.65 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.182 -0.949 . . . . 0.0 110.261 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.3 p -145.88 152.43 39.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.43 -0.794 . . . . 0.0 109.932 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 20.2 tttm -48.42 -43.5 34.3 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.118 -0.989 . . . . 0.0 110.509 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -64.95 -41.86 95.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.326 -0.859 . . . . 0.0 109.805 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -71.2 -45.55 63.14 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.344 -0.848 . . . . 0.0 109.953 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 62.0 mt -53.92 -51.16 64.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.936 . . . . 0.0 109.778 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 69.6 mt -56.58 -31.27 64.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.314 -0.866 . . . . 0.0 109.349 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -76.88 -37.34 55.67 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.428 -0.795 . . . . 0.0 109.524 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.476 ' CZ ' ' HB2' ' A' ' 197' ' ' ASN . 5.9 t80 -54.22 -63.38 1.17 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.397 -0.815 . . . . 0.0 109.893 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 94.8 mt -48.91 -57.64 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.231 -0.918 . . . . 0.0 110.292 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.07 -34.5 56.81 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.331 -0.855 . . . . 0.0 110.243 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -89.64 -7.56 54.43 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.35 -0.844 . . . . 0.0 110.695 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 0.9 OUTLIER -88.48 -79.68 0.3 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.083 -1.011 . . . . 0.0 110.429 -179.325 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.207 -0.933 . . . . 0.0 110.188 -179.848 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.252 0.548 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.9 t -101.15 166.15 10.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.161 -0.962 . . . . 0.0 110.442 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.3 m -107.06 105.49 15.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.322 -0.861 . . . . 0.0 110.074 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.1 mt -77.67 134.41 65.42 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.213 -0.93 . . . . 0.0 110.096 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.436 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 47.5 Cg_endo -72.85 -32.31 9.22 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 123.52 1.274 . . . . 0.0 110.331 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -168.25 -170.77 1.35 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.255 -0.903 . . . . 0.0 110.805 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.32 -27.95 68.49 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -55.57 -29.24 58.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -1.123 . . . . 0.0 110.382 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.436 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -86.08 -30.86 22.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.146 -0.971 . . . . 0.0 110.178 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.04 -24.36 66.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.041 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -88.59 -38.11 15.13 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.258 -0.901 . . . . 0.0 110.168 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.0 m -72.67 -24.57 61.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.175 -0.953 . . . . 0.0 109.979 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.4 tp -70.44 -47.02 62.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.412 -0.805 . . . . 0.0 110.096 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 69.1 t -62.5 -45.0 99.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.374 -0.829 . . . . 0.0 110.294 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -72.84 -19.69 61.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.938 . . . . 0.0 110.237 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.5 m -72.66 -20.81 61.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.148 -0.97 . . . . 0.0 110.36 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 80.0 p -149.42 154.92 39.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.254 -0.904 . . . . 0.0 110.361 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -57.44 -35.8 70.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.335 -0.853 . . . . 0.0 110.171 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.7 t -132.03 145.64 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.294 -0.879 . . . . 0.0 110.437 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.435 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -165.56 136.96 3.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.355 -0.841 . . . . 0.0 109.808 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.8 p -116.03 139.84 40.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 O-C-N 121.087 -1.008 . . . . 0.0 110.223 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 27.2 mt -128.4 110.26 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.315 -0.866 . . . . 0.0 109.87 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.55 127.64 8.22 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.486 ' CE2' HG11 ' A' ' 175' ' ' VAL . 50.3 m-85 -95.45 79.5 3.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.285 -1.127 . . . . 0.0 109.849 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -100.73 141.53 33.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.088 -1.008 . . . . 0.0 111.097 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.467 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 21.4 pttt -91.11 -36.41 14.01 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.602 0.715 . . . . 0.0 109.261 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.467 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 0.4 OUTLIER -122.34 70.77 0.99 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.024 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.0 p -52.22 -20.94 2.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.71 -0.619 . . . . 0.0 111.16 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -76.63 1.33 17.23 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.966 -1.084 . . . . 0.0 110.86 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 51.5 p -86.27 -156.92 0.32 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.879 -1.138 . . . . 0.0 110.381 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -90.45 -46.63 8.23 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.317 -0.864 . . . . 0.0 110.794 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.4 t -46.08 -33.27 3.36 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.38 -0.825 . . . . 0.0 111.065 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.79 -38.1 29.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.136 -0.977 . . . . 0.0 109.837 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.3 -51.3 59.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.0 109.911 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -52.9 -41.44 64.39 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.291 -0.88 . . . . 0.0 110.005 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -53.95 -57.19 11.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.402 -0.811 . . . . 0.0 109.918 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 15.2 mt -53.73 -53.95 44.92 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.502 -0.749 . . . . 0.0 110.365 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -54.52 -33.1 59.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.356 -0.84 . . . . 0.0 110.16 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -78.14 -35.62 48.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 110.148 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.95 -31.04 64.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.203 -0.936 . . . . 0.0 110.156 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -66.02 -20.97 66.36 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.192 -0.943 . . . . 0.0 110.285 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -79.63 -35.98 38.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.216 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 14.8 tt -97.51 154.96 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 110.119 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -142.28 21.92 2.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.184 -0.947 . . . . 0.0 110.493 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -120.92 12.91 11.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.182 -0.949 . . . . 0.0 110.629 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 49.7 mm -136.2 134.24 20.01 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.012 . . . . 0.0 110.267 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.435 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 48.8 Cg_endo -74.22 98.62 1.11 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.445 1.234 . . . . 0.0 110.371 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -85.94 127.58 34.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 110.316 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -128.79 154.2 20.05 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 11.6 tt -150.26 149.93 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.154 -1.204 . . . . 0.0 110.595 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.432 ' CG2' HG13 ' A' ' 175' ' ' VAL . 2.1 t -161.06 156.99 25.41 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.069 0.938 . . . . 0.0 110.527 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.4 p -124.12 3.98 8.59 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -63.32 131.69 49.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 110.418 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 92.7 p -53.76 -31.46 48.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.211 -0.93 . . . . 0.0 110.189 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -53.48 -32.05 48.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.968 . . . . 0.0 109.848 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.486 HG11 ' CE2' ' A' ' 143' ' ' PHE . 60.0 t -82.61 -25.38 8.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.385 -0.822 . . . . 0.0 109.51 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -76.87 -52.52 9.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.421 -0.799 . . . . 0.0 109.717 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.23 -15.87 58.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.383 -0.823 . . . . 0.0 110.559 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.429 ' HG2' ' CD1' ' A' ' 179' ' ' TYR . 16.4 tttp -79.21 -52.51 8.06 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.04 -1.038 . . . . 0.0 110.09 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.429 ' CD1' ' HG2' ' A' ' 178' ' ' LYS . 81.4 m-85 -92.2 4.51 53.08 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.201 -0.937 . . . . 0.0 110.578 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.26 64.42 1.79 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.055 -1.028 . . . . 0.0 111.025 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.421 ' CD1' ' HB2' ' A' ' 179' ' ' TYR . 4.5 mt -115.6 115.19 26.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.152 -0.967 . . . . 0.0 109.81 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.429 ' O ' ' CG ' ' A' ' 183' ' ' LYS . 0.7 OUTLIER -83.48 7.77 15.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.135 -0.978 . . . . 0.0 110.501 179.716 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 182' ' ' ASP . 25.2 mttt -162.73 -163.91 0.94 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.065 -1.022 . . . . 0.0 109.658 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -73.96 147.46 43.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.147 -0.971 . . . . 0.0 109.684 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -157.71 134.64 4.0 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 70.9 t -113.68 102.03 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.379 -1.071 . . . . 0.0 109.914 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 98.8 t -110.69 146.28 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.382 -0.823 . . . . 0.0 110.179 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.479 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 9.0 tt -109.91 127.9 55.02 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.158 -0.963 . . . . 0.0 108.53 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.41 ' N ' ' CD1' ' A' ' 189' ' ' PHE . 30.1 m-85 -100.43 120.43 39.97 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.832 -1.168 . . . . 0.0 111.179 -178.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.496 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -131.91 158.78 40.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.474 -0.766 . . . . 0.0 110.122 179.483 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -82.81 -24.9 33.15 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.217 -0.927 . . . . 0.0 110.259 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.496 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 1.3 p90 -91.69 -171.82 3.02 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.328 -0.858 . . . . 0.0 110.555 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 50.94 -159.1 0.09 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.616 0.722 . . . . 0.0 110.432 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -65.61 -45.52 82.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.655 -0.653 . . . . 0.0 110.222 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 142.09 -62.94 0.52 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -110.48 171.64 7.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.293 -1.122 . . . . 0.0 110.331 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ASN . . . . . 0.479 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 2.7 m-80 -127.71 -34.61 2.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.266 -0.896 . . . . 0.0 110.75 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 58.11 83.93 0.11 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.203 -0.936 . . . . 0.0 110.091 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.43 ' CD1' ' C ' ' A' ' 199' ' ' PHE . 12.1 t80 -56.78 121.31 9.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.343 -0.848 . . . . 0.0 110.21 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -118.14 100.24 7.4 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.231 -0.918 . . . . 0.0 110.345 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 160.27 -155.95 27.15 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.16 111.6 21.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.294 -1.121 . . . . 0.0 110.074 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 75.7 t -63.82 109.05 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.938 . . . . 0.0 110.336 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 41.2 p -146.87 152.3 38.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.435 -0.79 . . . . 0.0 110.008 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -46.85 -54.97 8.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.398 -0.814 . . . . 0.0 111.043 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 207' ' ' ASN . 17.0 pt-20 -55.1 -40.79 70.84 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.453 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.426 ' N ' ' HG3' ' A' ' 206' ' ' GLU . 72.8 m-20 -73.82 -49.26 26.04 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.226 -0.921 . . . . 0.0 110.12 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 90.5 mt -56.33 -55.0 38.89 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.302 -0.874 . . . . 0.0 110.285 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 15.5 mt -53.29 -24.66 12.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 0.0 110.077 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.99 -43.82 13.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.87 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.422 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 11.9 t80 -56.96 -56.7 18.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.333 -0.854 . . . . 0.0 110.418 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 8.0 mm -51.6 -39.29 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.24 -0.912 . . . . 0.0 110.091 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -61.86 -41.41 97.8 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.628 -0.67 . . . . 0.0 110.283 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -78.64 -6.64 56.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 110.699 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 2.2 m-80 -89.27 -79.62 0.32 Allowed 'General case' 0 N--CA 1.484 1.265 0 O-C-N 120.914 -1.116 . . . . 0.0 110.583 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 110.36 -179.793 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.261 0.553 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.0 t -94.21 164.78 12.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.241 -0.912 . . . . 0.0 110.166 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.2 m -104.63 106.43 16.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.237 -0.915 . . . . 0.0 110.108 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 26.4 mt -73.16 124.28 90.44 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.197 -0.939 . . . . 0.0 110.104 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.407 ' HD2' ' HB1' ' A' ' 128' ' ' ALA . 45.6 Cg_endo -70.75 -22.61 27.32 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 123.393 1.207 . . . . 0.0 110.343 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.71 -171.13 0.17 Allowed 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 122.239 1.019 . . . . 0.0 111.479 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.23 -31.88 74.84 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -52.3 -31.85 34.84 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.336 -1.096 . . . . 0.0 110.299 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.407 ' HB1' ' HD2' ' A' ' 124' ' ' PRO . . . -83.39 -38.02 22.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.901 . . . . 0.0 110.227 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -52.14 -32.69 36.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.228 -0.92 . . . . 0.0 110.094 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -90.24 -46.66 8.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.357 -0.84 . . . . 0.0 110.016 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 10.1 t -64.19 -27.05 68.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.279 -0.888 . . . . 0.0 110.151 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.434 ' CD2' ' HB3' ' A' ' 139' ' ' ALA . 6.6 tt -70.53 -60.32 2.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.281 -0.887 . . . . 0.0 109.507 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.438 ' CG2' ' HB3' ' A' ' 189' ' ' PHE . 87.8 t -49.34 -27.67 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.553 -0.717 . . . . 0.0 110.355 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.15 7.19 25.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.279 -0.888 . . . . 0.0 110.726 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.2 t -90.29 -27.86 19.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.968 -1.083 . . . . 0.0 110.23 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.7 p -147.75 167.09 25.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 110.174 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -67.48 -12.17 59.65 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.216 -0.927 . . . . 0.0 110.136 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.9 t -137.84 150.69 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.066 -1.021 . . . . 0.0 110.063 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.444 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -174.42 142.05 0.74 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.959 . . . . 0.0 110.246 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.408 HG12 ' CZ ' ' A' ' 167' ' ' PHE . 7.2 p -129.7 148.18 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 121.108 -0.995 . . . . 0.0 110.188 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.9 mp -137.27 113.54 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -0.872 . . . . 0.0 110.181 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -80.91 131.69 10.63 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.483 ' CE2' HG13 ' A' ' 175' ' ' VAL . 35.1 m-85 -101.95 76.29 1.6 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -1.162 . . . . 0.0 110.091 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -94.28 144.38 25.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.128 -0.983 . . . . 0.0 110.75 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.04 -26.94 20.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.611 -0.681 . . . . 0.0 109.412 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -134.1 76.3 1.64 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.672 -0.642 . . . . 0.0 109.306 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.434 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 34.7 m -49.05 -23.64 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.377 -0.827 . . . . 0.0 111.042 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -80.02 4.88 15.66 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.048 -1.032 . . . . 0.0 111.175 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.2 p -78.93 -165.25 0.71 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.874 -1.142 . . . . 0.0 110.534 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.02 -23.49 20.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.558 -0.713 . . . . 0.0 110.238 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.5 m -80.27 -19.81 45.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.294 -0.879 . . . . 0.0 110.554 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -84.34 -32.56 24.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.134 -0.979 . . . . 0.0 110.3 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.2 mtpt -58.89 -38.07 78.03 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 110.183 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.42 -47.48 81.78 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.207 -0.933 . . . . 0.0 110.065 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -52.72 -54.69 30.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.315 -0.865 . . . . 0.0 110.103 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 22.1 mt -49.13 -55.04 13.55 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.308 -0.87 . . . . 0.0 110.378 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -54.22 -37.62 64.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.316 -0.865 . . . . 0.0 109.674 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.411 ' CA ' ' HG3' ' A' ' 205' ' ' LYS . . . -65.85 -52.77 47.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.356 -0.84 . . . . 0.0 109.536 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -55.44 -35.21 65.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.288 -0.882 . . . . 0.0 109.602 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.58 -30.3 71.01 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.283 -0.886 . . . . 0.0 109.858 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.16 -48.97 79.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.356 -0.84 . . . . 0.0 109.801 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 162' ' ' ILE . 63.2 mt -95.42 149.52 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.338 -0.851 . . . . 0.0 109.882 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -126.69 8.98 6.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.178 -0.951 . . . . 0.0 110.819 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -110.6 -17.25 13.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.967 -1.083 . . . . 0.0 110.339 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 51.0 mm -91.43 133.44 31.35 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.935 . . . . 0.0 110.185 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.444 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 50.6 Cg_endo -73.63 69.63 4.33 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.576 1.303 . . . . 0.0 110.253 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.408 ' CZ ' HG12 ' A' ' 140' ' ' VAL . 3.3 m-85 -63.7 123.03 17.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.886 . . . . 0.0 109.932 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -125.19 151.07 17.38 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -141.83 148.18 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -1.146 . . . . 0.0 110.297 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.6 t -164.85 157.81 16.7 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.073 0.939 . . . . 0.0 110.913 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.7 t -123.39 2.31 9.06 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.394 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -60.92 120.79 10.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.121 -0.987 . . . . 0.0 110.171 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 3.0 p -51.29 -29.4 14.72 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -0.902 . . . . 0.0 110.35 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.22 -43.47 78.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 109.877 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.483 HG13 ' CE2' ' A' ' 143' ' ' PHE . 46.2 t -72.35 -26.31 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.239 -0.913 . . . . 0.0 109.832 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -75.46 -55.49 5.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.37 -0.831 . . . . 0.0 110.036 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -21.37 60.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.465 -0.772 . . . . 0.0 110.435 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.36 -56.06 26.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -0.972 . . . . 0.0 110.341 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -89.76 13.64 13.84 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.171 -0.956 . . . . 0.0 110.598 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 51.95 63.83 2.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 110.625 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 14.7 mt -96.06 124.27 40.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.412 -0.805 . . . . 0.0 109.911 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -61.29 -16.1 42.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.144 -0.973 . . . . 0.0 110.219 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -175.29 -142.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.569 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -86.71 159.81 19.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.995 -1.065 . . . . 0.0 110.365 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 176.76 179.74 47.33 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 m -133.74 120.28 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -1.148 . . . . 0.0 110.297 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 86.2 t -123.09 162.89 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.412 -0.805 . . . . 0.0 109.863 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.444 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 1.7 tt -113.36 148.79 35.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.078 -1.013 . . . . 0.0 109.761 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.438 ' HB3' ' CG2' ' A' ' 133' ' ' VAL . 40.0 m-85 -123.44 117.4 25.07 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.064 -1.022 . . . . 0.0 110.411 -179.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.495 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -134.52 165.86 24.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.311 -0.868 . . . . 0.0 110.16 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -88.67 -22.71 23.28 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.0 110.373 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.495 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 1.4 p90 -90.87 -172.32 3.32 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.243 -0.911 . . . . 0.0 110.928 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 47.22 -159.46 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.663 0.744 . . . . 0.0 110.728 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -55.0 -53.62 53.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.641 -0.662 . . . . 0.0 110.321 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 139.5 -49.2 0.82 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.68 172.83 8.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.252 -1.146 . . . . 0.0 110.442 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ASN . . . . . 0.464 ' N ' ' ND2' ' A' ' 197' ' ' ASN . 0.6 OUTLIER -138.44 -152.67 0.44 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.292 -0.88 . . . . 0.0 109.598 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -175.57 76.69 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.32 -0.862 . . . . 0.0 110.309 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -51.39 118.57 3.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.349 -0.844 . . . . 0.0 110.409 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -113.3 95.14 5.21 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.289 -0.882 . . . . 0.0 110.301 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 162.5 -174.07 38.84 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -61.46 135.95 57.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.295 -1.121 . . . . 0.0 110.166 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 74.7 t -91.15 104.43 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.885 . . . . 0.0 110.071 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 39.6 p -143.86 158.33 43.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.384 -0.822 . . . . 0.0 109.972 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.411 ' HG3' ' CA ' ' A' ' 158' ' ' ALA . 11.0 tttt -49.36 -51.54 34.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.287 -0.883 . . . . 0.0 110.916 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -59.54 -31.17 69.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 110.565 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -82.46 -38.94 23.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 110.344 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 51.1 mt -61.38 -56.59 18.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.315 -0.866 . . . . 0.0 110.35 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 4.1 mp -52.96 -23.26 6.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.263 -0.898 . . . . 0.0 110.326 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.2 -49.89 12.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.888 . . . . 0.0 110.279 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -55.8 -59.35 4.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -0.918 . . . . 0.0 110.386 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 5.7 mt -50.07 -39.45 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.219 -0.926 . . . . 0.0 110.466 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -58.67 -18.42 30.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.304 -0.873 . . . . 0.0 110.305 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 17.5 t60 -99.47 -18.6 17.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.176 -0.953 . . . . 0.0 110.676 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -97.66 -61.26 1.42 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.113 -0.992 . . . . 0.0 111.099 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.103 -0.998 . . . . 0.0 110.584 -179.459 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.202 0.525 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 t -98.29 166.07 11.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 110.144 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.7 m -107.11 109.0 20.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.186 -0.946 . . . . 0.0 110.121 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 26.2 mt -92.12 131.31 35.28 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.225 -0.922 . . . . 0.0 109.986 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.43 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 45.9 Cg_endo -72.49 -36.3 5.33 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.401 1.211 . . . . 0.0 110.47 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -154.96 -169.04 3.07 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.27 -0.894 . . . . 0.0 110.614 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.419 ' N ' HG21 ' A' ' 175' ' ' VAL . . . -67.84 -30.94 74.75 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -54.26 -25.85 25.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -1.104 . . . . 0.0 110.362 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.43 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -89.51 -25.29 21.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 110.162 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.99 -26.06 65.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 109.977 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -79.14 -50.71 10.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.209 -0.932 . . . . 0.0 110.056 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.5 m -56.87 -24.32 50.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -0.895 . . . . 0.0 110.08 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.414 HD21 ' CG1' ' A' ' 141' ' ' ILE . 12.4 tp -67.64 -51.62 47.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 0.0 110.062 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.493 HG23 ' CD2' ' A' ' 189' ' ' PHE . 42.4 t -53.55 -46.95 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.871 . . . . 0.0 110.343 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.28 -18.89 63.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 0.0 110.427 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.4 t -56.16 -59.32 5.1 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.24 -0.913 . . . . 0.0 110.277 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.6 p -127.26 -171.13 2.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.257 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -74.2 -44.63 52.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.879 . . . . 0.0 110.328 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.433 HG22 ' CD1' ' A' ' 165' ' ' ILE . 30.5 m -116.1 151.91 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 0.0 110.535 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.411 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -176.03 139.52 0.38 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.344 -0.848 . . . . 0.0 109.827 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 188' ' ' LEU . 10.0 p -122.33 146.82 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.112 -0.993 . . . . 0.0 110.47 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.436 ' O ' ' CE2' ' A' ' 143' ' ' PHE . 6.3 mt -128.18 112.65 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.424 -0.798 . . . . 0.0 109.928 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.07 125.35 7.16 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.436 ' CE2' ' O ' ' A' ' 141' ' ' ILE . 90.8 m-85 -103.2 66.56 0.9 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -1.134 . . . . 0.0 109.605 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.442 ' CD1' ' HB3' ' A' ' 184' ' ' ASP . 9.6 m-85 -93.92 140.1 30.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.351 -0.843 . . . . 0.0 111.03 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -26.83 43.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.462 -0.774 . . . . 0.0 109.775 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -122.32 90.69 3.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.51 -0.744 . . . . 0.0 109.913 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.15 -21.9 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 110.616 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -87.18 12.58 11.31 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.158 -0.964 . . . . 0.0 111.135 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 96.7 p -86.63 -164.26 1.03 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.094 -1.004 . . . . 0.0 110.118 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.53 -44.63 11.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.331 -0.856 . . . . 0.0 109.866 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.3 m -56.89 -21.31 28.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.317 -0.864 . . . . 0.0 110.085 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.29 -39.6 22.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.0 110.101 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -59.41 -39.91 84.95 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.268 -0.895 . . . . 0.0 110.339 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -63.97 -43.25 96.32 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.247 -0.908 . . . . 0.0 109.941 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -50.66 -55.81 14.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.333 -0.854 . . . . 0.0 110.307 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 75.2 mt -56.02 -51.53 67.45 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.374 -0.829 . . . . 0.0 110.08 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -51.17 -44.54 61.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.365 -0.834 . . . . 0.0 110.148 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -69.64 -34.18 73.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -0.885 . . . . 0.0 110.046 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.487 ' CB ' ' CD2' ' A' ' 167' ' ' PHE . . . -62.53 -30.98 71.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 110.136 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.97 -22.1 24.49 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.21 -0.931 . . . . 0.0 110.35 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -97.42 13.92 28.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.219 -0.926 . . . . 0.0 110.594 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.424 ' O ' ' N ' ' A' ' 164' ' ' ASP . 6.6 tt -103.78 174.67 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.093 -1.004 . . . . 0.0 110.211 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.42 62.89 0.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.37 -0.831 . . . . 0.0 110.25 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 162' ' ' ILE . 2.8 p-10 40.76 50.81 3.04 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.616 0.722 . . . . 0.0 111.56 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.456 HD11 HG22 ' A' ' 165' ' ' ILE . 39.1 mm -88.85 146.0 35.91 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.452 -0.78 . . . . 0.0 109.628 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.444 ' HD2' ' CG2' ' A' ' 165' ' ' ILE . 42.2 Cg_endo -68.63 100.8 0.71 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.58 1.305 . . . . 0.0 110.865 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.487 ' CD2' ' CB ' ' A' ' 159' ' ' ALA . 2.7 m-85 -97.6 136.32 38.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.42 -0.8 . . . . 0.0 110.158 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -129.47 143.81 14.92 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 11.1 tt -141.18 135.9 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.13 -1.218 . . . . 0.0 110.572 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.0 t -153.08 156.88 39.56 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.031 0.919 . . . . 0.0 110.571 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.4 t -122.68 2.59 9.53 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -64.31 123.23 18.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -0.945 . . . . 0.0 110.322 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 27.7 m -53.15 -28.36 25.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.229 -0.92 . . . . 0.0 110.131 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.45 -31.84 56.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -0.929 . . . . 0.0 109.764 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.419 HG21 ' N ' ' A' ' 126' ' ' GLY . 28.0 t -81.91 -26.21 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.429 -0.795 . . . . 0.0 109.32 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -76.24 -53.05 8.8 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.481 -0.762 . . . . 0.0 109.75 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 2.0 t -56.06 -21.93 24.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.402 -0.811 . . . . 0.0 110.08 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.51 -48.27 61.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 109.244 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -96.87 -0.67 47.4 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.432 -0.793 . . . . 0.0 110.352 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 53.83 70.63 0.58 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.103 -0.998 . . . . 0.0 110.589 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.64 129.11 53.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.314 -0.866 . . . . 0.0 110.045 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.422 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 24.6 p-10 -60.65 -16.21 36.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.251 -0.905 . . . . 0.0 110.512 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.2 -145.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.175 -0.953 . . . . 0.0 109.649 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.442 ' HB3' ' CD1' ' A' ' 144' ' ' PHE . 43.0 m-20 -54.3 151.54 7.3 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.04 -1.038 . . . . 0.0 109.62 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -152.19 129.94 2.94 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.416 -1.374 . . . . 0.0 110.108 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.427 ' O ' ' CB ' ' A' ' 199' ' ' PHE . 75.0 t -117.09 80.93 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.364 -1.08 . . . . 0.0 109.777 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 61.3 t -106.39 158.88 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 110.063 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.439 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 9.8 tt -116.25 163.61 15.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.032 -1.043 . . . . 0.0 109.87 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.493 ' CD2' HG23 ' A' ' 133' ' ' VAL . 64.4 m-85 -128.88 132.08 47.68 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.009 -1.057 . . . . 0.0 110.892 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.465 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.3 OUTLIER -140.49 163.69 32.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.242 -0.911 . . . . 0.0 110.122 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -83.43 -29.13 28.34 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.273 -0.892 . . . . 0.0 110.083 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.465 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.8 OUTLIER -91.5 -175.04 4.09 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.533 -0.73 . . . . 0.0 110.955 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 50.43 -160.15 0.07 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.697 0.76 . . . . 0.0 110.608 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -59.24 -28.36 66.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.774 -0.579 . . . . 0.0 110.552 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.402 ' HA2' ' HG2' ' A' ' 190' ' ' LYS . . . 107.33 -28.04 13.86 Favored Glycine 0 N--CA 1.483 1.779 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.06 -179.98 5.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.129 -1.218 . . . . 0.0 110.599 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ASN . . . . . 0.439 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.4 m-80 -141.96 -152.39 0.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.575 -0.703 . . . . 0.0 109.712 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -171.57 79.81 0.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.355 -0.84 . . . . 0.0 110.474 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.427 ' CB ' ' O ' ' A' ' 186' ' ' VAL . 26.7 t80 -60.3 143.05 53.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.172 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -146.51 129.95 16.8 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.341 -0.85 . . . . 0.0 109.717 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 121.79 -172.58 15.51 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -66.03 117.31 8.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -1.131 . . . . 0.0 110.349 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 71.7 t -74.14 118.88 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.887 . . . . 0.0 109.987 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.6 p -150.07 157.11 42.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.318 -0.863 . . . . 0.0 110.433 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -49.26 -52.98 23.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.392 -0.818 . . . . 0.0 110.456 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -55.78 -36.21 67.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.354 -0.841 . . . . 0.0 110.332 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 -77.56 -51.98 9.8 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.193 -0.942 . . . . 0.0 110.454 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 70.8 mt -52.34 -56.35 15.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.322 -0.861 . . . . 0.0 110.429 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 18.7 mt -51.11 -24.13 3.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.169 -0.957 . . . . 0.0 110.57 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -84.71 -41.8 15.89 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.195 -0.941 . . . . 0.0 110.073 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -63.29 -57.82 9.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.352 -0.843 . . . . 0.0 110.67 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.416 HD11 ' CD1' ' A' ' 162' ' ' ILE . 9.4 mt -52.8 -47.22 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.134 -0.979 . . . . 0.0 110.388 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.56 -21.13 51.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.228 -0.92 . . . . 0.0 110.222 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -90.01 -19.35 24.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.309 -0.869 . . . . 0.0 110.438 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -94.73 -49.98 5.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.2 -0.938 . . . . 0.0 110.418 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 . . . . . 0 N--CA 1.486 1.327 0 O-C-N 121.213 -0.93 . . . . 0.0 110.485 -179.792 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.26 0.552 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 51.9 m -101.56 125.51 48.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 110.149 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 87.0 m -76.84 126.91 31.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.25 -0.906 . . . . 0.0 110.169 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.7 mt -103.45 137.98 19.41 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.932 . . . . 0.0 109.95 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.427 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 46.8 Cg_endo -73.09 -26.21 15.23 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.554 1.292 . . . . 0.0 110.546 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -172.76 -170.33 0.66 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.159 -0.963 . . . . 0.0 110.912 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.8 -34.07 87.46 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -51.48 -28.2 12.67 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.276 -1.132 . . . . 0.0 110.4 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.427 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -86.06 -37.22 19.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 110.161 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.16 -30.15 48.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.197 -0.939 . . . . 0.0 110.118 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -81.62 -46.45 14.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.146 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 92.0 p -56.74 -33.34 66.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.894 . . . . 0.0 110.095 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.435 HD21 ' CG1' ' A' ' 141' ' ' ILE . 5.5 tp -61.09 -47.84 84.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -0.884 . . . . 0.0 110.165 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.491 HG23 ' CD1' ' A' ' 189' ' ' PHE . 39.4 t -54.67 -41.2 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.193 -0.942 . . . . 0.0 109.961 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -82.74 3.38 29.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.274 -0.891 . . . . 0.0 110.796 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.8 t -75.61 -41.92 53.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.934 -1.104 . . . . 0.0 110.111 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 28.2 p -147.24 -172.63 4.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 110.13 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.443 ' OE2' ' CD2' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -70.65 -44.76 66.43 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.205 -0.934 . . . . 0.0 110.163 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.4 t -116.26 150.51 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.276 -0.89 . . . . 0.0 110.191 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.436 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -172.15 146.0 1.85 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.843 . . . . 0.0 109.926 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.4 HG12 HG12 ' A' ' 212' ' ' ILE . 2.8 m -128.19 164.66 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.117 -0.99 . . . . 0.0 110.764 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.435 ' CG1' HD21 ' A' ' 132' ' ' LEU . 31.2 mt -149.96 114.4 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.753 -0.592 . . . . 0.0 110.173 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -87.06 133.05 11.53 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.488 ' CD2' HG13 ' A' ' 175' ' ' VAL . 76.1 m-85 -99.37 77.31 2.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.113 -1.228 . . . . 0.0 110.069 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -95.24 143.65 26.47 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.992 0.901 . . . . 0.0 110.939 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.4 -25.36 20.43 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.815 0.817 . . . . 0.0 109.167 179.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -137.3 78.85 1.72 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.407 HG21 ' N ' ' A' ' 148' ' ' GLU . 19.5 m -46.02 -25.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.457 -0.777 . . . . 0.0 111.167 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.407 ' N ' HG21 ' A' ' 147' ' ' VAL . 1.5 mm-40 -84.73 10.31 11.7 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.106 -0.996 . . . . 0.0 110.937 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 68.6 p -81.0 -159.36 0.25 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.967 -1.083 . . . . 0.0 110.182 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -89.87 -54.18 4.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 110.207 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.87 -23.38 63.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 0.0 110.268 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.12 -23.43 38.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 0.0 110.286 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.18 -41.05 77.69 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.216 -0.928 . . . . 0.0 110.115 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -60.43 -46.03 91.48 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.314 -0.867 . . . . 0.0 109.956 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -51.79 -55.35 20.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 110.268 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 41.2 mt -54.13 -55.75 24.69 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.383 -0.823 . . . . 0.0 110.152 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -52.45 -38.02 58.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.347 -0.845 . . . . 0.0 110.13 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.421 ' CB ' ' HG3' ' A' ' 205' ' ' LYS . . . -76.8 -41.61 43.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.198 -0.939 . . . . 0.0 109.841 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.405 ' HB3' ' CD2' ' A' ' 167' ' ' PHE . . . -58.73 -37.61 76.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.828 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -66.59 -28.21 68.33 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.243 -0.91 . . . . 0.0 110.113 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.36 -50.43 73.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.798 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.413 HG22 ' CG1' ' A' ' 165' ' ' ILE . 71.4 mt -90.31 152.17 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.367 -0.833 . . . . 0.0 109.891 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -127.6 -40.27 1.77 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.136 -0.978 . . . . 0.0 110.43 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -63.77 -16.25 60.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.249 -0.907 . . . . 0.0 110.615 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.498 HD11 HG22 ' A' ' 165' ' ' ILE . 46.2 mm -93.63 128.86 40.37 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.075 -1.016 . . . . 0.0 110.327 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.436 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 51.0 Cg_endo -77.31 82.55 2.35 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 O-C-N 123.538 1.283 . . . . 0.0 110.546 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.405 ' CD2' ' HB3' ' A' ' 159' ' ' ALA . 1.6 m-85 -71.44 137.57 48.38 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.173 -0.954 . . . . 0.0 110.238 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -128.9 145.07 15.91 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 4.8 tt -146.58 137.48 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -1.157 . . . . 0.0 110.439 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.2 t -159.49 156.94 29.13 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.001 0.905 . . . . 0.0 110.895 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 56.7 p -122.24 3.43 9.79 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.527 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -57.74 126.76 28.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.219 -0.926 . . . . 0.0 110.535 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.88 -35.88 58.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.244 -0.91 . . . . 0.0 110.143 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -53.09 -30.75 38.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.978 . . . . 0.0 109.815 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.488 HG13 ' CD2' ' A' ' 143' ' ' PHE . 57.3 t -81.29 -26.86 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.325 -0.859 . . . . 0.0 109.546 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -77.6 -52.86 8.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.351 -0.843 . . . . 0.0 109.345 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.4 m -58.96 -18.6 35.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.443 -0.786 . . . . 0.0 109.997 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -71.48 -53.91 12.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.559 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -91.11 4.6 51.76 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.41 -0.807 . . . . 0.0 110.292 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.13 64.64 1.76 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -0.946 . . . . 0.0 110.713 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 40.0 mt -102.7 122.41 44.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.256 -0.902 . . . . 0.0 110.17 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -62.83 -18.87 63.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 110.422 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 18.9 pttt -163.75 -148.22 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 109.983 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -70.71 150.98 45.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -0.933 . . . . 0.0 109.889 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -170.16 156.05 26.33 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 97.8 t -127.8 141.2 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.172 -1.193 . . . . 0.0 110.344 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.406 HG11 ' N ' ' A' ' 188' ' ' LEU . 70.6 t -143.06 149.24 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.337 -0.852 . . . . 0.0 109.646 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.462 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 3.7 tt -101.29 145.59 28.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.951 -1.093 . . . . 0.0 109.681 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.491 ' CD1' HG23 ' A' ' 133' ' ' VAL . 58.8 m-85 -121.87 108.34 13.34 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.131 -0.981 . . . . 0.0 110.624 -178.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.479 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -124.06 174.68 7.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.31 -0.869 . . . . 0.0 110.27 179.782 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -94.41 -26.22 16.6 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.321 -0.862 . . . . 0.0 110.007 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.479 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.5 OUTLIER -91.43 -170.92 2.76 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.833 179.577 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 49.87 -159.92 0.07 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.661 0.743 . . . . 0.0 110.595 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -56.05 -46.32 78.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.632 -0.667 . . . . 0.0 110.25 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 126.07 -32.86 3.67 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -136.55 173.14 12.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.193 -1.18 . . . . 0.0 110.429 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' ASN . . . . . 0.462 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 0.7 OUTLIER -144.22 -155.21 0.58 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.37 -0.831 . . . . 0.0 109.631 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 197' ' ' ASN . 0.2 OUTLIER -169.52 86.93 0.15 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.53 -0.731 . . . . 0.0 110.206 179.612 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -49.85 130.83 22.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.272 -0.893 . . . . 0.0 110.441 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -127.95 115.38 18.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.327 -0.858 . . . . 0.0 109.942 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 132.93 -158.74 23.25 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -84.43 132.28 34.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.298 -1.119 . . . . 0.0 110.167 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 92.3 t -81.46 116.17 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.33 -0.856 . . . . 0.0 110.376 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 15.6 p -143.56 159.73 41.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 109.988 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.421 ' HG3' ' CB ' ' A' ' 158' ' ' ALA . 2.9 ttpt -51.31 -49.24 61.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.12 -0.987 . . . . 0.0 110.584 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -62.98 -39.72 95.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.276 -0.89 . . . . 0.0 110.549 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -70.16 -48.79 55.86 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.197 -0.939 . . . . 0.0 110.374 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.3 mt -56.06 -49.87 72.55 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.257 -0.902 . . . . 0.0 110.428 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.26 -26.99 65.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.892 . . . . 0.0 110.298 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -78.28 -45.49 22.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.281 -0.887 . . . . 0.0 110.274 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -53.29 -60.92 2.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.318 -0.864 . . . . 0.0 110.393 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.4 HG12 HG12 ' A' ' 140' ' ' VAL . 9.9 mt -51.69 -46.47 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.242 -0.911 . . . . 0.0 110.586 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -18.85 13.79 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.258 -0.902 . . . . 0.0 110.956 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -96.52 -24.38 16.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.064 -1.022 . . . . 0.0 110.922 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -89.34 -48.58 7.25 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.922 -1.111 . . . . 0.0 111.139 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 . . . . . 0 N--CA 1.493 1.676 0 O-C-N 120.956 -1.09 . . . . 0.0 110.212 -179.777 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.106 0.479 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.7 t -102.19 171.11 7.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.139 -0.976 . . . . 0.0 110.516 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.2 m -113.95 103.47 11.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.357 -0.839 . . . . 0.0 110.193 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.432 ' CD1' HG22 ' A' ' 141' ' ' ILE . 57.7 mt -79.47 111.95 24.87 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.924 . . . . 0.0 110.04 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.434 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 44.7 Cg_endo -69.61 -21.57 34.02 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 O-C-N 123.561 1.295 . . . . 0.0 110.869 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.13 -170.03 2.19 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.052 -1.03 . . . . 0.0 111.076 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.404 ' HA3' ' HD3' ' A' ' 178' ' ' LYS . . . -67.69 -39.92 90.25 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -53.25 -22.56 7.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -1.15 . . . . 0.0 110.031 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.434 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -88.32 -23.91 23.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.205 -0.935 . . . . 0.0 109.301 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.0 -20.48 32.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.454 -0.779 . . . . 0.0 110.118 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 131' ' ' SER . 19.2 pt-20 -86.9 -37.61 17.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.177 -0.952 . . . . 0.0 110.228 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.426 ' N ' ' HG3' ' A' ' 130' ' ' GLU . 3.0 m -75.48 -31.45 60.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 0.0 109.998 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.4 tt -56.51 -59.47 4.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.336 -0.852 . . . . 0.0 110.067 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.487 HG23 ' CD2' ' A' ' 189' ' ' PHE . 51.4 t -53.63 -35.88 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 110.513 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.81 -19.86 57.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.125 -0.984 . . . . 0.0 110.581 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 68.4 m -68.56 -57.47 5.73 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.129 -0.982 . . . . 0.0 110.304 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 46.1 p -111.84 165.06 12.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.316 -0.865 . . . . 0.0 110.252 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.427 ' CG ' ' N ' ' A' ' 138' ' ' VAL . 14.6 pt-20 -64.86 -40.39 95.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 110.035 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.427 ' N ' ' CG ' ' A' ' 137' ' ' GLU . 94.1 t -121.67 147.7 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.429 -0.794 . . . . 0.0 110.17 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.429 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -173.99 133.26 0.43 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.298 -0.876 . . . . 0.0 110.061 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.432 HG21 ' N ' ' A' ' 141' ' ' ILE . 7.3 p -111.86 149.54 14.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.136 -0.977 . . . . 0.0 110.064 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.432 ' N ' HG21 ' A' ' 140' ' ' VAL . 66.5 mt -131.37 111.1 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 110.253 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -77.28 133.24 12.96 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.47 ' CE2' HG13 ' A' ' 175' ' ' VAL . 51.4 m-85 -105.36 67.2 0.76 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.26 -1.141 . . . . 0.0 109.735 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -91.76 130.33 37.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 111.228 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.44 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 26.0 pttt -80.07 -30.62 39.32 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.923 0.868 . . . . 0.0 108.828 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.44 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 5.2 m-20 -123.19 70.93 1.04 Allowed 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.323 0.582 . . . . 0.0 109.449 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.415 HG21 ' N ' ' A' ' 148' ' ' GLU . 25.6 m -49.17 -23.89 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.27 -0.894 . . . . 0.0 110.808 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.415 ' N ' HG21 ' A' ' 147' ' ' VAL . 2.7 mt-10 -78.33 2.55 18.2 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.08 -1.012 . . . . 0.0 111.032 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 21.5 p -80.45 -161.0 0.34 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.901 -1.124 . . . . 0.0 110.243 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -90.41 -51.59 5.34 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.21 -0.931 . . . . 0.0 110.582 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 66.4 m -52.25 -26.07 10.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.2 -0.938 . . . . 0.0 110.507 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.409 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -86.24 -32.1 21.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 110.353 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -60.23 -41.32 92.84 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.22 -0.925 . . . . 0.0 110.189 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -66.32 -36.91 84.12 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.169 -0.957 . . . . 0.0 109.93 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . 0.408 ' CE1' HD23 ' A' ' 208' ' ' LEU . 4.3 t80 -51.97 -57.78 8.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.286 -0.884 . . . . 0.0 110.097 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 19.2 mt -52.01 -50.57 61.11 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.45 -0.781 . . . . 0.0 110.245 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -52.1 -41.61 62.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.356 -0.84 . . . . 0.0 110.152 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -73.29 -35.47 66.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.335 -0.853 . . . . 0.0 109.889 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.58 -43.16 94.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 110.013 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -60.13 -35.62 75.68 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.256 -0.903 . . . . 0.0 110.139 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.3 -46.54 86.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.87 . . . . 0.0 110.182 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.425 HD11 HG22 ' A' ' 162' ' ' ILE . 49.8 mm -90.7 104.98 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.064 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.37 -20.54 20.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.122 -0.986 . . . . 0.0 110.373 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -76.88 -6.05 50.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.221 -0.925 . . . . 0.0 110.807 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.45 HD11 HG22 ' A' ' 165' ' ' ILE . 44.7 mm -116.3 130.35 24.54 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.941 -1.1 . . . . 0.0 110.132 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.429 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 50.6 Cg_endo -75.09 81.2 2.28 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.475 1.25 . . . . 0.0 110.549 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -68.23 132.38 47.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 110.316 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -126.54 153.34 18.71 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 7.2 tt -148.43 147.33 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -1.154 . . . . 0.0 110.329 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.4 t -164.01 156.96 17.86 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.065 0.936 . . . . 0.0 110.809 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 76.1 p -121.14 1.08 10.28 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.16 119.98 6.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.191 -0.943 . . . . 0.0 110.506 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.1 p -53.72 -32.48 52.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.229 -0.919 . . . . 0.0 110.095 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.47 -44.31 80.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.141 -0.975 . . . . 0.0 109.344 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.47 HG13 ' CE2' ' A' ' 143' ' ' PHE . 39.0 t -69.22 -29.84 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.346 -0.846 . . . . 0.0 109.41 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -68.57 -60.86 2.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.407 -0.808 . . . . 0.0 109.528 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 2.9 m -51.36 -36.62 43.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.61 -0.682 . . . . 0.0 110.562 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.404 ' HD3' ' HA3' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -48.44 -55.78 9.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.17 -0.956 . . . . 0.0 110.895 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -89.9 18.73 5.4 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.315 -0.866 . . . . 0.0 110.51 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.46 65.75 1.39 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.163 -0.961 . . . . 0.0 110.402 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 85.5 mt -112.92 92.29 3.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -0.836 . . . . 0.0 110.235 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.56 -26.98 9.65 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.038 -1.038 . . . . 0.0 109.53 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -138.66 177.73 7.67 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -58.65 -173.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.08 -1.012 . . . . 0.0 110.262 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 165.27 171.86 32.01 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.43 HG22 ' CB ' ' A' ' 199' ' ' PHE . 32.8 m -139.92 108.15 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.294 -1.121 . . . . 0.0 109.97 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 97.2 t -117.04 160.9 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.287 -0.883 . . . . 0.0 109.851 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.446 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 8.3 tt -110.3 150.79 28.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.026 -1.046 . . . . 0.0 109.941 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.487 ' CD2' HG23 ' A' ' 133' ' ' VAL . 40.6 m-85 -121.87 127.19 50.2 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.991 -1.068 . . . . 0.0 110.196 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.28 167.39 22.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -0.885 . . . . 0.0 110.358 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.0 mtpt -90.87 -27.09 19.02 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.244 -0.91 . . . . 0.0 110.596 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -90.96 -175.69 4.41 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.381 -0.824 . . . . 0.0 111.023 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 50.01 -160.0 0.07 Allowed 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.666 0.746 . . . . 0.0 110.667 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -53.86 -54.68 35.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.666 -0.646 . . . . 0.0 110.191 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 133.12 -24.31 3.79 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -140.85 176.81 8.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.051 -1.264 . . . . 0.0 110.781 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' ASN . . . . . 0.456 ' N ' ' ND2' ' A' ' 197' ' ' ASN . 1.1 m-80 -142.53 -151.76 0.38 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.549 -0.719 . . . . 0.0 109.509 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -176.51 79.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 0.0 109.97 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.43 ' CB ' HG22 ' A' ' 186' ' ' VAL . 17.1 t80 -51.26 120.1 4.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.285 -0.884 . . . . 0.0 110.52 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -119.56 104.91 10.72 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.248 -0.907 . . . . 0.0 110.111 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 152.21 -160.62 28.99 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -81.94 111.11 17.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -1.178 . . . . 0.0 110.16 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.82 116.68 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 110.173 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 67.9 p -149.63 155.72 40.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 110.284 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -52.62 -52.66 54.46 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.357 -0.839 . . . . 0.0 110.567 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -56.35 -25.83 50.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.0 110.293 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -87.47 -46.29 9.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.291 -0.881 . . . . 0.0 110.17 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.408 HD23 ' CE1' ' A' ' 155' ' ' PHE . 19.4 mt -59.02 -47.27 85.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.283 -0.886 . . . . 0.0 110.315 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 14.6 mt -52.31 -30.99 31.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.226 -0.921 . . . . 0.0 110.287 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.53 -42.06 14.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 0.0 110.089 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.428 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 18.5 t80 -51.31 -51.7 51.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.162 -0.961 . . . . 0.0 109.705 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 25.4 mm -48.53 -72.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.427 -0.796 . . . . 0.0 110.423 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.429 ' HA ' ' CG ' ' A' ' 216' ' ' GLN . 18.0 mttt -45.9 -37.08 5.94 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.779 -0.575 . . . . 0.0 111.132 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.61 -25.46 67.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.13 -0.981 . . . . 0.0 110.793 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 74.8 m-80 -102.18 -31.53 10.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.103 -0.998 . . . . 0.0 110.977 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' GLN . . . . . 0.429 ' CG ' ' HA ' ' A' ' 213' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 O-C-N 121.016 -1.053 . . . . 0.0 111.001 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.269 0.557 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.4 t -103.89 168.9 8.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 110.318 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.6 m -108.1 118.4 36.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 0.0 109.94 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 49.5 mt -90.88 138.35 26.28 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.218 -0.926 . . . . 0.0 110.378 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.42 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 46.5 Cg_endo -72.61 -36.63 4.78 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.565 1.297 . . . . 0.0 110.366 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -167.2 -170.24 1.45 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.222 -0.924 . . . . 0.0 110.805 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -57.56 -33.67 67.43 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -51.11 -26.72 6.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.22 -1.165 . . . . 0.0 110.406 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.42 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -88.12 -37.16 16.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 110.093 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.24 -25.88 25.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 0.0 109.995 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -88.88 -57.36 2.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.271 -0.893 . . . . 0.0 110.062 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.2 m -58.77 -27.87 65.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.233 -0.917 . . . . 0.0 110.205 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 20.6 tp -60.71 -54.31 46.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 109.988 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 98.4 t -57.39 -33.25 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.459 -0.776 . . . . 0.0 110.336 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -72.97 -17.69 61.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.903 . . . . 0.0 110.528 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.85 -27.12 57.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.189 -0.944 . . . . 0.0 110.393 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.1 p -141.58 163.55 32.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.188 -0.945 . . . . 0.0 110.391 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.426 ' HG3' ' CG2' ' A' ' 138' ' ' VAL . 18.3 pt-20 -63.8 -40.93 97.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 110.043 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.426 ' CG2' ' HG3' ' A' ' 137' ' ' GLU . 57.9 t -127.76 155.88 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.412 -0.805 . . . . 0.0 110.172 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -176.75 138.51 0.28 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.245 -0.91 . . . . 0.0 109.788 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.78 151.78 14.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.085 -1.01 . . . . 0.0 110.245 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 71.9 mt -132.65 117.36 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.377 -0.827 . . . . 0.0 110.163 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -84.22 126.72 7.74 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -100.24 70.03 1.51 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.356 -1.085 . . . . 0.0 109.924 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -94.99 141.5 28.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -0.875 . . . . 0.0 110.952 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.53 -27.96 18.83 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.501 -0.749 . . . . 0.0 110.554 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.418 ' O ' ' CB ' ' A' ' 147' ' ' VAL . 0.7 OUTLIER -90.69 -39.51 12.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.17 -0.956 . . . . 0.0 110.445 -179.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.418 ' CB ' ' O ' ' A' ' 146' ' ' ASP . 2.4 t 73.1 -51.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.743 -0.598 . . . . 0.0 110.634 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -90.83 8.96 32.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.067 -1.021 . . . . 0.0 110.507 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 7.5 p -70.01 -163.87 0.07 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.986 -1.071 . . . . 0.0 110.066 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.51 -41.31 13.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.338 -0.851 . . . . 0.0 110.431 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.7 p -59.55 -24.26 63.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.197 -0.94 . . . . 0.0 110.19 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -85.02 -37.17 20.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.253 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.88 -45.83 67.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 110.387 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -62.49 -39.48 93.61 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.219 -0.925 . . . . 0.0 110.355 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -51.6 -56.63 12.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 110.418 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.7 mt -51.21 -54.31 26.82 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.324 -0.86 . . . . 0.0 110.534 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -51.91 -40.46 60.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.254 -0.903 . . . . 0.0 110.252 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -69.47 -49.61 53.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.93 . . . . 0.0 109.885 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -55.61 -35.93 66.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 110.011 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -68.48 -22.76 64.54 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.329 -0.857 . . . . 0.0 110.435 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.89 -56.42 17.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.168 -0.957 . . . . 0.0 110.333 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.408 HD11 HG22 ' A' ' 162' ' ' ILE . 98.8 mt -90.02 151.1 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 0.0 110.177 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -119.67 -16.39 8.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 110.597 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -91.2 19.7 5.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.073 -1.017 . . . . 0.0 110.519 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.551 ' CG2' ' CE1' ' A' ' 167' ' ' PHE . 31.8 mm -132.21 125.1 19.75 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.135 -0.978 . . . . 0.0 109.899 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -81.5 101.56 1.22 Allowed 'Trans proline' 0 C--N 1.315 -1.228 0 O-C-N 123.443 1.233 . . . . 0.0 110.697 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.551 ' CE1' ' CG2' ' A' ' 165' ' ' ILE . 1.1 m-85 -92.85 140.07 29.88 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.249 -0.907 . . . . 0.0 109.487 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -132.58 156.37 22.04 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.3 tt -146.0 150.86 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.096 -1.237 . . . . 0.0 110.282 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.421 HG22 ' CG1' ' A' ' 175' ' ' VAL . 2.4 t -162.01 158.55 25.2 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.11 0.957 . . . . 0.0 110.891 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.402 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . 26.3 t -125.09 2.12 7.94 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.319 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -67.98 123.39 20.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.22 -0.925 . . . . 0.0 110.31 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 14.9 m -50.53 -25.43 4.07 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.224 -0.922 . . . . 0.0 110.445 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -59.91 -29.06 68.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.194 -0.941 . . . . 0.0 109.848 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.421 ' CG1' HG22 ' A' ' 170' ' ' THR . 39.2 t -88.87 -22.16 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.358 -0.839 . . . . 0.0 109.734 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -80.69 -44.31 18.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.347 -0.846 . . . . 0.0 109.711 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.0 -25.23 67.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.431 -0.793 . . . . 0.0 110.107 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.82 -61.42 2.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -0.852 . . . . 0.0 110.44 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.49 ' CZ ' ' CZ ' ' A' ' 189' ' ' PHE . 88.9 m-85 -89.59 12.24 17.29 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.181 -0.949 . . . . 0.0 110.675 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 50.34 60.62 3.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.143 -0.973 . . . . 0.0 110.719 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 83.8 mt -91.75 124.18 35.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.142 -0.974 . . . . 0.0 109.965 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -60.0 -19.32 51.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.244 -0.91 . . . . 0.0 110.615 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -168.84 -146.96 0.06 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.211 -0.931 . . . . 0.0 110.168 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -75.32 150.06 38.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.229 -0.92 . . . . 0.0 110.171 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -171.54 154.01 21.28 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.427 ' O ' ' CG2' ' A' ' 186' ' ' VAL . 33.3 m -126.04 104.71 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.278 -1.131 . . . . 0.0 110.174 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 95.2 t -111.27 157.91 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 0.0 109.494 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.518 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 9.1 tt -107.15 148.45 28.83 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.887 -1.133 . . . . 0.0 108.926 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.49 ' CZ ' ' CZ ' ' A' ' 179' ' ' TYR . 39.0 m-85 -113.78 129.06 56.63 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.756 -1.215 . . . . 0.0 111.304 -178.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.494 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -137.97 151.95 48.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.274 -0.891 . . . . 0.0 110.269 179.578 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp -83.27 -25.26 31.78 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.337 -0.852 . . . . 0.0 110.252 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.494 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 1.7 p90 -91.77 -176.99 4.63 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.397 -0.814 . . . . 0.0 110.976 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 193' ' ' ASP . 11.1 m-20 48.91 -158.37 0.06 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.574 0.702 . . . . 0.0 110.624 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.25 -46.94 46.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.553 -0.717 . . . . 0.0 110.55 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 133.37 -33.45 2.57 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.6 ptt180 -147.4 -165.84 2.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.188 -1.183 . . . . 0.0 110.593 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' ASN . . . . . 0.518 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.0 OUTLIER -142.7 -153.7 0.48 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.549 -0.719 . . . . 0.0 109.895 -179.273 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -171.94 80.93 0.06 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.467 -0.77 . . . . 0.0 109.935 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.403 ' HB3' HG21 ' A' ' 186' ' ' VAL . 24.9 t80 -53.92 119.49 5.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.833 . . . . 0.0 110.27 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -120.69 89.15 3.07 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.417 -0.802 . . . . 0.0 110.354 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 164.66 -165.68 37.58 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -73.17 126.32 29.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -1.132 . . . . 0.0 110.243 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 97.2 t -76.0 110.19 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 110.139 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 77.6 p -145.79 151.28 37.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.491 -0.756 . . . . 0.0 109.979 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt -48.69 -52.28 24.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.277 -0.889 . . . . 0.0 110.413 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -52.77 -39.86 62.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.324 -0.86 . . . . 0.0 110.19 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -77.31 -44.51 29.35 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.36 -0.838 . . . . 0.0 110.39 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 71.6 mt -53.97 -46.54 71.68 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.317 -0.864 . . . . 0.0 110.29 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 24.6 mt -59.09 -31.64 69.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 0.0 110.027 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -72.19 -28.18 63.04 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.217 -0.927 . . . . 0.0 109.864 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -65.09 -66.67 0.51 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.424 -0.798 . . . . 0.0 110.328 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 5.6 mt -46.37 -42.19 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.436 -0.79 . . . . 0.0 110.778 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -24.73 37.08 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.238 -0.914 . . . . 0.0 110.156 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -113.12 3.74 16.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.331 -0.855 . . . . 0.0 110.832 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -92.25 -60.06 1.94 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.882 -1.136 . . . . 0.0 110.195 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' GLN . . . . . 0.484 ' HA ' ' CZ ' ' A' ' 192' ' ' PHE . 7.4 pt20 . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.335 -0.853 . . . . 0.0 110.407 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.26 0.552 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.436 ' CG2' ' HA2' ' A' ' 168' ' ' GLY . 10.0 t -124.95 171.7 9.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.375 -0.828 . . . . 0.0 110.113 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 50.6 m -109.2 108.76 19.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.34 -0.85 . . . . 0.0 110.095 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.0 mt -84.4 125.7 71.19 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.892 . . . . 0.0 109.973 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.404 ' HD2' ' HB1' ' A' ' 128' ' ' ALA . 46.1 Cg_endo -71.23 -42.82 1.79 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.53 1.279 . . . . 0.0 110.468 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -152.57 -170.05 3.52 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.301 -0.874 . . . . 0.0 110.807 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.09 -26.51 67.59 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -53.26 -34.53 57.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.338 -1.095 . . . . 0.0 110.4 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.404 ' HB1' ' HD2' ' A' ' 124' ' ' PRO . . . -79.26 -33.1 43.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.06 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.35 -32.25 64.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -0.881 . . . . 0.0 110.193 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -90.22 -41.17 11.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.348 -0.845 . . . . 0.0 110.406 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.0 m -62.62 -34.75 77.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.935 . . . . 0.0 110.079 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.1 tp -60.74 -45.29 94.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 110.246 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.496 HG23 ' CD1' ' A' ' 189' ' ' PHE . 43.8 t -56.11 -41.59 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.231 -0.918 . . . . 0.0 110.596 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -85.29 -19.9 30.84 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.219 -0.926 . . . . 0.0 110.496 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.5 m -55.48 -36.97 67.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.202 -0.936 . . . . 0.0 110.3 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.8 p -145.16 -178.82 6.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.159 -0.963 . . . . 0.0 110.288 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.15 -30.54 60.79 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.289 -0.882 . . . . 0.0 110.276 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 92.9 t -130.95 144.99 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 110.129 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -174.95 136.75 0.4 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 110.208 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.439 ' CG1' ' CD1' ' A' ' 167' ' ' PHE . 7.5 p -123.7 150.61 28.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.198 -0.938 . . . . 0.0 110.009 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.465 HG23 ' CE1' ' A' ' 143' ' ' PHE . 5.7 mt -131.17 116.42 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.232 -0.918 . . . . 0.0 110.067 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -87.13 121.63 5.88 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.465 ' CE1' HG23 ' A' ' 141' ' ' ILE . 65.4 m-85 -99.08 98.25 9.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -1.161 . . . . 0.0 109.53 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.437 ' CE1' ' HB2' ' A' ' 151' ' ' SER . 19.8 m-85 -115.67 147.33 40.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.026 -1.046 . . . . 0.0 111.357 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.4 ptmt -91.17 -27.38 18.55 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.643 0.735 . . . . 0.0 109.345 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.03 72.34 1.36 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.603 -0.685 . . . . 0.0 109.502 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.411 ' O ' ' CB ' ' A' ' 152' ' ' ALA . 23.9 m -54.8 -19.77 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.283 -0.886 . . . . 0.0 110.617 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -76.33 0.96 17.53 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.111 -0.993 . . . . 0.0 110.927 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 83.6 p -88.06 -170.19 2.88 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.827 -1.17 . . . . 0.0 109.949 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -81.35 -30.8 33.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.289 -0.882 . . . . 0.0 110.167 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.437 ' HB2' ' CE1' ' A' ' 144' ' ' PHE . 94.9 p -56.92 -28.92 62.59 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.138 -0.976 . . . . 0.0 110.134 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.411 ' CB ' ' O ' ' A' ' 147' ' ' VAL . . . -83.34 -43.16 16.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 109.935 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.6 -53.05 52.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.265 -0.897 . . . . 0.0 110.255 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -56.32 -43.3 78.86 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.386 -0.821 . . . . 0.0 109.974 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -53.3 -57.45 10.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.384 -0.823 . . . . 0.0 110.175 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.9 mt -53.44 -54.33 38.46 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.208 -0.932 . . . . 0.0 110.349 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -50.57 -30.98 14.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.33 -0.856 . . . . 0.0 110.466 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -77.71 -33.18 53.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 0.0 110.021 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.401 ' O ' ' CG2' ' A' ' 162' ' ' ILE . . . -59.33 -44.72 92.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.27 -0.894 . . . . 0.0 110.166 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -79.84 -29.24 40.07 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.36 -0.837 . . . . 0.0 110.307 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -80.62 -6.51 58.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.267 -0.896 . . . . 0.0 110.743 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 212' ' ' ILE . 4.7 tt -92.44 179.66 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.964 -1.085 . . . . 0.0 109.967 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -70.33 62.34 0.23 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.035 -1.04 . . . . 0.0 110.429 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 40.3 52.33 2.85 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.478 0.656 . . . . 0.0 111.194 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.442 ' CG2' ' HD2' ' A' ' 166' ' ' PRO . 34.6 mm -88.25 145.41 35.87 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.497 -0.752 . . . . 0.0 109.835 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.442 ' HD2' ' CG2' ' A' ' 165' ' ' ILE . 43.5 Cg_endo -68.59 91.3 0.41 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.639 1.336 . . . . 0.0 110.759 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.439 ' CD1' ' CG1' ' A' ' 140' ' ' VAL . 2.9 m-85 -88.83 133.91 34.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 0.0 110.133 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.436 ' HA2' ' CG2' ' A' ' 121' ' ' THR . . . -122.43 150.74 16.91 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 5.9 tt -150.04 142.01 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -1.118 . . . . 0.0 110.65 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.1 t -159.23 155.36 26.89 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.125 0.964 . . . . 0.0 110.755 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 85.0 p -116.01 1.04 13.2 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.608 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -57.56 128.28 36.27 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.085 -1.009 . . . . 0.0 110.34 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.14 -28.05 66.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.271 -0.893 . . . . 0.0 110.224 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.41 -45.61 76.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.112 -0.992 . . . . 0.0 109.838 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 42.8 t -67.68 -29.79 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.2 -0.938 . . . . 0.0 109.573 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -76.5 -44.15 36.45 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.376 -0.828 . . . . 0.0 109.357 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 12.1 t -71.59 -5.75 35.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.539 -0.726 . . . . 0.0 110.499 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.59 -47.12 8.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.993 -1.067 . . . . 0.0 108.888 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -90.28 8.4 33.49 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.685 -0.634 . . . . 0.0 110.235 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 53.6 67.29 1.03 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.088 -1.007 . . . . 0.0 110.587 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 42.0 mt -117.27 107.5 14.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.112 -0.992 . . . . 0.0 109.88 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.74 -19.49 17.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.0 110.135 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.53 -164.72 2.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.166 -0.959 . . . . 0.0 109.492 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 3.3 p30 -61.51 164.23 6.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.074 -1.016 . . . . 0.0 109.958 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -158.55 153.84 24.96 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.419 ' O ' ' CB ' ' A' ' 199' ' ' PHE . 92.8 t -129.59 98.73 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.301 -1.117 . . . . 0.0 109.982 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 94.6 t -119.74 158.54 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.275 -0.89 . . . . 0.0 110.111 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.464 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 6.8 tt -109.21 150.48 27.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.085 -1.009 . . . . 0.0 109.572 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.496 ' CD1' HG23 ' A' ' 133' ' ' VAL . 44.4 m-85 -124.63 123.86 40.96 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.938 -1.101 . . . . 0.0 110.511 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.31 174.23 10.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.44 -0.788 . . . . 0.0 110.105 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -94.37 -34.24 12.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.174 -0.954 . . . . 0.0 110.263 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.27 -170.58 2.68 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.388 -0.82 . . . . 0.0 110.948 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 54.68 -160.34 0.16 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.544 0.687 . . . . 0.0 110.5 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -55.02 -53.68 52.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.701 -0.625 . . . . 0.0 110.14 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 130.93 -24.79 4.23 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 24.4 mtm-85 -144.48 178.93 7.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.12 -1.223 . . . . 0.0 110.686 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' ASN . . . . . 0.464 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.0 OUTLIER -147.63 -155.11 0.6 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.343 -0.848 . . . . 0.0 109.687 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 197' ' ' ASN . 6.4 m-80 -169.44 85.48 0.14 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.486 -0.759 . . . . 0.0 110.187 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.419 ' CB ' ' O ' ' A' ' 186' ' ' VAL . 12.5 t80 -57.74 122.32 12.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.279 -0.888 . . . . 0.0 110.433 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -123.33 104.55 9.19 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.251 -0.905 . . . . 0.0 110.24 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 148.79 -167.0 29.31 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.79 134.87 49.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -1.128 . . . . 0.0 110.222 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 70.7 t -86.04 111.17 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.904 . . . . 0.0 110.348 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 68.8 p -149.18 153.96 38.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.472 -0.768 . . . . 0.0 110.097 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -48.06 -54.35 13.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.937 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -54.21 -41.36 68.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.447 -0.783 . . . . 0.0 110.484 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -71.44 -42.87 67.68 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.425 -0.797 . . . . 0.0 110.687 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 71.0 mt -59.7 -51.75 68.43 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.145 -0.972 . . . . 0.0 110.711 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.68 -33.33 60.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.171 -0.955 . . . . 0.0 110.337 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -71.57 -47.62 53.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.216 -0.928 . . . . 0.0 110.3 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -57.95 -55.18 38.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.286 -0.884 . . . . 0.0 110.315 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 162' ' ' ILE . 82.3 mt -54.42 -52.89 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.0 110.447 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.21 -23.77 0.97 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.422 -0.799 . . . . 0.0 111.285 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 214' ' ' HIS . 21.3 m170 -92.19 -20.74 20.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.928 -1.108 . . . . 0.0 110.733 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -93.19 -53.12 4.24 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.034 -1.041 . . . . 0.0 111.516 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 . . . . . 0 N--CA 1.488 1.471 0 O-C-N 121.033 -1.042 . . . . 0.0 111.306 -179.048 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.231 0.539 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.407 ' CG2' ' HA2' ' A' ' 168' ' ' GLY . 7.9 t -89.71 170.72 10.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.891 . . . . 0.0 110.257 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 96.1 m -109.14 104.4 13.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 0.0 110.192 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.5 mt -76.78 139.83 66.8 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.261 -0.899 . . . . 0.0 110.191 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 46.4 Cg_endo -72.15 -35.15 7.22 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 O-C-N 123.556 1.292 . . . . 0.0 110.41 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -165.86 -170.37 1.75 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.235 -0.915 . . . . 0.0 110.932 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.428 ' HA3' ' CD ' ' A' ' 178' ' ' LYS . . . -66.7 -38.03 92.87 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -51.64 -32.97 31.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.231 -1.158 . . . . 0.0 110.4 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.428 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -82.13 -32.21 30.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.896 . . . . 0.0 110.242 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.59 -25.51 26.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.997 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -89.93 -44.63 9.76 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.312 -0.867 . . . . 0.0 109.058 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.3 m -60.51 -28.31 68.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.225 -0.922 . . . . 0.0 109.675 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.8 tt -65.14 -61.74 1.96 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.354 -0.842 . . . . 0.0 109.967 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.438 ' CG2' ' CB ' ' A' ' 189' ' ' PHE . 86.8 t -50.95 -31.11 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.404 -0.81 . . . . 0.0 110.253 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.34 -12.65 61.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.294 -0.879 . . . . 0.0 110.673 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 35.8 m -75.83 -21.97 56.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.015 -1.053 . . . . 0.0 110.25 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.14 168.98 22.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.296 -0.878 . . . . 0.0 110.432 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -72.05 -19.51 61.82 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.396 -0.815 . . . . 0.0 109.724 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 26.0 m -129.9 141.83 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.279 -0.888 . . . . 0.0 110.311 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -175.85 137.36 0.34 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.252 -0.905 . . . . 0.0 110.086 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.477 HG13 ' CE1' ' A' ' 167' ' ' PHE . 14.5 p -123.57 150.49 27.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.18 -0.95 . . . . 0.0 110.351 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.9 mt -132.86 110.39 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.371 -0.831 . . . . 0.0 110.099 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.8 123.94 6.84 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.351 -1.499 . . . . 0.0 109.351 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.46 ' CD2' ' CD1' ' A' ' 181' ' ' LEU . 47.0 m-85 -93.9 80.56 4.15 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.229 -1.159 . . . . 0.0 110.141 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -105.8 140.99 37.99 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.059 -1.026 . . . . 0.0 111.128 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.441 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 61.3 pttt -91.48 -36.18 13.9 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.75 0.785 . . . . 0.0 109.165 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.441 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 4.7 m-20 -122.78 79.97 1.7 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.744 -0.598 . . . . 0.0 109.642 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.7 m -55.26 -19.37 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.239 -0.913 . . . . 0.0 110.708 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.79 11.81 8.49 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.092 -1.005 . . . . 0.0 110.9 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 91.9 p -87.81 -163.7 0.99 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.912 -1.118 . . . . 0.0 110.102 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -90.17 -42.43 11.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.328 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 55.5 m -62.03 -28.82 69.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 110.493 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.8 -25.66 40.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.183 -0.948 . . . . 0.0 110.265 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -63.16 -44.83 94.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 110.08 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -62.2 -40.78 97.22 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.275 -0.891 . . . . 0.0 110.214 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -50.86 -54.89 19.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.198 -0.939 . . . . 0.0 110.256 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 32.0 mt -52.4 -56.14 16.99 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.397 -0.815 . . . . 0.0 110.233 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -52.74 -49.85 64.61 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.322 -0.862 . . . . 0.0 110.257 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.81 -45.58 82.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.892 . . . . 0.0 110.114 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.426 ' HB3' ' CD2' ' A' ' 167' ' ' PHE . . . -64.71 -31.83 73.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 110.1 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.77 -31.26 72.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.359 -0.838 . . . . 0.0 110.157 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.23 -41.53 88.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 110.245 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 76.0 mt -99.72 140.33 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.929 . . . . 0.0 110.274 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -122.66 16.29 10.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.296 -0.877 . . . . 0.0 110.48 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -120.35 19.67 12.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.156 -0.965 . . . . 0.0 110.323 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.437 HG21 HD11 ' A' ' 165' ' ' ILE . 48.1 mm -128.98 132.58 24.46 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.17 -0.956 . . . . 0.0 110.014 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -72.72 70.83 3.4 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.515 1.271 . . . . 0.0 110.281 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.477 ' CE1' HG13 ' A' ' 140' ' ' VAL . 2.2 m-85 -65.54 125.46 25.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 109.954 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.407 ' HA2' ' CG2' ' A' ' 121' ' ' THR . . . -125.0 149.12 16.93 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 12.4 tt -146.76 144.77 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.286 -1.126 . . . . 0.0 110.318 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.2 t -158.15 156.97 31.85 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.022 0.915 . . . . 0.0 110.789 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.5 m -124.17 3.54 8.57 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -60.81 129.89 43.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 0.0 110.279 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 84.4 p -53.52 -29.21 35.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.217 -0.927 . . . . 0.0 110.045 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -56.55 -26.77 55.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.904 . . . . 0.0 109.684 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 42.9 t -86.93 -24.75 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.416 -0.803 . . . . 0.0 109.558 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 176' ' ' PHE . 10.6 m-85 -80.0 -47.9 14.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.295 -0.878 . . . . 0.0 109.403 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.81 -11.25 60.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.391 -0.818 . . . . 0.0 110.693 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.428 ' CD ' ' HA3' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -85.55 -50.54 7.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.061 -1.025 . . . . 0.0 109.697 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 179' ' ' TYR . 32.8 m-85 -89.35 13.62 13.12 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.485 -0.759 . . . . 0.0 110.196 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 49.81 65.3 1.45 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.123 -0.985 . . . . 0.0 110.482 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.46 ' CD1' ' CD2' ' A' ' 143' ' ' PHE . 79.4 mt -118.33 106.4 12.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 110.249 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.41 -30.27 70.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.061 -1.024 . . . . 0.0 109.825 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.17 -149.24 0.35 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.364 -0.835 . . . . 0.0 109.697 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -78.16 175.42 10.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.007 -1.058 . . . . 0.0 109.748 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -167.63 139.75 5.87 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.459 -1.353 . . . . 0.0 109.924 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.418 HG12 ' CD2' ' A' ' 208' ' ' LEU . 95.0 t -121.33 85.75 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.477 -1.014 . . . . 0.0 109.799 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.7 t -109.86 160.26 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.399 -0.813 . . . . 0.0 110.45 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.452 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 2.2 tt -113.15 147.05 38.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.19 -0.944 . . . . 0.0 109.447 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.438 ' CB ' ' CG2' ' A' ' 133' ' ' VAL . 45.2 m-85 -118.7 125.15 49.05 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.981 -1.075 . . . . 0.0 110.651 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -139.92 161.75 36.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.888 . . . . 0.0 109.907 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.0 mmpp? -87.24 -20.65 26.59 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.181 -0.949 . . . . 0.0 110.563 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.448 ' CZ ' ' HB2' ' A' ' 190' ' ' LYS . 3.4 p90 -90.87 179.73 5.7 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.292 -0.88 . . . . 0.0 110.823 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 44.55 -158.24 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.551 0.691 . . . . 0.0 111.035 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -50.99 -43.74 60.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.577 -0.702 . . . . 0.0 110.235 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 112.37 -21.07 20.22 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -137.9 174.26 10.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.099 -1.236 . . . . 0.0 110.735 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' ASN . . . . . 0.452 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.0 OUTLIER -144.54 -152.29 0.41 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.502 -0.749 . . . . 0.0 109.515 -179.827 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 27.8 p30 -173.77 76.06 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 0.0 110.548 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -54.01 125.47 18.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -0.938 . . . . 0.0 109.92 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -132.72 33.01 3.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.928 . . . . 0.0 110.096 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -117.96 175.74 15.84 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.77 122.74 10.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -1.157 . . . . 0.0 110.161 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 78.4 t -65.55 102.75 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.157 -0.965 . . . . 0.0 110.18 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 82.1 p -150.11 151.91 33.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.389 -0.819 . . . . 0.0 110.24 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 23.2 tttt -50.44 -50.1 53.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 0.0 110.491 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -53.28 -35.44 60.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.203 -0.936 . . . . 0.0 110.388 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -79.03 -46.76 17.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 0.0 110.147 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.418 ' CD2' HG12 ' A' ' 186' ' ' VAL . 82.8 mt -62.53 -31.02 71.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 110.263 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 19.0 mt -70.44 -26.67 63.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 110.187 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -86.9 -47.69 8.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.166 -0.959 . . . . 0.0 110.039 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -49.45 -50.15 42.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.317 -0.865 . . . . 0.0 110.213 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 28.2 mm -55.38 -69.26 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.533 -0.729 . . . . 0.0 110.185 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.34 -36.81 4.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.759 -0.588 . . . . 0.0 111.063 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -40.04 95.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.137 -0.977 . . . . 0.0 110.121 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -89.71 -45.04 9.6 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.3 -0.875 . . . . 0.0 110.451 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.221 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.299 0.571 . . . . 0.0 110.387 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 167' ' ' PHE . 7.9 m -104.68 116.7 32.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.336 -0.853 . . . . 0.0 109.706 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 79.8 m -69.17 142.01 54.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 0.0 110.191 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.7 mt -124.29 144.41 45.63 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 110.148 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.419 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 45.8 Cg_endo -72.48 -37.42 4.25 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.713 1.375 . . . . 0.0 110.372 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.41 ' HA ' ' CG2' ' A' ' 175' ' ' VAL . 0.9 OUTLIER -173.27 -170.46 0.62 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.205 -0.934 . . . . 0.0 110.687 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -57.8 -30.59 63.11 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -51.49 -35.55 40.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.257 -1.143 . . . . 0.0 110.498 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.419 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -82.85 -38.19 23.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.108 -0.995 . . . . 0.0 110.203 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.73 -24.86 24.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.108 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -77.66 -64.16 1.21 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 110.165 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.0 -23.14 12.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 110.139 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.1 tt -64.76 -59.48 4.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 0.0 109.946 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.482 HG23 ' CD2' ' A' ' 189' ' ' PHE . 56.4 t -50.49 -41.53 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.37 -0.831 . . . . 0.0 110.562 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -80.22 1.72 27.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.919 . . . . 0.0 110.931 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 17.5 t -82.71 -27.38 31.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.898 -1.126 . . . . 0.0 110.051 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.42 171.59 16.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.262 -0.899 . . . . 0.0 110.168 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.25 -20.15 63.94 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.335 -0.853 . . . . 0.0 109.583 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 18.2 m -135.13 149.15 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.259 -0.901 . . . . 0.0 110.169 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -173.64 138.06 0.65 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.233 -0.917 . . . . 0.0 110.232 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.442 ' CG1' ' HA ' ' A' ' 167' ' ' PHE . 7.2 p -125.99 153.67 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 121.072 -1.017 . . . . 0.0 110.365 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.422 ' O ' ' CE1' ' A' ' 143' ' ' PHE . 52.9 mt -137.96 114.5 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 109.905 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.56 136.69 18.33 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.478 ' CE2' HG13 ' A' ' 175' ' ' VAL . 67.6 m-85 -112.97 72.84 0.79 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.299 -1.118 . . . . 0.0 110.014 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.414 ' CE1' ' HB3' ' A' ' 184' ' ' ASP . 10.8 m-85 -102.35 142.7 33.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 111.051 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.88 -27.38 23.46 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.765 0.793 . . . . 0.0 109.494 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.7 p30 -126.24 69.63 1.22 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.694 -0.629 . . . . 0.0 109.616 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.441 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 31.4 m -50.41 -23.27 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.725 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.414 ' N ' HG21 ' A' ' 147' ' ' VAL . 0.7 OUTLIER -85.16 -9.47 57.81 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.115 -0.991 . . . . 0.0 111.296 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 52.7 p -69.95 -159.69 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.894 -1.129 . . . . 0.0 110.333 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -90.35 -45.74 8.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.386 -0.822 . . . . 0.0 110.267 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.9 p -52.32 -30.0 26.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.318 -0.864 . . . . 0.0 110.224 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -83.24 -34.99 25.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.372 -0.83 . . . . 0.0 110.174 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.2 mmtt -49.89 -40.1 41.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.309 -0.87 . . . . 0.0 110.357 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.8 -45.03 83.9 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.288 -0.882 . . . . 0.0 110.002 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -48.05 -55.4 10.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.273 -0.892 . . . . 0.0 110.597 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.0 mt -48.59 -54.6 13.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.277 -0.89 . . . . 0.0 110.667 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -52.23 -51.61 57.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.217 -0.927 . . . . 0.0 110.171 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.0 -39.37 85.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.145 -0.972 . . . . 0.0 109.824 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.39 -32.21 71.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.343 -0.848 . . . . 0.0 110.066 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -80.62 -29.48 36.8 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.314 -0.866 . . . . 0.0 110.277 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.16 -52.21 61.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -0.893 . . . . 0.0 110.365 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 19.0 tt -89.79 150.04 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 110.064 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -132.57 35.77 3.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.108 -0.995 . . . . 0.0 110.661 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -136.05 17.79 3.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.169 -0.957 . . . . 0.0 110.228 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.449 ' CG2' ' HD2' ' A' ' 166' ' ' PRO . 39.5 mm -135.17 146.5 58.53 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.238 -0.914 . . . . 0.0 109.923 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.449 ' HD2' ' CG2' ' A' ' 165' ' ' ILE . 47.6 Cg_endo -84.18 90.83 0.85 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.779 1.41 . . . . 0.0 110.248 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.442 ' HA ' ' CG1' ' A' ' 140' ' ' VAL . 3.9 m-85 -85.81 130.93 34.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.29 -0.882 . . . . 0.0 110.554 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -120.01 153.07 16.86 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 14.7 tt -147.42 144.36 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -1.125 . . . . 0.0 110.305 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.425 HG22 ' CG1' ' A' ' 175' ' ' VAL . 2.5 t -162.17 157.58 23.36 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.064 0.935 . . . . 0.0 110.693 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.1 1.58 9.2 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.411 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -59.41 121.52 11.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.115 -0.991 . . . . 0.0 110.259 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 79.4 p -51.65 -29.99 20.02 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.096 -1.002 . . . . 0.0 110.296 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -59.19 -35.6 73.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.136 -0.978 . . . . 0.0 109.842 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.478 HG13 ' CE2' ' A' ' 143' ' ' PHE . 60.3 t -76.85 -26.54 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.39 -0.819 . . . . 0.0 109.812 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -79.59 -53.26 7.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.395 -0.816 . . . . 0.0 109.865 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -25.45 63.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.955 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.43 -53.01 62.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 110.037 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -92.83 16.99 11.21 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.222 -0.923 . . . . 0.0 110.409 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 53.54 69.47 0.7 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.249 -0.907 . . . . 0.0 110.603 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 77.6 mt -115.02 123.01 47.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.212 -0.93 . . . . 0.0 110.024 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -86.39 -21.01 27.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.166 -0.959 . . . . 0.0 110.19 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -148.84 -166.14 2.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.329 -0.857 . . . . 0.0 109.914 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.414 ' HB3' ' CE1' ' A' ' 144' ' ' PHE . 71.2 m-20 -53.46 152.33 4.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.938 . . . . 0.0 109.997 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -157.77 131.74 2.96 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 72.8 t -115.21 85.69 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.356 -1.085 . . . . 0.0 109.619 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.437 HG11 ' N ' ' A' ' 188' ' ' LEU . 85.5 t -102.72 149.25 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.371 -0.831 . . . . 0.0 110.18 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.453 ' CD2' ' CD ' ' A' ' 190' ' ' LYS . 5.3 tt -105.53 150.59 25.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.122 -0.986 . . . . 0.0 109.627 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.482 ' CD2' HG23 ' A' ' 133' ' ' VAL . 46.1 m-85 -119.52 121.19 38.85 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.931 -1.106 . . . . 0.0 110.554 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.453 ' CD ' ' CD2' ' A' ' 188' ' ' LEU . 0.0 OUTLIER -136.33 160.76 37.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 0.0 110.171 179.815 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -85.53 -22.94 27.91 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.312 -0.868 . . . . 0.0 110.556 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.415 ' CZ ' ' HB2' ' A' ' 190' ' ' LYS . 2.5 p90 -90.45 -176.29 4.73 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.392 -0.817 . . . . 0.0 110.865 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 193' ' ' ASP . 0.7 OUTLIER 46.52 -157.97 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.481 0.658 . . . . 0.0 110.511 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -54.83 -54.96 35.53 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.475 -0.766 . . . . 0.0 110.094 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 134.47 -31.61 2.74 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -131.56 173.09 11.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.157 -1.202 . . . . 0.0 110.66 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' ASN . . . . . 0.45 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.6 m-80 -138.21 -151.51 0.39 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.515 -0.741 . . . . 0.0 109.673 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -175.6 77.0 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.356 -0.84 . . . . 0.0 110.051 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -48.41 142.84 5.3 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.329 -0.857 . . . . 0.0 110.915 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -150.29 134.98 17.48 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.31 -0.869 . . . . 0.0 109.649 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 125.08 -178.39 16.55 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -54.98 121.15 8.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -1.139 . . . . 0.0 110.232 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 75.8 t -74.91 102.57 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.191 -0.943 . . . . 0.0 110.212 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.3 p -136.6 145.26 44.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.367 -0.833 . . . . 0.0 109.705 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.08 -47.53 34.05 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.157 -0.964 . . . . 0.0 110.838 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -59.11 -40.49 85.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.24 -0.912 . . . . 0.0 110.458 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -67.68 -39.53 84.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.123 -0.986 . . . . 0.0 110.407 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.412 ' O ' ' CD1' ' A' ' 212' ' ' ILE . 36.7 mt -63.42 -52.63 60.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 110.41 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 6.9 mt -51.69 -24.39 5.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.172 -0.955 . . . . 0.0 110.407 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -82.4 -48.76 10.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.17 -0.956 . . . . 0.0 110.031 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -53.27 -57.22 11.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 110.474 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.412 ' CD1' ' O ' ' A' ' 208' ' ' LEU . 4.4 mt -49.79 -54.2 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.179 -0.95 . . . . 0.0 110.61 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.29 -29.45 9.74 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.286 -0.884 . . . . 0.0 110.66 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -81.45 -15.97 53.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.31 -0.869 . . . . 0.0 110.782 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -104.77 -35.52 7.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.08 -1.013 . . . . 0.0 110.849 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.13 -0.982 . . . . 0.0 110.949 -179.525 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.191 0.52 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.428 ' O ' ' CG2' ' A' ' 169' ' ' ILE . 7.2 t -145.31 152.32 39.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.154 -0.966 . . . . 0.0 110.048 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 169' ' ' ILE . 1.5 m -86.15 125.49 33.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.067 -1.02 . . . . 0.0 109.891 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.473 ' CD1' ' CG2' ' A' ' 141' ' ' ILE . 71.0 mt -88.47 130.87 43.94 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.88 -1.137 . . . . 0.0 110.297 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 48.6 Cg_endo -72.68 -51.21 0.19 Allowed 'Trans proline' 0 C--N 1.315 -1.207 0 O-C-N 123.422 1.222 . . . . 0.0 110.556 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -141.9 -169.43 2.91 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.247 -0.908 . . . . 0.0 110.778 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.94 -27.04 72.87 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.13 -27.48 65.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.205 -1.173 . . . . 0.0 110.237 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.435 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -90.05 -21.28 22.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.944 . . . . 0.0 110.227 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.95 -21.88 50.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 110.252 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -90.31 -40.75 11.93 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.27 -0.894 . . . . 0.0 109.623 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.83 -31.18 66.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.147 -0.971 . . . . 0.0 110.385 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.4 tp -68.69 -43.98 74.95 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.296 -0.877 . . . . 0.0 110.391 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.401 ' CG2' ' HB3' ' A' ' 189' ' ' PHE . 46.2 t -51.56 -53.99 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.339 -0.85 . . . . 0.0 110.519 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.27 -17.84 60.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.196 -0.94 . . . . 0.0 110.471 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.6 p -53.3 -38.6 63.27 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.126 -0.984 . . . . 0.0 110.331 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.3 p -147.27 -172.77 4.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.301 -0.875 . . . . 0.0 110.249 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.06 -45.8 47.17 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.341 -0.85 . . . . 0.0 110.362 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.4 m -116.76 151.63 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.938 . . . . 0.0 110.464 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.418 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -175.26 127.11 0.26 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.911 . . . . 0.0 109.934 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.83 153.03 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.102 -0.999 . . . . 0.0 110.02 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.473 ' CG2' ' CD1' ' A' ' 123' ' ' LEU . 56.8 mt -139.98 114.74 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.144 -0.972 . . . . 0.0 110.47 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.0 132.4 11.06 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 143' ' ' PHE . 18.7 m-85 -100.68 92.3 5.03 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.243 -1.151 . . . . 0.0 109.679 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -114.78 147.31 39.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.065 -1.022 . . . . 0.0 111.536 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.76 -26.85 19.28 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.57 0.7 . . . . 0.0 109.652 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.03 78.49 1.68 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.607 -0.683 . . . . 0.0 109.603 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.448 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 22.2 m -50.77 -23.2 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.289 -0.882 . . . . 0.0 110.69 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -72.5 -3.59 25.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.0 110.899 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 7.4 p -78.61 -164.73 0.61 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.851 -1.155 . . . . 0.0 110.161 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.2 -47.52 7.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.277 -0.889 . . . . 0.0 110.436 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.2 m -51.14 -27.34 8.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.24 -0.913 . . . . 0.0 110.541 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -81.16 -40.48 23.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.931 . . . . 0.0 110.026 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.8 mtpt -50.95 -47.07 61.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.354 -0.841 . . . . 0.0 110.317 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -53.63 -33.73 56.11 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.118 -0.989 . . . . 0.0 109.689 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . 0.405 ' CE1' ' CG1' ' A' ' 186' ' ' VAL . 4.0 t80 -66.96 -56.65 9.26 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.405 -0.809 . . . . 0.0 109.935 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.3 mp -46.71 -55.98 6.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.535 -0.728 . . . . 0.0 110.649 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -51.17 -46.73 62.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.35 -0.844 . . . . 0.0 110.292 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.27 -45.59 83.88 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.944 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.79 -38.03 71.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.21 -0.931 . . . . 0.0 109.971 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.35 -28.2 59.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.193 -0.942 . . . . 0.0 110.051 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.21 -42.09 76.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.869 . . . . 0.0 110.201 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.434 ' CD1' HG13 ' A' ' 165' ' ' ILE . 5.5 tt -96.41 152.06 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 110.343 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -131.22 15.35 5.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.272 -0.892 . . . . 0.0 110.558 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -124.05 16.14 9.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.077 -1.014 . . . . 0.0 110.415 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.454 ' CG2' ' HD2' ' A' ' 166' ' ' PRO . 39.4 mm -132.49 146.27 60.77 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.176 -0.952 . . . . 0.0 110.016 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.454 ' HD2' ' CG2' ' A' ' 165' ' ' ILE . 46.4 Cg_endo -84.34 78.93 2.7 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.747 1.393 . . . . 0.0 110.495 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -77.29 135.03 38.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 0.0 110.221 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -136.06 153.62 21.55 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.428 ' CG2' ' O ' ' A' ' 121' ' ' THR . 1.7 tt -130.85 151.09 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.173 -1.192 . . . . 0.0 109.451 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.472 ' CG2' ' CG2' ' A' ' 175' ' ' VAL . 0.7 OUTLIER -119.36 144.61 46.78 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.1 -1.0 . . . . 0.0 110.94 -178.577 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.5 t -130.85 12.89 5.29 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.503 -0.748 . . . . 0.0 109.814 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.435 ' ND2' ' HB2' ' A' ' 174' ' ' ASP . 50.8 t30 -112.36 160.76 17.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.068 -1.02 . . . . 0.0 110.893 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 39.6 t -83.29 -28.43 29.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.448 -0.782 . . . . 0.0 109.966 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.435 ' HB2' ' ND2' ' A' ' 172' ' ' ASN . 1.7 m-20 -53.8 -32.01 51.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -0.947 . . . . 0.0 109.519 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.472 ' CG2' ' CG2' ' A' ' 170' ' ' THR . 38.4 t -76.89 -32.17 19.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -69.83 -59.13 3.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.477 -0.765 . . . . 0.0 109.215 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.6 m -53.18 -23.76 9.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.444 -0.785 . . . . 0.0 109.514 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.45 ' HD2' ' CE1' ' A' ' 179' ' ' TYR . 3.4 tmtt? -61.31 -61.38 2.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.525 -0.734 . . . . 0.0 110.067 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.45 ' CE1' ' HD2' ' A' ' 178' ' ' LYS . 94.1 m-85 -89.58 8.39 31.52 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.47 -0.769 . . . . 0.0 110.645 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.9 62.68 2.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.039 -1.038 . . . . 0.0 110.55 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 mt -92.83 134.41 35.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.282 -0.886 . . . . 0.0 110.11 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -73.67 -9.72 58.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 110.587 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -175.94 -165.91 0.17 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.022 -1.049 . . . . 0.0 110.067 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -70.01 152.33 44.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.21 -0.931 . . . . 0.0 110.015 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -177.21 166.86 37.71 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.405 ' CG1' ' CE1' ' A' ' 155' ' ' PHE . 18.6 m -126.22 121.88 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -1.154 . . . . 0.0 110.328 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 89.8 t -118.39 158.84 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.452 -0.78 . . . . 0.0 109.5 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.478 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 7.1 tt -107.27 140.2 40.54 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.826 -1.171 . . . . 0.0 109.8 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.401 ' HB3' ' CG2' ' A' ' 133' ' ' VAL . 49.6 m-85 -117.38 111.15 18.94 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.995 -1.066 . . . . 0.0 110.598 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.432 ' HD3' ' CD2' ' A' ' 188' ' ' LEU . 0.0 OUTLIER -124.22 -172.81 2.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.27 -0.894 . . . . 0.0 110.06 179.852 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 11.5 mttt -106.62 -26.04 11.53 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.128 -0.983 . . . . 0.0 110.526 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -90.83 -175.89 4.51 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.381 -0.824 . . . . 0.0 110.829 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 47.68 -159.06 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.54 -0.725 . . . . 0.0 110.887 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -52.98 -43.54 66.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.662 -0.649 . . . . 0.0 110.294 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 113.9 -27.08 9.43 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 11.8 mtm180 -135.76 163.98 28.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.184 -1.186 . . . . 0.0 110.386 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' ASN . . . . . 0.478 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 0.8 OUTLIER -136.49 -153.82 0.52 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.342 -0.848 . . . . 0.0 109.796 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -172.89 80.84 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.421 -0.799 . . . . 0.0 110.267 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -48.61 119.67 3.24 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.341 -0.849 . . . . 0.0 110.634 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -113.77 90.2 3.28 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.275 -0.89 . . . . 0.0 110.288 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 164.4 -165.44 37.3 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -74.85 117.88 17.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -1.145 . . . . 0.0 110.278 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 6.9 p -66.95 83.28 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 110.091 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 81.4 p -121.24 153.83 37.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 0.0 110.212 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -46.93 -55.18 8.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.372 -0.83 . . . . 0.0 110.543 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -54.74 -30.67 56.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.477 -0.764 . . . . 0.0 110.236 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -86.95 -23.96 24.92 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.228 -0.92 . . . . 0.0 110.248 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 18.7 mt -75.54 -53.46 8.6 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.295 -0.878 . . . . 0.0 110.541 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 4.7 mp -57.58 -20.57 33.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.88 . . . . 0.0 110.633 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -81.94 -53.74 5.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.152 -0.968 . . . . 0.0 110.15 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -60.69 -55.64 30.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.33 -0.856 . . . . 0.0 110.677 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 8.1 mt -51.57 -41.98 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.227 -0.921 . . . . 0.0 110.695 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -69.58 -15.01 63.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.122 -0.986 . . . . 0.0 110.836 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.64 -16.83 27.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.129 -0.982 . . . . 0.0 110.795 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -103.69 -39.63 6.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.995 -1.066 . . . . 0.0 110.862 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.071 -1.018 . . . . 0.0 110.519 -179.772 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.207 0.527 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.6 t -92.14 164.71 13.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 110.305 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 91.1 m -101.91 100.72 11.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.928 . . . . 0.0 110.149 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.4 mt -75.93 131.68 75.71 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.284 -0.885 . . . . 0.0 110.081 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -72.34 -36.95 4.83 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 O-C-N 123.52 1.273 . . . . 0.0 110.485 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -163.26 -169.5 2.0 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 122.073 0.939 . . . . 0.0 111.262 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.67 -27.2 65.95 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -55.62 -29.26 58.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -1.141 . . . . 0.0 110.278 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.43 -26.02 20.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.278 -0.888 . . . . 0.0 110.171 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.09 68.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.866 . . . . 0.0 110.119 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -90.26 -40.97 11.84 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.23 -0.918 . . . . 0.0 109.188 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 41.4 m -66.71 -22.68 66.06 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.233 -0.917 . . . . 0.0 110.147 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.0 tp -69.95 -50.76 38.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 110.429 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 91.3 t -58.21 -37.82 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.298 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -77.86 -17.36 57.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 110.419 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.5 p -63.84 -44.76 92.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.035 -1.041 . . . . 0.0 110.303 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 89.4 p -138.2 -173.72 3.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -0.882 . . . . 0.0 110.26 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.19 -44.93 74.75 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.273 -0.892 . . . . 0.0 110.258 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.437 HG22 ' CD1' ' A' ' 165' ' ' ILE . 33.6 m -120.53 163.71 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.261 -0.899 . . . . 0.0 110.453 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -176.38 125.42 0.18 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.411 -0.806 . . . . 0.0 109.634 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.498 HG13 ' CE2' ' A' ' 167' ' ' PHE . 8.2 p -112.29 139.64 36.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.049 -1.032 . . . . 0.0 110.781 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.468 ' O ' ' CE1' ' A' ' 143' ' ' PHE . 3.4 mt -130.97 113.58 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.316 -0.865 . . . . 0.0 109.671 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.76 136.68 20.34 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.469 ' CE2' HG13 ' A' ' 175' ' ' VAL . 28.6 m-85 -105.87 69.07 0.8 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -1.134 . . . . 0.0 109.715 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -95.37 145.79 24.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 110.835 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.04 -27.15 24.95 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.51 -0.744 . . . . 0.0 109.724 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.85 78.56 1.75 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.528 -0.733 . . . . 0.0 109.677 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.444 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 22.6 m -51.12 -23.08 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.242 -0.911 . . . . 0.0 110.561 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -76.94 1.01 18.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.06 -1.025 . . . . 0.0 110.933 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 95.1 p -75.55 -164.89 0.37 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.835 -1.166 . . . . 0.0 110.31 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.63 -34.36 15.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.324 -0.86 . . . . 0.0 110.603 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 38.6 t -68.32 -27.88 66.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.263 -0.898 . . . . 0.0 110.269 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.444 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -78.47 -34.04 47.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.142 -0.973 . . . . 0.0 109.939 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -53.78 -52.06 61.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 0.0 110.065 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -54.94 -33.68 62.49 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.263 -0.898 . . . . 0.0 109.787 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . 0.526 ' CE1' ' CG1' ' A' ' 186' ' ' VAL . 4.3 t80 -60.06 -57.4 13.01 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.457 -0.777 . . . . 0.0 109.903 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.6 mp -46.74 -57.04 5.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.508 -0.745 . . . . 0.0 110.591 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -52.36 -52.42 53.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.292 -0.88 . . . . 0.0 110.093 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.02 -38.64 79.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 0.0 109.907 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -68.11 -31.88 71.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -0.872 . . . . 0.0 109.813 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -80.82 -24.17 38.67 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.3 -0.875 . . . . 0.0 110.045 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.78 -40.34 94.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.31 -0.869 . . . . 0.0 110.072 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.5 tt -89.98 151.04 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.33 -0.856 . . . . 0.0 109.978 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.59 16.28 4.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.157 -0.965 . . . . 0.0 110.665 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -125.5 14.21 8.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.029 -1.045 . . . . 0.0 110.604 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.437 ' CD1' HG22 ' A' ' 138' ' ' VAL . 47.8 mm -134.91 135.53 23.35 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.018 -1.051 . . . . 0.0 110.15 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -78.3 81.62 2.68 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.543 1.286 . . . . 0.0 110.873 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.498 ' CE2' HG13 ' A' ' 140' ' ' VAL . 5.4 m-85 -71.14 145.19 49.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.133 -0.979 . . . . 0.0 109.857 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -137.65 159.29 24.88 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 4.4 tt -150.75 149.34 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -1.165 . . . . 0.0 110.304 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.3 t -168.82 157.12 8.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.188 -0.945 . . . . 0.0 111.005 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.4 ' HA ' ' CE1' ' A' ' 176' ' ' PHE . 87.6 p -125.54 2.84 7.62 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.378 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -61.73 124.2 20.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.171 -0.956 . . . . 0.0 110.248 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.06 -31.52 7.96 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.189 -0.945 . . . . 0.0 110.553 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.43 -41.78 66.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 110.023 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.469 HG13 ' CE2' ' A' ' 143' ' ' PHE . 61.3 t -75.54 -24.01 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.299 -0.875 . . . . 0.0 109.963 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.4 ' CE1' ' HA ' ' A' ' 171' ' ' SER . 10.6 m-85 -77.28 -54.29 6.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.891 . . . . 0.0 109.721 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.34 -21.86 60.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.367 -0.833 . . . . 0.0 110.085 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.95 -58.79 6.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 110.086 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.421 ' O ' ' HG2' ' A' ' 180' ' ' GLN . 96.3 m-85 -94.78 30.47 2.06 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.194 -0.941 . . . . 0.0 110.456 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 0.1 OUTLIER 29.57 62.02 0.16 Allowed 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 179.728 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.9 mt -89.61 128.24 36.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.073 -1.017 . . . . 0.0 109.962 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.29 -3.86 29.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.933 . . . . 0.0 110.74 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -174.77 -147.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.99 -1.069 . . . . 0.0 109.876 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -89.14 150.32 22.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.191 -0.943 . . . . 0.0 109.974 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -179.82 137.61 3.13 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.526 ' CG1' ' CE1' ' A' ' 155' ' ' PHE . 18.8 m -100.59 119.27 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.274 -1.133 . . . . 0.0 110.357 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 98.0 t -121.39 150.35 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.924 . . . . 0.0 110.029 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.479 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 6.3 tt -106.39 144.29 33.28 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.217 -0.927 . . . . 0.0 108.903 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -119.83 122.0 40.36 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.896 -1.127 . . . . 0.0 110.545 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.488 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -130.14 165.4 22.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 110.116 179.687 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.4 mmtm -84.32 -33.29 23.94 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.297 -0.877 . . . . 0.0 110.396 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.488 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.2 OUTLIER -90.9 -173.65 3.76 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.54 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 56.11 -153.86 0.34 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.23 -0.919 . . . . 0.0 110.076 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -71.93 -24.87 61.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.7 -0.625 . . . . 0.0 110.378 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 103.4 -30.53 10.16 Favored Glycine 0 N--CA 1.484 1.861 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -130.3 175.75 8.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.125 -1.221 . . . . 0.0 110.454 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' ASN . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 211' ' ' PHE . 1.7 m-80 -139.7 -44.64 0.44 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.322 -0.861 . . . . 0.0 110.227 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 63.66 87.42 0.11 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.346 -0.846 . . . . 0.0 109.839 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -57.85 134.74 56.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.448 -0.783 . . . . 0.0 110.472 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -130.63 114.84 15.93 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.273 -0.892 . . . . 0.0 109.831 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 139.95 -128.61 3.96 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -115.16 125.3 53.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.238 -1.154 . . . . 0.0 110.272 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 70.8 t -74.78 107.02 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 110.029 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 50.0 p -148.0 158.69 44.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.326 -0.859 . . . . 0.0 110.161 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -49.22 -52.61 25.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.216 -0.927 . . . . 0.0 110.804 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -57.56 -37.15 72.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.315 -0.866 . . . . 0.0 110.429 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 45.2 m-20 -81.65 -42.89 19.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.435 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.409 ' CD1' ' HA ' ' A' ' 155' ' ' PHE . 51.1 mt -57.86 -54.71 43.83 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.226 -0.921 . . . . 0.0 110.257 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.54 -28.19 43.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.148 -0.97 . . . . 0.0 109.748 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -77.05 -43.62 33.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.414 -0.804 . . . . 0.0 109.691 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.485 ' CZ ' ' HB3' ' A' ' 197' ' ' ASN . 8.4 t80 -62.01 -59.85 4.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.418 -0.801 . . . . 0.0 110.025 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 4.7 mt -50.1 -40.47 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.306 -0.871 . . . . 0.0 110.375 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -66.04 -32.3 73.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.332 -0.855 . . . . 0.0 110.07 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . 0.424 ' CD2' ' O ' ' A' ' 214' ' ' HIS . 16.8 t60 -90.44 8.38 34.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.275 -0.89 . . . . 0.0 110.716 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 6.8 m120 -95.55 -61.99 1.37 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.892 -1.13 . . . . 0.0 110.165 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.308 -0.87 . . . . 0.0 110.557 -179.841 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.436 ' HB2' ' CA ' ' A' ' 168' ' ' GLY . . . . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.014 0.435 . . . . 0.0 110.051 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.8 t -82.54 162.03 22.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.093 -1.004 . . . . 0.0 109.917 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.1 m -97.42 119.87 36.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.951 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 40.7 mt -105.92 134.13 19.88 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.95 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.22 -39.16 1.72 Allowed 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.466 1.245 . . . . 0.0 110.054 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.37 -169.31 2.72 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.056 0.932 . . . . 0.0 110.873 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -63.11 -21.92 64.4 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.77 -27.78 63.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -1.113 . . . . 0.0 110.389 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -88.45 -31.95 18.52 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.093 -1.004 . . . . 0.0 110.061 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -55.17 -22.02 15.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 109.913 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -89.17 -35.61 16.14 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.299 -0.875 . . . . 0.0 109.025 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.0 m -69.89 -23.94 63.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 109.967 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.2 tp -72.73 -48.64 36.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.337 -0.852 . . . . 0.0 110.072 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.431 ' CG2' ' HB3' ' A' ' 189' ' ' PHE . 46.9 t -52.74 -43.77 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.338 -0.851 . . . . 0.0 110.31 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -78.84 -20.82 48.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.238 -0.914 . . . . 0.0 110.429 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 25.3 t -56.72 -56.36 22.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -0.927 . . . . 0.0 110.165 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 86.8 p -128.97 165.75 20.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 0.0 110.301 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.418 ' CG ' ' N ' ' A' ' 138' ' ' VAL . 18.3 pt-20 -57.94 -40.77 81.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.27 -0.894 . . . . 0.0 110.098 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.418 ' N ' ' CG ' ' A' ' 137' ' ' GLU . 74.6 t -124.01 144.8 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.405 -0.809 . . . . 0.0 110.154 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -170.47 144.55 2.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.328 -0.858 . . . . 0.0 109.709 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.482 HG12 ' CE2' ' A' ' 167' ' ' PHE . 7.3 p -129.35 153.05 38.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 121.011 -1.056 . . . . 0.0 110.252 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.427 ' O ' ' CE1' ' A' ' 143' ' ' PHE . 20.5 mt -131.41 123.07 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.88 . . . . 0.0 109.9 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -85.81 129.01 9.09 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' A' ' 143' ' ' PHE . 28.8 m-85 -101.74 78.98 1.88 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -1.159 . . . . 0.0 109.898 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -106.17 146.4 30.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.199 -0.938 . . . . 0.0 111.051 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.11 -27.12 18.77 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.617 0.722 . . . . 0.0 109.522 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.55 73.72 1.55 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.664 -0.647 . . . . 0.0 109.405 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.452 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 21.7 m -49.3 -23.35 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.397 -0.815 . . . . 0.0 111.02 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -81.57 7.12 12.91 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.965 -1.084 . . . . 0.0 111.255 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.6 p -78.52 -164.37 0.56 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.864 -1.148 . . . . 0.0 110.506 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -91.04 -24.41 20.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.521 -0.737 . . . . 0.0 110.282 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.64 -30.66 46.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.29 -0.881 . . . . 0.0 109.974 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.452 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -80.26 -19.96 45.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 0.0 110.196 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -38.83 92.72 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.309 -0.869 . . . . 0.0 109.925 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -69.97 -42.14 73.54 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.396 -0.815 . . . . 0.0 110.027 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . 0.408 ' HA ' ' CD1' ' A' ' 208' ' ' LEU . 4.3 t80 -50.86 -57.75 7.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.359 -0.838 . . . . 0.0 110.337 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 74.9 mt -57.43 -49.7 75.39 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.435 -0.79 . . . . 0.0 110.095 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -52.33 -52.98 50.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.511 -0.743 . . . . 0.0 110.304 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -66.64 -46.0 77.2 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.192 -0.942 . . . . 0.0 110.173 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -53.15 -32.41 47.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.209 -0.932 . . . . 0.0 110.223 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -66.84 -38.42 86.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 110.2 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.81 -40.79 92.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.263 -0.898 . . . . 0.0 110.162 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 72.3 mt -91.53 92.53 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.292 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -90.62 -27.83 18.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -0.872 . . . . 0.0 110.308 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 164' ' ' ASP . 16.2 p-10 -57.79 -26.62 62.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.915 . . . . 0.0 110.221 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.405 HD11 HG22 ' A' ' 165' ' ' ILE . 45.9 mm -104.75 127.24 29.26 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.175 -0.953 . . . . 0.0 109.953 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -78.24 85.84 1.76 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.448 1.236 . . . . 0.0 110.675 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.482 ' CE2' HG12 ' A' ' 140' ' ' VAL . 3.8 m-85 -66.16 174.88 2.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.087 -1.008 . . . . 0.0 109.996 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.436 ' CA ' ' HB2' ' A' ' 120' ' ' ALA . . . -150.11 151.37 23.45 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 6.3 tt -150.47 142.46 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.939 -1.33 . . . . 0.0 110.539 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.2 t -160.78 155.67 24.08 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.013 0.911 . . . . 0.0 110.759 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 24.5 p -115.57 -1.9 12.64 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.589 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.416 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 20.4 t30 -52.65 164.24 0.37 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.195 -0.941 . . . . 0.0 110.161 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 26.2 p -91.44 -33.41 15.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.221 -0.924 . . . . 0.0 109.958 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -57.29 -27.4 62.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.229 -0.919 . . . . 0.0 109.826 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.477 HG13 ' CD2' ' A' ' 143' ' ' PHE . 47.6 t -78.08 -29.14 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.336 -0.852 . . . . 0.0 109.725 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.425 ' N ' ' CD1' ' A' ' 176' ' ' PHE . 16.7 m-85 -85.27 -50.2 7.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.4 -0.812 . . . . 0.0 109.685 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 32.6 m -62.34 -18.05 60.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.433 -0.792 . . . . 0.0 110.361 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -74.61 -50.59 17.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.16 -0.963 . . . . 0.0 109.922 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -89.55 14.46 11.46 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.147 -0.97 . . . . 0.0 110.37 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 49.11 65.01 1.5 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.214 -0.928 . . . . 0.0 110.848 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 14.2 mt -112.75 100.95 9.08 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.061 -1.024 . . . . 0.0 109.794 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -57.96 -19.0 27.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.032 -1.042 . . . . 0.0 110.089 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt -147.38 -165.2 2.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -0.959 . . . . 0.0 109.661 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -60.31 156.81 14.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.089 -1.007 . . . . 0.0 109.855 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -159.98 118.83 0.85 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.433 HG23 ' CG2' ' A' ' 203' ' ' VAL . 79.7 t -99.21 95.75 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -1.128 . . . . 0.0 110.111 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 94.9 t -113.71 152.66 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.299 -0.875 . . . . 0.0 109.862 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.453 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 7.7 tt -108.27 155.45 20.47 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.052 -1.03 . . . . 0.0 109.868 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.431 ' HB3' ' CG2' ' A' ' 133' ' ' VAL . 60.5 m-85 -125.0 126.38 45.35 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.943 -1.098 . . . . 0.0 110.466 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.426 ' HD2' ' CD2' ' A' ' 188' ' ' LEU . 0.0 OUTLIER -134.8 179.18 6.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.379 -0.826 . . . . 0.0 110.074 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -102.52 -29.57 11.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.171 -0.955 . . . . 0.0 110.311 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -90.96 -174.39 3.99 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.446 -0.784 . . . . 0.0 110.811 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 48.0 -159.11 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.643 0.735 . . . . 0.0 110.863 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -50.94 -51.8 48.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.568 -0.707 . . . . 0.0 110.359 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 123.47 -21.58 7.18 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -141.42 177.51 8.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -1.186 . . . . 0.0 110.399 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' ASN . . . . . 0.453 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.1 m-80 -141.89 -152.73 0.42 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.364 -0.835 . . . . 0.0 109.527 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -175.43 79.1 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.274 -0.891 . . . . 0.0 110.496 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -64.34 117.54 7.38 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.384 -0.822 . . . . 0.0 109.88 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -122.64 28.88 7.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 110.571 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -110.92 -123.1 4.4 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 204' ' ' THR . 6.4 mt-10 -119.07 100.45 7.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.292 -1.122 . . . . 0.0 109.885 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.433 ' CG2' HG23 ' A' ' 186' ' ' VAL . 7.3 p -51.17 93.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 110.699 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.42 ' N ' ' O ' ' A' ' 202' ' ' GLU . 21.9 p -136.03 160.88 37.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 109.995 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.415 ' O ' ' CD1' ' A' ' 209' ' ' LEU . 0.0 OUTLIER -50.46 -50.21 53.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.292 -0.88 . . . . 0.0 110.662 -179.823 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' A' ' 207' ' ' ASN . 16.6 pt-20 -61.89 -41.22 97.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.24 -0.912 . . . . 0.0 110.552 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.408 ' N ' ' HG3' ' A' ' 206' ' ' GLU . 70.2 m-20 -73.24 -40.08 64.95 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.142 -0.974 . . . . 0.0 110.113 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.408 ' CD1' ' HA ' ' A' ' 155' ' ' PHE . 54.7 mt -61.9 -45.95 91.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.868 . . . . 0.0 110.066 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.415 ' CD1' ' O ' ' A' ' 205' ' ' LYS . 12.0 mt -59.45 -25.68 64.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.861 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -85.05 -46.11 11.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.292 -0.88 . . . . 0.0 109.901 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.422 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 22.3 t80 -48.22 -53.27 17.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.388 -0.82 . . . . 0.0 110.169 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.429 HG23 ' NE2' ' A' ' 216' ' ' GLN . 21.4 mm -48.92 -71.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.409 -0.807 . . . . 0.0 110.085 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -46.2 -34.38 4.29 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.71 -0.619 . . . . 0.0 110.965 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -71.64 -27.91 63.41 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.216 -0.927 . . . . 0.0 110.587 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 79.7 m-20 -97.84 -51.36 4.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.082 -1.012 . . . . 0.0 110.988 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' GLN . . . . . 0.429 ' NE2' HG23 ' A' ' 212' ' ' ILE . 3.5 pt20 . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.042 -1.036 . . . . 0.0 110.53 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.2 0.524 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.6 t -118.61 161.14 20.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 110.219 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.8 m -99.85 110.16 22.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 0.0 109.835 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.426 ' CD1' HG22 ' A' ' 141' ' ' ILE . 34.9 mt -87.66 113.01 52.43 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.231 -0.918 . . . . 0.0 110.072 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.17 -24.13 23.79 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.491 1.258 . . . . 0.0 110.373 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -173.77 -169.88 0.53 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.307 -0.871 . . . . 0.0 110.541 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -59.24 -25.24 59.89 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -53.5 -34.24 57.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -1.132 . . . . 0.0 110.222 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.31 -36.27 14.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 110.149 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.13 -19.94 62.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 110.271 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -88.5 -60.03 2.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 0.0 110.262 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.5 t -55.27 -21.56 14.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.198 -0.939 . . . . 0.0 110.243 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.423 HD22 ' CG1' ' A' ' 141' ' ' ILE . 18.0 tp -69.92 -48.69 57.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 0.0 110.035 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.424 ' CG2' ' HB3' ' A' ' 189' ' ' PHE . 60.7 t -65.46 -37.82 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.834 . . . . 0.0 110.398 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -83.75 5.85 23.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.114 -0.991 . . . . 0.0 110.816 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.9 t -90.19 -27.83 19.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.95 -1.094 . . . . 0.0 110.353 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.53 165.06 33.34 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.208 -0.933 . . . . 0.0 110.523 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -65.17 -19.03 65.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.395 -0.816 . . . . 0.0 109.859 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 43.4 t -136.96 149.71 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.9 . . . . 0.0 110.201 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.431 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -175.32 142.61 0.61 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.379 -0.826 . . . . 0.0 109.551 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.415 HG12 ' CD1' ' A' ' 212' ' ' ILE . 3.6 m -124.15 158.38 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 118.979 -1.089 . . . . 0.0 111.07 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.426 HG22 ' CD1' ' A' ' 123' ' ' LEU . 60.5 mt -148.22 104.31 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.651 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.82 128.04 9.9 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.472 ' CE2' HG13 ' A' ' 175' ' ' VAL . 37.8 m-85 -98.8 84.56 3.13 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.139 -1.212 . . . . 0.0 109.488 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.476 ' CE1' ' CB ' ' A' ' 151' ' ' SER . 16.4 m-85 -105.85 141.35 37.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.087 -1.008 . . . . 0.0 111.361 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.61 -28.94 26.18 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.959 -0.696 . . . . 0.0 110.015 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.04 87.0 2.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.367 -0.833 . . . . 0.0 109.895 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 98.0 t -60.18 -21.41 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.39 -0.819 . . . . 0.0 110.713 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -82.26 1.01 38.73 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.163 -0.961 . . . . 0.0 111.06 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 82.4 p -81.17 -168.08 1.69 Allowed 'General case' 0 C--N 1.307 -1.271 0 O-C-N 120.921 -1.112 . . . . 0.0 110.379 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -90.22 -18.08 26.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.423 -0.798 . . . . 0.0 110.168 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.476 ' CB ' ' CE1' ' A' ' 144' ' ' PHE . 1.4 m -71.4 -33.15 69.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.193 -0.942 . . . . 0.0 110.235 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.36 -37.64 27.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.141 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -55.92 -40.05 72.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.894 . . . . 0.0 110.094 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -64.19 -42.47 96.64 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.271 -0.893 . . . . 0.0 110.054 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -51.44 -55.45 18.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.362 -0.836 . . . . 0.0 110.18 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 25.8 mt -54.58 -55.18 32.08 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.298 -0.876 . . . . 0.0 110.244 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -51.31 -49.65 60.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.329 -0.857 . . . . 0.0 110.129 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.52 -36.99 85.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 109.78 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.424 ' O ' ' CE2' ' A' ' 167' ' ' PHE . . . -68.84 -29.61 67.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.301 -0.874 . . . . 0.0 109.947 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -67.7 -39.86 84.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.342 -0.849 . . . . 0.0 110.12 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.68 -50.35 66.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.863 . . . . 0.0 110.034 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.427 ' CG2' ' OD1' ' A' ' 164' ' ' ASP . 96.7 mt -97.38 163.4 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 109.806 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -136.73 -40.61 0.62 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.118 -0.989 . . . . 0.0 110.548 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.427 ' OD1' ' CG2' ' A' ' 162' ' ' ILE . 26.3 p-10 -55.29 -24.75 30.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 110.593 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.478 ' HB ' ' CE1' ' A' ' 167' ' ' PHE . 31.3 mm -92.59 129.78 39.34 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.073 -1.017 . . . . 0.0 110.226 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.431 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 55.2 Cg_endo -79.06 117.67 3.91 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 123.466 1.245 . . . . 0.0 110.274 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.478 ' CE1' ' HB ' ' A' ' 165' ' ' ILE . 6.1 m-85 -107.32 124.3 49.61 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.089 -1.007 . . . . 0.0 109.427 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -120.74 154.95 16.33 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 6.7 tt -150.43 140.94 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.124 -1.221 . . . . 0.0 110.78 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.8 t -155.12 156.93 36.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.307 -0.871 . . . . 0.0 110.414 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.1 t -119.87 1.35 10.98 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.468 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 41.4 p30 -67.93 151.29 47.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.117 -0.989 . . . . 0.0 109.985 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.8 p -78.44 -18.7 54.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.188 -0.945 . . . . 0.0 110.66 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.01 -39.14 84.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.933 . . . . 0.0 110.254 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.472 HG13 ' CE2' ' A' ' 143' ' ' PHE . 46.4 t -79.61 -24.45 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -0.956 . . . . 0.0 109.922 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.468 ' CD1' ' O ' ' A' ' 172' ' ' ASN . 9.0 m-85 -75.44 -50.59 15.33 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.32 -0.863 . . . . 0.0 109.878 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.18 -19.19 64.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.473 -0.767 . . . . 0.0 110.45 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.66 -56.47 17.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.971 . . . . 0.0 110.282 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.431 ' O ' ' CD1' ' A' ' 181' ' ' LEU . 92.3 m-85 -92.83 26.28 2.81 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.18 -0.95 . . . . 0.0 110.374 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 179' ' ' TYR . 2.2 mm-40 55.97 67.06 1.06 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.498 -0.751 . . . . 0.0 110.712 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.431 ' CD1' ' O ' ' A' ' 179' ' ' TYR . 6.6 mp -124.7 102.98 7.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.555 -0.715 . . . . 0.0 110.227 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.74 14.7 9.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -0.935 . . . . 0.0 110.147 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 6.2 mtmm -162.49 -165.3 1.15 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.276 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 10.6 p-10 -82.86 157.87 22.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.949 -1.094 . . . . 0.0 110.138 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 179.14 121.71 0.73 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.418 ' O ' ' CB ' ' A' ' 199' ' ' PHE . 94.7 t -92.8 121.62 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.329 -1.101 . . . . 0.0 110.049 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.433 HG11 ' N ' ' A' ' 188' ' ' LEU . 90.6 t -128.97 149.77 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 0.0 109.83 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.491 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 8.5 tt -104.61 131.5 51.96 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.995 -1.066 . . . . 0.0 108.458 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.424 ' HB3' ' CG2' ' A' ' 133' ' ' VAL . 57.3 m-85 -102.95 121.64 42.95 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.899 -1.126 . . . . 0.0 110.902 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.5 168.02 18.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.545 -0.722 . . . . 0.0 110.213 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -89.58 -24.9 21.6 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.293 -0.879 . . . . 0.0 110.579 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -90.71 -175.45 4.4 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.43 -0.794 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 47.08 -159.24 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.53 -0.732 . . . . 0.0 110.724 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -59.67 -44.25 93.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.642 -0.661 . . . . 0.0 110.265 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 128.99 -31.5 3.48 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.08 171.48 11.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -1.21 . . . . 0.0 110.532 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' ASN . . . . . 0.491 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 3.5 m-80 -131.66 -35.12 1.3 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.317 -0.864 . . . . 0.0 111.188 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 63.71 85.45 0.13 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.152 -0.968 . . . . 0.0 110.015 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.432 ' C ' ' CD1' ' A' ' 199' ' ' PHE . 9.4 t80 -62.16 118.73 7.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.398 -0.814 . . . . 0.0 110.161 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -113.63 101.5 9.38 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.264 -0.897 . . . . 0.0 110.511 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 157.13 -140.11 6.91 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -107.48 113.47 26.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.309 -1.113 . . . . 0.0 110.102 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.405 ' O ' ' CG1' ' A' ' 203' ' ' VAL . 7.5 p -64.29 110.74 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 110.218 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 70.5 p -143.13 157.14 44.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.167 -0.958 . . . . 0.0 110.376 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -51.1 -49.59 60.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.322 -0.861 . . . . 0.0 110.397 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -61.13 -34.67 75.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 110.097 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -78.72 -47.69 16.39 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.207 -0.933 . . . . 0.0 110.084 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 80.7 mt -52.78 -37.95 60.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.196 -0.94 . . . . 0.0 110.054 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.08 -23.07 62.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.29 -0.881 . . . . 0.0 109.924 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.66 -45.81 9.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.362 -0.836 . . . . 0.0 109.88 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.431 ' CE1' ' HA ' ' A' ' 199' ' ' PHE . 25.6 t80 -49.66 -50.15 44.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.213 -0.929 . . . . 0.0 109.822 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.422 HD11 HG21 ' A' ' 212' ' ' ILE . 23.5 mm -50.72 -73.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.467 -0.771 . . . . 0.0 110.296 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -46.21 -25.87 0.68 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.705 -0.622 . . . . 0.0 111.114 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -76.51 -23.19 53.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 110.568 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.421 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 78.2 m-20 -101.42 -57.62 2.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.182 -0.949 . . . . 0.0 110.866 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.1 -1.0 . . . . 0.0 110.588 -179.573 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.419 ' CA ' ' O ' ' A' ' 167' ' ' PHE . . . . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.096 0.474 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.9 t -108.49 167.65 9.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.106 -0.996 . . . . 0.0 110.246 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.3 m -110.48 109.25 19.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 110.115 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.9 mt -87.14 126.4 62.93 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.334 -0.853 . . . . 0.0 110.097 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.426 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 46.0 Cg_endo -71.73 -22.45 23.89 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.457 1.241 . . . . 0.0 110.462 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -174.31 -170.64 0.54 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.183 -0.948 . . . . 0.0 110.938 179.885 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.82 -34.79 90.79 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -51.63 -24.93 6.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -1.159 . . . . 0.0 110.343 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.426 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -90.13 -27.14 19.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.941 . . . . 0.0 110.191 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.17 -18.53 65.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 110.266 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -89.75 -48.7 7.09 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.158 -0.964 . . . . 0.0 109.21 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 32.4 p -63.35 -19.75 64.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.28 -0.888 . . . . 0.0 110.253 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.411 HD11 ' CG1' ' A' ' 141' ' ' ILE . 1.6 tt -73.83 -58.96 2.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.209 -0.932 . . . . 0.0 110.262 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.49 HG23 ' CD2' ' A' ' 189' ' ' PHE . 48.1 t -50.03 -25.34 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.268 -0.895 . . . . 0.0 110.581 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.96 -20.11 23.7 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.253 -0.905 . . . . 0.0 109.846 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.7 m -54.45 -50.67 67.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.162 -0.961 . . . . 0.0 110.362 -179.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.4 p -130.87 -173.52 3.11 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.12 -0.987 . . . . 0.0 110.487 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.01 -45.12 28.39 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.22 -0.925 . . . . 0.0 109.988 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.3 m -115.22 130.07 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.353 -0.842 . . . . 0.0 109.97 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -152.76 148.22 26.98 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.123 -0.986 . . . . 0.0 110.015 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.499 ' CG1' ' CD1' ' A' ' 167' ' ' PHE . 7.1 p -130.9 149.97 34.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.104 -0.998 . . . . 0.0 110.437 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.411 ' CG1' HD11 ' A' ' 132' ' ' LEU . 45.7 mt -133.9 124.13 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.424 -0.797 . . . . 0.0 109.682 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -90.74 131.75 10.93 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 143' ' ' PHE . 22.0 m-85 -103.95 69.69 0.96 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -1.149 . . . . 0.0 109.643 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -94.9 139.02 31.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.145 -0.972 . . . . 0.0 110.769 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -76.2 -27.84 57.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.427 -0.796 . . . . 0.0 110.136 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -126.89 88.46 2.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 0.0 109.908 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 45.1 t -55.55 -21.03 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.449 -0.782 . . . . 0.0 110.36 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -91.79 18.39 7.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -0.897 . . . . 0.0 110.622 -179.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 86.8 p -87.2 -164.64 1.12 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.948 . . . . 0.0 110.169 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -90.13 -34.09 16.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.348 -0.845 . . . . 0.0 110.141 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 49.3 m -63.81 -31.7 72.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.3 -0.875 . . . . 0.0 110.245 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.55 -28.58 59.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.824 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -58.66 -52.0 67.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.418 -0.801 . . . . 0.0 110.184 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -61.22 -39.73 91.36 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.182 -0.949 . . . . 0.0 110.083 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -47.62 -54.9 10.56 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.304 -0.873 . . . . 0.0 110.606 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 17.2 mt -55.57 -53.35 57.54 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.414 -0.804 . . . . 0.0 110.33 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -49.78 -50.22 45.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.325 -0.859 . . . . 0.0 110.464 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -64.24 -25.03 67.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.18 -0.95 . . . . 0.0 110.052 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.503 ' CB ' ' CD2' ' A' ' 167' ' ' PHE . . . -76.1 -41.06 51.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.309 -0.87 . . . . 0.0 110.324 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -76.02 -9.64 58.78 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.291 -0.88 . . . . 0.0 110.909 -179.69 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -118.0 28.12 8.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.971 -1.081 . . . . 0.0 110.565 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.443 HG12 ' CG1' ' A' ' 165' ' ' ILE . 5.7 tt -113.44 176.76 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.077 -1.014 . . . . 0.0 110.25 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.48 63.36 0.16 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.896 . . . . 0.0 110.511 -179.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 40.92 50.91 3.16 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.535 0.683 . . . . 0.0 111.628 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.494 ' CG2' ' HD2' ' A' ' 166' ' ' PRO . 42.7 mm -88.77 149.2 43.33 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.472 -0.767 . . . . 0.0 109.097 179.044 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.494 ' HD2' ' CG2' ' A' ' 165' ' ' ILE . 43.8 Cg_endo -81.43 99.75 1.09 Allowed 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.555 1.292 . . . . 0.0 110.772 -179.063 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.503 ' CD2' ' CB ' ' A' ' 159' ' ' ALA . 3.2 m-85 -92.12 131.05 37.68 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.524 -0.735 . . . . 0.0 110.109 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -121.61 144.53 16.52 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.979 -1.649 . . . . 0.0 108.979 179.244 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 13.5 tt -140.75 135.36 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.268 -1.136 . . . . 0.0 110.86 -179.357 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.1 t -151.82 155.85 39.01 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.999 0.904 . . . . 0.0 110.386 179.189 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.9 t -125.3 4.62 7.76 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -65.72 132.32 48.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.223 -0.923 . . . . 0.0 110.409 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 88.6 p -54.26 -29.04 45.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.163 -0.961 . . . . 0.0 110.047 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -54.49 -35.48 63.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.939 . . . . 0.0 109.867 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 61.4 t -78.71 -25.67 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.409 -0.807 . . . . 0.0 109.728 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.417 ' O ' ' N ' ' A' ' 180' ' ' GLN . 15.9 m-85 -79.13 -50.1 11.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 109.758 179.638 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 75.1 m -60.68 -19.19 57.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.863 . . . . 0.0 110.116 179.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.419 ' HD3' ' CE1' ' A' ' 179' ' ' TYR . 7.2 tttp -74.43 -51.46 14.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.132 -0.98 . . . . 0.0 109.653 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.419 ' CE1' ' HD3' ' A' ' 178' ' ' LYS . 78.3 m-85 -92.7 -5.34 51.53 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.436 -0.79 . . . . 0.0 110.427 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 176' ' ' PHE . 0.2 OUTLIER 56.77 63.61 1.89 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.128 -0.982 . . . . 0.0 111.079 179.457 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.0 mt -102.52 119.53 38.97 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.12 -0.988 . . . . 0.0 109.679 178.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.412 ' O ' ' CG ' ' A' ' 183' ' ' LYS . 5.8 t0 -65.2 -11.78 44.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 110.333 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.412 ' CG ' ' O ' ' A' ' 182' ' ' ASP . 0.5 OUTLIER -156.42 -165.78 1.98 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.175 -0.953 . . . . 0.0 109.545 -179.977 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -62.22 164.17 7.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.062 -1.024 . . . . 0.0 109.44 179.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -161.4 150.05 19.36 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.231 -179.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 77.3 t -132.09 84.95 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.49 -1.006 . . . . 0.0 109.506 179.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 47.6 t -101.31 159.8 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.336 -0.853 . . . . 0.0 110.472 -179.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.439 ' O ' ' ND2' ' A' ' 197' ' ' ASN . 4.3 tt -116.44 155.08 29.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.866 . . . . 0.0 109.374 179.721 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.49 ' CD2' HG23 ' A' ' 133' ' ' VAL . 51.6 m-85 -125.03 127.21 46.62 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.898 -1.126 . . . . 0.0 110.659 -179.051 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.486 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.5 OUTLIER -141.03 166.86 23.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.315 -0.866 . . . . 0.0 110.235 179.751 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -91.21 -22.59 20.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 110.329 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.486 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.9 OUTLIER -91.08 -176.55 4.64 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.362 -0.837 . . . . 0.0 111.069 -179.988 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 48.04 -154.77 0.08 Allowed 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.802 0.81 . . . . 0.0 110.649 -179.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -57.37 -54.52 45.93 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.694 -0.629 . . . . 0.0 110.325 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 133.01 -24.21 3.83 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -139.41 176.34 8.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.208 -1.172 . . . . 0.0 110.548 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 197' ' ' ASN . . . . . 0.449 ' N ' ' ND2' ' A' ' 197' ' ' ASN . 0.7 OUTLIER -145.36 -155.33 0.6 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.389 -0.819 . . . . 0.0 109.786 -179.776 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -171.02 81.77 0.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.377 -0.827 . . . . 0.0 110.083 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -64.97 126.99 29.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.377 -0.827 . . . . 0.0 110.287 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -140.82 124.12 16.67 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.236 -0.915 . . . . 0.0 109.901 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 141.7 -167.62 25.84 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -62.67 109.02 1.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.339 -1.095 . . . . 0.0 110.26 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 91.7 t -65.88 112.24 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.226 -0.921 . . . . 0.0 110.203 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 41.7 p -150.2 152.39 34.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.36 -0.838 . . . . 0.0 110.314 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -49.76 -52.67 30.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.3 -0.875 . . . . 0.0 110.487 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -54.34 -32.5 56.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 110.157 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -83.96 -41.46 17.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.27 -0.894 . . . . 0.0 110.044 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 27.4 mt -65.83 -41.79 91.35 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.311 -0.868 . . . . 0.0 110.061 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 85.7 mt -69.39 -21.74 63.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 0.0 110.128 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -83.81 -56.38 3.73 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.292 -0.88 . . . . 0.0 110.076 179.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.401 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 20.5 t80 -51.52 -53.02 42.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.237 -0.914 . . . . 0.0 110.146 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 84.6 mt -52.78 -58.5 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.348 -0.845 . . . . 0.0 110.178 179.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.418 ' HA ' ' CG ' ' A' ' 216' ' ' GLN . 14.4 tttt -49.24 -38.74 27.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 110.132 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.27 -22.81 67.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.399 -0.813 . . . . 0.0 109.826 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.401 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 75.7 m-80 -96.77 -42.51 7.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.296 -0.878 . . . . 0.0 110.359 -179.682 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 216' ' ' GLN . . . . . 0.418 ' CG ' ' HA ' ' A' ' 213' ' ' LYS . 2.1 pt20 . . . . . 0 N--CA 1.493 1.675 0 O-C-N 121.2 -0.937 . . . . 0.0 110.205 179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.257 0.551 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.42 ' CG2' ' HA2' ' A' ' 168' ' ' GLY . 10.1 t -97.85 171.07 8.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.922 . . . . 0.0 110.353 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.3 m -111.68 111.9 23.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.91 . . . . 0.0 110.065 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.9 mt -94.64 130.39 33.51 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.173 -0.954 . . . . 0.0 110.068 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.441 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 43.5 Cg_endo -69.69 -53.09 0.29 Allowed 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.442 1.233 . . . . 0.0 111.015 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -146.65 -170.45 3.52 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.099 -1.001 . . . . 0.0 111.184 -179.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -57.31 -39.91 91.05 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -49.62 -25.29 2.71 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.268 -1.137 . . . . 0.0 110.714 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.441 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -90.07 -35.31 15.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.138 -0.976 . . . . 0.0 110.067 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.23 -24.68 43.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.359 -0.838 . . . . 0.0 110.177 179.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -84.53 -54.37 4.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.227 -0.921 . . . . 0.0 110.248 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.7 t -52.65 -26.49 13.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.256 -0.903 . . . . 0.0 110.324 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.1 tp -70.07 -46.04 65.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.291 -0.88 . . . . 0.0 110.398 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.498 HG23 ' CD1' ' A' ' 189' ' ' PHE . 40.5 t -56.88 -38.64 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.267 -0.896 . . . . 0.0 110.583 -179.629 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -85.29 -15.97 41.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.281 -0.887 . . . . 0.0 110.761 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.2 m -56.68 -45.81 81.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.025 -1.047 . . . . 0.0 110.288 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 92.3 p -133.35 -175.59 3.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.342 -0.849 . . . . 0.0 110.215 -179.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.59 -35.22 62.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.318 -0.864 . . . . 0.0 110.249 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 87.6 t -129.33 147.27 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.064 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.402 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -173.76 134.13 0.47 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.244 -0.91 . . . . 0.0 110.048 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.413 HG21 ' N ' ' A' ' 141' ' ' ILE . 9.4 p -120.46 147.33 24.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.097 -1.002 . . . . 0.0 110.371 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.413 ' N ' HG21 ' A' ' 140' ' ' VAL . 7.4 mt -125.76 113.83 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.361 -0.837 . . . . 0.0 109.912 179.726 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -80.81 120.96 5.28 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -91.22 80.86 5.56 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.193 -1.181 . . . . 0.0 109.753 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.415 ' CZ ' ' HA ' ' A' ' 152' ' ' ALA . 15.1 m-85 -100.06 140.39 34.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.079 -1.013 . . . . 0.0 111.033 -179.317 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.12 -27.83 18.3 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.671 0.748 . . . . 0.0 109.473 179.028 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.26 69.03 1.48 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.024 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.442 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 4.6 p -48.25 -24.0 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.717 -0.614 . . . . 0.0 111.327 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -78.91 3.45 16.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.102 -0.999 . . . . 0.0 110.873 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 94.5 p -85.56 -163.16 0.81 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.843 -1.161 . . . . 0.0 110.23 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.19 -49.65 6.44 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.327 -0.858 . . . . 0.0 110.353 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.21 -28.85 8.23 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.299 -0.876 . . . . 0.0 110.448 -179.83 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.442 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -88.5 -29.25 20.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.346 -0.846 . . . . 0.0 110.136 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.82 -36.11 78.23 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.215 -0.928 . . . . 0.0 109.639 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -59.26 -49.09 79.19 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.103 -0.998 . . . . 0.0 108.607 178.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -50.96 -47.77 61.13 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.538 -0.726 . . . . 0.0 110.04 178.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.7 mt -47.4 -59.51 3.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.512 -0.743 . . . . 0.0 110.375 179.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -58.21 -50.53 73.21 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.424 -0.797 . . . . 0.0 110.057 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -53.82 -43.74 69.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.333 -0.854 . . . . 0.0 109.948 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.95 -24.41 63.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.86 . . . . 0.0 110.074 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -77.76 -40.58 40.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.871 . . . . 0.0 110.303 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.8 -39.9 68.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 0.0 110.334 -179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -89.81 144.76 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.296 -0.877 . . . . 0.0 110.262 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -132.29 18.6 4.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.215 -0.928 . . . . 0.0 110.394 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -125.51 21.36 7.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -0.959 . . . . 0.0 110.266 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.427 HG22 HD11 ' A' ' 165' ' ' ILE . 45.0 mm -136.43 134.05 19.61 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.172 -0.955 . . . . 0.0 110.175 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.402 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 48.2 Cg_endo -74.67 75.2 3.61 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 O-C-N 123.542 1.285 . . . . 0.0 110.474 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.405 ' CE1' ' CG2' ' A' ' 165' ' ' ILE . 5.7 m-85 -67.9 134.0 50.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.303 -0.873 . . . . 0.0 110.323 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.42 ' HA2' ' CG2' ' A' ' 121' ' ' THR . . . -124.72 149.23 16.93 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 9.2 tt -148.27 125.03 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.206 -1.173 . . . . 0.0 110.29 -179.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.3 t -141.5 157.14 45.52 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 122.196 0.998 . . . . 0.0 110.933 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 94.9 p -124.77 3.41 8.17 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.47 178.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 124' ' ' PRO . 64.1 t30 -63.5 127.66 32.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.194 -0.941 . . . . 0.0 110.32 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.27 -32.78 11.47 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.241 -0.912 . . . . 0.0 110.597 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.22 -31.82 54.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.098 -1.001 . . . . 0.0 109.88 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 39.8 t -79.08 -27.02 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 109.692 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -84.32 -39.81 18.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 109.14 179.328 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 46.5 t -72.89 -4.78 34.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.464 -0.772 . . . . 0.0 110.231 178.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.67 -52.19 5.13 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.067 -1.021 . . . . 0.0 109.171 179.609 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -89.84 4.5 49.65 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.749 -0.595 . . . . 0.0 110.532 179.769 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 53.56 59.99 3.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.078 -1.014 . . . . 0.0 110.451 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 60.0 mt -102.82 102.77 12.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 110.13 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -53.47 -26.76 21.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.194 -0.941 . . . . 0.0 109.992 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -141.54 -175.44 4.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.406 -0.808 . . . . 0.0 109.839 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -72.25 165.09 25.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.093 -1.004 . . . . 0.0 110.131 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -172.18 160.19 31.57 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.41 ' O ' ' CG2' ' A' ' 186' ' ' VAL . 34.2 m -123.91 97.25 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -1.18 . . . . 0.0 110.158 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 89.1 t -108.81 155.77 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 109.96 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.453 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 6.6 tt -107.96 159.47 16.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.023 -1.048 . . . . 0.0 109.709 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.498 ' CD1' HG23 ' A' ' 133' ' ' VAL . 45.0 m-85 -130.11 121.26 26.0 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.901 -1.124 . . . . 0.0 110.349 -179.313 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.432 ' HG3' ' CD1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -132.86 164.05 27.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.381 -0.824 . . . . 0.0 110.163 179.876 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -82.63 -26.15 32.48 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.206 -0.933 . . . . 0.0 110.845 -179.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.432 ' CD1' ' HG3' ' A' ' 190' ' ' LYS . 1.6 p90 -90.86 -176.81 4.78 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.287 -0.883 . . . . 0.0 110.988 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 47.01 -159.67 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.632 0.729 . . . . 0.0 110.928 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.91 -29.48 60.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.667 -0.646 . . . . 0.0 110.4 -179.731 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 96.09 -16.92 60.23 Favored Glycine 0 N--CA 1.483 1.822 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.478 ' HG3' ' CE1' ' A' ' 189' ' ' PHE . 4.2 ttp180 -138.34 154.31 48.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.018 -1.283 . . . . 0.0 110.479 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 197' ' ' ASN . . . . . 0.453 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.5 m-80 -125.15 -153.91 0.59 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.312 -0.867 . . . . 0.0 110.038 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -178.77 78.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.511 -0.743 . . . . 0.0 109.998 179.61 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -46.21 142.68 2.74 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.367 -0.833 . . . . 0.0 111.062 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -140.94 123.62 16.09 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.299 -0.876 . . . . 0.0 109.819 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 133.38 -121.64 2.89 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -120.04 104.61 10.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.203 -1.174 . . . . 0.0 110.213 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 6.5 p -58.84 91.38 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.15 -0.968 . . . . 0.0 110.224 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 66.0 p -126.12 160.1 31.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 110.079 179.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.87 -47.46 51.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 0.0 110.648 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -63.25 -41.63 99.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.283 -0.885 . . . . 0.0 110.652 -179.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -79.04 -26.61 43.12 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.159 -0.963 . . . . 0.0 110.474 -179.713 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 19.1 mt -73.52 -59.25 2.8 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.248 -0.908 . . . . 0.0 110.499 -179.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 5.5 mt -49.13 -40.16 31.39 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.303 -0.873 . . . . 0.0 110.886 -179.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -67.83 -45.14 75.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.12 -0.987 . . . . 0.0 110.451 -179.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.406 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 16.6 t80 -58.57 -54.41 47.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.933 . . . . 0.0 110.8 -179.624 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.415 ' N ' HD11 ' A' ' 212' ' ' ILE . 6.4 mm -58.09 -47.96 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.155 -0.966 . . . . 0.0 110.026 -179.624 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.412 ' HA ' ' NE2' ' A' ' 216' ' ' GLN . 0.3 OUTLIER -58.04 -21.92 47.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.507 -0.746 . . . . 0.0 110.429 -179.766 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -90.03 -25.36 20.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.098 -1.001 . . . . 0.0 110.57 -179.716 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.406 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 76.1 m-20 -90.61 -39.81 12.29 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.169 -0.957 . . . . 0.0 110.893 -179.361 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 216' ' ' GLN . . . . . 0.412 ' NE2' ' HA ' ' A' ' 213' ' ' LYS . 5.6 pt20 . . . . . 0 N--CA 1.487 1.391 0 O-C-N 121.196 -0.94 . . . . 0.0 110.813 -179.512 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.208 0.528 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.9 t -85.8 169.39 13.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 110.249 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.7 m -108.66 104.41 13.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 110.342 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 67.3 mt -80.65 133.67 55.34 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.192 -0.942 . . . . 0.0 110.048 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.432 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 45.3 Cg_endo -71.23 -35.13 9.01 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.387 1.204 . . . . 0.0 110.556 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -167.75 -170.76 1.45 Allowed 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.169 0.985 . . . . 0.0 111.487 -179.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -58.09 -31.77 65.91 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -54.63 -28.81 49.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -1.141 . . . . 0.0 110.295 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.432 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -84.08 -35.02 24.03 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.931 . . . . 0.0 110.103 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -53.46 -29.16 34.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 0.0 109.98 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -90.15 -29.98 17.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.426 -0.796 . . . . 0.0 110.22 179.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.56 -35.19 30.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.195 -0.94 . . . . 0.0 110.263 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.2 tt -59.9 -58.26 9.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.316 -0.865 . . . . 0.0 109.739 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.434 HG23 ' CG ' ' A' ' 189' ' ' PHE . 97.9 t -51.98 -24.61 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.45 -0.781 . . . . 0.0 110.212 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -82.38 -21.81 35.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.311 -0.868 . . . . 0.0 110.262 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.8 m -53.14 -58.85 5.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.221 -0.924 . . . . 0.0 110.203 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 82.6 p -121.9 -179.03 4.0 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.288 -0.882 . . . . 0.0 110.296 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -69.56 -39.96 77.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.287 -0.883 . . . . 0.0 110.179 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.6 t -117.94 143.44 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.389 -0.82 . . . . 0.0 110.275 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.436 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -165.95 147.54 6.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.241 -0.912 . . . . 0.0 109.957 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.466 HG12 ' CE2' ' A' ' 167' ' ' PHE . 7.3 p -127.11 150.09 32.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 O-C-N 121.103 -0.998 . . . . 0.0 110.205 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.465 HD12 HG22 ' A' ' 141' ' ' ILE . 75.5 mt -143.48 120.19 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.41 -0.806 . . . . 0.0 109.647 179.599 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.411 ' C ' ' CD1' ' A' ' 143' ' ' PHE . . . -85.89 166.68 39.37 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 143' ' ' PHE . 26.5 m-85 -129.86 76.56 1.73 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.405 -1.056 . . . . 0.0 109.85 179.833 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -104.1 145.82 29.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.99 -1.069 . . . . 0.0 111.099 -179.528 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.26 -27.75 19.26 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.786 0.803 . . . . 0.0 109.464 179.523 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -131.0 73.0 1.52 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.687 -0.633 . . . . 0.0 109.511 179.014 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.446 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 18.4 m -48.36 -24.54 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.262 -0.899 . . . . 0.0 110.869 -179.543 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -83.95 5.53 25.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.063 -1.023 . . . . 0.0 110.844 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 33.5 p -75.19 -166.29 0.49 Allowed 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.905 -1.122 . . . . 0.0 110.34 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -90.45 -19.95 23.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.537 -0.727 . . . . 0.0 110.159 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 10.5 t -81.93 -31.62 31.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.163 -0.961 . . . . 0.0 110.078 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.446 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -80.67 -20.05 43.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 110.2 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -61.45 -39.16 89.86 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.221 -0.924 . . . . 0.0 109.751 179.471 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -67.09 -41.18 86.74 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.358 -0.839 . . . . 0.0 109.619 179.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -48.96 -57.09 7.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.397 -0.814 . . . . 0.0 110.607 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 52.8 mt -53.87 -54.76 34.07 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.449 -0.782 . . . . 0.0 110.289 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -54.2 -46.67 72.51 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.42 -0.8 . . . . 0.0 110.347 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.409 ' CB ' HD11 ' A' ' 208' ' ' LEU . . . -65.09 -45.36 85.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.148 -0.97 . . . . 0.0 110.379 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.82 -31.11 72.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.939 . . . . 0.0 110.435 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -63.69 -29.59 70.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.183 -0.948 . . . . 0.0 110.232 -179.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -57.33 -48.38 79.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.907 . . . . 0.0 110.227 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.9 tt -90.85 158.27 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.175 -0.953 . . . . 0.0 110.01 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.11 19.16 1.24 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.033 -1.042 . . . . 0.0 110.609 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -116.25 16.3 15.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.141 -0.974 . . . . 0.0 110.495 179.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.402 HD11 HG22 ' A' ' 165' ' ' ILE . 49.7 mm -134.41 140.35 35.49 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.126 -0.984 . . . . 0.0 110.11 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.436 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 48.0 Cg_endo -74.77 79.5 2.58 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.618 1.325 . . . . 0.0 110.508 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.466 ' CE2' HG12 ' A' ' 140' ' ' VAL . 3.6 m-85 -68.79 135.64 51.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.33 -0.856 . . . . 0.0 109.933 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -131.35 151.99 19.88 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.564 -1.303 . . . . 0.0 109.942 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 11.7 tt -150.19 140.34 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -1.105 . . . . 0.0 109.979 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.4 HG22 HG22 ' A' ' 175' ' ' VAL . 2.9 t -153.77 158.05 40.35 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.118 0.961 . . . . 0.0 111.069 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.1 m -119.97 0.97 10.9 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.44 178.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -60.53 145.97 46.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.138 -0.976 . . . . 0.0 110.174 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 37.8 t -70.41 -30.91 67.91 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.167 -0.958 . . . . 0.0 110.471 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -54.56 -40.88 69.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.073 -1.017 . . . . 0.0 109.955 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.403 HG11 ' CE2' ' A' ' 143' ' ' PHE . 58.8 t -69.82 -30.69 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 0.0 109.546 179.481 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.405 ' N ' ' CD1' ' A' ' 176' ' ' PHE . 10.6 m-85 -80.34 -41.17 25.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.445 -0.784 . . . . 0.0 109.751 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.87 -6.34 37.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.416 -0.802 . . . . 0.0 110.551 179.531 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 15.0 tttp -90.03 -45.39 9.2 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.014 -1.054 . . . . 0.0 109.382 179.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -91.5 0.78 57.47 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.562 -0.711 . . . . 0.0 110.642 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 53.97 66.47 1.22 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.985 -1.072 . . . . 0.0 110.728 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 55.3 mt -107.97 114.34 28.19 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.236 -0.915 . . . . 0.0 109.945 179.62 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.423 ' O ' ' CG ' ' A' ' 183' ' ' LYS . 45.2 m-20 -61.81 -17.26 55.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.936 . . . . 0.0 110.33 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 182' ' ' ASP . 22.6 mtmt -157.75 -166.39 1.98 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.206 -0.934 . . . . 0.0 110.012 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -63.9 162.98 12.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.184 -0.947 . . . . 0.0 110.049 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -176.32 152.28 12.52 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.434 ' CG2' HG13 ' A' ' 203' ' ' VAL . 70.4 t -118.75 133.97 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.383 -1.069 . . . . 0.0 109.697 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 77.3 t -141.92 145.06 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.223 -0.923 . . . . 0.0 110.468 -179.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.447 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 7.1 tt -105.03 146.85 28.51 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.434 ' CG ' HG23 ' A' ' 133' ' ' VAL . 46.2 m-85 -118.81 127.18 53.28 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.722 -1.236 . . . . 0.0 110.834 -178.689 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.496 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -138.47 158.06 44.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.389 -0.819 . . . . 0.0 110.222 179.827 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.1 mmmm -84.3 -21.3 31.06 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.244 -0.91 . . . . 0.0 110.433 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.496 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 1.7 p90 -90.55 -176.23 4.68 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.244 -0.91 . . . . 0.0 110.883 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 46.79 -158.76 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.684 0.754 . . . . 0.0 110.74 -179.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.46 -54.0 49.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.634 -0.666 . . . . 0.0 110.313 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 137.81 -31.11 2.51 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.82 173.88 10.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.172 -1.193 . . . . 0.0 110.156 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 197' ' ' ASN . . . . . 0.451 ' N ' ' ND2' ' A' ' 197' ' ' ASN . 1.3 m-80 -134.14 -40.36 0.83 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.121 -0.987 . . . . 0.0 110.811 -179.181 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 63.98 94.23 0.05 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.248 -0.907 . . . . 0.0 110.202 -179.273 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.491 ' HB2' ' CZ ' ' A' ' 211' ' ' PHE . 41.0 t80 -88.96 136.73 32.86 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.338 -0.851 . . . . 0.0 110.201 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.477 ' O ' ' CE1' ' A' ' 199' ' ' PHE . 5.1 mt-10 -121.0 -147.38 0.39 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.209 -0.932 . . . . 0.0 109.678 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 58.15 -128.27 47.14 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.03 130.39 53.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.316 -1.108 . . . . 0.0 110.35 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.446 HG11 ' CE1' ' A' ' 199' ' ' PHE . 28.2 m -77.49 59.13 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.383 -0.823 . . . . 0.0 110.073 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.403 ' OG1' ' ND2' ' A' ' 207' ' ' ASN . 7.6 p -93.76 156.18 16.82 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.587 -0.695 . . . . 0.0 110.354 -179.826 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -48.64 -48.24 39.73 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.24 -0.913 . . . . 0.0 110.532 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . 0.407 ' HG3' ' N ' ' A' ' 207' ' ' ASN . 14.2 pt-20 -54.34 -41.15 68.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.941 . . . . 0.0 110.42 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.407 ' N ' ' HG3' ' A' ' 206' ' ' GLU . 79.9 m-20 -83.21 -28.41 29.28 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.287 -0.883 . . . . 0.0 110.149 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.409 HD11 ' CB ' ' A' ' 158' ' ' ALA . 19.9 mt -72.16 -48.58 42.36 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.267 -0.896 . . . . 0.0 110.264 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 9.1 mt -53.56 -38.92 64.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 109.899 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -74.17 -49.11 25.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.84 . . . . 0.0 109.925 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.491 ' CZ ' ' HB2' ' A' ' 199' ' ' PHE . 23.8 t80 -47.94 -58.14 4.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 110.79 179.752 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 21.6 mt -52.83 -47.61 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -0.867 . . . . 0.0 110.212 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.55 -41.37 88.78 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.24 -0.912 . . . . 0.0 109.939 179.722 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -62.03 -19.87 63.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.383 -0.823 . . . . 0.0 109.945 179.649 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -89.23 -60.71 1.88 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.253 -0.905 . . . . 0.0 109.553 179.827 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 O-C-N 121.395 -0.816 . . . . 0.0 111.18 179.84 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.238 0.542 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.434 ' CG2' ' HA2' ' A' ' 168' ' ' GLY . 10.1 t -96.31 169.69 9.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.119 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.6 m -109.15 107.89 18.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 110.249 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 24.8 mt -85.43 128.86 57.59 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.361 -0.837 . . . . 0.0 109.98 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.409 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 46.6 Cg_endo -72.05 -43.61 1.12 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.425 1.223 . . . . 0.0 110.431 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.2 -170.42 3.12 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 122.108 0.956 . . . . 0.0 111.242 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -58.5 -27.97 61.7 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -54.04 -32.27 53.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -1.129 . . . . 0.0 110.096 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.409 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -87.11 -34.93 18.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 110.016 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.0 -22.75 61.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.349 -0.844 . . . . 0.0 110.033 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -84.69 -57.88 2.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 110.134 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.5 p -61.06 -18.2 56.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.312 -0.867 . . . . 0.0 110.377 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 17.2 tp -71.05 -49.44 44.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.151 -0.968 . . . . 0.0 109.891 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.427 ' CG2' ' HB3' ' A' ' 189' ' ' PHE . 59.1 t -64.83 -28.59 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.478 -0.764 . . . . 0.0 110.262 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -90.0 -0.74 57.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.276 -0.89 . . . . 0.0 110.96 -179.836 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 46.9 t -86.44 -23.19 26.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.915 -1.115 . . . . 0.0 110.31 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.44 160.0 43.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.236 -0.915 . . . . 0.0 110.495 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.77 -22.85 59.06 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.401 -0.812 . . . . 0.0 109.592 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.8 m -138.43 152.22 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.315 -0.866 . . . . 0.0 110.377 -179.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -173.41 134.48 0.52 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 0.0 109.862 179.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.89 149.8 23.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 120.994 -1.067 . . . . 0.0 110.271 -179.685 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.459 ' O ' ' CE1' ' A' ' 143' ' ' PHE . 2.8 mp -134.9 117.26 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.342 -0.849 . . . . 0.0 110.139 179.733 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.21 126.12 7.34 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.459 ' CE1' ' O ' ' A' ' 141' ' ' ILE . 65.7 m-85 -100.74 78.77 2.0 Allowed 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.102 -1.234 . . . . 0.0 110.206 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -104.52 146.32 29.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.061 -1.024 . . . . 0.0 110.835 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.43 -27.89 21.25 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.575 -0.703 . . . . 0.0 109.827 179.375 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.15 74.35 1.59 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.502 -0.749 . . . . 0.0 109.525 179.506 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.414 ' O ' ' CB ' ' A' ' 152' ' ' ALA . 23.5 m -52.82 -21.4 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.367 -0.833 . . . . 0.0 110.846 -179.542 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -82.65 8.41 12.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.125 -0.984 . . . . 0.0 110.838 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 7.5 p -84.67 -161.71 0.6 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.869 -1.144 . . . . 0.0 110.37 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -90.74 -21.31 21.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 0.0 110.269 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.36 -37.13 68.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.214 -0.929 . . . . 0.0 110.255 -179.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 147' ' ' VAL . . . -74.04 -26.85 60.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.207 -0.933 . . . . 0.0 109.722 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -54.05 -49.83 68.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.887 . . . . 0.0 109.858 179.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -64.42 -39.71 94.36 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.343 -0.848 . . . . 0.0 109.782 179.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -52.07 -55.7 19.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.356 -0.84 . . . . 0.0 110.161 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.43 -56.66 16.46 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.382 -0.824 . . . . 0.0 110.169 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -49.38 -57.97 5.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.33 -0.856 . . . . 0.0 110.489 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.72 -36.34 71.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.806 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.403 ' HB3' ' CD2' ' A' ' 167' ' ' PHE . . . -67.9 -32.63 73.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.993 179.655 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -67.63 -31.77 72.02 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.224 -0.923 . . . . 0.0 110.098 179.683 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.77 -32.54 63.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 109.961 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.432 HG22 ' CG1' ' A' ' 165' ' ' ILE . 58.1 mt -102.76 139.41 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.33 -0.856 . . . . 0.0 110.111 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.81 15.61 8.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.921 . . . . 0.0 110.539 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -119.86 -10.21 9.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.194 -0.941 . . . . 0.0 110.549 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.437 ' CG2' ' HD2' ' A' ' 166' ' ' PRO . 39.7 mm -101.51 146.06 31.54 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.045 -1.034 . . . . 0.0 110.249 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.437 ' HD2' ' CG2' ' A' ' 165' ' ' ILE . 47.6 Cg_endo -85.53 72.86 4.16 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 O-C-N 123.722 1.38 . . . . 0.0 110.458 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.403 ' CD2' ' HB3' ' A' ' 159' ' ' ALA . 5.6 m-85 -65.61 124.69 23.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.303 -0.873 . . . . 0.0 110.19 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.434 ' HA2' ' CG2' ' A' ' 121' ' ' THR . . . -121.09 153.05 16.68 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 8.1 tt -150.16 137.69 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -1.12 . . . . 0.0 110.159 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.5 t -154.17 156.89 37.99 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.116 0.96 . . . . 0.0 110.884 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 13.7 m -115.09 -2.08 12.87 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.506 178.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -59.19 118.72 6.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.182 -0.949 . . . . 0.0 110.252 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.4 m -50.46 -33.09 19.86 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.153 -0.967 . . . . 0.0 110.458 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.32 -35.81 60.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.208 -0.932 . . . . 0.0 110.076 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.44 HG13 ' CE2' ' A' ' 143' ' ' PHE . 40.6 t -79.25 -24.91 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.338 -0.851 . . . . 0.0 109.734 179.66 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 176' ' ' PHE . 12.2 m-85 -80.97 -45.87 15.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.37 -0.831 . . . . 0.0 109.704 179.75 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 41.4 t -67.74 -22.76 65.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.353 -0.842 . . . . 0.0 110.066 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.5 tttm -52.68 -57.49 9.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.247 -0.908 . . . . 0.0 110.207 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -89.7 13.97 12.9 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.266 -0.896 . . . . 0.0 110.565 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 51.99 61.0 3.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.132 -0.98 . . . . 0.0 110.423 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 68.0 mt -96.85 -26.65 15.02 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.125 -0.984 . . . . 0.0 110.417 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 52.71 21.1 1.76 Allowed 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.896 -0.503 . . . . 0.0 110.684 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -178.6 -163.37 0.06 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.208 -0.932 . . . . 0.0 109.764 179.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 4.1 m-20 -90.57 152.6 20.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.12 -0.987 . . . . 0.0 109.838 179.468 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -164.93 149.52 16.29 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.46 -1.352 . . . . 0.0 109.917 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 82.3 t -117.55 94.46 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.403 -1.057 . . . . 0.0 109.484 179.561 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 84.9 t -113.71 156.39 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.141 -0.974 . . . . 0.0 110.682 -179.294 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.451 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 8.2 tt -108.91 157.73 18.35 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.195 -0.941 . . . . 0.0 109.275 179.674 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.427 ' HB3' ' CG2' ' A' ' 133' ' ' VAL . 46.7 m-85 -129.9 124.85 34.15 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.924 -1.11 . . . . 0.0 110.733 -179.099 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.33 179.11 6.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.369 -0.832 . . . . 0.0 109.964 179.475 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -95.96 -29.7 14.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.131 -0.98 . . . . 0.0 110.74 -179.36 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.11 -172.01 3.17 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.964 0.888 . . . . 0.0 111.211 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 47.89 -155.42 0.07 Allowed 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.733 0.777 . . . . 0.0 110.654 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.61 -26.12 68.54 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.668 -0.645 . . . . 0.0 110.214 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 100.42 -34.93 5.16 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.36 172.31 8.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.072 -1.252 . . . . 0.0 110.743 -179.716 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 197' ' ' ASN . . . . . 0.451 ' N ' ' ND2' ' A' ' 197' ' ' ASN . 0.9 OUTLIER -139.45 -148.16 0.25 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.6 -0.688 . . . . 0.0 109.494 -179.44 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -175.54 84.27 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.189 -0.944 . . . . 0.0 110.259 179.397 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.47 ' CE2' HG21 ' A' ' 203' ' ' VAL . 83.4 t80 -51.28 119.73 4.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.196 -0.94 . . . . 0.0 110.535 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -117.45 95.98 5.2 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.299 -0.875 . . . . 0.0 110.31 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 156.11 -178.41 32.65 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.8 119.73 16.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -1.15 . . . . 0.0 110.137 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.47 HG21 ' CE2' ' A' ' 199' ' ' PHE . 80.0 t -60.06 108.25 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.195 -0.94 . . . . 0.0 110.137 -179.878 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.415 ' OG1' ' ND2' ' A' ' 207' ' ' ASN . 10.6 p -147.68 157.67 43.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.365 -0.835 . . . . 0.0 110.11 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -52.16 -48.15 65.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.282 -0.886 . . . . 0.0 110.587 -179.752 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -63.87 -24.85 67.91 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.184 -0.947 . . . . 0.0 110.483 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.415 ' ND2' ' OG1' ' A' ' 204' ' ' THR . 75.9 m-20 -90.31 -44.65 9.56 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.184 -0.948 . . . . 0.0 110.333 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 46.4 mt -58.96 -55.83 30.09 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.224 -0.923 . . . . 0.0 110.277 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.74 -23.69 18.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 0.0 110.094 179.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -80.81 -57.98 3.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 110.048 179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -54.98 -54.04 48.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.898 . . . . 0.0 109.974 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 82.0 mt -49.15 -55.64 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.274 -0.891 . . . . 0.0 110.284 179.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.06 -30.48 6.37 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.432 -0.792 . . . . 0.0 110.352 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . 0.448 ' CD2' ' N ' ' A' ' 214' ' ' HIS . 29.2 m170 -87.78 -7.12 57.72 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.202 -0.936 . . . . 0.0 110.626 179.765 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -89.31 -70.41 0.66 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.029 -1.044 . . . . 0.0 109.935 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.18 -0.95 . . . . 0.0 109.68 179.607 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.239 0.542 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -105.22 141.83 36.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 110.239 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.2 t -86.26 170.53 12.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.277 -0.889 . . . . 0.0 110.3 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.8 m -104.13 105.03 15.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.105 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 17.8 mt -79.65 129.24 71.99 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.9 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 49.1 Cg_endo -72.85 -44.84 0.56 Allowed 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.421 1.222 . . . . 0.0 110.39 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.415 ' OD2' ' CB ' ' A' ' 127' ' ' ALA . 0.9 OUTLIER -157.44 -169.3 2.85 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.325 -0.86 . . . . 0.0 110.572 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.44 -23.4 60.28 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.415 ' CB ' ' OD2' ' A' ' 125' ' ' ASP . . . -57.24 -29.7 64.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.263 -1.139 . . . . 0.0 110.25 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.428 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -88.26 -31.15 19.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 110.035 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.3 -30.7 68.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -0.901 . . . . 0.0 110.002 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -87.88 -37.99 16.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.343 -0.848 . . . . 0.0 110.09 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 10.1 p -73.95 -29.65 62.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 110.106 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.425 ' CD2' HG12 ' A' ' 141' ' ' ILE . 15.1 tp -61.9 -55.55 28.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.212 -0.93 . . . . 0.0 110.082 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.424 ' CG2' ' HB3' ' A' ' 189' ' ' PHE . 55.5 t -55.37 -25.87 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.895 . . . . 0.0 110.155 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -83.33 -29.21 28.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.319 -0.863 . . . . 0.0 110.422 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.5 m -61.05 -31.2 70.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.236 -0.915 . . . . 0.0 110.312 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 95.8 p -146.34 159.21 43.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.219 -0.925 . . . . 0.0 110.25 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.426 ' HG3' ' CG2' ' A' ' 138' ' ' VAL . 12.7 pt-20 -64.38 -40.65 96.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.879 . . . . 0.0 110.155 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.426 ' CG2' ' HG3' ' A' ' 137' ' ' GLU . 95.1 t -113.24 128.32 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.477 -0.764 . . . . 0.0 110.194 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -158.11 145.31 18.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.859 . . . . 0.0 109.839 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.481 HG12 ' CE2' ' A' ' 167' ' ' PHE . 7.5 p -124.63 151.29 29.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.125 -0.985 . . . . 0.0 110.298 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.425 HG12 ' CD2' ' A' ' 132' ' ' LEU . 66.7 mt -143.11 119.52 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.441 -0.787 . . . . 0.0 109.576 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -90.62 164.95 30.67 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.473 ' CE2' HG13 ' A' ' 175' ' ' VAL . 46.7 m-85 -130.72 69.09 1.46 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.52 -0.988 . . . . 0.0 109.375 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -89.03 132.63 34.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.139 -0.975 . . . . 0.0 111.379 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.3 -28.52 59.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.582 -0.699 . . . . 0.0 110.077 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -127.38 73.87 1.47 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.392 -0.817 . . . . 0.0 109.923 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.428 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 24.0 m -53.21 -21.8 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.348 -0.845 . . . . 0.0 110.611 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.49 13.39 8.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.134 -0.979 . . . . 0.0 110.801 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 85.3 p -98.6 -163.53 1.05 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.04 -1.038 . . . . 0.0 110.131 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.43 -43.67 14.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.114 -0.991 . . . . 0.0 110.293 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 85.6 p -52.74 -27.65 18.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -0.928 . . . . 0.0 110.25 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.428 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -85.48 -35.17 21.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 110.057 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.6 mmmt -54.28 -50.04 68.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 110.216 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -57.74 -38.9 76.16 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.261 -0.899 . . . . 0.0 110.085 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.477 ' CE1' HG13 ' A' ' 186' ' ' VAL . 4.1 t80 -52.41 -63.24 1.2 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 0.0 110.278 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.4 mt -53.86 -52.13 61.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.346 -0.846 . . . . 0.0 110.205 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -52.01 -50.44 61.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.369 -0.832 . . . . 0.0 110.12 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.428 ' CA ' ' HG3' ' A' ' 205' ' ' LYS . . . -66.15 -29.13 69.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.127 -0.983 . . . . 0.0 109.738 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.454 ' HB3' ' CD2' ' A' ' 167' ' ' PHE . . . -73.12 -34.3 66.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.389 -0.819 . . . . 0.0 109.995 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -57.11 -22.84 42.79 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.296 -0.877 . . . . 0.0 110.125 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.13 -51.47 69.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.896 . . . . 0.0 110.134 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.449 HD11 HG22 ' A' ' 162' ' ' ILE . 76.8 mt -100.96 139.76 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.32 -0.862 . . . . 0.0 110.246 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -117.51 -21.87 8.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 0.0 110.47 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -74.17 -11.0 60.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.184 -0.947 . . . . 0.0 110.729 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.429 HD11 HG21 ' A' ' 165' ' ' ILE . 49.4 mm -100.02 130.96 25.11 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 120.995 -1.066 . . . . 0.0 110.107 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -75.88 78.38 3.15 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.409 1.216 . . . . 0.0 110.683 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.481 ' CE2' HG12 ' A' ' 140' ' ' VAL . 5.8 m-85 -68.87 138.78 54.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.212 -0.93 . . . . 0.0 109.813 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -133.02 150.34 19.77 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 14.6 tt -149.67 137.81 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -1.191 . . . . 0.0 110.693 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.6 t -150.88 157.37 42.83 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.092 0.948 . . . . 0.0 110.774 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 79.7 p -118.78 0.78 11.5 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.581 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.48 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 43.3 t30 -53.56 -177.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.216 -0.928 . . . . 0.0 110.136 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 18.3 m -106.8 -35.96 6.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.137 -0.977 . . . . 0.0 110.077 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -57.91 -31.52 66.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -0.914 . . . . 0.0 109.819 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.473 HG13 ' CE2' ' A' ' 143' ' ' PHE . 40.2 t -76.42 -30.03 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.282 -0.886 . . . . 0.0 109.562 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 172' ' ' ASN . 11.4 m-85 -77.33 -57.36 3.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 109.613 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.2 m -53.2 -23.58 8.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.342 -0.849 . . . . 0.0 110.052 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -58.69 -57.91 10.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.873 . . . . 0.0 110.288 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -89.98 17.41 6.87 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.237 -0.914 . . . . 0.0 110.445 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 53.84 65.53 1.49 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.045 -1.035 . . . . 0.0 110.347 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 83.3 mt -108.29 100.79 10.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.316 -0.865 . . . . 0.0 110.194 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.97 -26.12 46.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 109.978 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -144.3 -165.5 2.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.362 -0.837 . . . . 0.0 110.122 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -68.89 163.56 24.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.171 -0.956 . . . . 0.0 110.233 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 175.81 144.75 5.21 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.477 HG13 ' CE1' ' A' ' 155' ' ' PHE . 11.5 m -114.32 128.47 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -1.131 . . . . 0.0 110.283 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 94.8 t -132.75 163.3 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.389 -0.819 . . . . 0.0 109.326 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.453 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 6.6 tt -110.79 161.55 15.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.939 -1.101 . . . . 0.0 109.907 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.424 ' HB3' ' CG2' ' A' ' 133' ' ' VAL . 52.6 m-85 -128.53 124.85 37.05 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.989 -1.07 . . . . 0.0 110.418 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.408 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -138.14 161.24 37.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.265 -0.897 . . . . 0.0 110.378 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -90.87 -27.89 18.5 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.342 -0.849 . . . . 0.0 110.552 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.408 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.8 OUTLIER -90.75 -176.39 4.68 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.435 -0.79 . . . . 0.0 110.873 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 48.02 -154.52 0.08 Allowed 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.718 0.77 . . . . 0.0 110.587 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.04 -55.6 22.51 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.72 -0.613 . . . . 0.0 110.243 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 121.52 -25.69 6.85 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -134.89 161.56 34.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.268 -1.137 . . . . 0.0 110.203 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . 0.462 ' N ' ' ND2' ' A' ' 197' ' ' ASN . 0.6 OUTLIER -133.34 -153.57 0.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.151 -0.968 . . . . 0.0 109.998 -179.481 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -174.57 88.3 0.05 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.446 -0.784 . . . . 0.0 110.217 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.468 ' CE1' ' O ' ' A' ' 200' ' ' GLU . 29.3 t80 -60.75 139.97 57.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.334 -0.854 . . . . 0.0 110.398 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.468 ' O ' ' CE1' ' A' ' 199' ' ' PHE . 55.7 mt-10 -130.0 -151.33 0.47 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.141 -0.974 . . . . 0.0 109.679 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 51.34 -146.66 10.96 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.08 158.45 16.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -1.157 . . . . 0.0 110.016 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 73.2 t -89.13 114.69 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.255 -0.903 . . . . 0.0 110.251 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 38.8 p -150.27 147.78 28.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.329 -0.857 . . . . 0.0 110.165 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.428 ' HG3' ' CA ' ' A' ' 158' ' ' ALA . 13.2 tttm -46.78 -50.26 18.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.25 -0.906 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . 0.423 ' HG3' ' N ' ' A' ' 207' ' ' ASN . 17.7 pt-20 -56.77 -39.36 73.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 110.191 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.423 ' N ' ' HG3' ' A' ' 206' ' ' GLU . 54.8 m-20 -72.33 -45.63 59.1 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.315 -0.865 . . . . 0.0 110.165 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 89.7 mt -54.52 -54.54 39.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 110.285 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 1.4 mt -52.69 -29.09 24.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 0.0 110.002 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -77.72 -48.18 17.31 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.34 -0.85 . . . . 0.0 109.651 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.428 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 18.3 t80 -52.22 -56.04 17.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.865 . . . . 0.0 109.763 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 36.9 mm -51.24 -65.4 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.319 -0.863 . . . . 0.0 110.001 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -50.86 -25.31 4.38 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.755 -0.591 . . . . 0.0 110.452 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -89.57 -14.77 34.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.176 -0.952 . . . . 0.0 110.565 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 1.7 m-80 -89.06 -81.99 0.26 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.074 -1.016 . . . . 0.0 110.27 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.49 177.9 0.35 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.157 -0.965 . . . . 0.0 110.164 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 28.9 mt 54.59 100.03 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.391 -0.818 . . . . 0.0 110.314 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.23 -176.75 1.72 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.586 1.308 . . . . 0.0 110.294 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.0 -165.32 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.191 -0.943 . . . . 0.0 109.917 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 8.7 p -149.48 137.85 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 110.241 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 7.2 mt -70.42 78.22 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.205 -0.934 . . . . 0.0 110.202 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -157.99 144.38 17.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.34 -0.85 . . . . 0.0 110.143 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 53.83 -170.12 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.194 -0.941 . . . . 0.0 110.119 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.1 t -154.61 22.44 0.46 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.228 -0.92 . . . . 0.0 110.223 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 52.88 62.0 2.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.258 -0.901 . . . . 0.0 110.269 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -59.54 96.31 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.218 -0.926 . . . . 0.0 110.17 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 72.2 m -140.1 -61.33 0.52 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 110.132 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.224 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.256 0.55 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.15 160.71 14.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.0 110.195 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.8 t -99.38 169.95 8.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.124 -0.985 . . . . 0.0 110.318 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 92.8 m -108.18 121.12 44.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.288 -0.882 . . . . 0.0 110.119 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.1 mt -100.06 136.49 20.12 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.241 -0.912 . . . . 0.0 110.08 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.88 -51.76 0.14 Allowed 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.509 1.268 . . . . 0.0 110.44 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.08 -170.42 3.48 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.224 -0.922 . . . . 0.0 110.788 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -58.86 -28.8 63.81 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -51.2 -36.69 42.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.176 -1.191 . . . . 0.0 110.472 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.68 -29.19 27.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.145 -0.972 . . . . 0.0 110.03 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.2 -27.3 68.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.131 -0.98 . . . . 0.0 109.95 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -89.07 -49.74 6.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.893 . . . . 0.0 109.971 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.3 t -58.7 -32.22 68.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.893 . . . . 0.0 110.197 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 27.0 tp -59.91 -52.52 65.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.321 -0.862 . . . . 0.0 110.011 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.498 HG23 ' CD2' ' A' ' 189' ' ' PHE . 47.7 t -58.56 -37.62 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.295 -0.878 . . . . 0.0 110.033 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -74.13 -5.69 43.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.32 -0.862 . . . . 0.0 110.909 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.35 -21.98 25.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.903 -1.123 . . . . 0.0 110.615 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.08 162.24 40.79 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.196 -0.94 . . . . 0.0 110.571 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.06 -17.39 62.01 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.314 -0.866 . . . . 0.0 109.912 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 99.2 t -135.13 139.6 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.976 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.431 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -173.13 146.9 1.51 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 0.0 110.121 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.489 HG12 ' CE2' ' A' ' 167' ' ' PHE . 7.7 p -129.13 152.74 37.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.089 -1.007 . . . . 0.0 109.919 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.477 ' O ' ' CE1' ' A' ' 143' ' ' PHE . 62.5 mt -139.47 117.68 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.209 -0.932 . . . . 0.0 110.204 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -81.85 139.68 20.2 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.477 ' CE1' ' O ' ' A' ' 141' ' ' ILE . 70.9 m-85 -114.07 79.38 1.25 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.154 -1.204 . . . . 0.0 109.971 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -107.15 148.35 28.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.109 -0.994 . . . . 0.0 110.842 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.32 -28.59 18.65 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.3 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.69 82.88 1.95 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -0.837 . . . . 0.0 109.638 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 87.6 t -52.87 -21.93 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.366 -0.833 . . . . 0.0 110.76 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.81 18.39 6.59 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.218 -0.926 . . . . 0.0 110.563 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 10.3 p -90.8 -162.84 0.95 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.139 -0.976 . . . . 0.0 110.245 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -90.27 -47.94 7.46 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.267 -0.896 . . . . 0.0 110.489 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 62.5 m -52.35 -29.97 26.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.167 -0.958 . . . . 0.0 110.245 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.53 -29.08 41.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 109.975 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.1 -54.36 45.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -0.907 . . . . 0.0 109.865 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -58.21 -37.91 75.74 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.309 -0.87 . . . . 0.0 109.864 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -50.22 -59.84 3.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.315 -0.866 . . . . 0.0 110.32 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 17.4 mt -50.44 -50.23 52.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.328 -0.858 . . . . 0.0 110.39 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -52.83 -54.76 29.61 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.392 -0.818 . . . . 0.0 110.113 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.58 -40.94 93.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.051 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.452 ' CB ' ' CD2' ' A' ' 167' ' ' PHE . . . -67.46 -25.67 66.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.307 -0.87 . . . . 0.0 110.158 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -82.94 -31.19 27.82 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.304 -0.873 . . . . 0.0 110.214 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.77 -38.64 64.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 0.0 110.195 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.8 tt -96.37 156.36 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.914 . . . . 0.0 110.339 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -133.93 16.01 3.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.93 . . . . 0.0 110.481 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -123.68 10.43 9.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.08 -1.013 . . . . 0.0 110.716 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.424 HG21 HD11 ' A' ' 165' ' ' ILE . 50.0 mm -126.67 136.52 28.85 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.0 -1.062 . . . . 0.0 110.189 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.431 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 49.9 Cg_endo -77.13 91.94 1.15 Allowed 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.499 1.262 . . . . 0.0 110.915 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.489 ' CE2' HG12 ' A' ' 140' ' ' VAL . 4.1 m-85 -86.66 130.75 34.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.288 -0.882 . . . . 0.0 109.823 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -133.56 156.06 22.07 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 12.6 tt -150.84 150.78 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.094 -1.239 . . . . 0.0 110.418 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.3 t -157.65 157.78 34.24 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.06 0.933 . . . . 0.0 110.819 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.2 t -120.13 -0.18 10.57 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.389 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.429 ' ND2' ' HB2' ' A' ' 174' ' ' ASP . 23.8 t30 -61.55 129.47 41.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.096 -1.002 . . . . 0.0 110.24 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.6 t -58.83 -29.36 66.85 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.261 -0.9 . . . . 0.0 110.448 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.429 ' HB2' ' ND2' ' A' ' 172' ' ' ASN . 1.0 OUTLIER -56.36 -33.66 65.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.125 -0.984 . . . . 0.0 110.206 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 42.3 t -80.03 -25.29 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.913 . . . . 0.0 109.947 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 176' ' ' PHE . 11.9 m-85 -80.39 -53.06 6.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.304 -0.873 . . . . 0.0 109.777 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 14.2 m -54.45 -23.19 15.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.886 . . . . 0.0 109.932 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.71 -50.28 45.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.361 -0.837 . . . . 0.0 110.025 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -89.84 8.21 33.21 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.319 -0.863 . . . . 0.0 110.735 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 52.51 57.94 5.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.991 -1.068 . . . . 0.0 110.4 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 83.7 mt -99.45 100.27 11.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.197 -0.939 . . . . 0.0 110.351 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 3.7 m-20 -54.07 -26.74 28.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.96 . . . . 0.0 110.198 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -146.94 -165.29 2.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.217 -0.927 . . . . 0.0 109.914 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -64.1 162.49 14.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.14 -0.975 . . . . 0.0 109.91 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -170.57 140.3 5.92 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.466 -1.35 . . . . 0.0 110.064 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.405 ' HB ' ' HB3' ' A' ' 199' ' ' PHE . 53.3 t -109.46 90.32 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.423 -1.045 . . . . 0.0 109.448 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.427 HG11 ' N ' ' A' ' 188' ' ' LEU . 94.0 t -102.55 147.75 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.338 -0.851 . . . . 0.0 110.277 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.463 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 7.7 tt -107.46 158.98 16.75 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.292 -0.88 . . . . 0.0 109.306 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.498 ' CD2' HG23 ' A' ' 133' ' ' VAL . 71.2 m-85 -123.86 139.76 53.65 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.995 -1.066 . . . . 0.0 110.707 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.91 166.16 26.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.399 -0.813 . . . . 0.0 109.796 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -84.4 -36.55 22.35 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.138 -0.976 . . . . 0.0 110.409 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.07 -170.98 2.83 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.743 0.782 . . . . 0.0 110.782 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 53.54 -160.58 0.13 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.666 0.746 . . . . 0.0 110.575 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -60.79 -29.59 69.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.668 -0.645 . . . . 0.0 110.241 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 105.38 -21.87 34.05 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.71 172.84 12.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.083 -1.245 . . . . 0.0 110.616 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . 0.463 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.8 m-80 -134.65 -148.9 0.33 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.585 -0.697 . . . . 0.0 109.48 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -173.73 81.25 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.228 -0.92 . . . . 0.0 110.393 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.414 ' CD1' ' C ' ' A' ' 199' ' ' PHE . 12.1 t80 -69.64 123.55 21.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.372 -0.83 . . . . 0.0 109.96 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -138.26 122.0 17.55 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.214 -0.929 . . . . 0.0 109.949 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 144.01 -145.2 14.61 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.53 112.92 19.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -1.132 . . . . 0.0 110.333 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 83.6 t -74.72 109.57 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.103 -0.998 . . . . 0.0 110.03 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 71.9 p -147.95 151.67 36.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.315 -0.865 . . . . 0.0 110.47 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 12.5 tttm -46.84 -55.14 8.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.468 -0.77 . . . . 0.0 110.928 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -54.65 -28.14 44.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.357 -0.839 . . . . 0.0 110.479 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 24.8 m-20 -86.18 -44.38 12.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 0.0 110.396 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 80.4 mt -57.28 -55.02 40.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.938 . . . . 0.0 110.695 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 8.0 mp -50.99 -50.32 58.61 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.116 -0.99 . . . . 0.0 110.653 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.01 -37.16 76.26 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.251 -0.906 . . . . 0.0 110.497 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.417 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 8.9 t80 -64.36 -60.46 3.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.145 -0.972 . . . . 0.0 110.472 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 8.9 mt -53.77 -47.37 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.337 -0.852 . . . . 0.0 110.697 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.6 mmtt -50.79 -23.21 2.57 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.235 -0.916 . . . . 0.0 110.863 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -96.69 -16.13 21.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.167 -0.958 . . . . 0.0 110.862 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 77.6 m-20 -94.66 -40.04 10.01 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.108 -0.995 . . . . 0.0 111.33 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -91.09 19.94 5.36 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.897 -1.127 . . . . 0.0 110.662 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 14.4 mt -145.53 57.95 4.59 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.146 -0.971 . . . . 0.0 109.949 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.93 150.16 54.58 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.718 1.378 . . . . 0.0 110.215 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . 0.467 ' N ' ' CD2' ' A' ' 219' ' ' LEU . 4.5 mm? -98.02 118.0 33.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.887 . . . . 0.0 110.228 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 34.0 m -90.55 156.48 3.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.471 -0.768 . . . . 0.0 110.152 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.401 HG23 HD11 ' A' ' 221' ' ' ILE . 94.5 mt -118.18 150.37 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.177 -0.952 . . . . 0.0 110.181 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 52.9 89.27 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.287 -0.883 . . . . 0.0 110.361 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -55.39 171.37 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.909 . . . . 0.0 110.251 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.9 t -110.94 175.4 5.44 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.253 -0.904 . . . . 0.0 110.23 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.54 61.68 0.36 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.915 . . . . 0.0 110.172 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.17 -55.82 0.28 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.934 . . . . 0.0 110.131 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 6.6 t -150.67 167.74 26.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.293 -0.879 . . . . 0.0 110.188 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.232 -179.942 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.301 0.572 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -103.99 157.79 16.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 110.301 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.3 t -74.66 169.23 18.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.288 -0.883 . . . . 0.0 110.093 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.4 m -101.66 121.32 41.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.262 -0.899 . . . . 0.0 110.548 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.3 mt -102.34 118.33 59.12 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.336 -0.853 . . . . 0.0 109.619 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.411 ' O ' ' ND2' ' A' ' 172' ' ' ASN . 46.1 Cg_endo -71.0 -18.34 31.27 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.453 1.239 . . . . 0.0 110.848 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 179.4 -170.03 0.12 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.088 -1.007 . . . . 0.0 111.466 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.96 -29.43 70.72 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -53.47 -29.9 38.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -1.12 . . . . 0.0 110.159 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.75 -35.17 15.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.906 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.59 -39.16 79.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.327 -0.858 . . . . 0.0 109.996 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.49 -51.11 12.38 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.249 -0.907 . . . . 0.0 110.253 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.0 m -57.27 -20.46 28.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.35 -0.844 . . . . 0.0 110.408 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.9 tp -79.15 -48.14 14.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 110.381 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.444 ' CG2' ' HB3' ' A' ' 189' ' ' PHE . 90.9 t -60.02 -31.39 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.142 -0.974 . . . . 0.0 110.38 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -85.79 -23.69 27.12 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.238 -0.913 . . . . 0.0 109.582 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.12 -63.41 1.19 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.143 -0.973 . . . . 0.0 110.12 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.4 p -115.7 -176.63 2.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.927 . . . . 0.0 110.259 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.5 -35.56 58.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.872 . . . . 0.0 110.248 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.5 t -120.86 149.29 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.247 -0.908 . . . . 0.0 110.261 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -175.27 130.45 0.29 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.316 -0.865 . . . . 0.0 109.907 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.455 HG12 ' CZ ' ' A' ' 167' ' ' PHE . 9.6 p -119.13 147.99 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.142 -0.974 . . . . 0.0 110.329 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.432 ' N ' HG21 ' A' ' 140' ' ' VAL . 3.2 mt -134.83 113.92 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.342 -0.849 . . . . 0.0 109.945 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -80.98 128.23 8.33 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 143' ' ' PHE . 32.0 m-85 -94.89 76.57 3.6 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.235 -1.156 . . . . 0.0 109.904 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -96.63 139.21 33.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 110.965 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.39 -26.89 26.16 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.425 -0.797 . . . . 0.0 109.576 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -137.96 78.39 1.68 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.51 -0.744 . . . . 0.0 109.508 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 27.3 m -50.36 -23.86 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.349 -0.844 . . . . 0.0 110.717 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -84.66 10.59 10.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 110.892 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 11.2 p -88.11 -161.65 0.75 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.963 -1.085 . . . . 0.0 110.187 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.05 -42.81 10.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.262 -0.899 . . . . 0.0 110.344 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.0 m -59.4 -28.66 67.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.158 -0.964 . . . . 0.0 110.355 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.8 -31.26 45.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.309 -0.87 . . . . 0.0 110.174 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -58.94 -25.43 63.48 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.21 -0.931 . . . . 0.0 109.96 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -75.37 -46.31 33.84 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.394 -0.816 . . . . 0.0 110.133 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -49.97 -56.56 10.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 110.476 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 64.9 mt -49.36 -52.29 29.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.42 -0.8 . . . . 0.0 110.584 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -51.82 -46.49 64.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.422 -0.799 . . . . 0.0 110.36 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.4 -39.81 74.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 110.261 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.25 -27.61 69.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 110.298 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -60.42 -47.44 86.1 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.208 -0.932 . . . . 0.0 110.38 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.76 -35.65 56.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.165 -0.959 . . . . 0.0 110.342 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.7 mm -89.8 112.26 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 109.89 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -114.0 13.9 18.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 110.446 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -124.32 17.35 9.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.086 -1.009 . . . . 0.0 110.366 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 42.2 mm -128.22 141.03 40.01 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.162 -0.961 . . . . 0.0 110.057 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -75.32 73.68 4.42 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.533 1.281 . . . . 0.0 110.409 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.455 ' CZ ' HG12 ' A' ' 140' ' ' VAL . 2.6 m-85 -66.32 132.67 48.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.23 -0.919 . . . . 0.0 110.09 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -123.99 154.08 17.59 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 16.9 tt -149.2 138.96 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -1.14 . . . . 0.0 110.283 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.3 t -159.46 157.35 29.96 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.113 0.958 . . . . 0.0 110.753 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.2 t -122.79 2.15 9.43 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.495 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 124' ' ' PRO . 60.8 t30 -57.08 123.77 16.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.135 -0.978 . . . . 0.0 110.277 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 77.2 p -49.65 -33.18 14.86 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.253 -0.905 . . . . 0.0 110.504 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -54.1 -32.61 55.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 109.887 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 41.4 t -78.83 -24.45 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -0.872 . . . . 0.0 109.861 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 176' ' ' PHE . 20.6 m-85 -86.64 -44.91 11.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -0.871 . . . . 0.0 109.891 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 5.6 m -70.83 -7.22 43.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -0.844 . . . . 0.0 110.777 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 45.7 tttp -88.09 -47.49 8.46 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.058 -1.026 . . . . 0.0 109.563 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -90.06 12.19 18.47 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.371 -0.831 . . . . 0.0 110.385 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.93 68.6 0.78 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.054 -1.028 . . . . 0.0 110.483 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 62.2 mt -116.23 103.35 10.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 110.143 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -51.57 -26.14 8.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.27 -0.894 . . . . 0.0 110.226 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -149.93 -169.0 3.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 110.023 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -63.43 162.94 11.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.202 -0.936 . . . . 0.0 110.137 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -169.18 166.73 39.93 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.421 ' O ' ' CG2' ' A' ' 186' ' ' VAL . 21.4 m -135.19 114.68 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.247 -1.149 . . . . 0.0 110.11 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.419 ' CG2' ' HA ' ' A' ' 198' ' ' ASN . 99.5 t -127.29 153.67 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.924 . . . . 0.0 110.082 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.478 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 6.1 tt -109.27 137.96 46.36 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.285 -0.884 . . . . 0.0 108.668 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.444 ' HB3' ' CG2' ' A' ' 133' ' ' VAL . 62.4 m-85 -111.28 135.87 51.2 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.726 -1.234 . . . . 0.0 111.19 -178.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.487 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -150.16 159.76 44.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.453 -0.779 . . . . 0.0 109.967 179.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -83.97 -22.18 31.51 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.242 -0.911 . . . . 0.0 110.491 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.487 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 2.4 p90 -90.7 -178.91 5.4 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.284 -0.885 . . . . 0.0 110.633 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 48.79 -159.17 0.05 Allowed 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.659 0.742 . . . . 0.0 110.509 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -60.61 -31.05 70.24 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.583 -0.698 . . . . 0.0 110.293 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 114.58 -42.74 1.85 Allowed Glycine 0 N--CA 1.483 1.822 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.09 177.95 5.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.147 -1.208 . . . . 0.0 110.462 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . 0.478 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 2.5 m-80 -134.47 -37.3 0.85 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 0.0 110.55 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.419 ' HA ' ' CG2' ' A' ' 187' ' ' VAL . 4.0 m-80 57.73 83.29 0.11 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.171 -0.955 . . . . 0.0 109.991 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.406 ' HB3' ' CG2' ' A' ' 186' ' ' VAL . 84.3 t80 -66.61 115.27 6.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.396 -0.815 . . . . 0.0 110.433 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -115.6 80.16 1.4 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.368 -0.832 . . . . 0.0 110.12 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -169.12 -157.6 11.92 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -79.36 122.47 26.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -1.154 . . . . 0.0 110.305 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 70.6 t -71.87 101.36 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 110.076 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 57.9 p -150.27 152.08 33.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.388 -0.82 . . . . 0.0 110.268 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.419 ' HG2' ' CD1' ' A' ' 209' ' ' LEU . 3.9 tttm -49.49 -48.54 47.82 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.321 -0.862 . . . . 0.0 110.426 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -57.1 -39.81 75.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.342 -0.849 . . . . 0.0 110.283 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -80.03 -48.48 13.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.231 -0.918 . . . . 0.0 110.368 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 98.8 mt -54.19 -55.44 27.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.935 . . . . 0.0 110.257 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.419 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 8.2 mt -54.35 -29.88 49.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.283 -0.885 . . . . 0.0 110.221 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -76.42 -45.88 29.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.911 . . . . 0.0 110.065 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 197' ' ' ASN . 6.9 t80 -56.46 -62.79 1.48 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.411 -0.806 . . . . 0.0 110.462 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 5.8 mt -52.42 -42.56 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.0 110.593 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -56.15 -19.74 14.73 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.218 -0.926 . . . . 0.0 110.786 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -110.92 11.64 22.27 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.198 -0.939 . . . . 0.0 110.755 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.431 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 1.3 m120 -91.89 -64.41 1.12 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.946 -1.096 . . . . 0.0 110.611 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . 0.483 ' HA ' ' CZ ' ' A' ' 192' ' ' PHE . 5.9 pt20 -53.11 -41.41 64.97 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.289 -0.882 . . . . 0.0 111.002 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 3.4 mt -63.84 111.9 6.25 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.165 -0.96 . . . . 0.0 110.53 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -77.39 -168.54 0.6 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 O-C-N 123.454 1.239 . . . . 0.0 110.382 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 3.5 mt -84.75 104.97 15.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.289 -0.882 . . . . 0.0 110.194 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.41 ' O ' ' CG2' ' A' ' 220' ' ' VAL . 8.3 p -137.3 47.05 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.374 -0.829 . . . . 0.0 110.135 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 47.9 mm -79.25 89.32 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.318 -0.864 . . . . 0.0 110.252 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -136.0 -72.63 0.45 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.888 . . . . 0.0 110.119 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -108.5 -169.4 1.5 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.0 110.05 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 55.9 m -120.26 134.86 55.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.0 110.193 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -101.07 -38.19 8.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.225 -0.922 . . . . 0.0 110.077 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -86.7 97.87 10.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.283 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 18.2 p -75.43 116.94 16.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.185 -0.947 . . . . 0.0 110.15 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.216 179.976 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.282 0.563 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -105.9 176.12 5.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -0.911 . . . . 0.0 110.178 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.429 ' CG2' ' HA2' ' A' ' 168' ' ' GLY . 8.9 t -97.87 166.89 11.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.182 -0.949 . . . . 0.0 110.15 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.8 m -115.02 103.92 11.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.942 . . . . 0.0 110.346 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.3 mt -77.85 126.2 84.43 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.299 -0.876 . . . . 0.0 110.015 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.27 -40.25 2.47 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.418 1.22 . . . . 0.0 110.508 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -153.82 -170.59 3.62 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.308 -0.87 . . . . 0.0 110.813 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.02 -29.93 72.19 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -52.15 -30.36 26.29 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.157 -1.202 . . . . 0.0 110.371 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.79 -38.7 13.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.947 . . . . 0.0 110.032 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.451 ' HB3' ' HH ' ' A' ' 179' ' ' TYR . . . -54.53 -25.22 24.5 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.283 -0.885 . . . . 0.0 110.036 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -86.62 -54.49 4.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.353 -0.842 . . . . 0.0 110.115 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.07 -18.31 33.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.912 . . . . 0.0 110.291 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.3 tt -73.25 -59.35 2.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 0.0 109.747 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.429 ' CG2' ' HB3' ' A' ' 189' ' ' PHE . 49.8 t -53.01 -37.21 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.414 -0.803 . . . . 0.0 110.257 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -73.16 -25.58 60.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.274 -0.891 . . . . 0.0 110.313 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.81 -48.82 69.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 110.28 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 78.0 p -135.65 173.86 11.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.224 -0.922 . . . . 0.0 110.338 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.91 -41.22 91.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -0.862 . . . . 0.0 110.309 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 95.7 t -112.97 151.02 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.283 -0.886 . . . . 0.0 110.371 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -174.4 137.79 0.52 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.854 . . . . 0.0 109.845 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.469 HG12 ' CE2' ' A' ' 167' ' ' PHE . 9.1 p -123.38 147.09 27.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.203 -0.936 . . . . 0.0 110.302 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.47 HG23 ' CE1' ' A' ' 143' ' ' PHE . 3.4 mt -135.79 115.82 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.265 -0.897 . . . . 0.0 109.666 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -79.82 134.25 13.39 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.511 ' CE2' ' CG1' ' A' ' 175' ' ' VAL . 11.5 m-85 -103.48 71.25 1.08 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.181 -1.188 . . . . 0.0 109.615 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -91.74 137.45 32.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.026 -1.046 . . . . 0.0 110.992 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.464 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -91.19 -31.94 15.98 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 121.614 0.721 . . . . 0.0 109.846 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.464 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 1.7 t70 -89.5 -41.49 12.01 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.534 0.683 . . . . 0.0 110.166 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.432 ' CB ' ' O ' ' A' ' 146' ' ' ASP . 2.5 t 72.97 -51.08 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.859 -0.526 . . . . 0.0 110.714 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -90.72 8.87 32.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.093 -1.005 . . . . 0.0 110.551 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 19.8 p -70.34 -164.68 0.09 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.863 -1.148 . . . . 0.0 109.971 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.41 -31.18 16.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.895 . . . . 0.0 110.277 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.5 p -68.49 -25.6 65.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.906 . . . . 0.0 110.123 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.39 -34.01 25.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.9 . . . . 0.0 110.173 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -53.2 -44.77 68.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.355 -0.841 . . . . 0.0 110.4 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -66.89 -36.83 83.17 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.221 -0.925 . . . . 0.0 110.316 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -51.58 -58.22 6.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.392 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.6 mt -50.52 -54.25 23.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.4 -0.813 . . . . 0.0 110.45 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -50.88 -29.93 13.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.258 -0.901 . . . . 0.0 110.342 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -75.63 -56.47 4.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.338 -0.852 . . . . 0.0 110.006 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.404 ' CB ' ' CD2' ' A' ' 167' ' ' PHE . . . -54.86 -33.58 62.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 110.059 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -66.69 -28.7 68.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.331 -0.856 . . . . 0.0 110.226 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -64.67 -42.88 95.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.285 -0.884 . . . . 0.0 110.231 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 4.1 tt -93.12 164.42 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.254 -0.904 . . . . 0.0 110.209 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 163' ' ' ASP . 17.1 p-10 -145.23 19.2 1.57 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.101 -0.999 . . . . 0.0 110.467 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -125.57 8.82 7.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.196 -0.94 . . . . 0.0 110.652 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.463 HD11 HG22 ' A' ' 165' ' ' ILE . 45.8 mm -125.53 137.21 29.46 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.04 -1.037 . . . . 0.0 109.798 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.69 78.97 2.33 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.568 1.299 . . . . 0.0 110.724 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.469 ' CE2' HG12 ' A' ' 140' ' ' VAL . 2.9 m-85 -71.4 125.64 27.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.186 -0.946 . . . . 0.0 109.694 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.429 ' HA2' ' CG2' ' A' ' 121' ' ' THR . . . -123.33 156.15 17.59 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.134 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 14.7 tt -150.17 142.95 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.459 -1.024 . . . . 0.0 109.912 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.4 t -164.98 157.57 16.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.117 -0.989 . . . . 0.0 110.892 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 91.2 p -122.97 3.58 9.38 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.375 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -54.98 122.05 10.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.158 -0.964 . . . . 0.0 110.306 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 83.9 p -51.52 -31.85 25.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.321 -0.862 . . . . 0.0 110.477 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -54.32 -33.8 59.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.142 -0.974 . . . . 0.0 109.809 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.511 ' CG1' ' CE2' ' A' ' 143' ' ' PHE . 41.0 t -79.78 -24.46 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.44 -0.788 . . . . 0.0 109.642 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 176' ' ' PHE . 10.8 m-85 -79.44 -54.96 5.41 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.441 -0.787 . . . . 0.0 109.907 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 29.9 t -66.53 -14.27 62.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.366 -0.834 . . . . 0.0 110.562 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 11.3 tttt -82.01 -44.94 15.99 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.086 -1.009 . . . . 0.0 110.034 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.451 ' HH ' ' HB3' ' A' ' 129' ' ' ALA . 49.6 m-85 -90.7 8.08 36.25 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.15 -0.969 . . . . 0.0 110.674 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.69 67.81 0.87 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.05 -1.032 . . . . 0.0 110.676 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.434 ' CD1' ' CD2' ' A' ' 143' ' ' PHE . 3.4 mt -109.06 124.43 50.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.226 -0.921 . . . . 0.0 110.137 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -62.08 -15.83 47.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.108 -0.995 . . . . 0.0 110.012 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -175.26 -157.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.233 -0.917 . . . . 0.0 109.551 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -71.57 160.45 32.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.087 -1.008 . . . . 0.0 109.945 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -177.33 172.97 45.82 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 74.9 t -126.5 107.54 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.385 -1.068 . . . . 0.0 110.006 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.428 HG11 ' N ' ' A' ' 188' ' ' LEU . 75.0 t -111.57 148.22 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.339 -0.851 . . . . 0.0 109.94 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.466 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 6.3 tt -108.16 143.74 36.54 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.008 -1.057 . . . . 0.0 109.421 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.429 ' HB3' ' CG2' ' A' ' 133' ' ' VAL . 59.9 m-85 -115.62 118.6 33.56 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.017 -1.052 . . . . 0.0 110.874 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.445 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -130.55 164.02 25.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.279 -0.888 . . . . 0.0 109.996 179.513 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -88.86 -24.9 22.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.165 -0.959 . . . . 0.0 110.148 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.445 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 1.6 p90 -91.01 -176.17 4.55 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.46 -0.775 . . . . 0.0 110.741 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 46.22 -159.13 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.605 0.717 . . . . 0.0 110.966 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -50.9 -56.33 12.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.66 -0.65 . . . . 0.0 110.284 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 125.17 -21.71 6.43 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.4 mtm180 -143.63 156.91 44.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.132 -1.216 . . . . 0.0 110.571 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . 0.466 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.1 m-80 -131.46 -167.35 1.84 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.36 -0.837 . . . . 0.0 109.84 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -156.82 80.69 0.94 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.442 -0.787 . . . . 0.0 109.892 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.471 ' CE2' HG23 ' A' ' 203' ' ' VAL . 84.7 t80 -51.3 121.87 6.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.138 -0.976 . . . . 0.0 110.484 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.03 91.72 3.49 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.344 -0.847 . . . . 0.0 110.271 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 165.34 177.41 37.71 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -55.96 107.52 0.36 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.25 -1.147 . . . . 0.0 110.237 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.471 HG23 ' CE2' ' A' ' 199' ' ' PHE . 93.1 t -64.84 113.66 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -0.879 . . . . 0.0 110.071 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 12.5 p -150.33 157.36 42.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.87 . . . . 0.0 110.475 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.424 ' HG2' ' CD1' ' A' ' 209' ' ' LEU . 11.4 tttt -50.09 -52.25 36.26 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.196 -0.94 . . . . 0.0 110.597 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . 0.431 ' HG3' ' N ' ' A' ' 207' ' ' ASN . 12.3 pt-20 -55.91 -40.04 72.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.221 -0.924 . . . . 0.0 110.329 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.431 ' N ' ' HG3' ' A' ' 206' ' ' GLU . 87.6 m-20 -78.12 -48.01 16.93 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.271 -0.893 . . . . 0.0 110.253 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 68.2 mt -53.53 -57.99 8.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.221 -0.924 . . . . 0.0 110.346 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.424 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 0.4 OUTLIER -53.54 -22.83 9.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.293 -0.88 . . . . 0.0 110.467 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -81.76 -49.62 10.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.099 -1.001 . . . . 0.0 110.093 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -58.97 -56.92 16.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.317 -0.864 . . . . 0.0 110.428 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 6.9 mt -55.22 -49.03 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.267 -0.896 . . . . 0.0 110.621 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -50.33 -27.35 6.04 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.173 -0.954 . . . . 0.0 110.598 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -88.0 -24.67 23.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -0.925 . . . . 0.0 110.412 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -89.58 -33.59 16.65 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.263 -0.898 . . . . 0.0 110.753 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.87 19.78 4.59 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.13 -0.981 . . . . 0.0 110.63 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 25.8 mt -140.4 74.52 28.9 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.068 -1.02 . . . . 0.0 110.211 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.17 179.55 4.86 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.619 1.326 . . . . 0.0 110.41 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.2 mp -111.57 118.22 35.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.344 -0.848 . . . . 0.0 110.289 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 8.5 p -100.0 147.91 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.912 . . . . 0.0 110.035 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 34.5 mm 52.67 85.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.181 -0.949 . . . . 0.0 110.11 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -162.52 104.33 1.08 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.18 -0.95 . . . . 0.0 110.218 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.02 131.78 45.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 109.978 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.1 p -125.74 98.48 5.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.913 . . . . 0.0 110.369 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -99.0 -69.99 0.74 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.875 . . . . 0.0 110.068 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -116.41 150.15 38.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.188 -0.945 . . . . 0.0 110.205 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 98.9 m -83.97 -30.93 25.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.29 -0.881 . . . . 0.0 110.25 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.252 179.951 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.16 0.505 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -112.39 -171.23 1.81 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 0.0 110.317 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.432 ' N ' ' O ' ' A' ' 167' ' ' PHE . 28.6 m -97.53 95.7 7.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 110.172 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 95.9 m -61.34 104.24 0.38 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -0.9 . . . . 0.0 109.88 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.98 137.1 43.5 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.124 -0.985 . . . . 0.0 110.169 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 48.9 Cg_endo -73.33 -39.62 2.0 Allowed 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.532 1.28 . . . . 0.0 110.206 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.06 -169.11 2.84 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.992 0.901 . . . . 0.0 111.085 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.4 -31.7 79.66 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -53.21 -27.14 20.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.233 -1.157 . . . . 0.0 110.119 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.428 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -88.2 -32.75 18.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.87 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.85 -41.54 78.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.349 -0.844 . . . . 0.0 109.946 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.77 -52.79 11.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.331 -0.856 . . . . 0.0 110.086 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.96 -40.31 63.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.333 -0.854 . . . . 0.0 110.099 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.443 ' CD2' HG12 ' A' ' 141' ' ' ILE . 21.3 tp -53.55 -50.72 64.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.247 -0.908 . . . . 0.0 109.961 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.428 HG23 ' CD2' ' A' ' 189' ' ' PHE . 39.9 t -53.63 -32.71 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.459 -0.775 . . . . 0.0 110.186 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -87.54 -32.11 19.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.186 -0.946 . . . . 0.0 110.377 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 59.7 p -52.0 -46.29 64.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.193 -0.942 . . . . 0.0 110.382 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.2 p -132.29 163.94 27.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.145 -0.972 . . . . 0.0 110.109 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -63.4 -43.66 96.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.902 . . . . 0.0 110.166 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 28.1 m -117.63 147.99 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.215 -0.928 . . . . 0.0 110.422 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -175.27 126.34 0.26 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.364 -0.835 . . . . 0.0 110.031 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.446 ' CG1' ' HA ' ' A' ' 167' ' ' PHE . 13.7 p -97.91 147.96 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 121.119 -0.988 . . . . 0.0 110.535 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.443 HG12 ' CD2' ' A' ' 132' ' ' LEU . 44.7 mt -141.43 107.71 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.91 . . . . 0.0 109.734 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -84.36 163.15 38.89 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 143' ' ' PHE . 26.2 m-85 -126.72 70.42 1.27 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.632 -0.923 . . . . 0.0 109.647 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -97.21 146.02 25.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 111.071 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.61 -28.22 18.57 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.145 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.89 84.17 1.94 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -0.833 . . . . 0.0 109.94 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.9 t -66.89 -12.45 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.345 -0.847 . . . . 0.0 110.8 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -99.07 4.03 46.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.009 -1.057 . . . . 0.0 110.805 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 38.7 p -85.97 -159.52 0.47 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.824 -1.173 . . . . 0.0 110.27 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -88.82 -35.34 16.66 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.232 -0.918 . . . . 0.0 110.135 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.1 t -54.89 -33.24 61.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.34 -0.85 . . . . 0.0 110.226 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.49 -33.51 28.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.917 . . . . 0.0 110.203 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -53.46 -50.48 65.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.879 . . . . 0.0 110.128 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -57.34 -41.96 81.02 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.369 -0.832 . . . . 0.0 110.124 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -52.22 -57.31 10.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 110.1 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.65 -55.13 24.68 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.42 -0.8 . . . . 0.0 110.207 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -47.64 -48.58 28.7 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.414 -0.804 . . . . 0.0 110.551 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.418 ' N ' ' HG3' ' A' ' 205' ' ' LYS . . . -64.84 -43.6 92.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 109.766 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.05 -35.28 74.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.372 -0.83 . . . . 0.0 109.862 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -68.16 -29.09 67.89 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.319 -0.863 . . . . 0.0 110.301 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.32 -61.61 2.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.197 -0.939 . . . . 0.0 110.171 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.437 HG22 HD11 ' A' ' 162' ' ' ILE . 73.6 mt -89.67 149.28 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.928 . . . . 0.0 109.95 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.47 -31.06 4.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.205 -0.934 . . . . 0.0 110.375 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -68.74 -14.51 63.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.22 -0.925 . . . . 0.0 110.698 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.531 ' CG2' ' CE1' ' A' ' 167' ' ' PHE . 37.1 mm -98.46 123.98 48.31 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.08 -1.013 . . . . 0.0 110.263 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -83.38 107.6 1.44 Allowed 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.471 1.248 . . . . 0.0 110.064 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.531 ' CE1' ' CG2' ' A' ' 165' ' ' ILE . 0.4 OUTLIER -99.25 154.46 18.15 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.12 -0.988 . . . . 0.0 109.969 -179.489 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -137.71 145.03 16.57 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 16.8 tt -143.27 126.31 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.269 -1.136 . . . . 0.0 110.231 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.8 t -143.77 157.96 44.01 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.146 0.974 . . . . 0.0 111.131 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.7 t -127.09 5.37 6.46 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.181 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.405 ' ND2' ' HB2' ' A' ' 174' ' ' ASP . 43.4 t30 -62.0 128.32 35.58 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.182 -0.949 . . . . 0.0 110.231 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 9.0 t -52.23 -33.88 43.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.187 -0.946 . . . . 0.0 110.323 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.405 ' HB2' ' ND2' ' A' ' 172' ' ' ASN . 0.3 OUTLIER -54.67 -34.23 61.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.949 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 57.3 t -78.35 -27.19 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.537 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.401 ' N ' ' CD1' ' A' ' 176' ' ' PHE . 12.5 m-85 -81.54 -42.45 20.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.424 -0.798 . . . . 0.0 109.805 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.03 -7.47 46.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.343 -0.848 . . . . 0.0 110.629 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.86 -45.11 9.98 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.901 -1.124 . . . . 0.0 109.304 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -89.59 5.07 47.25 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.742 -0.599 . . . . 0.0 110.555 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.42 ' CG ' ' O ' ' A' ' 180' ' ' GLN . 0.0 OUTLIER 51.81 58.81 5.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.1 -1.0 . . . . 0.0 110.722 179.587 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.4 mt -98.66 130.35 45.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.063 -1.023 . . . . 0.0 109.824 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -87.06 12.22 11.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.1 -1.0 . . . . 0.0 110.295 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 13.8 pttp 179.13 -163.34 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.227 -0.921 . . . . 0.0 109.618 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -87.47 156.63 19.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.287 -0.883 . . . . 0.0 110.133 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -177.54 152.09 11.58 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.434 HG12 ' CD2' ' A' ' 208' ' ' LEU . 88.2 t -103.65 128.4 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.317 -1.108 . . . . 0.0 110.468 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.412 HG11 ' N ' ' A' ' 188' ' ' LEU . 83.1 t -134.56 151.48 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.363 -0.836 . . . . 0.0 109.655 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.461 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 7.8 tt -113.21 158.67 20.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.996 -1.065 . . . . 0.0 109.915 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.428 ' CD2' HG23 ' A' ' 133' ' ' VAL . 52.6 m-85 -128.67 130.03 46.63 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.078 -1.014 . . . . 0.0 110.459 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.21 166.61 23.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.877 . . . . 0.0 110.069 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.01 -33.73 18.27 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.199 -0.938 . . . . 0.0 110.128 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -90.91 -173.4 3.68 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.443 -0.786 . . . . 0.0 110.647 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 51.95 -159.73 0.11 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.434 -0.792 . . . . 0.0 110.458 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -54.93 -54.17 46.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.634 -0.666 . . . . 0.0 110.271 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 128.65 -38.49 2.04 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.18 165.31 21.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -1.166 . . . . 0.0 110.359 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . 0.461 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.8 m-80 -128.72 -151.31 0.47 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.3 -0.875 . . . . 0.0 109.865 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -174.37 78.37 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.279 -0.888 . . . . 0.0 110.381 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.417 ' CB ' ' O ' ' A' ' 186' ' ' VAL . 28.3 t80 -57.95 118.7 5.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 109.838 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -125.53 38.8 4.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.302 -0.874 . . . . 0.0 110.413 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -128.83 -149.24 6.86 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -90.71 97.38 11.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.149 -1.206 . . . . 0.0 109.928 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.409 ' O ' ' CG1' ' A' ' 203' ' ' VAL . 7.4 p -51.33 102.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.212 -0.93 . . . . 0.0 110.373 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 26.2 p -140.93 150.59 43.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.357 -0.84 . . . . 0.0 110.323 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.418 ' HG3' ' N ' ' A' ' 158' ' ' ALA . 3.7 tttp -47.21 -31.31 3.56 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.359 -0.838 . . . . 0.0 110.946 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -79.42 -33.06 42.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.178 -0.951 . . . . 0.0 110.316 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 59.9 m-20 -83.57 -47.06 11.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 110.289 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.434 ' CD2' HG12 ' A' ' 186' ' ' VAL . 65.6 mt -52.87 -48.65 66.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 110.33 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 13.6 mt -59.26 -29.13 67.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 110.095 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.47 -34.42 41.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 0.0 110.144 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.412 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 7.1 t80 -62.88 -62.98 1.35 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.306 -0.871 . . . . 0.0 110.192 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 7.0 mt -51.03 -49.75 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.391 -0.818 . . . . 0.0 110.473 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -48.7 -25.08 1.62 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.364 -0.835 . . . . 0.0 110.868 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.75 -14.77 21.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.125 -0.984 . . . . 0.0 110.815 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.412 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 73.4 m-80 -102.27 -24.29 13.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.078 -1.014 . . . . 0.0 110.767 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -86.75 5.74 34.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.066 -1.021 . . . . 0.0 110.736 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 14.0 mt -126.59 106.92 23.37 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.954 -1.091 . . . . 0.0 110.094 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.56 144.31 44.48 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.594 1.313 . . . . 0.0 110.281 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 18.3 mt -91.93 -167.02 1.68 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.233 -0.917 . . . . 0.0 109.969 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 11.3 p -150.14 59.31 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.37 -0.832 . . . . 0.0 110.33 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.425 HD11 HG22 ' A' ' 221' ' ' ILE . 15.2 tt -114.79 162.36 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 110.19 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -108.12 141.49 39.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.088 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -106.17 -178.86 3.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.165 -0.959 . . . . 0.0 110.191 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 37.9 p -104.36 81.85 1.86 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.0 110.306 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -96.61 62.73 2.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.341 -0.85 . . . . 0.0 110.087 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 53.94 82.49 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 0.0 110.098 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 19.7 p -56.69 94.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.905 . . . . 0.0 110.265 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.19 179.996 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.252 0.548 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -133.96 -176.56 4.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.271 -0.893 . . . . 0.0 110.366 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 167' ' ' PHE . 3.9 m -119.92 112.69 19.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.348 -0.845 . . . . 0.0 109.729 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.5 m -68.57 144.04 54.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 110.047 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 20.5 mt -125.3 143.98 46.17 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.0 110.106 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.06 -40.33 2.58 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.705 1.371 . . . . 0.0 110.293 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.415 ' OD1' ' CB ' ' A' ' 127' ' ' ALA . 0.2 OUTLIER -170.5 -169.93 0.87 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.346 -0.846 . . . . 0.0 110.636 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -54.74 -27.77 44.35 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.415 ' CB ' ' OD1' ' A' ' 125' ' ' ASP . . . -52.88 -31.51 39.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.194 -1.18 . . . . 0.0 110.434 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.77 -37.5 14.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.177 -0.952 . . . . 0.0 109.912 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.0 -33.19 68.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.332 -0.855 . . . . 0.0 110.004 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -74.28 -51.2 15.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.06 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.14 -30.71 71.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.307 -0.871 . . . . 0.0 110.07 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.1 tp -59.74 -48.68 80.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.207 -0.933 . . . . 0.0 109.961 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.5 t -56.05 -52.13 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 110.07 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -65.59 -20.21 66.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.234 -0.916 . . . . 0.0 110.243 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.2 t -52.49 -51.43 59.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.146 -0.971 . . . . 0.0 110.351 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 53.7 p -137.31 -171.88 3.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.252 -0.905 . . . . 0.0 110.313 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -75.57 -39.74 57.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -0.878 . . . . 0.0 110.169 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 87.1 t -119.43 147.29 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.25 -0.906 . . . . 0.0 110.175 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.408 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -170.89 121.94 0.57 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.201 -0.937 . . . . 0.0 110.203 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.442 ' CG1' ' HA ' ' A' ' 167' ' ' PHE . 14.8 p -104.41 148.78 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.311 -0.868 . . . . 0.0 110.361 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.491 HG23 ' CE1' ' A' ' 143' ' ' PHE . 51.1 mt -133.79 107.71 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.258 -0.902 . . . . 0.0 109.992 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.49 122.81 6.91 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.491 ' CE1' HG23 ' A' ' 141' ' ' ILE . 93.0 m-85 -101.63 67.48 1.12 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.273 -1.134 . . . . 0.0 109.961 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -95.48 146.34 24.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.091 -1.006 . . . . 0.0 110.418 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.449 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -91.08 -32.5 15.85 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.586 -0.696 . . . . 0.0 109.585 179.083 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.449 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 88.5 m-20 -122.32 69.7 0.97 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.517 -0.739 . . . . 0.0 109.862 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.445 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 26.4 m -53.8 -21.31 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.206 -0.934 . . . . 0.0 110.51 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -79.74 4.32 16.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.09 -1.006 . . . . 0.0 111.008 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 32.9 p -87.34 -163.72 0.97 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.904 -1.122 . . . . 0.0 110.284 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.87 -40.83 12.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.0 110.103 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.83 -28.99 59.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.187 -0.946 . . . . 0.0 109.807 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.445 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -79.68 -35.26 39.44 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.332 -0.855 . . . . 0.0 109.849 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -51.32 -44.99 62.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.277 -0.89 . . . . 0.0 110.192 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -54.7 -47.36 73.78 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.156 -0.965 . . . . 0.0 109.514 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -52.48 -56.44 15.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 0.0 109.831 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.426 ' CD1' ' O ' ' A' ' 152' ' ' ALA . 2.6 mp -51.44 -58.27 6.71 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.362 -0.836 . . . . 0.0 110.095 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -49.61 -41.79 43.12 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.343 -0.848 . . . . 0.0 110.313 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.61 -26.88 60.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.995 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.2 -29.03 42.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 0.0 110.067 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -63.4 -37.82 88.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 110.111 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.97 -29.82 69.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.358 -0.838 . . . . 0.0 109.961 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.441 ' CG2' ' HB ' ' A' ' 165' ' ' ILE . 18.2 mm -90.1 122.48 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.423 -0.798 . . . . 0.0 109.634 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -123.88 2.07 8.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.243 -0.91 . . . . 0.0 110.727 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -109.36 -19.85 13.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.952 -1.092 . . . . 0.0 110.252 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.452 ' CG2' ' HD2' ' A' ' 166' ' ' PRO . 41.4 mm -91.4 146.1 32.69 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.146 -0.971 . . . . 0.0 110.182 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.452 ' HD2' ' CG2' ' A' ' 165' ' ' ILE . 44.9 Cg_endo -84.25 79.26 2.64 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.807 1.425 . . . . 0.0 110.089 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.442 ' HA ' ' CG1' ' A' ' 140' ' ' VAL . 3.6 m-85 -71.92 126.94 31.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.406 -0.809 . . . . 0.0 110.589 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.404 ' HA2' ' HB ' ' A' ' 121' ' ' THR . . . -118.69 157.24 15.33 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 6.3 tt -150.42 141.96 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.255 -1.144 . . . . 0.0 110.618 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.2 t -158.25 155.52 29.07 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.004 0.907 . . . . 0.0 110.463 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 78.8 p -127.47 7.83 6.41 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.38 179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -67.39 119.84 12.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.073 -1.017 . . . . 0.0 110.383 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.5 p -49.02 -28.17 3.76 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.211 -0.93 . . . . 0.0 110.535 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -54.8 -41.09 70.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.115 -0.991 . . . . 0.0 109.734 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 45.1 t -78.77 -23.68 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.381 -0.824 . . . . 0.0 109.691 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -72.43 -51.81 18.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.394 -0.816 . . . . 0.0 109.531 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 33.9 t -70.58 -17.06 62.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.482 -0.761 . . . . 0.0 110.366 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 23.9 tttm -73.52 -52.43 13.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.137 -0.977 . . . . 0.0 109.96 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -90.53 22.55 3.4 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.221 -0.924 . . . . 0.0 110.53 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 54.56 56.96 6.19 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.129 -0.982 . . . . 0.0 110.176 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 86.1 mt -113.13 96.63 6.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 110.181 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -63.18 -19.15 64.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.291 -0.881 . . . . 0.0 110.427 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.51 -159.74 1.05 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.194 -0.941 . . . . 0.0 110.152 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -53.52 152.31 5.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.182 -0.949 . . . . 0.0 109.896 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -153.4 136.74 5.44 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.59 -1.29 . . . . 0.0 110.008 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 59.0 t -121.53 84.43 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.367 -1.079 . . . . 0.0 109.479 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.424 ' CG2' ' HA ' ' A' ' 198' ' ' ASN . 98.2 t -111.55 150.11 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.111 -0.993 . . . . 0.0 110.352 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.466 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 6.0 tt -106.55 150.88 25.7 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.182 -0.949 . . . . 0.0 108.833 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -120.64 116.58 25.6 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.863 -1.148 . . . . 0.0 110.438 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.511 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -124.6 170.62 10.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.0 110.153 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.26 -24.12 19.1 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.316 -0.865 . . . . 0.0 110.339 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.511 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.4 OUTLIER -91.25 -171.71 3.05 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.881 179.666 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 47.23 -154.67 0.06 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.699 0.761 . . . . 0.0 110.502 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.45 -44.45 91.1 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.619 -0.675 . . . . 0.0 110.191 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 131.19 -39.88 1.72 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -116.65 175.55 5.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.16 -1.2 . . . . 0.0 110.248 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . 0.466 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 2.7 m-80 -134.93 -44.99 0.72 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.271 -0.893 . . . . 0.0 110.952 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.424 ' HA ' ' CG2' ' A' ' 187' ' ' VAL . 0.9 OUTLIER 65.46 89.04 0.1 Allowed 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.27 -0.894 . . . . 0.0 110.196 -179.251 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.401 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 45.5 t80 -56.62 123.79 16.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.464 -0.772 . . . . 0.0 110.501 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -120.65 101.37 7.69 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.212 -0.93 . . . . 0.0 110.269 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 152.99 -159.32 28.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -81.51 118.66 22.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -1.1 . . . . 0.0 110.357 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 78.2 t -68.07 103.5 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.93 . . . . 0.0 110.056 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 14.0 p -138.68 149.03 44.69 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.444 -0.785 . . . . 0.0 109.858 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -51.05 -39.19 55.37 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.223 -0.923 . . . . 0.0 110.321 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . 0.412 ' CG ' ' N ' ' A' ' 207' ' ' ASN . 11.5 pt-20 -66.11 -40.32 90.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.295 -0.878 . . . . 0.0 110.001 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.412 ' N ' ' CG ' ' A' ' 206' ' ' GLU . 79.3 m-20 -78.33 -30.83 48.38 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.384 -0.822 . . . . 0.0 109.923 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 64.0 mt -65.5 -55.84 15.62 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.459 -0.776 . . . . 0.0 110.272 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 5.9 mt -56.03 -25.65 45.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 110.289 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -80.49 -48.58 12.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.324 -0.86 . . . . 0.0 110.029 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.421 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 10.8 t80 -51.55 -57.67 8.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.341 -0.849 . . . . 0.0 110.468 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.408 ' N ' HD11 ' A' ' 212' ' ' ILE . 6.9 mm -53.32 -52.37 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.329 -0.857 . . . . 0.0 110.133 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.404 ' HA ' ' NE2' ' A' ' 216' ' ' GLN . 3.7 tmtt? -52.99 -31.51 41.29 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.624 -0.673 . . . . 0.0 110.586 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -77.44 -15.6 59.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.884 . . . . 0.0 110.702 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.421 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 74.3 m-20 -105.8 -40.31 5.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.119 -0.988 . . . . 0.0 110.55 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . 0.404 ' NE2' ' HA ' ' A' ' 213' ' ' LYS . 10.2 pt20 -63.38 -25.88 68.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.095 -1.003 . . . . 0.0 110.133 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.6 mt -130.5 76.13 77.98 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.995 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.38 130.53 16.33 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.672 1.354 . . . . 0.0 110.376 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.74 104.07 0.26 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.364 -0.835 . . . . 0.0 109.989 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 50.0 t -119.09 120.79 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 0.0 110.358 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 2.0 pt -110.21 -178.22 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.22 -0.925 . . . . 0.0 110.23 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -170.28 165.3 8.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.195 -0.94 . . . . 0.0 110.294 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 1.5 t80 56.53 168.23 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.235 -0.915 . . . . 0.0 110.259 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 68.5 p -109.71 72.36 0.8 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.222 -0.924 . . . . 0.0 110.129 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -152.18 64.03 0.83 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.281 -0.887 . . . . 0.0 110.186 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -60.64 174.86 0.53 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.266 -0.896 . . . . 0.0 110.294 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 6.0 t -143.4 47.06 1.5 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.906 . . . . 0.0 110.226 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.228 -179.949 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.221 0.534 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -113.44 -176.64 2.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.147 -0.97 . . . . 0.0 110.296 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.8 m -104.91 116.82 32.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.291 -0.88 . . . . 0.0 109.833 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.6 m -78.86 118.49 20.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.302 -0.874 . . . . 0.0 110.221 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.433 HD21 ' CB ' ' A' ' 128' ' ' ALA . 0.9 OUTLIER -101.84 128.8 27.93 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.171 -0.956 . . . . 0.0 110.027 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 47.7 Cg_endo -73.22 -27.87 13.18 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.447 1.235 . . . . 0.0 110.107 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.93 -170.49 1.97 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.063 0.935 . . . . 0.0 111.077 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.405 ' HA3' ' CE ' ' A' ' 178' ' ' LYS . . . -64.53 -25.93 70.49 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.401 ' O ' ' HG2' ' A' ' 130' ' ' GLU . . . -58.72 -30.56 67.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.298 -1.119 . . . . 0.0 110.183 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.433 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -84.45 -20.92 30.98 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.004 -1.06 . . . . 0.0 109.625 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.36 -23.98 37.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.426 -0.796 . . . . 0.0 110.266 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 127' ' ' ALA . 13.9 pt-20 -84.78 -36.47 21.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.94 . . . . 0.0 110.171 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 135' ' ' SER . 0.6 OUTLIER -77.57 -32.45 53.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.334 -0.854 . . . . 0.0 110.552 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.427 HD21 ' CG1' ' A' ' 141' ' ' ILE . 6.3 tp -59.05 -52.97 63.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.058 -1.026 . . . . 0.0 110.045 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.456 ' CG2' ' CB ' ' A' ' 189' ' ' PHE . 87.9 t -55.49 -37.04 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 110.085 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -83.93 -22.04 31.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.391 -0.818 . . . . 0.0 110.192 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 131' ' ' SER . 0.7 OUTLIER -66.29 -54.34 25.99 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.376 -0.828 . . . . 0.0 110.199 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.9 p -115.77 157.9 23.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -0.91 . . . . 0.0 110.259 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -59.47 -45.75 90.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.169 -0.957 . . . . 0.0 110.196 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.5 t -119.71 123.77 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 110.262 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -152.2 120.24 6.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 109.599 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.436 ' CG1' ' HA ' ' A' ' 167' ' ' PHE . 11.6 p -98.51 143.05 13.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.093 -1.005 . . . . 0.0 110.664 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.427 ' CG1' HD21 ' A' ' 132' ' ' LEU . 77.2 mt -133.84 115.13 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.463 -0.773 . . . . 0.0 109.446 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -82.97 163.45 41.72 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.132 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 143' ' ' PHE . 30.3 m-85 -127.7 63.18 1.38 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.723 -0.869 . . . . 0.0 109.421 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.522 ' CE1' ' CB ' ' A' ' 151' ' ' SER . 12.4 m-85 -81.34 133.3 35.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 111.311 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.96 -26.69 43.47 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.729 0.776 . . . . 0.0 109.582 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.45 98.79 5.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.73 -0.606 . . . . 0.0 109.624 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.4 t -63.67 -12.82 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.0 110.903 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -103.01 14.83 31.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.968 -1.083 . . . . 0.0 110.776 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 21.9 p -83.29 -164.89 0.96 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.054 -1.029 . . . . 0.0 110.165 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -90.33 -18.2 25.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 110.317 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.522 ' CB ' ' CE1' ' A' ' 144' ' ' PHE . 6.1 m -83.36 -26.13 30.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 110.326 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.63 -32.75 36.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -0.915 . . . . 0.0 110.089 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.83 -49.85 75.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 109.993 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -57.69 -41.66 82.09 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.37 -0.831 . . . . 0.0 110.278 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -50.68 -55.68 15.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.181 -0.949 . . . . 0.0 110.523 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 16.4 mt -51.01 -55.85 15.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.167 -0.958 . . . . 0.0 110.427 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -53.09 -49.24 66.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.26 -0.9 . . . . 0.0 110.007 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.87 -48.11 80.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 109.977 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.466 ' HB3' ' CD2' ' A' ' 167' ' ' PHE . . . -63.66 -27.09 68.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 110.011 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -75.15 -27.37 59.69 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.367 -0.833 . . . . 0.0 110.297 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.87 -47.84 73.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.902 . . . . 0.0 110.254 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.428 HG23 HD11 ' A' ' 162' ' ' ILE . 68.4 mt -98.38 150.25 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -0.899 . . . . 0.0 110.133 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -125.0 -12.57 6.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.253 -0.904 . . . . 0.0 111.105 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -86.99 5.81 35.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.861 -1.149 . . . . 0.0 110.843 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.536 ' CG2' ' CE1' ' A' ' 167' ' ' PHE . 32.6 mm -128.31 126.04 23.47 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.857 -1.152 . . . . 0.0 110.186 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -81.32 110.65 2.27 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.428 1.225 . . . . 0.0 110.585 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.536 ' CE1' ' CG2' ' A' ' 165' ' ' ILE . 1.1 m-85 -102.63 126.49 49.73 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.218 -0.926 . . . . 0.0 109.49 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -106.85 155.52 16.4 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 9.5 tt -149.49 133.04 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.374 -1.074 . . . . 0.0 110.378 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.6 t -152.82 157.24 40.47 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 122.003 0.906 . . . . 0.0 110.889 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.6 t -125.51 2.68 7.64 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -64.42 129.21 39.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 0.0 110.3 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.4 m -53.42 -28.06 27.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.301 -0.875 . . . . 0.0 110.225 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -54.89 -39.96 69.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.887 . . . . 0.0 110.024 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 34.0 t -77.15 -24.92 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.81 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -77.54 -49.69 14.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.201 -0.937 . . . . 0.0 109.942 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.88 -34.21 40.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.278 -0.889 . . . . 0.0 110.023 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.405 ' CE ' ' HA3' ' A' ' 126' ' ' GLY . 0.2 OUTLIER -55.34 -55.68 28.71 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.359 -0.838 . . . . 0.0 110.202 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -92.88 6.84 46.28 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.15 -0.969 . . . . 0.0 110.629 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 49.59 65.24 1.46 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.02 -1.05 . . . . 0.0 110.495 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 92.6 mt -101.84 124.33 47.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.263 -0.898 . . . . 0.0 110.282 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.68 0.13 31.64 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.2 -0.937 . . . . 0.0 110.665 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -171.09 -174.67 1.54 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.094 -1.004 . . . . 0.0 109.827 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 21.4 p30 -54.61 156.95 3.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.17 -0.956 . . . . 0.0 110.247 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -172.94 118.78 0.73 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 96.4 t -95.18 128.99 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -1.154 . . . . 0.0 110.152 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 98.7 t -138.06 149.28 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 110.148 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.49 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 9.3 tt -109.75 139.25 45.03 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.105 -0.997 . . . . 0.0 108.437 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.456 ' CB ' ' CG2' ' A' ' 133' ' ' VAL . 50.7 m-85 -112.66 126.18 55.1 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.768 -1.207 . . . . 0.0 110.866 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.9 166.1 23.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.338 -0.851 . . . . 0.0 110.211 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -89.29 -31.4 17.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.913 . . . . 0.0 110.422 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -90.56 -173.32 3.72 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.443 -0.786 . . . . 0.0 110.729 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 51.93 -159.43 0.11 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.431 -0.793 . . . . 0.0 110.456 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.06 -48.9 78.17 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.633 -0.667 . . . . 0.0 110.238 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 136.58 -58.94 0.65 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 17.6 mtm-85 -108.7 175.21 5.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.183 -1.187 . . . . 0.0 110.329 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . 0.49 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.8 m-80 -132.49 -34.7 1.18 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.263 -0.898 . . . . 0.0 110.996 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.89 87.81 0.09 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.162 -0.961 . . . . 0.0 110.021 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.467 ' HA ' ' CE1' ' A' ' 211' ' ' PHE . 28.6 t80 -57.83 124.11 18.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.379 -0.826 . . . . 0.0 110.265 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -118.15 103.37 9.8 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.318 -0.864 . . . . 0.0 110.337 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 147.52 -148.72 20.54 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -97.66 123.74 41.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -1.147 . . . . 0.0 110.129 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 79.2 t -70.6 113.65 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.182 -0.949 . . . . 0.0 110.261 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.3 p -145.88 152.43 39.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.43 -0.794 . . . . 0.0 109.932 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 20.2 tttm -48.42 -43.5 34.3 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.118 -0.989 . . . . 0.0 110.509 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -64.95 -41.86 95.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.326 -0.859 . . . . 0.0 109.805 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -71.2 -45.55 63.14 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.344 -0.848 . . . . 0.0 109.953 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 62.0 mt -53.92 -51.16 64.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.936 . . . . 0.0 109.778 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 69.6 mt -56.58 -31.27 64.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.314 -0.866 . . . . 0.0 109.349 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -76.88 -37.34 55.67 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.428 -0.795 . . . . 0.0 109.524 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.476 ' CZ ' ' HB2' ' A' ' 197' ' ' ASN . 5.9 t80 -54.22 -63.38 1.17 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.397 -0.815 . . . . 0.0 109.893 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 94.8 mt -48.91 -57.64 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.231 -0.918 . . . . 0.0 110.292 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.07 -34.5 56.81 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.331 -0.855 . . . . 0.0 110.243 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -89.64 -7.56 54.43 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.35 -0.844 . . . . 0.0 110.695 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 0.9 OUTLIER -88.48 -79.68 0.3 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.083 -1.011 . . . . 0.0 110.429 -179.325 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -64.97 -174.79 0.16 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.207 -0.933 . . . . 0.0 110.188 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 45.8 mt 52.81 89.76 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 0.0 110.2 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.56 -173.07 1.05 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.685 1.36 . . . . 0.0 110.567 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 12.8 mt -92.6 72.96 5.08 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.279 -0.888 . . . . 0.0 110.476 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 54.8 t -96.73 74.86 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.858 . . . . 0.0 110.097 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 4.9 mt -88.04 87.7 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 110.279 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -128.43 -150.28 0.44 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 110.144 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.435 ' O ' ' N ' ' A' ' 225' ' ' GLU . 0.1 OUTLIER -73.78 -45.33 52.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.306 -0.871 . . . . 0.0 110.088 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 55.3 m 55.7 -86.17 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.628 -0.67 . . . . 0.0 110.729 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 223' ' ' PHE . 1.2 mt-10 55.7 79.67 0.16 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.943 -1.098 . . . . 0.0 110.068 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 52.92 -178.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.295 -0.878 . . . . 0.0 110.149 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 14.9 m -154.25 -43.51 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 110.061 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.182 179.819 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.291 0.567 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.03 167.56 15.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 110.239 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.9 t -101.15 166.15 10.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.161 -0.962 . . . . 0.0 110.442 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.3 m -107.06 105.49 15.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.322 -0.861 . . . . 0.0 110.074 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.1 mt -77.67 134.41 65.42 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.213 -0.93 . . . . 0.0 110.096 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.436 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 47.5 Cg_endo -72.85 -32.31 9.22 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 123.52 1.274 . . . . 0.0 110.331 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -168.25 -170.77 1.35 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.255 -0.903 . . . . 0.0 110.805 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.32 -27.95 68.49 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -55.57 -29.24 58.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -1.123 . . . . 0.0 110.382 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.436 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -86.08 -30.86 22.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.146 -0.971 . . . . 0.0 110.178 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.04 -24.36 66.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.041 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -88.59 -38.11 15.13 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.258 -0.901 . . . . 0.0 110.168 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.0 m -72.67 -24.57 61.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.175 -0.953 . . . . 0.0 109.979 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.4 tp -70.44 -47.02 62.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.412 -0.805 . . . . 0.0 110.096 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 69.1 t -62.5 -45.0 99.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.374 -0.829 . . . . 0.0 110.294 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -72.84 -19.69 61.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.938 . . . . 0.0 110.237 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.5 m -72.66 -20.81 61.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.148 -0.97 . . . . 0.0 110.36 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 80.0 p -149.42 154.92 39.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.254 -0.904 . . . . 0.0 110.361 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -57.44 -35.8 70.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.335 -0.853 . . . . 0.0 110.171 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.7 t -132.03 145.64 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.294 -0.879 . . . . 0.0 110.437 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.435 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -165.56 136.96 3.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.355 -0.841 . . . . 0.0 109.808 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.8 p -116.03 139.84 40.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 O-C-N 121.087 -1.008 . . . . 0.0 110.223 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 27.2 mt -128.4 110.26 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.315 -0.866 . . . . 0.0 109.87 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.55 127.64 8.22 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.486 ' CE2' HG11 ' A' ' 175' ' ' VAL . 50.3 m-85 -95.45 79.5 3.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.285 -1.127 . . . . 0.0 109.849 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -100.73 141.53 33.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.088 -1.008 . . . . 0.0 111.097 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.467 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 21.4 pttt -91.11 -36.41 14.01 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.602 0.715 . . . . 0.0 109.261 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.467 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 0.4 OUTLIER -122.34 70.77 0.99 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.024 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.0 p -52.22 -20.94 2.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.71 -0.619 . . . . 0.0 111.16 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -76.63 1.33 17.23 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.966 -1.084 . . . . 0.0 110.86 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 51.5 p -86.27 -156.92 0.32 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.879 -1.138 . . . . 0.0 110.381 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -90.45 -46.63 8.23 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.317 -0.864 . . . . 0.0 110.794 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.4 t -46.08 -33.27 3.36 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.38 -0.825 . . . . 0.0 111.065 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.79 -38.1 29.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.136 -0.977 . . . . 0.0 109.837 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.3 -51.3 59.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.0 109.911 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -52.9 -41.44 64.39 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.291 -0.88 . . . . 0.0 110.005 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -53.95 -57.19 11.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.402 -0.811 . . . . 0.0 109.918 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 15.2 mt -53.73 -53.95 44.92 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.502 -0.749 . . . . 0.0 110.365 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -54.52 -33.1 59.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.356 -0.84 . . . . 0.0 110.16 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -78.14 -35.62 48.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 110.148 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.95 -31.04 64.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.203 -0.936 . . . . 0.0 110.156 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -66.02 -20.97 66.36 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.192 -0.943 . . . . 0.0 110.285 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -79.63 -35.98 38.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.216 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 14.8 tt -97.51 154.96 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 110.119 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -142.28 21.92 2.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.184 -0.947 . . . . 0.0 110.493 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -120.92 12.91 11.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.182 -0.949 . . . . 0.0 110.629 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 49.7 mm -136.2 134.24 20.01 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.012 . . . . 0.0 110.267 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.435 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 48.8 Cg_endo -74.22 98.62 1.11 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.445 1.234 . . . . 0.0 110.371 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -85.94 127.58 34.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 110.316 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -128.79 154.2 20.05 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 11.6 tt -150.26 149.93 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.154 -1.204 . . . . 0.0 110.595 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.432 ' CG2' HG13 ' A' ' 175' ' ' VAL . 2.1 t -161.06 156.99 25.41 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.069 0.938 . . . . 0.0 110.527 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.4 p -124.12 3.98 8.59 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -63.32 131.69 49.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 110.418 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 92.7 p -53.76 -31.46 48.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.211 -0.93 . . . . 0.0 110.189 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -53.48 -32.05 48.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.968 . . . . 0.0 109.848 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.486 HG11 ' CE2' ' A' ' 143' ' ' PHE . 60.0 t -82.61 -25.38 8.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.385 -0.822 . . . . 0.0 109.51 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -76.87 -52.52 9.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.421 -0.799 . . . . 0.0 109.717 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.23 -15.87 58.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.383 -0.823 . . . . 0.0 110.559 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.429 ' HG2' ' CD1' ' A' ' 179' ' ' TYR . 16.4 tttp -79.21 -52.51 8.06 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.04 -1.038 . . . . 0.0 110.09 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.429 ' CD1' ' HG2' ' A' ' 178' ' ' LYS . 81.4 m-85 -92.2 4.51 53.08 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.201 -0.937 . . . . 0.0 110.578 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.26 64.42 1.79 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.055 -1.028 . . . . 0.0 111.025 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.421 ' CD1' ' HB2' ' A' ' 179' ' ' TYR . 4.5 mt -115.6 115.19 26.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.152 -0.967 . . . . 0.0 109.81 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.429 ' O ' ' CG ' ' A' ' 183' ' ' LYS . 0.7 OUTLIER -83.48 7.77 15.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.135 -0.978 . . . . 0.0 110.501 179.716 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 182' ' ' ASP . 25.2 mttt -162.73 -163.91 0.94 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.065 -1.022 . . . . 0.0 109.658 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -73.96 147.46 43.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.147 -0.971 . . . . 0.0 109.684 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -157.71 134.64 4.0 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 70.9 t -113.68 102.03 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.379 -1.071 . . . . 0.0 109.914 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 98.8 t -110.69 146.28 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.382 -0.823 . . . . 0.0 110.179 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.479 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 9.0 tt -109.91 127.9 55.02 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.158 -0.963 . . . . 0.0 108.53 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.41 ' N ' ' CD1' ' A' ' 189' ' ' PHE . 30.1 m-85 -100.43 120.43 39.97 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.832 -1.168 . . . . 0.0 111.179 -178.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.496 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -131.91 158.78 40.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.474 -0.766 . . . . 0.0 110.122 179.483 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -82.81 -24.9 33.15 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.217 -0.927 . . . . 0.0 110.259 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.496 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 1.3 p90 -91.69 -171.82 3.02 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.328 -0.858 . . . . 0.0 110.555 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 50.94 -159.1 0.09 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.616 0.722 . . . . 0.0 110.432 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -65.61 -45.52 82.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.655 -0.653 . . . . 0.0 110.222 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 142.09 -62.94 0.52 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -110.48 171.64 7.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.293 -1.122 . . . . 0.0 110.331 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . 0.479 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 2.7 m-80 -127.71 -34.61 2.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.266 -0.896 . . . . 0.0 110.75 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 58.11 83.93 0.11 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.203 -0.936 . . . . 0.0 110.091 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.43 ' CD1' ' C ' ' A' ' 199' ' ' PHE . 12.1 t80 -56.78 121.31 9.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.343 -0.848 . . . . 0.0 110.21 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -118.14 100.24 7.4 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.231 -0.918 . . . . 0.0 110.345 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 160.27 -155.95 27.15 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.16 111.6 21.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.294 -1.121 . . . . 0.0 110.074 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 75.7 t -63.82 109.05 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.938 . . . . 0.0 110.336 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 41.2 p -146.87 152.3 38.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.435 -0.79 . . . . 0.0 110.008 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -46.85 -54.97 8.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.398 -0.814 . . . . 0.0 111.043 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 207' ' ' ASN . 17.0 pt-20 -55.1 -40.79 70.84 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.453 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.426 ' N ' ' HG3' ' A' ' 206' ' ' GLU . 72.8 m-20 -73.82 -49.26 26.04 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.226 -0.921 . . . . 0.0 110.12 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 90.5 mt -56.33 -55.0 38.89 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.302 -0.874 . . . . 0.0 110.285 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 15.5 mt -53.29 -24.66 12.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 0.0 110.077 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.99 -43.82 13.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.87 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.422 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 11.9 t80 -56.96 -56.7 18.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.333 -0.854 . . . . 0.0 110.418 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 8.0 mm -51.6 -39.29 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.24 -0.912 . . . . 0.0 110.091 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -61.86 -41.41 97.8 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.628 -0.67 . . . . 0.0 110.283 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -78.64 -6.64 56.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 110.699 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 2.2 m-80 -89.27 -79.62 0.32 Allowed 'General case' 0 N--CA 1.484 1.265 0 O-C-N 120.914 -1.116 . . . . 0.0 110.583 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -59.02 -171.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 110.36 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 12.5 mt 53.5 64.81 6.35 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.304 -0.873 . . . . 0.0 110.302 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.51 117.79 5.29 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.723 1.38 . . . . 0.0 110.351 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 2.7 mt -129.31 135.19 48.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.309 -0.869 . . . . 0.0 110.296 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 54.4 t -94.78 91.84 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 110.146 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 70.1 mt -103.77 98.15 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.869 . . . . 0.0 110.307 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -142.16 169.95 16.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.184 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -120.35 158.81 26.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.358 -0.839 . . . . 0.0 110.147 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 226' ' ' GLN . 60.8 m -106.35 105.41 15.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.203 -0.936 . . . . 0.0 110.263 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 56.98 -86.14 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.437 -0.79 . . . . 0.0 110.454 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 224' ' ' THR . 1.1 mt-30 -148.8 144.43 26.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.949 -1.095 . . . . 0.0 110.306 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 19.1 m 52.68 78.59 0.13 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 110.322 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.154 179.9 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.252 0.548 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.1 166.56 9.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.876 . . . . 0.0 110.17 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.0 t -94.21 164.78 12.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.241 -0.912 . . . . 0.0 110.166 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.2 m -104.63 106.43 16.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.237 -0.915 . . . . 0.0 110.108 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 26.4 mt -73.16 124.28 90.44 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.197 -0.939 . . . . 0.0 110.104 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.407 ' HD2' ' HB1' ' A' ' 128' ' ' ALA . 45.6 Cg_endo -70.75 -22.61 27.32 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 123.393 1.207 . . . . 0.0 110.343 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.71 -171.13 0.17 Allowed 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 122.239 1.019 . . . . 0.0 111.479 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.23 -31.88 74.84 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -52.3 -31.85 34.84 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.336 -1.096 . . . . 0.0 110.299 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.407 ' HB1' ' HD2' ' A' ' 124' ' ' PRO . . . -83.39 -38.02 22.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.901 . . . . 0.0 110.227 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -52.14 -32.69 36.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.228 -0.92 . . . . 0.0 110.094 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -90.24 -46.66 8.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.357 -0.84 . . . . 0.0 110.016 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 10.1 t -64.19 -27.05 68.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.279 -0.888 . . . . 0.0 110.151 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.434 ' CD2' ' HB3' ' A' ' 139' ' ' ALA . 6.6 tt -70.53 -60.32 2.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.281 -0.887 . . . . 0.0 109.507 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.438 ' CG2' ' HB3' ' A' ' 189' ' ' PHE . 87.8 t -49.34 -27.67 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.553 -0.717 . . . . 0.0 110.355 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.15 7.19 25.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.279 -0.888 . . . . 0.0 110.726 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.2 t -90.29 -27.86 19.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.968 -1.083 . . . . 0.0 110.23 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.7 p -147.75 167.09 25.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 110.174 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -67.48 -12.17 59.65 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.216 -0.927 . . . . 0.0 110.136 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.9 t -137.84 150.69 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.066 -1.021 . . . . 0.0 110.063 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.444 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -174.42 142.05 0.74 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.959 . . . . 0.0 110.246 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.408 HG12 ' CZ ' ' A' ' 167' ' ' PHE . 7.2 p -129.7 148.18 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 121.108 -0.995 . . . . 0.0 110.188 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.9 mp -137.27 113.54 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -0.872 . . . . 0.0 110.181 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -80.91 131.69 10.63 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.483 ' CE2' HG13 ' A' ' 175' ' ' VAL . 35.1 m-85 -101.95 76.29 1.6 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -1.162 . . . . 0.0 110.091 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -94.28 144.38 25.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.128 -0.983 . . . . 0.0 110.75 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.04 -26.94 20.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.611 -0.681 . . . . 0.0 109.412 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -134.1 76.3 1.64 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.672 -0.642 . . . . 0.0 109.306 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.434 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 34.7 m -49.05 -23.64 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.377 -0.827 . . . . 0.0 111.042 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -80.02 4.88 15.66 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.048 -1.032 . . . . 0.0 111.175 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.2 p -78.93 -165.25 0.71 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.874 -1.142 . . . . 0.0 110.534 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.02 -23.49 20.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.558 -0.713 . . . . 0.0 110.238 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.5 m -80.27 -19.81 45.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.294 -0.879 . . . . 0.0 110.554 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -84.34 -32.56 24.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.134 -0.979 . . . . 0.0 110.3 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.2 mtpt -58.89 -38.07 78.03 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 110.183 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.42 -47.48 81.78 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.207 -0.933 . . . . 0.0 110.065 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -52.72 -54.69 30.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.315 -0.865 . . . . 0.0 110.103 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 22.1 mt -49.13 -55.04 13.55 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.308 -0.87 . . . . 0.0 110.378 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -54.22 -37.62 64.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.316 -0.865 . . . . 0.0 109.674 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.411 ' CA ' ' HG3' ' A' ' 205' ' ' LYS . . . -65.85 -52.77 47.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.356 -0.84 . . . . 0.0 109.536 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -55.44 -35.21 65.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.288 -0.882 . . . . 0.0 109.602 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.58 -30.3 71.01 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.283 -0.886 . . . . 0.0 109.858 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.16 -48.97 79.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.356 -0.84 . . . . 0.0 109.801 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 162' ' ' ILE . 63.2 mt -95.42 149.52 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.338 -0.851 . . . . 0.0 109.882 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -126.69 8.98 6.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.178 -0.951 . . . . 0.0 110.819 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -110.6 -17.25 13.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.967 -1.083 . . . . 0.0 110.339 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 51.0 mm -91.43 133.44 31.35 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.935 . . . . 0.0 110.185 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.444 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 50.6 Cg_endo -73.63 69.63 4.33 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.576 1.303 . . . . 0.0 110.253 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.408 ' CZ ' HG12 ' A' ' 140' ' ' VAL . 3.3 m-85 -63.7 123.03 17.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.886 . . . . 0.0 109.932 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -125.19 151.07 17.38 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -141.83 148.18 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -1.146 . . . . 0.0 110.297 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.6 t -164.85 157.81 16.7 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.073 0.939 . . . . 0.0 110.913 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.7 t -123.39 2.31 9.06 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.394 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -60.92 120.79 10.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.121 -0.987 . . . . 0.0 110.171 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 3.0 p -51.29 -29.4 14.72 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -0.902 . . . . 0.0 110.35 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.22 -43.47 78.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 109.877 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.483 HG13 ' CE2' ' A' ' 143' ' ' PHE . 46.2 t -72.35 -26.31 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.239 -0.913 . . . . 0.0 109.832 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -75.46 -55.49 5.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.37 -0.831 . . . . 0.0 110.036 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -21.37 60.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.465 -0.772 . . . . 0.0 110.435 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.36 -56.06 26.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -0.972 . . . . 0.0 110.341 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -89.76 13.64 13.84 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.171 -0.956 . . . . 0.0 110.598 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 51.95 63.83 2.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 110.625 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 14.7 mt -96.06 124.27 40.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.412 -0.805 . . . . 0.0 109.911 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -61.29 -16.1 42.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.144 -0.973 . . . . 0.0 110.219 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -175.29 -142.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.569 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -86.71 159.81 19.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.995 -1.065 . . . . 0.0 110.365 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 176.76 179.74 47.33 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 m -133.74 120.28 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -1.148 . . . . 0.0 110.297 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 86.2 t -123.09 162.89 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.412 -0.805 . . . . 0.0 109.863 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.444 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 1.7 tt -113.36 148.79 35.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.078 -1.013 . . . . 0.0 109.761 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.438 ' HB3' ' CG2' ' A' ' 133' ' ' VAL . 40.0 m-85 -123.44 117.4 25.07 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.064 -1.022 . . . . 0.0 110.411 -179.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.495 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -134.52 165.86 24.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.311 -0.868 . . . . 0.0 110.16 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -88.67 -22.71 23.28 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.0 110.373 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.495 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 1.4 p90 -90.87 -172.32 3.32 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.243 -0.911 . . . . 0.0 110.928 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 47.22 -159.46 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.663 0.744 . . . . 0.0 110.728 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -55.0 -53.62 53.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.641 -0.662 . . . . 0.0 110.321 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 139.5 -49.2 0.82 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.68 172.83 8.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.252 -1.146 . . . . 0.0 110.442 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . 0.464 ' N ' ' ND2' ' A' ' 197' ' ' ASN . 0.6 OUTLIER -138.44 -152.67 0.44 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.292 -0.88 . . . . 0.0 109.598 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -175.57 76.69 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.32 -0.862 . . . . 0.0 110.309 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -51.39 118.57 3.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.349 -0.844 . . . . 0.0 110.409 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -113.3 95.14 5.21 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.289 -0.882 . . . . 0.0 110.301 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 162.5 -174.07 38.84 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -61.46 135.95 57.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.295 -1.121 . . . . 0.0 110.166 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 74.7 t -91.15 104.43 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.885 . . . . 0.0 110.071 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 39.6 p -143.86 158.33 43.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.384 -0.822 . . . . 0.0 109.972 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.411 ' HG3' ' CA ' ' A' ' 158' ' ' ALA . 11.0 tttt -49.36 -51.54 34.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.287 -0.883 . . . . 0.0 110.916 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -59.54 -31.17 69.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 110.565 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -82.46 -38.94 23.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 110.344 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 51.1 mt -61.38 -56.59 18.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.315 -0.866 . . . . 0.0 110.35 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 4.1 mp -52.96 -23.26 6.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.263 -0.898 . . . . 0.0 110.326 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.2 -49.89 12.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.888 . . . . 0.0 110.279 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -55.8 -59.35 4.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -0.918 . . . . 0.0 110.386 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 5.7 mt -50.07 -39.45 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.219 -0.926 . . . . 0.0 110.466 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -58.67 -18.42 30.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.304 -0.873 . . . . 0.0 110.305 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 17.5 t60 -99.47 -18.6 17.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.176 -0.953 . . . . 0.0 110.676 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -97.66 -61.26 1.42 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.113 -0.992 . . . . 0.0 111.099 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . 0.425 ' HG3' ' N ' ' A' ' 217' ' ' LEU . 1.2 pt20 -61.11 -19.12 61.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.103 -0.998 . . . . 0.0 110.584 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.425 ' N ' ' HG3' ' A' ' 216' ' ' GLN . 12.6 mt -126.13 73.22 71.68 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.131 -0.981 . . . . 0.0 110.012 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.7 74.08 3.95 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.633 1.333 . . . . 0.0 110.82 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 41.9 mt 49.53 179.51 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.914 0.864 . . . . 0.0 111.279 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 10.5 p -146.01 46.59 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.344 0.593 . . . . 0.0 109.647 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.405 HG22 HD11 ' A' ' 221' ' ' ILE . 39.4 mm -52.35 156.15 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.366 -0.834 . . . . 0.0 110.424 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -117.89 -171.76 2.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.346 -0.846 . . . . 0.0 110.094 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.6 t80 52.68 74.1 0.31 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.236 -0.915 . . . . 0.0 110.163 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 58.4 p -91.89 -159.49 0.65 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.332 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.93 -51.62 12.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 110.365 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -80.71 -161.02 0.35 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.203 -0.936 . . . . 0.0 110.207 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 18.5 p -119.3 93.78 4.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.326 -0.858 . . . . 0.0 110.194 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.32 179.962 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.291 0.567 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.55 159.12 6.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -0.944 . . . . 0.0 110.134 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 t -98.29 166.07 11.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 110.144 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.7 m -107.11 109.0 20.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.186 -0.946 . . . . 0.0 110.121 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 26.2 mt -92.12 131.31 35.28 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.225 -0.922 . . . . 0.0 109.986 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.43 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 45.9 Cg_endo -72.49 -36.3 5.33 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.401 1.211 . . . . 0.0 110.47 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -154.96 -169.04 3.07 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.27 -0.894 . . . . 0.0 110.614 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.419 ' N ' HG21 ' A' ' 175' ' ' VAL . . . -67.84 -30.94 74.75 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -54.26 -25.85 25.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -1.104 . . . . 0.0 110.362 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.43 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -89.51 -25.29 21.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 110.162 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.99 -26.06 65.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 109.977 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -79.14 -50.71 10.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.209 -0.932 . . . . 0.0 110.056 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.5 m -56.87 -24.32 50.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -0.895 . . . . 0.0 110.08 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.414 HD21 ' CG1' ' A' ' 141' ' ' ILE . 12.4 tp -67.64 -51.62 47.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 0.0 110.062 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.493 HG23 ' CD2' ' A' ' 189' ' ' PHE . 42.4 t -53.55 -46.95 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.871 . . . . 0.0 110.343 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.28 -18.89 63.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 0.0 110.427 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.4 t -56.16 -59.32 5.1 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.24 -0.913 . . . . 0.0 110.277 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.6 p -127.26 -171.13 2.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.257 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -74.2 -44.63 52.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.879 . . . . 0.0 110.328 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.433 HG22 ' CD1' ' A' ' 165' ' ' ILE . 30.5 m -116.1 151.91 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 0.0 110.535 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.411 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -176.03 139.52 0.38 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.344 -0.848 . . . . 0.0 109.827 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 188' ' ' LEU . 10.0 p -122.33 146.82 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.112 -0.993 . . . . 0.0 110.47 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.436 ' O ' ' CE2' ' A' ' 143' ' ' PHE . 6.3 mt -128.18 112.65 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.424 -0.798 . . . . 0.0 109.928 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.07 125.35 7.16 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.436 ' CE2' ' O ' ' A' ' 141' ' ' ILE . 90.8 m-85 -103.2 66.56 0.9 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -1.134 . . . . 0.0 109.605 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.442 ' CD1' ' HB3' ' A' ' 184' ' ' ASP . 9.6 m-85 -93.92 140.1 30.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.351 -0.843 . . . . 0.0 111.03 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -26.83 43.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.462 -0.774 . . . . 0.0 109.775 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -122.32 90.69 3.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.51 -0.744 . . . . 0.0 109.913 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.15 -21.9 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 110.616 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -87.18 12.58 11.31 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.158 -0.964 . . . . 0.0 111.135 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 96.7 p -86.63 -164.26 1.03 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.094 -1.004 . . . . 0.0 110.118 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.53 -44.63 11.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.331 -0.856 . . . . 0.0 109.866 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.3 m -56.89 -21.31 28.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.317 -0.864 . . . . 0.0 110.085 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.29 -39.6 22.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.0 110.101 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -59.41 -39.91 84.95 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.268 -0.895 . . . . 0.0 110.339 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -63.97 -43.25 96.32 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.247 -0.908 . . . . 0.0 109.941 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -50.66 -55.81 14.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.333 -0.854 . . . . 0.0 110.307 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 75.2 mt -56.02 -51.53 67.45 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.374 -0.829 . . . . 0.0 110.08 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -51.17 -44.54 61.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.365 -0.834 . . . . 0.0 110.148 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -69.64 -34.18 73.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -0.885 . . . . 0.0 110.046 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.487 ' CB ' ' CD2' ' A' ' 167' ' ' PHE . . . -62.53 -30.98 71.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 110.136 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.97 -22.1 24.49 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.21 -0.931 . . . . 0.0 110.35 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -97.42 13.92 28.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.219 -0.926 . . . . 0.0 110.594 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.424 ' O ' ' N ' ' A' ' 164' ' ' ASP . 6.6 tt -103.78 174.67 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.093 -1.004 . . . . 0.0 110.211 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.42 62.89 0.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.37 -0.831 . . . . 0.0 110.25 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 162' ' ' ILE . 2.8 p-10 40.76 50.81 3.04 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.616 0.722 . . . . 0.0 111.56 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.456 HD11 HG22 ' A' ' 165' ' ' ILE . 39.1 mm -88.85 146.0 35.91 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.452 -0.78 . . . . 0.0 109.628 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.444 ' HD2' ' CG2' ' A' ' 165' ' ' ILE . 42.2 Cg_endo -68.63 100.8 0.71 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.58 1.305 . . . . 0.0 110.865 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.487 ' CD2' ' CB ' ' A' ' 159' ' ' ALA . 2.7 m-85 -97.6 136.32 38.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.42 -0.8 . . . . 0.0 110.158 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -129.47 143.81 14.92 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 11.1 tt -141.18 135.9 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.13 -1.218 . . . . 0.0 110.572 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.0 t -153.08 156.88 39.56 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.031 0.919 . . . . 0.0 110.571 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.4 t -122.68 2.59 9.53 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -64.31 123.23 18.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -0.945 . . . . 0.0 110.322 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 27.7 m -53.15 -28.36 25.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.229 -0.92 . . . . 0.0 110.131 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.45 -31.84 56.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -0.929 . . . . 0.0 109.764 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.419 HG21 ' N ' ' A' ' 126' ' ' GLY . 28.0 t -81.91 -26.21 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.429 -0.795 . . . . 0.0 109.32 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -76.24 -53.05 8.8 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.481 -0.762 . . . . 0.0 109.75 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 2.0 t -56.06 -21.93 24.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.402 -0.811 . . . . 0.0 110.08 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.51 -48.27 61.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 109.244 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -96.87 -0.67 47.4 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.432 -0.793 . . . . 0.0 110.352 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 53.83 70.63 0.58 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.103 -0.998 . . . . 0.0 110.589 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.64 129.11 53.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.314 -0.866 . . . . 0.0 110.045 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.422 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 24.6 p-10 -60.65 -16.21 36.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.251 -0.905 . . . . 0.0 110.512 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.2 -145.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.175 -0.953 . . . . 0.0 109.649 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.442 ' HB3' ' CD1' ' A' ' 144' ' ' PHE . 43.0 m-20 -54.3 151.54 7.3 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.04 -1.038 . . . . 0.0 109.62 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -152.19 129.94 2.94 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.416 -1.374 . . . . 0.0 110.108 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.427 ' O ' ' CB ' ' A' ' 199' ' ' PHE . 75.0 t -117.09 80.93 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.364 -1.08 . . . . 0.0 109.777 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 61.3 t -106.39 158.88 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 110.063 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.439 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 9.8 tt -116.25 163.61 15.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.032 -1.043 . . . . 0.0 109.87 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.493 ' CD2' HG23 ' A' ' 133' ' ' VAL . 64.4 m-85 -128.88 132.08 47.68 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.009 -1.057 . . . . 0.0 110.892 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.465 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.3 OUTLIER -140.49 163.69 32.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.242 -0.911 . . . . 0.0 110.122 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -83.43 -29.13 28.34 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.273 -0.892 . . . . 0.0 110.083 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.465 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.8 OUTLIER -91.5 -175.04 4.09 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.533 -0.73 . . . . 0.0 110.955 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 50.43 -160.15 0.07 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.697 0.76 . . . . 0.0 110.608 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -59.24 -28.36 66.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.774 -0.579 . . . . 0.0 110.552 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.402 ' HA2' ' HG2' ' A' ' 190' ' ' LYS . . . 107.33 -28.04 13.86 Favored Glycine 0 N--CA 1.483 1.779 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.06 -179.98 5.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.129 -1.218 . . . . 0.0 110.599 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . 0.439 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.4 m-80 -141.96 -152.39 0.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.575 -0.703 . . . . 0.0 109.712 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -171.57 79.81 0.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.355 -0.84 . . . . 0.0 110.474 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.427 ' CB ' ' O ' ' A' ' 186' ' ' VAL . 26.7 t80 -60.3 143.05 53.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.172 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -146.51 129.95 16.8 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.341 -0.85 . . . . 0.0 109.717 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 121.79 -172.58 15.51 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -66.03 117.31 8.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -1.131 . . . . 0.0 110.349 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 71.7 t -74.14 118.88 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.887 . . . . 0.0 109.987 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.6 p -150.07 157.11 42.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.318 -0.863 . . . . 0.0 110.433 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -49.26 -52.98 23.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.392 -0.818 . . . . 0.0 110.456 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -55.78 -36.21 67.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.354 -0.841 . . . . 0.0 110.332 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 -77.56 -51.98 9.8 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.193 -0.942 . . . . 0.0 110.454 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 70.8 mt -52.34 -56.35 15.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.322 -0.861 . . . . 0.0 110.429 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 18.7 mt -51.11 -24.13 3.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.169 -0.957 . . . . 0.0 110.57 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -84.71 -41.8 15.89 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.195 -0.941 . . . . 0.0 110.073 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -63.29 -57.82 9.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.352 -0.843 . . . . 0.0 110.67 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.416 HD11 ' CD1' ' A' ' 162' ' ' ILE . 9.4 mt -52.8 -47.22 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.134 -0.979 . . . . 0.0 110.388 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.56 -21.13 51.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.228 -0.92 . . . . 0.0 110.222 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -90.01 -19.35 24.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.309 -0.869 . . . . 0.0 110.438 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -94.73 -49.98 5.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.2 -0.938 . . . . 0.0 110.418 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -58.05 -18.93 27.84 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.213 -0.93 . . . . 0.0 110.485 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 22.8 mt -109.17 92.94 11.99 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 0.0 110.305 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.64 167.12 27.36 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.667 1.351 . . . . 0.0 110.257 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.26 53.75 0.76 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.158 -0.963 . . . . 0.0 110.364 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 95.5 t -122.43 60.16 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.331 -0.856 . . . . 0.0 110.013 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.41 ' O ' ' CG2' ' A' ' 221' ' ' ILE . 2.7 mp -99.2 18.63 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 0.0 110.459 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 52.26 29.76 7.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.177 -0.952 . . . . 0.0 110.354 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -168.88 60.29 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -0.918 . . . . 0.0 110.272 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 12.7 m -129.2 151.63 49.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -113.91 117.7 32.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.152 -0.967 . . . . 0.0 110.258 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.54 -71.94 0.73 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.212 -0.93 . . . . 0.0 110.256 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 20.4 p -75.55 128.49 35.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.235 -0.916 . . . . 0.0 110.198 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.291 179.984 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.238 0.542 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.53 179.71 7.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.181 -0.949 . . . . 0.0 110.154 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 51.9 m -101.56 125.51 48.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 110.149 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 87.0 m -76.84 126.91 31.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.25 -0.906 . . . . 0.0 110.169 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.7 mt -103.45 137.98 19.41 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.932 . . . . 0.0 109.95 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.427 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 46.8 Cg_endo -73.09 -26.21 15.23 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.554 1.292 . . . . 0.0 110.546 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -172.76 -170.33 0.66 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.159 -0.963 . . . . 0.0 110.912 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.8 -34.07 87.46 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -51.48 -28.2 12.67 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.276 -1.132 . . . . 0.0 110.4 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.427 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -86.06 -37.22 19.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 110.161 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.16 -30.15 48.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.197 -0.939 . . . . 0.0 110.118 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -81.62 -46.45 14.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.146 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 92.0 p -56.74 -33.34 66.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.894 . . . . 0.0 110.095 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.435 HD21 ' CG1' ' A' ' 141' ' ' ILE . 5.5 tp -61.09 -47.84 84.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -0.884 . . . . 0.0 110.165 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.491 HG23 ' CD1' ' A' ' 189' ' ' PHE . 39.4 t -54.67 -41.2 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.193 -0.942 . . . . 0.0 109.961 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -82.74 3.38 29.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.274 -0.891 . . . . 0.0 110.796 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.8 t -75.61 -41.92 53.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.934 -1.104 . . . . 0.0 110.111 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 28.2 p -147.24 -172.63 4.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 110.13 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.443 ' OE2' ' CD2' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -70.65 -44.76 66.43 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.205 -0.934 . . . . 0.0 110.163 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.4 t -116.26 150.51 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.276 -0.89 . . . . 0.0 110.191 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.436 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -172.15 146.0 1.85 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.843 . . . . 0.0 109.926 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.4 HG12 HG12 ' A' ' 212' ' ' ILE . 2.8 m -128.19 164.66 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.117 -0.99 . . . . 0.0 110.764 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.435 ' CG1' HD21 ' A' ' 132' ' ' LEU . 31.2 mt -149.96 114.4 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.753 -0.592 . . . . 0.0 110.173 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -87.06 133.05 11.53 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.488 ' CD2' HG13 ' A' ' 175' ' ' VAL . 76.1 m-85 -99.37 77.31 2.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.113 -1.228 . . . . 0.0 110.069 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -95.24 143.65 26.47 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.992 0.901 . . . . 0.0 110.939 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.4 -25.36 20.43 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.815 0.817 . . . . 0.0 109.167 179.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -137.3 78.85 1.72 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.407 HG21 ' N ' ' A' ' 148' ' ' GLU . 19.5 m -46.02 -25.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.457 -0.777 . . . . 0.0 111.167 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.407 ' N ' HG21 ' A' ' 147' ' ' VAL . 1.5 mm-40 -84.73 10.31 11.7 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.106 -0.996 . . . . 0.0 110.937 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 68.6 p -81.0 -159.36 0.25 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.967 -1.083 . . . . 0.0 110.182 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -89.87 -54.18 4.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 110.207 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.87 -23.38 63.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 0.0 110.268 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.12 -23.43 38.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 0.0 110.286 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.18 -41.05 77.69 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.216 -0.928 . . . . 0.0 110.115 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -60.43 -46.03 91.48 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.314 -0.867 . . . . 0.0 109.956 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -51.79 -55.35 20.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 110.268 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 41.2 mt -54.13 -55.75 24.69 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.383 -0.823 . . . . 0.0 110.152 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -52.45 -38.02 58.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.347 -0.845 . . . . 0.0 110.13 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.421 ' CB ' ' HG3' ' A' ' 205' ' ' LYS . . . -76.8 -41.61 43.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.198 -0.939 . . . . 0.0 109.841 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.405 ' HB3' ' CD2' ' A' ' 167' ' ' PHE . . . -58.73 -37.61 76.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.828 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -66.59 -28.21 68.33 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.243 -0.91 . . . . 0.0 110.113 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.36 -50.43 73.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.798 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.413 HG22 ' CG1' ' A' ' 165' ' ' ILE . 71.4 mt -90.31 152.17 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.367 -0.833 . . . . 0.0 109.891 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -127.6 -40.27 1.77 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.136 -0.978 . . . . 0.0 110.43 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -63.77 -16.25 60.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.249 -0.907 . . . . 0.0 110.615 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.498 HD11 HG22 ' A' ' 165' ' ' ILE . 46.2 mm -93.63 128.86 40.37 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.075 -1.016 . . . . 0.0 110.327 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.436 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 51.0 Cg_endo -77.31 82.55 2.35 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 O-C-N 123.538 1.283 . . . . 0.0 110.546 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.405 ' CD2' ' HB3' ' A' ' 159' ' ' ALA . 1.6 m-85 -71.44 137.57 48.38 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.173 -0.954 . . . . 0.0 110.238 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -128.9 145.07 15.91 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 4.8 tt -146.58 137.48 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -1.157 . . . . 0.0 110.439 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.2 t -159.49 156.94 29.13 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.001 0.905 . . . . 0.0 110.895 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 56.7 p -122.24 3.43 9.79 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.527 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -57.74 126.76 28.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.219 -0.926 . . . . 0.0 110.535 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.88 -35.88 58.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.244 -0.91 . . . . 0.0 110.143 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -53.09 -30.75 38.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.978 . . . . 0.0 109.815 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.488 HG13 ' CD2' ' A' ' 143' ' ' PHE . 57.3 t -81.29 -26.86 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.325 -0.859 . . . . 0.0 109.546 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -77.6 -52.86 8.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.351 -0.843 . . . . 0.0 109.345 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.4 m -58.96 -18.6 35.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.443 -0.786 . . . . 0.0 109.997 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -71.48 -53.91 12.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.559 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -91.11 4.6 51.76 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.41 -0.807 . . . . 0.0 110.292 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.13 64.64 1.76 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -0.946 . . . . 0.0 110.713 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 40.0 mt -102.7 122.41 44.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.256 -0.902 . . . . 0.0 110.17 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -62.83 -18.87 63.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 110.422 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 18.9 pttt -163.75 -148.22 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 109.983 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -70.71 150.98 45.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -0.933 . . . . 0.0 109.889 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -170.16 156.05 26.33 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 97.8 t -127.8 141.2 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.172 -1.193 . . . . 0.0 110.344 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.406 HG11 ' N ' ' A' ' 188' ' ' LEU . 70.6 t -143.06 149.24 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.337 -0.852 . . . . 0.0 109.646 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.462 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 3.7 tt -101.29 145.59 28.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.951 -1.093 . . . . 0.0 109.681 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.491 ' CD1' HG23 ' A' ' 133' ' ' VAL . 58.8 m-85 -121.87 108.34 13.34 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.131 -0.981 . . . . 0.0 110.624 -178.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.479 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -124.06 174.68 7.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.31 -0.869 . . . . 0.0 110.27 179.782 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -94.41 -26.22 16.6 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.321 -0.862 . . . . 0.0 110.007 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.479 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.5 OUTLIER -91.43 -170.92 2.76 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.833 179.577 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 49.87 -159.92 0.07 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.661 0.743 . . . . 0.0 110.595 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -56.05 -46.32 78.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.632 -0.667 . . . . 0.0 110.25 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 126.07 -32.86 3.67 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -136.55 173.14 12.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.193 -1.18 . . . . 0.0 110.429 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . 0.462 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 0.7 OUTLIER -144.22 -155.21 0.58 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.37 -0.831 . . . . 0.0 109.631 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 197' ' ' ASN . 0.2 OUTLIER -169.52 86.93 0.15 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.53 -0.731 . . . . 0.0 110.206 179.612 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -49.85 130.83 22.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.272 -0.893 . . . . 0.0 110.441 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -127.95 115.38 18.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.327 -0.858 . . . . 0.0 109.942 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 132.93 -158.74 23.25 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -84.43 132.28 34.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.298 -1.119 . . . . 0.0 110.167 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 92.3 t -81.46 116.17 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.33 -0.856 . . . . 0.0 110.376 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 15.6 p -143.56 159.73 41.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 109.988 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.421 ' HG3' ' CB ' ' A' ' 158' ' ' ALA . 2.9 ttpt -51.31 -49.24 61.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.12 -0.987 . . . . 0.0 110.584 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -62.98 -39.72 95.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.276 -0.89 . . . . 0.0 110.549 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -70.16 -48.79 55.86 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.197 -0.939 . . . . 0.0 110.374 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.3 mt -56.06 -49.87 72.55 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.257 -0.902 . . . . 0.0 110.428 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.26 -26.99 65.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.892 . . . . 0.0 110.298 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -78.28 -45.49 22.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.281 -0.887 . . . . 0.0 110.274 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -53.29 -60.92 2.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.318 -0.864 . . . . 0.0 110.393 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.4 HG12 HG12 ' A' ' 140' ' ' VAL . 9.9 mt -51.69 -46.47 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.242 -0.911 . . . . 0.0 110.586 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -18.85 13.79 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.258 -0.902 . . . . 0.0 110.956 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -96.52 -24.38 16.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.064 -1.022 . . . . 0.0 110.922 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -89.34 -48.58 7.25 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.922 -1.111 . . . . 0.0 111.139 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -57.37 -21.55 36.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.956 -1.09 . . . . 0.0 110.212 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 1.7 mt -104.97 124.99 34.86 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.899 . . . . 0.0 109.949 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.66 -177.08 2.6 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.404 1.213 . . . . 0.0 110.426 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 5.1 mp -116.57 131.17 57.02 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.237 -0.915 . . . . 0.0 110.001 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 33.0 m -89.39 59.27 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.275 -0.891 . . . . 0.0 110.212 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 2.2 pt -111.85 54.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.864 . . . . 0.0 110.069 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -161.18 142.58 11.68 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 110.397 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -150.63 46.65 0.87 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.082 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 25.4 m 54.95 48.84 19.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.29 -0.881 . . . . 0.0 110.293 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 52.52 -166.54 0.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.186 -0.947 . . . . 0.0 110.238 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.47 90.99 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.911 . . . . 0.0 110.204 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 26.7 m 55.86 170.49 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.217 -0.927 . . . . 0.0 110.227 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.237 -179.889 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.315 0.578 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -91.12 175.07 7.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 0.0 110.178 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.7 t -102.19 171.11 7.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.139 -0.976 . . . . 0.0 110.516 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.2 m -113.95 103.47 11.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.357 -0.839 . . . . 0.0 110.193 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.432 ' CD1' HG22 ' A' ' 141' ' ' ILE . 57.7 mt -79.47 111.95 24.87 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.924 . . . . 0.0 110.04 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.434 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 44.7 Cg_endo -69.61 -21.57 34.02 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 O-C-N 123.561 1.295 . . . . 0.0 110.869 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.13 -170.03 2.19 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.052 -1.03 . . . . 0.0 111.076 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.404 ' HA3' ' HD3' ' A' ' 178' ' ' LYS . . . -67.69 -39.92 90.25 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -53.25 -22.56 7.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -1.15 . . . . 0.0 110.031 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.434 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -88.32 -23.91 23.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.205 -0.935 . . . . 0.0 109.301 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.0 -20.48 32.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.454 -0.779 . . . . 0.0 110.118 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 131' ' ' SER . 19.2 pt-20 -86.9 -37.61 17.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.177 -0.952 . . . . 0.0 110.228 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.426 ' N ' ' HG3' ' A' ' 130' ' ' GLU . 3.0 m -75.48 -31.45 60.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 0.0 109.998 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.4 tt -56.51 -59.47 4.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.336 -0.852 . . . . 0.0 110.067 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.487 HG23 ' CD2' ' A' ' 189' ' ' PHE . 51.4 t -53.63 -35.88 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 110.513 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.81 -19.86 57.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.125 -0.984 . . . . 0.0 110.581 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 68.4 m -68.56 -57.47 5.73 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.129 -0.982 . . . . 0.0 110.304 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 46.1 p -111.84 165.06 12.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.316 -0.865 . . . . 0.0 110.252 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.427 ' CG ' ' N ' ' A' ' 138' ' ' VAL . 14.6 pt-20 -64.86 -40.39 95.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 110.035 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.427 ' N ' ' CG ' ' A' ' 137' ' ' GLU . 94.1 t -121.67 147.7 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.429 -0.794 . . . . 0.0 110.17 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.429 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -173.99 133.26 0.43 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.298 -0.876 . . . . 0.0 110.061 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.432 HG21 ' N ' ' A' ' 141' ' ' ILE . 7.3 p -111.86 149.54 14.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.136 -0.977 . . . . 0.0 110.064 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.432 ' N ' HG21 ' A' ' 140' ' ' VAL . 66.5 mt -131.37 111.1 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 110.253 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -77.28 133.24 12.96 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.47 ' CE2' HG13 ' A' ' 175' ' ' VAL . 51.4 m-85 -105.36 67.2 0.76 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.26 -1.141 . . . . 0.0 109.735 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -91.76 130.33 37.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 111.228 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.44 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 26.0 pttt -80.07 -30.62 39.32 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.923 0.868 . . . . 0.0 108.828 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.44 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 5.2 m-20 -123.19 70.93 1.04 Allowed 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.323 0.582 . . . . 0.0 109.449 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.415 HG21 ' N ' ' A' ' 148' ' ' GLU . 25.6 m -49.17 -23.89 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.27 -0.894 . . . . 0.0 110.808 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.415 ' N ' HG21 ' A' ' 147' ' ' VAL . 2.7 mt-10 -78.33 2.55 18.2 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.08 -1.012 . . . . 0.0 111.032 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 21.5 p -80.45 -161.0 0.34 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.901 -1.124 . . . . 0.0 110.243 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -90.41 -51.59 5.34 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.21 -0.931 . . . . 0.0 110.582 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 66.4 m -52.25 -26.07 10.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.2 -0.938 . . . . 0.0 110.507 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.409 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -86.24 -32.1 21.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 110.353 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -60.23 -41.32 92.84 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.22 -0.925 . . . . 0.0 110.189 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -66.32 -36.91 84.12 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.169 -0.957 . . . . 0.0 109.93 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.408 ' CE1' HD23 ' A' ' 208' ' ' LEU . 4.3 t80 -51.97 -57.78 8.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.286 -0.884 . . . . 0.0 110.097 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 19.2 mt -52.01 -50.57 61.11 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.45 -0.781 . . . . 0.0 110.245 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -52.1 -41.61 62.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.356 -0.84 . . . . 0.0 110.152 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -73.29 -35.47 66.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.335 -0.853 . . . . 0.0 109.889 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.58 -43.16 94.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 110.013 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -60.13 -35.62 75.68 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.256 -0.903 . . . . 0.0 110.139 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.3 -46.54 86.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.87 . . . . 0.0 110.182 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.425 HD11 HG22 ' A' ' 162' ' ' ILE . 49.8 mm -90.7 104.98 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.064 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.37 -20.54 20.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.122 -0.986 . . . . 0.0 110.373 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -76.88 -6.05 50.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.221 -0.925 . . . . 0.0 110.807 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.45 HD11 HG22 ' A' ' 165' ' ' ILE . 44.7 mm -116.3 130.35 24.54 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.941 -1.1 . . . . 0.0 110.132 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.429 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 50.6 Cg_endo -75.09 81.2 2.28 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.475 1.25 . . . . 0.0 110.549 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -68.23 132.38 47.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 110.316 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -126.54 153.34 18.71 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 7.2 tt -148.43 147.33 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -1.154 . . . . 0.0 110.329 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.4 t -164.01 156.96 17.86 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.065 0.936 . . . . 0.0 110.809 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 76.1 p -121.14 1.08 10.28 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.16 119.98 6.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.191 -0.943 . . . . 0.0 110.506 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.1 p -53.72 -32.48 52.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.229 -0.919 . . . . 0.0 110.095 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.47 -44.31 80.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.141 -0.975 . . . . 0.0 109.344 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.47 HG13 ' CE2' ' A' ' 143' ' ' PHE . 39.0 t -69.22 -29.84 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.346 -0.846 . . . . 0.0 109.41 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -68.57 -60.86 2.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.407 -0.808 . . . . 0.0 109.528 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 2.9 m -51.36 -36.62 43.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.61 -0.682 . . . . 0.0 110.562 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.404 ' HD3' ' HA3' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -48.44 -55.78 9.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.17 -0.956 . . . . 0.0 110.895 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -89.9 18.73 5.4 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.315 -0.866 . . . . 0.0 110.51 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.46 65.75 1.39 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.163 -0.961 . . . . 0.0 110.402 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 85.5 mt -112.92 92.29 3.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -0.836 . . . . 0.0 110.235 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.56 -26.98 9.65 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.038 -1.038 . . . . 0.0 109.53 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -138.66 177.73 7.67 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -58.65 -173.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.08 -1.012 . . . . 0.0 110.262 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 165.27 171.86 32.01 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.43 HG22 ' CB ' ' A' ' 199' ' ' PHE . 32.8 m -139.92 108.15 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.294 -1.121 . . . . 0.0 109.97 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 97.2 t -117.04 160.9 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.287 -0.883 . . . . 0.0 109.851 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.446 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 8.3 tt -110.3 150.79 28.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.026 -1.046 . . . . 0.0 109.941 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.487 ' CD2' HG23 ' A' ' 133' ' ' VAL . 40.6 m-85 -121.87 127.19 50.2 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.991 -1.068 . . . . 0.0 110.196 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.28 167.39 22.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -0.885 . . . . 0.0 110.358 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.0 mtpt -90.87 -27.09 19.02 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.244 -0.91 . . . . 0.0 110.596 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -90.96 -175.69 4.41 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.381 -0.824 . . . . 0.0 111.023 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 50.01 -160.0 0.07 Allowed 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.666 0.746 . . . . 0.0 110.667 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -53.86 -54.68 35.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.666 -0.646 . . . . 0.0 110.191 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 133.12 -24.31 3.79 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -140.85 176.81 8.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.051 -1.264 . . . . 0.0 110.781 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . 0.456 ' N ' ' ND2' ' A' ' 197' ' ' ASN . 1.1 m-80 -142.53 -151.76 0.38 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.549 -0.719 . . . . 0.0 109.509 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -176.51 79.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 0.0 109.97 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.43 ' CB ' HG22 ' A' ' 186' ' ' VAL . 17.1 t80 -51.26 120.1 4.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.285 -0.884 . . . . 0.0 110.52 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -119.56 104.91 10.72 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.248 -0.907 . . . . 0.0 110.111 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 152.21 -160.62 28.99 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -81.94 111.11 17.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -1.178 . . . . 0.0 110.16 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.82 116.68 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 110.173 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 67.9 p -149.63 155.72 40.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 110.284 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -52.62 -52.66 54.46 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.357 -0.839 . . . . 0.0 110.567 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -56.35 -25.83 50.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.0 110.293 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -87.47 -46.29 9.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.291 -0.881 . . . . 0.0 110.17 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.408 HD23 ' CE1' ' A' ' 155' ' ' PHE . 19.4 mt -59.02 -47.27 85.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.283 -0.886 . . . . 0.0 110.315 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 14.6 mt -52.31 -30.99 31.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.226 -0.921 . . . . 0.0 110.287 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.53 -42.06 14.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 0.0 110.089 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.428 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 18.5 t80 -51.31 -51.7 51.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.162 -0.961 . . . . 0.0 109.705 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 25.4 mm -48.53 -72.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.427 -0.796 . . . . 0.0 110.423 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.429 ' HA ' ' CG ' ' A' ' 216' ' ' GLN . 18.0 mttt -45.9 -37.08 5.94 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.779 -0.575 . . . . 0.0 111.132 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.61 -25.46 67.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.13 -0.981 . . . . 0.0 110.793 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 74.8 m-80 -102.18 -31.53 10.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.103 -0.998 . . . . 0.0 110.977 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . 0.429 ' CG ' ' HA ' ' A' ' 213' ' ' LYS . 0.0 OUTLIER -90.49 25.17 2.36 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.016 -1.053 . . . . 0.0 111.001 -179.414 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 30.3 mt -126.69 57.78 23.83 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.072 -1.017 . . . . 0.0 110.035 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.34 151.67 48.68 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.611 1.322 . . . . 0.0 110.668 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 44.5 mt 44.99 69.06 0.47 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.562 -0.711 . . . . 0.0 111.241 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 9.6 p -94.12 134.18 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 110.164 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 30.0 pt -87.99 -176.01 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.192 -0.942 . . . . 0.0 110.351 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.88 -152.7 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.267 -0.895 . . . . 0.0 110.174 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 53.47 -151.37 0.34 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.263 -0.898 . . . . 0.0 110.125 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.3 m -49.88 156.37 0.74 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.135 -0.978 . . . . 0.0 110.491 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -167.41 71.4 0.11 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 110.185 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.419 ' O ' ' CG2' ' A' ' 227' ' ' THR . 4.7 tt0 -60.36 -55.61 31.53 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.239 -0.913 . . . . 0.0 110.136 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' A' ' 226' ' ' GLN . 1.0 OUTLIER -161.15 160.79 30.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.323 -0.861 . . . . 0.0 110.12 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.216 -179.998 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.21 0.529 . . . . 0.0 110.261 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.22 170.84 6.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.34 -0.85 . . . . 0.0 110.38 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.4 t -103.89 168.9 8.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 110.318 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.6 m -108.1 118.4 36.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 0.0 109.94 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 49.5 mt -90.88 138.35 26.28 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.218 -0.926 . . . . 0.0 110.378 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.42 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 46.5 Cg_endo -72.61 -36.63 4.78 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.565 1.297 . . . . 0.0 110.366 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -167.2 -170.24 1.45 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.222 -0.924 . . . . 0.0 110.805 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -57.56 -33.67 67.43 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -51.11 -26.72 6.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.22 -1.165 . . . . 0.0 110.406 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.42 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -88.12 -37.16 16.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 110.093 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.24 -25.88 25.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 0.0 109.995 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -88.88 -57.36 2.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.271 -0.893 . . . . 0.0 110.062 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.2 m -58.77 -27.87 65.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.233 -0.917 . . . . 0.0 110.205 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 20.6 tp -60.71 -54.31 46.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 109.988 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 98.4 t -57.39 -33.25 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.459 -0.776 . . . . 0.0 110.336 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -72.97 -17.69 61.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.903 . . . . 0.0 110.528 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.85 -27.12 57.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.189 -0.944 . . . . 0.0 110.393 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.1 p -141.58 163.55 32.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.188 -0.945 . . . . 0.0 110.391 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.426 ' HG3' ' CG2' ' A' ' 138' ' ' VAL . 18.3 pt-20 -63.8 -40.93 97.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 110.043 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.426 ' CG2' ' HG3' ' A' ' 137' ' ' GLU . 57.9 t -127.76 155.88 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.412 -0.805 . . . . 0.0 110.172 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -176.75 138.51 0.28 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.245 -0.91 . . . . 0.0 109.788 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.78 151.78 14.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.085 -1.01 . . . . 0.0 110.245 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 71.9 mt -132.65 117.36 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.377 -0.827 . . . . 0.0 110.163 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -84.22 126.72 7.74 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -100.24 70.03 1.51 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.356 -1.085 . . . . 0.0 109.924 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -94.99 141.5 28.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -0.875 . . . . 0.0 110.952 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.53 -27.96 18.83 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.501 -0.749 . . . . 0.0 110.554 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.418 ' O ' ' CB ' ' A' ' 147' ' ' VAL . 0.7 OUTLIER -90.69 -39.51 12.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.17 -0.956 . . . . 0.0 110.445 -179.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.418 ' CB ' ' O ' ' A' ' 146' ' ' ASP . 2.4 t 73.1 -51.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.743 -0.598 . . . . 0.0 110.634 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -90.83 8.96 32.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.067 -1.021 . . . . 0.0 110.507 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 7.5 p -70.01 -163.87 0.07 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.986 -1.071 . . . . 0.0 110.066 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.51 -41.31 13.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.338 -0.851 . . . . 0.0 110.431 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.7 p -59.55 -24.26 63.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.197 -0.94 . . . . 0.0 110.19 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -85.02 -37.17 20.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.253 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.88 -45.83 67.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 110.387 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -62.49 -39.48 93.61 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.219 -0.925 . . . . 0.0 110.355 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -51.6 -56.63 12.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 110.418 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.7 mt -51.21 -54.31 26.82 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.324 -0.86 . . . . 0.0 110.534 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -51.91 -40.46 60.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.254 -0.903 . . . . 0.0 110.252 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -69.47 -49.61 53.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.93 . . . . 0.0 109.885 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -55.61 -35.93 66.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 110.011 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -68.48 -22.76 64.54 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.329 -0.857 . . . . 0.0 110.435 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.89 -56.42 17.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.168 -0.957 . . . . 0.0 110.333 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.408 HD11 HG22 ' A' ' 162' ' ' ILE . 98.8 mt -90.02 151.1 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 0.0 110.177 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -119.67 -16.39 8.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 110.597 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -91.2 19.7 5.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.073 -1.017 . . . . 0.0 110.519 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.551 ' CG2' ' CE1' ' A' ' 167' ' ' PHE . 31.8 mm -132.21 125.1 19.75 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.135 -0.978 . . . . 0.0 109.899 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -81.5 101.56 1.22 Allowed 'Trans proline' 0 C--N 1.315 -1.228 0 O-C-N 123.443 1.233 . . . . 0.0 110.697 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.551 ' CE1' ' CG2' ' A' ' 165' ' ' ILE . 1.1 m-85 -92.85 140.07 29.88 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.249 -0.907 . . . . 0.0 109.487 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -132.58 156.37 22.04 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.3 tt -146.0 150.86 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.096 -1.237 . . . . 0.0 110.282 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.421 HG22 ' CG1' ' A' ' 175' ' ' VAL . 2.4 t -162.01 158.55 25.2 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.11 0.957 . . . . 0.0 110.891 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.402 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . 26.3 t -125.09 2.12 7.94 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.319 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -67.98 123.39 20.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.22 -0.925 . . . . 0.0 110.31 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 14.9 m -50.53 -25.43 4.07 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.224 -0.922 . . . . 0.0 110.445 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -59.91 -29.06 68.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.194 -0.941 . . . . 0.0 109.848 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.421 ' CG1' HG22 ' A' ' 170' ' ' THR . 39.2 t -88.87 -22.16 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.358 -0.839 . . . . 0.0 109.734 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -80.69 -44.31 18.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.347 -0.846 . . . . 0.0 109.711 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.0 -25.23 67.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.431 -0.793 . . . . 0.0 110.107 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.82 -61.42 2.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -0.852 . . . . 0.0 110.44 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.49 ' CZ ' ' CZ ' ' A' ' 189' ' ' PHE . 88.9 m-85 -89.59 12.24 17.29 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.181 -0.949 . . . . 0.0 110.675 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 50.34 60.62 3.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.143 -0.973 . . . . 0.0 110.719 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 83.8 mt -91.75 124.18 35.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.142 -0.974 . . . . 0.0 109.965 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -60.0 -19.32 51.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.244 -0.91 . . . . 0.0 110.615 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -168.84 -146.96 0.06 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.211 -0.931 . . . . 0.0 110.168 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -75.32 150.06 38.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.229 -0.92 . . . . 0.0 110.171 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -171.54 154.01 21.28 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.427 ' O ' ' CG2' ' A' ' 186' ' ' VAL . 33.3 m -126.04 104.71 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.278 -1.131 . . . . 0.0 110.174 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 95.2 t -111.27 157.91 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 0.0 109.494 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.518 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 9.1 tt -107.15 148.45 28.83 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.887 -1.133 . . . . 0.0 108.926 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.49 ' CZ ' ' CZ ' ' A' ' 179' ' ' TYR . 39.0 m-85 -113.78 129.06 56.63 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.756 -1.215 . . . . 0.0 111.304 -178.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.494 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -137.97 151.95 48.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.274 -0.891 . . . . 0.0 110.269 179.578 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp -83.27 -25.26 31.78 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.337 -0.852 . . . . 0.0 110.252 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.494 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 1.7 p90 -91.77 -176.99 4.63 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.397 -0.814 . . . . 0.0 110.976 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 193' ' ' ASP . 11.1 m-20 48.91 -158.37 0.06 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.574 0.702 . . . . 0.0 110.624 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.25 -46.94 46.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.553 -0.717 . . . . 0.0 110.55 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 133.37 -33.45 2.57 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.6 ptt180 -147.4 -165.84 2.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.188 -1.183 . . . . 0.0 110.593 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . 0.518 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.0 OUTLIER -142.7 -153.7 0.48 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.549 -0.719 . . . . 0.0 109.895 -179.273 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -171.94 80.93 0.06 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.467 -0.77 . . . . 0.0 109.935 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.403 ' HB3' HG21 ' A' ' 186' ' ' VAL . 24.9 t80 -53.92 119.49 5.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.833 . . . . 0.0 110.27 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -120.69 89.15 3.07 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.417 -0.802 . . . . 0.0 110.354 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 164.66 -165.68 37.58 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -73.17 126.32 29.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -1.132 . . . . 0.0 110.243 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 97.2 t -76.0 110.19 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 110.139 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 77.6 p -145.79 151.28 37.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.491 -0.756 . . . . 0.0 109.979 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt -48.69 -52.28 24.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.277 -0.889 . . . . 0.0 110.413 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -52.77 -39.86 62.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.324 -0.86 . . . . 0.0 110.19 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -77.31 -44.51 29.35 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.36 -0.838 . . . . 0.0 110.39 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 71.6 mt -53.97 -46.54 71.68 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.317 -0.864 . . . . 0.0 110.29 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 24.6 mt -59.09 -31.64 69.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 0.0 110.027 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -72.19 -28.18 63.04 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.217 -0.927 . . . . 0.0 109.864 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -65.09 -66.67 0.51 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.424 -0.798 . . . . 0.0 110.328 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 5.6 mt -46.37 -42.19 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.436 -0.79 . . . . 0.0 110.778 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -24.73 37.08 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.238 -0.914 . . . . 0.0 110.156 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -113.12 3.74 16.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.331 -0.855 . . . . 0.0 110.832 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -92.25 -60.06 1.94 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.882 -1.136 . . . . 0.0 110.195 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . 0.484 ' HA ' ' CZ ' ' A' ' 192' ' ' PHE . 7.4 pt20 -85.09 -143.56 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.335 -0.853 . . . . 0.0 110.407 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 18.0 mt 54.92 57.96 11.3 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.137 -0.977 . . . . 0.0 110.299 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.58 111.92 3.35 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 O-C-N 123.692 1.364 . . . . 0.0 110.337 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 23.1 mt 50.93 92.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 110.427 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 33.1 m -90.29 41.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.289 -0.882 . . . . 0.0 110.554 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 53.1 mt -140.65 27.92 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.12 -0.988 . . . . 0.0 110.018 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -136.0 59.25 1.72 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.91 . . . . 0.0 110.308 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -119.04 108.99 15.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.258 -0.901 . . . . 0.0 110.239 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 30.1 m -147.11 95.9 2.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.209 -0.932 . . . . 0.0 110.293 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -105.05 -25.48 12.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 0.0 110.033 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.15 106.94 2.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.924 . . . . 0.0 110.123 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 41.7 m -136.86 148.28 47.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.262 -0.899 . . . . 0.0 110.162 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.181 179.977 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.201 0.524 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.47 -166.36 1.35 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.281 -0.887 . . . . 0.0 110.432 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.436 ' CG2' ' HA2' ' A' ' 168' ' ' GLY . 10.0 t -124.95 171.7 9.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.375 -0.828 . . . . 0.0 110.113 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 50.6 m -109.2 108.76 19.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.34 -0.85 . . . . 0.0 110.095 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.0 mt -84.4 125.7 71.19 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.892 . . . . 0.0 109.973 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.404 ' HD2' ' HB1' ' A' ' 128' ' ' ALA . 46.1 Cg_endo -71.23 -42.82 1.79 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.53 1.279 . . . . 0.0 110.468 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -152.57 -170.05 3.52 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.301 -0.874 . . . . 0.0 110.807 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.09 -26.51 67.59 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -53.26 -34.53 57.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.338 -1.095 . . . . 0.0 110.4 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.404 ' HB1' ' HD2' ' A' ' 124' ' ' PRO . . . -79.26 -33.1 43.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.06 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.35 -32.25 64.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -0.881 . . . . 0.0 110.193 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -90.22 -41.17 11.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.348 -0.845 . . . . 0.0 110.406 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.0 m -62.62 -34.75 77.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.935 . . . . 0.0 110.079 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.1 tp -60.74 -45.29 94.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 110.246 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.496 HG23 ' CD1' ' A' ' 189' ' ' PHE . 43.8 t -56.11 -41.59 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.231 -0.918 . . . . 0.0 110.596 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -85.29 -19.9 30.84 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.219 -0.926 . . . . 0.0 110.496 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.5 m -55.48 -36.97 67.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.202 -0.936 . . . . 0.0 110.3 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.8 p -145.16 -178.82 6.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.159 -0.963 . . . . 0.0 110.288 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.15 -30.54 60.79 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.289 -0.882 . . . . 0.0 110.276 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 92.9 t -130.95 144.99 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 110.129 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -174.95 136.75 0.4 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 110.208 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.439 ' CG1' ' CD1' ' A' ' 167' ' ' PHE . 7.5 p -123.7 150.61 28.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.198 -0.938 . . . . 0.0 110.009 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.465 HG23 ' CE1' ' A' ' 143' ' ' PHE . 5.7 mt -131.17 116.42 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.232 -0.918 . . . . 0.0 110.067 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -87.13 121.63 5.88 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.465 ' CE1' HG23 ' A' ' 141' ' ' ILE . 65.4 m-85 -99.08 98.25 9.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -1.161 . . . . 0.0 109.53 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.437 ' CE1' ' HB2' ' A' ' 151' ' ' SER . 19.8 m-85 -115.67 147.33 40.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.026 -1.046 . . . . 0.0 111.357 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.4 ptmt -91.17 -27.38 18.55 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.643 0.735 . . . . 0.0 109.345 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.03 72.34 1.36 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.603 -0.685 . . . . 0.0 109.502 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.411 ' O ' ' CB ' ' A' ' 152' ' ' ALA . 23.9 m -54.8 -19.77 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.283 -0.886 . . . . 0.0 110.617 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -76.33 0.96 17.53 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.111 -0.993 . . . . 0.0 110.927 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 83.6 p -88.06 -170.19 2.88 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.827 -1.17 . . . . 0.0 109.949 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -81.35 -30.8 33.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.289 -0.882 . . . . 0.0 110.167 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.437 ' HB2' ' CE1' ' A' ' 144' ' ' PHE . 94.9 p -56.92 -28.92 62.59 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.138 -0.976 . . . . 0.0 110.134 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.411 ' CB ' ' O ' ' A' ' 147' ' ' VAL . . . -83.34 -43.16 16.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 109.935 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.6 -53.05 52.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.265 -0.897 . . . . 0.0 110.255 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -56.32 -43.3 78.86 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.386 -0.821 . . . . 0.0 109.974 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -53.3 -57.45 10.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.384 -0.823 . . . . 0.0 110.175 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.9 mt -53.44 -54.33 38.46 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.208 -0.932 . . . . 0.0 110.349 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -50.57 -30.98 14.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.33 -0.856 . . . . 0.0 110.466 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -77.71 -33.18 53.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 0.0 110.021 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.401 ' O ' ' CG2' ' A' ' 162' ' ' ILE . . . -59.33 -44.72 92.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.27 -0.894 . . . . 0.0 110.166 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -79.84 -29.24 40.07 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.36 -0.837 . . . . 0.0 110.307 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -80.62 -6.51 58.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.267 -0.896 . . . . 0.0 110.743 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 212' ' ' ILE . 4.7 tt -92.44 179.66 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.964 -1.085 . . . . 0.0 109.967 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -70.33 62.34 0.23 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.035 -1.04 . . . . 0.0 110.429 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 40.3 52.33 2.85 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.478 0.656 . . . . 0.0 111.194 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.442 ' CG2' ' HD2' ' A' ' 166' ' ' PRO . 34.6 mm -88.25 145.41 35.87 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.497 -0.752 . . . . 0.0 109.835 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.442 ' HD2' ' CG2' ' A' ' 165' ' ' ILE . 43.5 Cg_endo -68.59 91.3 0.41 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.639 1.336 . . . . 0.0 110.759 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.439 ' CD1' ' CG1' ' A' ' 140' ' ' VAL . 2.9 m-85 -88.83 133.91 34.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 0.0 110.133 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.436 ' HA2' ' CG2' ' A' ' 121' ' ' THR . . . -122.43 150.74 16.91 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 5.9 tt -150.04 142.01 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -1.118 . . . . 0.0 110.65 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.1 t -159.23 155.36 26.89 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.125 0.964 . . . . 0.0 110.755 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 85.0 p -116.01 1.04 13.2 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.608 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -57.56 128.28 36.27 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.085 -1.009 . . . . 0.0 110.34 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.14 -28.05 66.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.271 -0.893 . . . . 0.0 110.224 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.41 -45.61 76.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.112 -0.992 . . . . 0.0 109.838 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 42.8 t -67.68 -29.79 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.2 -0.938 . . . . 0.0 109.573 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -76.5 -44.15 36.45 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.376 -0.828 . . . . 0.0 109.357 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 12.1 t -71.59 -5.75 35.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.539 -0.726 . . . . 0.0 110.499 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.59 -47.12 8.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.993 -1.067 . . . . 0.0 108.888 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -90.28 8.4 33.49 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.685 -0.634 . . . . 0.0 110.235 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 53.6 67.29 1.03 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.088 -1.007 . . . . 0.0 110.587 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 42.0 mt -117.27 107.5 14.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.112 -0.992 . . . . 0.0 109.88 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.74 -19.49 17.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.0 110.135 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.53 -164.72 2.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.166 -0.959 . . . . 0.0 109.492 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 3.3 p30 -61.51 164.23 6.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.074 -1.016 . . . . 0.0 109.958 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -158.55 153.84 24.96 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.419 ' O ' ' CB ' ' A' ' 199' ' ' PHE . 92.8 t -129.59 98.73 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.301 -1.117 . . . . 0.0 109.982 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 94.6 t -119.74 158.54 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.275 -0.89 . . . . 0.0 110.111 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.464 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 6.8 tt -109.21 150.48 27.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.085 -1.009 . . . . 0.0 109.572 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.496 ' CD1' HG23 ' A' ' 133' ' ' VAL . 44.4 m-85 -124.63 123.86 40.96 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.938 -1.101 . . . . 0.0 110.511 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.31 174.23 10.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.44 -0.788 . . . . 0.0 110.105 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -94.37 -34.24 12.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.174 -0.954 . . . . 0.0 110.263 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.27 -170.58 2.68 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.388 -0.82 . . . . 0.0 110.948 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 54.68 -160.34 0.16 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.544 0.687 . . . . 0.0 110.5 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -55.02 -53.68 52.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.701 -0.625 . . . . 0.0 110.14 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 130.93 -24.79 4.23 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 24.4 mtm-85 -144.48 178.93 7.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.12 -1.223 . . . . 0.0 110.686 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . 0.464 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.0 OUTLIER -147.63 -155.11 0.6 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.343 -0.848 . . . . 0.0 109.687 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 197' ' ' ASN . 6.4 m-80 -169.44 85.48 0.14 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.486 -0.759 . . . . 0.0 110.187 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.419 ' CB ' ' O ' ' A' ' 186' ' ' VAL . 12.5 t80 -57.74 122.32 12.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.279 -0.888 . . . . 0.0 110.433 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -123.33 104.55 9.19 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.251 -0.905 . . . . 0.0 110.24 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 148.79 -167.0 29.31 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.79 134.87 49.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -1.128 . . . . 0.0 110.222 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 70.7 t -86.04 111.17 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.904 . . . . 0.0 110.348 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 68.8 p -149.18 153.96 38.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.472 -0.768 . . . . 0.0 110.097 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -48.06 -54.35 13.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.937 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -54.21 -41.36 68.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.447 -0.783 . . . . 0.0 110.484 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -71.44 -42.87 67.68 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.425 -0.797 . . . . 0.0 110.687 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 71.0 mt -59.7 -51.75 68.43 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.145 -0.972 . . . . 0.0 110.711 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.68 -33.33 60.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.171 -0.955 . . . . 0.0 110.337 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -71.57 -47.62 53.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.216 -0.928 . . . . 0.0 110.3 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -57.95 -55.18 38.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.286 -0.884 . . . . 0.0 110.315 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 162' ' ' ILE . 82.3 mt -54.42 -52.89 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.0 110.447 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.425 ' HA ' ' CD1' ' A' ' 217' ' ' LEU . 0.0 OUTLIER -48.21 -23.77 0.97 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.422 -0.799 . . . . 0.0 111.285 -179.391 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 214' ' ' HIS . 21.3 m170 -92.19 -20.74 20.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.928 -1.108 . . . . 0.0 110.733 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -93.19 -53.12 4.24 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.034 -1.041 . . . . 0.0 111.516 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -85.57 43.87 1.06 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.033 -1.042 . . . . 0.0 111.306 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.425 ' CD1' ' HA ' ' A' ' 213' ' ' LYS . 0.2 OUTLIER -154.92 57.11 1.58 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.124 -0.985 . . . . 0.0 110.286 179.776 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.77 80.63 1.44 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.557 1.293 . . . . 0.0 110.59 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 51.59 69.31 0.68 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.899 . . . . 0.0 110.639 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' A' ' 220' ' ' VAL . 34.1 m -91.24 82.5 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.255 -0.903 . . . . 0.0 110.21 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 8.9 pt -110.04 -178.59 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.169 -0.957 . . . . 0.0 110.407 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.02 65.99 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.267 -0.896 . . . . 0.0 110.352 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.64 -36.21 61.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.11 -0.994 . . . . 0.0 110.267 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 23.0 p -151.98 161.07 43.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.911 . . . . 0.0 110.121 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.33 -66.82 1.03 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 110.308 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -78.28 85.03 4.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.23 -0.919 . . . . 0.0 110.177 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 7.7 p -89.23 149.76 22.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.871 . . . . 0.0 110.208 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.274 -179.915 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.211 0.529 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -107.05 164.84 11.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.234 -0.916 . . . . 0.0 110.308 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.407 ' CG2' ' HA2' ' A' ' 168' ' ' GLY . 7.9 t -89.71 170.72 10.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.891 . . . . 0.0 110.257 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 96.1 m -109.14 104.4 13.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 0.0 110.192 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.5 mt -76.78 139.83 66.8 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.261 -0.899 . . . . 0.0 110.191 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 46.4 Cg_endo -72.15 -35.15 7.22 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 O-C-N 123.556 1.292 . . . . 0.0 110.41 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -165.86 -170.37 1.75 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.235 -0.915 . . . . 0.0 110.932 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.428 ' HA3' ' CD ' ' A' ' 178' ' ' LYS . . . -66.7 -38.03 92.87 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -51.64 -32.97 31.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.231 -1.158 . . . . 0.0 110.4 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.428 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -82.13 -32.21 30.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.896 . . . . 0.0 110.242 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.59 -25.51 26.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.997 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -89.93 -44.63 9.76 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.312 -0.867 . . . . 0.0 109.058 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.3 m -60.51 -28.31 68.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.225 -0.922 . . . . 0.0 109.675 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.8 tt -65.14 -61.74 1.96 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.354 -0.842 . . . . 0.0 109.967 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.438 ' CG2' ' CB ' ' A' ' 189' ' ' PHE . 86.8 t -50.95 -31.11 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.404 -0.81 . . . . 0.0 110.253 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.34 -12.65 61.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.294 -0.879 . . . . 0.0 110.673 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 35.8 m -75.83 -21.97 56.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.015 -1.053 . . . . 0.0 110.25 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.14 168.98 22.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.296 -0.878 . . . . 0.0 110.432 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -72.05 -19.51 61.82 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.396 -0.815 . . . . 0.0 109.724 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 26.0 m -129.9 141.83 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.279 -0.888 . . . . 0.0 110.311 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -175.85 137.36 0.34 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.252 -0.905 . . . . 0.0 110.086 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.477 HG13 ' CE1' ' A' ' 167' ' ' PHE . 14.5 p -123.57 150.49 27.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.18 -0.95 . . . . 0.0 110.351 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.9 mt -132.86 110.39 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.371 -0.831 . . . . 0.0 110.099 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.8 123.94 6.84 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.351 -1.499 . . . . 0.0 109.351 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.46 ' CD2' ' CD1' ' A' ' 181' ' ' LEU . 47.0 m-85 -93.9 80.56 4.15 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.229 -1.159 . . . . 0.0 110.141 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -105.8 140.99 37.99 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.059 -1.026 . . . . 0.0 111.128 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.441 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 61.3 pttt -91.48 -36.18 13.9 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.75 0.785 . . . . 0.0 109.165 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.441 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 4.7 m-20 -122.78 79.97 1.7 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.744 -0.598 . . . . 0.0 109.642 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.7 m -55.26 -19.37 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.239 -0.913 . . . . 0.0 110.708 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.79 11.81 8.49 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.092 -1.005 . . . . 0.0 110.9 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 91.9 p -87.81 -163.7 0.99 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.912 -1.118 . . . . 0.0 110.102 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -90.17 -42.43 11.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.328 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 55.5 m -62.03 -28.82 69.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 110.493 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.8 -25.66 40.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.183 -0.948 . . . . 0.0 110.265 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -63.16 -44.83 94.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 110.08 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -62.2 -40.78 97.22 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.275 -0.891 . . . . 0.0 110.214 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -50.86 -54.89 19.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.198 -0.939 . . . . 0.0 110.256 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 32.0 mt -52.4 -56.14 16.99 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.397 -0.815 . . . . 0.0 110.233 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -52.74 -49.85 64.61 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.322 -0.862 . . . . 0.0 110.257 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.81 -45.58 82.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.892 . . . . 0.0 110.114 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.426 ' HB3' ' CD2' ' A' ' 167' ' ' PHE . . . -64.71 -31.83 73.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 110.1 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.77 -31.26 72.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.359 -0.838 . . . . 0.0 110.157 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.23 -41.53 88.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 110.245 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 76.0 mt -99.72 140.33 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.929 . . . . 0.0 110.274 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -122.66 16.29 10.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.296 -0.877 . . . . 0.0 110.48 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -120.35 19.67 12.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.156 -0.965 . . . . 0.0 110.323 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.437 HG21 HD11 ' A' ' 165' ' ' ILE . 48.1 mm -128.98 132.58 24.46 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.17 -0.956 . . . . 0.0 110.014 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -72.72 70.83 3.4 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.515 1.271 . . . . 0.0 110.281 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.477 ' CE1' HG13 ' A' ' 140' ' ' VAL . 2.2 m-85 -65.54 125.46 25.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 109.954 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.407 ' HA2' ' CG2' ' A' ' 121' ' ' THR . . . -125.0 149.12 16.93 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 12.4 tt -146.76 144.77 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.286 -1.126 . . . . 0.0 110.318 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.2 t -158.15 156.97 31.85 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.022 0.915 . . . . 0.0 110.789 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.5 m -124.17 3.54 8.57 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -60.81 129.89 43.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 0.0 110.279 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 84.4 p -53.52 -29.21 35.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.217 -0.927 . . . . 0.0 110.045 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -56.55 -26.77 55.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.904 . . . . 0.0 109.684 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 42.9 t -86.93 -24.75 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.416 -0.803 . . . . 0.0 109.558 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 176' ' ' PHE . 10.6 m-85 -80.0 -47.9 14.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.295 -0.878 . . . . 0.0 109.403 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.81 -11.25 60.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.391 -0.818 . . . . 0.0 110.693 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.428 ' CD ' ' HA3' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -85.55 -50.54 7.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.061 -1.025 . . . . 0.0 109.697 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 179' ' ' TYR . 32.8 m-85 -89.35 13.62 13.12 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.485 -0.759 . . . . 0.0 110.196 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 49.81 65.3 1.45 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.123 -0.985 . . . . 0.0 110.482 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.46 ' CD1' ' CD2' ' A' ' 143' ' ' PHE . 79.4 mt -118.33 106.4 12.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 110.249 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.41 -30.27 70.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.061 -1.024 . . . . 0.0 109.825 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.17 -149.24 0.35 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.364 -0.835 . . . . 0.0 109.697 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -78.16 175.42 10.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.007 -1.058 . . . . 0.0 109.748 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -167.63 139.75 5.87 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.459 -1.353 . . . . 0.0 109.924 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.418 HG12 ' CD2' ' A' ' 208' ' ' LEU . 95.0 t -121.33 85.75 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.477 -1.014 . . . . 0.0 109.799 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.7 t -109.86 160.26 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.399 -0.813 . . . . 0.0 110.45 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.452 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 2.2 tt -113.15 147.05 38.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.19 -0.944 . . . . 0.0 109.447 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.438 ' CB ' ' CG2' ' A' ' 133' ' ' VAL . 45.2 m-85 -118.7 125.15 49.05 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.981 -1.075 . . . . 0.0 110.651 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -139.92 161.75 36.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.888 . . . . 0.0 109.907 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.0 mmpp? -87.24 -20.65 26.59 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.181 -0.949 . . . . 0.0 110.563 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.448 ' CZ ' ' HB2' ' A' ' 190' ' ' LYS . 3.4 p90 -90.87 179.73 5.7 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.292 -0.88 . . . . 0.0 110.823 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 44.55 -158.24 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.551 0.691 . . . . 0.0 111.035 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -50.99 -43.74 60.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.577 -0.702 . . . . 0.0 110.235 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 112.37 -21.07 20.22 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -137.9 174.26 10.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.099 -1.236 . . . . 0.0 110.735 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . 0.452 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.0 OUTLIER -144.54 -152.29 0.41 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.502 -0.749 . . . . 0.0 109.515 -179.827 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 27.8 p30 -173.77 76.06 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 0.0 110.548 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -54.01 125.47 18.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -0.938 . . . . 0.0 109.92 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -132.72 33.01 3.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.928 . . . . 0.0 110.096 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -117.96 175.74 15.84 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.77 122.74 10.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -1.157 . . . . 0.0 110.161 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 78.4 t -65.55 102.75 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.157 -0.965 . . . . 0.0 110.18 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 82.1 p -150.11 151.91 33.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.389 -0.819 . . . . 0.0 110.24 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 23.2 tttt -50.44 -50.1 53.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 0.0 110.491 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -53.28 -35.44 60.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.203 -0.936 . . . . 0.0 110.388 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -79.03 -46.76 17.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 0.0 110.147 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.418 ' CD2' HG12 ' A' ' 186' ' ' VAL . 82.8 mt -62.53 -31.02 71.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 110.263 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 19.0 mt -70.44 -26.67 63.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 110.187 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -86.9 -47.69 8.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.166 -0.959 . . . . 0.0 110.039 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -49.45 -50.15 42.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.317 -0.865 . . . . 0.0 110.213 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 28.2 mm -55.38 -69.26 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.533 -0.729 . . . . 0.0 110.185 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.34 -36.81 4.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.759 -0.588 . . . . 0.0 111.063 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -40.04 95.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.137 -0.977 . . . . 0.0 110.121 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -89.71 -45.04 9.6 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.3 -0.875 . . . . 0.0 110.451 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -41.18 -72.6 0.06 Allowed 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 1.2 mt -112.69 94.62 29.28 Favored Pre-proline 0 C--N 1.301 -1.521 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.662 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.29 110.95 3.2 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.578 1.304 . . . . 0.0 110.359 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -103.4 128.23 50.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.146 -0.971 . . . . 0.0 110.152 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 45.4 t -125.54 31.67 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.468 -0.77 . . . . 0.0 110.02 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 3.9 mp -126.73 146.71 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 110.392 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.52 -29.18 13.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.89 . . . . 0.0 110.268 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -55.79 -38.1 69.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.249 -0.907 . . . . 0.0 110.269 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.2 m 52.11 86.5 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.262 -0.899 . . . . 0.0 110.433 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -152.17 98.32 2.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 110.293 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -75.31 165.42 25.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.239 -0.913 . . . . 0.0 110.214 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 17.1 m -154.67 56.32 0.68 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.884 . . . . 0.0 110.233 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.114 -179.951 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.282 0.563 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -89.04 -174.04 4.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -0.885 . . . . 0.0 110.387 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 167' ' ' PHE . 7.9 m -104.68 116.7 32.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.336 -0.853 . . . . 0.0 109.706 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 79.8 m -69.17 142.01 54.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 0.0 110.191 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.7 mt -124.29 144.41 45.63 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 110.148 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.419 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 45.8 Cg_endo -72.48 -37.42 4.25 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.713 1.375 . . . . 0.0 110.372 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.41 ' HA ' ' CG2' ' A' ' 175' ' ' VAL . 0.9 OUTLIER -173.27 -170.46 0.62 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.205 -0.934 . . . . 0.0 110.687 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -57.8 -30.59 63.11 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -51.49 -35.55 40.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.257 -1.143 . . . . 0.0 110.498 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.419 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -82.85 -38.19 23.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.108 -0.995 . . . . 0.0 110.203 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.73 -24.86 24.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.108 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -77.66 -64.16 1.21 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 110.165 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.0 -23.14 12.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 110.139 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.1 tt -64.76 -59.48 4.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 0.0 109.946 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.482 HG23 ' CD2' ' A' ' 189' ' ' PHE . 56.4 t -50.49 -41.53 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.37 -0.831 . . . . 0.0 110.562 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -80.22 1.72 27.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.919 . . . . 0.0 110.931 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 17.5 t -82.71 -27.38 31.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.898 -1.126 . . . . 0.0 110.051 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.42 171.59 16.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.262 -0.899 . . . . 0.0 110.168 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.25 -20.15 63.94 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.335 -0.853 . . . . 0.0 109.583 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 18.2 m -135.13 149.15 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.259 -0.901 . . . . 0.0 110.169 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -173.64 138.06 0.65 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.233 -0.917 . . . . 0.0 110.232 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.442 ' CG1' ' HA ' ' A' ' 167' ' ' PHE . 7.2 p -125.99 153.67 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 121.072 -1.017 . . . . 0.0 110.365 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.422 ' O ' ' CE1' ' A' ' 143' ' ' PHE . 52.9 mt -137.96 114.5 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 109.905 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.56 136.69 18.33 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.478 ' CE2' HG13 ' A' ' 175' ' ' VAL . 67.6 m-85 -112.97 72.84 0.79 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.299 -1.118 . . . . 0.0 110.014 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.414 ' CE1' ' HB3' ' A' ' 184' ' ' ASP . 10.8 m-85 -102.35 142.7 33.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 111.051 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.88 -27.38 23.46 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.765 0.793 . . . . 0.0 109.494 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.7 p30 -126.24 69.63 1.22 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.694 -0.629 . . . . 0.0 109.616 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.441 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 31.4 m -50.41 -23.27 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.725 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.414 ' N ' HG21 ' A' ' 147' ' ' VAL . 0.7 OUTLIER -85.16 -9.47 57.81 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.115 -0.991 . . . . 0.0 111.296 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 52.7 p -69.95 -159.69 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.894 -1.129 . . . . 0.0 110.333 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -90.35 -45.74 8.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.386 -0.822 . . . . 0.0 110.267 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.9 p -52.32 -30.0 26.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.318 -0.864 . . . . 0.0 110.224 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -83.24 -34.99 25.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.372 -0.83 . . . . 0.0 110.174 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.2 mmtt -49.89 -40.1 41.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.309 -0.87 . . . . 0.0 110.357 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.8 -45.03 83.9 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.288 -0.882 . . . . 0.0 110.002 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -48.05 -55.4 10.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.273 -0.892 . . . . 0.0 110.597 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.0 mt -48.59 -54.6 13.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.277 -0.89 . . . . 0.0 110.667 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -52.23 -51.61 57.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.217 -0.927 . . . . 0.0 110.171 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.0 -39.37 85.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.145 -0.972 . . . . 0.0 109.824 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.39 -32.21 71.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.343 -0.848 . . . . 0.0 110.066 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -80.62 -29.48 36.8 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.314 -0.866 . . . . 0.0 110.277 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.16 -52.21 61.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -0.893 . . . . 0.0 110.365 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 19.0 tt -89.79 150.04 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 110.064 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -132.57 35.77 3.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.108 -0.995 . . . . 0.0 110.661 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -136.05 17.79 3.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.169 -0.957 . . . . 0.0 110.228 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.449 ' CG2' ' HD2' ' A' ' 166' ' ' PRO . 39.5 mm -135.17 146.5 58.53 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.238 -0.914 . . . . 0.0 109.923 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.449 ' HD2' ' CG2' ' A' ' 165' ' ' ILE . 47.6 Cg_endo -84.18 90.83 0.85 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.779 1.41 . . . . 0.0 110.248 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.442 ' HA ' ' CG1' ' A' ' 140' ' ' VAL . 3.9 m-85 -85.81 130.93 34.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.29 -0.882 . . . . 0.0 110.554 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -120.01 153.07 16.86 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 14.7 tt -147.42 144.36 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -1.125 . . . . 0.0 110.305 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.425 HG22 ' CG1' ' A' ' 175' ' ' VAL . 2.5 t -162.17 157.58 23.36 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.064 0.935 . . . . 0.0 110.693 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.1 1.58 9.2 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.411 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -59.41 121.52 11.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.115 -0.991 . . . . 0.0 110.259 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 79.4 p -51.65 -29.99 20.02 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.096 -1.002 . . . . 0.0 110.296 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -59.19 -35.6 73.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.136 -0.978 . . . . 0.0 109.842 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.478 HG13 ' CE2' ' A' ' 143' ' ' PHE . 60.3 t -76.85 -26.54 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.39 -0.819 . . . . 0.0 109.812 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -79.59 -53.26 7.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.395 -0.816 . . . . 0.0 109.865 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -25.45 63.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.955 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.43 -53.01 62.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 110.037 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -92.83 16.99 11.21 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.222 -0.923 . . . . 0.0 110.409 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 53.54 69.47 0.7 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.249 -0.907 . . . . 0.0 110.603 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 77.6 mt -115.02 123.01 47.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.212 -0.93 . . . . 0.0 110.024 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -86.39 -21.01 27.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.166 -0.959 . . . . 0.0 110.19 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -148.84 -166.14 2.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.329 -0.857 . . . . 0.0 109.914 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.414 ' HB3' ' CE1' ' A' ' 144' ' ' PHE . 71.2 m-20 -53.46 152.33 4.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.938 . . . . 0.0 109.997 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -157.77 131.74 2.96 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 72.8 t -115.21 85.69 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.356 -1.085 . . . . 0.0 109.619 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.437 HG11 ' N ' ' A' ' 188' ' ' LEU . 85.5 t -102.72 149.25 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.371 -0.831 . . . . 0.0 110.18 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.453 ' CD2' ' CD ' ' A' ' 190' ' ' LYS . 5.3 tt -105.53 150.59 25.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.122 -0.986 . . . . 0.0 109.627 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.482 ' CD2' HG23 ' A' ' 133' ' ' VAL . 46.1 m-85 -119.52 121.19 38.85 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.931 -1.106 . . . . 0.0 110.554 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.453 ' CD ' ' CD2' ' A' ' 188' ' ' LEU . 0.0 OUTLIER -136.33 160.76 37.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 0.0 110.171 179.815 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -85.53 -22.94 27.91 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.312 -0.868 . . . . 0.0 110.556 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.415 ' CZ ' ' HB2' ' A' ' 190' ' ' LYS . 2.5 p90 -90.45 -176.29 4.73 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.392 -0.817 . . . . 0.0 110.865 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 193' ' ' ASP . 0.7 OUTLIER 46.52 -157.97 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.481 0.658 . . . . 0.0 110.511 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -54.83 -54.96 35.53 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.475 -0.766 . . . . 0.0 110.094 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 134.47 -31.61 2.74 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -131.56 173.09 11.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.157 -1.202 . . . . 0.0 110.66 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . 0.45 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.6 m-80 -138.21 -151.51 0.39 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.515 -0.741 . . . . 0.0 109.673 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -175.6 77.0 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.356 -0.84 . . . . 0.0 110.051 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -48.41 142.84 5.3 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.329 -0.857 . . . . 0.0 110.915 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -150.29 134.98 17.48 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.31 -0.869 . . . . 0.0 109.649 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 125.08 -178.39 16.55 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -54.98 121.15 8.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -1.139 . . . . 0.0 110.232 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 75.8 t -74.91 102.57 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.191 -0.943 . . . . 0.0 110.212 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.3 p -136.6 145.26 44.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.367 -0.833 . . . . 0.0 109.705 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.08 -47.53 34.05 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.157 -0.964 . . . . 0.0 110.838 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -59.11 -40.49 85.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.24 -0.912 . . . . 0.0 110.458 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -67.68 -39.53 84.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.123 -0.986 . . . . 0.0 110.407 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.412 ' O ' ' CD1' ' A' ' 212' ' ' ILE . 36.7 mt -63.42 -52.63 60.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 110.41 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 6.9 mt -51.69 -24.39 5.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.172 -0.955 . . . . 0.0 110.407 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -82.4 -48.76 10.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.17 -0.956 . . . . 0.0 110.031 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -53.27 -57.22 11.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 110.474 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.412 ' CD1' ' O ' ' A' ' 208' ' ' LEU . 4.4 mt -49.79 -54.2 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.179 -0.95 . . . . 0.0 110.61 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.29 -29.45 9.74 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.286 -0.884 . . . . 0.0 110.66 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -81.45 -15.97 53.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.31 -0.869 . . . . 0.0 110.782 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -104.77 -35.52 7.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.08 -1.013 . . . . 0.0 110.849 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -78.42 -9.0 59.11 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.13 -0.982 . . . . 0.0 110.949 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 19.6 mt -136.99 69.28 57.52 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 120.973 -1.079 . . . . 0.0 110.466 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.26 93.34 0.98 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.615 1.324 . . . . 0.0 110.571 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 48.1 mt 42.63 76.58 0.07 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.677 -0.639 . . . . 0.0 111.379 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 96.6 t -92.71 131.03 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.335 -0.853 . . . . 0.0 110.256 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 36.1 pt -135.24 160.24 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.192 -0.942 . . . . 0.0 110.341 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -131.29 -77.15 0.52 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.882 . . . . 0.0 110.137 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -100.26 74.58 1.76 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 0.0 110.044 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 41.1 p -121.43 -177.11 3.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 110.317 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -122.69 154.82 37.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -0.892 . . . . 0.0 110.176 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -105.98 113.33 26.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.0 110.258 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 15.6 m -138.47 55.23 1.75 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.193 -0.942 . . . . 0.0 110.181 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.193 179.997 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.165 0.507 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -97.31 -169.04 1.79 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -0.881 . . . . 0.0 110.111 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.428 ' O ' ' CG2' ' A' ' 169' ' ' ILE . 7.2 t -145.31 152.32 39.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.154 -0.966 . . . . 0.0 110.048 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 169' ' ' ILE . 1.5 m -86.15 125.49 33.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.067 -1.02 . . . . 0.0 109.891 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.473 ' CD1' ' CG2' ' A' ' 141' ' ' ILE . 71.0 mt -88.47 130.87 43.94 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.88 -1.137 . . . . 0.0 110.297 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 48.6 Cg_endo -72.68 -51.21 0.19 Allowed 'Trans proline' 0 C--N 1.315 -1.207 0 O-C-N 123.422 1.222 . . . . 0.0 110.556 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -141.9 -169.43 2.91 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.247 -0.908 . . . . 0.0 110.778 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.94 -27.04 72.87 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.13 -27.48 65.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.205 -1.173 . . . . 0.0 110.237 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.435 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -90.05 -21.28 22.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.944 . . . . 0.0 110.227 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.95 -21.88 50.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 110.252 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -90.31 -40.75 11.93 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.27 -0.894 . . . . 0.0 109.623 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.83 -31.18 66.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.147 -0.971 . . . . 0.0 110.385 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.4 tp -68.69 -43.98 74.95 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.296 -0.877 . . . . 0.0 110.391 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.401 ' CG2' ' HB3' ' A' ' 189' ' ' PHE . 46.2 t -51.56 -53.99 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.339 -0.85 . . . . 0.0 110.519 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.27 -17.84 60.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.196 -0.94 . . . . 0.0 110.471 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.6 p -53.3 -38.6 63.27 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.126 -0.984 . . . . 0.0 110.331 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.3 p -147.27 -172.77 4.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.301 -0.875 . . . . 0.0 110.249 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.06 -45.8 47.17 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.341 -0.85 . . . . 0.0 110.362 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.4 m -116.76 151.63 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.938 . . . . 0.0 110.464 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.418 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -175.26 127.11 0.26 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.911 . . . . 0.0 109.934 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.83 153.03 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.102 -0.999 . . . . 0.0 110.02 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.473 ' CG2' ' CD1' ' A' ' 123' ' ' LEU . 56.8 mt -139.98 114.74 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.144 -0.972 . . . . 0.0 110.47 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.0 132.4 11.06 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 143' ' ' PHE . 18.7 m-85 -100.68 92.3 5.03 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.243 -1.151 . . . . 0.0 109.679 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -114.78 147.31 39.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.065 -1.022 . . . . 0.0 111.536 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.76 -26.85 19.28 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.57 0.7 . . . . 0.0 109.652 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.03 78.49 1.68 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.607 -0.683 . . . . 0.0 109.603 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.448 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 22.2 m -50.77 -23.2 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.289 -0.882 . . . . 0.0 110.69 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -72.5 -3.59 25.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.0 110.899 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 7.4 p -78.61 -164.73 0.61 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.851 -1.155 . . . . 0.0 110.161 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.2 -47.52 7.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.277 -0.889 . . . . 0.0 110.436 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.2 m -51.14 -27.34 8.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.24 -0.913 . . . . 0.0 110.541 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -81.16 -40.48 23.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.931 . . . . 0.0 110.026 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.8 mtpt -50.95 -47.07 61.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.354 -0.841 . . . . 0.0 110.317 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -53.63 -33.73 56.11 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.118 -0.989 . . . . 0.0 109.689 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.405 ' CE1' ' CG1' ' A' ' 186' ' ' VAL . 4.0 t80 -66.96 -56.65 9.26 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.405 -0.809 . . . . 0.0 109.935 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.3 mp -46.71 -55.98 6.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.535 -0.728 . . . . 0.0 110.649 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -51.17 -46.73 62.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.35 -0.844 . . . . 0.0 110.292 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.27 -45.59 83.88 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.944 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.79 -38.03 71.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.21 -0.931 . . . . 0.0 109.971 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.35 -28.2 59.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.193 -0.942 . . . . 0.0 110.051 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.21 -42.09 76.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.869 . . . . 0.0 110.201 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.434 ' CD1' HG13 ' A' ' 165' ' ' ILE . 5.5 tt -96.41 152.06 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 110.343 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -131.22 15.35 5.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.272 -0.892 . . . . 0.0 110.558 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -124.05 16.14 9.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.077 -1.014 . . . . 0.0 110.415 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.454 ' CG2' ' HD2' ' A' ' 166' ' ' PRO . 39.4 mm -132.49 146.27 60.77 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.176 -0.952 . . . . 0.0 110.016 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.454 ' HD2' ' CG2' ' A' ' 165' ' ' ILE . 46.4 Cg_endo -84.34 78.93 2.7 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.747 1.393 . . . . 0.0 110.495 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -77.29 135.03 38.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 0.0 110.221 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -136.06 153.62 21.55 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.428 ' CG2' ' O ' ' A' ' 121' ' ' THR . 1.7 tt -130.85 151.09 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.173 -1.192 . . . . 0.0 109.451 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.472 ' CG2' ' CG2' ' A' ' 175' ' ' VAL . 0.7 OUTLIER -119.36 144.61 46.78 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.1 -1.0 . . . . 0.0 110.94 -178.577 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.5 t -130.85 12.89 5.29 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.503 -0.748 . . . . 0.0 109.814 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.435 ' ND2' ' HB2' ' A' ' 174' ' ' ASP . 50.8 t30 -112.36 160.76 17.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.068 -1.02 . . . . 0.0 110.893 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 39.6 t -83.29 -28.43 29.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.448 -0.782 . . . . 0.0 109.966 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.435 ' HB2' ' ND2' ' A' ' 172' ' ' ASN . 1.7 m-20 -53.8 -32.01 51.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -0.947 . . . . 0.0 109.519 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.472 ' CG2' ' CG2' ' A' ' 170' ' ' THR . 38.4 t -76.89 -32.17 19.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -69.83 -59.13 3.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.477 -0.765 . . . . 0.0 109.215 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.6 m -53.18 -23.76 9.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.444 -0.785 . . . . 0.0 109.514 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.45 ' HD2' ' CE1' ' A' ' 179' ' ' TYR . 3.4 tmtt? -61.31 -61.38 2.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.525 -0.734 . . . . 0.0 110.067 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.45 ' CE1' ' HD2' ' A' ' 178' ' ' LYS . 94.1 m-85 -89.58 8.39 31.52 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.47 -0.769 . . . . 0.0 110.645 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.9 62.68 2.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.039 -1.038 . . . . 0.0 110.55 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 mt -92.83 134.41 35.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.282 -0.886 . . . . 0.0 110.11 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -73.67 -9.72 58.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 110.587 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -175.94 -165.91 0.17 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.022 -1.049 . . . . 0.0 110.067 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -70.01 152.33 44.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.21 -0.931 . . . . 0.0 110.015 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -177.21 166.86 37.71 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.405 ' CG1' ' CE1' ' A' ' 155' ' ' PHE . 18.6 m -126.22 121.88 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -1.154 . . . . 0.0 110.328 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 89.8 t -118.39 158.84 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.452 -0.78 . . . . 0.0 109.5 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.478 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 7.1 tt -107.27 140.2 40.54 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.826 -1.171 . . . . 0.0 109.8 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.401 ' HB3' ' CG2' ' A' ' 133' ' ' VAL . 49.6 m-85 -117.38 111.15 18.94 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.995 -1.066 . . . . 0.0 110.598 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.432 ' HD3' ' CD2' ' A' ' 188' ' ' LEU . 0.0 OUTLIER -124.22 -172.81 2.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.27 -0.894 . . . . 0.0 110.06 179.852 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 11.5 mttt -106.62 -26.04 11.53 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.128 -0.983 . . . . 0.0 110.526 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -90.83 -175.89 4.51 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.381 -0.824 . . . . 0.0 110.829 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 47.68 -159.06 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.54 -0.725 . . . . 0.0 110.887 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -52.98 -43.54 66.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.662 -0.649 . . . . 0.0 110.294 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 113.9 -27.08 9.43 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 11.8 mtm180 -135.76 163.98 28.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.184 -1.186 . . . . 0.0 110.386 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . 0.478 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 0.8 OUTLIER -136.49 -153.82 0.52 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.342 -0.848 . . . . 0.0 109.796 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -172.89 80.84 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.421 -0.799 . . . . 0.0 110.267 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -48.61 119.67 3.24 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.341 -0.849 . . . . 0.0 110.634 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -113.77 90.2 3.28 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.275 -0.89 . . . . 0.0 110.288 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 164.4 -165.44 37.3 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -74.85 117.88 17.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -1.145 . . . . 0.0 110.278 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 6.9 p -66.95 83.28 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 110.091 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 81.4 p -121.24 153.83 37.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 0.0 110.212 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -46.93 -55.18 8.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.372 -0.83 . . . . 0.0 110.543 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -54.74 -30.67 56.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.477 -0.764 . . . . 0.0 110.236 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -86.95 -23.96 24.92 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.228 -0.92 . . . . 0.0 110.248 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 18.7 mt -75.54 -53.46 8.6 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.295 -0.878 . . . . 0.0 110.541 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 4.7 mp -57.58 -20.57 33.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.88 . . . . 0.0 110.633 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -81.94 -53.74 5.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.152 -0.968 . . . . 0.0 110.15 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -60.69 -55.64 30.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.33 -0.856 . . . . 0.0 110.677 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 8.1 mt -51.57 -41.98 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.227 -0.921 . . . . 0.0 110.695 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -69.58 -15.01 63.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.122 -0.986 . . . . 0.0 110.836 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.64 -16.83 27.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.129 -0.982 . . . . 0.0 110.795 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -103.69 -39.63 6.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.995 -1.066 . . . . 0.0 110.862 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -64.29 -17.54 63.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.071 -1.018 . . . . 0.0 110.519 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.1 mt -119.32 93.49 47.21 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.131 -0.98 . . . . 0.0 110.248 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -72.95 171.1 18.18 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.657 1.346 . . . . 0.0 110.42 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.1 mt 50.57 96.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.227 -0.921 . . . . 0.0 110.584 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 43.1 t -105.03 42.24 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 110.112 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.417 ' CG2' ' O ' ' A' ' 221' ' ' ILE . 5.1 tt -155.73 101.22 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.237 -0.914 . . . . 0.0 110.363 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 51.88 -170.21 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.277 -0.889 . . . . 0.0 110.529 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 223' ' ' PHE . 28.9 p90 -146.56 -170.7 3.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.315 -0.865 . . . . 0.0 110.107 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 7.2 t -160.71 -176.84 5.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.202 -0.936 . . . . 0.0 110.305 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -117.24 -161.5 0.82 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.208 -0.932 . . . . 0.0 110.213 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 53.15 44.17 30.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.191 -0.943 . . . . 0.0 110.327 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.1 p -128.15 162.01 27.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 110.241 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.284 179.895 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.218 0.532 . . . . 0.0 110.084 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.4 145.9 28.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.181 -0.949 . . . . 0.0 110.197 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.6 t -92.14 164.71 13.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 110.305 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 91.1 m -101.91 100.72 11.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.928 . . . . 0.0 110.149 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.4 mt -75.93 131.68 75.71 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.284 -0.885 . . . . 0.0 110.081 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -72.34 -36.95 4.83 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 O-C-N 123.52 1.273 . . . . 0.0 110.485 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -163.26 -169.5 2.0 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 122.073 0.939 . . . . 0.0 111.262 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.67 -27.2 65.95 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -55.62 -29.26 58.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -1.141 . . . . 0.0 110.278 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.43 -26.02 20.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.278 -0.888 . . . . 0.0 110.171 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.09 68.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.866 . . . . 0.0 110.119 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -90.26 -40.97 11.84 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.23 -0.918 . . . . 0.0 109.188 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 41.4 m -66.71 -22.68 66.06 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.233 -0.917 . . . . 0.0 110.147 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.0 tp -69.95 -50.76 38.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 110.429 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 91.3 t -58.21 -37.82 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.298 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -77.86 -17.36 57.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 110.419 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.5 p -63.84 -44.76 92.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.035 -1.041 . . . . 0.0 110.303 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 89.4 p -138.2 -173.72 3.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -0.882 . . . . 0.0 110.26 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.19 -44.93 74.75 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.273 -0.892 . . . . 0.0 110.258 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.437 HG22 ' CD1' ' A' ' 165' ' ' ILE . 33.6 m -120.53 163.71 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.261 -0.899 . . . . 0.0 110.453 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -176.38 125.42 0.18 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.411 -0.806 . . . . 0.0 109.634 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.498 HG13 ' CE2' ' A' ' 167' ' ' PHE . 8.2 p -112.29 139.64 36.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.049 -1.032 . . . . 0.0 110.781 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.468 ' O ' ' CE1' ' A' ' 143' ' ' PHE . 3.4 mt -130.97 113.58 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.316 -0.865 . . . . 0.0 109.671 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.76 136.68 20.34 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.469 ' CE2' HG13 ' A' ' 175' ' ' VAL . 28.6 m-85 -105.87 69.07 0.8 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -1.134 . . . . 0.0 109.715 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -95.37 145.79 24.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 110.835 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.04 -27.15 24.95 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.51 -0.744 . . . . 0.0 109.724 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.85 78.56 1.75 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.528 -0.733 . . . . 0.0 109.677 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.444 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 22.6 m -51.12 -23.08 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.242 -0.911 . . . . 0.0 110.561 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -76.94 1.01 18.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.06 -1.025 . . . . 0.0 110.933 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 95.1 p -75.55 -164.89 0.37 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.835 -1.166 . . . . 0.0 110.31 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.63 -34.36 15.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.324 -0.86 . . . . 0.0 110.603 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 38.6 t -68.32 -27.88 66.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.263 -0.898 . . . . 0.0 110.269 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.444 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -78.47 -34.04 47.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.142 -0.973 . . . . 0.0 109.939 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -53.78 -52.06 61.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 0.0 110.065 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -54.94 -33.68 62.49 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.263 -0.898 . . . . 0.0 109.787 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.526 ' CE1' ' CG1' ' A' ' 186' ' ' VAL . 4.3 t80 -60.06 -57.4 13.01 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.457 -0.777 . . . . 0.0 109.903 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.6 mp -46.74 -57.04 5.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.508 -0.745 . . . . 0.0 110.591 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -52.36 -52.42 53.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.292 -0.88 . . . . 0.0 110.093 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.02 -38.64 79.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 0.0 109.907 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -68.11 -31.88 71.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -0.872 . . . . 0.0 109.813 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -80.82 -24.17 38.67 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.3 -0.875 . . . . 0.0 110.045 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.78 -40.34 94.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.31 -0.869 . . . . 0.0 110.072 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.5 tt -89.98 151.04 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.33 -0.856 . . . . 0.0 109.978 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.59 16.28 4.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.157 -0.965 . . . . 0.0 110.665 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -125.5 14.21 8.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.029 -1.045 . . . . 0.0 110.604 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.437 ' CD1' HG22 ' A' ' 138' ' ' VAL . 47.8 mm -134.91 135.53 23.35 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.018 -1.051 . . . . 0.0 110.15 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -78.3 81.62 2.68 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.543 1.286 . . . . 0.0 110.873 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.498 ' CE2' HG13 ' A' ' 140' ' ' VAL . 5.4 m-85 -71.14 145.19 49.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.133 -0.979 . . . . 0.0 109.857 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -137.65 159.29 24.88 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 4.4 tt -150.75 149.34 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -1.165 . . . . 0.0 110.304 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.3 t -168.82 157.12 8.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.188 -0.945 . . . . 0.0 111.005 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.4 ' HA ' ' CE1' ' A' ' 176' ' ' PHE . 87.6 p -125.54 2.84 7.62 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.378 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -61.73 124.2 20.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.171 -0.956 . . . . 0.0 110.248 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.06 -31.52 7.96 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.189 -0.945 . . . . 0.0 110.553 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.43 -41.78 66.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 110.023 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.469 HG13 ' CE2' ' A' ' 143' ' ' PHE . 61.3 t -75.54 -24.01 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.299 -0.875 . . . . 0.0 109.963 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.4 ' CE1' ' HA ' ' A' ' 171' ' ' SER . 10.6 m-85 -77.28 -54.29 6.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.891 . . . . 0.0 109.721 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.34 -21.86 60.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.367 -0.833 . . . . 0.0 110.085 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.95 -58.79 6.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 110.086 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.421 ' O ' ' HG2' ' A' ' 180' ' ' GLN . 96.3 m-85 -94.78 30.47 2.06 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.194 -0.941 . . . . 0.0 110.456 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 0.1 OUTLIER 29.57 62.02 0.16 Allowed 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 179.728 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.9 mt -89.61 128.24 36.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.073 -1.017 . . . . 0.0 109.962 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.29 -3.86 29.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.933 . . . . 0.0 110.74 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -174.77 -147.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.99 -1.069 . . . . 0.0 109.876 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -89.14 150.32 22.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.191 -0.943 . . . . 0.0 109.974 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -179.82 137.61 3.13 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.526 ' CG1' ' CE1' ' A' ' 155' ' ' PHE . 18.8 m -100.59 119.27 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.274 -1.133 . . . . 0.0 110.357 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 98.0 t -121.39 150.35 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.924 . . . . 0.0 110.029 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.479 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 6.3 tt -106.39 144.29 33.28 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.217 -0.927 . . . . 0.0 108.903 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -119.83 122.0 40.36 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.896 -1.127 . . . . 0.0 110.545 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.488 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -130.14 165.4 22.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 110.116 179.687 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.4 mmtm -84.32 -33.29 23.94 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.297 -0.877 . . . . 0.0 110.396 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.488 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.2 OUTLIER -90.9 -173.65 3.76 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.54 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 56.11 -153.86 0.34 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.23 -0.919 . . . . 0.0 110.076 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -71.93 -24.87 61.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.7 -0.625 . . . . 0.0 110.378 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 103.4 -30.53 10.16 Favored Glycine 0 N--CA 1.484 1.861 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -130.3 175.75 8.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.125 -1.221 . . . . 0.0 110.454 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 211' ' ' PHE . 1.7 m-80 -139.7 -44.64 0.44 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.322 -0.861 . . . . 0.0 110.227 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 63.66 87.42 0.11 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.346 -0.846 . . . . 0.0 109.839 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -57.85 134.74 56.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.448 -0.783 . . . . 0.0 110.472 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -130.63 114.84 15.93 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.273 -0.892 . . . . 0.0 109.831 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 139.95 -128.61 3.96 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -115.16 125.3 53.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.238 -1.154 . . . . 0.0 110.272 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 70.8 t -74.78 107.02 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 110.029 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 50.0 p -148.0 158.69 44.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.326 -0.859 . . . . 0.0 110.161 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -49.22 -52.61 25.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.216 -0.927 . . . . 0.0 110.804 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -57.56 -37.15 72.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.315 -0.866 . . . . 0.0 110.429 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 45.2 m-20 -81.65 -42.89 19.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.435 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.409 ' CD1' ' HA ' ' A' ' 155' ' ' PHE . 51.1 mt -57.86 -54.71 43.83 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.226 -0.921 . . . . 0.0 110.257 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.54 -28.19 43.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.148 -0.97 . . . . 0.0 109.748 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -77.05 -43.62 33.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.414 -0.804 . . . . 0.0 109.691 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.485 ' CZ ' ' HB3' ' A' ' 197' ' ' ASN . 8.4 t80 -62.01 -59.85 4.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.418 -0.801 . . . . 0.0 110.025 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 4.7 mt -50.1 -40.47 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.306 -0.871 . . . . 0.0 110.375 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -66.04 -32.3 73.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.332 -0.855 . . . . 0.0 110.07 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . 0.424 ' CD2' ' O ' ' A' ' 214' ' ' HIS . 16.8 t60 -90.44 8.38 34.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.275 -0.89 . . . . 0.0 110.716 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 6.8 m120 -95.55 -61.99 1.37 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.892 -1.13 . . . . 0.0 110.165 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -70.34 62.04 0.23 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.308 -0.87 . . . . 0.0 110.557 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 24.7 mt -138.06 97.39 9.82 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.881 . . . . 0.0 110.2 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.57 99.2 0.92 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.676 1.356 . . . . 0.0 110.326 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 37.4 mt -80.27 56.21 2.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.274 -0.891 . . . . 0.0 110.388 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 14.5 p -96.58 57.01 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.927 . . . . 0.0 110.258 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 3.1 mt -70.24 92.97 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 110.237 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -138.32 25.78 2.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.135 -0.978 . . . . 0.0 110.104 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -74.63 -175.54 2.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.396 -0.815 . . . . 0.0 110.267 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 5.9 t -106.28 33.67 3.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.218 -0.926 . . . . 0.0 110.249 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -104.1 -50.32 3.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.875 . . . . 0.0 110.13 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 53.01 58.27 5.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.29 -0.881 . . . . 0.0 110.329 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 57.6 m -137.92 -51.59 0.61 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 110.336 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.206 179.98 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.304 0.573 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.436 ' HB2' ' CA ' ' A' ' 168' ' ' GLY . . . -129.06 166.54 19.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.255 -0.903 . . . . 0.0 110.051 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.8 t -82.54 162.03 22.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.093 -1.004 . . . . 0.0 109.917 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.1 m -97.42 119.87 36.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.951 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 40.7 mt -105.92 134.13 19.88 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.95 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.22 -39.16 1.72 Allowed 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.466 1.245 . . . . 0.0 110.054 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.37 -169.31 2.72 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.056 0.932 . . . . 0.0 110.873 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -63.11 -21.92 64.4 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.77 -27.78 63.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -1.113 . . . . 0.0 110.389 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -88.45 -31.95 18.52 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.093 -1.004 . . . . 0.0 110.061 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -55.17 -22.02 15.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 109.913 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -89.17 -35.61 16.14 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.299 -0.875 . . . . 0.0 109.025 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.0 m -69.89 -23.94 63.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 109.967 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.2 tp -72.73 -48.64 36.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.337 -0.852 . . . . 0.0 110.072 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.431 ' CG2' ' HB3' ' A' ' 189' ' ' PHE . 46.9 t -52.74 -43.77 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.338 -0.851 . . . . 0.0 110.31 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -78.84 -20.82 48.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.238 -0.914 . . . . 0.0 110.429 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 25.3 t -56.72 -56.36 22.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -0.927 . . . . 0.0 110.165 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 86.8 p -128.97 165.75 20.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 0.0 110.301 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.418 ' CG ' ' N ' ' A' ' 138' ' ' VAL . 18.3 pt-20 -57.94 -40.77 81.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.27 -0.894 . . . . 0.0 110.098 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.418 ' N ' ' CG ' ' A' ' 137' ' ' GLU . 74.6 t -124.01 144.8 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.405 -0.809 . . . . 0.0 110.154 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -170.47 144.55 2.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.328 -0.858 . . . . 0.0 109.709 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.482 HG12 ' CE2' ' A' ' 167' ' ' PHE . 7.3 p -129.35 153.05 38.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 121.011 -1.056 . . . . 0.0 110.252 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.427 ' O ' ' CE1' ' A' ' 143' ' ' PHE . 20.5 mt -131.41 123.07 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.88 . . . . 0.0 109.9 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -85.81 129.01 9.09 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' A' ' 143' ' ' PHE . 28.8 m-85 -101.74 78.98 1.88 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -1.159 . . . . 0.0 109.898 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -106.17 146.4 30.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.199 -0.938 . . . . 0.0 111.051 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.11 -27.12 18.77 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.617 0.722 . . . . 0.0 109.522 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.55 73.72 1.55 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.664 -0.647 . . . . 0.0 109.405 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.452 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 21.7 m -49.3 -23.35 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.397 -0.815 . . . . 0.0 111.02 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -81.57 7.12 12.91 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.965 -1.084 . . . . 0.0 111.255 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.6 p -78.52 -164.37 0.56 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.864 -1.148 . . . . 0.0 110.506 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -91.04 -24.41 20.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.521 -0.737 . . . . 0.0 110.282 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.64 -30.66 46.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.29 -0.881 . . . . 0.0 109.974 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.452 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -80.26 -19.96 45.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 0.0 110.196 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -38.83 92.72 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.309 -0.869 . . . . 0.0 109.925 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -69.97 -42.14 73.54 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.396 -0.815 . . . . 0.0 110.027 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.408 ' HA ' ' CD1' ' A' ' 208' ' ' LEU . 4.3 t80 -50.86 -57.75 7.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.359 -0.838 . . . . 0.0 110.337 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 74.9 mt -57.43 -49.7 75.39 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.435 -0.79 . . . . 0.0 110.095 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -52.33 -52.98 50.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.511 -0.743 . . . . 0.0 110.304 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -66.64 -46.0 77.2 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.192 -0.942 . . . . 0.0 110.173 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -53.15 -32.41 47.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.209 -0.932 . . . . 0.0 110.223 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -66.84 -38.42 86.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 110.2 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.81 -40.79 92.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.263 -0.898 . . . . 0.0 110.162 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 72.3 mt -91.53 92.53 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.292 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -90.62 -27.83 18.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -0.872 . . . . 0.0 110.308 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 164' ' ' ASP . 16.2 p-10 -57.79 -26.62 62.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.915 . . . . 0.0 110.221 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.405 HD11 HG22 ' A' ' 165' ' ' ILE . 45.9 mm -104.75 127.24 29.26 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.175 -0.953 . . . . 0.0 109.953 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -78.24 85.84 1.76 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.448 1.236 . . . . 0.0 110.675 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.482 ' CE2' HG12 ' A' ' 140' ' ' VAL . 3.8 m-85 -66.16 174.88 2.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.087 -1.008 . . . . 0.0 109.996 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.436 ' CA ' ' HB2' ' A' ' 120' ' ' ALA . . . -150.11 151.37 23.45 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 6.3 tt -150.47 142.46 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.939 -1.33 . . . . 0.0 110.539 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.2 t -160.78 155.67 24.08 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.013 0.911 . . . . 0.0 110.759 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 24.5 p -115.57 -1.9 12.64 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.589 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.416 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 20.4 t30 -52.65 164.24 0.37 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.195 -0.941 . . . . 0.0 110.161 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 26.2 p -91.44 -33.41 15.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.221 -0.924 . . . . 0.0 109.958 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -57.29 -27.4 62.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.229 -0.919 . . . . 0.0 109.826 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.477 HG13 ' CD2' ' A' ' 143' ' ' PHE . 47.6 t -78.08 -29.14 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.336 -0.852 . . . . 0.0 109.725 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.425 ' N ' ' CD1' ' A' ' 176' ' ' PHE . 16.7 m-85 -85.27 -50.2 7.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.4 -0.812 . . . . 0.0 109.685 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 32.6 m -62.34 -18.05 60.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.433 -0.792 . . . . 0.0 110.361 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -74.61 -50.59 17.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.16 -0.963 . . . . 0.0 109.922 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -89.55 14.46 11.46 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.147 -0.97 . . . . 0.0 110.37 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 49.11 65.01 1.5 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.214 -0.928 . . . . 0.0 110.848 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 14.2 mt -112.75 100.95 9.08 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.061 -1.024 . . . . 0.0 109.794 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -57.96 -19.0 27.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.032 -1.042 . . . . 0.0 110.089 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt -147.38 -165.2 2.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -0.959 . . . . 0.0 109.661 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -60.31 156.81 14.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.089 -1.007 . . . . 0.0 109.855 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -159.98 118.83 0.85 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.433 HG23 ' CG2' ' A' ' 203' ' ' VAL . 79.7 t -99.21 95.75 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -1.128 . . . . 0.0 110.111 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 94.9 t -113.71 152.66 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.299 -0.875 . . . . 0.0 109.862 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.453 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 7.7 tt -108.27 155.45 20.47 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.052 -1.03 . . . . 0.0 109.868 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.431 ' HB3' ' CG2' ' A' ' 133' ' ' VAL . 60.5 m-85 -125.0 126.38 45.35 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.943 -1.098 . . . . 0.0 110.466 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.426 ' HD2' ' CD2' ' A' ' 188' ' ' LEU . 0.0 OUTLIER -134.8 179.18 6.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.379 -0.826 . . . . 0.0 110.074 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -102.52 -29.57 11.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.171 -0.955 . . . . 0.0 110.311 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -90.96 -174.39 3.99 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.446 -0.784 . . . . 0.0 110.811 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 48.0 -159.11 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.643 0.735 . . . . 0.0 110.863 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -50.94 -51.8 48.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.568 -0.707 . . . . 0.0 110.359 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 123.47 -21.58 7.18 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -141.42 177.51 8.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -1.186 . . . . 0.0 110.399 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . 0.453 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.1 m-80 -141.89 -152.73 0.42 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.364 -0.835 . . . . 0.0 109.527 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -175.43 79.1 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.274 -0.891 . . . . 0.0 110.496 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -64.34 117.54 7.38 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.384 -0.822 . . . . 0.0 109.88 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -122.64 28.88 7.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 110.571 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -110.92 -123.1 4.4 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 204' ' ' THR . 6.4 mt-10 -119.07 100.45 7.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.292 -1.122 . . . . 0.0 109.885 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.433 ' CG2' HG23 ' A' ' 186' ' ' VAL . 7.3 p -51.17 93.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 110.699 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.42 ' N ' ' O ' ' A' ' 202' ' ' GLU . 21.9 p -136.03 160.88 37.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 109.995 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.415 ' O ' ' CD1' ' A' ' 209' ' ' LEU . 0.0 OUTLIER -50.46 -50.21 53.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.292 -0.88 . . . . 0.0 110.662 -179.823 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' A' ' 207' ' ' ASN . 16.6 pt-20 -61.89 -41.22 97.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.24 -0.912 . . . . 0.0 110.552 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.408 ' N ' ' HG3' ' A' ' 206' ' ' GLU . 70.2 m-20 -73.24 -40.08 64.95 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.142 -0.974 . . . . 0.0 110.113 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.408 ' CD1' ' HA ' ' A' ' 155' ' ' PHE . 54.7 mt -61.9 -45.95 91.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.868 . . . . 0.0 110.066 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.415 ' CD1' ' O ' ' A' ' 205' ' ' LYS . 12.0 mt -59.45 -25.68 64.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.861 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -85.05 -46.11 11.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.292 -0.88 . . . . 0.0 109.901 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.422 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 22.3 t80 -48.22 -53.27 17.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.388 -0.82 . . . . 0.0 110.169 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.429 HG23 ' NE2' ' A' ' 216' ' ' GLN . 21.4 mm -48.92 -71.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.409 -0.807 . . . . 0.0 110.085 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -46.2 -34.38 4.29 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.71 -0.619 . . . . 0.0 110.965 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -71.64 -27.91 63.41 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.216 -0.927 . . . . 0.0 110.587 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 79.7 m-20 -97.84 -51.36 4.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.082 -1.012 . . . . 0.0 110.988 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . 0.429 ' NE2' HG23 ' A' ' 212' ' ' ILE . 3.5 pt20 -52.39 -24.05 7.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.042 -1.036 . . . . 0.0 110.53 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 16.5 mt -129.94 101.97 17.91 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.316 -0.865 . . . . 0.0 110.286 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.46 134.61 24.8 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.532 1.28 . . . . 0.0 110.494 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.7 48.43 1.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.272 -0.893 . . . . 0.0 110.308 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 59.4 t -120.93 31.46 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 110.102 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -172.01 124.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.4 -0.813 . . . . 0.0 109.967 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -127.04 116.53 20.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.23 -0.918 . . . . 0.0 110.281 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -145.09 37.2 1.14 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.196 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 6.6 p -121.81 37.54 4.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.23 -0.919 . . . . 0.0 110.103 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -94.02 126.25 39.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.184 -0.947 . . . . 0.0 110.318 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 52.55 46.27 27.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 110.36 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 29.3 m -156.98 170.8 21.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.311 -0.868 . . . . 0.0 110.232 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.251 -179.983 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.252 0.548 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -92.34 -178.94 5.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.9 . . . . 0.0 110.338 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.6 t -118.61 161.14 20.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 110.219 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.8 m -99.85 110.16 22.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 0.0 109.835 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.426 ' CD1' HG22 ' A' ' 141' ' ' ILE . 34.9 mt -87.66 113.01 52.43 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.231 -0.918 . . . . 0.0 110.072 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.17 -24.13 23.79 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.491 1.258 . . . . 0.0 110.373 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -173.77 -169.88 0.53 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.307 -0.871 . . . . 0.0 110.541 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -59.24 -25.24 59.89 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -53.5 -34.24 57.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -1.132 . . . . 0.0 110.222 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.31 -36.27 14.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 110.149 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.13 -19.94 62.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 110.271 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -88.5 -60.03 2.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 0.0 110.262 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.5 t -55.27 -21.56 14.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.198 -0.939 . . . . 0.0 110.243 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.423 HD22 ' CG1' ' A' ' 141' ' ' ILE . 18.0 tp -69.92 -48.69 57.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 0.0 110.035 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.424 ' CG2' ' HB3' ' A' ' 189' ' ' PHE . 60.7 t -65.46 -37.82 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.834 . . . . 0.0 110.398 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -83.75 5.85 23.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.114 -0.991 . . . . 0.0 110.816 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.9 t -90.19 -27.83 19.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.95 -1.094 . . . . 0.0 110.353 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.53 165.06 33.34 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.208 -0.933 . . . . 0.0 110.523 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -65.17 -19.03 65.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.395 -0.816 . . . . 0.0 109.859 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 43.4 t -136.96 149.71 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.9 . . . . 0.0 110.201 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.431 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -175.32 142.61 0.61 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.379 -0.826 . . . . 0.0 109.551 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.415 HG12 ' CD1' ' A' ' 212' ' ' ILE . 3.6 m -124.15 158.38 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 118.979 -1.089 . . . . 0.0 111.07 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.426 HG22 ' CD1' ' A' ' 123' ' ' LEU . 60.5 mt -148.22 104.31 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.651 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.82 128.04 9.9 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.472 ' CE2' HG13 ' A' ' 175' ' ' VAL . 37.8 m-85 -98.8 84.56 3.13 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.139 -1.212 . . . . 0.0 109.488 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.476 ' CE1' ' CB ' ' A' ' 151' ' ' SER . 16.4 m-85 -105.85 141.35 37.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.087 -1.008 . . . . 0.0 111.361 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.61 -28.94 26.18 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.959 -0.696 . . . . 0.0 110.015 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.04 87.0 2.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.367 -0.833 . . . . 0.0 109.895 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 98.0 t -60.18 -21.41 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.39 -0.819 . . . . 0.0 110.713 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -82.26 1.01 38.73 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.163 -0.961 . . . . 0.0 111.06 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 82.4 p -81.17 -168.08 1.69 Allowed 'General case' 0 C--N 1.307 -1.271 0 O-C-N 120.921 -1.112 . . . . 0.0 110.379 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -90.22 -18.08 26.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.423 -0.798 . . . . 0.0 110.168 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.476 ' CB ' ' CE1' ' A' ' 144' ' ' PHE . 1.4 m -71.4 -33.15 69.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.193 -0.942 . . . . 0.0 110.235 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.36 -37.64 27.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.141 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -55.92 -40.05 72.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.894 . . . . 0.0 110.094 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -64.19 -42.47 96.64 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.271 -0.893 . . . . 0.0 110.054 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -51.44 -55.45 18.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.362 -0.836 . . . . 0.0 110.18 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 25.8 mt -54.58 -55.18 32.08 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.298 -0.876 . . . . 0.0 110.244 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -51.31 -49.65 60.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.329 -0.857 . . . . 0.0 110.129 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.52 -36.99 85.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 109.78 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.424 ' O ' ' CE2' ' A' ' 167' ' ' PHE . . . -68.84 -29.61 67.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.301 -0.874 . . . . 0.0 109.947 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -67.7 -39.86 84.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.342 -0.849 . . . . 0.0 110.12 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.68 -50.35 66.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.863 . . . . 0.0 110.034 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.427 ' CG2' ' OD1' ' A' ' 164' ' ' ASP . 96.7 mt -97.38 163.4 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 109.806 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -136.73 -40.61 0.62 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.118 -0.989 . . . . 0.0 110.548 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.427 ' OD1' ' CG2' ' A' ' 162' ' ' ILE . 26.3 p-10 -55.29 -24.75 30.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 110.593 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.478 ' HB ' ' CE1' ' A' ' 167' ' ' PHE . 31.3 mm -92.59 129.78 39.34 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.073 -1.017 . . . . 0.0 110.226 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.431 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 55.2 Cg_endo -79.06 117.67 3.91 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 123.466 1.245 . . . . 0.0 110.274 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.478 ' CE1' ' HB ' ' A' ' 165' ' ' ILE . 6.1 m-85 -107.32 124.3 49.61 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.089 -1.007 . . . . 0.0 109.427 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -120.74 154.95 16.33 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 6.7 tt -150.43 140.94 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.124 -1.221 . . . . 0.0 110.78 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.8 t -155.12 156.93 36.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.307 -0.871 . . . . 0.0 110.414 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.1 t -119.87 1.35 10.98 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.468 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 41.4 p30 -67.93 151.29 47.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.117 -0.989 . . . . 0.0 109.985 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.8 p -78.44 -18.7 54.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.188 -0.945 . . . . 0.0 110.66 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.01 -39.14 84.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.933 . . . . 0.0 110.254 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.472 HG13 ' CE2' ' A' ' 143' ' ' PHE . 46.4 t -79.61 -24.45 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -0.956 . . . . 0.0 109.922 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.468 ' CD1' ' O ' ' A' ' 172' ' ' ASN . 9.0 m-85 -75.44 -50.59 15.33 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.32 -0.863 . . . . 0.0 109.878 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.18 -19.19 64.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.473 -0.767 . . . . 0.0 110.45 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.66 -56.47 17.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.971 . . . . 0.0 110.282 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.431 ' O ' ' CD1' ' A' ' 181' ' ' LEU . 92.3 m-85 -92.83 26.28 2.81 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.18 -0.95 . . . . 0.0 110.374 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 179' ' ' TYR . 2.2 mm-40 55.97 67.06 1.06 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.498 -0.751 . . . . 0.0 110.712 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.431 ' CD1' ' O ' ' A' ' 179' ' ' TYR . 6.6 mp -124.7 102.98 7.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.555 -0.715 . . . . 0.0 110.227 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.74 14.7 9.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -0.935 . . . . 0.0 110.147 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 6.2 mtmm -162.49 -165.3 1.15 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.276 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 10.6 p-10 -82.86 157.87 22.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.949 -1.094 . . . . 0.0 110.138 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 179.14 121.71 0.73 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.418 ' O ' ' CB ' ' A' ' 199' ' ' PHE . 94.7 t -92.8 121.62 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.329 -1.101 . . . . 0.0 110.049 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.433 HG11 ' N ' ' A' ' 188' ' ' LEU . 90.6 t -128.97 149.77 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 0.0 109.83 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.491 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 8.5 tt -104.61 131.5 51.96 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.995 -1.066 . . . . 0.0 108.458 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.424 ' HB3' ' CG2' ' A' ' 133' ' ' VAL . 57.3 m-85 -102.95 121.64 42.95 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.899 -1.126 . . . . 0.0 110.902 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.5 168.02 18.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.545 -0.722 . . . . 0.0 110.213 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -89.58 -24.9 21.6 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.293 -0.879 . . . . 0.0 110.579 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -90.71 -175.45 4.4 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.43 -0.794 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 47.08 -159.24 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.53 -0.732 . . . . 0.0 110.724 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -59.67 -44.25 93.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.642 -0.661 . . . . 0.0 110.265 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 128.99 -31.5 3.48 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.08 171.48 11.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -1.21 . . . . 0.0 110.532 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . 0.491 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 3.5 m-80 -131.66 -35.12 1.3 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.317 -0.864 . . . . 0.0 111.188 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 63.71 85.45 0.13 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.152 -0.968 . . . . 0.0 110.015 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.432 ' C ' ' CD1' ' A' ' 199' ' ' PHE . 9.4 t80 -62.16 118.73 7.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.398 -0.814 . . . . 0.0 110.161 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -113.63 101.5 9.38 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.264 -0.897 . . . . 0.0 110.511 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 157.13 -140.11 6.91 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -107.48 113.47 26.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.309 -1.113 . . . . 0.0 110.102 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.405 ' O ' ' CG1' ' A' ' 203' ' ' VAL . 7.5 p -64.29 110.74 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 110.218 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 70.5 p -143.13 157.14 44.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.167 -0.958 . . . . 0.0 110.376 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -51.1 -49.59 60.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.322 -0.861 . . . . 0.0 110.397 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -61.13 -34.67 75.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 110.097 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -78.72 -47.69 16.39 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.207 -0.933 . . . . 0.0 110.084 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 80.7 mt -52.78 -37.95 60.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.196 -0.94 . . . . 0.0 110.054 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.08 -23.07 62.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.29 -0.881 . . . . 0.0 109.924 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.66 -45.81 9.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.362 -0.836 . . . . 0.0 109.88 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.431 ' CE1' ' HA ' ' A' ' 199' ' ' PHE . 25.6 t80 -49.66 -50.15 44.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.213 -0.929 . . . . 0.0 109.822 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.422 HD11 HG21 ' A' ' 212' ' ' ILE . 23.5 mm -50.72 -73.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.467 -0.771 . . . . 0.0 110.296 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -46.21 -25.87 0.68 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.705 -0.622 . . . . 0.0 111.114 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -76.51 -23.19 53.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 110.568 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.421 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 78.2 m-20 -101.42 -57.62 2.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.182 -0.949 . . . . 0.0 110.866 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -51.52 178.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.1 -1.0 . . . . 0.0 110.588 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 81.4 mt 53.32 72.88 1.03 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 110.428 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.58 168.45 24.38 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.684 1.36 . . . . 0.0 110.282 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.37 -168.76 1.35 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -0.937 . . . . 0.0 110.233 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 95.1 t -105.12 134.16 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.931 . . . . 0.0 110.189 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 73.1 mt -105.19 77.45 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.907 . . . . 0.0 110.173 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.92 32.77 3.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 0.0 110.192 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -152.62 145.0 24.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.906 . . . . 0.0 110.213 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 18.1 m -135.31 123.23 22.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 109.969 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -89.46 -179.16 5.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.318 -0.864 . . . . 0.0 110.383 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.35 -45.65 5.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.329 -0.857 . . . . 0.0 110.107 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.8 p -128.17 99.89 5.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.298 -0.877 . . . . 0.0 110.216 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.102 -0.952 . . . . 0.0 110.299 179.933 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.293 0.568 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.419 ' CA ' ' O ' ' A' ' 167' ' ' PHE . . . -59.44 -178.27 0.06 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.159 -0.963 . . . . 0.0 110.112 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.9 t -108.49 167.65 9.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.106 -0.996 . . . . 0.0 110.246 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.3 m -110.48 109.25 19.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 110.115 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.9 mt -87.14 126.4 62.93 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.334 -0.853 . . . . 0.0 110.097 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.426 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 46.0 Cg_endo -71.73 -22.45 23.89 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.457 1.241 . . . . 0.0 110.462 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -174.31 -170.64 0.54 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.183 -0.948 . . . . 0.0 110.938 179.885 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.82 -34.79 90.79 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -51.63 -24.93 6.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -1.159 . . . . 0.0 110.343 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.426 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -90.13 -27.14 19.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.941 . . . . 0.0 110.191 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.17 -18.53 65.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 110.266 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -89.75 -48.7 7.09 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.158 -0.964 . . . . 0.0 109.21 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 32.4 p -63.35 -19.75 64.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.28 -0.888 . . . . 0.0 110.253 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.411 HD11 ' CG1' ' A' ' 141' ' ' ILE . 1.6 tt -73.83 -58.96 2.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.209 -0.932 . . . . 0.0 110.262 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.49 HG23 ' CD2' ' A' ' 189' ' ' PHE . 48.1 t -50.03 -25.34 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.268 -0.895 . . . . 0.0 110.581 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.96 -20.11 23.7 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.253 -0.905 . . . . 0.0 109.846 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.7 m -54.45 -50.67 67.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.162 -0.961 . . . . 0.0 110.362 -179.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.4 p -130.87 -173.52 3.11 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.12 -0.987 . . . . 0.0 110.487 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.01 -45.12 28.39 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.22 -0.925 . . . . 0.0 109.988 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.3 m -115.22 130.07 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.353 -0.842 . . . . 0.0 109.97 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -152.76 148.22 26.98 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.123 -0.986 . . . . 0.0 110.015 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.499 ' CG1' ' CD1' ' A' ' 167' ' ' PHE . 7.1 p -130.9 149.97 34.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.104 -0.998 . . . . 0.0 110.437 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.411 ' CG1' HD11 ' A' ' 132' ' ' LEU . 45.7 mt -133.9 124.13 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.424 -0.797 . . . . 0.0 109.682 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -90.74 131.75 10.93 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 143' ' ' PHE . 22.0 m-85 -103.95 69.69 0.96 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -1.149 . . . . 0.0 109.643 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -94.9 139.02 31.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.145 -0.972 . . . . 0.0 110.769 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -76.2 -27.84 57.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.427 -0.796 . . . . 0.0 110.136 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -126.89 88.46 2.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 0.0 109.908 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 45.1 t -55.55 -21.03 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.449 -0.782 . . . . 0.0 110.36 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -91.79 18.39 7.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -0.897 . . . . 0.0 110.622 -179.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 86.8 p -87.2 -164.64 1.12 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.948 . . . . 0.0 110.169 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -90.13 -34.09 16.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.348 -0.845 . . . . 0.0 110.141 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 49.3 m -63.81 -31.7 72.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.3 -0.875 . . . . 0.0 110.245 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.55 -28.58 59.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.824 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -58.66 -52.0 67.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.418 -0.801 . . . . 0.0 110.184 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -61.22 -39.73 91.36 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.182 -0.949 . . . . 0.0 110.083 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -47.62 -54.9 10.56 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.304 -0.873 . . . . 0.0 110.606 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 17.2 mt -55.57 -53.35 57.54 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.414 -0.804 . . . . 0.0 110.33 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -49.78 -50.22 45.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.325 -0.859 . . . . 0.0 110.464 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -64.24 -25.03 67.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.18 -0.95 . . . . 0.0 110.052 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.503 ' CB ' ' CD2' ' A' ' 167' ' ' PHE . . . -76.1 -41.06 51.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.309 -0.87 . . . . 0.0 110.324 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -76.02 -9.64 58.78 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.291 -0.88 . . . . 0.0 110.909 -179.69 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -118.0 28.12 8.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.971 -1.081 . . . . 0.0 110.565 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.443 HG12 ' CG1' ' A' ' 165' ' ' ILE . 5.7 tt -113.44 176.76 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.077 -1.014 . . . . 0.0 110.25 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.48 63.36 0.16 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.896 . . . . 0.0 110.511 -179.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 40.92 50.91 3.16 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.535 0.683 . . . . 0.0 111.628 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.494 ' CG2' ' HD2' ' A' ' 166' ' ' PRO . 42.7 mm -88.77 149.2 43.33 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.472 -0.767 . . . . 0.0 109.097 179.044 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.494 ' HD2' ' CG2' ' A' ' 165' ' ' ILE . 43.8 Cg_endo -81.43 99.75 1.09 Allowed 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.555 1.292 . . . . 0.0 110.772 -179.063 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.503 ' CD2' ' CB ' ' A' ' 159' ' ' ALA . 3.2 m-85 -92.12 131.05 37.68 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.524 -0.735 . . . . 0.0 110.109 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -121.61 144.53 16.52 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.979 -1.649 . . . . 0.0 108.979 179.244 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 13.5 tt -140.75 135.36 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.268 -1.136 . . . . 0.0 110.86 -179.357 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.1 t -151.82 155.85 39.01 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.999 0.904 . . . . 0.0 110.386 179.189 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.9 t -125.3 4.62 7.76 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -65.72 132.32 48.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.223 -0.923 . . . . 0.0 110.409 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 88.6 p -54.26 -29.04 45.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.163 -0.961 . . . . 0.0 110.047 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -54.49 -35.48 63.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.939 . . . . 0.0 109.867 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 61.4 t -78.71 -25.67 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.409 -0.807 . . . . 0.0 109.728 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.417 ' O ' ' N ' ' A' ' 180' ' ' GLN . 15.9 m-85 -79.13 -50.1 11.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 109.758 179.638 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 75.1 m -60.68 -19.19 57.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.863 . . . . 0.0 110.116 179.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.419 ' HD3' ' CE1' ' A' ' 179' ' ' TYR . 7.2 tttp -74.43 -51.46 14.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.132 -0.98 . . . . 0.0 109.653 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.419 ' CE1' ' HD3' ' A' ' 178' ' ' LYS . 78.3 m-85 -92.7 -5.34 51.53 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.436 -0.79 . . . . 0.0 110.427 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 176' ' ' PHE . 0.2 OUTLIER 56.77 63.61 1.89 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.128 -0.982 . . . . 0.0 111.079 179.457 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.0 mt -102.52 119.53 38.97 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.12 -0.988 . . . . 0.0 109.679 178.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.412 ' O ' ' CG ' ' A' ' 183' ' ' LYS . 5.8 t0 -65.2 -11.78 44.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 110.333 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.412 ' CG ' ' O ' ' A' ' 182' ' ' ASP . 0.5 OUTLIER -156.42 -165.78 1.98 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.175 -0.953 . . . . 0.0 109.545 -179.977 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -62.22 164.17 7.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.062 -1.024 . . . . 0.0 109.44 179.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -161.4 150.05 19.36 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.231 -179.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 77.3 t -132.09 84.95 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.49 -1.006 . . . . 0.0 109.506 179.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 47.6 t -101.31 159.8 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.336 -0.853 . . . . 0.0 110.472 -179.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.439 ' O ' ' ND2' ' A' ' 197' ' ' ASN . 4.3 tt -116.44 155.08 29.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.866 . . . . 0.0 109.374 179.721 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.49 ' CD2' HG23 ' A' ' 133' ' ' VAL . 51.6 m-85 -125.03 127.21 46.62 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.898 -1.126 . . . . 0.0 110.659 -179.051 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.486 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.5 OUTLIER -141.03 166.86 23.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.315 -0.866 . . . . 0.0 110.235 179.751 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -91.21 -22.59 20.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 110.329 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.486 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.9 OUTLIER -91.08 -176.55 4.64 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.362 -0.837 . . . . 0.0 111.069 -179.988 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 48.04 -154.77 0.08 Allowed 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.802 0.81 . . . . 0.0 110.649 -179.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -57.37 -54.52 45.93 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.694 -0.629 . . . . 0.0 110.325 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 133.01 -24.21 3.83 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -139.41 176.34 8.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.208 -1.172 . . . . 0.0 110.548 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . 0.449 ' N ' ' ND2' ' A' ' 197' ' ' ASN . 0.7 OUTLIER -145.36 -155.33 0.6 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.389 -0.819 . . . . 0.0 109.786 -179.776 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -171.02 81.77 0.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.377 -0.827 . . . . 0.0 110.083 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -64.97 126.99 29.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.377 -0.827 . . . . 0.0 110.287 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -140.82 124.12 16.67 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.236 -0.915 . . . . 0.0 109.901 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 141.7 -167.62 25.84 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -62.67 109.02 1.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.339 -1.095 . . . . 0.0 110.26 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 91.7 t -65.88 112.24 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.226 -0.921 . . . . 0.0 110.203 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 41.7 p -150.2 152.39 34.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.36 -0.838 . . . . 0.0 110.314 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -49.76 -52.67 30.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.3 -0.875 . . . . 0.0 110.487 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -54.34 -32.5 56.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 110.157 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -83.96 -41.46 17.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.27 -0.894 . . . . 0.0 110.044 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 27.4 mt -65.83 -41.79 91.35 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.311 -0.868 . . . . 0.0 110.061 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 85.7 mt -69.39 -21.74 63.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 0.0 110.128 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -83.81 -56.38 3.73 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.292 -0.88 . . . . 0.0 110.076 179.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.401 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 20.5 t80 -51.52 -53.02 42.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.237 -0.914 . . . . 0.0 110.146 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 84.6 mt -52.78 -58.5 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.348 -0.845 . . . . 0.0 110.178 179.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.418 ' HA ' ' CG ' ' A' ' 216' ' ' GLN . 14.4 tttt -49.24 -38.74 27.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 110.132 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.27 -22.81 67.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.399 -0.813 . . . . 0.0 109.826 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.401 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 75.7 m-80 -96.77 -42.51 7.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.296 -0.878 . . . . 0.0 110.359 -179.682 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . 0.418 ' CG ' ' HA ' ' A' ' 213' ' ' LYS . 2.1 pt20 -85.06 -176.83 6.36 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.2 -0.937 . . . . 0.0 110.205 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 19.0 mt 52.67 68.69 2.85 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.254 -0.904 . . . . 0.0 110.289 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.35 152.56 49.78 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.631 1.332 . . . . 0.0 110.303 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -112.09 170.82 7.89 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.248 -0.908 . . . . 0.0 109.967 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 29.1 m -103.39 38.57 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.521 -0.737 . . . . 0.0 110.561 -179.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 59.8 mt 53.74 98.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.198 -0.939 . . . . 0.0 110.287 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -62.4 156.03 23.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.288 -0.883 . . . . 0.0 109.953 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -131.01 131.07 44.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.168 -0.957 . . . . 0.0 110.449 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 224' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 226' ' ' GLN . 2.8 m -143.86 42.38 1.45 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.364 -0.835 . . . . 0.0 110.006 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.428 ' HG2' ' N ' ' A' ' 226' ' ' GLN . 38.4 tt0 54.49 -90.32 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.381 -0.825 . . . . 0.0 110.311 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.428 ' N ' ' HG2' ' A' ' 225' ' ' GLU . 0.0 OUTLIER 178.79 -63.73 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.858 -1.151 . . . . 0.0 110.035 179.931 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.4 m -71.55 88.54 0.94 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -0.88 . . . . 0.0 110.3 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.129 179.95 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.224 0.535 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -155.96 166.47 33.39 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.312 -0.867 . . . . 0.0 110.275 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.42 ' CG2' ' HA2' ' A' ' 168' ' ' GLY . 10.1 t -97.85 171.07 8.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.922 . . . . 0.0 110.353 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.3 m -111.68 111.9 23.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.91 . . . . 0.0 110.065 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.9 mt -94.64 130.39 33.51 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.173 -0.954 . . . . 0.0 110.068 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.441 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 43.5 Cg_endo -69.69 -53.09 0.29 Allowed 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.442 1.233 . . . . 0.0 111.015 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -146.65 -170.45 3.52 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.099 -1.001 . . . . 0.0 111.184 -179.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -57.31 -39.91 91.05 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -49.62 -25.29 2.71 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.268 -1.137 . . . . 0.0 110.714 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.441 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -90.07 -35.31 15.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.138 -0.976 . . . . 0.0 110.067 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.23 -24.68 43.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.359 -0.838 . . . . 0.0 110.177 179.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -84.53 -54.37 4.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.227 -0.921 . . . . 0.0 110.248 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.7 t -52.65 -26.49 13.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.256 -0.903 . . . . 0.0 110.324 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.1 tp -70.07 -46.04 65.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.291 -0.88 . . . . 0.0 110.398 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.498 HG23 ' CD1' ' A' ' 189' ' ' PHE . 40.5 t -56.88 -38.64 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.267 -0.896 . . . . 0.0 110.583 -179.629 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -85.29 -15.97 41.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.281 -0.887 . . . . 0.0 110.761 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.2 m -56.68 -45.81 81.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.025 -1.047 . . . . 0.0 110.288 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 92.3 p -133.35 -175.59 3.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.342 -0.849 . . . . 0.0 110.215 -179.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.59 -35.22 62.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.318 -0.864 . . . . 0.0 110.249 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 87.6 t -129.33 147.27 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.064 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.402 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -173.76 134.13 0.47 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.244 -0.91 . . . . 0.0 110.048 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.413 HG21 ' N ' ' A' ' 141' ' ' ILE . 9.4 p -120.46 147.33 24.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.097 -1.002 . . . . 0.0 110.371 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.413 ' N ' HG21 ' A' ' 140' ' ' VAL . 7.4 mt -125.76 113.83 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.361 -0.837 . . . . 0.0 109.912 179.726 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -80.81 120.96 5.28 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -91.22 80.86 5.56 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.193 -1.181 . . . . 0.0 109.753 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.415 ' CZ ' ' HA ' ' A' ' 152' ' ' ALA . 15.1 m-85 -100.06 140.39 34.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.079 -1.013 . . . . 0.0 111.033 -179.317 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.12 -27.83 18.3 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.671 0.748 . . . . 0.0 109.473 179.028 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.26 69.03 1.48 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.024 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.442 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 4.6 p -48.25 -24.0 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.717 -0.614 . . . . 0.0 111.327 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -78.91 3.45 16.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.102 -0.999 . . . . 0.0 110.873 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 94.5 p -85.56 -163.16 0.81 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.843 -1.161 . . . . 0.0 110.23 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.19 -49.65 6.44 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.327 -0.858 . . . . 0.0 110.353 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.21 -28.85 8.23 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.299 -0.876 . . . . 0.0 110.448 -179.83 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.442 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -88.5 -29.25 20.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.346 -0.846 . . . . 0.0 110.136 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.82 -36.11 78.23 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.215 -0.928 . . . . 0.0 109.639 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -59.26 -49.09 79.19 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.103 -0.998 . . . . 0.0 108.607 178.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -50.96 -47.77 61.13 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.538 -0.726 . . . . 0.0 110.04 178.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.7 mt -47.4 -59.51 3.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.512 -0.743 . . . . 0.0 110.375 179.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -58.21 -50.53 73.21 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.424 -0.797 . . . . 0.0 110.057 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -53.82 -43.74 69.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.333 -0.854 . . . . 0.0 109.948 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.95 -24.41 63.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.86 . . . . 0.0 110.074 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -77.76 -40.58 40.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.871 . . . . 0.0 110.303 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.8 -39.9 68.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 0.0 110.334 -179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -89.81 144.76 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.296 -0.877 . . . . 0.0 110.262 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -132.29 18.6 4.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.215 -0.928 . . . . 0.0 110.394 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -125.51 21.36 7.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -0.959 . . . . 0.0 110.266 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.427 HG22 HD11 ' A' ' 165' ' ' ILE . 45.0 mm -136.43 134.05 19.61 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.172 -0.955 . . . . 0.0 110.175 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.402 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 48.2 Cg_endo -74.67 75.2 3.61 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 O-C-N 123.542 1.285 . . . . 0.0 110.474 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.405 ' CE1' ' CG2' ' A' ' 165' ' ' ILE . 5.7 m-85 -67.9 134.0 50.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.303 -0.873 . . . . 0.0 110.323 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.42 ' HA2' ' CG2' ' A' ' 121' ' ' THR . . . -124.72 149.23 16.93 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 9.2 tt -148.27 125.03 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.206 -1.173 . . . . 0.0 110.29 -179.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.3 t -141.5 157.14 45.52 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 122.196 0.998 . . . . 0.0 110.933 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 94.9 p -124.77 3.41 8.17 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.47 178.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 124' ' ' PRO . 64.1 t30 -63.5 127.66 32.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.194 -0.941 . . . . 0.0 110.32 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.27 -32.78 11.47 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.241 -0.912 . . . . 0.0 110.597 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.22 -31.82 54.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.098 -1.001 . . . . 0.0 109.88 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 39.8 t -79.08 -27.02 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 109.692 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -84.32 -39.81 18.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 109.14 179.328 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 46.5 t -72.89 -4.78 34.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.464 -0.772 . . . . 0.0 110.231 178.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.67 -52.19 5.13 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.067 -1.021 . . . . 0.0 109.171 179.609 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -89.84 4.5 49.65 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.749 -0.595 . . . . 0.0 110.532 179.769 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 53.56 59.99 3.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.078 -1.014 . . . . 0.0 110.451 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 60.0 mt -102.82 102.77 12.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 110.13 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -53.47 -26.76 21.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.194 -0.941 . . . . 0.0 109.992 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -141.54 -175.44 4.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.406 -0.808 . . . . 0.0 109.839 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -72.25 165.09 25.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.093 -1.004 . . . . 0.0 110.131 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -172.18 160.19 31.57 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.41 ' O ' ' CG2' ' A' ' 186' ' ' VAL . 34.2 m -123.91 97.25 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -1.18 . . . . 0.0 110.158 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 89.1 t -108.81 155.77 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 109.96 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.453 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 6.6 tt -107.96 159.47 16.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.023 -1.048 . . . . 0.0 109.709 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.498 ' CD1' HG23 ' A' ' 133' ' ' VAL . 45.0 m-85 -130.11 121.26 26.0 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.901 -1.124 . . . . 0.0 110.349 -179.313 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.432 ' HG3' ' CD1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -132.86 164.05 27.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.381 -0.824 . . . . 0.0 110.163 179.876 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -82.63 -26.15 32.48 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.206 -0.933 . . . . 0.0 110.845 -179.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.432 ' CD1' ' HG3' ' A' ' 190' ' ' LYS . 1.6 p90 -90.86 -176.81 4.78 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.287 -0.883 . . . . 0.0 110.988 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 47.01 -159.67 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.632 0.729 . . . . 0.0 110.928 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.91 -29.48 60.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.667 -0.646 . . . . 0.0 110.4 -179.731 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 96.09 -16.92 60.23 Favored Glycine 0 N--CA 1.483 1.822 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.478 ' HG3' ' CE1' ' A' ' 189' ' ' PHE . 4.2 ttp180 -138.34 154.31 48.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.018 -1.283 . . . . 0.0 110.479 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . 0.453 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.5 m-80 -125.15 -153.91 0.59 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.312 -0.867 . . . . 0.0 110.038 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -178.77 78.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.511 -0.743 . . . . 0.0 109.998 179.61 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -46.21 142.68 2.74 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.367 -0.833 . . . . 0.0 111.062 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -140.94 123.62 16.09 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.299 -0.876 . . . . 0.0 109.819 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 133.38 -121.64 2.89 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -120.04 104.61 10.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.203 -1.174 . . . . 0.0 110.213 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 6.5 p -58.84 91.38 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.15 -0.968 . . . . 0.0 110.224 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 66.0 p -126.12 160.1 31.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 110.079 179.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.87 -47.46 51.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 0.0 110.648 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -63.25 -41.63 99.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.283 -0.885 . . . . 0.0 110.652 -179.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -79.04 -26.61 43.12 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.159 -0.963 . . . . 0.0 110.474 -179.713 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 19.1 mt -73.52 -59.25 2.8 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.248 -0.908 . . . . 0.0 110.499 -179.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 5.5 mt -49.13 -40.16 31.39 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.303 -0.873 . . . . 0.0 110.886 -179.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -67.83 -45.14 75.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.12 -0.987 . . . . 0.0 110.451 -179.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.406 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 16.6 t80 -58.57 -54.41 47.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.933 . . . . 0.0 110.8 -179.624 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.415 ' N ' HD11 ' A' ' 212' ' ' ILE . 6.4 mm -58.09 -47.96 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.155 -0.966 . . . . 0.0 110.026 -179.624 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.412 ' HA ' ' NE2' ' A' ' 216' ' ' GLN . 0.3 OUTLIER -58.04 -21.92 47.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.507 -0.746 . . . . 0.0 110.429 -179.766 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -90.03 -25.36 20.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.098 -1.001 . . . . 0.0 110.57 -179.716 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.406 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 76.1 m-20 -90.61 -39.81 12.29 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.169 -0.957 . . . . 0.0 110.893 -179.361 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . 0.412 ' NE2' ' HA ' ' A' ' 213' ' ' LYS . 5.6 pt20 -58.47 -28.89 65.76 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.196 -0.94 . . . . 0.0 110.813 -179.512 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.402 ' N ' ' HG3' ' A' ' 216' ' ' GLN . 48.1 mt -136.17 94.6 13.98 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.091 -1.006 . . . . 0.0 110.753 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -74.33 111.65 3.36 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.725 1.381 . . . . 0.0 110.189 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -94.43 56.45 2.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.155 -0.966 . . . . 0.0 110.192 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 11.5 p -111.9 29.46 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 110.096 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 2.9 mp -127.94 -42.27 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.297 -0.877 . . . . 0.0 110.338 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.32 132.75 34.58 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.684 -0.635 . . . . 0.0 110.215 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -88.12 -45.48 10.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.193 -0.942 . . . . 0.0 110.283 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 10.2 t -57.44 134.92 56.48 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.267 -0.896 . . . . 0.0 110.237 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -116.29 73.48 0.85 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.942 . . . . 0.0 110.357 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -164.35 66.63 0.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.927 . . . . 0.0 110.193 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.6 m -117.13 130.01 56.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.904 . . . . 0.0 110.207 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.186 -179.97 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.24 0.543 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.98 161.44 23.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 110.183 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.9 t -85.8 169.39 13.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 110.249 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.7 m -108.66 104.41 13.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 110.342 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 67.3 mt -80.65 133.67 55.34 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.192 -0.942 . . . . 0.0 110.048 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.432 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 45.3 Cg_endo -71.23 -35.13 9.01 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.387 1.204 . . . . 0.0 110.556 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -167.75 -170.76 1.45 Allowed 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.169 0.985 . . . . 0.0 111.487 -179.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -58.09 -31.77 65.91 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -54.63 -28.81 49.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -1.141 . . . . 0.0 110.295 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.432 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -84.08 -35.02 24.03 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.931 . . . . 0.0 110.103 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -53.46 -29.16 34.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 0.0 109.98 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -90.15 -29.98 17.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.426 -0.796 . . . . 0.0 110.22 179.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.56 -35.19 30.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.195 -0.94 . . . . 0.0 110.263 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.2 tt -59.9 -58.26 9.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.316 -0.865 . . . . 0.0 109.739 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.434 HG23 ' CG ' ' A' ' 189' ' ' PHE . 97.9 t -51.98 -24.61 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.45 -0.781 . . . . 0.0 110.212 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -82.38 -21.81 35.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.311 -0.868 . . . . 0.0 110.262 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.8 m -53.14 -58.85 5.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.221 -0.924 . . . . 0.0 110.203 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 82.6 p -121.9 -179.03 4.0 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.288 -0.882 . . . . 0.0 110.296 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -69.56 -39.96 77.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.287 -0.883 . . . . 0.0 110.179 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.6 t -117.94 143.44 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.389 -0.82 . . . . 0.0 110.275 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.436 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -165.95 147.54 6.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.241 -0.912 . . . . 0.0 109.957 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.466 HG12 ' CE2' ' A' ' 167' ' ' PHE . 7.3 p -127.11 150.09 32.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 O-C-N 121.103 -0.998 . . . . 0.0 110.205 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.465 HD12 HG22 ' A' ' 141' ' ' ILE . 75.5 mt -143.48 120.19 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.41 -0.806 . . . . 0.0 109.647 179.599 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.411 ' C ' ' CD1' ' A' ' 143' ' ' PHE . . . -85.89 166.68 39.37 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 143' ' ' PHE . 26.5 m-85 -129.86 76.56 1.73 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.405 -1.056 . . . . 0.0 109.85 179.833 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -104.1 145.82 29.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.99 -1.069 . . . . 0.0 111.099 -179.528 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.26 -27.75 19.26 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.786 0.803 . . . . 0.0 109.464 179.523 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -131.0 73.0 1.52 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.687 -0.633 . . . . 0.0 109.511 179.014 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.446 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 18.4 m -48.36 -24.54 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.262 -0.899 . . . . 0.0 110.869 -179.543 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -83.95 5.53 25.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.063 -1.023 . . . . 0.0 110.844 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 33.5 p -75.19 -166.29 0.49 Allowed 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.905 -1.122 . . . . 0.0 110.34 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -90.45 -19.95 23.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.537 -0.727 . . . . 0.0 110.159 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 10.5 t -81.93 -31.62 31.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.163 -0.961 . . . . 0.0 110.078 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.446 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -80.67 -20.05 43.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 110.2 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -61.45 -39.16 89.86 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.221 -0.924 . . . . 0.0 109.751 179.471 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -67.09 -41.18 86.74 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.358 -0.839 . . . . 0.0 109.619 179.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -48.96 -57.09 7.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.397 -0.814 . . . . 0.0 110.607 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 52.8 mt -53.87 -54.76 34.07 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.449 -0.782 . . . . 0.0 110.289 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -54.2 -46.67 72.51 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.42 -0.8 . . . . 0.0 110.347 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.409 ' CB ' HD11 ' A' ' 208' ' ' LEU . . . -65.09 -45.36 85.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.148 -0.97 . . . . 0.0 110.379 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.82 -31.11 72.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.939 . . . . 0.0 110.435 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -63.69 -29.59 70.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.183 -0.948 . . . . 0.0 110.232 -179.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -57.33 -48.38 79.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.907 . . . . 0.0 110.227 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.9 tt -90.85 158.27 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.175 -0.953 . . . . 0.0 110.01 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.11 19.16 1.24 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.033 -1.042 . . . . 0.0 110.609 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -116.25 16.3 15.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.141 -0.974 . . . . 0.0 110.495 179.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.402 HD11 HG22 ' A' ' 165' ' ' ILE . 49.7 mm -134.41 140.35 35.49 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.126 -0.984 . . . . 0.0 110.11 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.436 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 48.0 Cg_endo -74.77 79.5 2.58 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.618 1.325 . . . . 0.0 110.508 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.466 ' CE2' HG12 ' A' ' 140' ' ' VAL . 3.6 m-85 -68.79 135.64 51.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.33 -0.856 . . . . 0.0 109.933 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -131.35 151.99 19.88 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.564 -1.303 . . . . 0.0 109.942 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 11.7 tt -150.19 140.34 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -1.105 . . . . 0.0 109.979 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.4 HG22 HG22 ' A' ' 175' ' ' VAL . 2.9 t -153.77 158.05 40.35 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.118 0.961 . . . . 0.0 111.069 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.1 m -119.97 0.97 10.9 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.44 178.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -60.53 145.97 46.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.138 -0.976 . . . . 0.0 110.174 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 37.8 t -70.41 -30.91 67.91 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.167 -0.958 . . . . 0.0 110.471 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -54.56 -40.88 69.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.073 -1.017 . . . . 0.0 109.955 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.403 HG11 ' CE2' ' A' ' 143' ' ' PHE . 58.8 t -69.82 -30.69 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 0.0 109.546 179.481 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.405 ' N ' ' CD1' ' A' ' 176' ' ' PHE . 10.6 m-85 -80.34 -41.17 25.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.445 -0.784 . . . . 0.0 109.751 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.87 -6.34 37.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.416 -0.802 . . . . 0.0 110.551 179.531 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 15.0 tttp -90.03 -45.39 9.2 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.014 -1.054 . . . . 0.0 109.382 179.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -91.5 0.78 57.47 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.562 -0.711 . . . . 0.0 110.642 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 53.97 66.47 1.22 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.985 -1.072 . . . . 0.0 110.728 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 55.3 mt -107.97 114.34 28.19 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.236 -0.915 . . . . 0.0 109.945 179.62 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.423 ' O ' ' CG ' ' A' ' 183' ' ' LYS . 45.2 m-20 -61.81 -17.26 55.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.936 . . . . 0.0 110.33 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 182' ' ' ASP . 22.6 mtmt -157.75 -166.39 1.98 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.206 -0.934 . . . . 0.0 110.012 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -63.9 162.98 12.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.184 -0.947 . . . . 0.0 110.049 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -176.32 152.28 12.52 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.434 ' CG2' HG13 ' A' ' 203' ' ' VAL . 70.4 t -118.75 133.97 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.383 -1.069 . . . . 0.0 109.697 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 77.3 t -141.92 145.06 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.223 -0.923 . . . . 0.0 110.468 -179.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.447 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 7.1 tt -105.03 146.85 28.51 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.434 ' CG ' HG23 ' A' ' 133' ' ' VAL . 46.2 m-85 -118.81 127.18 53.28 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.722 -1.236 . . . . 0.0 110.834 -178.689 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.496 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -138.47 158.06 44.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.389 -0.819 . . . . 0.0 110.222 179.827 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.1 mmmm -84.3 -21.3 31.06 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.244 -0.91 . . . . 0.0 110.433 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.496 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 1.7 p90 -90.55 -176.23 4.68 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.244 -0.91 . . . . 0.0 110.883 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 46.79 -158.76 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.684 0.754 . . . . 0.0 110.74 -179.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.46 -54.0 49.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.634 -0.666 . . . . 0.0 110.313 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 137.81 -31.11 2.51 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.82 173.88 10.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.172 -1.193 . . . . 0.0 110.156 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . 0.451 ' N ' ' ND2' ' A' ' 197' ' ' ASN . 1.3 m-80 -134.14 -40.36 0.83 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.121 -0.987 . . . . 0.0 110.811 -179.181 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 63.98 94.23 0.05 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.248 -0.907 . . . . 0.0 110.202 -179.273 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.491 ' HB2' ' CZ ' ' A' ' 211' ' ' PHE . 41.0 t80 -88.96 136.73 32.86 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.338 -0.851 . . . . 0.0 110.201 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.477 ' O ' ' CE1' ' A' ' 199' ' ' PHE . 5.1 mt-10 -121.0 -147.38 0.39 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.209 -0.932 . . . . 0.0 109.678 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 58.15 -128.27 47.14 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.03 130.39 53.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.316 -1.108 . . . . 0.0 110.35 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.446 HG11 ' CE1' ' A' ' 199' ' ' PHE . 28.2 m -77.49 59.13 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.383 -0.823 . . . . 0.0 110.073 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.403 ' OG1' ' ND2' ' A' ' 207' ' ' ASN . 7.6 p -93.76 156.18 16.82 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.587 -0.695 . . . . 0.0 110.354 -179.826 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -48.64 -48.24 39.73 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.24 -0.913 . . . . 0.0 110.532 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . 0.407 ' HG3' ' N ' ' A' ' 207' ' ' ASN . 14.2 pt-20 -54.34 -41.15 68.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.941 . . . . 0.0 110.42 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.407 ' N ' ' HG3' ' A' ' 206' ' ' GLU . 79.9 m-20 -83.21 -28.41 29.28 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.287 -0.883 . . . . 0.0 110.149 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.409 HD11 ' CB ' ' A' ' 158' ' ' ALA . 19.9 mt -72.16 -48.58 42.36 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.267 -0.896 . . . . 0.0 110.264 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 9.1 mt -53.56 -38.92 64.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 109.899 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -74.17 -49.11 25.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.84 . . . . 0.0 109.925 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.491 ' CZ ' ' HB2' ' A' ' 199' ' ' PHE . 23.8 t80 -47.94 -58.14 4.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 110.79 179.752 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 21.6 mt -52.83 -47.61 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -0.867 . . . . 0.0 110.212 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.55 -41.37 88.78 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.24 -0.912 . . . . 0.0 109.939 179.722 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -62.03 -19.87 63.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.383 -0.823 . . . . 0.0 109.945 179.649 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -89.23 -60.71 1.88 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.253 -0.905 . . . . 0.0 109.553 179.827 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.55 156.1 0.2 Allowed 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.395 -0.816 . . . . 0.0 111.18 179.84 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 8.0 mt 54.94 92.7 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.524 -0.735 . . . . 0.0 110.01 179.237 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.74 73.35 2.39 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.607 1.32 . . . . 0.0 110.414 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 87.2 mt -125.72 67.89 1.17 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 110.191 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.42 ' O ' ' CG1' ' A' ' 220' ' ' VAL . 7.8 p -120.84 77.9 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.955 . . . . 0.0 110.333 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 7.4 tt -160.05 123.88 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -0.914 . . . . 0.0 110.155 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.33 -57.6 0.2 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.28 -0.888 . . . . 0.0 110.18 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -128.08 -52.58 1.31 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 110.098 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.2 p -93.52 152.24 19.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 110.231 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -116.88 33.53 5.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 110.29 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 53.42 69.26 0.72 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.289 -0.882 . . . . 0.0 110.198 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.5 m -60.7 -27.59 67.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 110.216 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.195 -179.918 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.307 0.575 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -79.86 167.01 21.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.218 -0.926 . . . . 0.0 110.366 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.434 ' CG2' ' HA2' ' A' ' 168' ' ' GLY . 10.1 t -96.31 169.69 9.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.119 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.6 m -109.15 107.89 18.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 110.249 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 24.8 mt -85.43 128.86 57.59 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.361 -0.837 . . . . 0.0 109.98 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.409 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 46.6 Cg_endo -72.05 -43.61 1.12 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.425 1.223 . . . . 0.0 110.431 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.2 -170.42 3.12 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 122.108 0.956 . . . . 0.0 111.242 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -58.5 -27.97 61.7 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -54.04 -32.27 53.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -1.129 . . . . 0.0 110.096 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.409 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -87.11 -34.93 18.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 110.016 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.0 -22.75 61.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.349 -0.844 . . . . 0.0 110.033 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -84.69 -57.88 2.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 110.134 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.5 p -61.06 -18.2 56.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.312 -0.867 . . . . 0.0 110.377 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 17.2 tp -71.05 -49.44 44.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.151 -0.968 . . . . 0.0 109.891 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.427 ' CG2' ' HB3' ' A' ' 189' ' ' PHE . 59.1 t -64.83 -28.59 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.478 -0.764 . . . . 0.0 110.262 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -90.0 -0.74 57.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.276 -0.89 . . . . 0.0 110.96 -179.836 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 46.9 t -86.44 -23.19 26.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.915 -1.115 . . . . 0.0 110.31 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.44 160.0 43.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.236 -0.915 . . . . 0.0 110.495 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.77 -22.85 59.06 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.401 -0.812 . . . . 0.0 109.592 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.8 m -138.43 152.22 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.315 -0.866 . . . . 0.0 110.377 -179.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -173.41 134.48 0.52 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 0.0 109.862 179.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.89 149.8 23.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 120.994 -1.067 . . . . 0.0 110.271 -179.685 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.459 ' O ' ' CE1' ' A' ' 143' ' ' PHE . 2.8 mp -134.9 117.26 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.342 -0.849 . . . . 0.0 110.139 179.733 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.21 126.12 7.34 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.459 ' CE1' ' O ' ' A' ' 141' ' ' ILE . 65.7 m-85 -100.74 78.77 2.0 Allowed 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.102 -1.234 . . . . 0.0 110.206 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -104.52 146.32 29.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.061 -1.024 . . . . 0.0 110.835 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.43 -27.89 21.25 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.575 -0.703 . . . . 0.0 109.827 179.375 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.15 74.35 1.59 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.502 -0.749 . . . . 0.0 109.525 179.506 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.414 ' O ' ' CB ' ' A' ' 152' ' ' ALA . 23.5 m -52.82 -21.4 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.367 -0.833 . . . . 0.0 110.846 -179.542 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -82.65 8.41 12.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.125 -0.984 . . . . 0.0 110.838 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 7.5 p -84.67 -161.71 0.6 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.869 -1.144 . . . . 0.0 110.37 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -90.74 -21.31 21.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 0.0 110.269 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.36 -37.13 68.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.214 -0.929 . . . . 0.0 110.255 -179.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 147' ' ' VAL . . . -74.04 -26.85 60.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.207 -0.933 . . . . 0.0 109.722 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -54.05 -49.83 68.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.887 . . . . 0.0 109.858 179.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -64.42 -39.71 94.36 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.343 -0.848 . . . . 0.0 109.782 179.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -52.07 -55.7 19.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.356 -0.84 . . . . 0.0 110.161 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.43 -56.66 16.46 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.382 -0.824 . . . . 0.0 110.169 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -49.38 -57.97 5.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.33 -0.856 . . . . 0.0 110.489 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.72 -36.34 71.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.806 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.403 ' HB3' ' CD2' ' A' ' 167' ' ' PHE . . . -67.9 -32.63 73.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.993 179.655 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -67.63 -31.77 72.02 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.224 -0.923 . . . . 0.0 110.098 179.683 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.77 -32.54 63.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 109.961 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.432 HG22 ' CG1' ' A' ' 165' ' ' ILE . 58.1 mt -102.76 139.41 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.33 -0.856 . . . . 0.0 110.111 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.81 15.61 8.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.921 . . . . 0.0 110.539 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -119.86 -10.21 9.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.194 -0.941 . . . . 0.0 110.549 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.437 ' CG2' ' HD2' ' A' ' 166' ' ' PRO . 39.7 mm -101.51 146.06 31.54 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.045 -1.034 . . . . 0.0 110.249 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.437 ' HD2' ' CG2' ' A' ' 165' ' ' ILE . 47.6 Cg_endo -85.53 72.86 4.16 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 O-C-N 123.722 1.38 . . . . 0.0 110.458 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.403 ' CD2' ' HB3' ' A' ' 159' ' ' ALA . 5.6 m-85 -65.61 124.69 23.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.303 -0.873 . . . . 0.0 110.19 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.434 ' HA2' ' CG2' ' A' ' 121' ' ' THR . . . -121.09 153.05 16.68 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 8.1 tt -150.16 137.69 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -1.12 . . . . 0.0 110.159 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.5 t -154.17 156.89 37.99 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.116 0.96 . . . . 0.0 110.884 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 13.7 m -115.09 -2.08 12.87 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.506 178.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -59.19 118.72 6.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.182 -0.949 . . . . 0.0 110.252 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.4 m -50.46 -33.09 19.86 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.153 -0.967 . . . . 0.0 110.458 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.32 -35.81 60.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.208 -0.932 . . . . 0.0 110.076 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.44 HG13 ' CE2' ' A' ' 143' ' ' PHE . 40.6 t -79.25 -24.91 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.338 -0.851 . . . . 0.0 109.734 179.66 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 176' ' ' PHE . 12.2 m-85 -80.97 -45.87 15.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.37 -0.831 . . . . 0.0 109.704 179.75 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 41.4 t -67.74 -22.76 65.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.353 -0.842 . . . . 0.0 110.066 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.5 tttm -52.68 -57.49 9.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.247 -0.908 . . . . 0.0 110.207 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -89.7 13.97 12.9 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.266 -0.896 . . . . 0.0 110.565 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 51.99 61.0 3.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.132 -0.98 . . . . 0.0 110.423 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 68.0 mt -96.85 -26.65 15.02 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.125 -0.984 . . . . 0.0 110.417 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 52.71 21.1 1.76 Allowed 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.896 -0.503 . . . . 0.0 110.684 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -178.6 -163.37 0.06 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.208 -0.932 . . . . 0.0 109.764 179.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 4.1 m-20 -90.57 152.6 20.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.12 -0.987 . . . . 0.0 109.838 179.468 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -164.93 149.52 16.29 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.46 -1.352 . . . . 0.0 109.917 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 82.3 t -117.55 94.46 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.403 -1.057 . . . . 0.0 109.484 179.561 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 84.9 t -113.71 156.39 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.141 -0.974 . . . . 0.0 110.682 -179.294 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.451 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 8.2 tt -108.91 157.73 18.35 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.195 -0.941 . . . . 0.0 109.275 179.674 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.427 ' HB3' ' CG2' ' A' ' 133' ' ' VAL . 46.7 m-85 -129.9 124.85 34.15 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.924 -1.11 . . . . 0.0 110.733 -179.099 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.33 179.11 6.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.369 -0.832 . . . . 0.0 109.964 179.475 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -95.96 -29.7 14.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.131 -0.98 . . . . 0.0 110.74 -179.36 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.11 -172.01 3.17 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.964 0.888 . . . . 0.0 111.211 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 47.89 -155.42 0.07 Allowed 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.733 0.777 . . . . 0.0 110.654 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.61 -26.12 68.54 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.668 -0.645 . . . . 0.0 110.214 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 100.42 -34.93 5.16 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.36 172.31 8.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.072 -1.252 . . . . 0.0 110.743 -179.716 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . 0.451 ' N ' ' ND2' ' A' ' 197' ' ' ASN . 0.9 OUTLIER -139.45 -148.16 0.25 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.6 -0.688 . . . . 0.0 109.494 -179.44 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -175.54 84.27 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.189 -0.944 . . . . 0.0 110.259 179.397 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.47 ' CE2' HG21 ' A' ' 203' ' ' VAL . 83.4 t80 -51.28 119.73 4.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.196 -0.94 . . . . 0.0 110.535 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -117.45 95.98 5.2 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.299 -0.875 . . . . 0.0 110.31 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 156.11 -178.41 32.65 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.8 119.73 16.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -1.15 . . . . 0.0 110.137 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.47 HG21 ' CE2' ' A' ' 199' ' ' PHE . 80.0 t -60.06 108.25 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.195 -0.94 . . . . 0.0 110.137 -179.878 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.415 ' OG1' ' ND2' ' A' ' 207' ' ' ASN . 10.6 p -147.68 157.67 43.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.365 -0.835 . . . . 0.0 110.11 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -52.16 -48.15 65.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.282 -0.886 . . . . 0.0 110.587 -179.752 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -63.87 -24.85 67.91 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.184 -0.947 . . . . 0.0 110.483 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.415 ' ND2' ' OG1' ' A' ' 204' ' ' THR . 75.9 m-20 -90.31 -44.65 9.56 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.184 -0.948 . . . . 0.0 110.333 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 46.4 mt -58.96 -55.83 30.09 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.224 -0.923 . . . . 0.0 110.277 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.74 -23.69 18.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 0.0 110.094 179.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -80.81 -57.98 3.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 110.048 179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -54.98 -54.04 48.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.898 . . . . 0.0 109.974 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 82.0 mt -49.15 -55.64 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.274 -0.891 . . . . 0.0 110.284 179.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.06 -30.48 6.37 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.432 -0.792 . . . . 0.0 110.352 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . 0.448 ' CD2' ' N ' ' A' ' 214' ' ' HIS . 29.2 m170 -87.78 -7.12 57.72 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.202 -0.936 . . . . 0.0 110.626 179.765 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -89.31 -70.41 0.66 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.029 -1.044 . . . . 0.0 109.935 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -59.25 161.44 5.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.18 -0.95 . . . . 0.0 109.68 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 19.2 mt 53.59 99.34 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.29 -0.881 . . . . 0.0 110.368 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.6 111.85 2.89 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.578 1.304 . . . . 0.0 110.38 179.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.1 mt -94.42 115.93 28.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 0.0 110.383 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 54.9 t -102.16 60.16 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.25 -0.906 . . . . 0.0 109.967 179.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.401 ' O ' ' CG1' ' A' ' 221' ' ' ILE . 1.3 tt -90.3 17.86 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.247 -0.908 . . . . 0.0 110.606 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -149.69 26.02 0.84 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.061 -1.024 . . . . 0.0 110.183 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 59.22 157.4 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.448 -0.783 . . . . 0.0 110.434 -180.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 4.1 m -136.87 106.25 6.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 0.0 110.144 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -56.61 126.93 28.88 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.317 -0.864 . . . . 0.0 110.249 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -145.23 126.79 15.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.285 -0.884 . . . . 0.0 110.133 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 6.1 t -144.74 151.97 39.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.246 -0.909 . . . . 0.0 110.263 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.185 179.921 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 167' ' ' PHE . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.235 0.541 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.542 HG22 ' HA2' ' A' ' 168' ' ' GLY . 13.2 t -86.26 170.53 12.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.277 -0.889 . . . . 0.0 110.3 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.8 m -104.13 105.03 15.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.105 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.619 ' CD1' HG23 ' A' ' 141' ' ' ILE . 17.8 mt -79.65 129.24 71.99 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.9 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 49.1 Cg_endo -72.85 -44.84 0.56 Allowed 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.421 1.222 . . . . 0.0 110.39 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 127' ' ' ALA . 0.9 OUTLIER -157.44 -169.3 2.85 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.325 -0.86 . . . . 0.0 110.572 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.44 -23.4 60.28 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 125' ' ' ASP . . . -57.24 -29.7 64.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.263 -1.139 . . . . 0.0 110.25 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.446 ' HB2' ' HD2' ' A' ' 124' ' ' PRO . . . -88.26 -31.15 19.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 110.035 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.457 ' HA ' HD13 ' A' ' 141' ' ' ILE . . . -59.3 -30.7 68.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -0.901 . . . . 0.0 110.002 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -87.88 -37.99 16.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.343 -0.848 . . . . 0.0 110.09 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 10.1 p -73.95 -29.65 62.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 110.106 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.549 HD23 ' CG1' ' A' ' 141' ' ' ILE . 15.1 tp -61.9 -55.55 28.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.212 -0.93 . . . . 0.0 110.082 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.596 HG22 ' HB3' ' A' ' 189' ' ' PHE . 55.5 t -55.37 -25.87 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.895 . . . . 0.0 110.155 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -83.33 -29.21 28.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.319 -0.863 . . . . 0.0 110.422 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.5 m -61.05 -31.2 70.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.236 -0.915 . . . . 0.0 110.312 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.401 ' OG ' ' HG3' ' A' ' 166' ' ' PRO . 95.8 p -146.34 159.21 43.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.219 -0.925 . . . . 0.0 110.25 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.937 ' HG3' HG23 ' A' ' 138' ' ' VAL . 12.7 pt-20 -64.38 -40.65 96.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.879 . . . . 0.0 110.155 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.937 HG23 ' HG3' ' A' ' 137' ' ' GLU . 95.1 t -113.24 128.32 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.477 -0.764 . . . . 0.0 110.194 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -158.11 145.31 18.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.859 . . . . 0.0 109.839 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.467 HG11 ' CE2' ' A' ' 167' ' ' PHE . 7.5 p -124.63 151.29 29.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.125 -0.985 . . . . 0.0 110.298 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.619 HG23 ' CD1' ' A' ' 123' ' ' LEU . 66.7 mt -143.11 119.52 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.441 -0.787 . . . . 0.0 109.576 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -90.62 164.95 30.67 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.831 ' CE2' HG12 ' A' ' 175' ' ' VAL . 46.7 m-85 -130.72 69.09 1.46 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.52 -0.988 . . . . 0.0 109.375 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.408 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 11.5 m-85 -89.03 132.63 34.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.139 -0.975 . . . . 0.0 111.379 -178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.3 -28.52 59.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.582 -0.699 . . . . 0.0 110.077 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -127.38 73.87 1.47 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.392 -0.817 . . . . 0.0 109.923 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.485 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 24.0 m -53.21 -21.8 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.348 -0.845 . . . . 0.0 110.611 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.49 13.39 8.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.134 -0.979 . . . . 0.0 110.801 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 85.3 p -98.6 -163.53 1.05 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.04 -1.038 . . . . 0.0 110.131 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.43 -43.67 14.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.114 -0.991 . . . . 0.0 110.293 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 85.6 p -52.74 -27.65 18.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -0.928 . . . . 0.0 110.25 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.485 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -85.48 -35.17 21.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 110.057 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.6 mmmt -54.28 -50.04 68.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 110.216 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -57.74 -38.9 76.16 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.261 -0.899 . . . . 0.0 110.085 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -52.41 -63.24 1.2 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 0.0 110.278 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.4 mt -53.86 -52.13 61.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.346 -0.846 . . . . 0.0 110.205 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.407 ' HB3' ' HD2' ' A' ' 205' ' ' LYS . 36.3 mt-30 -52.01 -50.44 61.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.369 -0.832 . . . . 0.0 110.12 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.714 ' HB2' ' HA ' ' A' ' 205' ' ' LYS . . . -66.15 -29.13 69.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.127 -0.983 . . . . 0.0 109.738 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.12 -34.3 66.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.389 -0.819 . . . . 0.0 109.995 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -57.11 -22.84 42.79 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.296 -0.877 . . . . 0.0 110.125 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.13 -51.47 69.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.896 . . . . 0.0 110.134 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.462 HG21 ' CG1' ' A' ' 165' ' ' ILE . 76.8 mt -100.96 139.76 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.32 -0.862 . . . . 0.0 110.246 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -117.51 -21.87 8.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 0.0 110.47 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -74.17 -11.0 60.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.184 -0.947 . . . . 0.0 110.729 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.462 ' CG1' HG21 ' A' ' 162' ' ' ILE . 49.4 mm -100.02 130.96 25.11 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 120.995 -1.066 . . . . 0.0 110.107 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.401 ' HG3' ' OG ' ' A' ' 136' ' ' SER . 50.3 Cg_endo -75.88 78.38 3.15 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.409 1.216 . . . . 0.0 110.683 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.467 ' CE2' HG11 ' A' ' 140' ' ' VAL . 5.8 m-85 -68.87 138.78 54.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.212 -0.93 . . . . 0.0 109.813 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.542 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -133.02 150.34 19.77 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 14.6 tt -149.67 137.81 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -1.191 . . . . 0.0 110.693 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.665 HG21 HG11 ' A' ' 175' ' ' VAL . 2.6 t -150.88 157.37 42.83 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.092 0.948 . . . . 0.0 110.774 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 79.7 p -118.78 0.78 11.5 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.581 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.48 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 43.3 t30 -53.56 -177.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.216 -0.928 . . . . 0.0 110.136 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 18.3 m -106.8 -35.96 6.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.137 -0.977 . . . . 0.0 110.077 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -57.91 -31.52 66.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -0.914 . . . . 0.0 109.819 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.831 HG12 ' CE2' ' A' ' 143' ' ' PHE . 40.2 t -76.42 -30.03 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.282 -0.886 . . . . 0.0 109.562 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 172' ' ' ASN . 11.4 m-85 -77.33 -57.36 3.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 109.613 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.2 m -53.2 -23.58 8.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.342 -0.849 . . . . 0.0 110.052 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -58.69 -57.91 10.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.873 . . . . 0.0 110.288 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -89.98 17.41 6.87 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.237 -0.914 . . . . 0.0 110.445 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 53.84 65.53 1.49 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.045 -1.035 . . . . 0.0 110.347 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 83.3 mt -108.29 100.79 10.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.316 -0.865 . . . . 0.0 110.194 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.97 -26.12 46.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 109.978 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -144.3 -165.5 2.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.362 -0.837 . . . . 0.0 110.122 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 9.7 p-10 -68.89 163.56 24.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.171 -0.956 . . . . 0.0 110.233 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 175.81 144.75 5.21 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.548 HG23 ' CB ' ' A' ' 199' ' ' PHE . 11.5 m -114.32 128.47 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -1.131 . . . . 0.0 110.283 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 188' ' ' LEU . 94.8 t -132.75 163.3 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.389 -0.819 . . . . 0.0 109.326 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.498 HD23 ' N ' ' A' ' 189' ' ' PHE . 6.6 tt -110.79 161.55 15.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.939 -1.101 . . . . 0.0 109.907 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.596 ' HB3' HG22 ' A' ' 133' ' ' VAL . 52.6 m-85 -128.53 124.85 37.05 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.989 -1.07 . . . . 0.0 110.418 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.426 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -138.14 161.24 37.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.265 -0.897 . . . . 0.0 110.378 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -90.87 -27.89 18.5 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.342 -0.849 . . . . 0.0 110.552 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.426 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.8 OUTLIER -90.75 -176.39 4.68 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.435 -0.79 . . . . 0.0 110.873 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 48.02 -154.52 0.08 Allowed 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.718 0.77 . . . . 0.0 110.587 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.04 -55.6 22.51 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.72 -0.613 . . . . 0.0 110.243 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 121.52 -25.69 6.85 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -134.89 161.56 34.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.268 -1.137 . . . . 0.0 110.203 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ASN . . . . . 0.462 ' N ' ' ND2' ' A' ' 197' ' ' ASN . 0.6 OUTLIER -133.34 -153.57 0.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.151 -0.968 . . . . 0.0 109.998 -179.481 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.515 ' O ' ' ND2' ' A' ' 198' ' ' ASN . 4.3 p-10 -174.57 88.3 0.05 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.446 -0.784 . . . . 0.0 110.217 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.548 ' CB ' HG23 ' A' ' 186' ' ' VAL . 29.3 t80 -60.75 139.97 57.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.334 -0.854 . . . . 0.0 110.398 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.468 ' O ' ' CE1' ' A' ' 199' ' ' PHE . 55.7 mt-10 -130.0 -151.33 0.47 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.141 -0.974 . . . . 0.0 109.679 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 51.34 -146.66 10.96 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.08 158.45 16.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -1.157 . . . . 0.0 110.016 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.445 ' C ' HG23 ' A' ' 204' ' ' THR . 73.2 t -89.13 114.69 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.255 -0.903 . . . . 0.0 110.251 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.445 HG23 ' C ' ' A' ' 203' ' ' VAL . 38.8 p -150.27 147.78 28.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.329 -0.857 . . . . 0.0 110.165 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.714 ' HA ' ' HB2' ' A' ' 158' ' ' ALA . 13.2 tttm -46.78 -50.26 18.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.25 -0.906 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' GLU . . . . . 0.439 ' HG3' ' N ' ' A' ' 207' ' ' ASN . 17.7 pt-20 -56.77 -39.36 73.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 110.191 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.439 ' N ' ' HG3' ' A' ' 206' ' ' GLU . 54.8 m-20 -72.33 -45.63 59.1 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.315 -0.865 . . . . 0.0 110.165 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.412 HD13 ' HB3' ' A' ' 158' ' ' ALA . 89.7 mt -54.52 -54.54 39.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 110.285 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.69 HD12 ' O ' ' A' ' 205' ' ' LYS . 1.4 mt -52.69 -29.09 24.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 0.0 110.002 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -77.72 -48.18 17.31 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.34 -0.85 . . . . 0.0 109.651 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.428 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 18.3 t80 -52.22 -56.04 17.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.865 . . . . 0.0 109.763 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.462 HD13 HD12 ' A' ' 188' ' ' LEU . 36.9 mm -51.24 -65.4 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.319 -0.863 . . . . 0.0 110.001 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -50.86 -25.31 4.38 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.755 -0.591 . . . . 0.0 110.452 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -89.57 -14.77 34.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.176 -0.952 . . . . 0.0 110.565 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.477 ' CB ' HD13 ' A' ' 188' ' ' LEU . 1.7 m-80 -89.06 -81.99 0.26 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.074 -1.016 . . . . 0.0 110.27 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 . . . . . 0 N--CA 1.487 1.379 0 O-C-N 121.157 -0.965 . . . . 0.0 110.164 -179.943 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 167' ' ' PHE . . . . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.263 0.554 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.451 HG22 ' HA2' ' A' ' 168' ' ' GLY . 7.8 t -99.38 169.95 8.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.124 -0.985 . . . . 0.0 110.318 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 92.8 m -108.18 121.12 44.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.288 -0.882 . . . . 0.0 110.119 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.618 HD22 ' HB1' ' A' ' 128' ' ' ALA . 28.1 mt -100.06 136.49 20.12 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.241 -0.912 . . . . 0.0 110.08 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.88 -51.76 0.14 Allowed 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.509 1.268 . . . . 0.0 110.44 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.653 ' C ' HG22 ' A' ' 175' ' ' VAL . 0.6 OUTLIER -146.08 -170.42 3.48 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.224 -0.922 . . . . 0.0 110.788 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.589 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -58.86 -28.8 63.81 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -51.2 -36.69 42.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.176 -1.191 . . . . 0.0 110.472 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.618 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -83.68 -29.19 27.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.145 -0.972 . . . . 0.0 110.03 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.2 -27.3 68.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.131 -0.98 . . . . 0.0 109.95 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -89.07 -49.74 6.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.893 . . . . 0.0 109.971 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.3 t -58.7 -32.22 68.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.893 . . . . 0.0 110.197 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 27.0 tp -59.91 -52.52 65.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.321 -0.862 . . . . 0.0 110.011 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.487 HG22 ' CB ' ' A' ' 189' ' ' PHE . 47.7 t -58.56 -37.62 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.295 -0.878 . . . . 0.0 110.033 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -74.13 -5.69 43.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.32 -0.862 . . . . 0.0 110.909 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.35 -21.98 25.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.903 -1.123 . . . . 0.0 110.615 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.405 ' OG ' ' HG3' ' A' ' 166' ' ' PRO . 0.7 OUTLIER -150.08 162.24 40.79 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.196 -0.94 . . . . 0.0 110.571 -179.692 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.06 -17.39 62.01 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.314 -0.866 . . . . 0.0 109.912 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 99.2 t -135.13 139.6 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.976 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.449 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -173.13 146.9 1.51 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 0.0 110.121 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.543 HG11 ' CZ ' ' A' ' 167' ' ' PHE . 7.7 p -129.13 152.74 37.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.089 -1.007 . . . . 0.0 109.919 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.477 ' O ' ' CE1' ' A' ' 143' ' ' PHE . 62.5 mt -139.47 117.68 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.209 -0.932 . . . . 0.0 110.204 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -81.85 139.68 20.2 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.477 ' CE1' ' O ' ' A' ' 141' ' ' ILE . 70.9 m-85 -114.07 79.38 1.25 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.154 -1.204 . . . . 0.0 109.971 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' A' ' 151' ' ' SER . 15.9 m-85 -107.15 148.35 28.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.109 -0.994 . . . . 0.0 110.842 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.32 -28.59 18.65 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.3 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.418 ' HB3' ' HB3' ' A' ' 149' ' ' SER . 0.9 OUTLIER -119.69 82.88 1.95 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -0.837 . . . . 0.0 109.638 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 87.6 t -52.87 -21.93 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.366 -0.833 . . . . 0.0 110.76 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.81 18.39 6.59 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.218 -0.926 . . . . 0.0 110.563 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.418 ' HB3' ' HB3' ' A' ' 146' ' ' ASP . 10.3 p -90.8 -162.84 0.95 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.139 -0.976 . . . . 0.0 110.245 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -90.27 -47.94 7.46 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.267 -0.896 . . . . 0.0 110.489 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.413 ' HB3' ' CE1' ' A' ' 144' ' ' PHE . 62.5 m -52.35 -29.97 26.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.167 -0.958 . . . . 0.0 110.245 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.53 -29.08 41.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 109.975 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 149' ' ' SER . 1.0 OUTLIER -61.1 -54.36 45.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -0.907 . . . . 0.0 109.865 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -58.21 -37.91 75.74 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.309 -0.87 . . . . 0.0 109.864 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.45 ' HE1' HG13 ' A' ' 186' ' ' VAL . 4.8 t80 -50.22 -59.84 3.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.315 -0.866 . . . . 0.0 110.32 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' A' ' 156' ' ' LEU . 17.4 mt -50.44 -50.23 52.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.328 -0.858 . . . . 0.0 110.39 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -52.83 -54.76 29.61 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.392 -0.818 . . . . 0.0 110.113 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.58 -40.94 93.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.051 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.452 ' CB ' ' CD2' ' A' ' 167' ' ' PHE . . . -67.46 -25.67 66.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.307 -0.87 . . . . 0.0 110.158 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -82.94 -31.19 27.82 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.304 -0.873 . . . . 0.0 110.214 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.77 -38.64 64.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 0.0 110.195 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.8 tt -96.37 156.36 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.914 . . . . 0.0 110.339 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -133.93 16.01 3.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.93 . . . . 0.0 110.481 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.483 ' O ' HD13 ' A' ' 165' ' ' ILE . 4.5 p30 -123.68 10.43 9.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.08 -1.013 . . . . 0.0 110.716 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.483 HD13 ' O ' ' A' ' 164' ' ' ASP . 50.0 mm -126.67 136.52 28.85 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.0 -1.062 . . . . 0.0 110.189 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.449 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 49.9 Cg_endo -77.13 91.94 1.15 Allowed 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.499 1.262 . . . . 0.0 110.915 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.543 ' CZ ' HG11 ' A' ' 140' ' ' VAL . 4.1 m-85 -86.66 130.75 34.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.288 -0.882 . . . . 0.0 109.823 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.451 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -133.56 156.06 22.07 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.402 HD12 ' CD2' ' A' ' 155' ' ' PHE . 12.6 tt -150.84 150.78 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.094 -1.239 . . . . 0.0 110.418 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.515 HG21 HG11 ' A' ' 175' ' ' VAL . 2.3 t -157.65 157.78 34.24 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.06 0.933 . . . . 0.0 110.819 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.2 t -120.13 -0.18 10.57 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.389 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -61.55 129.47 41.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.096 -1.002 . . . . 0.0 110.24 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.6 t -58.83 -29.36 66.85 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.261 -0.9 . . . . 0.0 110.448 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.36 -33.66 65.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.125 -0.984 . . . . 0.0 110.206 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.653 HG22 ' C ' ' A' ' 125' ' ' ASP . 42.3 t -80.03 -25.29 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.913 . . . . 0.0 109.947 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.404 ' N ' ' CD1' ' A' ' 176' ' ' PHE . 11.9 m-85 -80.39 -53.06 6.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.304 -0.873 . . . . 0.0 109.777 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 14.2 m -54.45 -23.19 15.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.886 . . . . 0.0 109.932 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.71 -50.28 45.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.361 -0.837 . . . . 0.0 110.025 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -89.84 8.21 33.21 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.319 -0.863 . . . . 0.0 110.735 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 52.51 57.94 5.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.991 -1.068 . . . . 0.0 110.4 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 83.7 mt -99.45 100.27 11.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.197 -0.939 . . . . 0.0 110.351 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 3.7 m-20 -54.07 -26.74 28.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.96 . . . . 0.0 110.198 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -146.94 -165.29 2.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.217 -0.927 . . . . 0.0 109.914 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.43 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 2.7 p30 -64.1 162.49 14.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.14 -0.975 . . . . 0.0 109.91 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -170.57 140.3 5.92 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.466 -1.35 . . . . 0.0 110.064 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.45 HG13 ' HE1' ' A' ' 155' ' ' PHE . 53.3 t -109.46 90.32 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.423 -1.045 . . . . 0.0 109.448 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.517 HG13 ' H ' ' A' ' 197' ' ' ASN . 94.0 t -102.55 147.75 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.338 -0.851 . . . . 0.0 110.277 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.552 HD22 ' HB3' ' A' ' 215' ' ' ASN . 7.7 tt -107.46 158.98 16.75 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.292 -0.88 . . . . 0.0 109.306 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.487 ' CB ' HG22 ' A' ' 133' ' ' VAL . 71.2 m-85 -123.86 139.76 53.65 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.995 -1.066 . . . . 0.0 110.707 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.402 ' HG2' ' HA2' ' A' ' 195' ' ' GLY . 0.0 OUTLIER -145.91 166.16 26.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.399 -0.813 . . . . 0.0 109.796 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -84.4 -36.55 22.35 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.138 -0.976 . . . . 0.0 110.409 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.07 -170.98 2.83 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.743 0.782 . . . . 0.0 110.782 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 53.54 -160.58 0.13 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.666 0.746 . . . . 0.0 110.575 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -60.79 -29.59 69.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.668 -0.645 . . . . 0.0 110.241 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.402 ' HA2' ' HG2' ' A' ' 190' ' ' LYS . . . 105.38 -21.87 34.05 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.71 172.84 12.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.083 -1.245 . . . . 0.0 110.616 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ASN . . . . . 0.517 ' H ' HG13 ' A' ' 187' ' ' VAL . 1.8 m-80 -134.65 -148.9 0.33 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.585 -0.697 . . . . 0.0 109.48 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -173.73 81.25 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.228 -0.92 . . . . 0.0 110.393 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.431 ' HB3' ' HB ' ' A' ' 186' ' ' VAL . 12.1 t80 -69.64 123.55 21.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.372 -0.83 . . . . 0.0 109.96 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -138.26 122.0 17.55 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.214 -0.929 . . . . 0.0 109.949 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 144.01 -145.2 14.61 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.53 112.92 19.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -1.132 . . . . 0.0 110.333 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.435 ' C ' HG23 ' A' ' 204' ' ' THR . 83.6 t -74.72 109.57 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.103 -0.998 . . . . 0.0 110.03 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.435 HG23 ' C ' ' A' ' 203' ' ' VAL . 71.9 p -147.95 151.67 36.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.315 -0.865 . . . . 0.0 110.47 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 12.5 tttm -46.84 -55.14 8.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.468 -0.77 . . . . 0.0 110.928 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -54.65 -28.14 44.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.357 -0.839 . . . . 0.0 110.479 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 24.8 m-20 -86.18 -44.38 12.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 0.0 110.396 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 80.4 mt -57.28 -55.02 40.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.938 . . . . 0.0 110.695 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 8.0 mp -50.99 -50.32 58.61 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.116 -0.99 . . . . 0.0 110.653 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.01 -37.16 76.26 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.251 -0.906 . . . . 0.0 110.497 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.417 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 8.9 t80 -64.36 -60.46 3.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.145 -0.972 . . . . 0.0 110.472 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 8.9 mt -53.77 -47.37 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.337 -0.852 . . . . 0.0 110.697 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.6 mmtt -50.79 -23.21 2.57 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.235 -0.916 . . . . 0.0 110.863 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -96.69 -16.13 21.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.167 -0.958 . . . . 0.0 110.862 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.552 ' HB3' HD22 ' A' ' 188' ' ' LEU . 77.6 m-20 -94.66 -40.04 10.01 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.108 -0.995 . . . . 0.0 111.33 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 . . . . . 0 N--CA 1.493 1.715 0 O-C-N 120.897 -1.127 . . . . 0.0 110.662 -179.674 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.183 0.515 . . . . 0.0 110.301 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.593 HG22 ' HA2' ' A' ' 168' ' ' GLY . 9.3 t -74.66 169.23 18.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.288 -0.883 . . . . 0.0 110.093 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.4 m -101.66 121.32 41.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.262 -0.899 . . . . 0.0 110.548 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.3 mt -102.34 118.33 59.12 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.336 -0.853 . . . . 0.0 109.619 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.411 ' O ' ' ND2' ' A' ' 172' ' ' ASN . 46.1 Cg_endo -71.0 -18.34 31.27 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.453 1.239 . . . . 0.0 110.848 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.61 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.0 OUTLIER 179.4 -170.03 0.12 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.088 -1.007 . . . . 0.0 111.466 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.96 -29.43 70.72 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.61 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -53.47 -29.9 38.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -1.12 . . . . 0.0 110.159 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.75 -35.17 15.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.906 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.59 -39.16 79.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.327 -0.858 . . . . 0.0 109.996 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.49 -51.11 12.38 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.249 -0.907 . . . . 0.0 110.253 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.0 m -57.27 -20.46 28.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.35 -0.844 . . . . 0.0 110.408 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.9 tp -79.15 -48.14 14.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 110.381 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.699 HG22 ' CB ' ' A' ' 189' ' ' PHE . 90.9 t -60.02 -31.39 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.142 -0.974 . . . . 0.0 110.38 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -85.79 -23.69 27.12 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.238 -0.913 . . . . 0.0 109.582 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.12 -63.41 1.19 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.143 -0.973 . . . . 0.0 110.12 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.4 p -115.7 -176.63 2.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.927 . . . . 0.0 110.259 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.5 -35.56 58.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.872 . . . . 0.0 110.248 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.5 t -120.86 149.29 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.247 -0.908 . . . . 0.0 110.261 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -175.27 130.45 0.29 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.316 -0.865 . . . . 0.0 109.907 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.529 HG11 ' CZ ' ' A' ' 167' ' ' PHE . 9.6 p -119.13 147.99 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.142 -0.974 . . . . 0.0 110.329 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.2 mt -134.83 113.92 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.342 -0.849 . . . . 0.0 109.945 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -80.98 128.23 8.33 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.665 ' CE2' HG12 ' A' ' 175' ' ' VAL . 32.0 m-85 -94.89 76.57 3.6 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.235 -1.156 . . . . 0.0 109.904 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -96.63 139.21 33.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 110.965 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.39 -26.89 26.16 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.425 -0.797 . . . . 0.0 109.576 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -137.96 78.39 1.68 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.51 -0.744 . . . . 0.0 109.508 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.431 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 27.3 m -50.36 -23.86 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.349 -0.844 . . . . 0.0 110.717 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -84.66 10.59 10.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 110.892 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 11.2 p -88.11 -161.65 0.75 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.963 -1.085 . . . . 0.0 110.187 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.05 -42.81 10.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.262 -0.899 . . . . 0.0 110.344 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.0 m -59.4 -28.66 67.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.158 -0.964 . . . . 0.0 110.355 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.431 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -78.8 -31.26 45.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.309 -0.87 . . . . 0.0 110.174 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -58.94 -25.43 63.48 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.21 -0.931 . . . . 0.0 109.96 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -75.37 -46.31 33.84 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.394 -0.816 . . . . 0.0 110.133 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -49.97 -56.56 10.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 110.476 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 156' ' ' LEU . 64.9 mt -49.36 -52.29 29.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.42 -0.8 . . . . 0.0 110.584 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.414 ' HB3' ' HD2' ' A' ' 205' ' ' LYS . 1.6 mm100 -51.82 -46.49 64.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.422 -0.799 . . . . 0.0 110.36 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.4 -39.81 74.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 110.261 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.25 -27.61 69.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 110.298 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -60.42 -47.44 86.1 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.208 -0.932 . . . . 0.0 110.38 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.76 -35.65 56.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.165 -0.959 . . . . 0.0 110.342 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.7 mm -89.8 112.26 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 109.89 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -114.0 13.9 18.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 110.446 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.583 ' O ' HD13 ' A' ' 165' ' ' ILE . 8.4 p-10 -124.32 17.35 9.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.086 -1.009 . . . . 0.0 110.366 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.583 HD13 ' O ' ' A' ' 164' ' ' ASP . 42.2 mm -128.22 141.03 40.01 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.162 -0.961 . . . . 0.0 110.057 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -75.32 73.68 4.42 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.533 1.281 . . . . 0.0 110.409 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.529 ' CZ ' HG11 ' A' ' 140' ' ' VAL . 2.6 m-85 -66.32 132.67 48.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.23 -0.919 . . . . 0.0 110.09 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.593 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -123.99 154.08 17.59 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 16.9 tt -149.2 138.96 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -1.14 . . . . 0.0 110.283 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.3 t -159.46 157.35 29.96 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.113 0.958 . . . . 0.0 110.753 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.2 t -122.79 2.15 9.43 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.495 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 124' ' ' PRO . 60.8 t30 -57.08 123.77 16.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.135 -0.978 . . . . 0.0 110.277 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 77.2 p -49.65 -33.18 14.86 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.253 -0.905 . . . . 0.0 110.504 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -54.1 -32.61 55.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 109.887 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.665 HG12 ' CE2' ' A' ' 143' ' ' PHE . 41.4 t -78.83 -24.45 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -0.872 . . . . 0.0 109.861 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 176' ' ' PHE . 20.6 m-85 -86.64 -44.91 11.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -0.871 . . . . 0.0 109.891 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 5.6 m -70.83 -7.22 43.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -0.844 . . . . 0.0 110.777 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 45.7 tttp -88.09 -47.49 8.46 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.058 -1.026 . . . . 0.0 109.563 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -90.06 12.19 18.47 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.371 -0.831 . . . . 0.0 110.385 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.93 68.6 0.78 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.054 -1.028 . . . . 0.0 110.483 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 62.2 mt -116.23 103.35 10.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 110.143 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -51.57 -26.14 8.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.27 -0.894 . . . . 0.0 110.226 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -149.93 -169.0 3.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 110.023 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 2.1 p30 -63.43 162.94 11.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.202 -0.936 . . . . 0.0 110.137 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -169.18 166.73 39.93 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 186' ' ' VAL . 21.4 m -135.19 114.68 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.247 -1.149 . . . . 0.0 110.11 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.828 HG22 ' HA ' ' A' ' 198' ' ' ASN . 99.5 t -127.29 153.67 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.924 . . . . 0.0 110.082 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.922 HD22 ' HB3' ' A' ' 215' ' ' ASN . 6.1 tt -109.27 137.96 46.36 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.285 -0.884 . . . . 0.0 108.668 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.699 ' CB ' HG22 ' A' ' 133' ' ' VAL . 62.4 m-85 -111.28 135.87 51.2 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.726 -1.234 . . . . 0.0 111.19 -178.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.535 ' HD2' HD23 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -150.16 159.76 44.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.453 -0.779 . . . . 0.0 109.967 179.499 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -83.97 -22.18 31.51 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.242 -0.911 . . . . 0.0 110.491 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.518 ' CZ ' ' HA ' ' A' ' 216' ' ' GLN . 2.4 p90 -90.7 -178.91 5.4 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.284 -0.885 . . . . 0.0 110.633 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 48.79 -159.17 0.05 Allowed 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.659 0.742 . . . . 0.0 110.509 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -60.61 -31.05 70.24 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.583 -0.698 . . . . 0.0 110.293 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 114.58 -42.74 1.85 Allowed Glycine 0 N--CA 1.483 1.822 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.09 177.95 5.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.147 -1.208 . . . . 0.0 110.462 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ASN . . . . . 0.487 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 2.5 m-80 -134.47 -37.3 0.85 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 0.0 110.55 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.828 ' HA ' HG22 ' A' ' 187' ' ' VAL . 4.0 m-80 57.73 83.29 0.11 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.171 -0.955 . . . . 0.0 109.991 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.494 ' HB3' HG23 ' A' ' 186' ' ' VAL . 84.3 t80 -66.61 115.27 6.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.396 -0.815 . . . . 0.0 110.433 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -115.6 80.16 1.4 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.368 -0.832 . . . . 0.0 110.12 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -169.12 -157.6 11.92 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -79.36 122.47 26.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -1.154 . . . . 0.0 110.305 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.467 ' C ' HG23 ' A' ' 204' ' ' THR . 70.6 t -71.87 101.36 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 110.076 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.467 HG23 ' C ' ' A' ' 203' ' ' VAL . 57.9 p -150.27 152.08 33.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.388 -0.82 . . . . 0.0 110.268 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.426 ' HG2' ' CD1' ' A' ' 209' ' ' LEU . 3.9 tttm -49.49 -48.54 47.82 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.321 -0.862 . . . . 0.0 110.426 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -57.1 -39.81 75.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.342 -0.849 . . . . 0.0 110.283 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -80.03 -48.48 13.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.231 -0.918 . . . . 0.0 110.368 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.542 ' O ' HD12 ' A' ' 212' ' ' ILE . 98.8 mt -54.19 -55.44 27.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.935 . . . . 0.0 110.257 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.426 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 8.2 mt -54.35 -29.88 49.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.283 -0.885 . . . . 0.0 110.221 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -76.42 -45.88 29.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.911 . . . . 0.0 110.065 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 197' ' ' ASN . 6.9 t80 -56.46 -62.79 1.48 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.411 -0.806 . . . . 0.0 110.462 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.542 HD12 ' O ' ' A' ' 208' ' ' LEU . 5.8 mt -52.42 -42.56 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.0 110.593 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -56.15 -19.74 14.73 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.218 -0.926 . . . . 0.0 110.786 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -110.92 11.64 22.27 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.198 -0.939 . . . . 0.0 110.755 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.922 ' HB3' HD22 ' A' ' 188' ' ' LEU . 1.3 m120 -91.89 -64.41 1.12 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.946 -1.096 . . . . 0.0 110.611 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' GLN . . . . . 0.518 ' HA ' ' CZ ' ' A' ' 192' ' ' PHE . 5.9 pt20 . . . . . 0 C--N 1.303 -1.427 0 O-C-N 121.289 -0.882 . . . . 0.0 111.002 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.289 0.566 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.558 HG22 ' HA2' ' A' ' 168' ' ' GLY . 8.9 t -97.87 166.89 11.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.182 -0.949 . . . . 0.0 110.15 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.8 m -115.02 103.92 11.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.942 . . . . 0.0 110.346 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.566 HD22 ' HB1' ' A' ' 128' ' ' ALA . 39.3 mt -77.85 126.2 84.43 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.299 -0.876 . . . . 0.0 110.015 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.27 -40.25 2.47 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.418 1.22 . . . . 0.0 110.508 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.541 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.9 OUTLIER -153.82 -170.59 3.62 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.308 -0.87 . . . . 0.0 110.813 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.02 -29.93 72.19 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.541 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -52.15 -30.36 26.29 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.157 -1.202 . . . . 0.0 110.371 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.566 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -89.79 -38.7 13.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.947 . . . . 0.0 110.032 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.53 -25.22 24.5 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.283 -0.885 . . . . 0.0 110.036 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -86.62 -54.49 4.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.353 -0.842 . . . . 0.0 110.115 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.07 -18.31 33.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.912 . . . . 0.0 110.291 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.535 HD21 ' HB2' ' A' ' 166' ' ' PRO . 3.3 tt -73.25 -59.35 2.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 0.0 109.747 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.59 HG22 ' CB ' ' A' ' 189' ' ' PHE . 49.8 t -53.01 -37.21 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.414 -0.803 . . . . 0.0 110.257 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -73.16 -25.58 60.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.274 -0.891 . . . . 0.0 110.313 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.81 -48.82 69.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 110.28 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 78.0 p -135.65 173.86 11.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.224 -0.922 . . . . 0.0 110.338 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.91 -41.22 91.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -0.862 . . . . 0.0 110.309 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 95.7 t -112.97 151.02 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.283 -0.886 . . . . 0.0 110.371 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.526 ' HB1' HD22 ' A' ' 132' ' ' LEU . . . -174.4 137.79 0.52 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.854 . . . . 0.0 109.845 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.484 HG11 ' CZ ' ' A' ' 167' ' ' PHE . 9.1 p -123.38 147.09 27.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.203 -0.936 . . . . 0.0 110.302 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.486 HD12 ' CD1' ' A' ' 189' ' ' PHE . 3.4 mt -135.79 115.82 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.265 -0.897 . . . . 0.0 109.666 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -79.82 134.25 13.39 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.908 ' CE2' HG12 ' A' ' 175' ' ' VAL . 11.5 m-85 -103.48 71.25 1.08 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.181 -1.188 . . . . 0.0 109.615 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.529 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 15.1 m-85 -91.74 137.45 32.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.026 -1.046 . . . . 0.0 110.992 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.483 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -91.19 -31.94 15.98 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 121.614 0.721 . . . . 0.0 109.846 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.566 ' C ' HG23 ' A' ' 147' ' ' VAL . 1.7 t70 -89.5 -41.49 12.01 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.534 0.683 . . . . 0.0 110.166 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.566 HG23 ' C ' ' A' ' 146' ' ' ASP . 2.5 t 72.97 -51.08 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.859 -0.526 . . . . 0.0 110.714 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -90.72 8.87 32.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.093 -1.005 . . . . 0.0 110.551 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 19.8 p -70.34 -164.68 0.09 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.863 -1.148 . . . . 0.0 109.971 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.41 -31.18 16.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.895 . . . . 0.0 110.277 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.5 p -68.49 -25.6 65.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.906 . . . . 0.0 110.123 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.39 -34.01 25.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.9 . . . . 0.0 110.173 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -53.2 -44.77 68.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.355 -0.841 . . . . 0.0 110.4 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -66.89 -36.83 83.17 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.221 -0.925 . . . . 0.0 110.316 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.434 ' O ' ' HB3' ' A' ' 158' ' ' ALA . 4.5 t80 -51.58 -58.22 6.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.392 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.6 mt -50.52 -54.25 23.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.4 -0.813 . . . . 0.0 110.45 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -50.88 -29.93 13.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.258 -0.901 . . . . 0.0 110.342 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 155' ' ' PHE . . . -75.63 -56.47 4.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.338 -0.852 . . . . 0.0 110.006 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.623 ' HB2' ' CD2' ' A' ' 167' ' ' PHE . . . -54.86 -33.58 62.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 110.059 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -66.69 -28.7 68.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.331 -0.856 . . . . 0.0 110.226 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -64.67 -42.88 95.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.285 -0.884 . . . . 0.0 110.231 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.402 HG13 ' OD1' ' A' ' 164' ' ' ASP . 4.1 tt -93.12 164.42 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.254 -0.904 . . . . 0.0 110.209 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 163' ' ' ASP . 17.1 p-10 -145.23 19.2 1.57 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.101 -0.999 . . . . 0.0 110.467 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.402 ' OD1' HG13 ' A' ' 162' ' ' ILE . 5.0 p-10 -125.57 8.82 7.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.196 -0.94 . . . . 0.0 110.652 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 45.8 mm -125.53 137.21 29.46 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.04 -1.037 . . . . 0.0 109.798 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.535 ' HB2' HD21 ' A' ' 132' ' ' LEU . 48.2 Cg_endo -73.69 78.97 2.33 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.568 1.299 . . . . 0.0 110.724 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.623 ' CD2' ' HB2' ' A' ' 159' ' ' ALA . 2.9 m-85 -71.4 125.64 27.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.186 -0.946 . . . . 0.0 109.694 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.558 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -123.33 156.15 17.59 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.134 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 14.7 tt -150.17 142.95 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.459 -1.024 . . . . 0.0 109.912 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.4 t -164.98 157.57 16.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.117 -0.989 . . . . 0.0 110.892 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' SER . . . . . 0.4 ' HB3' ' CG2' ' A' ' 147' ' ' VAL . 91.2 p -122.97 3.58 9.38 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.375 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -54.98 122.05 10.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.158 -0.964 . . . . 0.0 110.306 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 83.9 p -51.52 -31.85 25.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.321 -0.862 . . . . 0.0 110.477 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -54.32 -33.8 59.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.142 -0.974 . . . . 0.0 109.809 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.908 HG12 ' CE2' ' A' ' 143' ' ' PHE . 41.0 t -79.78 -24.46 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.44 -0.788 . . . . 0.0 109.642 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 176' ' ' PHE . 10.8 m-85 -79.44 -54.96 5.41 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.441 -0.787 . . . . 0.0 109.907 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 29.9 t -66.53 -14.27 62.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.366 -0.834 . . . . 0.0 110.562 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 11.3 tttt -82.01 -44.94 15.99 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.086 -1.009 . . . . 0.0 110.034 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -90.7 8.08 36.25 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.15 -0.969 . . . . 0.0 110.674 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 50.69 67.81 0.87 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.05 -1.032 . . . . 0.0 110.676 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.454 HD13 ' CD2' ' A' ' 143' ' ' PHE . 3.4 mt -109.06 124.43 50.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.226 -0.921 . . . . 0.0 110.137 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -62.08 -15.83 47.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.108 -0.995 . . . . 0.0 110.012 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -175.26 -157.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.233 -0.917 . . . . 0.0 109.551 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 8.4 p-10 -71.57 160.45 32.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.087 -1.008 . . . . 0.0 109.945 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -177.33 172.97 45.82 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 74.9 t -126.5 107.54 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.385 -1.068 . . . . 0.0 110.006 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 197' ' ' ASN . 75.0 t -111.57 148.22 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.339 -0.851 . . . . 0.0 109.94 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.805 HD22 ' HB3' ' A' ' 215' ' ' ASN . 6.3 tt -108.16 143.74 36.54 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.008 -1.057 . . . . 0.0 109.421 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.59 ' CB ' HG22 ' A' ' 133' ' ' VAL . 59.9 m-85 -115.62 118.6 33.56 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.017 -1.052 . . . . 0.0 110.874 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.458 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -130.55 164.02 25.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.279 -0.888 . . . . 0.0 109.996 179.513 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -88.86 -24.9 22.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.165 -0.959 . . . . 0.0 110.148 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.458 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 1.6 p90 -91.01 -176.17 4.55 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.46 -0.775 . . . . 0.0 110.741 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 46.22 -159.13 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.605 0.717 . . . . 0.0 110.966 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -50.9 -56.33 12.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.66 -0.65 . . . . 0.0 110.284 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 125.17 -21.71 6.43 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.4 mtm180 -143.63 156.91 44.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.132 -1.216 . . . . 0.0 110.571 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ASN . . . . . 0.473 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.1 m-80 -131.46 -167.35 1.84 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.36 -0.837 . . . . 0.0 109.84 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -156.82 80.69 0.94 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.442 -0.787 . . . . 0.0 109.892 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.534 ' CE2' HG22 ' A' ' 203' ' ' VAL . 84.7 t80 -51.3 121.87 6.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.138 -0.976 . . . . 0.0 110.484 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.03 91.72 3.49 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.344 -0.847 . . . . 0.0 110.271 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 165.34 177.41 37.71 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -55.96 107.52 0.36 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.25 -1.147 . . . . 0.0 110.237 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.534 HG22 ' CE2' ' A' ' 199' ' ' PHE . 93.1 t -64.84 113.66 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -0.879 . . . . 0.0 110.071 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 12.5 p -150.33 157.36 42.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.87 . . . . 0.0 110.475 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.469 ' O ' HD12 ' A' ' 209' ' ' LEU . 11.4 tttt -50.09 -52.25 36.26 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.196 -0.94 . . . . 0.0 110.597 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' GLU . . . . . 0.448 ' HG3' ' N ' ' A' ' 207' ' ' ASN . 12.3 pt-20 -55.91 -40.04 72.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.221 -0.924 . . . . 0.0 110.329 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.448 ' N ' ' HG3' ' A' ' 206' ' ' GLU . 87.6 m-20 -78.12 -48.01 16.93 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.271 -0.893 . . . . 0.0 110.253 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.667 ' O ' HD12 ' A' ' 212' ' ' ILE . 68.2 mt -53.53 -57.99 8.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.221 -0.924 . . . . 0.0 110.346 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 205' ' ' LYS . 0.4 OUTLIER -53.54 -22.83 9.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.293 -0.88 . . . . 0.0 110.467 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -81.76 -49.62 10.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.099 -1.001 . . . . 0.0 110.093 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -58.97 -56.92 16.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.317 -0.864 . . . . 0.0 110.428 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.667 HD12 ' O ' ' A' ' 208' ' ' LEU . 6.9 mt -55.22 -49.03 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.267 -0.896 . . . . 0.0 110.621 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -50.33 -27.35 6.04 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.173 -0.954 . . . . 0.0 110.598 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -88.0 -24.67 23.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -0.925 . . . . 0.0 110.412 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.805 ' HB3' HD22 ' A' ' 188' ' ' LEU . 70.8 m-80 -89.58 -33.59 16.65 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.263 -0.898 . . . . 0.0 110.753 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 O-C-N 121.13 -0.981 . . . . 0.0 110.63 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.209 0.528 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.434 ' HB ' ' HA2' ' A' ' 168' ' ' GLY . 28.6 m -97.53 95.7 7.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 110.172 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 95.9 m -61.34 104.24 0.38 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -0.9 . . . . 0.0 109.88 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.411 ' HB2' ' HB ' ' A' ' 170' ' ' THR . 0.8 OUTLIER -82.98 137.1 43.5 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.124 -0.985 . . . . 0.0 110.169 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.437 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 48.9 Cg_endo -73.33 -39.62 2.0 Allowed 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.532 1.28 . . . . 0.0 110.206 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.46 ' C ' HG22 ' A' ' 175' ' ' VAL . 0.4 OUTLIER -157.06 -169.11 2.84 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.992 0.901 . . . . 0.0 111.085 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.429 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -66.4 -31.7 79.66 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -53.21 -27.14 20.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.233 -1.157 . . . . 0.0 110.119 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.437 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -88.2 -32.75 18.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.87 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.431 ' O ' HG23 ' A' ' 133' ' ' VAL . . . -56.85 -41.54 78.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.349 -0.844 . . . . 0.0 109.946 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.77 -52.79 11.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.331 -0.856 . . . . 0.0 110.086 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.96 -40.31 63.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.333 -0.854 . . . . 0.0 110.099 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.779 HD23 HD11 ' A' ' 141' ' ' ILE . 21.3 tp -53.55 -50.72 64.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.247 -0.908 . . . . 0.0 109.961 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.76 HG22 ' HB3' ' A' ' 189' ' ' PHE . 39.9 t -53.63 -32.71 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.459 -0.775 . . . . 0.0 110.186 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -87.54 -32.11 19.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.186 -0.946 . . . . 0.0 110.377 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 59.7 p -52.0 -46.29 64.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.193 -0.942 . . . . 0.0 110.382 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.2 p -132.29 163.94 27.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.145 -0.972 . . . . 0.0 110.109 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -63.4 -43.66 96.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.902 . . . . 0.0 110.166 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 28.1 m -117.63 147.99 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.215 -0.928 . . . . 0.0 110.422 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -175.27 126.34 0.26 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.364 -0.835 . . . . 0.0 110.031 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.566 HG12 ' HA ' ' A' ' 167' ' ' PHE . 13.7 p -97.91 147.96 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 121.119 -0.988 . . . . 0.0 110.535 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.779 HD11 HD23 ' A' ' 132' ' ' LEU . 44.7 mt -141.43 107.71 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.91 . . . . 0.0 109.734 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -84.36 163.15 38.89 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.562 ' CE2' HG12 ' A' ' 175' ' ' VAL . 26.2 m-85 -126.72 70.42 1.27 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.632 -0.923 . . . . 0.0 109.647 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.5 ' CZ ' HG21 ' A' ' 203' ' ' VAL . 23.9 m-85 -97.21 146.02 25.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 111.071 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.61 -28.22 18.57 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.145 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.89 84.17 1.94 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -0.833 . . . . 0.0 109.94 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.9 t -66.89 -12.45 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.345 -0.847 . . . . 0.0 110.8 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -99.07 4.03 46.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.009 -1.057 . . . . 0.0 110.805 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 38.7 p -85.97 -159.52 0.47 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.824 -1.173 . . . . 0.0 110.27 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -88.82 -35.34 16.66 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.232 -0.918 . . . . 0.0 110.135 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.1 t -54.89 -33.24 61.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.34 -0.85 . . . . 0.0 110.226 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.495 ' O ' HD12 ' A' ' 156' ' ' LEU . . . -82.49 -33.51 28.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.917 . . . . 0.0 110.203 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -53.46 -50.48 65.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.879 . . . . 0.0 110.128 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -57.34 -41.96 81.02 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.369 -0.832 . . . . 0.0 110.124 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.412 ' CD2' HD12 ' A' ' 169' ' ' ILE . 4.2 t80 -52.22 -57.31 10.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 110.1 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.495 HD12 ' O ' ' A' ' 152' ' ' ALA . 0.6 OUTLIER -52.65 -55.13 24.68 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.42 -0.8 . . . . 0.0 110.207 179.569 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -47.64 -48.58 28.7 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.414 -0.804 . . . . 0.0 110.551 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.702 ' HB2' ' HA ' ' A' ' 205' ' ' LYS . . . -64.84 -43.6 92.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 109.766 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.05 -35.28 74.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.372 -0.83 . . . . 0.0 109.862 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -68.16 -29.09 67.89 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.319 -0.863 . . . . 0.0 110.301 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.32 -61.61 2.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.197 -0.939 . . . . 0.0 110.171 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 73.6 mt -89.67 149.28 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.928 . . . . 0.0 109.95 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.47 -31.06 4.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.205 -0.934 . . . . 0.0 110.375 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -68.74 -14.51 63.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.22 -0.925 . . . . 0.0 110.698 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.531 ' CG2' ' CE1' ' A' ' 167' ' ' PHE . 37.1 mm -98.46 123.98 48.31 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.08 -1.013 . . . . 0.0 110.263 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -83.38 107.6 1.44 Allowed 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.471 1.248 . . . . 0.0 110.064 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.566 ' HA ' HG12 ' A' ' 140' ' ' VAL . 0.4 OUTLIER -99.25 154.46 18.15 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.12 -0.988 . . . . 0.0 109.969 -179.489 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.434 ' HA2' ' HB ' ' A' ' 121' ' ' THR . . . -137.71 145.03 16.57 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.52 HG23 ' O ' ' A' ' 169' ' ' ILE . 16.8 tt -143.27 126.31 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.269 -1.136 . . . . 0.0 110.231 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.502 ' CG2' HG11 ' A' ' 175' ' ' VAL . 2.8 t -143.77 157.96 44.01 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.146 0.974 . . . . 0.0 111.131 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.7 t -127.09 5.37 6.46 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.181 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.428 ' ND2' ' HB2' ' A' ' 174' ' ' ASP . 43.4 t30 -62.0 128.32 35.58 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.182 -0.949 . . . . 0.0 110.231 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 9.0 t -52.23 -33.88 43.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.187 -0.946 . . . . 0.0 110.323 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.428 ' HB2' ' ND2' ' A' ' 172' ' ' ASN . 0.3 OUTLIER -54.67 -34.23 61.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.949 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.562 HG12 ' CE2' ' A' ' 143' ' ' PHE . 57.3 t -78.35 -27.19 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.537 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.401 ' N ' ' CD1' ' A' ' 176' ' ' PHE . 12.5 m-85 -81.54 -42.45 20.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.424 -0.798 . . . . 0.0 109.805 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.03 -7.47 46.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.343 -0.848 . . . . 0.0 110.629 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.86 -45.11 9.98 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.901 -1.124 . . . . 0.0 109.304 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -89.59 5.07 47.25 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.742 -0.599 . . . . 0.0 110.555 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.42 ' CG ' ' O ' ' A' ' 180' ' ' GLN . 0.0 OUTLIER 51.81 58.81 5.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.1 -1.0 . . . . 0.0 110.722 179.587 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.4 mt -98.66 130.35 45.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.063 -1.023 . . . . 0.0 109.824 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -87.06 12.22 11.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.1 -1.0 . . . . 0.0 110.295 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 13.8 pttp 179.13 -163.34 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.227 -0.921 . . . . 0.0 109.618 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.411 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 8.2 p-10 -87.47 156.63 19.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.287 -0.883 . . . . 0.0 110.133 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -177.54 152.09 11.58 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.426 HG11 ' CD2' ' A' ' 208' ' ' LEU . 88.2 t -103.65 128.4 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.317 -1.108 . . . . 0.0 110.468 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 83.1 t -134.56 151.48 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.363 -0.836 . . . . 0.0 109.655 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.504 HD22 ' HB3' ' A' ' 215' ' ' ASN . 7.8 tt -113.21 158.67 20.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.996 -1.065 . . . . 0.0 109.915 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.76 ' HB3' HG22 ' A' ' 133' ' ' VAL . 52.6 m-85 -128.67 130.03 46.63 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.078 -1.014 . . . . 0.0 110.459 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.21 166.61 23.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.877 . . . . 0.0 110.069 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.01 -33.73 18.27 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.199 -0.938 . . . . 0.0 110.128 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -90.91 -173.4 3.68 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.443 -0.786 . . . . 0.0 110.647 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 51.95 -159.73 0.11 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.434 -0.792 . . . . 0.0 110.458 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -54.93 -54.17 46.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.634 -0.666 . . . . 0.0 110.271 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 128.65 -38.49 2.04 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.18 165.31 21.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -1.166 . . . . 0.0 110.359 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ASN . . . . . 0.463 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.8 m-80 -128.72 -151.31 0.47 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.3 -0.875 . . . . 0.0 109.865 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -174.37 78.37 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.279 -0.888 . . . . 0.0 110.381 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.417 ' CB ' ' O ' ' A' ' 186' ' ' VAL . 28.3 t80 -57.95 118.7 5.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 109.838 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -125.53 38.8 4.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.302 -0.874 . . . . 0.0 110.413 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -128.83 -149.24 6.86 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -90.71 97.38 11.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.149 -1.206 . . . . 0.0 109.928 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 203' ' ' VAL . 7.4 p -51.33 102.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.212 -0.93 . . . . 0.0 110.373 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 26.2 p -140.93 150.59 43.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.357 -0.84 . . . . 0.0 110.323 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.881 ' O ' HD12 ' A' ' 209' ' ' LEU . 3.7 tttp -47.21 -31.31 3.56 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.359 -0.838 . . . . 0.0 110.946 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -79.42 -33.06 42.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.178 -0.951 . . . . 0.0 110.316 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 59.9 m-20 -83.57 -47.06 11.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 110.289 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.667 HD21 HG23 ' A' ' 203' ' ' VAL . 65.6 mt -52.87 -48.65 66.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 110.33 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.881 HD12 ' O ' ' A' ' 205' ' ' LYS . 13.6 mt -59.26 -29.13 67.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 110.095 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.47 -34.42 41.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 0.0 110.144 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.412 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 7.1 t80 -62.88 -62.98 1.35 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.306 -0.871 . . . . 0.0 110.192 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.404 HG22 ' OE1' ' A' ' 216' ' ' GLN . 7.0 mt -51.03 -49.75 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.391 -0.818 . . . . 0.0 110.473 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -48.7 -25.08 1.62 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.364 -0.835 . . . . 0.0 110.868 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.75 -14.77 21.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.125 -0.984 . . . . 0.0 110.815 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.504 ' HB3' HD22 ' A' ' 188' ' ' LEU . 73.4 m-80 -102.27 -24.29 13.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.078 -1.014 . . . . 0.0 110.767 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' GLN . . . . . 0.404 ' OE1' HG22 ' A' ' 212' ' ' ILE . 16.1 pt20 . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.066 -1.021 . . . . 0.0 110.736 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.33 0.586 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.444 ' HB ' ' HA2' ' A' ' 168' ' ' GLY . 3.9 m -119.92 112.69 19.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.348 -0.845 . . . . 0.0 109.729 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 169' ' ' ILE . 53.5 m -68.57 144.04 54.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 110.047 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.607 HD22 ' HB1' ' A' ' 128' ' ' ALA . 20.5 mt -125.3 143.98 46.17 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.0 110.106 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.06 -40.33 2.58 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.705 1.371 . . . . 0.0 110.293 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.534 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.2 OUTLIER -170.5 -169.93 0.87 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.346 -0.846 . . . . 0.0 110.636 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.543 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -54.74 -27.77 44.35 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.534 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -52.88 -31.51 39.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.194 -1.18 . . . . 0.0 110.434 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.607 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -89.77 -37.5 14.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.177 -0.952 . . . . 0.0 109.912 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.591 ' O ' HG23 ' A' ' 133' ' ' VAL . . . -58.0 -33.19 68.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.332 -0.855 . . . . 0.0 110.004 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -74.28 -51.2 15.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.06 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.14 -30.71 71.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.307 -0.871 . . . . 0.0 110.07 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.1 tp -59.74 -48.68 80.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.207 -0.933 . . . . 0.0 109.961 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 129' ' ' ALA . 38.5 t -56.05 -52.13 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 110.07 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -65.59 -20.21 66.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.234 -0.916 . . . . 0.0 110.243 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.2 t -52.49 -51.43 59.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.146 -0.971 . . . . 0.0 110.351 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 53.7 p -137.31 -171.88 3.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.252 -0.905 . . . . 0.0 110.313 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -75.57 -39.74 57.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -0.878 . . . . 0.0 110.169 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 87.1 t -119.43 147.29 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.25 -0.906 . . . . 0.0 110.175 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.423 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -170.89 121.94 0.57 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.201 -0.937 . . . . 0.0 110.203 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.43 ' CG1' ' HA ' ' A' ' 167' ' ' PHE . 14.8 p -104.41 148.78 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.311 -0.868 . . . . 0.0 110.361 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.47 ' O ' ' CE2' ' A' ' 143' ' ' PHE . 51.1 mt -133.79 107.71 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.258 -0.902 . . . . 0.0 109.992 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.49 122.81 6.91 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.47 ' CE2' ' O ' ' A' ' 141' ' ' ILE . 93.0 m-85 -101.63 67.48 1.12 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.273 -1.134 . . . . 0.0 109.961 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -95.48 146.34 24.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.091 -1.006 . . . . 0.0 110.418 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.46 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -91.08 -32.5 15.85 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.586 -0.696 . . . . 0.0 109.585 179.083 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.46 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 88.5 m-20 -122.32 69.7 0.97 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.517 -0.739 . . . . 0.0 109.862 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.502 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 26.4 m -53.8 -21.31 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.206 -0.934 . . . . 0.0 110.51 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -79.74 4.32 16.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.09 -1.006 . . . . 0.0 111.008 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 32.9 p -87.34 -163.72 0.97 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.904 -1.122 . . . . 0.0 110.284 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.87 -40.83 12.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.0 110.103 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.83 -28.99 59.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.187 -0.946 . . . . 0.0 109.807 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.767 ' O ' HD12 ' A' ' 156' ' ' LEU . . . -79.68 -35.26 39.44 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.332 -0.855 . . . . 0.0 109.849 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -51.32 -44.99 62.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.277 -0.89 . . . . 0.0 110.192 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.412 ' OE1' ' HA ' ' A' ' 204' ' ' THR . 21.5 mm-40 -54.7 -47.36 73.78 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.156 -0.965 . . . . 0.0 109.514 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.568 ' HE1' HG13 ' A' ' 186' ' ' VAL . 4.7 t80 -52.48 -56.44 15.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 0.0 109.831 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.767 HD12 ' O ' ' A' ' 152' ' ' ALA . 2.6 mp -51.44 -58.27 6.71 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.362 -0.836 . . . . 0.0 110.095 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -49.61 -41.79 43.12 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.343 -0.848 . . . . 0.0 110.313 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 205' ' ' LYS . . . -74.61 -26.88 60.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.995 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.2 -29.03 42.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 0.0 110.067 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -63.4 -37.82 88.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 110.111 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.97 -29.82 69.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.358 -0.838 . . . . 0.0 109.961 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.571 HG21 ' CE1' ' A' ' 167' ' ' PHE . 18.2 mm -90.1 122.48 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.423 -0.798 . . . . 0.0 109.634 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -123.88 2.07 8.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.243 -0.91 . . . . 0.0 110.727 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -109.36 -19.85 13.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.952 -1.092 . . . . 0.0 110.252 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.468 ' CG2' ' HD2' ' A' ' 166' ' ' PRO . 41.4 mm -91.4 146.1 32.69 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.146 -0.971 . . . . 0.0 110.182 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.468 ' HD2' ' CG2' ' A' ' 165' ' ' ILE . 44.9 Cg_endo -84.25 79.26 2.64 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.807 1.425 . . . . 0.0 110.089 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.571 ' CE1' HG21 ' A' ' 162' ' ' ILE . 3.6 m-85 -71.92 126.94 31.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.406 -0.809 . . . . 0.0 110.589 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.444 ' HA2' ' HB ' ' A' ' 121' ' ' THR . . . -118.69 157.24 15.33 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 122' ' ' THR . 6.3 tt -150.42 141.96 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.255 -1.144 . . . . 0.0 110.618 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.2 t -158.25 155.52 29.07 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.004 0.907 . . . . 0.0 110.463 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' SER . . . . . 0.429 ' HB2' ' HA ' ' A' ' 145' ' ' LYS . 78.8 p -127.47 7.83 6.41 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.38 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -67.39 119.84 12.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.073 -1.017 . . . . 0.0 110.383 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.431 ' HA ' ' HB2' ' A' ' 176' ' ' PHE . 10.5 p -49.02 -28.17 3.76 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.211 -0.93 . . . . 0.0 110.535 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -54.8 -41.09 70.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.115 -0.991 . . . . 0.0 109.734 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.543 HG22 ' N ' ' A' ' 126' ' ' GLY . 45.1 t -78.77 -23.68 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.381 -0.824 . . . . 0.0 109.691 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.431 ' HB2' ' HA ' ' A' ' 173' ' ' SER . 9.0 m-85 -72.43 -51.81 18.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.394 -0.816 . . . . 0.0 109.531 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 33.9 t -70.58 -17.06 62.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.482 -0.761 . . . . 0.0 110.366 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 23.9 tttm -73.52 -52.43 13.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.137 -0.977 . . . . 0.0 109.96 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -90.53 22.55 3.4 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.221 -0.924 . . . . 0.0 110.53 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 54.56 56.96 6.19 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.129 -0.982 . . . . 0.0 110.176 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 86.1 mt -113.13 96.63 6.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 110.181 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -63.18 -19.15 64.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.291 -0.881 . . . . 0.0 110.427 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.51 -159.74 1.05 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.194 -0.941 . . . . 0.0 110.152 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 32.1 m-20 -53.52 152.31 5.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.182 -0.949 . . . . 0.0 109.896 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -153.4 136.74 5.44 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.59 -1.29 . . . . 0.0 110.008 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.568 HG13 ' HE1' ' A' ' 155' ' ' PHE . 59.0 t -121.53 84.43 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.367 -1.079 . . . . 0.0 109.479 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.924 HG22 ' HA ' ' A' ' 198' ' ' ASN . 98.2 t -111.55 150.11 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.111 -0.993 . . . . 0.0 110.352 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.597 HD12 HD12 ' A' ' 212' ' ' ILE . 6.0 tt -106.55 150.88 25.7 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.182 -0.949 . . . . 0.0 108.833 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -120.64 116.58 25.6 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.863 -1.148 . . . . 0.0 110.438 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.527 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -124.6 170.62 10.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.0 110.153 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.26 -24.12 19.1 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.316 -0.865 . . . . 0.0 110.339 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.527 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.4 OUTLIER -91.25 -171.71 3.05 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.881 179.666 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 47.23 -154.67 0.06 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.699 0.761 . . . . 0.0 110.502 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.45 -44.45 91.1 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.619 -0.675 . . . . 0.0 110.191 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 131.19 -39.88 1.72 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.409 ' HG2' HG11 ' A' ' 187' ' ' VAL . 2.6 mtm180 -116.65 175.55 5.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.16 -1.2 . . . . 0.0 110.248 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ASN . . . . . 0.465 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 2.7 m-80 -134.93 -44.99 0.72 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.271 -0.893 . . . . 0.0 110.952 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.924 ' HA ' HG22 ' A' ' 187' ' ' VAL . 0.9 OUTLIER 65.46 89.04 0.1 Allowed 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.27 -0.894 . . . . 0.0 110.196 -179.251 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' A' ' 186' ' ' VAL . 45.5 t80 -56.62 123.79 16.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.464 -0.772 . . . . 0.0 110.501 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -120.65 101.37 7.69 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.212 -0.93 . . . . 0.0 110.269 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 152.99 -159.32 28.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -81.51 118.66 22.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -1.1 . . . . 0.0 110.357 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 78.2 t -68.07 103.5 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.93 . . . . 0.0 110.056 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.412 ' HA ' ' OE1' ' A' ' 154' ' ' GLN . 14.0 p -138.68 149.03 44.69 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.444 -0.785 . . . . 0.0 109.858 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.508 ' HA ' ' HB2' ' A' ' 158' ' ' ALA . 31.4 tttt -51.05 -39.19 55.37 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.223 -0.923 . . . . 0.0 110.321 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' GLU . . . . . 0.412 ' CG ' ' N ' ' A' ' 207' ' ' ASN . 11.5 pt-20 -66.11 -40.32 90.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.295 -0.878 . . . . 0.0 110.001 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.412 ' N ' ' CG ' ' A' ' 206' ' ' GLU . 79.3 m-20 -78.33 -30.83 48.38 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.384 -0.822 . . . . 0.0 109.923 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.427 HD13 ' HA ' ' A' ' 155' ' ' PHE . 64.0 mt -65.5 -55.84 15.62 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.459 -0.776 . . . . 0.0 110.272 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.494 HD12 ' O ' ' A' ' 205' ' ' LYS . 5.9 mt -56.03 -25.65 45.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 110.289 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -80.49 -48.58 12.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.324 -0.86 . . . . 0.0 110.029 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.421 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 10.8 t80 -51.55 -57.67 8.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.341 -0.849 . . . . 0.0 110.468 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.597 HD12 HD12 ' A' ' 188' ' ' LEU . 6.9 mm -53.32 -52.37 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.329 -0.857 . . . . 0.0 110.133 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.439 ' HA ' ' HG2' ' A' ' 216' ' ' GLN . 3.7 tmtt? -52.99 -31.51 41.29 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.624 -0.673 . . . . 0.0 110.586 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -77.44 -15.6 59.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.884 . . . . 0.0 110.702 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.483 ' HB3' HD22 ' A' ' 188' ' ' LEU . 74.3 m-20 -105.8 -40.31 5.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.119 -0.988 . . . . 0.0 110.55 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' GLN . . . . . 0.439 ' HG2' ' HA ' ' A' ' 213' ' ' LYS . 19.2 pt20 . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.095 -1.003 . . . . 0.0 110.133 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.289 0.566 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.429 ' HB ' ' HA2' ' A' ' 168' ' ' GLY . 23.8 m -104.91 116.82 32.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.291 -0.88 . . . . 0.0 109.833 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.6 m -78.86 118.49 20.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.302 -0.874 . . . . 0.0 110.221 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.556 HD23 ' HB1' ' A' ' 128' ' ' ALA . 0.9 OUTLIER -101.84 128.8 27.93 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.171 -0.956 . . . . 0.0 110.027 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.494 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 47.7 Cg_endo -73.22 -27.87 13.18 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.447 1.235 . . . . 0.0 110.107 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.535 ' C ' HG22 ' A' ' 175' ' ' VAL . 0.2 OUTLIER -164.93 -170.49 1.97 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.063 0.935 . . . . 0.0 111.077 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.495 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -64.53 -25.93 70.49 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.441 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -58.72 -30.56 67.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.298 -1.119 . . . . 0.0 110.183 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.556 ' HB1' HD23 ' A' ' 123' ' ' LEU . . . -84.45 -20.92 30.98 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.004 -1.06 . . . . 0.0 109.625 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.529 ' HA ' HD13 ' A' ' 141' ' ' ILE . . . -81.36 -23.98 37.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.426 -0.796 . . . . 0.0 110.266 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 127' ' ' ALA . 13.9 pt-20 -84.78 -36.47 21.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.94 . . . . 0.0 110.171 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.57 -32.45 53.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.334 -0.854 . . . . 0.0 110.552 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.451 ' HB3' HD11 ' A' ' 141' ' ' ILE . 6.3 tp -59.05 -52.97 63.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.058 -1.026 . . . . 0.0 110.045 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.745 HG22 ' CB ' ' A' ' 189' ' ' PHE . 87.9 t -55.49 -37.04 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 110.085 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -83.93 -22.04 31.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.391 -0.818 . . . . 0.0 110.192 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.29 -54.34 25.99 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.376 -0.828 . . . . 0.0 110.199 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.9 p -115.77 157.9 23.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -0.91 . . . . 0.0 110.259 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -59.47 -45.75 90.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.169 -0.957 . . . . 0.0 110.196 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.5 t -119.71 123.77 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 110.262 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -152.2 120.24 6.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 109.599 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.49 HG23 ' HA ' ' A' ' 188' ' ' LEU . 11.6 p -98.51 143.05 13.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.093 -1.005 . . . . 0.0 110.664 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.529 HD13 ' HA ' ' A' ' 129' ' ' ALA . 77.2 mt -133.84 115.13 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.463 -0.773 . . . . 0.0 109.446 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -82.97 163.45 41.72 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.132 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.755 ' CE2' HG12 ' A' ' 175' ' ' VAL . 30.3 m-85 -127.7 63.18 1.38 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.723 -0.869 . . . . 0.0 109.421 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.616 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 12.4 m-85 -81.34 133.3 35.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 111.311 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.403 ' HD2' ' HB2' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -78.96 -26.69 43.47 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.729 0.776 . . . . 0.0 109.582 179.451 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.403 ' HB2' ' HD2' ' A' ' 145' ' ' LYS . 0.3 OUTLIER -127.45 98.79 5.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.73 -0.606 . . . . 0.0 109.624 179.413 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.4 t -63.67 -12.82 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.0 110.903 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -103.01 14.83 31.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.968 -1.083 . . . . 0.0 110.776 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 21.9 p -83.29 -164.89 0.96 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.054 -1.029 . . . . 0.0 110.165 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -90.33 -18.2 25.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 110.317 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.522 ' CB ' ' CE1' ' A' ' 144' ' ' PHE . 6.1 m -83.36 -26.13 30.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 110.326 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.63 -32.75 36.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -0.915 . . . . 0.0 110.089 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.83 -49.85 75.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 109.993 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -57.69 -41.66 82.09 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.37 -0.831 . . . . 0.0 110.278 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -50.68 -55.68 15.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.181 -0.949 . . . . 0.0 110.523 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 16.4 mt -51.01 -55.85 15.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.167 -0.958 . . . . 0.0 110.427 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -53.09 -49.24 66.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.26 -0.9 . . . . 0.0 110.007 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.87 -48.11 80.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 109.977 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.602 ' HB1' ' CD2' ' A' ' 167' ' ' PHE . . . -63.66 -27.09 68.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 110.011 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -75.15 -27.37 59.69 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.367 -0.833 . . . . 0.0 110.297 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.87 -47.84 73.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.902 . . . . 0.0 110.254 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.445 HG23 ' OD1' ' A' ' 164' ' ' ASP . 68.4 mt -98.38 150.25 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -0.899 . . . . 0.0 110.133 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -125.0 -12.57 6.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.253 -0.904 . . . . 0.0 111.105 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.445 ' OD1' HG23 ' A' ' 162' ' ' ILE . 7.9 p-10 -86.99 5.81 35.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.861 -1.149 . . . . 0.0 110.843 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.536 ' CG2' ' CE1' ' A' ' 167' ' ' PHE . 32.6 mm -128.31 126.04 23.47 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.857 -1.152 . . . . 0.0 110.186 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -81.32 110.65 2.27 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.428 1.225 . . . . 0.0 110.585 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.602 ' CD2' ' HB1' ' A' ' 159' ' ' ALA . 1.1 m-85 -102.63 126.49 49.73 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.218 -0.926 . . . . 0.0 109.49 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.429 ' HA2' ' HB ' ' A' ' 121' ' ' THR . . . -106.85 155.52 16.4 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.419 ' O ' HG23 ' A' ' 169' ' ' ILE . 9.5 tt -149.49 133.04 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.374 -1.074 . . . . 0.0 110.378 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.568 HG21 HG11 ' A' ' 175' ' ' VAL . 2.6 t -152.82 157.24 40.47 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 122.003 0.906 . . . . 0.0 110.889 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.6 t -125.51 2.68 7.64 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -64.42 129.21 39.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 0.0 110.3 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.4 m -53.42 -28.06 27.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.301 -0.875 . . . . 0.0 110.225 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -54.89 -39.96 69.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.887 . . . . 0.0 110.024 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.755 HG12 ' CE2' ' A' ' 143' ' ' PHE . 34.0 t -77.15 -24.92 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.81 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -77.54 -49.69 14.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.201 -0.937 . . . . 0.0 109.942 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.88 -34.21 40.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.278 -0.889 . . . . 0.0 110.023 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.408 ' CE ' ' HA3' ' A' ' 126' ' ' GLY . 0.2 OUTLIER -55.34 -55.68 28.71 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.359 -0.838 . . . . 0.0 110.202 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -92.88 6.84 46.28 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.15 -0.969 . . . . 0.0 110.629 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 49.59 65.24 1.46 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.02 -1.05 . . . . 0.0 110.495 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 92.6 mt -101.84 124.33 47.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.263 -0.898 . . . . 0.0 110.282 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.68 0.13 31.64 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.2 -0.937 . . . . 0.0 110.665 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -171.09 -174.67 1.54 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.094 -1.004 . . . . 0.0 109.827 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 21.4 p30 -54.61 156.95 3.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.17 -0.956 . . . . 0.0 110.247 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -172.94 118.78 0.73 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 96.4 t -95.18 128.99 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -1.154 . . . . 0.0 110.152 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.629 HG22 ' HA ' ' A' ' 198' ' ' ASN . 98.7 t -138.06 149.28 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 110.148 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.49 ' HA ' HG23 ' A' ' 140' ' ' VAL . 9.3 tt -109.75 139.25 45.03 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.105 -0.997 . . . . 0.0 108.437 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.745 ' CB ' HG22 ' A' ' 133' ' ' VAL . 50.7 m-85 -112.66 126.18 55.1 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.768 -1.207 . . . . 0.0 110.866 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.9 166.1 23.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.338 -0.851 . . . . 0.0 110.211 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -89.29 -31.4 17.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.913 . . . . 0.0 110.422 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -90.56 -173.32 3.72 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.443 -0.786 . . . . 0.0 110.729 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 51.93 -159.43 0.11 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.431 -0.793 . . . . 0.0 110.456 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.06 -48.9 78.17 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.633 -0.667 . . . . 0.0 110.238 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 136.58 -58.94 0.65 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 17.6 mtm-85 -108.7 175.21 5.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.183 -1.187 . . . . 0.0 110.329 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ASN . . . . . 0.503 ' HB2' ' CZ ' ' A' ' 211' ' ' PHE . 5.9 m120 -132.49 -34.7 1.18 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.263 -0.898 . . . . 0.0 110.996 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.629 ' HA ' HG22 ' A' ' 187' ' ' VAL . 0.7 OUTLIER 61.89 87.81 0.09 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.162 -0.961 . . . . 0.0 110.021 -179.266 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.431 ' HA ' ' CE1' ' A' ' 211' ' ' PHE . 28.6 t80 -57.83 124.11 18.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.379 -0.826 . . . . 0.0 110.265 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -118.15 103.37 9.8 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.318 -0.864 . . . . 0.0 110.337 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 147.52 -148.72 20.54 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -97.66 123.74 41.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -1.147 . . . . 0.0 110.129 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.616 HG11 ' HZ ' ' A' ' 144' ' ' PHE . 79.2 t -70.6 113.65 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.182 -0.949 . . . . 0.0 110.261 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.3 p -145.88 152.43 39.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.43 -0.794 . . . . 0.0 109.932 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 20.2 tttm -48.42 -43.5 34.3 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.118 -0.989 . . . . 0.0 110.509 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -64.95 -41.86 95.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.326 -0.859 . . . . 0.0 109.805 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -71.2 -45.55 63.14 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.344 -0.848 . . . . 0.0 109.953 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' A' ' 208' ' ' LEU . 62.0 mt -53.92 -51.16 64.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.936 . . . . 0.0 109.778 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 69.6 mt -56.58 -31.27 64.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.314 -0.866 . . . . 0.0 109.349 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -76.88 -37.34 55.67 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.428 -0.795 . . . . 0.0 109.524 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.503 ' CZ ' ' HB2' ' A' ' 197' ' ' ASN . 5.9 t80 -54.22 -63.38 1.17 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.397 -0.815 . . . . 0.0 109.893 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 94.8 mt -48.91 -57.64 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.231 -0.918 . . . . 0.0 110.292 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.07 -34.5 56.81 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.331 -0.855 . . . . 0.0 110.243 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -89.64 -7.56 54.43 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.35 -0.844 . . . . 0.0 110.695 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 0.9 OUTLIER -88.48 -79.68 0.3 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.083 -1.011 . . . . 0.0 110.429 -179.325 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.207 -0.933 . . . . 0.0 110.188 -179.848 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 167' ' ' PHE . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.252 0.548 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.538 HG22 ' HA2' ' A' ' 168' ' ' GLY . 8.9 t -101.15 166.15 10.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.161 -0.962 . . . . 0.0 110.442 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.3 m -107.06 105.49 15.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.322 -0.861 . . . . 0.0 110.074 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.423 HD22 ' HB1' ' A' ' 128' ' ' ALA . 32.1 mt -77.67 134.41 65.42 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.213 -0.93 . . . . 0.0 110.096 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.459 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 47.5 Cg_endo -72.85 -32.31 9.22 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 123.52 1.274 . . . . 0.0 110.331 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -168.25 -170.77 1.35 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.255 -0.903 . . . . 0.0 110.805 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.41 ' HA3' ' HD2' ' A' ' 178' ' ' LYS . . . -61.32 -27.95 68.49 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -55.57 -29.24 58.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -1.123 . . . . 0.0 110.382 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.459 ' HB2' ' HD2' ' A' ' 124' ' ' PRO . . . -86.08 -30.86 22.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.146 -0.971 . . . . 0.0 110.178 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.04 -24.36 66.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.041 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -88.59 -38.11 15.13 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.258 -0.901 . . . . 0.0 110.168 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.0 m -72.67 -24.57 61.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.175 -0.953 . . . . 0.0 109.979 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.421 HD13 HD21 ' A' ' 123' ' ' LEU . 2.4 tp -70.44 -47.02 62.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.412 -0.805 . . . . 0.0 110.096 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 69.1 t -62.5 -45.0 99.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.374 -0.829 . . . . 0.0 110.294 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -72.84 -19.69 61.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.938 . . . . 0.0 110.237 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.5 m -72.66 -20.81 61.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.148 -0.97 . . . . 0.0 110.36 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.401 ' OG ' ' HG3' ' A' ' 166' ' ' PRO . 80.0 p -149.42 154.92 39.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.254 -0.904 . . . . 0.0 110.361 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.432 ' HA ' ' HD2' ' A' ' 191' ' ' LYS . 1.6 tt0 -57.44 -35.8 70.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.335 -0.853 . . . . 0.0 110.171 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.7 t -132.03 145.64 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.294 -0.879 . . . . 0.0 110.437 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.457 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -165.56 136.96 3.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.355 -0.841 . . . . 0.0 109.808 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.8 p -116.03 139.84 40.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 O-C-N 121.087 -1.008 . . . . 0.0 110.223 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 27.2 mt -128.4 110.26 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.315 -0.866 . . . . 0.0 109.87 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.55 127.64 8.22 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.491 ' CE2' HG12 ' A' ' 175' ' ' VAL . 50.3 m-85 -95.45 79.5 3.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.285 -1.127 . . . . 0.0 109.849 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.582 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 17.0 m-85 -100.73 141.53 33.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.088 -1.008 . . . . 0.0 111.097 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 21.4 pttt -91.11 -36.41 14.01 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.602 0.715 . . . . 0.0 109.261 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.485 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 0.4 OUTLIER -122.34 70.77 0.99 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.024 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.484 ' HA ' ' HB2' ' A' ' 152' ' ' ALA . 5.0 p -52.22 -20.94 2.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.71 -0.619 . . . . 0.0 111.16 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -76.63 1.33 17.23 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.966 -1.084 . . . . 0.0 110.86 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 51.5 p -86.27 -156.92 0.32 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.879 -1.138 . . . . 0.0 110.381 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -90.45 -46.63 8.23 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.317 -0.864 . . . . 0.0 110.794 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.4 t -46.08 -33.27 3.36 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.38 -0.825 . . . . 0.0 111.065 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 147' ' ' VAL . . . -80.79 -38.1 29.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.136 -0.977 . . . . 0.0 109.837 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.3 -51.3 59.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.0 109.911 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -52.9 -41.44 64.39 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.291 -0.88 . . . . 0.0 110.005 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -53.95 -57.19 11.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.402 -0.811 . . . . 0.0 109.918 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 15.2 mt -53.73 -53.95 44.92 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.502 -0.749 . . . . 0.0 110.365 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -54.52 -33.1 59.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.356 -0.84 . . . . 0.0 110.16 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.436 ' HB2' ' HA ' ' A' ' 205' ' ' LYS . . . -78.14 -35.62 48.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 110.148 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.511 ' HB2' ' CD2' ' A' ' 167' ' ' PHE . . . -72.95 -31.04 64.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.203 -0.936 . . . . 0.0 110.156 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -66.02 -20.97 66.36 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.192 -0.943 . . . . 0.0 110.285 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.479 ' HB3' HD21 ' A' ' 209' ' ' LEU . . . -79.63 -35.98 38.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.216 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.41 HG13 ' OD1' ' A' ' 164' ' ' ASP . 14.8 tt -97.51 154.96 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 110.119 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -142.28 21.92 2.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.184 -0.947 . . . . 0.0 110.493 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.554 ' O ' HD13 ' A' ' 165' ' ' ILE . 6.6 p-10 -120.92 12.91 11.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.182 -0.949 . . . . 0.0 110.629 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.595 HD11 ' OE1' ' A' ' 216' ' ' GLN . 49.7 mm -136.2 134.24 20.01 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.012 . . . . 0.0 110.267 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.457 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 48.8 Cg_endo -74.22 98.62 1.11 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.445 1.234 . . . . 0.0 110.371 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.511 ' CD2' ' HB2' ' A' ' 159' ' ' ALA . 3.3 m-85 -85.94 127.58 34.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 110.316 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.538 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -128.79 154.2 20.05 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.442 HD11 HG23 ' A' ' 147' ' ' VAL . 11.6 tt -150.26 149.93 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.154 -1.204 . . . . 0.0 110.595 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.475 HG21 HG21 ' A' ' 175' ' ' VAL . 2.1 t -161.06 156.99 25.41 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.069 0.938 . . . . 0.0 110.527 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.4 p -124.12 3.98 8.59 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -63.32 131.69 49.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 110.418 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 92.7 p -53.76 -31.46 48.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.211 -0.93 . . . . 0.0 110.189 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -53.48 -32.05 48.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.968 . . . . 0.0 109.848 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.491 HG12 ' CE2' ' A' ' 143' ' ' PHE . 60.0 t -82.61 -25.38 8.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.385 -0.822 . . . . 0.0 109.51 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -76.87 -52.52 9.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.421 -0.799 . . . . 0.0 109.717 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.23 -15.87 58.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.383 -0.823 . . . . 0.0 110.559 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.423 ' HG2' ' CD1' ' A' ' 179' ' ' TYR . 16.4 tttp -79.21 -52.51 8.06 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.04 -1.038 . . . . 0.0 110.09 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.446 ' HB2' ' CD1' ' A' ' 181' ' ' LEU . 81.4 m-85 -92.2 4.51 53.08 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.201 -0.937 . . . . 0.0 110.578 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.26 64.42 1.79 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.055 -1.028 . . . . 0.0 111.025 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.446 ' CD1' ' HB2' ' A' ' 179' ' ' TYR . 4.5 mt -115.6 115.19 26.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.152 -0.967 . . . . 0.0 109.81 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.429 ' O ' ' CG ' ' A' ' 183' ' ' LYS . 0.7 OUTLIER -83.48 7.77 15.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.135 -0.978 . . . . 0.0 110.501 179.716 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 182' ' ' ASP . 25.2 mttt -162.73 -163.91 0.94 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.065 -1.022 . . . . 0.0 109.658 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.409 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 44.1 m-20 -73.96 147.46 43.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.147 -0.971 . . . . 0.0 109.684 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -157.71 134.64 4.0 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.405 ' HB ' ' HB3' ' A' ' 199' ' ' PHE . 70.9 t -113.68 102.03 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.379 -1.071 . . . . 0.0 109.914 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.758 HG22 ' HA ' ' A' ' 198' ' ' ASN . 98.8 t -110.69 146.28 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.382 -0.823 . . . . 0.0 110.179 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.556 HD12 HD12 ' A' ' 212' ' ' ILE . 9.0 tt -109.91 127.9 55.02 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.158 -0.963 . . . . 0.0 108.53 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 189' ' ' PHE . 30.1 m-85 -100.43 120.43 39.97 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.832 -1.168 . . . . 0.0 111.179 -178.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.512 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -131.91 158.78 40.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.474 -0.766 . . . . 0.0 110.122 179.483 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.432 ' HD2' ' HA ' ' A' ' 137' ' ' GLU . 10.2 mttt -82.81 -24.9 33.15 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.217 -0.927 . . . . 0.0 110.259 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.512 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 1.3 p90 -91.69 -171.82 3.02 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.328 -0.858 . . . . 0.0 110.555 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 50.94 -159.1 0.09 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.616 0.722 . . . . 0.0 110.432 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -65.61 -45.52 82.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.655 -0.653 . . . . 0.0 110.222 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 142.09 -62.94 0.52 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -110.48 171.64 7.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.293 -1.122 . . . . 0.0 110.331 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ASN . . . . . 0.484 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 2.7 m-80 -127.71 -34.61 2.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.266 -0.896 . . . . 0.0 110.75 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.758 ' HA ' HG22 ' A' ' 187' ' ' VAL . 0.4 OUTLIER 58.11 83.93 0.11 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.203 -0.936 . . . . 0.0 110.091 -179.494 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.43 ' C ' ' CD1' ' A' ' 199' ' ' PHE . 12.1 t80 -56.78 121.31 9.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.343 -0.848 . . . . 0.0 110.21 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -118.14 100.24 7.4 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.231 -0.918 . . . . 0.0 110.345 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 160.27 -155.95 27.15 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.16 111.6 21.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.294 -1.121 . . . . 0.0 110.074 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.582 HG11 ' HZ ' ' A' ' 144' ' ' PHE . 75.7 t -63.82 109.05 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.938 . . . . 0.0 110.336 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 41.2 p -146.87 152.3 38.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.435 -0.79 . . . . 0.0 110.008 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.516 ' HG2' HD12 ' A' ' 209' ' ' LEU . 1.4 ttpt -46.85 -54.97 8.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.398 -0.814 . . . . 0.0 111.043 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 207' ' ' ASN . 17.0 pt-20 -55.1 -40.79 70.84 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.453 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.445 ' N ' ' HG3' ' A' ' 206' ' ' GLU . 72.8 m-20 -73.82 -49.26 26.04 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.226 -0.921 . . . . 0.0 110.12 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 208' ' ' LEU . 90.5 mt -56.33 -55.0 38.89 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.302 -0.874 . . . . 0.0 110.285 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.516 HD12 ' HG2' ' A' ' 205' ' ' LYS . 15.5 mt -53.29 -24.66 12.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 0.0 110.077 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.99 -43.82 13.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.87 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.422 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 11.9 t80 -56.96 -56.7 18.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.333 -0.854 . . . . 0.0 110.418 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.556 HD12 HD12 ' A' ' 188' ' ' LEU . 8.0 mm -51.6 -39.29 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.24 -0.912 . . . . 0.0 110.091 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -61.86 -41.41 97.8 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.628 -0.67 . . . . 0.0 110.283 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -78.64 -6.64 56.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 110.699 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.435 ' CB ' HD13 ' A' ' 188' ' ' LEU . 2.2 m-80 -89.27 -79.62 0.32 Allowed 'General case' 0 N--CA 1.484 1.265 0 O-C-N 120.914 -1.116 . . . . 0.0 110.583 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' GLN . . . . . 0.595 ' OE1' HD11 ' A' ' 165' ' ' ILE . 28.6 pt20 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 110.36 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.261 0.553 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.581 HG22 ' HA2' ' A' ' 168' ' ' GLY . 10.0 t -94.21 164.78 12.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.241 -0.912 . . . . 0.0 110.166 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.2 m -104.63 106.43 16.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.237 -0.915 . . . . 0.0 110.108 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.758 HD21 HD12 ' A' ' 132' ' ' LEU . 26.4 mt -73.16 124.28 90.44 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.197 -0.939 . . . . 0.0 110.104 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -70.75 -22.61 27.32 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 123.393 1.207 . . . . 0.0 110.343 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.71 -171.13 0.17 Allowed 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 122.239 1.019 . . . . 0.0 111.479 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.23 -31.88 74.84 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -52.3 -31.85 34.84 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.336 -1.096 . . . . 0.0 110.299 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.39 -38.02 22.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.901 . . . . 0.0 110.227 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -52.14 -32.69 36.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.228 -0.92 . . . . 0.0 110.094 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -90.24 -46.66 8.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.357 -0.84 . . . . 0.0 110.016 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 10.1 t -64.19 -27.05 68.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.279 -0.888 . . . . 0.0 110.151 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.758 HD12 HD21 ' A' ' 123' ' ' LEU . 6.6 tt -70.53 -60.32 2.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.281 -0.887 . . . . 0.0 109.507 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.507 HG22 ' CB ' ' A' ' 189' ' ' PHE . 87.8 t -49.34 -27.67 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.553 -0.717 . . . . 0.0 110.355 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.15 7.19 25.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.279 -0.888 . . . . 0.0 110.726 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.2 t -90.29 -27.86 19.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.968 -1.083 . . . . 0.0 110.23 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.7 p -147.75 167.09 25.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 110.174 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -67.48 -12.17 59.65 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.216 -0.927 . . . . 0.0 110.136 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.9 t -137.84 150.69 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.066 -1.021 . . . . 0.0 110.063 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.47 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -174.42 142.05 0.74 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.959 . . . . 0.0 110.246 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.424 HG11 ' CZ ' ' A' ' 167' ' ' PHE . 7.2 p -129.7 148.18 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 121.108 -0.995 . . . . 0.0 110.188 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 2.9 mp -137.27 113.54 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -0.872 . . . . 0.0 110.181 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -80.91 131.69 10.63 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.817 ' CE2' HG12 ' A' ' 175' ' ' VAL . 35.1 m-85 -101.95 76.29 1.6 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -1.162 . . . . 0.0 110.091 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.636 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 18.6 m-85 -94.28 144.38 25.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.128 -0.983 . . . . 0.0 110.75 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.04 -26.94 20.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.611 -0.681 . . . . 0.0 109.412 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -134.1 76.3 1.64 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.672 -0.642 . . . . 0.0 109.306 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.556 ' O ' ' HB3' ' A' ' 152' ' ' ALA . 34.7 m -49.05 -23.64 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.377 -0.827 . . . . 0.0 111.042 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -80.02 4.88 15.66 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.048 -1.032 . . . . 0.0 111.175 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.2 p -78.93 -165.25 0.71 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.874 -1.142 . . . . 0.0 110.534 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.02 -23.49 20.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.558 -0.713 . . . . 0.0 110.238 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.5 m -80.27 -19.81 45.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.294 -0.879 . . . . 0.0 110.554 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 147' ' ' VAL . . . -84.34 -32.56 24.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.134 -0.979 . . . . 0.0 110.3 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.2 mtpt -58.89 -38.07 78.03 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 110.183 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.42 -47.48 81.78 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.207 -0.933 . . . . 0.0 110.065 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.435 ' O ' ' HB3' ' A' ' 158' ' ' ALA . 4.5 t80 -52.72 -54.69 30.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.315 -0.865 . . . . 0.0 110.103 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' A' ' 156' ' ' LEU . 22.1 mt -49.13 -55.04 13.55 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.308 -0.87 . . . . 0.0 110.378 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -54.22 -37.62 64.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.316 -0.865 . . . . 0.0 109.674 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 155' ' ' PHE . . . -65.85 -52.77 47.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.356 -0.84 . . . . 0.0 109.536 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.521 ' HB2' ' CD2' ' A' ' 167' ' ' PHE . . . -55.44 -35.21 65.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.288 -0.882 . . . . 0.0 109.602 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.58 -30.3 71.01 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.283 -0.886 . . . . 0.0 109.858 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.16 -48.97 79.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.356 -0.84 . . . . 0.0 109.801 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.434 HG22 ' H ' ' A' ' 164' ' ' ASP . 63.2 mt -95.42 149.52 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.338 -0.851 . . . . 0.0 109.882 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -126.69 8.98 6.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.178 -0.951 . . . . 0.0 110.819 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.434 ' H ' HG22 ' A' ' 162' ' ' ILE . 4.1 p30 -110.6 -17.25 13.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.967 -1.083 . . . . 0.0 110.339 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 51.0 mm -91.43 133.44 31.35 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.935 . . . . 0.0 110.185 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.507 ' HB2' HD21 ' A' ' 132' ' ' LEU . 50.6 Cg_endo -73.63 69.63 4.33 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.576 1.303 . . . . 0.0 110.253 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.521 ' CD2' ' HB2' ' A' ' 159' ' ' ALA . 3.3 m-85 -63.7 123.03 17.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.886 . . . . 0.0 109.932 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.581 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -125.19 151.07 17.38 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -141.83 148.18 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -1.146 . . . . 0.0 110.297 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.496 HG21 HG11 ' A' ' 175' ' ' VAL . 2.6 t -164.85 157.81 16.7 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.073 0.939 . . . . 0.0 110.913 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.7 t -123.39 2.31 9.06 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.394 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -60.92 120.79 10.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.121 -0.987 . . . . 0.0 110.171 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 3.0 p -51.29 -29.4 14.72 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -0.902 . . . . 0.0 110.35 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.22 -43.47 78.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 109.877 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.817 HG12 ' CE2' ' A' ' 143' ' ' PHE . 46.2 t -72.35 -26.31 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.239 -0.913 . . . . 0.0 109.832 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -75.46 -55.49 5.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.37 -0.831 . . . . 0.0 110.036 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -21.37 60.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.465 -0.772 . . . . 0.0 110.435 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.36 -56.06 26.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -0.972 . . . . 0.0 110.341 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -89.76 13.64 13.84 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.171 -0.956 . . . . 0.0 110.598 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 51.95 63.83 2.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 110.625 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 14.7 mt -96.06 124.27 40.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.412 -0.805 . . . . 0.0 109.911 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -61.29 -16.1 42.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.144 -0.973 . . . . 0.0 110.219 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -175.29 -142.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.569 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -86.71 159.81 19.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.995 -1.065 . . . . 0.0 110.365 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 176.76 179.74 47.33 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 186' ' ' VAL . 21.5 m -133.74 120.28 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -1.148 . . . . 0.0 110.297 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 188' ' ' LEU . 86.2 t -123.09 162.89 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.412 -0.805 . . . . 0.0 109.863 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.554 HD22 ' HB3' ' A' ' 215' ' ' ASN . 1.7 tt -113.36 148.79 35.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.078 -1.013 . . . . 0.0 109.761 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.507 ' CB ' HG22 ' A' ' 133' ' ' VAL . 40.0 m-85 -123.44 117.4 25.07 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.064 -1.022 . . . . 0.0 110.411 -179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.511 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -134.52 165.86 24.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.311 -0.868 . . . . 0.0 110.16 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -88.67 -22.71 23.28 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.0 110.373 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.511 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 1.4 p90 -90.87 -172.32 3.32 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.243 -0.911 . . . . 0.0 110.928 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 47.22 -159.46 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.663 0.744 . . . . 0.0 110.728 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -55.0 -53.62 53.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.641 -0.662 . . . . 0.0 110.321 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 139.5 -49.2 0.82 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.68 172.83 8.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.252 -1.146 . . . . 0.0 110.442 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ASN . . . . . 0.464 ' N ' ' ND2' ' A' ' 197' ' ' ASN . 0.6 OUTLIER -138.44 -152.67 0.44 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.292 -0.88 . . . . 0.0 109.598 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -175.57 76.69 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.32 -0.862 . . . . 0.0 110.309 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.41 ' CB ' HG23 ' A' ' 186' ' ' VAL . 70.5 t80 -51.39 118.57 3.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.349 -0.844 . . . . 0.0 110.409 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -113.3 95.14 5.21 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.289 -0.882 . . . . 0.0 110.301 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 162.5 -174.07 38.84 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -61.46 135.95 57.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.295 -1.121 . . . . 0.0 110.166 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.636 HG11 ' HZ ' ' A' ' 144' ' ' PHE . 74.7 t -91.15 104.43 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.885 . . . . 0.0 110.071 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 39.6 p -143.86 158.33 43.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.384 -0.822 . . . . 0.0 109.972 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.424 ' HG3' ' CA ' ' A' ' 158' ' ' ALA . 11.0 tttt -49.36 -51.54 34.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.287 -0.883 . . . . 0.0 110.916 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -59.54 -31.17 69.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 110.565 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -82.46 -38.94 23.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 110.344 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.548 ' O ' HD12 ' A' ' 212' ' ' ILE . 51.1 mt -61.38 -56.59 18.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.315 -0.866 . . . . 0.0 110.35 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 4.1 mp -52.96 -23.26 6.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.263 -0.898 . . . . 0.0 110.326 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.2 -49.89 12.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.888 . . . . 0.0 110.279 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -55.8 -59.35 4.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -0.918 . . . . 0.0 110.386 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.646 HG22 ' HG2' ' A' ' 216' ' ' GLN . 5.7 mt -50.07 -39.45 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.219 -0.926 . . . . 0.0 110.466 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -58.67 -18.42 30.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.304 -0.873 . . . . 0.0 110.305 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 17.5 t60 -99.47 -18.6 17.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.176 -0.953 . . . . 0.0 110.676 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.554 ' HB3' HD22 ' A' ' 188' ' ' LEU . 77.5 m-20 -97.66 -61.26 1.42 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.113 -0.992 . . . . 0.0 111.099 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' GLN . . . . . 0.646 ' HG2' HG22 ' A' ' 212' ' ' ILE . 1.2 pt20 . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.103 -0.998 . . . . 0.0 110.584 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.202 0.525 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.573 HG22 ' HA2' ' A' ' 168' ' ' GLY . 11.3 t -98.29 166.07 11.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 110.144 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.7 m -107.11 109.0 20.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.186 -0.946 . . . . 0.0 110.121 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 26.2 mt -92.12 131.31 35.28 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.225 -0.922 . . . . 0.0 109.986 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.437 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 45.9 Cg_endo -72.49 -36.3 5.33 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.401 1.211 . . . . 0.0 110.47 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.678 ' C ' HG22 ' A' ' 175' ' ' VAL . 1.7 p30 -154.96 -169.04 3.07 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.27 -0.894 . . . . 0.0 110.614 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.726 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -67.84 -30.94 74.75 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -54.26 -25.85 25.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -1.104 . . . . 0.0 110.362 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.437 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -89.51 -25.29 21.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 110.162 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.99 -26.06 65.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 109.977 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -79.14 -50.71 10.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.209 -0.932 . . . . 0.0 110.056 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.5 m -56.87 -24.32 50.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -0.895 . . . . 0.0 110.08 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.4 tp -67.64 -51.62 47.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 0.0 110.062 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.625 HG22 ' CB ' ' A' ' 189' ' ' PHE . 42.4 t -53.55 -46.95 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.871 . . . . 0.0 110.343 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.28 -18.89 63.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 0.0 110.427 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.4 t -56.16 -59.32 5.1 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.24 -0.913 . . . . 0.0 110.277 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.6 p -127.26 -171.13 2.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.257 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -74.2 -44.63 52.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.879 . . . . 0.0 110.328 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.483 ' CG2' HD12 ' A' ' 165' ' ' ILE . 30.5 m -116.1 151.91 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 0.0 110.535 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.432 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -176.03 139.52 0.38 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.344 -0.848 . . . . 0.0 109.827 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 188' ' ' LEU . 10.0 p -122.33 146.82 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.112 -0.993 . . . . 0.0 110.47 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.854 HD12 ' CD1' ' A' ' 189' ' ' PHE . 6.3 mt -128.18 112.65 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.424 -0.798 . . . . 0.0 109.928 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.07 125.35 7.16 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.436 ' CE2' ' O ' ' A' ' 141' ' ' ILE . 90.8 m-85 -103.2 66.56 0.9 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -1.134 . . . . 0.0 109.605 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.442 ' CD1' ' HB3' ' A' ' 184' ' ' ASP . 9.6 m-85 -93.92 140.1 30.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.351 -0.843 . . . . 0.0 111.03 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -26.83 43.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.462 -0.774 . . . . 0.0 109.775 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -122.32 90.69 3.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.51 -0.744 . . . . 0.0 109.913 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.15 -21.9 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 110.616 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -87.18 12.58 11.31 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.158 -0.964 . . . . 0.0 111.135 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 96.7 p -86.63 -164.26 1.03 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.094 -1.004 . . . . 0.0 110.118 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.53 -44.63 11.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.331 -0.856 . . . . 0.0 109.866 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 1.3 m -56.89 -21.31 28.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.317 -0.864 . . . . 0.0 110.085 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.29 -39.6 22.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.0 110.101 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -59.41 -39.91 84.95 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.268 -0.895 . . . . 0.0 110.339 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -63.97 -43.25 96.32 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.247 -0.908 . . . . 0.0 109.941 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.616 ' HE1' HG13 ' A' ' 186' ' ' VAL . 4.1 t80 -50.66 -55.81 14.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.333 -0.854 . . . . 0.0 110.307 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.415 ' HA ' HD23 ' A' ' 156' ' ' LEU . 75.2 mt -56.02 -51.53 67.45 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.374 -0.829 . . . . 0.0 110.08 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -51.17 -44.54 61.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.365 -0.834 . . . . 0.0 110.148 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -69.64 -34.18 73.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -0.885 . . . . 0.0 110.046 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.691 ' HB2' ' CD2' ' A' ' 167' ' ' PHE . . . -62.53 -30.98 71.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 110.136 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.97 -22.1 24.49 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.21 -0.931 . . . . 0.0 110.35 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -97.42 13.92 28.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.219 -0.926 . . . . 0.0 110.594 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.77 HD11 HG21 ' A' ' 212' ' ' ILE . 6.6 tt -103.78 174.67 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.093 -1.004 . . . . 0.0 110.211 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.42 62.89 0.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.37 -0.831 . . . . 0.0 110.25 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 162' ' ' ILE . 2.8 p-10 40.76 50.81 3.04 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.616 0.722 . . . . 0.0 111.56 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.576 HG23 ' HD2' ' A' ' 166' ' ' PRO . 39.1 mm -88.85 146.0 35.91 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.452 -0.78 . . . . 0.0 109.628 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.576 ' HD2' HG23 ' A' ' 165' ' ' ILE . 42.2 Cg_endo -68.63 100.8 0.71 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.58 1.305 . . . . 0.0 110.865 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.691 ' CD2' ' HB2' ' A' ' 159' ' ' ALA . 2.7 m-85 -97.6 136.32 38.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.42 -0.8 . . . . 0.0 110.158 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.573 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -129.47 143.81 14.92 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 11.1 tt -141.18 135.9 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.13 -1.218 . . . . 0.0 110.572 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.0 t -153.08 156.88 39.56 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.031 0.919 . . . . 0.0 110.571 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.4 t -122.68 2.59 9.53 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -64.31 123.23 18.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -0.945 . . . . 0.0 110.322 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 27.7 m -53.15 -28.36 25.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.229 -0.92 . . . . 0.0 110.131 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.45 -31.84 56.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -0.929 . . . . 0.0 109.764 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.726 HG22 ' N ' ' A' ' 126' ' ' GLY . 28.0 t -81.91 -26.21 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.429 -0.795 . . . . 0.0 109.32 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -76.24 -53.05 8.8 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.481 -0.762 . . . . 0.0 109.75 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 2.0 t -56.06 -21.93 24.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.402 -0.811 . . . . 0.0 110.08 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.51 -48.27 61.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 109.244 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -96.87 -0.67 47.4 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.432 -0.793 . . . . 0.0 110.352 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 53.83 70.63 0.58 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.103 -0.998 . . . . 0.0 110.589 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.549 HD22 ' HA3' ' A' ' 185' ' ' GLY . 1.1 mt -105.64 129.11 53.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.314 -0.866 . . . . 0.0 110.045 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.422 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 24.6 p-10 -60.65 -16.21 36.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.251 -0.905 . . . . 0.0 110.512 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.2 -145.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.175 -0.953 . . . . 0.0 109.649 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.442 ' HB3' ' CD1' ' A' ' 144' ' ' PHE . 43.0 m-20 -54.3 151.54 7.3 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.04 -1.038 . . . . 0.0 109.62 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.549 ' HA3' HD22 ' A' ' 181' ' ' LEU . . . -152.19 129.94 2.94 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.416 -1.374 . . . . 0.0 110.108 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.616 HG13 ' HE1' ' A' ' 155' ' ' PHE . 75.0 t -117.09 80.93 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.364 -1.08 . . . . 0.0 109.777 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 61.3 t -106.39 158.88 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 110.063 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.683 HD23 ' N ' ' A' ' 189' ' ' PHE . 9.8 tt -116.25 163.61 15.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.032 -1.043 . . . . 0.0 109.87 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.854 ' CD1' HD12 ' A' ' 141' ' ' ILE . 64.4 m-85 -128.88 132.08 47.68 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.009 -1.057 . . . . 0.0 110.892 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.481 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.3 OUTLIER -140.49 163.69 32.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.242 -0.911 . . . . 0.0 110.122 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -83.43 -29.13 28.34 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.273 -0.892 . . . . 0.0 110.083 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.8 OUTLIER -91.5 -175.04 4.09 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.533 -0.73 . . . . 0.0 110.955 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 50.43 -160.15 0.07 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.697 0.76 . . . . 0.0 110.608 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -59.24 -28.36 66.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.774 -0.579 . . . . 0.0 110.552 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.405 ' HA2' ' HG2' ' A' ' 190' ' ' LYS . . . 107.33 -28.04 13.86 Favored Glycine 0 N--CA 1.483 1.779 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.06 -179.98 5.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.129 -1.218 . . . . 0.0 110.599 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ASN . . . . . 0.441 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.4 m-80 -141.96 -152.39 0.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.575 -0.703 . . . . 0.0 109.712 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -171.57 79.81 0.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.355 -0.84 . . . . 0.0 110.474 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.482 ' CE1' HG22 ' A' ' 203' ' ' VAL . 26.7 t80 -60.3 143.05 53.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.172 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -146.51 129.95 16.8 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.341 -0.85 . . . . 0.0 109.717 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 121.79 -172.58 15.51 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -66.03 117.31 8.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -1.131 . . . . 0.0 110.349 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.484 ' C ' HG23 ' A' ' 204' ' ' THR . 71.7 t -74.14 118.88 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.887 . . . . 0.0 109.987 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.484 HG23 ' C ' ' A' ' 203' ' ' VAL . 72.6 p -150.07 157.11 42.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.318 -0.863 . . . . 0.0 110.433 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -49.26 -52.98 23.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.392 -0.818 . . . . 0.0 110.456 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -55.78 -36.21 67.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.354 -0.841 . . . . 0.0 110.332 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 -77.56 -51.98 9.8 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.193 -0.942 . . . . 0.0 110.454 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' A' ' 208' ' ' LEU . 70.8 mt -52.34 -56.35 15.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.322 -0.861 . . . . 0.0 110.429 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 18.7 mt -51.11 -24.13 3.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.169 -0.957 . . . . 0.0 110.57 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -84.71 -41.8 15.89 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.195 -0.941 . . . . 0.0 110.073 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -63.29 -57.82 9.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.352 -0.843 . . . . 0.0 110.67 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.77 HG21 HD11 ' A' ' 162' ' ' ILE . 9.4 mt -52.8 -47.22 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.134 -0.979 . . . . 0.0 110.388 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.56 -21.13 51.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.228 -0.92 . . . . 0.0 110.222 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -90.01 -19.35 24.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.309 -0.869 . . . . 0.0 110.438 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -94.73 -49.98 5.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.2 -0.938 . . . . 0.0 110.418 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' GLN . . . . . 0.758 ' OE1' HG22 ' A' ' 212' ' ' ILE . 17.5 pt20 . . . . . 0 N--CA 1.486 1.327 0 O-C-N 121.213 -0.93 . . . . 0.0 110.485 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.26 0.552 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 51.9 m -101.56 125.51 48.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 110.149 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 87.0 m -76.84 126.91 31.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.25 -0.906 . . . . 0.0 110.169 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.618 HD22 ' HB1' ' A' ' 128' ' ' ALA . 45.7 mt -103.45 137.98 19.41 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.932 . . . . 0.0 109.95 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 46.8 Cg_endo -73.09 -26.21 15.23 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.554 1.292 . . . . 0.0 110.546 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -172.76 -170.33 0.66 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.159 -0.963 . . . . 0.0 110.912 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.462 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -61.8 -34.07 87.46 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -51.48 -28.2 12.67 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.276 -1.132 . . . . 0.0 110.4 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.618 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -86.06 -37.22 19.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 110.161 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.16 -30.15 48.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.197 -0.939 . . . . 0.0 110.118 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -81.62 -46.45 14.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.146 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 92.0 p -56.74 -33.34 66.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.894 . . . . 0.0 110.095 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.5 tp -61.09 -47.84 84.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -0.884 . . . . 0.0 110.165 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.842 HG22 ' HB3' ' A' ' 189' ' ' PHE . 39.4 t -54.67 -41.2 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.193 -0.942 . . . . 0.0 109.961 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -82.74 3.38 29.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.274 -0.891 . . . . 0.0 110.796 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.8 t -75.61 -41.92 53.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.934 -1.104 . . . . 0.0 110.111 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 28.2 p -147.24 -172.63 4.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 110.13 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.443 ' OE2' ' CD2' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -70.65 -44.76 66.43 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.205 -0.934 . . . . 0.0 110.163 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.4 t -116.26 150.51 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.276 -0.89 . . . . 0.0 110.191 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.455 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -172.15 146.0 1.85 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.843 . . . . 0.0 109.926 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.583 ' CG1' HD12 ' A' ' 188' ' ' LEU . 2.8 m -128.19 164.66 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.117 -0.99 . . . . 0.0 110.764 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 31.2 mt -149.96 114.4 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.753 -0.592 . . . . 0.0 110.173 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -87.06 133.05 11.53 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.546 ' CE2' HG12 ' A' ' 175' ' ' VAL . 76.1 m-85 -99.37 77.31 2.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.113 -1.228 . . . . 0.0 110.069 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.41 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 25.6 m-85 -95.24 143.65 26.47 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.992 0.901 . . . . 0.0 110.939 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.4 -25.36 20.43 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.815 0.817 . . . . 0.0 109.167 179.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -137.3 78.85 1.72 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.576 ' HA ' ' HB1' ' A' ' 152' ' ' ALA . 19.5 m -46.02 -25.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.457 -0.777 . . . . 0.0 111.167 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -84.73 10.31 11.7 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.106 -0.996 . . . . 0.0 110.937 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 68.6 p -81.0 -159.36 0.25 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.967 -1.083 . . . . 0.0 110.182 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -89.87 -54.18 4.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 110.207 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.87 -23.38 63.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 0.0 110.268 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.576 ' HB1' ' HA ' ' A' ' 147' ' ' VAL . . . -81.12 -23.43 38.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 0.0 110.286 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.18 -41.05 77.69 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.216 -0.928 . . . . 0.0 110.115 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.403 ' OE1' HG22 ' A' ' 204' ' ' THR . 1.1 mm-40 -60.43 -46.03 91.48 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.314 -0.867 . . . . 0.0 109.956 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -51.79 -55.35 20.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 110.268 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 156' ' ' LEU . 41.2 mt -54.13 -55.75 24.69 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.383 -0.823 . . . . 0.0 110.152 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -52.45 -38.02 58.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.347 -0.845 . . . . 0.0 110.13 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.729 ' HB2' ' HG3' ' A' ' 205' ' ' LYS . . . -76.8 -41.61 43.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.198 -0.939 . . . . 0.0 109.841 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -58.73 -37.61 76.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.828 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -66.59 -28.21 68.33 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.243 -0.91 . . . . 0.0 110.113 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 158' ' ' ALA . . . -60.36 -50.43 73.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.798 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.54 HG21 ' CG1' ' A' ' 165' ' ' ILE . 71.4 mt -90.31 152.17 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.367 -0.833 . . . . 0.0 109.891 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -127.6 -40.27 1.77 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.136 -0.978 . . . . 0.0 110.43 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -63.77 -16.25 60.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.249 -0.907 . . . . 0.0 110.615 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.54 ' CG1' HG21 ' A' ' 162' ' ' ILE . 46.2 mm -93.63 128.86 40.37 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.075 -1.016 . . . . 0.0 110.327 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.455 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 51.0 Cg_endo -77.31 82.55 2.35 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 O-C-N 123.538 1.283 . . . . 0.0 110.546 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -71.44 137.57 48.38 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.173 -0.954 . . . . 0.0 110.238 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 141' ' ' ILE . . . -128.9 145.07 15.91 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 4.8 tt -146.58 137.48 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -1.157 . . . . 0.0 110.439 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.2 t -159.49 156.94 29.13 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.001 0.905 . . . . 0.0 110.895 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 56.7 p -122.24 3.43 9.79 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.527 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -57.74 126.76 28.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.219 -0.926 . . . . 0.0 110.535 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.88 -35.88 58.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.244 -0.91 . . . . 0.0 110.143 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -53.09 -30.75 38.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.978 . . . . 0.0 109.815 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.546 HG12 ' CE2' ' A' ' 143' ' ' PHE . 57.3 t -81.29 -26.86 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.325 -0.859 . . . . 0.0 109.546 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -77.6 -52.86 8.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.351 -0.843 . . . . 0.0 109.345 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.4 m -58.96 -18.6 35.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.443 -0.786 . . . . 0.0 109.997 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -71.48 -53.91 12.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.559 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -91.11 4.6 51.76 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.41 -0.807 . . . . 0.0 110.292 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.13 64.64 1.76 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -0.946 . . . . 0.0 110.713 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 40.0 mt -102.7 122.41 44.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.256 -0.902 . . . . 0.0 110.17 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -62.83 -18.87 63.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 110.422 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 18.9 pttt -163.75 -148.22 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 109.983 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -70.71 150.98 45.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -0.933 . . . . 0.0 109.889 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -170.16 156.05 26.33 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 97.8 t -127.8 141.2 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.172 -1.193 . . . . 0.0 110.344 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.49 HG13 ' H ' ' A' ' 197' ' ' ASN . 70.6 t -143.06 149.24 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.337 -0.852 . . . . 0.0 109.646 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.69 HD23 ' HD3' ' A' ' 190' ' ' LYS . 3.7 tt -101.29 145.59 28.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.951 -1.093 . . . . 0.0 109.681 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.842 ' HB3' HG22 ' A' ' 133' ' ' VAL . 58.8 m-85 -121.87 108.34 13.34 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.131 -0.981 . . . . 0.0 110.624 -178.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.69 ' HD3' HD23 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -124.06 174.68 7.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.31 -0.869 . . . . 0.0 110.27 179.782 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -94.41 -26.22 16.6 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.321 -0.862 . . . . 0.0 110.007 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.493 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.5 OUTLIER -91.43 -170.92 2.76 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.833 179.577 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 49.87 -159.92 0.07 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.661 0.743 . . . . 0.0 110.595 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -56.05 -46.32 78.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.632 -0.667 . . . . 0.0 110.25 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 126.07 -32.86 3.67 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -136.55 173.14 12.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.193 -1.18 . . . . 0.0 110.429 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' ASN . . . . . 0.49 ' H ' HG13 ' A' ' 187' ' ' VAL . 0.7 OUTLIER -144.22 -155.21 0.58 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.37 -0.831 . . . . 0.0 109.631 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.435 ' HA ' HG22 ' A' ' 187' ' ' VAL . 0.2 OUTLIER -169.52 86.93 0.15 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.53 -0.731 . . . . 0.0 110.206 179.612 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -49.85 130.83 22.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.272 -0.893 . . . . 0.0 110.441 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -127.95 115.38 18.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.327 -0.858 . . . . 0.0 109.942 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 132.93 -158.74 23.25 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -84.43 132.28 34.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.298 -1.119 . . . . 0.0 110.167 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.644 HG13 HD21 ' A' ' 208' ' ' LEU . 92.3 t -81.46 116.17 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.33 -0.856 . . . . 0.0 110.376 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.403 HG22 ' OE1' ' A' ' 154' ' ' GLN . 15.6 p -143.56 159.73 41.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 109.988 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.769 ' O ' HD12 ' A' ' 209' ' ' LEU . 2.9 ttpt -51.31 -49.24 61.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.12 -0.987 . . . . 0.0 110.584 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -62.98 -39.72 95.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.276 -0.89 . . . . 0.0 110.549 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -70.16 -48.79 55.86 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.197 -0.939 . . . . 0.0 110.374 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.644 HD21 HG13 ' A' ' 203' ' ' VAL . 95.3 mt -56.06 -49.87 72.55 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.257 -0.902 . . . . 0.0 110.428 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.769 HD12 ' O ' ' A' ' 205' ' ' LYS . 0.7 OUTLIER -59.26 -26.99 65.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.892 . . . . 0.0 110.298 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -78.28 -45.49 22.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.281 -0.887 . . . . 0.0 110.274 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -53.29 -60.92 2.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.318 -0.864 . . . . 0.0 110.393 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 9.9 mt -51.69 -46.47 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.242 -0.911 . . . . 0.0 110.586 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -18.85 13.79 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.258 -0.902 . . . . 0.0 110.956 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -96.52 -24.38 16.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.064 -1.022 . . . . 0.0 110.922 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.555 ' HB3' HD22 ' A' ' 188' ' ' LEU . 72.1 m-20 -89.34 -48.58 7.25 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.922 -1.111 . . . . 0.0 111.139 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 . . . . . 0 N--CA 1.493 1.676 0 O-C-N 120.956 -1.09 . . . . 0.0 110.212 -179.777 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 167' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.106 0.479 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.554 HG22 ' HA2' ' A' ' 168' ' ' GLY . 7.7 t -102.19 171.11 7.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.139 -0.976 . . . . 0.0 110.516 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.2 m -113.95 103.47 11.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.357 -0.839 . . . . 0.0 110.193 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.655 HD21 HD12 ' A' ' 132' ' ' LEU . 57.7 mt -79.47 111.95 24.87 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.924 . . . . 0.0 110.04 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.433 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 44.7 Cg_endo -69.61 -21.57 34.02 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 O-C-N 123.561 1.295 . . . . 0.0 110.869 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.577 ' OD2' ' HB3' ' A' ' 127' ' ' ALA . 0.4 OUTLIER -163.13 -170.03 2.19 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.052 -1.03 . . . . 0.0 111.076 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.452 ' HA3' ' HD3' ' A' ' 178' ' ' LYS . . . -67.69 -39.92 90.25 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.577 ' HB3' ' OD2' ' A' ' 125' ' ' ASP . . . -53.25 -22.56 7.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -1.15 . . . . 0.0 110.031 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.433 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -88.32 -23.91 23.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.205 -0.935 . . . . 0.0 109.301 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.0 -20.48 32.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.454 -0.779 . . . . 0.0 110.118 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 131' ' ' SER . 19.2 pt-20 -86.9 -37.61 17.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.177 -0.952 . . . . 0.0 110.228 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.44 ' N ' ' HG3' ' A' ' 130' ' ' GLU . 3.0 m -75.48 -31.45 60.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 0.0 109.998 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.655 HD12 HD21 ' A' ' 123' ' ' LEU . 2.4 tt -56.51 -59.47 4.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.336 -0.852 . . . . 0.0 110.067 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.54 HG22 ' CB ' ' A' ' 189' ' ' PHE . 51.4 t -53.63 -35.88 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 110.513 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.81 -19.86 57.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.125 -0.984 . . . . 0.0 110.581 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 68.4 m -68.56 -57.47 5.73 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.129 -0.982 . . . . 0.0 110.304 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 46.1 p -111.84 165.06 12.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.316 -0.865 . . . . 0.0 110.252 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.879 ' HG3' HG23 ' A' ' 138' ' ' VAL . 14.6 pt-20 -64.86 -40.39 95.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 110.035 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.879 HG23 ' HG3' ' A' ' 137' ' ' GLU . 94.1 t -121.67 147.7 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.429 -0.794 . . . . 0.0 110.17 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.501 ' HB1' HD22 ' A' ' 132' ' ' LEU . . . -173.99 133.26 0.43 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.298 -0.876 . . . . 0.0 110.061 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 187' ' ' VAL . 7.3 p -111.86 149.54 14.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.136 -0.977 . . . . 0.0 110.064 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.451 HG23 HD12 ' A' ' 123' ' ' LEU . 66.5 mt -131.37 111.1 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 110.253 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -77.28 133.24 12.96 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.733 ' CE2' HG12 ' A' ' 175' ' ' VAL . 51.4 m-85 -105.36 67.2 0.76 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.26 -1.141 . . . . 0.0 109.735 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -91.76 130.33 37.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 111.228 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.456 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 26.0 pttt -80.07 -30.62 39.32 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.923 0.868 . . . . 0.0 108.828 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.456 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 5.2 m-20 -123.19 70.93 1.04 Allowed 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.323 0.582 . . . . 0.0 109.449 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.46 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 25.6 m -49.17 -23.89 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.27 -0.894 . . . . 0.0 110.808 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -78.33 2.55 18.2 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.08 -1.012 . . . . 0.0 111.032 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 21.5 p -80.45 -161.0 0.34 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.901 -1.124 . . . . 0.0 110.243 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -90.41 -51.59 5.34 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.21 -0.931 . . . . 0.0 110.582 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 66.4 m -52.25 -26.07 10.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.2 -0.938 . . . . 0.0 110.507 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.46 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -86.24 -32.1 21.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 110.353 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -60.23 -41.32 92.84 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.22 -0.925 . . . . 0.0 110.189 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -66.32 -36.91 84.12 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.169 -0.957 . . . . 0.0 109.93 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.453 ' HA ' HD13 ' A' ' 208' ' ' LEU . 4.3 t80 -51.97 -57.78 8.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.286 -0.884 . . . . 0.0 110.097 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 19.2 mt -52.01 -50.57 61.11 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.45 -0.781 . . . . 0.0 110.245 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -52.1 -41.61 62.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.356 -0.84 . . . . 0.0 110.152 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.613 ' HB2' ' HA ' ' A' ' 205' ' ' LYS . . . -73.29 -35.47 66.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.335 -0.853 . . . . 0.0 109.889 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.58 -43.16 94.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 110.013 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -60.13 -35.62 75.68 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.256 -0.903 . . . . 0.0 110.139 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.3 -46.54 86.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.87 . . . . 0.0 110.182 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 49.8 mm -90.7 104.98 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.064 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.37 -20.54 20.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.122 -0.986 . . . . 0.0 110.373 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -76.88 -6.05 50.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.221 -0.925 . . . . 0.0 110.807 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 44.7 mm -116.3 130.35 24.54 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.941 -1.1 . . . . 0.0 110.132 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.445 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 50.6 Cg_endo -75.09 81.2 2.28 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.475 1.25 . . . . 0.0 110.549 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 120' ' ' ALA . 2.9 m-85 -68.23 132.38 47.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 110.316 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.554 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -126.54 153.34 18.71 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 7.2 tt -148.43 147.33 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -1.154 . . . . 0.0 110.329 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.507 HG21 HG11 ' A' ' 175' ' ' VAL . 2.4 t -164.01 156.96 17.86 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.065 0.936 . . . . 0.0 110.809 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' SER . . . . . 0.415 ' HA ' ' CE1' ' A' ' 176' ' ' PHE . 76.1 p -121.14 1.08 10.28 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.16 119.98 6.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.191 -0.943 . . . . 0.0 110.506 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.1 p -53.72 -32.48 52.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.229 -0.919 . . . . 0.0 110.095 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.404 ' O ' ' HE2' ' A' ' 178' ' ' LYS . 0.4 OUTLIER -56.47 -44.31 80.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.141 -0.975 . . . . 0.0 109.344 179.543 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.733 HG12 ' CE2' ' A' ' 143' ' ' PHE . 39.0 t -69.22 -29.84 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.346 -0.846 . . . . 0.0 109.41 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.415 ' CE1' ' HA ' ' A' ' 171' ' ' SER . 5.5 m-85 -68.57 -60.86 2.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.407 -0.808 . . . . 0.0 109.528 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 2.9 m -51.36 -36.62 43.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.61 -0.682 . . . . 0.0 110.562 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.452 ' HD3' ' HA3' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -48.44 -55.78 9.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.17 -0.956 . . . . 0.0 110.895 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -89.9 18.73 5.4 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.315 -0.866 . . . . 0.0 110.51 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.46 65.75 1.39 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.163 -0.961 . . . . 0.0 110.402 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 85.5 mt -112.92 92.29 3.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -0.836 . . . . 0.0 110.235 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.56 -26.98 9.65 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.038 -1.038 . . . . 0.0 109.53 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -138.66 177.73 7.67 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 3.7 p-10 -58.65 -173.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.08 -1.012 . . . . 0.0 110.262 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 165.27 171.86 32.01 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 186' ' ' VAL . 32.8 m -139.92 108.15 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.294 -1.121 . . . . 0.0 109.97 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.495 ' O ' HG23 ' A' ' 140' ' ' VAL . 97.2 t -117.04 160.9 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.287 -0.883 . . . . 0.0 109.851 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.785 HD12 HD13 ' A' ' 212' ' ' ILE . 8.3 tt -110.3 150.79 28.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.026 -1.046 . . . . 0.0 109.941 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.54 ' CB ' HG22 ' A' ' 133' ' ' VAL . 40.6 m-85 -121.87 127.19 50.2 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.991 -1.068 . . . . 0.0 110.196 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.28 167.39 22.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -0.885 . . . . 0.0 110.358 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.0 mtpt -90.87 -27.09 19.02 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.244 -0.91 . . . . 0.0 110.596 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -90.96 -175.69 4.41 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.381 -0.824 . . . . 0.0 111.023 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 50.01 -160.0 0.07 Allowed 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.666 0.746 . . . . 0.0 110.667 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -53.86 -54.68 35.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.666 -0.646 . . . . 0.0 110.191 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 133.12 -24.31 3.79 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -140.85 176.81 8.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.051 -1.264 . . . . 0.0 110.781 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' ASN . . . . . 0.456 ' N ' ' ND2' ' A' ' 197' ' ' ASN . 1.1 m-80 -142.53 -151.76 0.38 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.549 -0.719 . . . . 0.0 109.509 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -176.51 79.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 0.0 109.97 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.574 ' CB ' HG23 ' A' ' 186' ' ' VAL . 17.1 t80 -51.26 120.1 4.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.285 -0.884 . . . . 0.0 110.52 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -119.56 104.91 10.72 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.248 -0.907 . . . . 0.0 110.111 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 152.21 -160.62 28.99 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -81.94 111.11 17.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -1.178 . . . . 0.0 110.16 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.453 ' C ' HG23 ' A' ' 204' ' ' THR . 86.9 t -61.82 116.68 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 110.173 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.453 HG23 ' C ' ' A' ' 203' ' ' VAL . 67.9 p -149.63 155.72 40.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 110.284 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.613 ' HA ' ' HB2' ' A' ' 158' ' ' ALA . 1.5 ttpt -52.62 -52.66 54.46 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.357 -0.839 . . . . 0.0 110.567 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -56.35 -25.83 50.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.0 110.293 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -87.47 -46.29 9.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.291 -0.881 . . . . 0.0 110.17 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 155' ' ' PHE . 19.4 mt -59.02 -47.27 85.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.283 -0.886 . . . . 0.0 110.315 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 14.6 mt -52.31 -30.99 31.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.226 -0.921 . . . . 0.0 110.287 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.53 -42.06 14.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 0.0 110.089 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.428 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 18.5 t80 -51.31 -51.7 51.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.162 -0.961 . . . . 0.0 109.705 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.785 HD13 HD12 ' A' ' 188' ' ' LEU . 25.4 mm -48.53 -72.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.427 -0.796 . . . . 0.0 110.423 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.459 ' HA ' ' CG ' ' A' ' 216' ' ' GLN . 18.0 mttt -45.9 -37.08 5.94 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.779 -0.575 . . . . 0.0 111.132 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.61 -25.46 67.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.13 -0.981 . . . . 0.0 110.793 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 74.8 m-80 -102.18 -31.53 10.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.103 -0.998 . . . . 0.0 110.977 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' GLN . . . . . 0.459 ' CG ' ' HA ' ' A' ' 213' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 O-C-N 121.016 -1.053 . . . . 0.0 111.001 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.269 0.557 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.4 t -103.89 168.9 8.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 110.318 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.6 m -108.1 118.4 36.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 0.0 109.94 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.765 HD22 ' HB1' ' A' ' 128' ' ' ALA . 49.5 mt -90.88 138.35 26.28 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.218 -0.926 . . . . 0.0 110.378 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 46.5 Cg_endo -72.61 -36.63 4.78 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.565 1.297 . . . . 0.0 110.366 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.662 ' C ' HG22 ' A' ' 175' ' ' VAL . 0.9 OUTLIER -167.2 -170.24 1.45 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.222 -0.924 . . . . 0.0 110.805 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.5 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -57.56 -33.67 67.43 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.52 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -51.11 -26.72 6.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.22 -1.165 . . . . 0.0 110.406 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.765 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -88.12 -37.16 16.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 110.093 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.24 -25.88 25.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 0.0 109.995 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -88.88 -57.36 2.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.271 -0.893 . . . . 0.0 110.062 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.2 m -58.77 -27.87 65.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.233 -0.917 . . . . 0.0 110.205 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 20.6 tp -60.71 -54.31 46.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 109.988 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 98.4 t -57.39 -33.25 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.459 -0.776 . . . . 0.0 110.336 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -72.97 -17.69 61.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.903 . . . . 0.0 110.528 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.85 -27.12 57.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.189 -0.944 . . . . 0.0 110.393 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.404 ' OG ' ' HG3' ' A' ' 166' ' ' PRO . 31.1 p -141.58 163.55 32.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.188 -0.945 . . . . 0.0 110.391 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.855 ' HG3' HG23 ' A' ' 138' ' ' VAL . 18.3 pt-20 -63.8 -40.93 97.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 110.043 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.855 HG23 ' HG3' ' A' ' 137' ' ' GLU . 57.9 t -127.76 155.88 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.412 -0.805 . . . . 0.0 110.172 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.434 ' HB2' ' HG2' ' A' ' 166' ' ' PRO . . . -176.75 138.51 0.28 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.245 -0.91 . . . . 0.0 109.788 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 187' ' ' VAL . 7.5 p -112.78 151.78 14.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.085 -1.01 . . . . 0.0 110.245 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 71.9 mt -132.65 117.36 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.377 -0.827 . . . . 0.0 110.163 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -84.22 126.72 7.74 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.713 ' CE2' HG12 ' A' ' 175' ' ' VAL . 83.7 m-85 -100.24 70.03 1.51 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.356 -1.085 . . . . 0.0 109.924 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -94.99 141.5 28.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -0.875 . . . . 0.0 110.952 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.53 -27.96 18.83 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.501 -0.749 . . . . 0.0 110.554 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.587 ' C ' HG23 ' A' ' 147' ' ' VAL . 0.7 OUTLIER -90.69 -39.51 12.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.17 -0.956 . . . . 0.0 110.445 -179.875 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.587 HG23 ' C ' ' A' ' 146' ' ' ASP . 2.4 t 73.1 -51.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.743 -0.598 . . . . 0.0 110.634 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -90.83 8.96 32.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.067 -1.021 . . . . 0.0 110.507 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 7.5 p -70.01 -163.87 0.07 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.986 -1.071 . . . . 0.0 110.066 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.51 -41.31 13.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.338 -0.851 . . . . 0.0 110.431 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.7 p -59.55 -24.26 63.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.197 -0.94 . . . . 0.0 110.19 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -85.02 -37.17 20.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.253 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.88 -45.83 67.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 110.387 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -62.49 -39.48 93.61 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.219 -0.925 . . . . 0.0 110.355 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -51.6 -56.63 12.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 110.418 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.7 mt -51.21 -54.31 26.82 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.324 -0.86 . . . . 0.0 110.534 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -51.91 -40.46 60.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.254 -0.903 . . . . 0.0 110.252 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.468 ' HB2' ' HG3' ' A' ' 205' ' ' LYS . . . -69.47 -49.61 53.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.93 . . . . 0.0 109.885 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.456 ' HB1' ' CD2' ' A' ' 167' ' ' PHE . . . -55.61 -35.93 66.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 110.011 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -68.48 -22.76 64.54 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.329 -0.857 . . . . 0.0 110.435 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.89 -56.42 17.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.168 -0.957 . . . . 0.0 110.333 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 98.8 mt -90.02 151.1 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 0.0 110.177 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -119.67 -16.39 8.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 110.597 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -91.2 19.7 5.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.073 -1.017 . . . . 0.0 110.519 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.551 ' CG2' ' CE1' ' A' ' 167' ' ' PHE . 31.8 mm -132.21 125.1 19.75 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.135 -0.978 . . . . 0.0 109.899 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.434 ' HG2' ' HB2' ' A' ' 139' ' ' ALA . 50.0 Cg_endo -81.5 101.56 1.22 Allowed 'Trans proline' 0 C--N 1.315 -1.228 0 O-C-N 123.443 1.233 . . . . 0.0 110.697 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.551 ' CE1' ' CG2' ' A' ' 165' ' ' ILE . 1.1 m-85 -92.85 140.07 29.88 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.249 -0.907 . . . . 0.0 109.487 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 141' ' ' ILE . . . -132.58 156.37 22.04 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.3 tt -146.0 150.86 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.096 -1.237 . . . . 0.0 110.282 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.917 HG21 HG11 ' A' ' 175' ' ' VAL . 2.4 t -162.01 158.55 25.2 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.11 0.957 . . . . 0.0 110.891 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' SER . . . . . 0.421 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . 26.3 t -125.09 2.12 7.94 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.319 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -67.98 123.39 20.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.22 -0.925 . . . . 0.0 110.31 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 14.9 m -50.53 -25.43 4.07 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.224 -0.922 . . . . 0.0 110.445 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -59.91 -29.06 68.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.194 -0.941 . . . . 0.0 109.848 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.917 HG11 HG21 ' A' ' 170' ' ' THR . 39.2 t -88.87 -22.16 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.358 -0.839 . . . . 0.0 109.734 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -80.69 -44.31 18.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.347 -0.846 . . . . 0.0 109.711 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.0 -25.23 67.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.431 -0.793 . . . . 0.0 110.107 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.82 -61.42 2.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -0.852 . . . . 0.0 110.44 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.49 ' CZ ' ' CZ ' ' A' ' 189' ' ' PHE . 88.9 m-85 -89.59 12.24 17.29 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.181 -0.949 . . . . 0.0 110.675 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 50.34 60.62 3.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.143 -0.973 . . . . 0.0 110.719 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 83.8 mt -91.75 124.18 35.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.142 -0.974 . . . . 0.0 109.965 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -60.0 -19.32 51.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.244 -0.91 . . . . 0.0 110.615 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -168.84 -146.96 0.06 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.211 -0.931 . . . . 0.0 110.168 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -75.32 150.06 38.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.229 -0.92 . . . . 0.0 110.171 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -171.54 154.01 21.28 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 186' ' ' VAL . 33.3 m -126.04 104.71 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.278 -1.131 . . . . 0.0 110.174 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.479 HG22 ' HA ' ' A' ' 198' ' ' ASN . 95.2 t -111.27 157.91 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 0.0 109.494 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.785 HD22 ' HB3' ' A' ' 215' ' ' ASN . 9.1 tt -107.15 148.45 28.83 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.887 -1.133 . . . . 0.0 108.926 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.49 ' CZ ' ' CZ ' ' A' ' 179' ' ' TYR . 39.0 m-85 -113.78 129.06 56.63 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.756 -1.215 . . . . 0.0 111.304 -178.383 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.517 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -137.97 151.95 48.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.274 -0.891 . . . . 0.0 110.269 179.578 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp -83.27 -25.26 31.78 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.337 -0.852 . . . . 0.0 110.252 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.517 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 1.7 p90 -91.77 -176.99 4.63 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.397 -0.814 . . . . 0.0 110.976 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 193' ' ' ASP . 11.1 m-20 48.91 -158.37 0.06 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.574 0.702 . . . . 0.0 110.624 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.25 -46.94 46.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.553 -0.717 . . . . 0.0 110.55 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 133.37 -33.45 2.57 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.6 ptt180 -147.4 -165.84 2.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.188 -1.183 . . . . 0.0 110.593 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' ASN . . . . . 0.526 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.0 OUTLIER -142.7 -153.7 0.48 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.549 -0.719 . . . . 0.0 109.895 -179.273 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.479 ' HA ' HG22 ' A' ' 187' ' ' VAL . 8.3 p-10 -171.94 80.93 0.06 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.467 -0.77 . . . . 0.0 109.935 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -53.92 119.49 5.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.833 . . . . 0.0 110.27 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -120.69 89.15 3.07 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.417 -0.802 . . . . 0.0 110.354 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 164.66 -165.68 37.58 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -73.17 126.32 29.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -1.132 . . . . 0.0 110.243 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 97.2 t -76.0 110.19 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 110.139 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 77.6 p -145.79 151.28 37.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.491 -0.756 . . . . 0.0 109.979 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.468 ' HG3' ' HB2' ' A' ' 158' ' ' ALA . 6.4 ttpt -48.69 -52.28 24.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.277 -0.889 . . . . 0.0 110.413 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -52.77 -39.86 62.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.324 -0.86 . . . . 0.0 110.19 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -77.31 -44.51 29.35 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.36 -0.838 . . . . 0.0 110.39 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 71.6 mt -53.97 -46.54 71.68 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.317 -0.864 . . . . 0.0 110.29 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 24.6 mt -59.09 -31.64 69.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 0.0 110.027 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -72.19 -28.18 63.04 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.217 -0.927 . . . . 0.0 109.864 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -65.09 -66.67 0.51 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.424 -0.798 . . . . 0.0 110.328 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 5.6 mt -46.37 -42.19 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.436 -0.79 . . . . 0.0 110.778 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -24.73 37.08 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.238 -0.914 . . . . 0.0 110.156 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -113.12 3.74 16.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.331 -0.855 . . . . 0.0 110.832 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.785 ' HB3' HD22 ' A' ' 188' ' ' LEU . 8.1 m120 -92.25 -60.06 1.94 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.882 -1.136 . . . . 0.0 110.195 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' GLN . . . . . 0.491 ' HA ' ' CZ ' ' A' ' 192' ' ' PHE . 7.4 pt20 . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.335 -0.853 . . . . 0.0 110.407 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.26 0.552 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.639 HG22 ' HA2' ' A' ' 168' ' ' GLY . 10.0 t -124.95 171.7 9.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.375 -0.828 . . . . 0.0 110.113 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 50.6 m -109.2 108.76 19.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.34 -0.85 . . . . 0.0 110.095 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.581 HD22 ' HB1' ' A' ' 128' ' ' ALA . 39.0 mt -84.4 125.7 71.19 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.892 . . . . 0.0 109.973 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -71.23 -42.82 1.79 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.53 1.279 . . . . 0.0 110.468 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.476 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 1.3 p30 -152.57 -170.05 3.52 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.301 -0.874 . . . . 0.0 110.807 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.427 ' HA3' ' HD2' ' A' ' 178' ' ' LYS . . . -62.09 -26.51 67.59 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.476 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -53.26 -34.53 57.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.338 -1.095 . . . . 0.0 110.4 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.581 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -79.26 -33.1 43.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.06 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.35 -32.25 64.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -0.881 . . . . 0.0 110.193 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -90.22 -41.17 11.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.348 -0.845 . . . . 0.0 110.406 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.0 m -62.62 -34.75 77.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.935 . . . . 0.0 110.079 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.1 tp -60.74 -45.29 94.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 110.246 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.723 HG22 ' HB3' ' A' ' 189' ' ' PHE . 43.8 t -56.11 -41.59 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.231 -0.918 . . . . 0.0 110.596 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -85.29 -19.9 30.84 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.219 -0.926 . . . . 0.0 110.496 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.5 m -55.48 -36.97 67.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.202 -0.936 . . . . 0.0 110.3 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.8 p -145.16 -178.82 6.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.159 -0.963 . . . . 0.0 110.288 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.15 -30.54 60.79 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.289 -0.882 . . . . 0.0 110.276 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 92.9 t -130.95 144.99 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 110.129 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -174.95 136.75 0.4 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 110.208 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.503 HG11 ' CE1' ' A' ' 167' ' ' PHE . 7.5 p -123.7 150.61 28.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.198 -0.938 . . . . 0.0 110.009 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.458 HG23 ' CD1' ' A' ' 123' ' ' LEU . 5.7 mt -131.17 116.42 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.232 -0.918 . . . . 0.0 110.067 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -87.13 121.63 5.88 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 184' ' ' ASP . 65.4 m-85 -99.08 98.25 9.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -1.161 . . . . 0.0 109.53 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.618 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 19.8 m-85 -115.67 147.33 40.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.026 -1.046 . . . . 0.0 111.357 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.4 ptmt -91.17 -27.38 18.55 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.643 0.735 . . . . 0.0 109.345 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.03 72.34 1.36 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.603 -0.685 . . . . 0.0 109.502 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.578 ' HA ' ' HB2' ' A' ' 152' ' ' ALA . 23.9 m -54.8 -19.77 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.283 -0.886 . . . . 0.0 110.617 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -76.33 0.96 17.53 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.111 -0.993 . . . . 0.0 110.927 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' A' ' 153' ' ' LYS . 83.6 p -88.06 -170.19 2.88 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.827 -1.17 . . . . 0.0 109.949 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -81.35 -30.8 33.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.289 -0.882 . . . . 0.0 110.167 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.43 ' HB2' ' CE1' ' A' ' 144' ' ' PHE . 94.9 p -56.92 -28.92 62.59 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.138 -0.976 . . . . 0.0 110.134 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.578 ' HB2' ' HA ' ' A' ' 147' ' ' VAL . . . -83.34 -43.16 16.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 109.935 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 149' ' ' SER . 0.1 OUTLIER -52.6 -53.05 52.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.265 -0.897 . . . . 0.0 110.255 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -56.32 -43.3 78.86 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.386 -0.821 . . . . 0.0 109.974 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.49 ' HE2' HG13 ' A' ' 186' ' ' VAL . 3.9 t80 -53.3 -57.45 10.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.384 -0.823 . . . . 0.0 110.175 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.9 mt -53.44 -54.33 38.46 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.208 -0.932 . . . . 0.0 110.349 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -50.57 -30.98 14.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.33 -0.856 . . . . 0.0 110.466 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.516 ' HB2' ' HG3' ' A' ' 205' ' ' LYS . . . -77.71 -33.18 53.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 0.0 110.021 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.878 ' O ' HG22 ' A' ' 162' ' ' ILE . . . -59.33 -44.72 92.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.27 -0.894 . . . . 0.0 110.166 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -79.84 -29.24 40.07 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.36 -0.837 . . . . 0.0 110.307 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -80.62 -6.51 58.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.267 -0.896 . . . . 0.0 110.743 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.878 HG22 ' O ' ' A' ' 159' ' ' ALA . 4.7 tt -92.44 179.66 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.964 -1.085 . . . . 0.0 109.967 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -70.33 62.34 0.23 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.035 -1.04 . . . . 0.0 110.429 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 162' ' ' ILE . 3.9 p-10 40.3 52.33 2.85 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.478 0.656 . . . . 0.0 111.194 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.555 HG23 ' HD2' ' A' ' 166' ' ' PRO . 34.6 mm -88.25 145.41 35.87 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.497 -0.752 . . . . 0.0 109.835 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.555 ' HD2' HG23 ' A' ' 165' ' ' ILE . 43.5 Cg_endo -68.59 91.3 0.41 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.639 1.336 . . . . 0.0 110.759 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.519 ' CZ ' HD13 ' A' ' 162' ' ' ILE . 2.9 m-85 -88.83 133.91 34.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 0.0 110.133 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.639 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -122.43 150.74 16.91 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 5.9 tt -150.04 142.01 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -1.118 . . . . 0.0 110.65 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.1 t -159.23 155.36 26.89 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.125 0.964 . . . . 0.0 110.755 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 85.0 p -116.01 1.04 13.2 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.608 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.404 ' ND2' ' HB2' ' A' ' 174' ' ' ASP . 56.2 t30 -57.56 128.28 36.27 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.085 -1.009 . . . . 0.0 110.34 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.14 -28.05 66.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.271 -0.893 . . . . 0.0 110.224 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.404 ' HB2' ' ND2' ' A' ' 172' ' ' ASN . 0.1 OUTLIER -55.41 -45.61 76.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.112 -0.992 . . . . 0.0 109.838 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 42.8 t -67.68 -29.79 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.2 -0.938 . . . . 0.0 109.573 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -76.5 -44.15 36.45 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.376 -0.828 . . . . 0.0 109.357 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 12.1 t -71.59 -5.75 35.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.539 -0.726 . . . . 0.0 110.499 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.427 ' HD2' ' HA3' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -88.59 -47.12 8.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.993 -1.067 . . . . 0.0 108.888 179.516 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -90.28 8.4 33.49 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.685 -0.634 . . . . 0.0 110.235 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 53.6 67.29 1.03 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.088 -1.007 . . . . 0.0 110.587 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 42.0 mt -117.27 107.5 14.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.112 -0.992 . . . . 0.0 109.88 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.74 -19.49 17.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.0 110.135 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.53 -164.72 2.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.166 -0.959 . . . . 0.0 109.492 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 3.3 p30 -61.51 164.23 6.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.074 -1.016 . . . . 0.0 109.958 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -158.55 153.84 24.96 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.49 HG13 ' HE2' ' A' ' 155' ' ' PHE . 92.8 t -129.59 98.73 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.301 -1.117 . . . . 0.0 109.982 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 140' ' ' VAL . 94.6 t -119.74 158.54 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.275 -0.89 . . . . 0.0 110.111 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.578 HD12 HG12 ' A' ' 212' ' ' ILE . 6.8 tt -109.21 150.48 27.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.085 -1.009 . . . . 0.0 109.572 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.723 ' HB3' HG22 ' A' ' 133' ' ' VAL . 44.4 m-85 -124.63 123.86 40.96 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.938 -1.101 . . . . 0.0 110.511 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.31 174.23 10.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.44 -0.788 . . . . 0.0 110.105 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -94.37 -34.24 12.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.174 -0.954 . . . . 0.0 110.263 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.27 -170.58 2.68 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.388 -0.82 . . . . 0.0 110.948 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 54.68 -160.34 0.16 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.544 0.687 . . . . 0.0 110.5 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -55.02 -53.68 52.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.701 -0.625 . . . . 0.0 110.14 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 130.93 -24.79 4.23 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 24.4 mtm-85 -144.48 178.93 7.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.12 -1.223 . . . . 0.0 110.686 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' ASN . . . . . 0.468 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.0 OUTLIER -147.63 -155.11 0.6 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.343 -0.848 . . . . 0.0 109.687 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -169.44 85.48 0.14 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.486 -0.759 . . . . 0.0 110.187 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.419 ' CB ' ' O ' ' A' ' 186' ' ' VAL . 12.5 t80 -57.74 122.32 12.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.279 -0.888 . . . . 0.0 110.433 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -123.33 104.55 9.19 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.251 -0.905 . . . . 0.0 110.24 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 148.79 -167.0 29.31 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.79 134.87 49.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -1.128 . . . . 0.0 110.222 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.618 HG11 ' HZ ' ' A' ' 144' ' ' PHE . 70.7 t -86.04 111.17 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.904 . . . . 0.0 110.348 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.481 HG23 ' C ' ' A' ' 203' ' ' VAL . 68.8 p -149.18 153.96 38.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.472 -0.768 . . . . 0.0 110.097 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.756 ' O ' HD12 ' A' ' 209' ' ' LEU . 0.9 OUTLIER -48.06 -54.35 13.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.937 -179.806 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -54.21 -41.36 68.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.447 -0.783 . . . . 0.0 110.484 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -71.44 -42.87 67.68 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.425 -0.797 . . . . 0.0 110.687 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 71.0 mt -59.7 -51.75 68.43 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.145 -0.972 . . . . 0.0 110.711 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.756 HD12 ' O ' ' A' ' 205' ' ' LYS . 0.7 OUTLIER -54.68 -33.33 60.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.171 -0.955 . . . . 0.0 110.337 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -71.57 -47.62 53.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.216 -0.928 . . . . 0.0 110.3 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -57.95 -55.18 38.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.286 -0.884 . . . . 0.0 110.315 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.578 HG12 HD12 ' A' ' 188' ' ' LEU . 82.3 mt -54.42 -52.89 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.0 110.447 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.21 -23.77 0.97 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.422 -0.799 . . . . 0.0 111.285 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -92.19 -20.74 20.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.928 -1.108 . . . . 0.0 110.733 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -93.19 -53.12 4.24 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.034 -1.041 . . . . 0.0 111.516 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 . . . . . 0 N--CA 1.488 1.471 0 O-C-N 121.033 -1.042 . . . . 0.0 111.306 -179.048 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.231 0.539 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.656 HG22 ' HA2' ' A' ' 168' ' ' GLY . 7.9 t -89.71 170.72 10.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.891 . . . . 0.0 110.257 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 96.1 m -109.14 104.4 13.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 0.0 110.192 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.888 HD21 HD12 ' A' ' 132' ' ' LEU . 85.5 mt -76.78 139.83 66.8 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.261 -0.899 . . . . 0.0 110.191 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 46.4 Cg_endo -72.15 -35.15 7.22 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 O-C-N 123.556 1.292 . . . . 0.0 110.41 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.557 ' C ' HG22 ' A' ' 175' ' ' VAL . 1.0 OUTLIER -165.86 -170.37 1.75 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.235 -0.915 . . . . 0.0 110.932 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.51 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -66.7 -38.03 92.87 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -51.64 -32.97 31.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.231 -1.158 . . . . 0.0 110.4 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.431 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -82.13 -32.21 30.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.896 . . . . 0.0 110.242 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.59 -25.51 26.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.997 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -89.93 -44.63 9.76 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.312 -0.867 . . . . 0.0 109.058 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.3 m -60.51 -28.31 68.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.225 -0.922 . . . . 0.0 109.675 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.888 HD12 HD21 ' A' ' 123' ' ' LEU . 5.8 tt -65.14 -61.74 1.96 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.354 -0.842 . . . . 0.0 109.967 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.493 HG21 ' CB ' ' A' ' 189' ' ' PHE . 86.8 t -50.95 -31.11 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.404 -0.81 . . . . 0.0 110.253 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.34 -12.65 61.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.294 -0.879 . . . . 0.0 110.673 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 35.8 m -75.83 -21.97 56.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.015 -1.053 . . . . 0.0 110.25 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.14 168.98 22.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.296 -0.878 . . . . 0.0 110.432 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -72.05 -19.51 61.82 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.396 -0.815 . . . . 0.0 109.724 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 26.0 m -129.9 141.83 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.279 -0.888 . . . . 0.0 110.311 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.408 ' HB3' ' HA ' ' A' ' 133' ' ' VAL . . . -175.85 137.36 0.34 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.252 -0.905 . . . . 0.0 110.086 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.467 HG11 ' CZ ' ' A' ' 167' ' ' PHE . 14.5 p -123.57 150.49 27.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.18 -0.95 . . . . 0.0 110.351 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 69.9 mt -132.86 110.39 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.371 -0.831 . . . . 0.0 110.099 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.8 123.94 6.84 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.351 -1.499 . . . . 0.0 109.351 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.462 ' CD2' HD12 ' A' ' 181' ' ' LEU . 47.0 m-85 -93.9 80.56 4.15 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.229 -1.159 . . . . 0.0 110.141 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -105.8 140.99 37.99 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.059 -1.026 . . . . 0.0 111.128 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.462 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 61.3 pttt -91.48 -36.18 13.9 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.75 0.785 . . . . 0.0 109.165 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.462 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 4.7 m-20 -122.78 79.97 1.7 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.744 -0.598 . . . . 0.0 109.642 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.433 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 29.7 m -55.26 -19.37 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.239 -0.913 . . . . 0.0 110.708 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.79 11.81 8.49 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.092 -1.005 . . . . 0.0 110.9 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.407 ' O ' ' HG2' ' A' ' 153' ' ' LYS . 91.9 p -87.81 -163.7 0.99 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.912 -1.118 . . . . 0.0 110.102 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -90.17 -42.43 11.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.328 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 55.5 m -62.03 -28.82 69.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 110.493 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.433 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -79.8 -25.66 40.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.183 -0.948 . . . . 0.0 110.265 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 149' ' ' SER . 19.6 mmtt -63.16 -44.83 94.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 110.08 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -62.2 -40.78 97.22 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.275 -0.891 . . . . 0.0 110.214 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.506 ' HE1' HG13 ' A' ' 186' ' ' VAL . 4.6 t80 -50.86 -54.89 19.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.198 -0.939 . . . . 0.0 110.256 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 32.0 mt -52.4 -56.14 16.99 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.397 -0.815 . . . . 0.0 110.233 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -52.74 -49.85 64.61 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.322 -0.862 . . . . 0.0 110.257 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.81 -45.58 82.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.892 . . . . 0.0 110.114 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.451 ' HB2' ' CD2' ' A' ' 167' ' ' PHE . . . -64.71 -31.83 73.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 110.1 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.77 -31.26 72.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.359 -0.838 . . . . 0.0 110.157 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.23 -41.53 88.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 110.245 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 76.0 mt -99.72 140.33 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.929 . . . . 0.0 110.274 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -122.66 16.29 10.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.296 -0.877 . . . . 0.0 110.48 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.403 ' O ' HD13 ' A' ' 165' ' ' ILE . 3.7 p30 -120.35 19.67 12.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.156 -0.965 . . . . 0.0 110.323 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.403 HD13 ' O ' ' A' ' 164' ' ' ASP . 48.1 mm -128.98 132.58 24.46 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.17 -0.956 . . . . 0.0 110.014 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.54 ' HB2' HD21 ' A' ' 132' ' ' LEU . 48.6 Cg_endo -72.72 70.83 3.4 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.515 1.271 . . . . 0.0 110.281 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.467 ' CZ ' HG11 ' A' ' 140' ' ' VAL . 2.2 m-85 -65.54 125.46 25.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 109.954 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.656 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -125.0 149.12 16.93 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 12.4 tt -146.76 144.77 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.286 -1.126 . . . . 0.0 110.318 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.425 ' CG2' HG11 ' A' ' 175' ' ' VAL . 2.2 t -158.15 156.97 31.85 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.022 0.915 . . . . 0.0 110.789 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.5 m -124.17 3.54 8.57 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -60.81 129.89 43.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 0.0 110.279 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 84.4 p -53.52 -29.21 35.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.217 -0.927 . . . . 0.0 110.045 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -56.55 -26.77 55.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.904 . . . . 0.0 109.684 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.557 HG22 ' C ' ' A' ' 125' ' ' ASP . 42.9 t -86.93 -24.75 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.416 -0.803 . . . . 0.0 109.558 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 176' ' ' PHE . 10.6 m-85 -80.0 -47.9 14.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.295 -0.878 . . . . 0.0 109.403 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.81 -11.25 60.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.391 -0.818 . . . . 0.0 110.693 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.426 ' CD ' ' HA3' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -85.55 -50.54 7.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.061 -1.025 . . . . 0.0 109.697 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 179' ' ' TYR . 32.8 m-85 -89.35 13.62 13.12 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.485 -0.759 . . . . 0.0 110.196 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 49.81 65.3 1.45 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.123 -0.985 . . . . 0.0 110.482 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.462 HD12 ' CD2' ' A' ' 143' ' ' PHE . 79.4 mt -118.33 106.4 12.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 110.249 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.41 -30.27 70.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.061 -1.024 . . . . 0.0 109.825 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.17 -149.24 0.35 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.364 -0.835 . . . . 0.0 109.697 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.411 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 45.3 m-20 -78.16 175.42 10.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.007 -1.058 . . . . 0.0 109.748 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -167.63 139.75 5.87 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.459 -1.353 . . . . 0.0 109.924 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.506 HG13 ' HE1' ' A' ' 155' ' ' PHE . 95.0 t -121.33 85.75 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.477 -1.014 . . . . 0.0 109.799 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.7 t -109.86 160.26 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.399 -0.813 . . . . 0.0 110.45 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.649 HD22 ' HB3' ' A' ' 215' ' ' ASN . 2.2 tt -113.15 147.05 38.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.19 -0.944 . . . . 0.0 109.447 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.493 ' CB ' HG21 ' A' ' 133' ' ' VAL . 45.2 m-85 -118.7 125.15 49.05 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.981 -1.075 . . . . 0.0 110.651 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.595 ' HD3' HD23 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -139.92 161.75 36.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.888 . . . . 0.0 109.907 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.0 mmpp? -87.24 -20.65 26.59 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.181 -0.949 . . . . 0.0 110.563 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 190' ' ' LYS . 3.4 p90 -90.87 179.73 5.7 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.292 -0.88 . . . . 0.0 110.823 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 44.55 -158.24 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.551 0.691 . . . . 0.0 111.035 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -50.99 -43.74 60.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.577 -0.702 . . . . 0.0 110.235 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.405 ' HA2' ' HG2' ' A' ' 190' ' ' LYS . . . 112.37 -21.07 20.22 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -137.9 174.26 10.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.099 -1.236 . . . . 0.0 110.735 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' ASN . . . . . 0.46 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.0 OUTLIER -144.54 -152.29 0.41 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.502 -0.749 . . . . 0.0 109.515 -179.827 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 27.8 p30 -173.77 76.06 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 0.0 110.548 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -54.01 125.47 18.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -0.938 . . . . 0.0 109.92 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -132.72 33.01 3.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.928 . . . . 0.0 110.096 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -117.96 175.74 15.84 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.77 122.74 10.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -1.157 . . . . 0.0 110.161 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.492 ' C ' HG23 ' A' ' 204' ' ' THR . 78.4 t -65.55 102.75 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.157 -0.965 . . . . 0.0 110.18 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.492 HG23 ' C ' ' A' ' 203' ' ' VAL . 82.1 p -150.11 151.91 33.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.389 -0.819 . . . . 0.0 110.24 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 23.2 tttt -50.44 -50.1 53.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 0.0 110.491 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -53.28 -35.44 60.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.203 -0.936 . . . . 0.0 110.388 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -79.03 -46.76 17.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 0.0 110.147 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.43 ' CD2' HG11 ' A' ' 186' ' ' VAL . 82.8 mt -62.53 -31.02 71.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 110.263 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 19.0 mt -70.44 -26.67 63.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 110.187 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -86.9 -47.69 8.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.166 -0.959 . . . . 0.0 110.039 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -49.45 -50.15 42.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.317 -0.865 . . . . 0.0 110.213 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.498 HD13 HD12 ' A' ' 188' ' ' LEU . 28.2 mm -55.38 -69.26 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.533 -0.729 . . . . 0.0 110.185 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.34 -36.81 4.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.759 -0.588 . . . . 0.0 111.063 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -40.04 95.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.137 -0.977 . . . . 0.0 110.121 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.649 ' HB3' HD22 ' A' ' 188' ' ' LEU . 79.5 m-20 -89.71 -45.04 9.6 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.3 -0.875 . . . . 0.0 110.451 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.221 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.299 0.571 . . . . 0.0 110.387 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.432 ' HB ' ' HA2' ' A' ' 168' ' ' GLY . 7.9 m -104.68 116.7 32.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.336 -0.853 . . . . 0.0 109.706 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 79.8 m -69.17 142.01 54.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 0.0 110.191 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.7 mt -124.29 144.41 45.63 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 110.148 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.432 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 45.8 Cg_endo -72.48 -37.42 4.25 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.713 1.375 . . . . 0.0 110.372 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.68 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.9 OUTLIER -173.27 -170.46 0.62 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.205 -0.934 . . . . 0.0 110.687 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.488 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -57.8 -30.59 63.11 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.68 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -51.49 -35.55 40.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.257 -1.143 . . . . 0.0 110.498 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.432 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -82.85 -38.19 23.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.108 -0.995 . . . . 0.0 110.203 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.73 -24.86 24.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.108 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -77.66 -64.16 1.21 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 110.165 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.0 -23.14 12.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 110.139 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.717 HD22 ' HB1' ' A' ' 139' ' ' ALA . 2.1 tt -64.76 -59.48 4.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 0.0 109.946 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.74 HG22 ' HB3' ' A' ' 189' ' ' PHE . 56.4 t -50.49 -41.53 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.37 -0.831 . . . . 0.0 110.562 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -80.22 1.72 27.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.919 . . . . 0.0 110.931 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 17.5 t -82.71 -27.38 31.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.898 -1.126 . . . . 0.0 110.051 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.42 171.59 16.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.262 -0.899 . . . . 0.0 110.168 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.25 -20.15 63.94 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.335 -0.853 . . . . 0.0 109.583 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 18.2 m -135.13 149.15 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.259 -0.901 . . . . 0.0 110.169 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.717 ' HB1' HD22 ' A' ' 132' ' ' LEU . . . -173.64 138.06 0.65 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.233 -0.917 . . . . 0.0 110.232 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.43 ' CG1' ' HA ' ' A' ' 167' ' ' PHE . 7.2 p -125.99 153.67 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 121.072 -1.017 . . . . 0.0 110.365 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.422 ' O ' ' CE1' ' A' ' 143' ' ' PHE . 52.9 mt -137.96 114.5 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 109.905 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.56 136.69 18.33 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.715 ' CE2' HG12 ' A' ' 175' ' ' VAL . 67.6 m-85 -112.97 72.84 0.79 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.299 -1.118 . . . . 0.0 110.014 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.417 ' CE1' ' HB3' ' A' ' 184' ' ' ASP . 10.8 m-85 -102.35 142.7 33.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 111.051 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.88 -27.38 23.46 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.765 0.793 . . . . 0.0 109.494 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.7 p30 -126.24 69.63 1.22 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.694 -0.629 . . . . 0.0 109.616 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.499 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 31.4 m -50.41 -23.27 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.725 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.16 -9.47 57.81 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.115 -0.991 . . . . 0.0 111.296 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 52.7 p -69.95 -159.69 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.894 -1.129 . . . . 0.0 110.333 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -90.35 -45.74 8.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.386 -0.822 . . . . 0.0 110.267 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.9 p -52.32 -30.0 26.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.318 -0.864 . . . . 0.0 110.224 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.499 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -83.24 -34.99 25.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.372 -0.83 . . . . 0.0 110.174 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.2 mmtt -49.89 -40.1 41.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.309 -0.87 . . . . 0.0 110.357 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -65.8 -45.03 83.9 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.288 -0.882 . . . . 0.0 110.002 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.44 ' HE1' HG13 ' A' ' 186' ' ' VAL . 5.7 t80 -48.05 -55.4 10.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.273 -0.892 . . . . 0.0 110.597 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.0 mt -48.59 -54.6 13.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.277 -0.89 . . . . 0.0 110.667 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -52.23 -51.61 57.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.217 -0.927 . . . . 0.0 110.171 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' A' ' 205' ' ' LYS . . . -60.0 -39.37 85.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.145 -0.972 . . . . 0.0 109.824 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.39 -32.21 71.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.343 -0.848 . . . . 0.0 110.066 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -80.62 -29.48 36.8 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.314 -0.866 . . . . 0.0 110.277 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.468 ' HB3' HD21 ' A' ' 209' ' ' LEU . . . -54.16 -52.21 61.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -0.893 . . . . 0.0 110.365 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.401 HG13 ' OD2' ' A' ' 164' ' ' ASP . 19.0 tt -89.79 150.04 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 110.064 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -132.57 35.77 3.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.108 -0.995 . . . . 0.0 110.661 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.722 ' O ' HD13 ' A' ' 165' ' ' ILE . 3.5 p30 -136.05 17.79 3.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.169 -0.957 . . . . 0.0 110.228 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.722 HD13 ' O ' ' A' ' 164' ' ' ASP . 39.5 mm -135.17 146.5 58.53 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.238 -0.914 . . . . 0.0 109.923 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.467 ' HD2' ' CG2' ' A' ' 165' ' ' ILE . 47.6 Cg_endo -84.18 90.83 0.85 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.779 1.41 . . . . 0.0 110.248 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.43 ' HA ' ' CG1' ' A' ' 140' ' ' VAL . 3.9 m-85 -85.81 130.93 34.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.29 -0.882 . . . . 0.0 110.554 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.432 ' HA2' ' HB ' ' A' ' 121' ' ' THR . . . -120.01 153.07 16.86 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 14.7 tt -147.42 144.36 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -1.125 . . . . 0.0 110.305 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.707 HG21 HG11 ' A' ' 175' ' ' VAL . 2.5 t -162.17 157.58 23.36 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.064 0.935 . . . . 0.0 110.693 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.1 1.58 9.2 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.411 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -59.41 121.52 11.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.115 -0.991 . . . . 0.0 110.259 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 79.4 p -51.65 -29.99 20.02 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.096 -1.002 . . . . 0.0 110.296 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -59.19 -35.6 73.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.136 -0.978 . . . . 0.0 109.842 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.715 HG12 ' CE2' ' A' ' 143' ' ' PHE . 60.3 t -76.85 -26.54 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.39 -0.819 . . . . 0.0 109.812 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -79.59 -53.26 7.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.395 -0.816 . . . . 0.0 109.865 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -25.45 63.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.955 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.43 -53.01 62.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 110.037 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -92.83 16.99 11.21 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.222 -0.923 . . . . 0.0 110.409 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 53.54 69.47 0.7 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.249 -0.907 . . . . 0.0 110.603 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 77.6 mt -115.02 123.01 47.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.212 -0.93 . . . . 0.0 110.024 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -86.39 -21.01 27.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.166 -0.959 . . . . 0.0 110.19 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -148.84 -166.14 2.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.329 -0.857 . . . . 0.0 109.914 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.417 ' HB3' ' CE1' ' A' ' 144' ' ' PHE . 71.2 m-20 -53.46 152.33 4.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.938 . . . . 0.0 109.997 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -157.77 131.74 2.96 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.44 HG13 ' HE1' ' A' ' 155' ' ' PHE . 72.8 t -115.21 85.69 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.356 -1.085 . . . . 0.0 109.619 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.555 HG13 ' H ' ' A' ' 197' ' ' ASN . 85.5 t -102.72 149.25 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.371 -0.831 . . . . 0.0 110.18 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.696 HD23 ' HD3' ' A' ' 190' ' ' LYS . 5.3 tt -105.53 150.59 25.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.122 -0.986 . . . . 0.0 109.627 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.74 ' HB3' HG22 ' A' ' 133' ' ' VAL . 46.1 m-85 -119.52 121.19 38.85 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.931 -1.106 . . . . 0.0 110.554 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.696 ' HD3' HD23 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -136.33 160.76 37.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 0.0 110.171 179.815 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -85.53 -22.94 27.91 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.312 -0.868 . . . . 0.0 110.556 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 190' ' ' LYS . 2.5 p90 -90.45 -176.29 4.73 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.392 -0.817 . . . . 0.0 110.865 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 193' ' ' ASP . 0.7 OUTLIER 46.52 -157.97 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.481 0.658 . . . . 0.0 110.511 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -54.83 -54.96 35.53 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.475 -0.766 . . . . 0.0 110.094 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 134.47 -31.61 2.74 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -131.56 173.09 11.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.157 -1.202 . . . . 0.0 110.66 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' ASN . . . . . 0.555 ' H ' HG13 ' A' ' 187' ' ' VAL . 1.6 m-80 -138.21 -151.51 0.39 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.515 -0.741 . . . . 0.0 109.673 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -175.6 77.0 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.356 -0.84 . . . . 0.0 110.051 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -48.41 142.84 5.3 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.329 -0.857 . . . . 0.0 110.915 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -150.29 134.98 17.48 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.31 -0.869 . . . . 0.0 109.649 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 125.08 -178.39 16.55 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -54.98 121.15 8.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -1.139 . . . . 0.0 110.232 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 75.8 t -74.91 102.57 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.191 -0.943 . . . . 0.0 110.212 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.3 p -136.6 145.26 44.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.367 -0.833 . . . . 0.0 109.705 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.521 ' HA ' HD12 ' A' ' 208' ' ' LEU . 0.1 OUTLIER -48.08 -47.53 34.05 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.157 -0.964 . . . . 0.0 110.838 -179.722 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -59.11 -40.49 85.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.24 -0.912 . . . . 0.0 110.458 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -67.68 -39.53 84.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.123 -0.986 . . . . 0.0 110.407 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.812 ' O ' HD12 ' A' ' 212' ' ' ILE . 36.7 mt -63.42 -52.63 60.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 110.41 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.468 HD21 ' HB3' ' A' ' 161' ' ' ALA . 6.9 mt -51.69 -24.39 5.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.172 -0.955 . . . . 0.0 110.407 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -82.4 -48.76 10.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.17 -0.956 . . . . 0.0 110.031 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -53.27 -57.22 11.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 110.474 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.812 HD12 ' O ' ' A' ' 208' ' ' LEU . 4.4 mt -49.79 -54.2 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.179 -0.95 . . . . 0.0 110.61 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.29 -29.45 9.74 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.286 -0.884 . . . . 0.0 110.66 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -81.45 -15.97 53.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.31 -0.869 . . . . 0.0 110.782 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.664 ' HB3' HD22 ' A' ' 188' ' ' LEU . 74.5 m-20 -104.77 -35.52 7.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.08 -1.013 . . . . 0.0 110.849 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' GLN . . . . . 0.443 ' OE1' HG22 ' A' ' 212' ' ' ILE . 13.7 pt20 . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.13 -0.982 . . . . 0.0 110.949 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 167' ' ' PHE . . . . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.191 0.52 . . . . 0.0 110.111 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.576 ' O ' HG22 ' A' ' 169' ' ' ILE . 7.2 t -145.31 152.32 39.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.154 -0.966 . . . . 0.0 110.048 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 169' ' ' ILE . 1.5 m -86.15 125.49 33.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.067 -1.02 . . . . 0.0 109.891 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.955 ' HB2' HG23 ' A' ' 170' ' ' THR . 71.0 mt -88.47 130.87 43.94 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.88 -1.137 . . . . 0.0 110.297 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.44 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 48.6 Cg_endo -72.68 -51.21 0.19 Allowed 'Trans proline' 0 C--N 1.315 -1.207 0 O-C-N 123.422 1.222 . . . . 0.0 110.556 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.687 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.5 OUTLIER -141.9 -169.43 2.91 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.247 -0.908 . . . . 0.0 110.778 -179.84 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.94 -27.04 72.87 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.687 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -59.13 -27.48 65.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.205 -1.173 . . . . 0.0 110.237 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.44 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -90.05 -21.28 22.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.944 . . . . 0.0 110.227 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.95 -21.88 50.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 110.252 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -90.31 -40.75 11.93 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.27 -0.894 . . . . 0.0 109.623 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.83 -31.18 66.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.147 -0.971 . . . . 0.0 110.385 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.4 tp -68.69 -43.98 74.95 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.296 -0.877 . . . . 0.0 110.391 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.837 HG22 ' HB3' ' A' ' 189' ' ' PHE . 46.2 t -51.56 -53.99 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.339 -0.85 . . . . 0.0 110.519 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.27 -17.84 60.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.196 -0.94 . . . . 0.0 110.471 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.6 p -53.3 -38.6 63.27 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.126 -0.984 . . . . 0.0 110.331 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.401 ' OG ' ' HG3' ' A' ' 166' ' ' PRO . 2.3 p -147.27 -172.77 4.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.301 -0.875 . . . . 0.0 110.249 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.06 -45.8 47.17 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.341 -0.85 . . . . 0.0 110.362 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.4 m -116.76 151.63 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.938 . . . . 0.0 110.464 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.434 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -175.26 127.11 0.26 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.911 . . . . 0.0 109.934 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.83 153.03 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.102 -0.999 . . . . 0.0 110.02 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.683 HG23 HD11 ' A' ' 123' ' ' LEU . 56.8 mt -139.98 114.74 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.144 -0.972 . . . . 0.0 110.47 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.0 132.4 11.06 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.709 ' CE2' HG12 ' A' ' 175' ' ' VAL . 18.7 m-85 -100.68 92.3 5.03 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.243 -1.151 . . . . 0.0 109.679 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.555 ' HZ ' HG21 ' A' ' 203' ' ' VAL . 25.1 m-85 -114.78 147.31 39.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.065 -1.022 . . . . 0.0 111.536 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.76 -26.85 19.28 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.57 0.7 . . . . 0.0 109.652 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.03 78.49 1.68 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.607 -0.683 . . . . 0.0 109.603 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.499 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 22.2 m -50.77 -23.2 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.289 -0.882 . . . . 0.0 110.69 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -72.5 -3.59 25.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.0 110.899 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 7.4 p -78.61 -164.73 0.61 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.851 -1.155 . . . . 0.0 110.161 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.2 -47.52 7.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.277 -0.889 . . . . 0.0 110.436 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.2 m -51.14 -27.34 8.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.24 -0.913 . . . . 0.0 110.541 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.499 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -81.16 -40.48 23.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.931 . . . . 0.0 110.026 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.8 mtpt -50.95 -47.07 61.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.354 -0.841 . . . . 0.0 110.317 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -53.63 -33.73 56.11 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.118 -0.989 . . . . 0.0 109.689 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.424 ' CE1' HG11 ' A' ' 186' ' ' VAL . 4.0 t80 -66.96 -56.65 9.26 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.405 -0.809 . . . . 0.0 109.935 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 152' ' ' ALA . 1.3 mp -46.71 -55.98 6.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.535 -0.728 . . . . 0.0 110.649 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -51.17 -46.73 62.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.35 -0.844 . . . . 0.0 110.292 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.544 ' HB2' ' HG3' ' A' ' 205' ' ' LYS . . . -65.27 -45.59 83.88 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.944 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.79 -38.03 71.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.21 -0.931 . . . . 0.0 109.971 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.35 -28.2 59.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.193 -0.942 . . . . 0.0 110.051 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.21 -42.09 76.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.869 . . . . 0.0 110.201 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.46 ' CD1' HG13 ' A' ' 165' ' ' ILE . 5.5 tt -96.41 152.06 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 110.343 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -131.22 15.35 5.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.272 -0.892 . . . . 0.0 110.558 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.696 ' O ' HD13 ' A' ' 165' ' ' ILE . 4.1 p30 -124.05 16.14 9.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.077 -1.014 . . . . 0.0 110.415 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.696 HD13 ' O ' ' A' ' 164' ' ' ASP . 39.4 mm -132.49 146.27 60.77 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.176 -0.952 . . . . 0.0 110.016 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.472 ' HD2' ' CG2' ' A' ' 165' ' ' ILE . 46.4 Cg_endo -84.34 78.93 2.7 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.747 1.393 . . . . 0.0 110.495 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 120' ' ' ALA . 3.6 m-85 -77.29 135.03 38.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 0.0 110.221 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 141' ' ' ILE . . . -136.06 153.62 21.55 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.576 HG22 ' O ' ' A' ' 121' ' ' THR . 1.7 tt -130.85 151.09 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.173 -1.192 . . . . 0.0 109.451 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' THR . . . . . 1.063 HG21 HG11 ' A' ' 175' ' ' VAL . 0.7 OUTLIER -119.36 144.61 46.78 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.1 -1.0 . . . . 0.0 110.94 -178.577 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 171' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 144' ' ' PHE . 2.5 t -130.85 12.89 5.29 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.503 -0.748 . . . . 0.0 109.814 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.437 ' ND2' ' HB2' ' A' ' 174' ' ' ASP . 50.8 t30 -112.36 160.76 17.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.068 -1.02 . . . . 0.0 110.893 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 39.6 t -83.29 -28.43 29.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.448 -0.782 . . . . 0.0 109.966 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.437 ' HB2' ' ND2' ' A' ' 172' ' ' ASN . 1.7 m-20 -53.8 -32.01 51.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -0.947 . . . . 0.0 109.519 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 1.063 HG11 HG21 ' A' ' 170' ' ' THR . 38.4 t -76.89 -32.17 19.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -69.83 -59.13 3.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.477 -0.765 . . . . 0.0 109.215 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.6 m -53.18 -23.76 9.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.444 -0.785 . . . . 0.0 109.514 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.474 ' HD2' ' CE1' ' A' ' 179' ' ' TYR . 3.4 tmtt? -61.31 -61.38 2.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.525 -0.734 . . . . 0.0 110.067 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.474 ' CE1' ' HD2' ' A' ' 178' ' ' LYS . 94.1 m-85 -89.58 8.39 31.52 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.47 -0.769 . . . . 0.0 110.645 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.9 62.68 2.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.039 -1.038 . . . . 0.0 110.55 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 mt -92.83 134.41 35.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.282 -0.886 . . . . 0.0 110.11 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -73.67 -9.72 58.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 110.587 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -175.94 -165.91 0.17 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.022 -1.049 . . . . 0.0 110.067 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -70.01 152.33 44.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.21 -0.931 . . . . 0.0 110.015 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -177.21 166.86 37.71 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 186' ' ' VAL . 18.6 m -126.22 121.88 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -1.154 . . . . 0.0 110.328 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 89.8 t -118.39 158.84 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.452 -0.78 . . . . 0.0 109.5 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.673 HD13 ' HB2' ' A' ' 215' ' ' ASN . 7.1 tt -107.27 140.2 40.54 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.826 -1.171 . . . . 0.0 109.8 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.837 ' HB3' HG22 ' A' ' 133' ' ' VAL . 49.6 m-85 -117.38 111.15 18.94 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.995 -1.066 . . . . 0.0 110.598 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.625 ' HD3' HD23 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -124.22 -172.81 2.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.27 -0.894 . . . . 0.0 110.06 179.852 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 11.5 mttt -106.62 -26.04 11.53 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.128 -0.983 . . . . 0.0 110.526 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -90.83 -175.89 4.51 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.381 -0.824 . . . . 0.0 110.829 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 47.68 -159.06 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.54 -0.725 . . . . 0.0 110.887 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -52.98 -43.54 66.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.662 -0.649 . . . . 0.0 110.294 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 113.9 -27.08 9.43 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 11.8 mtm180 -135.76 163.98 28.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.184 -1.186 . . . . 0.0 110.386 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' ASN . . . . . 0.486 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 0.8 OUTLIER -136.49 -153.82 0.52 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.342 -0.848 . . . . 0.0 109.796 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -172.89 80.84 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.421 -0.799 . . . . 0.0 110.267 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -48.61 119.67 3.24 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.341 -0.849 . . . . 0.0 110.634 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -113.77 90.2 3.28 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.275 -0.89 . . . . 0.0 110.288 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 164.4 -165.44 37.3 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -74.85 117.88 17.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -1.145 . . . . 0.0 110.278 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.609 HG13 ' O ' ' A' ' 203' ' ' VAL . 6.9 p -66.95 83.28 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 110.091 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 81.4 p -121.24 153.83 37.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 0.0 110.212 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.544 ' HG3' ' HB2' ' A' ' 158' ' ' ALA . 0.6 OUTLIER -46.93 -55.18 8.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.372 -0.83 . . . . 0.0 110.543 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -54.74 -30.67 56.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.477 -0.764 . . . . 0.0 110.236 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -86.95 -23.96 24.92 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.228 -0.92 . . . . 0.0 110.248 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.881 ' O ' HD12 ' A' ' 212' ' ' ILE . 18.7 mt -75.54 -53.46 8.6 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.295 -0.878 . . . . 0.0 110.541 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 4.7 mp -57.58 -20.57 33.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.88 . . . . 0.0 110.633 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -81.94 -53.74 5.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.152 -0.968 . . . . 0.0 110.15 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -60.69 -55.64 30.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.33 -0.856 . . . . 0.0 110.677 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.881 HD12 ' O ' ' A' ' 208' ' ' LEU . 8.1 mt -51.57 -41.98 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.227 -0.921 . . . . 0.0 110.695 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -69.58 -15.01 63.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.122 -0.986 . . . . 0.0 110.836 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.64 -16.83 27.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.129 -0.982 . . . . 0.0 110.795 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.673 ' HB2' HD13 ' A' ' 188' ' ' LEU . 73.5 m-80 -103.69 -39.63 6.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.995 -1.066 . . . . 0.0 110.862 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' GLN . . . . . 0.515 ' OE1' HG22 ' A' ' 212' ' ' ILE . 15.1 pt20 . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.071 -1.018 . . . . 0.0 110.519 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 167' ' ' PHE . . . . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.207 0.527 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.515 HG22 ' HA2' ' A' ' 168' ' ' GLY . 11.6 t -92.14 164.71 13.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 110.305 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 91.1 m -101.91 100.72 11.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.928 . . . . 0.0 110.149 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.54 HD12 HG23 ' A' ' 141' ' ' ILE . 45.4 mt -75.93 131.68 75.71 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.284 -0.885 . . . . 0.0 110.081 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.402 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 47.6 Cg_endo -72.34 -36.95 4.83 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 O-C-N 123.52 1.273 . . . . 0.0 110.485 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.593 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.0 OUTLIER -163.26 -169.5 2.0 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 122.073 0.939 . . . . 0.0 111.262 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.4 ' HA3' ' HD2' ' A' ' 178' ' ' LYS . . . -60.67 -27.2 65.95 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.593 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -55.62 -29.26 58.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -1.141 . . . . 0.0 110.278 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.524 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -90.43 -26.02 20.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.278 -0.888 . . . . 0.0 110.171 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.09 68.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.866 . . . . 0.0 110.119 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -90.26 -40.97 11.84 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.23 -0.918 . . . . 0.0 109.188 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 41.4 m -66.71 -22.68 66.06 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.233 -0.917 . . . . 0.0 110.147 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.58 HD23 HD11 ' A' ' 141' ' ' ILE . 9.0 tp -69.95 -50.76 38.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 110.429 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 91.3 t -58.21 -37.82 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.298 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -77.86 -17.36 57.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 110.419 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.5 p -63.84 -44.76 92.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.035 -1.041 . . . . 0.0 110.303 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 89.4 p -138.2 -173.72 3.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -0.882 . . . . 0.0 110.26 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.19 -44.93 74.75 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.273 -0.892 . . . . 0.0 110.258 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.624 HG21 HD12 ' A' ' 165' ' ' ILE . 33.6 m -120.53 163.71 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.261 -0.899 . . . . 0.0 110.453 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -176.38 125.42 0.18 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.411 -0.806 . . . . 0.0 109.634 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.509 HG11 ' CE2' ' A' ' 167' ' ' PHE . 8.2 p -112.29 139.64 36.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.049 -1.032 . . . . 0.0 110.781 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.58 HD11 HD23 ' A' ' 132' ' ' LEU . 3.4 mt -130.97 113.58 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.316 -0.865 . . . . 0.0 109.671 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.76 136.68 20.34 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.771 ' CE2' HG12 ' A' ' 175' ' ' VAL . 28.6 m-85 -105.87 69.07 0.8 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -1.134 . . . . 0.0 109.715 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.571 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 22.6 m-85 -95.37 145.79 24.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 110.835 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.04 -27.15 24.95 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.51 -0.744 . . . . 0.0 109.724 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.85 78.56 1.75 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.528 -0.733 . . . . 0.0 109.677 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.521 ' O ' ' HB3' ' A' ' 152' ' ' ALA . 22.6 m -51.12 -23.08 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.242 -0.911 . . . . 0.0 110.561 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -76.94 1.01 18.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.06 -1.025 . . . . 0.0 110.933 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 95.1 p -75.55 -164.89 0.37 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.835 -1.166 . . . . 0.0 110.31 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.435 ' HA ' ' HG3' ' A' ' 153' ' ' LYS . 0.3 OUTLIER -90.63 -34.36 15.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.324 -0.86 . . . . 0.0 110.603 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 38.6 t -68.32 -27.88 66.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.263 -0.898 . . . . 0.0 110.269 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.684 ' O ' HD12 ' A' ' 156' ' ' LEU . . . -78.47 -34.04 47.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.142 -0.973 . . . . 0.0 109.939 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.435 ' HG3' ' HA ' ' A' ' 150' ' ' ASP . 2.7 mmmt -53.78 -52.06 61.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 0.0 110.065 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -54.94 -33.68 62.49 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.263 -0.898 . . . . 0.0 109.787 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.652 ' CE1' HG11 ' A' ' 186' ' ' VAL . 4.3 t80 -60.06 -57.4 13.01 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.457 -0.777 . . . . 0.0 109.903 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.684 HD12 ' O ' ' A' ' 152' ' ' ALA . 3.6 mp -46.74 -57.04 5.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.508 -0.745 . . . . 0.0 110.591 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -52.36 -52.42 53.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.292 -0.88 . . . . 0.0 110.093 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.02 -38.64 79.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 0.0 109.907 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -68.11 -31.88 71.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -0.872 . . . . 0.0 109.813 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -80.82 -24.17 38.67 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.3 -0.875 . . . . 0.0 110.045 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.78 -40.34 94.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.31 -0.869 . . . . 0.0 110.072 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.416 HG21 ' CE1' ' A' ' 167' ' ' PHE . 1.5 tt -89.98 151.04 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.33 -0.856 . . . . 0.0 109.978 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.59 16.28 4.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.157 -0.965 . . . . 0.0 110.665 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.62 ' O ' HD13 ' A' ' 165' ' ' ILE . 5.8 p-10 -125.5 14.21 8.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.029 -1.045 . . . . 0.0 110.604 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.624 HD12 HG21 ' A' ' 138' ' ' VAL . 47.8 mm -134.91 135.53 23.35 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.018 -1.051 . . . . 0.0 110.15 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -78.3 81.62 2.68 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.543 1.286 . . . . 0.0 110.873 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.509 ' CE2' HG11 ' A' ' 140' ' ' VAL . 5.4 m-85 -71.14 145.19 49.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.133 -0.979 . . . . 0.0 109.857 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.515 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -137.65 159.29 24.88 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 121' ' ' THR . 4.4 tt -150.75 149.34 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -1.165 . . . . 0.0 110.304 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.447 HG21 HG11 ' A' ' 175' ' ' VAL . 3.3 t -168.82 157.12 8.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.188 -0.945 . . . . 0.0 111.005 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' SER . . . . . 0.447 ' HA ' ' CE1' ' A' ' 176' ' ' PHE . 87.6 p -125.54 2.84 7.62 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.378 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -61.73 124.2 20.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.171 -0.956 . . . . 0.0 110.248 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.06 -31.52 7.96 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.189 -0.945 . . . . 0.0 110.553 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.43 -41.78 66.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 110.023 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.771 HG12 ' CE2' ' A' ' 143' ' ' PHE . 61.3 t -75.54 -24.01 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.299 -0.875 . . . . 0.0 109.963 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.447 ' CE1' ' HA ' ' A' ' 171' ' ' SER . 10.6 m-85 -77.28 -54.29 6.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.891 . . . . 0.0 109.721 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.34 -21.86 60.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.367 -0.833 . . . . 0.0 110.085 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.4 ' HD2' ' HA3' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -62.95 -58.79 6.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 110.086 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.42 ' O ' ' HG2' ' A' ' 180' ' ' GLN . 96.3 m-85 -94.78 30.47 2.06 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.194 -0.941 . . . . 0.0 110.456 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 0.1 OUTLIER 29.57 62.02 0.16 Allowed 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 179.728 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.9 mt -89.61 128.24 36.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.073 -1.017 . . . . 0.0 109.962 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.29 -3.86 29.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.933 . . . . 0.0 110.74 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -174.77 -147.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.99 -1.069 . . . . 0.0 109.876 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -89.14 150.32 22.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.191 -0.943 . . . . 0.0 109.974 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -179.82 137.61 3.13 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.652 HG11 ' CE1' ' A' ' 155' ' ' PHE . 18.8 m -100.59 119.27 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.274 -1.133 . . . . 0.0 110.357 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.831 HG22 ' HA ' ' A' ' 198' ' ' ASN . 98.0 t -121.39 150.35 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.924 . . . . 0.0 110.029 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.91 HD22 ' HB3' ' A' ' 215' ' ' ASN . 6.3 tt -106.39 144.29 33.28 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.217 -0.927 . . . . 0.0 108.903 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -119.83 122.0 40.36 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.896 -1.127 . . . . 0.0 110.545 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.504 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -130.14 165.4 22.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 110.116 179.687 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.4 mmtm -84.32 -33.29 23.94 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.297 -0.877 . . . . 0.0 110.396 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.504 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.2 OUTLIER -90.9 -173.65 3.76 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.54 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 56.11 -153.86 0.34 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.23 -0.919 . . . . 0.0 110.076 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -71.93 -24.87 61.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.7 -0.625 . . . . 0.0 110.378 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 103.4 -30.53 10.16 Favored Glycine 0 N--CA 1.484 1.861 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -130.3 175.75 8.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.125 -1.221 . . . . 0.0 110.454 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' ASN . . . . . 0.509 ' HB3' ' CZ ' ' A' ' 211' ' ' PHE . 1.7 m-80 -139.7 -44.64 0.44 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.322 -0.861 . . . . 0.0 110.227 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.831 ' HA ' HG22 ' A' ' 187' ' ' VAL . 0.3 OUTLIER 63.66 87.42 0.11 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.346 -0.846 . . . . 0.0 109.839 -179.308 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -57.85 134.74 56.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.448 -0.783 . . . . 0.0 110.472 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -130.63 114.84 15.93 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.273 -0.892 . . . . 0.0 109.831 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 139.95 -128.61 3.96 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -115.16 125.3 53.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.238 -1.154 . . . . 0.0 110.272 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.571 HG11 ' HZ ' ' A' ' 144' ' ' PHE . 70.8 t -74.78 107.02 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 110.029 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.452 HG23 ' C ' ' A' ' 203' ' ' VAL . 50.0 p -148.0 158.69 44.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.326 -0.859 . . . . 0.0 110.161 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.54 ' O ' HD12 ' A' ' 209' ' ' LEU . 5.1 tttt -49.22 -52.61 25.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.216 -0.927 . . . . 0.0 110.804 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -57.56 -37.15 72.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.315 -0.866 . . . . 0.0 110.429 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 45.2 m-20 -81.65 -42.89 19.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.435 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.839 ' O ' HD12 ' A' ' 212' ' ' ILE . 51.1 mt -57.86 -54.71 43.83 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.226 -0.921 . . . . 0.0 110.257 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.54 HD12 ' O ' ' A' ' 205' ' ' LYS . 0.4 OUTLIER -54.54 -28.19 43.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.148 -0.97 . . . . 0.0 109.748 179.732 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -77.05 -43.62 33.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.414 -0.804 . . . . 0.0 109.691 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.509 ' CZ ' ' HB3' ' A' ' 197' ' ' ASN . 8.4 t80 -62.01 -59.85 4.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.418 -0.801 . . . . 0.0 110.025 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.839 HD12 ' O ' ' A' ' 208' ' ' LEU . 4.7 mt -50.1 -40.47 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.306 -0.871 . . . . 0.0 110.375 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -66.04 -32.3 73.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.332 -0.855 . . . . 0.0 110.07 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -90.44 8.38 34.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.275 -0.89 . . . . 0.0 110.716 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.91 ' HB3' HD22 ' A' ' 188' ' ' LEU . 6.8 m120 -95.55 -61.99 1.37 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.892 -1.13 . . . . 0.0 110.165 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.308 -0.87 . . . . 0.0 110.557 -179.841 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.502 ' HB1' ' CA ' ' A' ' 168' ' ' GLY . . . . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.014 0.435 . . . . 0.0 110.051 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.525 HG22 ' HA2' ' A' ' 168' ' ' GLY . 12.8 t -82.54 162.03 22.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.093 -1.004 . . . . 0.0 109.917 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.1 m -97.42 119.87 36.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.951 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.669 HD22 ' HB1' ' A' ' 128' ' ' ALA . 40.7 mt -105.92 134.13 19.88 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.95 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.22 -39.16 1.72 Allowed 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.466 1.245 . . . . 0.0 110.054 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.47 ' C ' HG22 ' A' ' 175' ' ' VAL . 0.4 OUTLIER -158.37 -169.31 2.72 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.056 0.932 . . . . 0.0 110.873 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.408 ' HA3' ' HD3' ' A' ' 178' ' ' LYS . . . -63.11 -21.92 64.4 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.77 -27.78 63.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -1.113 . . . . 0.0 110.389 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.669 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -88.45 -31.95 18.52 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.093 -1.004 . . . . 0.0 110.061 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -55.17 -22.02 15.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 109.913 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -89.17 -35.61 16.14 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.299 -0.875 . . . . 0.0 109.025 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.0 m -69.89 -23.94 63.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 109.967 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.2 tp -72.73 -48.64 36.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.337 -0.852 . . . . 0.0 110.072 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.9 HG22 ' HB3' ' A' ' 189' ' ' PHE . 46.9 t -52.74 -43.77 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.338 -0.851 . . . . 0.0 110.31 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -78.84 -20.82 48.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.238 -0.914 . . . . 0.0 110.429 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 25.3 t -56.72 -56.36 22.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -0.927 . . . . 0.0 110.165 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 86.8 p -128.97 165.75 20.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 0.0 110.301 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.627 ' HG3' HG23 ' A' ' 138' ' ' VAL . 18.3 pt-20 -57.94 -40.77 81.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.27 -0.894 . . . . 0.0 110.098 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.627 HG23 ' HG3' ' A' ' 137' ' ' GLU . 74.6 t -124.01 144.8 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.405 -0.809 . . . . 0.0 110.154 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -170.47 144.55 2.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.328 -0.858 . . . . 0.0 109.709 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.624 HG11 ' CE2' ' A' ' 167' ' ' PHE . 7.3 p -129.35 153.05 38.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 121.011 -1.056 . . . . 0.0 110.252 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 20.5 mt -131.41 123.07 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.88 . . . . 0.0 109.9 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -85.81 129.01 9.09 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.62 ' CE2' HG12 ' A' ' 175' ' ' VAL . 28.8 m-85 -101.74 78.98 1.88 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -1.159 . . . . 0.0 109.898 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.483 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 10.9 m-85 -106.17 146.4 30.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.199 -0.938 . . . . 0.0 111.051 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.11 -27.12 18.77 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.617 0.722 . . . . 0.0 109.522 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.55 73.72 1.55 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.664 -0.647 . . . . 0.0 109.405 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.526 ' O ' ' HB3' ' A' ' 152' ' ' ALA . 21.7 m -49.3 -23.35 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.397 -0.815 . . . . 0.0 111.02 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -81.57 7.12 12.91 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.965 -1.084 . . . . 0.0 111.255 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.6 p -78.52 -164.37 0.56 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.864 -1.148 . . . . 0.0 110.506 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -91.04 -24.41 20.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.521 -0.737 . . . . 0.0 110.282 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.64 -30.66 46.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.29 -0.881 . . . . 0.0 109.974 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 147' ' ' VAL . . . -80.26 -19.96 45.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 0.0 110.196 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -38.83 92.72 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.309 -0.869 . . . . 0.0 109.925 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -69.97 -42.14 73.54 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.396 -0.815 . . . . 0.0 110.027 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.423 ' HE1' HG13 ' A' ' 186' ' ' VAL . 4.3 t80 -50.86 -57.75 7.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.359 -0.838 . . . . 0.0 110.337 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 74.9 mt -57.43 -49.7 75.39 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.435 -0.79 . . . . 0.0 110.095 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -52.33 -52.98 50.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.511 -0.743 . . . . 0.0 110.304 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.623 ' HB2' ' HG3' ' A' ' 205' ' ' LYS . . . -66.64 -46.0 77.2 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.192 -0.942 . . . . 0.0 110.173 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -53.15 -32.41 47.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.209 -0.932 . . . . 0.0 110.223 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -66.84 -38.42 86.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 110.2 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.81 -40.79 92.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.263 -0.898 . . . . 0.0 110.162 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 72.3 mt -91.53 92.53 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.292 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -90.62 -27.83 18.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -0.872 . . . . 0.0 110.308 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 164' ' ' ASP . 16.2 p-10 -57.79 -26.62 62.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.915 . . . . 0.0 110.221 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.411 HD12 ' CG1' ' A' ' 138' ' ' VAL . 45.9 mm -104.75 127.24 29.26 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.175 -0.953 . . . . 0.0 109.953 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -78.24 85.84 1.76 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.448 1.236 . . . . 0.0 110.675 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.624 ' CE2' HG11 ' A' ' 140' ' ' VAL . 3.8 m-85 -66.16 174.88 2.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.087 -1.008 . . . . 0.0 109.996 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.525 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -150.11 151.37 23.45 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 6.3 tt -150.47 142.46 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.939 -1.33 . . . . 0.0 110.539 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.493 ' CG2' HG11 ' A' ' 175' ' ' VAL . 2.2 t -160.78 155.67 24.08 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.013 0.911 . . . . 0.0 110.759 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 24.5 p -115.57 -1.9 12.64 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.589 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.416 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 7.5 t-20 -52.65 164.24 0.37 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.195 -0.941 . . . . 0.0 110.161 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 26.2 p -91.44 -33.41 15.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.221 -0.924 . . . . 0.0 109.958 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -57.29 -27.4 62.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.229 -0.919 . . . . 0.0 109.826 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.62 HG12 ' CE2' ' A' ' 143' ' ' PHE . 47.6 t -78.08 -29.14 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.336 -0.852 . . . . 0.0 109.725 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.425 ' N ' ' CD1' ' A' ' 176' ' ' PHE . 16.7 m-85 -85.27 -50.2 7.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.4 -0.812 . . . . 0.0 109.685 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 32.6 m -62.34 -18.05 60.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.433 -0.792 . . . . 0.0 110.361 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.408 ' HD3' ' HA3' ' A' ' 126' ' ' GLY . 5.3 tttp -74.61 -50.59 17.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.16 -0.963 . . . . 0.0 109.922 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -89.55 14.46 11.46 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.147 -0.97 . . . . 0.0 110.37 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 49.11 65.01 1.5 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.214 -0.928 . . . . 0.0 110.848 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 14.2 mt -112.75 100.95 9.08 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.061 -1.024 . . . . 0.0 109.794 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -57.96 -19.0 27.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.032 -1.042 . . . . 0.0 110.089 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt -147.38 -165.2 2.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -0.959 . . . . 0.0 109.661 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -60.31 156.81 14.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.089 -1.007 . . . . 0.0 109.855 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -159.98 118.83 0.85 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.54 HG21 ' CG2' ' A' ' 203' ' ' VAL . 79.7 t -99.21 95.75 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -1.128 . . . . 0.0 110.111 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.502 ' O ' HG23 ' A' ' 140' ' ' VAL . 94.9 t -113.71 152.66 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.299 -0.875 . . . . 0.0 109.862 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.706 ' CD1' HD13 ' A' ' 212' ' ' ILE . 7.7 tt -108.27 155.45 20.47 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.052 -1.03 . . . . 0.0 109.868 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.9 ' HB3' HG22 ' A' ' 133' ' ' VAL . 60.5 m-85 -125.0 126.38 45.35 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.943 -1.098 . . . . 0.0 110.466 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.445 ' HD2' ' CD2' ' A' ' 188' ' ' LEU . 0.0 OUTLIER -134.8 179.18 6.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.379 -0.826 . . . . 0.0 110.074 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -102.52 -29.57 11.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.171 -0.955 . . . . 0.0 110.311 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -90.96 -174.39 3.99 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.446 -0.784 . . . . 0.0 110.811 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 48.0 -159.11 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.643 0.735 . . . . 0.0 110.863 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -50.94 -51.8 48.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.568 -0.707 . . . . 0.0 110.359 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 123.47 -21.58 7.18 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -141.42 177.51 8.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -1.186 . . . . 0.0 110.399 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' ASN . . . . . 0.454 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.1 m-80 -141.89 -152.73 0.42 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.364 -0.835 . . . . 0.0 109.527 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.462 ' HA ' HG22 ' A' ' 187' ' ' VAL . 11.5 p-10 -175.43 79.1 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.274 -0.891 . . . . 0.0 110.496 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -64.34 117.54 7.38 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.384 -0.822 . . . . 0.0 109.88 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -122.64 28.88 7.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 110.571 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -110.92 -123.1 4.4 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 204' ' ' THR . 6.4 mt-10 -119.07 100.45 7.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.292 -1.122 . . . . 0.0 109.885 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.67 HG13 ' O ' ' A' ' 203' ' ' VAL . 7.3 p -51.17 93.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 110.699 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.42 ' N ' ' O ' ' A' ' 202' ' ' GLU . 21.9 p -136.03 160.88 37.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 109.995 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.623 ' HG3' ' HB2' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -50.46 -50.21 53.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.292 -0.88 . . . . 0.0 110.662 -179.823 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 206' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 207' ' ' ASN . 16.6 pt-20 -61.89 -41.22 97.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.24 -0.912 . . . . 0.0 110.552 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.425 ' N ' ' HG3' ' A' ' 206' ' ' GLU . 70.2 m-20 -73.24 -40.08 64.95 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.142 -0.974 . . . . 0.0 110.113 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.418 ' HA ' HD23 ' A' ' 208' ' ' LEU . 54.7 mt -61.9 -45.95 91.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.868 . . . . 0.0 110.066 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.534 HD12 ' O ' ' A' ' 205' ' ' LYS . 12.0 mt -59.45 -25.68 64.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.861 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -85.05 -46.11 11.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.292 -0.88 . . . . 0.0 109.901 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.422 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 22.3 t80 -48.22 -53.27 17.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.388 -0.82 . . . . 0.0 110.169 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.706 HD13 ' CD1' ' A' ' 188' ' ' LEU . 21.4 mm -48.92 -71.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.409 -0.807 . . . . 0.0 110.085 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.445 ' HA ' ' HG2' ' A' ' 216' ' ' GLN . 20.8 mttt -46.2 -34.38 4.29 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.71 -0.619 . . . . 0.0 110.965 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -71.64 -27.91 63.41 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.216 -0.927 . . . . 0.0 110.587 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 79.7 m-20 -97.84 -51.36 4.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.082 -1.012 . . . . 0.0 110.988 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' GLN . . . . . 0.445 ' HG2' ' HA ' ' A' ' 213' ' ' LYS . 11.3 pt20 . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.042 -1.036 . . . . 0.0 110.53 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.2 0.524 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.449 HG22 ' HA2' ' A' ' 168' ' ' GLY . 14.6 t -118.61 161.14 20.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 110.219 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.8 m -99.85 110.16 22.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 0.0 109.835 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.421 ' HB2' ' HB ' ' A' ' 170' ' ' THR . 34.9 mt -87.66 113.01 52.43 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.231 -0.918 . . . . 0.0 110.072 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.17 -24.13 23.79 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.491 1.258 . . . . 0.0 110.373 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.61 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 1.1 p30 -173.77 -169.88 0.53 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.307 -0.871 . . . . 0.0 110.541 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.406 ' HA3' ' HD2' ' A' ' 178' ' ' LYS . . . -59.24 -25.24 59.89 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.61 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -53.5 -34.24 57.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -1.132 . . . . 0.0 110.222 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.31 -36.27 14.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 110.149 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.13 -19.94 62.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 110.271 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -88.5 -60.03 2.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 0.0 110.262 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.5 t -55.27 -21.56 14.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.198 -0.939 . . . . 0.0 110.243 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.669 HD23 HD11 ' A' ' 141' ' ' ILE . 18.0 tp -69.92 -48.69 57.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 0.0 110.035 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.641 HG22 ' CB ' ' A' ' 189' ' ' PHE . 60.7 t -65.46 -37.82 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.834 . . . . 0.0 110.398 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -83.75 5.85 23.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.114 -0.991 . . . . 0.0 110.816 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.9 t -90.19 -27.83 19.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.95 -1.094 . . . . 0.0 110.353 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.53 165.06 33.34 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.208 -0.933 . . . . 0.0 110.523 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -65.17 -19.03 65.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.395 -0.816 . . . . 0.0 109.859 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 43.4 t -136.96 149.71 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.9 . . . . 0.0 110.201 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.455 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -175.32 142.61 0.61 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.379 -0.826 . . . . 0.0 109.551 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.673 HG11 HD11 ' A' ' 212' ' ' ILE . 3.6 m -124.15 158.38 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 118.979 -1.089 . . . . 0.0 111.07 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.669 HD11 HD23 ' A' ' 132' ' ' LEU . 60.5 mt -148.22 104.31 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.651 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.82 128.04 9.9 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.834 ' CE2' HG12 ' A' ' 175' ' ' VAL . 37.8 m-85 -98.8 84.56 3.13 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.139 -1.212 . . . . 0.0 109.488 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.673 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 16.4 m-85 -105.85 141.35 37.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.087 -1.008 . . . . 0.0 111.361 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.61 -28.94 26.18 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.959 -0.696 . . . . 0.0 110.015 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.04 87.0 2.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.367 -0.833 . . . . 0.0 109.895 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 98.0 t -60.18 -21.41 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.39 -0.819 . . . . 0.0 110.713 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -82.26 1.01 38.73 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.163 -0.961 . . . . 0.0 111.06 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 82.4 p -81.17 -168.08 1.69 Allowed 'General case' 0 C--N 1.307 -1.271 0 O-C-N 120.921 -1.112 . . . . 0.0 110.379 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -90.22 -18.08 26.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.423 -0.798 . . . . 0.0 110.168 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.476 ' CB ' ' CE1' ' A' ' 144' ' ' PHE . 1.4 m -71.4 -33.15 69.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.193 -0.942 . . . . 0.0 110.235 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.36 -37.64 27.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.141 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -55.92 -40.05 72.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.894 . . . . 0.0 110.094 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -64.19 -42.47 96.64 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.271 -0.893 . . . . 0.0 110.054 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.423 ' HA ' HD13 ' A' ' 208' ' ' LEU . 3.9 t80 -51.44 -55.45 18.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.362 -0.836 . . . . 0.0 110.18 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 156' ' ' LEU . 25.8 mt -54.58 -55.18 32.08 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.298 -0.876 . . . . 0.0 110.244 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.406 ' HB3' ' HD2' ' A' ' 205' ' ' LYS . 89.5 mt-30 -51.31 -49.65 60.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.329 -0.857 . . . . 0.0 110.129 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.601 ' HB2' ' HA ' ' A' ' 205' ' ' LYS . . . -63.52 -36.99 85.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 109.78 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.747 ' HB1' ' CD2' ' A' ' 167' ' ' PHE . . . -68.84 -29.61 67.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.301 -0.874 . . . . 0.0 109.947 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -67.7 -39.86 84.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.342 -0.849 . . . . 0.0 110.12 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.68 -50.35 66.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.863 . . . . 0.0 110.034 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.427 ' CG2' ' OD1' ' A' ' 164' ' ' ASP . 96.7 mt -97.38 163.4 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 109.806 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.425 ' N ' HG22 ' A' ' 162' ' ' ILE . 22.1 m-20 -136.73 -40.61 0.62 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.118 -0.989 . . . . 0.0 110.548 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.427 ' OD1' ' CG2' ' A' ' 162' ' ' ILE . 26.3 p-10 -55.29 -24.75 30.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 110.593 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.485 ' HB ' ' CE1' ' A' ' 167' ' ' PHE . 31.3 mm -92.59 129.78 39.34 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.073 -1.017 . . . . 0.0 110.226 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.455 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 55.2 Cg_endo -79.06 117.67 3.91 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 123.466 1.245 . . . . 0.0 110.274 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.747 ' CD2' ' HB1' ' A' ' 159' ' ' ALA . 6.1 m-85 -107.32 124.3 49.61 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.089 -1.007 . . . . 0.0 109.427 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.449 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -120.74 154.95 16.33 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 6.7 tt -150.43 140.94 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.124 -1.221 . . . . 0.0 110.78 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.421 ' HB ' ' HB2' ' A' ' 123' ' ' LEU . 1.8 t -155.12 156.93 36.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.307 -0.871 . . . . 0.0 110.414 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.1 t -119.87 1.35 10.98 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.468 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 41.4 p30 -67.93 151.29 47.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.117 -0.989 . . . . 0.0 109.985 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.8 p -78.44 -18.7 54.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.188 -0.945 . . . . 0.0 110.66 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.01 -39.14 84.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.933 . . . . 0.0 110.254 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.834 HG12 ' CE2' ' A' ' 143' ' ' PHE . 46.4 t -79.61 -24.45 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -0.956 . . . . 0.0 109.922 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.468 ' CD1' ' O ' ' A' ' 172' ' ' ASN . 9.0 m-85 -75.44 -50.59 15.33 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.32 -0.863 . . . . 0.0 109.878 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.18 -19.19 64.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.473 -0.767 . . . . 0.0 110.45 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.406 ' HD2' ' HA3' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -62.66 -56.47 17.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.971 . . . . 0.0 110.282 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.52 ' HB2' HD13 ' A' ' 181' ' ' LEU . 92.3 m-85 -92.83 26.28 2.81 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.18 -0.95 . . . . 0.0 110.374 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.552 ' C ' HD12 ' A' ' 181' ' ' LEU . 2.2 mm-40 55.97 67.06 1.06 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.498 -0.751 . . . . 0.0 110.712 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.552 HD12 ' C ' ' A' ' 180' ' ' GLN . 6.6 mp -124.7 102.98 7.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.555 -0.715 . . . . 0.0 110.227 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.405 ' O ' ' HG3' ' A' ' 183' ' ' LYS . 0.8 OUTLIER -88.74 14.7 9.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -0.935 . . . . 0.0 110.147 179.366 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 182' ' ' ASP . 6.2 mtmm -162.49 -165.3 1.15 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.276 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 10.6 p-10 -82.86 157.87 22.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.949 -1.094 . . . . 0.0 110.138 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 179.14 121.71 0.73 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.418 ' O ' ' CB ' ' A' ' 199' ' ' PHE . 94.7 t -92.8 121.62 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.329 -1.101 . . . . 0.0 110.049 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.858 HG22 ' HA ' ' A' ' 198' ' ' ASN . 90.6 t -128.97 149.77 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 0.0 109.83 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.804 HD12 HD13 ' A' ' 212' ' ' ILE . 8.5 tt -104.61 131.5 51.96 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.995 -1.066 . . . . 0.0 108.458 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.641 ' CB ' HG22 ' A' ' 133' ' ' VAL . 57.3 m-85 -102.95 121.64 42.95 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.899 -1.126 . . . . 0.0 110.902 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.402 ' HD3' HD23 ' A' ' 188' ' ' LEU . 0.1 OUTLIER -131.5 168.02 18.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.545 -0.722 . . . . 0.0 110.213 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -89.58 -24.9 21.6 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.293 -0.879 . . . . 0.0 110.579 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -90.71 -175.45 4.4 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.43 -0.794 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 47.08 -159.24 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.53 -0.732 . . . . 0.0 110.724 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -59.67 -44.25 93.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.642 -0.661 . . . . 0.0 110.265 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 128.99 -31.5 3.48 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.08 171.48 11.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -1.21 . . . . 0.0 110.532 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' ASN . . . . . 0.536 ' H ' HG13 ' A' ' 187' ' ' VAL . 7.8 m120 -131.66 -35.12 1.3 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.317 -0.864 . . . . 0.0 111.188 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.858 ' HA ' HG22 ' A' ' 187' ' ' VAL . 0.8 OUTLIER 63.71 85.45 0.13 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.152 -0.968 . . . . 0.0 110.015 -179.193 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.432 ' C ' ' CD1' ' A' ' 199' ' ' PHE . 9.4 t80 -62.16 118.73 7.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.398 -0.814 . . . . 0.0 110.161 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -113.63 101.5 9.38 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.264 -0.897 . . . . 0.0 110.511 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 157.13 -140.11 6.91 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -107.48 113.47 26.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.309 -1.113 . . . . 0.0 110.102 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.673 HG11 ' HZ ' ' A' ' 144' ' ' PHE . 7.5 p -64.29 110.74 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 110.218 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 70.5 p -143.13 157.14 44.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.167 -0.958 . . . . 0.0 110.376 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.855 ' O ' HD12 ' A' ' 209' ' ' LEU . 12.2 tttt -51.1 -49.59 60.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.322 -0.861 . . . . 0.0 110.397 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -61.13 -34.67 75.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 110.097 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -78.72 -47.69 16.39 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.207 -0.933 . . . . 0.0 110.084 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 155' ' ' PHE . 80.7 mt -52.78 -37.95 60.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.196 -0.94 . . . . 0.0 110.054 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.855 HD12 ' O ' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -71.08 -23.07 62.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.29 -0.881 . . . . 0.0 109.924 179.755 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.66 -45.81 9.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.362 -0.836 . . . . 0.0 109.88 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.421 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 25.6 t80 -49.66 -50.15 44.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.213 -0.929 . . . . 0.0 109.822 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.804 HD13 HD12 ' A' ' 188' ' ' LEU . 23.5 mm -50.72 -73.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.467 -0.771 . . . . 0.0 110.296 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -46.21 -25.87 0.68 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.705 -0.622 . . . . 0.0 111.114 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -76.51 -23.19 53.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 110.568 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.484 ' CG ' ' ND2' ' A' ' 197' ' ' ASN . 78.2 m-20 -101.42 -57.62 2.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.182 -0.949 . . . . 0.0 110.866 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 212' ' ' ILE . 7.3 pt20 . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.1 -1.0 . . . . 0.0 110.588 -179.573 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 167' ' ' PHE . . . . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.096 0.474 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.546 HG22 ' HA2' ' A' ' 168' ' ' GLY . 9.9 t -108.49 167.65 9.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.106 -0.996 . . . . 0.0 110.246 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.3 m -110.48 109.25 19.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 110.115 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.9 mt -87.14 126.4 62.93 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.334 -0.853 . . . . 0.0 110.097 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 46.0 Cg_endo -71.73 -22.45 23.89 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.457 1.241 . . . . 0.0 110.462 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.495 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.8 OUTLIER -174.31 -170.64 0.54 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.183 -0.948 . . . . 0.0 110.938 179.885 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.82 -34.79 90.79 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.495 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -51.63 -24.93 6.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -1.159 . . . . 0.0 110.343 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.431 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -90.13 -27.14 19.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.941 . . . . 0.0 110.191 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.17 -18.53 65.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 110.266 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -89.75 -48.7 7.09 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.158 -0.964 . . . . 0.0 109.21 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 32.4 p -63.35 -19.75 64.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.28 -0.888 . . . . 0.0 110.253 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.459 HD22 ' HB1' ' A' ' 139' ' ' ALA . 1.6 tt -73.83 -58.96 2.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.209 -0.932 . . . . 0.0 110.262 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.651 HG13 ' HB3' ' A' ' 189' ' ' PHE . 48.1 t -50.03 -25.34 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.268 -0.895 . . . . 0.0 110.581 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.96 -20.11 23.7 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.253 -0.905 . . . . 0.0 109.846 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.7 m -54.45 -50.67 67.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.162 -0.961 . . . . 0.0 110.362 -179.82 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.4 p -130.87 -173.52 3.11 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.12 -0.987 . . . . 0.0 110.487 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.01 -45.12 28.39 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.22 -0.925 . . . . 0.0 109.988 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.3 m -115.22 130.07 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.353 -0.842 . . . . 0.0 109.97 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.459 ' HB1' HD22 ' A' ' 132' ' ' LEU . . . -152.76 148.22 26.98 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.123 -0.986 . . . . 0.0 110.015 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.499 ' CG1' ' CD1' ' A' ' 167' ' ' PHE . 7.1 p -130.9 149.97 34.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.104 -0.998 . . . . 0.0 110.437 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.42 ' CG1' HD13 ' A' ' 132' ' ' LEU . 45.7 mt -133.9 124.13 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.424 -0.797 . . . . 0.0 109.682 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -90.74 131.75 10.93 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.587 ' CD2' HG12 ' A' ' 175' ' ' VAL . 22.0 m-85 -103.95 69.69 0.96 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -1.149 . . . . 0.0 109.643 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -94.9 139.02 31.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.145 -0.972 . . . . 0.0 110.769 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -76.2 -27.84 57.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.427 -0.796 . . . . 0.0 110.136 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -126.89 88.46 2.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 0.0 109.908 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 45.1 t -55.55 -21.03 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.449 -0.782 . . . . 0.0 110.36 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -91.79 18.39 7.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -0.897 . . . . 0.0 110.622 -179.782 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 86.8 p -87.2 -164.64 1.12 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.948 . . . . 0.0 110.169 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.409 ' HA ' ' HG3' ' A' ' 153' ' ' LYS . 28.0 t70 -90.13 -34.09 16.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.348 -0.845 . . . . 0.0 110.141 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 49.3 m -63.81 -31.7 72.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.3 -0.875 . . . . 0.0 110.245 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.55 -28.58 59.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.824 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.409 ' HG3' ' HA ' ' A' ' 150' ' ' ASP . 3.6 mmtt -58.66 -52.0 67.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.418 -0.801 . . . . 0.0 110.184 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' A' ' 204' ' ' THR . 7.0 mm-40 -61.22 -39.73 91.36 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.182 -0.949 . . . . 0.0 110.083 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.475 ' HE1' HG13 ' A' ' 186' ' ' VAL . 5.1 t80 -47.62 -54.9 10.56 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.304 -0.873 . . . . 0.0 110.606 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.411 ' O ' ' HB3' ' A' ' 159' ' ' ALA . 17.2 mt -55.57 -53.35 57.54 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.414 -0.804 . . . . 0.0 110.33 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.419 ' HB3' ' HD2' ' A' ' 205' ' ' LYS . 4.2 mt-30 -49.78 -50.22 45.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.325 -0.859 . . . . 0.0 110.464 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -64.24 -25.03 67.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.18 -0.95 . . . . 0.0 110.052 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.721 ' HB2' ' CD2' ' A' ' 167' ' ' PHE . . . -76.1 -41.06 51.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.309 -0.87 . . . . 0.0 110.324 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -76.02 -9.64 58.78 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.291 -0.88 . . . . 0.0 110.909 -179.69 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -118.0 28.12 8.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.971 -1.081 . . . . 0.0 110.565 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.655 HD13 ' CZ ' ' A' ' 167' ' ' PHE . 5.7 tt -113.44 176.76 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.077 -1.014 . . . . 0.0 110.25 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.48 63.36 0.16 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.896 . . . . 0.0 110.511 -179.566 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 162' ' ' ILE . 3.7 p-10 40.92 50.91 3.16 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.535 0.683 . . . . 0.0 111.628 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.512 ' CG2' ' HD2' ' A' ' 166' ' ' PRO . 42.7 mm -88.77 149.2 43.33 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.472 -0.767 . . . . 0.0 109.097 179.044 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.512 ' HD2' ' CG2' ' A' ' 165' ' ' ILE . 43.8 Cg_endo -81.43 99.75 1.09 Allowed 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.555 1.292 . . . . 0.0 110.772 -179.063 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.721 ' CD2' ' HB2' ' A' ' 159' ' ' ALA . 3.2 m-85 -92.12 131.05 37.68 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.524 -0.735 . . . . 0.0 110.109 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.546 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -121.61 144.53 16.52 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.979 -1.649 . . . . 0.0 108.979 179.244 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.402 ' O ' HG23 ' A' ' 169' ' ' ILE . 13.5 tt -140.75 135.36 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.268 -1.136 . . . . 0.0 110.86 -179.357 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.502 HG21 HG21 ' A' ' 175' ' ' VAL . 2.1 t -151.82 155.85 39.01 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.999 0.904 . . . . 0.0 110.386 179.189 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.9 t -125.3 4.62 7.76 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.028 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -65.72 132.32 48.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.223 -0.923 . . . . 0.0 110.409 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 88.6 p -54.26 -29.04 45.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.163 -0.961 . . . . 0.0 110.047 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -54.49 -35.48 63.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.939 . . . . 0.0 109.867 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.587 HG12 ' CD2' ' A' ' 143' ' ' PHE . 61.4 t -78.71 -25.67 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.409 -0.807 . . . . 0.0 109.728 179.599 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -79.13 -50.1 11.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 109.758 179.638 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 75.1 m -60.68 -19.19 57.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.863 . . . . 0.0 110.116 179.621 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.437 ' HD3' ' CE1' ' A' ' 179' ' ' TYR . 7.2 tttp -74.43 -51.46 14.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.132 -0.98 . . . . 0.0 109.653 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.437 ' CE1' ' HD3' ' A' ' 178' ' ' LYS . 78.3 m-85 -92.7 -5.34 51.53 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.436 -0.79 . . . . 0.0 110.427 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 56.77 63.61 1.89 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.128 -0.982 . . . . 0.0 111.079 179.457 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.0 mt -102.52 119.53 38.97 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.12 -0.988 . . . . 0.0 109.679 178.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.412 ' O ' ' CG ' ' A' ' 183' ' ' LYS . 5.8 t0 -65.2 -11.78 44.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 110.333 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.412 ' CG ' ' O ' ' A' ' 182' ' ' ASP . 0.5 OUTLIER -156.42 -165.78 1.98 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.175 -0.953 . . . . 0.0 109.545 -179.977 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.422 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 3.9 p30 -62.22 164.17 7.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.062 -1.024 . . . . 0.0 109.44 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -161.4 150.05 19.36 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.231 -179.761 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.475 HG13 ' HE1' ' A' ' 155' ' ' PHE . 77.3 t -132.09 84.95 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.49 -1.006 . . . . 0.0 109.506 179.58 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 47.6 t -101.31 159.8 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.336 -0.853 . . . . 0.0 110.472 -179.599 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.435 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 4.3 tt -116.44 155.08 29.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.866 . . . . 0.0 109.374 179.721 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.651 ' HB3' HG13 ' A' ' 133' ' ' VAL . 51.6 m-85 -125.03 127.21 46.62 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.898 -1.126 . . . . 0.0 110.659 -179.051 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.501 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.5 OUTLIER -141.03 166.86 23.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.315 -0.866 . . . . 0.0 110.235 179.751 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -91.21 -22.59 20.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 110.329 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.501 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.9 OUTLIER -91.08 -176.55 4.64 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.362 -0.837 . . . . 0.0 111.069 -179.988 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 48.04 -154.77 0.08 Allowed 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.802 0.81 . . . . 0.0 110.649 -179.782 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -57.37 -54.52 45.93 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.694 -0.629 . . . . 0.0 110.325 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 133.01 -24.21 3.83 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -139.41 176.34 8.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.208 -1.172 . . . . 0.0 110.548 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 197' ' ' ASN . . . . . 0.449 ' N ' ' ND2' ' A' ' 197' ' ' ASN . 0.7 OUTLIER -145.36 -155.33 0.6 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.389 -0.819 . . . . 0.0 109.786 -179.776 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -171.02 81.77 0.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.377 -0.827 . . . . 0.0 110.083 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -64.97 126.99 29.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.377 -0.827 . . . . 0.0 110.287 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -140.82 124.12 16.67 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.236 -0.915 . . . . 0.0 109.901 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 141.7 -167.62 25.84 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -62.67 109.02 1.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.339 -1.095 . . . . 0.0 110.26 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.456 ' C ' HG23 ' A' ' 204' ' ' THR . 91.7 t -65.88 112.24 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.226 -0.921 . . . . 0.0 110.203 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.456 HG23 ' C ' ' A' ' 203' ' ' VAL . 41.7 p -150.2 152.39 34.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.36 -0.838 . . . . 0.0 110.314 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.453 ' CE ' HD11 ' A' ' 209' ' ' LEU . 3.1 tttt -49.76 -52.67 30.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.3 -0.875 . . . . 0.0 110.487 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -54.34 -32.5 56.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 110.157 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -83.96 -41.46 17.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.27 -0.894 . . . . 0.0 110.044 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.452 ' CD2' HG11 ' A' ' 186' ' ' VAL . 27.4 mt -65.83 -41.79 91.35 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.311 -0.868 . . . . 0.0 110.061 179.86 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.453 HD11 ' CE ' ' A' ' 205' ' ' LYS . 85.7 mt -69.39 -21.74 63.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 0.0 110.128 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -83.81 -56.38 3.73 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.292 -0.88 . . . . 0.0 110.076 179.828 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.401 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 20.5 t80 -51.52 -53.02 42.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.237 -0.914 . . . . 0.0 110.146 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.627 HG21 HD11 ' A' ' 162' ' ' ILE . 84.6 mt -52.78 -58.5 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.348 -0.845 . . . . 0.0 110.178 179.753 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.443 ' HA ' ' CG ' ' A' ' 216' ' ' GLN . 14.4 tttt -49.24 -38.74 27.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 110.132 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.27 -22.81 67.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.399 -0.813 . . . . 0.0 109.826 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.401 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 75.7 m-80 -96.77 -42.51 7.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.296 -0.878 . . . . 0.0 110.359 -179.682 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 216' ' ' GLN . . . . . 0.443 ' CG ' ' HA ' ' A' ' 213' ' ' LYS . 5.3 pt20 . . . . . 0 N--CA 1.493 1.675 0 O-C-N 121.2 -0.937 . . . . 0.0 110.205 179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.257 0.551 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.618 HG22 ' HA2' ' A' ' 168' ' ' GLY . 10.1 t -97.85 171.07 8.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.922 . . . . 0.0 110.353 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.3 m -111.68 111.9 23.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.91 . . . . 0.0 110.065 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.9 mt -94.64 130.39 33.51 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.173 -0.954 . . . . 0.0 110.068 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.439 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 43.5 Cg_endo -69.69 -53.09 0.29 Allowed 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.442 1.233 . . . . 0.0 111.015 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.4 ' HB2' ' OD1' ' A' ' 174' ' ' ASP . 1.4 p30 -146.65 -170.45 3.52 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.099 -1.001 . . . . 0.0 111.184 -179.673 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -57.31 -39.91 91.05 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.715 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -49.62 -25.29 2.71 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.268 -1.137 . . . . 0.0 110.714 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.439 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -90.07 -35.31 15.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.138 -0.976 . . . . 0.0 110.067 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.409 ' O ' HG23 ' A' ' 133' ' ' VAL . . . -56.23 -24.68 43.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.359 -0.838 . . . . 0.0 110.177 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -84.53 -54.37 4.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.227 -0.921 . . . . 0.0 110.248 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.7 t -52.65 -26.49 13.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.256 -0.903 . . . . 0.0 110.324 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.1 tp -70.07 -46.04 65.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.291 -0.88 . . . . 0.0 110.398 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.667 HG13 ' HB3' ' A' ' 189' ' ' PHE . 40.5 t -56.88 -38.64 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.267 -0.896 . . . . 0.0 110.583 -179.629 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -85.29 -15.97 41.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.281 -0.887 . . . . 0.0 110.761 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.2 m -56.68 -45.81 81.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.025 -1.047 . . . . 0.0 110.288 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 92.3 p -133.35 -175.59 3.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.342 -0.849 . . . . 0.0 110.215 -179.847 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.59 -35.22 62.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.318 -0.864 . . . . 0.0 110.249 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 87.6 t -129.33 147.27 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.064 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.42 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -173.76 134.13 0.47 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.244 -0.91 . . . . 0.0 110.048 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 187' ' ' VAL . 9.4 p -120.46 147.33 24.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.097 -1.002 . . . . 0.0 110.371 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.628 HD12 ' CD2' ' A' ' 189' ' ' PHE . 7.4 mt -125.76 113.83 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.361 -0.837 . . . . 0.0 109.912 179.726 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -80.81 120.96 5.28 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.542 ' CE2' HG12 ' A' ' 175' ' ' VAL . 46.5 m-85 -91.22 80.86 5.56 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.193 -1.181 . . . . 0.0 109.753 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -100.06 140.39 34.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.079 -1.013 . . . . 0.0 111.033 -179.317 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.12 -27.83 18.3 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.671 0.748 . . . . 0.0 109.473 179.028 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.26 69.03 1.48 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.024 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.504 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 4.6 p -48.25 -24.0 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.717 -0.614 . . . . 0.0 111.327 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -78.91 3.45 16.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.102 -0.999 . . . . 0.0 110.873 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 94.5 p -85.56 -163.16 0.81 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.843 -1.161 . . . . 0.0 110.23 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.19 -49.65 6.44 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.327 -0.858 . . . . 0.0 110.353 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.21 -28.85 8.23 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.299 -0.876 . . . . 0.0 110.448 -179.83 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.504 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -88.5 -29.25 20.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.346 -0.846 . . . . 0.0 110.136 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.82 -36.11 78.23 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.215 -0.928 . . . . 0.0 109.639 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -59.26 -49.09 79.19 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.103 -0.998 . . . . 0.0 108.607 178.762 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -50.96 -47.77 61.13 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.538 -0.726 . . . . 0.0 110.04 178.862 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.7 mt -47.4 -59.51 3.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.512 -0.743 . . . . 0.0 110.375 179.655 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -58.21 -50.53 73.21 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.424 -0.797 . . . . 0.0 110.057 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -53.82 -43.74 69.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.333 -0.854 . . . . 0.0 109.948 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.95 -24.41 63.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.86 . . . . 0.0 110.074 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -77.76 -40.58 40.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.871 . . . . 0.0 110.303 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.8 -39.9 68.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 0.0 110.334 -179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.449 HG21 ' CE1' ' A' ' 167' ' ' PHE . 0.7 OUTLIER -89.81 144.76 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.296 -0.877 . . . . 0.0 110.262 -179.862 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -132.29 18.6 4.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.215 -0.928 . . . . 0.0 110.394 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.461 ' O ' HD13 ' A' ' 165' ' ' ILE . 6.0 p-10 -125.51 21.36 7.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -0.959 . . . . 0.0 110.266 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.461 HD13 ' O ' ' A' ' 164' ' ' ASP . 45.0 mm -136.43 134.05 19.61 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.172 -0.955 . . . . 0.0 110.175 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.42 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 48.2 Cg_endo -74.67 75.2 3.61 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 O-C-N 123.542 1.285 . . . . 0.0 110.474 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.449 ' CE1' HG21 ' A' ' 162' ' ' ILE . 5.7 m-85 -67.9 134.0 50.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.303 -0.873 . . . . 0.0 110.323 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.618 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -124.72 149.23 16.93 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.54 HG23 ' O ' ' A' ' 169' ' ' ILE . 9.2 tt -148.27 125.03 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.206 -1.173 . . . . 0.0 110.29 -179.82 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.626 ' CG2' HG11 ' A' ' 175' ' ' VAL . 2.3 t -141.5 157.14 45.52 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 122.196 0.998 . . . . 0.0 110.933 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 94.9 p -124.77 3.41 8.17 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.47 178.803 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 124' ' ' PRO . 64.1 t30 -63.5 127.66 32.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.194 -0.941 . . . . 0.0 110.32 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.27 -32.78 11.47 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.241 -0.912 . . . . 0.0 110.597 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.4 ' OD1' ' HB2' ' A' ' 125' ' ' ASP . 0.8 OUTLIER -54.22 -31.82 54.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.098 -1.001 . . . . 0.0 109.88 179.84 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.626 HG11 ' CG2' ' A' ' 170' ' ' THR . 39.8 t -79.08 -27.02 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 109.692 179.593 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -84.32 -39.81 18.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 109.14 179.328 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 46.5 t -72.89 -4.78 34.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.464 -0.772 . . . . 0.0 110.231 178.959 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.67 -52.19 5.13 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.067 -1.021 . . . . 0.0 109.171 179.609 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -89.84 4.5 49.65 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.749 -0.595 . . . . 0.0 110.532 179.769 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 53.56 59.99 3.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.078 -1.014 . . . . 0.0 110.451 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 60.0 mt -102.82 102.77 12.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 110.13 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -53.47 -26.76 21.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.194 -0.941 . . . . 0.0 109.992 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -141.54 -175.44 4.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.406 -0.808 . . . . 0.0 109.839 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.409 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 11.8 p-10 -72.25 165.09 25.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.093 -1.004 . . . . 0.0 110.131 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -172.18 160.19 31.57 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 186' ' ' VAL . 34.2 m -123.91 97.25 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -1.18 . . . . 0.0 110.158 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.68 ' O ' HG23 ' A' ' 140' ' ' VAL . 89.1 t -108.81 155.77 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 109.96 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.751 HD22 ' HB3' ' A' ' 215' ' ' ASN . 6.6 tt -107.96 159.47 16.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.023 -1.048 . . . . 0.0 109.709 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.667 ' HB3' HG13 ' A' ' 133' ' ' VAL . 45.0 m-85 -130.11 121.26 26.0 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.901 -1.124 . . . . 0.0 110.349 -179.313 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.432 ' HD3' HD23 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -132.86 164.05 27.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.381 -0.824 . . . . 0.0 110.163 179.876 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -82.63 -26.15 32.48 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.206 -0.933 . . . . 0.0 110.845 -179.624 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.429 ' CD1' ' HG3' ' A' ' 190' ' ' LYS . 1.6 p90 -90.86 -176.81 4.78 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.287 -0.883 . . . . 0.0 110.988 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 47.01 -159.67 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.632 0.729 . . . . 0.0 110.928 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.91 -29.48 60.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.667 -0.646 . . . . 0.0 110.4 -179.731 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.4 ' HA2' ' HG2' ' A' ' 190' ' ' LYS . . . 96.09 -16.92 60.23 Favored Glycine 0 N--CA 1.483 1.822 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.494 ' HG3' ' CE1' ' A' ' 189' ' ' PHE . 4.2 ttp180 -138.34 154.31 48.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.018 -1.283 . . . . 0.0 110.479 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 197' ' ' ASN . . . . . 0.455 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.5 m-80 -125.15 -153.91 0.59 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.312 -0.867 . . . . 0.0 110.038 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.574 ' HA ' HG22 ' A' ' 187' ' ' VAL . 18.1 p30 -178.77 78.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.511 -0.743 . . . . 0.0 109.998 179.61 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -46.21 142.68 2.74 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.367 -0.833 . . . . 0.0 111.062 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 198' ' ' ASN . 6.5 mt-10 -140.94 123.62 16.09 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.299 -0.876 . . . . 0.0 109.819 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 133.38 -121.64 2.89 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -120.04 104.61 10.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.203 -1.174 . . . . 0.0 110.213 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.637 HG13 ' O ' ' A' ' 203' ' ' VAL . 6.5 p -58.84 91.38 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.15 -0.968 . . . . 0.0 110.224 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 66.0 p -126.12 160.1 31.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 110.079 179.84 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.554 ' O ' HD12 ' A' ' 209' ' ' LEU . 0.2 OUTLIER -49.87 -47.46 51.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 0.0 110.648 -179.956 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -63.25 -41.63 99.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.283 -0.885 . . . . 0.0 110.652 -179.694 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -79.04 -26.61 43.12 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.159 -0.963 . . . . 0.0 110.474 -179.713 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.59 HD21 HG23 ' A' ' 203' ' ' VAL . 19.1 mt -73.52 -59.25 2.8 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.248 -0.908 . . . . 0.0 110.499 -179.622 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.554 HD12 ' O ' ' A' ' 205' ' ' LYS . 5.5 mt -49.13 -40.16 31.39 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.303 -0.873 . . . . 0.0 110.886 -179.635 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -67.83 -45.14 75.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.12 -0.987 . . . . 0.0 110.451 -179.746 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.406 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 16.6 t80 -58.57 -54.41 47.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.933 . . . . 0.0 110.8 -179.624 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.503 HD12 HD12 ' A' ' 188' ' ' LEU . 6.4 mm -58.09 -47.96 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.155 -0.966 . . . . 0.0 110.026 -179.624 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.04 -21.92 47.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.507 -0.746 . . . . 0.0 110.429 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -90.03 -25.36 20.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.098 -1.001 . . . . 0.0 110.57 -179.716 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.751 ' HB3' HD22 ' A' ' 188' ' ' LEU . 76.1 m-20 -90.61 -39.81 12.29 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.169 -0.957 . . . . 0.0 110.893 -179.361 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 . . . . . 0 N--CA 1.487 1.391 0 O-C-N 121.196 -0.94 . . . . 0.0 110.813 -179.512 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.208 0.528 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.674 HG22 ' HA2' ' A' ' 168' ' ' GLY . 9.9 t -85.8 169.39 13.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 110.249 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.7 m -108.66 104.41 13.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 110.342 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.999 HD21 HD12 ' A' ' 132' ' ' LEU . 67.3 mt -80.65 133.67 55.34 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.192 -0.942 . . . . 0.0 110.048 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.513 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 45.3 Cg_endo -71.23 -35.13 9.01 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.387 1.204 . . . . 0.0 110.556 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.421 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.3 OUTLIER -167.75 -170.76 1.45 Allowed 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.169 0.985 . . . . 0.0 111.487 -179.919 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -58.09 -31.77 65.91 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.421 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -54.63 -28.81 49.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -1.141 . . . . 0.0 110.295 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.653 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -84.08 -35.02 24.03 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.931 . . . . 0.0 110.103 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -53.46 -29.16 34.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 0.0 109.98 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -90.15 -29.98 17.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.426 -0.796 . . . . 0.0 110.22 179.911 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.56 -35.19 30.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.195 -0.94 . . . . 0.0 110.263 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.999 HD12 HD21 ' A' ' 123' ' ' LEU . 3.2 tt -59.9 -58.26 9.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.316 -0.865 . . . . 0.0 109.739 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 97.9 t -51.98 -24.61 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.45 -0.781 . . . . 0.0 110.212 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -82.38 -21.81 35.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.311 -0.868 . . . . 0.0 110.262 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.8 m -53.14 -58.85 5.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.221 -0.924 . . . . 0.0 110.203 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 82.6 p -121.9 -179.03 4.0 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.288 -0.882 . . . . 0.0 110.296 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -69.56 -39.96 77.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.287 -0.883 . . . . 0.0 110.179 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.6 t -117.94 143.44 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.389 -0.82 . . . . 0.0 110.275 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.456 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -165.95 147.54 6.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.241 -0.912 . . . . 0.0 109.957 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.498 HG11 ' CZ ' ' A' ' 167' ' ' PHE . 7.3 p -127.11 150.09 32.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 O-C-N 121.103 -0.998 . . . . 0.0 110.205 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.433 HD11 ' HB3' ' A' ' 132' ' ' LEU . 75.5 mt -143.48 120.19 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.41 -0.806 . . . . 0.0 109.647 179.599 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.411 ' C ' ' CD1' ' A' ' 143' ' ' PHE . . . -85.89 166.68 39.37 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.507 ' CE2' HG12 ' A' ' 175' ' ' VAL . 26.5 m-85 -129.86 76.56 1.73 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.405 -1.056 . . . . 0.0 109.85 179.833 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.73 ' HZ ' HG21 ' A' ' 203' ' ' VAL . 19.6 m-85 -104.1 145.82 29.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.99 -1.069 . . . . 0.0 111.099 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.26 -27.75 19.26 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.786 0.803 . . . . 0.0 109.464 179.523 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.407 ' HB3' ' HB3' ' A' ' 149' ' ' SER . 0.3 OUTLIER -131.0 73.0 1.52 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.687 -0.633 . . . . 0.0 109.511 179.014 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.522 ' O ' ' HB3' ' A' ' 152' ' ' ALA . 18.4 m -48.36 -24.54 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.262 -0.899 . . . . 0.0 110.869 -179.543 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -83.95 5.53 25.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.063 -1.023 . . . . 0.0 110.844 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.407 ' HB3' ' HB3' ' A' ' 146' ' ' ASP . 33.5 p -75.19 -166.29 0.49 Allowed 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.905 -1.122 . . . . 0.0 110.34 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -90.45 -19.95 23.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.537 -0.727 . . . . 0.0 110.159 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 10.5 t -81.93 -31.62 31.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.163 -0.961 . . . . 0.0 110.078 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 147' ' ' VAL . . . -80.67 -20.05 43.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 110.2 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -61.45 -39.16 89.86 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.221 -0.924 . . . . 0.0 109.751 179.471 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -67.09 -41.18 86.74 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.358 -0.839 . . . . 0.0 109.619 179.436 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -48.96 -57.09 7.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.397 -0.814 . . . . 0.0 110.607 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 156' ' ' LEU . 52.8 mt -53.87 -54.76 34.07 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.449 -0.782 . . . . 0.0 110.289 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -54.2 -46.67 72.51 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.42 -0.8 . . . . 0.0 110.347 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.09 -45.36 85.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.148 -0.97 . . . . 0.0 110.379 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.82 -31.11 72.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.939 . . . . 0.0 110.435 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -63.69 -29.59 70.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.183 -0.948 . . . . 0.0 110.232 -179.833 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -57.33 -48.38 79.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.907 . . . . 0.0 110.227 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.401 HG13 ' OD1' ' A' ' 164' ' ' ASP . 8.9 tt -90.85 158.27 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.175 -0.953 . . . . 0.0 110.01 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.11 19.16 1.24 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.033 -1.042 . . . . 0.0 110.609 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.524 ' O ' HD13 ' A' ' 165' ' ' ILE . 5.9 p-10 -116.25 16.3 15.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.141 -0.974 . . . . 0.0 110.495 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.524 HD13 ' O ' ' A' ' 164' ' ' ASP . 49.7 mm -134.41 140.35 35.49 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.126 -0.984 . . . . 0.0 110.11 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.456 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 48.0 Cg_endo -74.77 79.5 2.58 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.618 1.325 . . . . 0.0 110.508 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.498 ' CZ ' HG11 ' A' ' 140' ' ' VAL . 3.6 m-85 -68.79 135.64 51.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.33 -0.856 . . . . 0.0 109.933 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.674 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -131.35 151.99 19.88 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.564 -1.303 . . . . 0.0 109.942 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 169' ' ' ILE . 11.7 tt -150.19 140.34 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -1.105 . . . . 0.0 109.979 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.568 HG21 HG21 ' A' ' 175' ' ' VAL . 2.9 t -153.77 158.05 40.35 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.118 0.961 . . . . 0.0 111.069 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.1 m -119.97 0.97 10.9 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.44 178.859 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -60.53 145.97 46.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.138 -0.976 . . . . 0.0 110.174 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 37.8 t -70.41 -30.91 67.91 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.167 -0.958 . . . . 0.0 110.471 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -54.56 -40.88 69.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.073 -1.017 . . . . 0.0 109.955 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.568 HG21 HG21 ' A' ' 170' ' ' THR . 58.8 t -69.82 -30.69 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 0.0 109.546 179.481 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.405 ' N ' ' CD1' ' A' ' 176' ' ' PHE . 10.6 m-85 -80.34 -41.17 25.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.445 -0.784 . . . . 0.0 109.751 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.87 -6.34 37.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.416 -0.802 . . . . 0.0 110.551 179.531 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 15.0 tttp -90.03 -45.39 9.2 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.014 -1.054 . . . . 0.0 109.382 179.7 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -91.5 0.78 57.47 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.562 -0.711 . . . . 0.0 110.642 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 53.97 66.47 1.22 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.985 -1.072 . . . . 0.0 110.728 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 55.3 mt -107.97 114.34 28.19 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.236 -0.915 . . . . 0.0 109.945 179.62 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.423 ' O ' ' CG ' ' A' ' 183' ' ' LYS . 45.2 m-20 -61.81 -17.26 55.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.936 . . . . 0.0 110.33 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 182' ' ' ASP . 22.6 mtmt -157.75 -166.39 1.98 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.206 -0.934 . . . . 0.0 110.012 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 3.5 p30 -63.9 162.98 12.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.184 -0.947 . . . . 0.0 110.049 179.814 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -176.32 152.28 12.52 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 70.4 t -118.75 133.97 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.383 -1.069 . . . . 0.0 109.697 179.629 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.739 HG22 ' HA ' ' A' ' 198' ' ' ASN . 77.3 t -141.92 145.06 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.223 -0.923 . . . . 0.0 110.468 -179.738 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.513 HD13 ' CB ' ' A' ' 215' ' ' ASN . 7.1 tt -105.03 146.85 28.51 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.9 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -118.81 127.18 53.28 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.722 -1.236 . . . . 0.0 110.834 -178.689 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.509 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -138.47 158.06 44.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.389 -0.819 . . . . 0.0 110.222 179.827 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.1 mmmm -84.3 -21.3 31.06 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.244 -0.91 . . . . 0.0 110.433 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.509 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 1.7 p90 -90.55 -176.23 4.68 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.244 -0.91 . . . . 0.0 110.883 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 46.79 -158.76 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.684 0.754 . . . . 0.0 110.74 -179.73 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.46 -54.0 49.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.634 -0.666 . . . . 0.0 110.313 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 137.81 -31.11 2.51 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.82 173.88 10.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.172 -1.193 . . . . 0.0 110.156 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 197' ' ' ASN . . . . . 0.451 ' N ' ' ND2' ' A' ' 197' ' ' ASN . 1.3 m-80 -134.14 -40.36 0.83 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.121 -0.987 . . . . 0.0 110.811 -179.181 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.739 ' HA ' HG22 ' A' ' 187' ' ' VAL . 0.6 OUTLIER 63.98 94.23 0.05 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.248 -0.907 . . . . 0.0 110.202 -179.273 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.506 ' HB2' ' CZ ' ' A' ' 211' ' ' PHE . 41.0 t80 -88.96 136.73 32.86 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.338 -0.851 . . . . 0.0 110.201 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.477 ' O ' ' CE1' ' A' ' 199' ' ' PHE . 5.1 mt-10 -121.0 -147.38 0.39 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.209 -0.932 . . . . 0.0 109.678 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 58.15 -128.27 47.14 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.03 130.39 53.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.316 -1.108 . . . . 0.0 110.35 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.73 HG21 ' HZ ' ' A' ' 144' ' ' PHE . 28.2 m -77.49 59.13 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.383 -0.823 . . . . 0.0 110.073 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.403 ' OG1' ' ND2' ' A' ' 207' ' ' ASN . 7.6 p -93.76 156.18 16.82 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.587 -0.695 . . . . 0.0 110.354 -179.826 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.471 ' O ' HD12 ' A' ' 209' ' ' LEU . 9.6 tttt -48.64 -48.24 39.73 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.24 -0.913 . . . . 0.0 110.532 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 206' ' ' GLU . . . . . 0.423 ' HG3' ' N ' ' A' ' 207' ' ' ASN . 14.2 pt-20 -54.34 -41.15 68.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.941 . . . . 0.0 110.42 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.423 ' N ' ' HG3' ' A' ' 206' ' ' GLU . 79.9 m-20 -83.21 -28.41 29.28 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.287 -0.883 . . . . 0.0 110.149 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.45 ' HA ' HD23 ' A' ' 208' ' ' LEU . 19.9 mt -72.16 -48.58 42.36 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.267 -0.896 . . . . 0.0 110.264 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.471 HD12 ' O ' ' A' ' 205' ' ' LYS . 9.1 mt -53.56 -38.92 64.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 109.899 179.719 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -74.17 -49.11 25.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.84 . . . . 0.0 109.925 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.506 ' CZ ' ' HB2' ' A' ' 199' ' ' PHE . 23.8 t80 -47.94 -58.14 4.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 110.79 179.752 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 21.6 mt -52.83 -47.61 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -0.867 . . . . 0.0 110.212 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.55 -41.37 88.78 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.24 -0.912 . . . . 0.0 109.939 179.722 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -62.03 -19.87 63.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.383 -0.823 . . . . 0.0 109.945 179.649 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.513 ' CB ' HD13 ' A' ' 188' ' ' LEU . 2.3 m-80 -89.23 -60.71 1.88 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.253 -0.905 . . . . 0.0 109.553 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 O-C-N 121.395 -0.816 . . . . 0.0 111.18 179.84 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.238 0.542 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.616 HG22 ' HA2' ' A' ' 168' ' ' GLY . 10.1 t -96.31 169.69 9.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.119 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.6 m -109.15 107.89 18.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 110.249 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 24.8 mt -85.43 128.86 57.59 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.361 -0.837 . . . . 0.0 109.98 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.419 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 46.6 Cg_endo -72.05 -43.61 1.12 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.425 1.223 . . . . 0.0 110.431 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.425 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.3 OUTLIER -158.2 -170.42 3.12 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 122.108 0.956 . . . . 0.0 111.242 179.936 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -58.5 -27.97 61.7 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.425 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -54.04 -32.27 53.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -1.129 . . . . 0.0 110.096 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.419 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -87.11 -34.93 18.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 110.016 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.0 -22.75 61.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.349 -0.844 . . . . 0.0 110.033 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -84.69 -57.88 2.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 110.134 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.5 p -61.06 -18.2 56.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.312 -0.867 . . . . 0.0 110.377 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.55 HD23 HD11 ' A' ' 141' ' ' ILE . 17.2 tp -71.05 -49.44 44.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.151 -0.968 . . . . 0.0 109.891 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.619 HG22 ' HB3' ' A' ' 189' ' ' PHE . 59.1 t -64.83 -28.59 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.478 -0.764 . . . . 0.0 110.262 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -90.0 -0.74 57.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.276 -0.89 . . . . 0.0 110.96 -179.836 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 46.9 t -86.44 -23.19 26.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.915 -1.115 . . . . 0.0 110.31 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.401 ' OG ' ' HG3' ' A' ' 166' ' ' PRO . 0.6 OUTLIER -148.44 160.0 43.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.236 -0.915 . . . . 0.0 110.495 -179.94 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.77 -22.85 59.06 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.401 -0.812 . . . . 0.0 109.592 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.8 m -138.43 152.22 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.315 -0.866 . . . . 0.0 110.377 -179.773 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -173.41 134.48 0.52 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 0.0 109.862 179.799 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.89 149.8 23.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 120.994 -1.067 . . . . 0.0 110.271 -179.685 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.55 HD11 HD23 ' A' ' 132' ' ' LEU . 2.8 mp -134.9 117.26 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.342 -0.849 . . . . 0.0 110.139 179.733 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.21 126.12 7.34 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.649 ' CE2' HG12 ' A' ' 175' ' ' VAL . 65.7 m-85 -100.74 78.77 2.0 Allowed 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.102 -1.234 . . . . 0.0 110.206 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -104.52 146.32 29.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.061 -1.024 . . . . 0.0 110.835 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.43 -27.89 21.25 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.575 -0.703 . . . . 0.0 109.827 179.375 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.422 ' HB3' ' HB3' ' A' ' 149' ' ' SER . 0.5 OUTLIER -130.15 74.35 1.59 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.502 -0.749 . . . . 0.0 109.525 179.506 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.596 ' O ' ' HB3' ' A' ' 152' ' ' ALA . 23.5 m -52.82 -21.4 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.367 -0.833 . . . . 0.0 110.846 -179.542 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -82.65 8.41 12.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.125 -0.984 . . . . 0.0 110.838 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.422 ' HB3' ' HB3' ' A' ' 146' ' ' ASP . 7.5 p -84.67 -161.71 0.6 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.869 -1.144 . . . . 0.0 110.37 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -90.74 -21.31 21.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 0.0 110.269 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.36 -37.13 68.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.214 -0.929 . . . . 0.0 110.255 -179.803 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 147' ' ' VAL . . . -74.04 -26.85 60.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.207 -0.933 . . . . 0.0 109.722 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 149' ' ' SER . 25.1 mmtt -54.05 -49.83 68.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.887 . . . . 0.0 109.858 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -64.42 -39.71 94.36 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.343 -0.848 . . . . 0.0 109.782 179.511 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -52.07 -55.7 19.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.356 -0.84 . . . . 0.0 110.161 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.43 -56.66 16.46 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.382 -0.824 . . . . 0.0 110.169 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -49.38 -57.97 5.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.33 -0.856 . . . . 0.0 110.489 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.582 ' HB2' ' HA ' ' A' ' 205' ' ' LYS . . . -57.72 -36.34 71.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.806 179.652 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.9 -32.63 73.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.993 179.655 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -67.63 -31.77 72.02 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.224 -0.923 . . . . 0.0 110.098 179.683 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.77 -32.54 63.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 109.961 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.464 HG21 ' CG1' ' A' ' 165' ' ' ILE . 58.1 mt -102.76 139.41 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.33 -0.856 . . . . 0.0 110.111 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.81 15.61 8.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.921 . . . . 0.0 110.539 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -119.86 -10.21 9.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.194 -0.941 . . . . 0.0 110.549 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.464 ' CG1' HG21 ' A' ' 162' ' ' ILE . 39.7 mm -101.51 146.06 31.54 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.045 -1.034 . . . . 0.0 110.249 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.45 ' HD2' ' CG2' ' A' ' 165' ' ' ILE . 47.6 Cg_endo -85.53 72.86 4.16 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 O-C-N 123.722 1.38 . . . . 0.0 110.458 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.609 ' HZ ' HD13 ' A' ' 212' ' ' ILE . 5.6 m-85 -65.61 124.69 23.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.303 -0.873 . . . . 0.0 110.19 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.616 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -121.09 153.05 16.68 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 8.1 tt -150.16 137.69 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -1.12 . . . . 0.0 110.159 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.6 HG21 HG11 ' A' ' 175' ' ' VAL . 2.5 t -154.17 156.89 37.99 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.116 0.96 . . . . 0.0 110.884 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 13.7 m -115.09 -2.08 12.87 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.506 178.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -59.19 118.72 6.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.182 -0.949 . . . . 0.0 110.252 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.4 m -50.46 -33.09 19.86 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.153 -0.967 . . . . 0.0 110.458 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.32 -35.81 60.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.208 -0.932 . . . . 0.0 110.076 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.649 HG12 ' CE2' ' A' ' 143' ' ' PHE . 40.6 t -79.25 -24.91 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.338 -0.851 . . . . 0.0 109.734 179.66 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.41 ' N ' ' CD1' ' A' ' 176' ' ' PHE . 12.2 m-85 -80.97 -45.87 15.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.37 -0.831 . . . . 0.0 109.704 179.75 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 41.4 t -67.74 -22.76 65.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.353 -0.842 . . . . 0.0 110.066 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.5 tttm -52.68 -57.49 9.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.247 -0.908 . . . . 0.0 110.207 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -89.7 13.97 12.9 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.266 -0.896 . . . . 0.0 110.565 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 51.99 61.0 3.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.132 -0.98 . . . . 0.0 110.423 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 68.0 mt -96.85 -26.65 15.02 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.125 -0.984 . . . . 0.0 110.417 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 52.71 21.1 1.76 Allowed 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.896 -0.503 . . . . 0.0 110.684 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.403 ' HD3' ' O ' ' A' ' 184' ' ' ASP . 0.3 OUTLIER -178.6 -163.37 0.06 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.208 -0.932 . . . . 0.0 109.764 179.888 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 4.1 m-20 -90.57 152.6 20.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.12 -0.987 . . . . 0.0 109.838 179.468 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -164.93 149.52 16.29 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.46 -1.352 . . . . 0.0 109.917 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 199' ' ' PHE . 82.3 t -117.55 94.46 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.403 -1.057 . . . . 0.0 109.484 179.561 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 84.9 t -113.71 156.39 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.141 -0.974 . . . . 0.0 110.682 -179.294 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.656 HD13 ' CB ' ' A' ' 215' ' ' ASN . 8.2 tt -108.91 157.73 18.35 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.195 -0.941 . . . . 0.0 109.275 179.674 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.619 ' HB3' HG22 ' A' ' 133' ' ' VAL . 46.7 m-85 -129.9 124.85 34.15 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.924 -1.11 . . . . 0.0 110.733 -179.099 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.33 179.11 6.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.369 -0.832 . . . . 0.0 109.964 179.475 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -95.96 -29.7 14.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.131 -0.98 . . . . 0.0 110.74 -179.36 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.11 -172.01 3.17 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.964 0.888 . . . . 0.0 111.211 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 47.89 -155.42 0.07 Allowed 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.733 0.777 . . . . 0.0 110.654 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.61 -26.12 68.54 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.668 -0.645 . . . . 0.0 110.214 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 100.42 -34.93 5.16 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.63 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.36 172.31 8.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.072 -1.252 . . . . 0.0 110.743 -179.716 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 197' ' ' ASN . . . . . 0.458 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 0.9 OUTLIER -139.45 -148.16 0.25 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.6 -0.688 . . . . 0.0 109.494 -179.44 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -175.54 84.27 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.189 -0.944 . . . . 0.0 110.259 179.397 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 186' ' ' VAL . 83.4 t80 -51.28 119.73 4.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.196 -0.94 . . . . 0.0 110.535 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -117.45 95.98 5.2 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.299 -0.875 . . . . 0.0 110.31 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 156.11 -178.41 32.65 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.8 119.73 16.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -1.15 . . . . 0.0 110.137 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 80.0 t -60.06 108.25 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.195 -0.94 . . . . 0.0 110.137 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.415 ' OG1' ' ND2' ' A' ' 207' ' ' ASN . 10.6 p -147.68 157.67 43.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.365 -0.835 . . . . 0.0 110.11 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.582 ' HA ' ' HB2' ' A' ' 158' ' ' ALA . 27.0 tttt -52.16 -48.15 65.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.282 -0.886 . . . . 0.0 110.587 -179.752 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -63.87 -24.85 67.91 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.184 -0.947 . . . . 0.0 110.483 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.415 ' ND2' ' OG1' ' A' ' 204' ' ' THR . 75.9 m-20 -90.31 -44.65 9.56 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.184 -0.948 . . . . 0.0 110.333 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' A' ' 208' ' ' LEU . 46.4 mt -58.96 -55.83 30.09 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.224 -0.923 . . . . 0.0 110.277 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 205' ' ' LYS . 0.9 OUTLIER -54.74 -23.69 18.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 0.0 110.094 179.899 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -80.81 -57.98 3.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 110.048 179.91 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -54.98 -54.04 48.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.898 . . . . 0.0 109.974 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.609 HD13 ' HZ ' ' A' ' 167' ' ' PHE . 82.0 mt -49.15 -55.64 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.274 -0.891 . . . . 0.0 110.284 179.676 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.06 -30.48 6.37 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.432 -0.792 . . . . 0.0 110.352 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -87.78 -7.12 57.72 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.202 -0.936 . . . . 0.0 110.626 179.765 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.656 ' CB ' HD13 ' A' ' 188' ' ' LEU . 2.1 m-80 -89.31 -70.41 0.66 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.029 -1.044 . . . . 0.0 109.935 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.18 -0.95 . . . . 0.0 109.68 179.607 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.239 0.542 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 167' ' ' PHE . . . -105.22 141.83 36.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 110.239 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.542 HG22 ' HA2' ' A' ' 168' ' ' GLY . 13.2 t -86.26 170.53 12.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.277 -0.889 . . . . 0.0 110.3 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.8 m -104.13 105.03 15.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.105 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.619 ' CD1' HG23 ' A' ' 141' ' ' ILE . 17.8 mt -79.65 129.24 71.99 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.9 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 49.1 Cg_endo -72.85 -44.84 0.56 Allowed 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.421 1.222 . . . . 0.0 110.39 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 127' ' ' ALA . 0.9 OUTLIER -157.44 -169.3 2.85 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.325 -0.86 . . . . 0.0 110.572 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.44 -23.4 60.28 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 125' ' ' ASP . . . -57.24 -29.7 64.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.263 -1.139 . . . . 0.0 110.25 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.446 ' HB2' ' HD2' ' A' ' 124' ' ' PRO . . . -88.26 -31.15 19.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 110.035 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.457 ' HA ' HD13 ' A' ' 141' ' ' ILE . . . -59.3 -30.7 68.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -0.901 . . . . 0.0 110.002 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -87.88 -37.99 16.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.343 -0.848 . . . . 0.0 110.09 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 10.1 p -73.95 -29.65 62.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 110.106 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.549 HD23 ' CG1' ' A' ' 141' ' ' ILE . 15.1 tp -61.9 -55.55 28.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.212 -0.93 . . . . 0.0 110.082 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.596 HG22 ' HB3' ' A' ' 189' ' ' PHE . 55.5 t -55.37 -25.87 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.895 . . . . 0.0 110.155 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -83.33 -29.21 28.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.319 -0.863 . . . . 0.0 110.422 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.5 m -61.05 -31.2 70.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.236 -0.915 . . . . 0.0 110.312 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.401 ' OG ' ' HG3' ' A' ' 166' ' ' PRO . 95.8 p -146.34 159.21 43.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.219 -0.925 . . . . 0.0 110.25 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.937 ' HG3' HG23 ' A' ' 138' ' ' VAL . 12.7 pt-20 -64.38 -40.65 96.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.879 . . . . 0.0 110.155 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.937 HG23 ' HG3' ' A' ' 137' ' ' GLU . 95.1 t -113.24 128.32 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.477 -0.764 . . . . 0.0 110.194 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -158.11 145.31 18.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.859 . . . . 0.0 109.839 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.467 HG11 ' CE2' ' A' ' 167' ' ' PHE . 7.5 p -124.63 151.29 29.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.125 -0.985 . . . . 0.0 110.298 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.619 HG23 ' CD1' ' A' ' 123' ' ' LEU . 66.7 mt -143.11 119.52 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.441 -0.787 . . . . 0.0 109.576 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -90.62 164.95 30.67 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.831 ' CE2' HG12 ' A' ' 175' ' ' VAL . 46.7 m-85 -130.72 69.09 1.46 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.52 -0.988 . . . . 0.0 109.375 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.408 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 11.5 m-85 -89.03 132.63 34.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.139 -0.975 . . . . 0.0 111.379 -178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.3 -28.52 59.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.582 -0.699 . . . . 0.0 110.077 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -127.38 73.87 1.47 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.392 -0.817 . . . . 0.0 109.923 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.485 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 24.0 m -53.21 -21.8 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.348 -0.845 . . . . 0.0 110.611 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.49 13.39 8.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.134 -0.979 . . . . 0.0 110.801 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 85.3 p -98.6 -163.53 1.05 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.04 -1.038 . . . . 0.0 110.131 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.43 -43.67 14.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.114 -0.991 . . . . 0.0 110.293 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 85.6 p -52.74 -27.65 18.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -0.928 . . . . 0.0 110.25 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.485 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -85.48 -35.17 21.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 110.057 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.6 mmmt -54.28 -50.04 68.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 110.216 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -57.74 -38.9 76.16 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.261 -0.899 . . . . 0.0 110.085 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -52.41 -63.24 1.2 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 0.0 110.278 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.4 mt -53.86 -52.13 61.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.346 -0.846 . . . . 0.0 110.205 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.407 ' HB3' ' HD2' ' A' ' 205' ' ' LYS . 36.3 mt-30 -52.01 -50.44 61.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.369 -0.832 . . . . 0.0 110.12 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.714 ' HB2' ' HA ' ' A' ' 205' ' ' LYS . . . -66.15 -29.13 69.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.127 -0.983 . . . . 0.0 109.738 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.12 -34.3 66.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.389 -0.819 . . . . 0.0 109.995 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -57.11 -22.84 42.79 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.296 -0.877 . . . . 0.0 110.125 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.13 -51.47 69.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.896 . . . . 0.0 110.134 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.462 HG21 ' CG1' ' A' ' 165' ' ' ILE . 76.8 mt -100.96 139.76 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.32 -0.862 . . . . 0.0 110.246 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -117.51 -21.87 8.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 0.0 110.47 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -74.17 -11.0 60.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.184 -0.947 . . . . 0.0 110.729 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.462 ' CG1' HG21 ' A' ' 162' ' ' ILE . 49.4 mm -100.02 130.96 25.11 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 120.995 -1.066 . . . . 0.0 110.107 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.401 ' HG3' ' OG ' ' A' ' 136' ' ' SER . 50.3 Cg_endo -75.88 78.38 3.15 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.409 1.216 . . . . 0.0 110.683 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.467 ' CE2' HG11 ' A' ' 140' ' ' VAL . 5.8 m-85 -68.87 138.78 54.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.212 -0.93 . . . . 0.0 109.813 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.542 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -133.02 150.34 19.77 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 14.6 tt -149.67 137.81 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -1.191 . . . . 0.0 110.693 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.665 HG21 HG11 ' A' ' 175' ' ' VAL . 2.6 t -150.88 157.37 42.83 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.092 0.948 . . . . 0.0 110.774 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 79.7 p -118.78 0.78 11.5 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.581 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.48 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 43.3 t30 -53.56 -177.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.216 -0.928 . . . . 0.0 110.136 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 18.3 m -106.8 -35.96 6.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.137 -0.977 . . . . 0.0 110.077 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -57.91 -31.52 66.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -0.914 . . . . 0.0 109.819 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.831 HG12 ' CE2' ' A' ' 143' ' ' PHE . 40.2 t -76.42 -30.03 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.282 -0.886 . . . . 0.0 109.562 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 172' ' ' ASN . 11.4 m-85 -77.33 -57.36 3.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 109.613 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.2 m -53.2 -23.58 8.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.342 -0.849 . . . . 0.0 110.052 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -58.69 -57.91 10.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.873 . . . . 0.0 110.288 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -89.98 17.41 6.87 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.237 -0.914 . . . . 0.0 110.445 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 53.84 65.53 1.49 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.045 -1.035 . . . . 0.0 110.347 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 83.3 mt -108.29 100.79 10.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.316 -0.865 . . . . 0.0 110.194 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.97 -26.12 46.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 109.978 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -144.3 -165.5 2.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.362 -0.837 . . . . 0.0 110.122 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 9.7 p-10 -68.89 163.56 24.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.171 -0.956 . . . . 0.0 110.233 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 175.81 144.75 5.21 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.548 HG23 ' CB ' ' A' ' 199' ' ' PHE . 11.5 m -114.32 128.47 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -1.131 . . . . 0.0 110.283 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 188' ' ' LEU . 94.8 t -132.75 163.3 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.389 -0.819 . . . . 0.0 109.326 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.498 HD23 ' N ' ' A' ' 189' ' ' PHE . 6.6 tt -110.79 161.55 15.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.939 -1.101 . . . . 0.0 109.907 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.596 ' HB3' HG22 ' A' ' 133' ' ' VAL . 52.6 m-85 -128.53 124.85 37.05 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.989 -1.07 . . . . 0.0 110.418 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.426 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -138.14 161.24 37.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.265 -0.897 . . . . 0.0 110.378 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -90.87 -27.89 18.5 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.342 -0.849 . . . . 0.0 110.552 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.426 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.8 OUTLIER -90.75 -176.39 4.68 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.435 -0.79 . . . . 0.0 110.873 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 48.02 -154.52 0.08 Allowed 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.718 0.77 . . . . 0.0 110.587 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.04 -55.6 22.51 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.72 -0.613 . . . . 0.0 110.243 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 121.52 -25.69 6.85 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -134.89 161.56 34.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.268 -1.137 . . . . 0.0 110.203 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ASN . . . . . 0.462 ' N ' ' ND2' ' A' ' 197' ' ' ASN . 0.6 OUTLIER -133.34 -153.57 0.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.151 -0.968 . . . . 0.0 109.998 -179.481 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.515 ' O ' ' ND2' ' A' ' 198' ' ' ASN . 4.3 p-10 -174.57 88.3 0.05 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.446 -0.784 . . . . 0.0 110.217 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.548 ' CB ' HG23 ' A' ' 186' ' ' VAL . 29.3 t80 -60.75 139.97 57.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.334 -0.854 . . . . 0.0 110.398 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.468 ' O ' ' CE1' ' A' ' 199' ' ' PHE . 55.7 mt-10 -130.0 -151.33 0.47 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.141 -0.974 . . . . 0.0 109.679 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 51.34 -146.66 10.96 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.08 158.45 16.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -1.157 . . . . 0.0 110.016 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.445 ' C ' HG23 ' A' ' 204' ' ' THR . 73.2 t -89.13 114.69 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.255 -0.903 . . . . 0.0 110.251 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.445 HG23 ' C ' ' A' ' 203' ' ' VAL . 38.8 p -150.27 147.78 28.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.329 -0.857 . . . . 0.0 110.165 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.714 ' HA ' ' HB2' ' A' ' 158' ' ' ALA . 13.2 tttm -46.78 -50.26 18.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.25 -0.906 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLU . . . . . 0.439 ' HG3' ' N ' ' A' ' 207' ' ' ASN . 17.7 pt-20 -56.77 -39.36 73.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 110.191 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.439 ' N ' ' HG3' ' A' ' 206' ' ' GLU . 54.8 m-20 -72.33 -45.63 59.1 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.315 -0.865 . . . . 0.0 110.165 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.412 HD13 ' HB3' ' A' ' 158' ' ' ALA . 89.7 mt -54.52 -54.54 39.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 110.285 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.69 HD12 ' O ' ' A' ' 205' ' ' LYS . 1.4 mt -52.69 -29.09 24.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 0.0 110.002 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -77.72 -48.18 17.31 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.34 -0.85 . . . . 0.0 109.651 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.428 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 18.3 t80 -52.22 -56.04 17.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.865 . . . . 0.0 109.763 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.462 HD13 HD12 ' A' ' 188' ' ' LEU . 36.9 mm -51.24 -65.4 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.319 -0.863 . . . . 0.0 110.001 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -50.86 -25.31 4.38 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.755 -0.591 . . . . 0.0 110.452 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -89.57 -14.77 34.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.176 -0.952 . . . . 0.0 110.565 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.477 ' CB ' HD13 ' A' ' 188' ' ' LEU . 1.7 m-80 -89.06 -81.99 0.26 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.074 -1.016 . . . . 0.0 110.27 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.49 177.9 0.35 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.157 -0.965 . . . . 0.0 110.164 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 28.9 mt 54.59 100.03 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.391 -0.818 . . . . 0.0 110.314 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.23 -176.75 1.72 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.586 1.308 . . . . 0.0 110.294 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.0 -165.32 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.191 -0.943 . . . . 0.0 109.917 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 8.7 p -149.48 137.85 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 110.241 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 7.2 mt -70.42 78.22 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.205 -0.934 . . . . 0.0 110.202 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -157.99 144.38 17.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.34 -0.85 . . . . 0.0 110.143 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 53.83 -170.12 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.194 -0.941 . . . . 0.0 110.119 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.1 t -154.61 22.44 0.46 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.228 -0.92 . . . . 0.0 110.223 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 52.88 62.0 2.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.258 -0.901 . . . . 0.0 110.269 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -59.54 96.31 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.218 -0.926 . . . . 0.0 110.17 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 72.2 m -140.1 -61.33 0.52 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 110.132 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.224 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.256 0.55 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 167' ' ' PHE . . . -94.15 160.71 14.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.0 110.195 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.451 HG22 ' HA2' ' A' ' 168' ' ' GLY . 7.8 t -99.38 169.95 8.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.124 -0.985 . . . . 0.0 110.318 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 92.8 m -108.18 121.12 44.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.288 -0.882 . . . . 0.0 110.119 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.618 HD22 ' HB1' ' A' ' 128' ' ' ALA . 28.1 mt -100.06 136.49 20.12 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.241 -0.912 . . . . 0.0 110.08 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.88 -51.76 0.14 Allowed 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.509 1.268 . . . . 0.0 110.44 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.653 ' C ' HG22 ' A' ' 175' ' ' VAL . 0.6 OUTLIER -146.08 -170.42 3.48 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.224 -0.922 . . . . 0.0 110.788 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.589 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -58.86 -28.8 63.81 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -51.2 -36.69 42.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.176 -1.191 . . . . 0.0 110.472 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.618 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -83.68 -29.19 27.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.145 -0.972 . . . . 0.0 110.03 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.2 -27.3 68.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.131 -0.98 . . . . 0.0 109.95 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -89.07 -49.74 6.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.893 . . . . 0.0 109.971 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.3 t -58.7 -32.22 68.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.893 . . . . 0.0 110.197 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 27.0 tp -59.91 -52.52 65.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.321 -0.862 . . . . 0.0 110.011 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.487 HG22 ' CB ' ' A' ' 189' ' ' PHE . 47.7 t -58.56 -37.62 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.295 -0.878 . . . . 0.0 110.033 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -74.13 -5.69 43.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.32 -0.862 . . . . 0.0 110.909 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.35 -21.98 25.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.903 -1.123 . . . . 0.0 110.615 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.405 ' OG ' ' HG3' ' A' ' 166' ' ' PRO . 0.7 OUTLIER -150.08 162.24 40.79 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.196 -0.94 . . . . 0.0 110.571 -179.692 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.06 -17.39 62.01 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.314 -0.866 . . . . 0.0 109.912 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 99.2 t -135.13 139.6 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.976 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.449 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -173.13 146.9 1.51 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 0.0 110.121 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.543 HG11 ' CZ ' ' A' ' 167' ' ' PHE . 7.7 p -129.13 152.74 37.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.089 -1.007 . . . . 0.0 109.919 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.477 ' O ' ' CE1' ' A' ' 143' ' ' PHE . 62.5 mt -139.47 117.68 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.209 -0.932 . . . . 0.0 110.204 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -81.85 139.68 20.2 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.477 ' CE1' ' O ' ' A' ' 141' ' ' ILE . 70.9 m-85 -114.07 79.38 1.25 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.154 -1.204 . . . . 0.0 109.971 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' A' ' 151' ' ' SER . 15.9 m-85 -107.15 148.35 28.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.109 -0.994 . . . . 0.0 110.842 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.32 -28.59 18.65 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.3 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.418 ' HB3' ' HB3' ' A' ' 149' ' ' SER . 0.9 OUTLIER -119.69 82.88 1.95 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -0.837 . . . . 0.0 109.638 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 87.6 t -52.87 -21.93 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.366 -0.833 . . . . 0.0 110.76 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.81 18.39 6.59 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.218 -0.926 . . . . 0.0 110.563 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.418 ' HB3' ' HB3' ' A' ' 146' ' ' ASP . 10.3 p -90.8 -162.84 0.95 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.139 -0.976 . . . . 0.0 110.245 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -90.27 -47.94 7.46 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.267 -0.896 . . . . 0.0 110.489 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.413 ' HB3' ' CE1' ' A' ' 144' ' ' PHE . 62.5 m -52.35 -29.97 26.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.167 -0.958 . . . . 0.0 110.245 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.53 -29.08 41.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 109.975 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 149' ' ' SER . 1.0 OUTLIER -61.1 -54.36 45.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -0.907 . . . . 0.0 109.865 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -58.21 -37.91 75.74 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.309 -0.87 . . . . 0.0 109.864 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.45 ' HE1' HG13 ' A' ' 186' ' ' VAL . 4.8 t80 -50.22 -59.84 3.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.315 -0.866 . . . . 0.0 110.32 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' A' ' 156' ' ' LEU . 17.4 mt -50.44 -50.23 52.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.328 -0.858 . . . . 0.0 110.39 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -52.83 -54.76 29.61 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.392 -0.818 . . . . 0.0 110.113 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.58 -40.94 93.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.051 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.452 ' CB ' ' CD2' ' A' ' 167' ' ' PHE . . . -67.46 -25.67 66.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.307 -0.87 . . . . 0.0 110.158 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -82.94 -31.19 27.82 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.304 -0.873 . . . . 0.0 110.214 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.77 -38.64 64.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 0.0 110.195 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.8 tt -96.37 156.36 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.914 . . . . 0.0 110.339 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -133.93 16.01 3.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.93 . . . . 0.0 110.481 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.483 ' O ' HD13 ' A' ' 165' ' ' ILE . 4.5 p30 -123.68 10.43 9.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.08 -1.013 . . . . 0.0 110.716 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.483 HD13 ' O ' ' A' ' 164' ' ' ASP . 50.0 mm -126.67 136.52 28.85 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.0 -1.062 . . . . 0.0 110.189 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.449 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 49.9 Cg_endo -77.13 91.94 1.15 Allowed 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.499 1.262 . . . . 0.0 110.915 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.543 ' CZ ' HG11 ' A' ' 140' ' ' VAL . 4.1 m-85 -86.66 130.75 34.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.288 -0.882 . . . . 0.0 109.823 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.451 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -133.56 156.06 22.07 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.402 HD12 ' CD2' ' A' ' 155' ' ' PHE . 12.6 tt -150.84 150.78 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.094 -1.239 . . . . 0.0 110.418 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.515 HG21 HG11 ' A' ' 175' ' ' VAL . 2.3 t -157.65 157.78 34.24 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.06 0.933 . . . . 0.0 110.819 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.2 t -120.13 -0.18 10.57 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.389 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -61.55 129.47 41.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.096 -1.002 . . . . 0.0 110.24 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.6 t -58.83 -29.36 66.85 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.261 -0.9 . . . . 0.0 110.448 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.36 -33.66 65.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.125 -0.984 . . . . 0.0 110.206 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.653 HG22 ' C ' ' A' ' 125' ' ' ASP . 42.3 t -80.03 -25.29 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.913 . . . . 0.0 109.947 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.404 ' N ' ' CD1' ' A' ' 176' ' ' PHE . 11.9 m-85 -80.39 -53.06 6.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.304 -0.873 . . . . 0.0 109.777 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 14.2 m -54.45 -23.19 15.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.886 . . . . 0.0 109.932 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.71 -50.28 45.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.361 -0.837 . . . . 0.0 110.025 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -89.84 8.21 33.21 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.319 -0.863 . . . . 0.0 110.735 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 52.51 57.94 5.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.991 -1.068 . . . . 0.0 110.4 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 83.7 mt -99.45 100.27 11.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.197 -0.939 . . . . 0.0 110.351 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 3.7 m-20 -54.07 -26.74 28.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.96 . . . . 0.0 110.198 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -146.94 -165.29 2.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.217 -0.927 . . . . 0.0 109.914 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.43 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 2.7 p30 -64.1 162.49 14.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.14 -0.975 . . . . 0.0 109.91 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -170.57 140.3 5.92 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.466 -1.35 . . . . 0.0 110.064 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.45 HG13 ' HE1' ' A' ' 155' ' ' PHE . 53.3 t -109.46 90.32 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.423 -1.045 . . . . 0.0 109.448 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.517 HG13 ' H ' ' A' ' 197' ' ' ASN . 94.0 t -102.55 147.75 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.338 -0.851 . . . . 0.0 110.277 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.552 HD22 ' HB3' ' A' ' 215' ' ' ASN . 7.7 tt -107.46 158.98 16.75 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.292 -0.88 . . . . 0.0 109.306 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.487 ' CB ' HG22 ' A' ' 133' ' ' VAL . 71.2 m-85 -123.86 139.76 53.65 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.995 -1.066 . . . . 0.0 110.707 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.402 ' HG2' ' HA2' ' A' ' 195' ' ' GLY . 0.0 OUTLIER -145.91 166.16 26.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.399 -0.813 . . . . 0.0 109.796 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -84.4 -36.55 22.35 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.138 -0.976 . . . . 0.0 110.409 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.07 -170.98 2.83 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.743 0.782 . . . . 0.0 110.782 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 53.54 -160.58 0.13 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.666 0.746 . . . . 0.0 110.575 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -60.79 -29.59 69.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.668 -0.645 . . . . 0.0 110.241 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.402 ' HA2' ' HG2' ' A' ' 190' ' ' LYS . . . 105.38 -21.87 34.05 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.71 172.84 12.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.083 -1.245 . . . . 0.0 110.616 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ASN . . . . . 0.517 ' H ' HG13 ' A' ' 187' ' ' VAL . 1.8 m-80 -134.65 -148.9 0.33 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.585 -0.697 . . . . 0.0 109.48 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -173.73 81.25 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.228 -0.92 . . . . 0.0 110.393 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.431 ' HB3' ' HB ' ' A' ' 186' ' ' VAL . 12.1 t80 -69.64 123.55 21.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.372 -0.83 . . . . 0.0 109.96 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -138.26 122.0 17.55 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.214 -0.929 . . . . 0.0 109.949 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 144.01 -145.2 14.61 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.53 112.92 19.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -1.132 . . . . 0.0 110.333 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.435 ' C ' HG23 ' A' ' 204' ' ' THR . 83.6 t -74.72 109.57 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.103 -0.998 . . . . 0.0 110.03 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.435 HG23 ' C ' ' A' ' 203' ' ' VAL . 71.9 p -147.95 151.67 36.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.315 -0.865 . . . . 0.0 110.47 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 12.5 tttm -46.84 -55.14 8.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.468 -0.77 . . . . 0.0 110.928 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -54.65 -28.14 44.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.357 -0.839 . . . . 0.0 110.479 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 24.8 m-20 -86.18 -44.38 12.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 0.0 110.396 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 80.4 mt -57.28 -55.02 40.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.938 . . . . 0.0 110.695 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 8.0 mp -50.99 -50.32 58.61 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.116 -0.99 . . . . 0.0 110.653 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.01 -37.16 76.26 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.251 -0.906 . . . . 0.0 110.497 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.417 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 8.9 t80 -64.36 -60.46 3.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.145 -0.972 . . . . 0.0 110.472 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 8.9 mt -53.77 -47.37 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.337 -0.852 . . . . 0.0 110.697 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.6 mmtt -50.79 -23.21 2.57 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.235 -0.916 . . . . 0.0 110.863 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -96.69 -16.13 21.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.167 -0.958 . . . . 0.0 110.862 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.552 ' HB3' HD22 ' A' ' 188' ' ' LEU . 77.6 m-20 -94.66 -40.04 10.01 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.108 -0.995 . . . . 0.0 111.33 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -91.09 19.94 5.36 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.897 -1.127 . . . . 0.0 110.662 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 217' ' ' LEU . 14.4 mt -145.53 57.95 4.59 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.146 -0.971 . . . . 0.0 109.949 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.455 ' C ' HD22 ' A' ' 219' ' ' LEU . 45.6 Cg_endo -71.93 150.16 54.58 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.718 1.378 . . . . 0.0 110.215 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.544 HD22 ' N ' ' A' ' 219' ' ' LEU . 4.5 mm? -98.02 118.0 33.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.887 . . . . 0.0 110.228 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 34.0 m -90.55 156.48 3.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.471 -0.768 . . . . 0.0 110.152 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 94.5 mt -118.18 150.37 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.177 -0.952 . . . . 0.0 110.181 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 52.9 89.27 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.287 -0.883 . . . . 0.0 110.361 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -55.39 171.37 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.909 . . . . 0.0 110.251 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.665 HG23 ' HB2' ' A' ' 226' ' ' GLN . 9.9 t -110.94 175.4 5.44 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.253 -0.904 . . . . 0.0 110.23 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.54 61.68 0.36 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.915 . . . . 0.0 110.172 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.665 ' HB2' HG23 ' A' ' 224' ' ' THR . 0.0 OUTLIER -146.17 -55.82 0.28 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.934 . . . . 0.0 110.131 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 6.6 t -150.67 167.74 26.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.293 -0.879 . . . . 0.0 110.188 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.232 -179.942 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.301 0.572 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -103.99 157.79 16.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 110.301 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.593 HG22 ' HA2' ' A' ' 168' ' ' GLY . 9.3 t -74.66 169.23 18.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.288 -0.883 . . . . 0.0 110.093 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.4 m -101.66 121.32 41.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.262 -0.899 . . . . 0.0 110.548 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.3 mt -102.34 118.33 59.12 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.336 -0.853 . . . . 0.0 109.619 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.411 ' O ' ' ND2' ' A' ' 172' ' ' ASN . 46.1 Cg_endo -71.0 -18.34 31.27 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.453 1.239 . . . . 0.0 110.848 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.61 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.0 OUTLIER 179.4 -170.03 0.12 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.088 -1.007 . . . . 0.0 111.466 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.96 -29.43 70.72 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.61 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -53.47 -29.9 38.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -1.12 . . . . 0.0 110.159 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.75 -35.17 15.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.906 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.59 -39.16 79.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.327 -0.858 . . . . 0.0 109.996 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.49 -51.11 12.38 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.249 -0.907 . . . . 0.0 110.253 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.0 m -57.27 -20.46 28.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.35 -0.844 . . . . 0.0 110.408 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.9 tp -79.15 -48.14 14.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 110.381 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.699 HG22 ' CB ' ' A' ' 189' ' ' PHE . 90.9 t -60.02 -31.39 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.142 -0.974 . . . . 0.0 110.38 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -85.79 -23.69 27.12 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.238 -0.913 . . . . 0.0 109.582 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.12 -63.41 1.19 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.143 -0.973 . . . . 0.0 110.12 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.4 p -115.7 -176.63 2.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.927 . . . . 0.0 110.259 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.5 -35.56 58.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.872 . . . . 0.0 110.248 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.5 t -120.86 149.29 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.247 -0.908 . . . . 0.0 110.261 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -175.27 130.45 0.29 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.316 -0.865 . . . . 0.0 109.907 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.529 HG11 ' CZ ' ' A' ' 167' ' ' PHE . 9.6 p -119.13 147.99 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.142 -0.974 . . . . 0.0 110.329 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.2 mt -134.83 113.92 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.342 -0.849 . . . . 0.0 109.945 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -80.98 128.23 8.33 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.665 ' CE2' HG12 ' A' ' 175' ' ' VAL . 32.0 m-85 -94.89 76.57 3.6 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.235 -1.156 . . . . 0.0 109.904 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -96.63 139.21 33.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 110.965 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.39 -26.89 26.16 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.425 -0.797 . . . . 0.0 109.576 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -137.96 78.39 1.68 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.51 -0.744 . . . . 0.0 109.508 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.431 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 27.3 m -50.36 -23.86 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.349 -0.844 . . . . 0.0 110.717 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -84.66 10.59 10.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 110.892 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 11.2 p -88.11 -161.65 0.75 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.963 -1.085 . . . . 0.0 110.187 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.05 -42.81 10.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.262 -0.899 . . . . 0.0 110.344 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.0 m -59.4 -28.66 67.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.158 -0.964 . . . . 0.0 110.355 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.431 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -78.8 -31.26 45.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.309 -0.87 . . . . 0.0 110.174 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -58.94 -25.43 63.48 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.21 -0.931 . . . . 0.0 109.96 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -75.37 -46.31 33.84 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.394 -0.816 . . . . 0.0 110.133 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -49.97 -56.56 10.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 110.476 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 156' ' ' LEU . 64.9 mt -49.36 -52.29 29.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.42 -0.8 . . . . 0.0 110.584 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.414 ' HB3' ' HD2' ' A' ' 205' ' ' LYS . 1.6 mm100 -51.82 -46.49 64.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.422 -0.799 . . . . 0.0 110.36 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.4 -39.81 74.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 110.261 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.25 -27.61 69.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 110.298 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -60.42 -47.44 86.1 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.208 -0.932 . . . . 0.0 110.38 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.76 -35.65 56.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.165 -0.959 . . . . 0.0 110.342 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.7 mm -89.8 112.26 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 109.89 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -114.0 13.9 18.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 110.446 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.583 ' O ' HD13 ' A' ' 165' ' ' ILE . 8.4 p-10 -124.32 17.35 9.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.086 -1.009 . . . . 0.0 110.366 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.583 HD13 ' O ' ' A' ' 164' ' ' ASP . 42.2 mm -128.22 141.03 40.01 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.162 -0.961 . . . . 0.0 110.057 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -75.32 73.68 4.42 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.533 1.281 . . . . 0.0 110.409 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.529 ' CZ ' HG11 ' A' ' 140' ' ' VAL . 2.6 m-85 -66.32 132.67 48.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.23 -0.919 . . . . 0.0 110.09 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.593 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -123.99 154.08 17.59 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 16.9 tt -149.2 138.96 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -1.14 . . . . 0.0 110.283 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.3 t -159.46 157.35 29.96 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.113 0.958 . . . . 0.0 110.753 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.2 t -122.79 2.15 9.43 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.495 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 124' ' ' PRO . 60.8 t30 -57.08 123.77 16.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.135 -0.978 . . . . 0.0 110.277 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 77.2 p -49.65 -33.18 14.86 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.253 -0.905 . . . . 0.0 110.504 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -54.1 -32.61 55.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 109.887 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.665 HG12 ' CE2' ' A' ' 143' ' ' PHE . 41.4 t -78.83 -24.45 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -0.872 . . . . 0.0 109.861 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 176' ' ' PHE . 20.6 m-85 -86.64 -44.91 11.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -0.871 . . . . 0.0 109.891 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 5.6 m -70.83 -7.22 43.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -0.844 . . . . 0.0 110.777 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 45.7 tttp -88.09 -47.49 8.46 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.058 -1.026 . . . . 0.0 109.563 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -90.06 12.19 18.47 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.371 -0.831 . . . . 0.0 110.385 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.93 68.6 0.78 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.054 -1.028 . . . . 0.0 110.483 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 62.2 mt -116.23 103.35 10.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 110.143 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -51.57 -26.14 8.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.27 -0.894 . . . . 0.0 110.226 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -149.93 -169.0 3.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 110.023 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 2.1 p30 -63.43 162.94 11.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.202 -0.936 . . . . 0.0 110.137 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -169.18 166.73 39.93 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 186' ' ' VAL . 21.4 m -135.19 114.68 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.247 -1.149 . . . . 0.0 110.11 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.828 HG22 ' HA ' ' A' ' 198' ' ' ASN . 99.5 t -127.29 153.67 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.924 . . . . 0.0 110.082 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.922 HD22 ' HB3' ' A' ' 215' ' ' ASN . 6.1 tt -109.27 137.96 46.36 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.285 -0.884 . . . . 0.0 108.668 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.699 ' CB ' HG22 ' A' ' 133' ' ' VAL . 62.4 m-85 -111.28 135.87 51.2 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.726 -1.234 . . . . 0.0 111.19 -178.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.535 ' HD2' HD23 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -150.16 159.76 44.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.453 -0.779 . . . . 0.0 109.967 179.499 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -83.97 -22.18 31.51 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.242 -0.911 . . . . 0.0 110.491 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.518 ' CZ ' ' HA ' ' A' ' 216' ' ' GLN . 2.4 p90 -90.7 -178.91 5.4 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.284 -0.885 . . . . 0.0 110.633 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 48.79 -159.17 0.05 Allowed 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.659 0.742 . . . . 0.0 110.509 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -60.61 -31.05 70.24 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.583 -0.698 . . . . 0.0 110.293 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 114.58 -42.74 1.85 Allowed Glycine 0 N--CA 1.483 1.822 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.09 177.95 5.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.147 -1.208 . . . . 0.0 110.462 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ASN . . . . . 0.487 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 2.5 m-80 -134.47 -37.3 0.85 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 0.0 110.55 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.828 ' HA ' HG22 ' A' ' 187' ' ' VAL . 4.0 m-80 57.73 83.29 0.11 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.171 -0.955 . . . . 0.0 109.991 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.494 ' HB3' HG23 ' A' ' 186' ' ' VAL . 84.3 t80 -66.61 115.27 6.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.396 -0.815 . . . . 0.0 110.433 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -115.6 80.16 1.4 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.368 -0.832 . . . . 0.0 110.12 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -169.12 -157.6 11.92 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -79.36 122.47 26.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -1.154 . . . . 0.0 110.305 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.467 ' C ' HG23 ' A' ' 204' ' ' THR . 70.6 t -71.87 101.36 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 110.076 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.467 HG23 ' C ' ' A' ' 203' ' ' VAL . 57.9 p -150.27 152.08 33.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.388 -0.82 . . . . 0.0 110.268 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.426 ' HG2' ' CD1' ' A' ' 209' ' ' LEU . 3.9 tttm -49.49 -48.54 47.82 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.321 -0.862 . . . . 0.0 110.426 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -57.1 -39.81 75.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.342 -0.849 . . . . 0.0 110.283 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -80.03 -48.48 13.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.231 -0.918 . . . . 0.0 110.368 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.542 ' O ' HD12 ' A' ' 212' ' ' ILE . 98.8 mt -54.19 -55.44 27.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.935 . . . . 0.0 110.257 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.426 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 8.2 mt -54.35 -29.88 49.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.283 -0.885 . . . . 0.0 110.221 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -76.42 -45.88 29.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.911 . . . . 0.0 110.065 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 197' ' ' ASN . 6.9 t80 -56.46 -62.79 1.48 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.411 -0.806 . . . . 0.0 110.462 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.542 HD12 ' O ' ' A' ' 208' ' ' LEU . 5.8 mt -52.42 -42.56 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.0 110.593 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.41 ' O ' HD12 ' A' ' 217' ' ' LEU . 12.1 mttp -56.15 -19.74 14.73 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.218 -0.926 . . . . 0.0 110.786 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -110.92 11.64 22.27 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.198 -0.939 . . . . 0.0 110.755 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.922 ' HB3' HD22 ' A' ' 188' ' ' LEU . 1.3 m120 -91.89 -64.41 1.12 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.946 -1.096 . . . . 0.0 110.611 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.518 ' HA ' ' CZ ' ' A' ' 192' ' ' PHE . 5.9 pt20 -53.11 -41.41 64.97 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.289 -0.882 . . . . 0.0 111.002 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 213' ' ' LYS . 3.4 mt -63.84 111.9 6.25 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.165 -0.96 . . . . 0.0 110.53 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -77.39 -168.54 0.6 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 O-C-N 123.454 1.239 . . . . 0.0 110.382 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 3.5 mt -84.75 104.97 15.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.289 -0.882 . . . . 0.0 110.194 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.65 HG22 ' O ' ' A' ' 220' ' ' VAL . 8.3 p -137.3 47.05 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.374 -0.829 . . . . 0.0 110.135 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 47.9 mm -79.25 89.32 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.318 -0.864 . . . . 0.0 110.252 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -136.0 -72.63 0.45 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.888 . . . . 0.0 110.119 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -108.5 -169.4 1.5 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.0 110.05 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 55.9 m -120.26 134.86 55.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.0 110.193 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -101.07 -38.19 8.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.225 -0.922 . . . . 0.0 110.077 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -86.7 97.87 10.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.283 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 18.2 p -75.43 116.94 16.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.185 -0.947 . . . . 0.0 110.15 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.216 179.976 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.282 0.563 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -105.9 176.12 5.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -0.911 . . . . 0.0 110.178 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.558 HG22 ' HA2' ' A' ' 168' ' ' GLY . 8.9 t -97.87 166.89 11.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.182 -0.949 . . . . 0.0 110.15 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.8 m -115.02 103.92 11.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.942 . . . . 0.0 110.346 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.566 HD22 ' HB1' ' A' ' 128' ' ' ALA . 39.3 mt -77.85 126.2 84.43 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.299 -0.876 . . . . 0.0 110.015 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.27 -40.25 2.47 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.418 1.22 . . . . 0.0 110.508 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.541 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.9 OUTLIER -153.82 -170.59 3.62 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.308 -0.87 . . . . 0.0 110.813 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.02 -29.93 72.19 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.541 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -52.15 -30.36 26.29 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.157 -1.202 . . . . 0.0 110.371 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.566 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -89.79 -38.7 13.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.947 . . . . 0.0 110.032 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.53 -25.22 24.5 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.283 -0.885 . . . . 0.0 110.036 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -86.62 -54.49 4.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.353 -0.842 . . . . 0.0 110.115 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.07 -18.31 33.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.912 . . . . 0.0 110.291 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.535 HD21 ' HB2' ' A' ' 166' ' ' PRO . 3.3 tt -73.25 -59.35 2.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 0.0 109.747 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.59 HG22 ' CB ' ' A' ' 189' ' ' PHE . 49.8 t -53.01 -37.21 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.414 -0.803 . . . . 0.0 110.257 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -73.16 -25.58 60.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.274 -0.891 . . . . 0.0 110.313 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.81 -48.82 69.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 110.28 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 78.0 p -135.65 173.86 11.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.224 -0.922 . . . . 0.0 110.338 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.91 -41.22 91.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -0.862 . . . . 0.0 110.309 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 95.7 t -112.97 151.02 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.283 -0.886 . . . . 0.0 110.371 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.526 ' HB1' HD22 ' A' ' 132' ' ' LEU . . . -174.4 137.79 0.52 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.854 . . . . 0.0 109.845 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.484 HG11 ' CZ ' ' A' ' 167' ' ' PHE . 9.1 p -123.38 147.09 27.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.203 -0.936 . . . . 0.0 110.302 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.486 HD12 ' CD1' ' A' ' 189' ' ' PHE . 3.4 mt -135.79 115.82 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.265 -0.897 . . . . 0.0 109.666 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -79.82 134.25 13.39 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.908 ' CE2' HG12 ' A' ' 175' ' ' VAL . 11.5 m-85 -103.48 71.25 1.08 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.181 -1.188 . . . . 0.0 109.615 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.529 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 15.1 m-85 -91.74 137.45 32.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.026 -1.046 . . . . 0.0 110.992 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.483 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -91.19 -31.94 15.98 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 121.614 0.721 . . . . 0.0 109.846 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.566 ' C ' HG23 ' A' ' 147' ' ' VAL . 1.7 t70 -89.5 -41.49 12.01 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.534 0.683 . . . . 0.0 110.166 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.566 HG23 ' C ' ' A' ' 146' ' ' ASP . 2.5 t 72.97 -51.08 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.859 -0.526 . . . . 0.0 110.714 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -90.72 8.87 32.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.093 -1.005 . . . . 0.0 110.551 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 19.8 p -70.34 -164.68 0.09 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.863 -1.148 . . . . 0.0 109.971 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.41 -31.18 16.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.895 . . . . 0.0 110.277 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.5 p -68.49 -25.6 65.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.906 . . . . 0.0 110.123 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.39 -34.01 25.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.9 . . . . 0.0 110.173 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -53.2 -44.77 68.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.355 -0.841 . . . . 0.0 110.4 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -66.89 -36.83 83.17 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.221 -0.925 . . . . 0.0 110.316 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.434 ' O ' ' HB3' ' A' ' 158' ' ' ALA . 4.5 t80 -51.58 -58.22 6.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.392 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.6 mt -50.52 -54.25 23.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.4 -0.813 . . . . 0.0 110.45 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -50.88 -29.93 13.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.258 -0.901 . . . . 0.0 110.342 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 155' ' ' PHE . . . -75.63 -56.47 4.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.338 -0.852 . . . . 0.0 110.006 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.623 ' HB2' ' CD2' ' A' ' 167' ' ' PHE . . . -54.86 -33.58 62.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 110.059 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -66.69 -28.7 68.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.331 -0.856 . . . . 0.0 110.226 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -64.67 -42.88 95.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.285 -0.884 . . . . 0.0 110.231 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.402 HG13 ' OD1' ' A' ' 164' ' ' ASP . 4.1 tt -93.12 164.42 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.254 -0.904 . . . . 0.0 110.209 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 163' ' ' ASP . 17.1 p-10 -145.23 19.2 1.57 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.101 -0.999 . . . . 0.0 110.467 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.402 ' OD1' HG13 ' A' ' 162' ' ' ILE . 5.0 p-10 -125.57 8.82 7.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.196 -0.94 . . . . 0.0 110.652 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 45.8 mm -125.53 137.21 29.46 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.04 -1.037 . . . . 0.0 109.798 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.535 ' HB2' HD21 ' A' ' 132' ' ' LEU . 48.2 Cg_endo -73.69 78.97 2.33 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.568 1.299 . . . . 0.0 110.724 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.623 ' CD2' ' HB2' ' A' ' 159' ' ' ALA . 2.9 m-85 -71.4 125.64 27.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.186 -0.946 . . . . 0.0 109.694 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.558 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -123.33 156.15 17.59 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.134 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 14.7 tt -150.17 142.95 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.459 -1.024 . . . . 0.0 109.912 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.4 t -164.98 157.57 16.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.117 -0.989 . . . . 0.0 110.892 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.4 ' HB3' ' CG2' ' A' ' 147' ' ' VAL . 91.2 p -122.97 3.58 9.38 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.375 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -54.98 122.05 10.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.158 -0.964 . . . . 0.0 110.306 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 83.9 p -51.52 -31.85 25.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.321 -0.862 . . . . 0.0 110.477 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -54.32 -33.8 59.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.142 -0.974 . . . . 0.0 109.809 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.908 HG12 ' CE2' ' A' ' 143' ' ' PHE . 41.0 t -79.78 -24.46 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.44 -0.788 . . . . 0.0 109.642 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 176' ' ' PHE . 10.8 m-85 -79.44 -54.96 5.41 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.441 -0.787 . . . . 0.0 109.907 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 29.9 t -66.53 -14.27 62.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.366 -0.834 . . . . 0.0 110.562 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 11.3 tttt -82.01 -44.94 15.99 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.086 -1.009 . . . . 0.0 110.034 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -90.7 8.08 36.25 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.15 -0.969 . . . . 0.0 110.674 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 50.69 67.81 0.87 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.05 -1.032 . . . . 0.0 110.676 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.454 HD13 ' CD2' ' A' ' 143' ' ' PHE . 3.4 mt -109.06 124.43 50.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.226 -0.921 . . . . 0.0 110.137 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -62.08 -15.83 47.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.108 -0.995 . . . . 0.0 110.012 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -175.26 -157.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.233 -0.917 . . . . 0.0 109.551 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 8.4 p-10 -71.57 160.45 32.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.087 -1.008 . . . . 0.0 109.945 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -177.33 172.97 45.82 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 74.9 t -126.5 107.54 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.385 -1.068 . . . . 0.0 110.006 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 197' ' ' ASN . 75.0 t -111.57 148.22 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.339 -0.851 . . . . 0.0 109.94 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.805 HD22 ' HB3' ' A' ' 215' ' ' ASN . 6.3 tt -108.16 143.74 36.54 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.008 -1.057 . . . . 0.0 109.421 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.59 ' CB ' HG22 ' A' ' 133' ' ' VAL . 59.9 m-85 -115.62 118.6 33.56 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.017 -1.052 . . . . 0.0 110.874 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.458 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -130.55 164.02 25.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.279 -0.888 . . . . 0.0 109.996 179.513 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -88.86 -24.9 22.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.165 -0.959 . . . . 0.0 110.148 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.458 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 1.6 p90 -91.01 -176.17 4.55 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.46 -0.775 . . . . 0.0 110.741 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 46.22 -159.13 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.605 0.717 . . . . 0.0 110.966 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -50.9 -56.33 12.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.66 -0.65 . . . . 0.0 110.284 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 125.17 -21.71 6.43 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.4 mtm180 -143.63 156.91 44.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.132 -1.216 . . . . 0.0 110.571 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ASN . . . . . 0.473 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.1 m-80 -131.46 -167.35 1.84 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.36 -0.837 . . . . 0.0 109.84 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -156.82 80.69 0.94 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.442 -0.787 . . . . 0.0 109.892 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.534 ' CE2' HG22 ' A' ' 203' ' ' VAL . 84.7 t80 -51.3 121.87 6.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.138 -0.976 . . . . 0.0 110.484 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.03 91.72 3.49 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.344 -0.847 . . . . 0.0 110.271 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 165.34 177.41 37.71 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -55.96 107.52 0.36 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.25 -1.147 . . . . 0.0 110.237 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.534 HG22 ' CE2' ' A' ' 199' ' ' PHE . 93.1 t -64.84 113.66 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -0.879 . . . . 0.0 110.071 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 12.5 p -150.33 157.36 42.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.87 . . . . 0.0 110.475 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.469 ' O ' HD12 ' A' ' 209' ' ' LEU . 11.4 tttt -50.09 -52.25 36.26 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.196 -0.94 . . . . 0.0 110.597 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' GLU . . . . . 0.448 ' HG3' ' N ' ' A' ' 207' ' ' ASN . 12.3 pt-20 -55.91 -40.04 72.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.221 -0.924 . . . . 0.0 110.329 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.448 ' N ' ' HG3' ' A' ' 206' ' ' GLU . 87.6 m-20 -78.12 -48.01 16.93 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.271 -0.893 . . . . 0.0 110.253 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.667 ' O ' HD12 ' A' ' 212' ' ' ILE . 68.2 mt -53.53 -57.99 8.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.221 -0.924 . . . . 0.0 110.346 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 205' ' ' LYS . 0.4 OUTLIER -53.54 -22.83 9.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.293 -0.88 . . . . 0.0 110.467 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -81.76 -49.62 10.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.099 -1.001 . . . . 0.0 110.093 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -58.97 -56.92 16.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.317 -0.864 . . . . 0.0 110.428 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.667 HD12 ' O ' ' A' ' 208' ' ' LEU . 6.9 mt -55.22 -49.03 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.267 -0.896 . . . . 0.0 110.621 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.76 ' O ' HD12 ' A' ' 217' ' ' LEU . 1.8 mtpt -50.33 -27.35 6.04 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.173 -0.954 . . . . 0.0 110.598 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -88.0 -24.67 23.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -0.925 . . . . 0.0 110.412 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.805 ' HB3' HD22 ' A' ' 188' ' ' LEU . 70.8 m-80 -89.58 -33.59 16.65 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.263 -0.898 . . . . 0.0 110.753 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.87 19.78 4.59 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.13 -0.981 . . . . 0.0 110.63 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.76 HD12 ' O ' ' A' ' 213' ' ' LYS . 25.8 mt -140.4 74.52 28.9 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.068 -1.02 . . . . 0.0 110.211 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.17 179.55 4.86 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.619 1.326 . . . . 0.0 110.41 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.2 mp -111.57 118.22 35.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.344 -0.848 . . . . 0.0 110.289 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.697 HG22 HG12 ' A' ' 221' ' ' ILE . 8.5 p -100.0 147.91 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.912 . . . . 0.0 110.035 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.697 HG12 HG22 ' A' ' 220' ' ' VAL . 34.5 mm 52.67 85.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.181 -0.949 . . . . 0.0 110.11 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -162.52 104.33 1.08 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.18 -0.95 . . . . 0.0 110.218 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.02 131.78 45.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 109.978 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.1 p -125.74 98.48 5.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.913 . . . . 0.0 110.369 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -99.0 -69.99 0.74 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.875 . . . . 0.0 110.068 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -116.41 150.15 38.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.188 -0.945 . . . . 0.0 110.205 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 98.9 m -83.97 -30.93 25.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.29 -0.881 . . . . 0.0 110.25 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.252 179.951 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.16 0.505 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -112.39 -171.23 1.81 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 0.0 110.317 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.434 ' HB ' ' HA2' ' A' ' 168' ' ' GLY . 28.6 m -97.53 95.7 7.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 110.172 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 95.9 m -61.34 104.24 0.38 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -0.9 . . . . 0.0 109.88 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.411 ' HB2' ' HB ' ' A' ' 170' ' ' THR . 0.8 OUTLIER -82.98 137.1 43.5 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.124 -0.985 . . . . 0.0 110.169 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.437 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 48.9 Cg_endo -73.33 -39.62 2.0 Allowed 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.532 1.28 . . . . 0.0 110.206 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.46 ' C ' HG22 ' A' ' 175' ' ' VAL . 0.4 OUTLIER -157.06 -169.11 2.84 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.992 0.901 . . . . 0.0 111.085 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.429 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -66.4 -31.7 79.66 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -53.21 -27.14 20.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.233 -1.157 . . . . 0.0 110.119 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.437 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -88.2 -32.75 18.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.87 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.431 ' O ' HG23 ' A' ' 133' ' ' VAL . . . -56.85 -41.54 78.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.349 -0.844 . . . . 0.0 109.946 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.77 -52.79 11.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.331 -0.856 . . . . 0.0 110.086 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.96 -40.31 63.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.333 -0.854 . . . . 0.0 110.099 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.779 HD23 HD11 ' A' ' 141' ' ' ILE . 21.3 tp -53.55 -50.72 64.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.247 -0.908 . . . . 0.0 109.961 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.76 HG22 ' HB3' ' A' ' 189' ' ' PHE . 39.9 t -53.63 -32.71 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.459 -0.775 . . . . 0.0 110.186 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -87.54 -32.11 19.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.186 -0.946 . . . . 0.0 110.377 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 59.7 p -52.0 -46.29 64.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.193 -0.942 . . . . 0.0 110.382 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.2 p -132.29 163.94 27.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.145 -0.972 . . . . 0.0 110.109 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -63.4 -43.66 96.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.902 . . . . 0.0 110.166 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 28.1 m -117.63 147.99 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.215 -0.928 . . . . 0.0 110.422 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -175.27 126.34 0.26 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.364 -0.835 . . . . 0.0 110.031 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.566 HG12 ' HA ' ' A' ' 167' ' ' PHE . 13.7 p -97.91 147.96 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 121.119 -0.988 . . . . 0.0 110.535 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.779 HD11 HD23 ' A' ' 132' ' ' LEU . 44.7 mt -141.43 107.71 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.91 . . . . 0.0 109.734 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -84.36 163.15 38.89 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.562 ' CE2' HG12 ' A' ' 175' ' ' VAL . 26.2 m-85 -126.72 70.42 1.27 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.632 -0.923 . . . . 0.0 109.647 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.5 ' CZ ' HG21 ' A' ' 203' ' ' VAL . 23.9 m-85 -97.21 146.02 25.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 111.071 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.61 -28.22 18.57 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.145 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.89 84.17 1.94 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -0.833 . . . . 0.0 109.94 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.9 t -66.89 -12.45 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.345 -0.847 . . . . 0.0 110.8 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -99.07 4.03 46.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.009 -1.057 . . . . 0.0 110.805 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 38.7 p -85.97 -159.52 0.47 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.824 -1.173 . . . . 0.0 110.27 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -88.82 -35.34 16.66 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.232 -0.918 . . . . 0.0 110.135 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.1 t -54.89 -33.24 61.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.34 -0.85 . . . . 0.0 110.226 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.495 ' O ' HD12 ' A' ' 156' ' ' LEU . . . -82.49 -33.51 28.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.917 . . . . 0.0 110.203 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -53.46 -50.48 65.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.879 . . . . 0.0 110.128 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -57.34 -41.96 81.02 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.369 -0.832 . . . . 0.0 110.124 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.412 ' CD2' HD12 ' A' ' 169' ' ' ILE . 4.2 t80 -52.22 -57.31 10.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 110.1 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.495 HD12 ' O ' ' A' ' 152' ' ' ALA . 0.6 OUTLIER -52.65 -55.13 24.68 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.42 -0.8 . . . . 0.0 110.207 179.569 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -47.64 -48.58 28.7 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.414 -0.804 . . . . 0.0 110.551 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.702 ' HB2' ' HA ' ' A' ' 205' ' ' LYS . . . -64.84 -43.6 92.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 109.766 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.05 -35.28 74.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.372 -0.83 . . . . 0.0 109.862 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -68.16 -29.09 67.89 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.319 -0.863 . . . . 0.0 110.301 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.32 -61.61 2.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.197 -0.939 . . . . 0.0 110.171 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 73.6 mt -89.67 149.28 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.928 . . . . 0.0 109.95 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.47 -31.06 4.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.205 -0.934 . . . . 0.0 110.375 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -68.74 -14.51 63.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.22 -0.925 . . . . 0.0 110.698 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.531 ' CG2' ' CE1' ' A' ' 167' ' ' PHE . 37.1 mm -98.46 123.98 48.31 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.08 -1.013 . . . . 0.0 110.263 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -83.38 107.6 1.44 Allowed 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.471 1.248 . . . . 0.0 110.064 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.566 ' HA ' HG12 ' A' ' 140' ' ' VAL . 0.4 OUTLIER -99.25 154.46 18.15 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.12 -0.988 . . . . 0.0 109.969 -179.489 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.434 ' HA2' ' HB ' ' A' ' 121' ' ' THR . . . -137.71 145.03 16.57 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.52 HG23 ' O ' ' A' ' 169' ' ' ILE . 16.8 tt -143.27 126.31 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.269 -1.136 . . . . 0.0 110.231 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.502 ' CG2' HG11 ' A' ' 175' ' ' VAL . 2.8 t -143.77 157.96 44.01 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.146 0.974 . . . . 0.0 111.131 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.7 t -127.09 5.37 6.46 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.181 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.428 ' ND2' ' HB2' ' A' ' 174' ' ' ASP . 43.4 t30 -62.0 128.32 35.58 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.182 -0.949 . . . . 0.0 110.231 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 9.0 t -52.23 -33.88 43.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.187 -0.946 . . . . 0.0 110.323 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.428 ' HB2' ' ND2' ' A' ' 172' ' ' ASN . 0.3 OUTLIER -54.67 -34.23 61.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.949 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.562 HG12 ' CE2' ' A' ' 143' ' ' PHE . 57.3 t -78.35 -27.19 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.537 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.401 ' N ' ' CD1' ' A' ' 176' ' ' PHE . 12.5 m-85 -81.54 -42.45 20.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.424 -0.798 . . . . 0.0 109.805 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.03 -7.47 46.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.343 -0.848 . . . . 0.0 110.629 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.86 -45.11 9.98 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.901 -1.124 . . . . 0.0 109.304 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -89.59 5.07 47.25 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.742 -0.599 . . . . 0.0 110.555 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.42 ' CG ' ' O ' ' A' ' 180' ' ' GLN . 0.0 OUTLIER 51.81 58.81 5.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.1 -1.0 . . . . 0.0 110.722 179.587 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.4 mt -98.66 130.35 45.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.063 -1.023 . . . . 0.0 109.824 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -87.06 12.22 11.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.1 -1.0 . . . . 0.0 110.295 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 13.8 pttp 179.13 -163.34 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.227 -0.921 . . . . 0.0 109.618 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.411 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 8.2 p-10 -87.47 156.63 19.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.287 -0.883 . . . . 0.0 110.133 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -177.54 152.09 11.58 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.426 HG11 ' CD2' ' A' ' 208' ' ' LEU . 88.2 t -103.65 128.4 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.317 -1.108 . . . . 0.0 110.468 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 83.1 t -134.56 151.48 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.363 -0.836 . . . . 0.0 109.655 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.504 HD22 ' HB3' ' A' ' 215' ' ' ASN . 7.8 tt -113.21 158.67 20.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.996 -1.065 . . . . 0.0 109.915 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.76 ' HB3' HG22 ' A' ' 133' ' ' VAL . 52.6 m-85 -128.67 130.03 46.63 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.078 -1.014 . . . . 0.0 110.459 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.21 166.61 23.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.877 . . . . 0.0 110.069 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.01 -33.73 18.27 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.199 -0.938 . . . . 0.0 110.128 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -90.91 -173.4 3.68 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.443 -0.786 . . . . 0.0 110.647 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 51.95 -159.73 0.11 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.434 -0.792 . . . . 0.0 110.458 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -54.93 -54.17 46.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.634 -0.666 . . . . 0.0 110.271 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 128.65 -38.49 2.04 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.18 165.31 21.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -1.166 . . . . 0.0 110.359 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ASN . . . . . 0.463 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.8 m-80 -128.72 -151.31 0.47 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.3 -0.875 . . . . 0.0 109.865 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -174.37 78.37 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.279 -0.888 . . . . 0.0 110.381 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.417 ' CB ' ' O ' ' A' ' 186' ' ' VAL . 28.3 t80 -57.95 118.7 5.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 109.838 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -125.53 38.8 4.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.302 -0.874 . . . . 0.0 110.413 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -128.83 -149.24 6.86 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -90.71 97.38 11.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.149 -1.206 . . . . 0.0 109.928 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 203' ' ' VAL . 7.4 p -51.33 102.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.212 -0.93 . . . . 0.0 110.373 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 26.2 p -140.93 150.59 43.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.357 -0.84 . . . . 0.0 110.323 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.881 ' O ' HD12 ' A' ' 209' ' ' LEU . 3.7 tttp -47.21 -31.31 3.56 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.359 -0.838 . . . . 0.0 110.946 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -79.42 -33.06 42.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.178 -0.951 . . . . 0.0 110.316 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 59.9 m-20 -83.57 -47.06 11.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 110.289 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.667 HD21 HG23 ' A' ' 203' ' ' VAL . 65.6 mt -52.87 -48.65 66.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 110.33 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.881 HD12 ' O ' ' A' ' 205' ' ' LYS . 13.6 mt -59.26 -29.13 67.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 110.095 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.47 -34.42 41.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 0.0 110.144 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.412 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 7.1 t80 -62.88 -62.98 1.35 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.306 -0.871 . . . . 0.0 110.192 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.404 HG22 ' OE1' ' A' ' 216' ' ' GLN . 7.0 mt -51.03 -49.75 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.391 -0.818 . . . . 0.0 110.473 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.523 ' O ' HD12 ' A' ' 217' ' ' LEU . 7.1 mtmt -48.7 -25.08 1.62 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.364 -0.835 . . . . 0.0 110.868 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.75 -14.77 21.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.125 -0.984 . . . . 0.0 110.815 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.504 ' HB3' HD22 ' A' ' 188' ' ' LEU . 73.4 m-80 -102.27 -24.29 13.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.078 -1.014 . . . . 0.0 110.767 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.404 ' OE1' HG22 ' A' ' 212' ' ' ILE . 16.1 pt20 -86.75 5.74 34.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.066 -1.021 . . . . 0.0 110.736 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 213' ' ' LYS . 14.0 mt -126.59 106.92 23.37 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.954 -1.091 . . . . 0.0 110.094 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.56 144.31 44.48 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.594 1.313 . . . . 0.0 110.281 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 18.3 mt -91.93 -167.02 1.68 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.233 -0.917 . . . . 0.0 109.969 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.532 ' O ' HG13 ' A' ' 220' ' ' VAL . 11.3 p -150.14 59.31 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.37 -0.832 . . . . 0.0 110.33 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 15.2 tt -114.79 162.36 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 110.19 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -108.12 141.49 39.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.088 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -106.17 -178.86 3.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.165 -0.959 . . . . 0.0 110.191 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 37.9 p -104.36 81.85 1.86 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.0 110.306 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -96.61 62.73 2.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.341 -0.85 . . . . 0.0 110.087 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 53.94 82.49 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 0.0 110.098 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 19.7 p -56.69 94.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.905 . . . . 0.0 110.265 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.19 179.996 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.252 0.548 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -133.96 -176.56 4.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.271 -0.893 . . . . 0.0 110.366 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.444 ' HB ' ' HA2' ' A' ' 168' ' ' GLY . 3.9 m -119.92 112.69 19.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.348 -0.845 . . . . 0.0 109.729 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 169' ' ' ILE . 53.5 m -68.57 144.04 54.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 110.047 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.607 HD22 ' HB1' ' A' ' 128' ' ' ALA . 20.5 mt -125.3 143.98 46.17 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.0 110.106 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.06 -40.33 2.58 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.705 1.371 . . . . 0.0 110.293 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.534 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.2 OUTLIER -170.5 -169.93 0.87 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.346 -0.846 . . . . 0.0 110.636 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.543 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -54.74 -27.77 44.35 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.534 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -52.88 -31.51 39.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.194 -1.18 . . . . 0.0 110.434 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.607 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -89.77 -37.5 14.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.177 -0.952 . . . . 0.0 109.912 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.591 ' O ' HG23 ' A' ' 133' ' ' VAL . . . -58.0 -33.19 68.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.332 -0.855 . . . . 0.0 110.004 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -74.28 -51.2 15.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.06 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.14 -30.71 71.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.307 -0.871 . . . . 0.0 110.07 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.1 tp -59.74 -48.68 80.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.207 -0.933 . . . . 0.0 109.961 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 129' ' ' ALA . 38.5 t -56.05 -52.13 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 110.07 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -65.59 -20.21 66.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.234 -0.916 . . . . 0.0 110.243 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.2 t -52.49 -51.43 59.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.146 -0.971 . . . . 0.0 110.351 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 53.7 p -137.31 -171.88 3.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.252 -0.905 . . . . 0.0 110.313 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -75.57 -39.74 57.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -0.878 . . . . 0.0 110.169 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 87.1 t -119.43 147.29 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.25 -0.906 . . . . 0.0 110.175 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.423 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -170.89 121.94 0.57 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.201 -0.937 . . . . 0.0 110.203 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.43 ' CG1' ' HA ' ' A' ' 167' ' ' PHE . 14.8 p -104.41 148.78 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.311 -0.868 . . . . 0.0 110.361 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.47 ' O ' ' CE2' ' A' ' 143' ' ' PHE . 51.1 mt -133.79 107.71 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.258 -0.902 . . . . 0.0 109.992 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.49 122.81 6.91 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.47 ' CE2' ' O ' ' A' ' 141' ' ' ILE . 93.0 m-85 -101.63 67.48 1.12 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.273 -1.134 . . . . 0.0 109.961 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -95.48 146.34 24.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.091 -1.006 . . . . 0.0 110.418 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.46 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -91.08 -32.5 15.85 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.586 -0.696 . . . . 0.0 109.585 179.083 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.46 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 88.5 m-20 -122.32 69.7 0.97 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.517 -0.739 . . . . 0.0 109.862 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.502 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 26.4 m -53.8 -21.31 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.206 -0.934 . . . . 0.0 110.51 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -79.74 4.32 16.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.09 -1.006 . . . . 0.0 111.008 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 32.9 p -87.34 -163.72 0.97 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.904 -1.122 . . . . 0.0 110.284 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.87 -40.83 12.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.0 110.103 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.83 -28.99 59.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.187 -0.946 . . . . 0.0 109.807 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.767 ' O ' HD12 ' A' ' 156' ' ' LEU . . . -79.68 -35.26 39.44 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.332 -0.855 . . . . 0.0 109.849 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -51.32 -44.99 62.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.277 -0.89 . . . . 0.0 110.192 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.412 ' OE1' ' HA ' ' A' ' 204' ' ' THR . 21.5 mm-40 -54.7 -47.36 73.78 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.156 -0.965 . . . . 0.0 109.514 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.568 ' HE1' HG13 ' A' ' 186' ' ' VAL . 4.7 t80 -52.48 -56.44 15.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 0.0 109.831 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.767 HD12 ' O ' ' A' ' 152' ' ' ALA . 2.6 mp -51.44 -58.27 6.71 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.362 -0.836 . . . . 0.0 110.095 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -49.61 -41.79 43.12 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.343 -0.848 . . . . 0.0 110.313 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 205' ' ' LYS . . . -74.61 -26.88 60.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.995 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.2 -29.03 42.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 0.0 110.067 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -63.4 -37.82 88.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 110.111 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.97 -29.82 69.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.358 -0.838 . . . . 0.0 109.961 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.571 HG21 ' CE1' ' A' ' 167' ' ' PHE . 18.2 mm -90.1 122.48 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.423 -0.798 . . . . 0.0 109.634 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -123.88 2.07 8.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.243 -0.91 . . . . 0.0 110.727 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -109.36 -19.85 13.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.952 -1.092 . . . . 0.0 110.252 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.468 ' CG2' ' HD2' ' A' ' 166' ' ' PRO . 41.4 mm -91.4 146.1 32.69 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.146 -0.971 . . . . 0.0 110.182 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.468 ' HD2' ' CG2' ' A' ' 165' ' ' ILE . 44.9 Cg_endo -84.25 79.26 2.64 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.807 1.425 . . . . 0.0 110.089 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.571 ' CE1' HG21 ' A' ' 162' ' ' ILE . 3.6 m-85 -71.92 126.94 31.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.406 -0.809 . . . . 0.0 110.589 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.444 ' HA2' ' HB ' ' A' ' 121' ' ' THR . . . -118.69 157.24 15.33 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 122' ' ' THR . 6.3 tt -150.42 141.96 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.255 -1.144 . . . . 0.0 110.618 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.2 t -158.25 155.52 29.07 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.004 0.907 . . . . 0.0 110.463 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.429 ' HB2' ' HA ' ' A' ' 145' ' ' LYS . 78.8 p -127.47 7.83 6.41 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.38 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -67.39 119.84 12.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.073 -1.017 . . . . 0.0 110.383 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.431 ' HA ' ' HB2' ' A' ' 176' ' ' PHE . 10.5 p -49.02 -28.17 3.76 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.211 -0.93 . . . . 0.0 110.535 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -54.8 -41.09 70.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.115 -0.991 . . . . 0.0 109.734 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.543 HG22 ' N ' ' A' ' 126' ' ' GLY . 45.1 t -78.77 -23.68 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.381 -0.824 . . . . 0.0 109.691 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.431 ' HB2' ' HA ' ' A' ' 173' ' ' SER . 9.0 m-85 -72.43 -51.81 18.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.394 -0.816 . . . . 0.0 109.531 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 33.9 t -70.58 -17.06 62.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.482 -0.761 . . . . 0.0 110.366 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 23.9 tttm -73.52 -52.43 13.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.137 -0.977 . . . . 0.0 109.96 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -90.53 22.55 3.4 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.221 -0.924 . . . . 0.0 110.53 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 54.56 56.96 6.19 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.129 -0.982 . . . . 0.0 110.176 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 86.1 mt -113.13 96.63 6.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 110.181 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -63.18 -19.15 64.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.291 -0.881 . . . . 0.0 110.427 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.51 -159.74 1.05 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.194 -0.941 . . . . 0.0 110.152 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 32.1 m-20 -53.52 152.31 5.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.182 -0.949 . . . . 0.0 109.896 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -153.4 136.74 5.44 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.59 -1.29 . . . . 0.0 110.008 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.568 HG13 ' HE1' ' A' ' 155' ' ' PHE . 59.0 t -121.53 84.43 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.367 -1.079 . . . . 0.0 109.479 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.924 HG22 ' HA ' ' A' ' 198' ' ' ASN . 98.2 t -111.55 150.11 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.111 -0.993 . . . . 0.0 110.352 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.597 HD12 HD12 ' A' ' 212' ' ' ILE . 6.0 tt -106.55 150.88 25.7 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.182 -0.949 . . . . 0.0 108.833 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -120.64 116.58 25.6 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.863 -1.148 . . . . 0.0 110.438 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.527 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -124.6 170.62 10.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.0 110.153 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.26 -24.12 19.1 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.316 -0.865 . . . . 0.0 110.339 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.527 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.4 OUTLIER -91.25 -171.71 3.05 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.881 179.666 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 47.23 -154.67 0.06 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.699 0.761 . . . . 0.0 110.502 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.45 -44.45 91.1 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.619 -0.675 . . . . 0.0 110.191 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 131.19 -39.88 1.72 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.409 ' HG2' HG11 ' A' ' 187' ' ' VAL . 2.6 mtm180 -116.65 175.55 5.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.16 -1.2 . . . . 0.0 110.248 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ASN . . . . . 0.465 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 2.7 m-80 -134.93 -44.99 0.72 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.271 -0.893 . . . . 0.0 110.952 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.924 ' HA ' HG22 ' A' ' 187' ' ' VAL . 0.9 OUTLIER 65.46 89.04 0.1 Allowed 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.27 -0.894 . . . . 0.0 110.196 -179.251 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' A' ' 186' ' ' VAL . 45.5 t80 -56.62 123.79 16.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.464 -0.772 . . . . 0.0 110.501 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -120.65 101.37 7.69 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.212 -0.93 . . . . 0.0 110.269 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 152.99 -159.32 28.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -81.51 118.66 22.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -1.1 . . . . 0.0 110.357 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 78.2 t -68.07 103.5 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.93 . . . . 0.0 110.056 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.412 ' HA ' ' OE1' ' A' ' 154' ' ' GLN . 14.0 p -138.68 149.03 44.69 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.444 -0.785 . . . . 0.0 109.858 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.508 ' HA ' ' HB2' ' A' ' 158' ' ' ALA . 31.4 tttt -51.05 -39.19 55.37 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.223 -0.923 . . . . 0.0 110.321 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' GLU . . . . . 0.412 ' CG ' ' N ' ' A' ' 207' ' ' ASN . 11.5 pt-20 -66.11 -40.32 90.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.295 -0.878 . . . . 0.0 110.001 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.412 ' N ' ' CG ' ' A' ' 206' ' ' GLU . 79.3 m-20 -78.33 -30.83 48.38 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.384 -0.822 . . . . 0.0 109.923 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.427 HD13 ' HA ' ' A' ' 155' ' ' PHE . 64.0 mt -65.5 -55.84 15.62 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.459 -0.776 . . . . 0.0 110.272 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.494 HD12 ' O ' ' A' ' 205' ' ' LYS . 5.9 mt -56.03 -25.65 45.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 110.289 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -80.49 -48.58 12.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.324 -0.86 . . . . 0.0 110.029 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.421 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 10.8 t80 -51.55 -57.67 8.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.341 -0.849 . . . . 0.0 110.468 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.597 HD12 HD12 ' A' ' 188' ' ' LEU . 6.9 mm -53.32 -52.37 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.329 -0.857 . . . . 0.0 110.133 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.439 ' HA ' ' HG2' ' A' ' 216' ' ' GLN . 3.7 tmtt? -52.99 -31.51 41.29 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.624 -0.673 . . . . 0.0 110.586 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -77.44 -15.6 59.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.884 . . . . 0.0 110.702 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.483 ' HB3' HD22 ' A' ' 188' ' ' LEU . 74.3 m-20 -105.8 -40.31 5.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.119 -0.988 . . . . 0.0 110.55 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.439 ' HG2' ' HA ' ' A' ' 213' ' ' LYS . 19.2 pt20 -63.38 -25.88 68.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.095 -1.003 . . . . 0.0 110.133 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.6 mt -130.5 76.13 77.98 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.995 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.753 ' O ' HG23 ' A' ' 220' ' ' VAL . 45.8 Cg_endo -72.38 130.53 16.33 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.672 1.354 . . . . 0.0 110.376 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.74 104.07 0.26 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.364 -0.835 . . . . 0.0 109.989 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 218' ' ' PRO . 50.0 t -119.09 120.79 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 0.0 110.358 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 2.0 pt -110.21 -178.22 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.22 -0.925 . . . . 0.0 110.23 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -170.28 165.3 8.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.195 -0.94 . . . . 0.0 110.294 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 1.5 t80 56.53 168.23 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.235 -0.915 . . . . 0.0 110.259 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 68.5 p -109.71 72.36 0.8 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.222 -0.924 . . . . 0.0 110.129 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -152.18 64.03 0.83 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.281 -0.887 . . . . 0.0 110.186 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -60.64 174.86 0.53 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.266 -0.896 . . . . 0.0 110.294 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 6.0 t -143.4 47.06 1.5 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.906 . . . . 0.0 110.226 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.228 -179.949 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.221 0.534 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -113.44 -176.64 2.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.147 -0.97 . . . . 0.0 110.296 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.429 ' HB ' ' HA2' ' A' ' 168' ' ' GLY . 23.8 m -104.91 116.82 32.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.291 -0.88 . . . . 0.0 109.833 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.6 m -78.86 118.49 20.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.302 -0.874 . . . . 0.0 110.221 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.556 HD23 ' HB1' ' A' ' 128' ' ' ALA . 0.9 OUTLIER -101.84 128.8 27.93 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.171 -0.956 . . . . 0.0 110.027 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.494 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 47.7 Cg_endo -73.22 -27.87 13.18 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.447 1.235 . . . . 0.0 110.107 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.535 ' C ' HG22 ' A' ' 175' ' ' VAL . 0.2 OUTLIER -164.93 -170.49 1.97 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.063 0.935 . . . . 0.0 111.077 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.495 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -64.53 -25.93 70.49 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.441 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -58.72 -30.56 67.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.298 -1.119 . . . . 0.0 110.183 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.556 ' HB1' HD23 ' A' ' 123' ' ' LEU . . . -84.45 -20.92 30.98 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.004 -1.06 . . . . 0.0 109.625 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.529 ' HA ' HD13 ' A' ' 141' ' ' ILE . . . -81.36 -23.98 37.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.426 -0.796 . . . . 0.0 110.266 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 127' ' ' ALA . 13.9 pt-20 -84.78 -36.47 21.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.94 . . . . 0.0 110.171 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.57 -32.45 53.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.334 -0.854 . . . . 0.0 110.552 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.451 ' HB3' HD11 ' A' ' 141' ' ' ILE . 6.3 tp -59.05 -52.97 63.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.058 -1.026 . . . . 0.0 110.045 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.745 HG22 ' CB ' ' A' ' 189' ' ' PHE . 87.9 t -55.49 -37.04 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 110.085 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -83.93 -22.04 31.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.391 -0.818 . . . . 0.0 110.192 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.29 -54.34 25.99 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.376 -0.828 . . . . 0.0 110.199 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.9 p -115.77 157.9 23.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -0.91 . . . . 0.0 110.259 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -59.47 -45.75 90.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.169 -0.957 . . . . 0.0 110.196 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.5 t -119.71 123.77 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 110.262 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -152.2 120.24 6.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 109.599 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.49 HG23 ' HA ' ' A' ' 188' ' ' LEU . 11.6 p -98.51 143.05 13.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.093 -1.005 . . . . 0.0 110.664 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.529 HD13 ' HA ' ' A' ' 129' ' ' ALA . 77.2 mt -133.84 115.13 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.463 -0.773 . . . . 0.0 109.446 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -82.97 163.45 41.72 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.132 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.755 ' CE2' HG12 ' A' ' 175' ' ' VAL . 30.3 m-85 -127.7 63.18 1.38 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.723 -0.869 . . . . 0.0 109.421 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.616 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 12.4 m-85 -81.34 133.3 35.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 111.311 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.403 ' HD2' ' HB2' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -78.96 -26.69 43.47 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.729 0.776 . . . . 0.0 109.582 179.451 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.403 ' HB2' ' HD2' ' A' ' 145' ' ' LYS . 0.3 OUTLIER -127.45 98.79 5.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.73 -0.606 . . . . 0.0 109.624 179.413 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.4 t -63.67 -12.82 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.0 110.903 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -103.01 14.83 31.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.968 -1.083 . . . . 0.0 110.776 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 21.9 p -83.29 -164.89 0.96 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.054 -1.029 . . . . 0.0 110.165 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -90.33 -18.2 25.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 110.317 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.522 ' CB ' ' CE1' ' A' ' 144' ' ' PHE . 6.1 m -83.36 -26.13 30.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 110.326 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.63 -32.75 36.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -0.915 . . . . 0.0 110.089 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.83 -49.85 75.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 109.993 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -57.69 -41.66 82.09 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.37 -0.831 . . . . 0.0 110.278 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -50.68 -55.68 15.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.181 -0.949 . . . . 0.0 110.523 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 16.4 mt -51.01 -55.85 15.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.167 -0.958 . . . . 0.0 110.427 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -53.09 -49.24 66.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.26 -0.9 . . . . 0.0 110.007 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.87 -48.11 80.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 109.977 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.602 ' HB1' ' CD2' ' A' ' 167' ' ' PHE . . . -63.66 -27.09 68.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 110.011 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -75.15 -27.37 59.69 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.367 -0.833 . . . . 0.0 110.297 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.87 -47.84 73.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.902 . . . . 0.0 110.254 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.445 HG23 ' OD1' ' A' ' 164' ' ' ASP . 68.4 mt -98.38 150.25 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -0.899 . . . . 0.0 110.133 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -125.0 -12.57 6.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.253 -0.904 . . . . 0.0 111.105 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.445 ' OD1' HG23 ' A' ' 162' ' ' ILE . 7.9 p-10 -86.99 5.81 35.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.861 -1.149 . . . . 0.0 110.843 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.536 ' CG2' ' CE1' ' A' ' 167' ' ' PHE . 32.6 mm -128.31 126.04 23.47 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.857 -1.152 . . . . 0.0 110.186 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -81.32 110.65 2.27 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.428 1.225 . . . . 0.0 110.585 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.602 ' CD2' ' HB1' ' A' ' 159' ' ' ALA . 1.1 m-85 -102.63 126.49 49.73 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.218 -0.926 . . . . 0.0 109.49 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.429 ' HA2' ' HB ' ' A' ' 121' ' ' THR . . . -106.85 155.52 16.4 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.419 ' O ' HG23 ' A' ' 169' ' ' ILE . 9.5 tt -149.49 133.04 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.374 -1.074 . . . . 0.0 110.378 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.568 HG21 HG11 ' A' ' 175' ' ' VAL . 2.6 t -152.82 157.24 40.47 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 122.003 0.906 . . . . 0.0 110.889 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.6 t -125.51 2.68 7.64 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -64.42 129.21 39.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 0.0 110.3 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.4 m -53.42 -28.06 27.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.301 -0.875 . . . . 0.0 110.225 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -54.89 -39.96 69.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.887 . . . . 0.0 110.024 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.755 HG12 ' CE2' ' A' ' 143' ' ' PHE . 34.0 t -77.15 -24.92 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.81 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -77.54 -49.69 14.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.201 -0.937 . . . . 0.0 109.942 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.88 -34.21 40.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.278 -0.889 . . . . 0.0 110.023 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.408 ' CE ' ' HA3' ' A' ' 126' ' ' GLY . 0.2 OUTLIER -55.34 -55.68 28.71 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.359 -0.838 . . . . 0.0 110.202 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -92.88 6.84 46.28 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.15 -0.969 . . . . 0.0 110.629 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 49.59 65.24 1.46 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.02 -1.05 . . . . 0.0 110.495 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 92.6 mt -101.84 124.33 47.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.263 -0.898 . . . . 0.0 110.282 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.68 0.13 31.64 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.2 -0.937 . . . . 0.0 110.665 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -171.09 -174.67 1.54 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.094 -1.004 . . . . 0.0 109.827 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 21.4 p30 -54.61 156.95 3.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.17 -0.956 . . . . 0.0 110.247 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -172.94 118.78 0.73 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 96.4 t -95.18 128.99 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -1.154 . . . . 0.0 110.152 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.629 HG22 ' HA ' ' A' ' 198' ' ' ASN . 98.7 t -138.06 149.28 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 110.148 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.49 ' HA ' HG23 ' A' ' 140' ' ' VAL . 9.3 tt -109.75 139.25 45.03 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.105 -0.997 . . . . 0.0 108.437 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.745 ' CB ' HG22 ' A' ' 133' ' ' VAL . 50.7 m-85 -112.66 126.18 55.1 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.768 -1.207 . . . . 0.0 110.866 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.9 166.1 23.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.338 -0.851 . . . . 0.0 110.211 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -89.29 -31.4 17.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.913 . . . . 0.0 110.422 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -90.56 -173.32 3.72 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.443 -0.786 . . . . 0.0 110.729 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 51.93 -159.43 0.11 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.431 -0.793 . . . . 0.0 110.456 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.06 -48.9 78.17 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.633 -0.667 . . . . 0.0 110.238 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 136.58 -58.94 0.65 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 17.6 mtm-85 -108.7 175.21 5.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.183 -1.187 . . . . 0.0 110.329 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ASN . . . . . 0.503 ' HB2' ' CZ ' ' A' ' 211' ' ' PHE . 5.9 m120 -132.49 -34.7 1.18 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.263 -0.898 . . . . 0.0 110.996 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.629 ' HA ' HG22 ' A' ' 187' ' ' VAL . 0.7 OUTLIER 61.89 87.81 0.09 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.162 -0.961 . . . . 0.0 110.021 -179.266 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.431 ' HA ' ' CE1' ' A' ' 211' ' ' PHE . 28.6 t80 -57.83 124.11 18.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.379 -0.826 . . . . 0.0 110.265 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -118.15 103.37 9.8 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.318 -0.864 . . . . 0.0 110.337 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 147.52 -148.72 20.54 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -97.66 123.74 41.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -1.147 . . . . 0.0 110.129 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.616 HG11 ' HZ ' ' A' ' 144' ' ' PHE . 79.2 t -70.6 113.65 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.182 -0.949 . . . . 0.0 110.261 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.3 p -145.88 152.43 39.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.43 -0.794 . . . . 0.0 109.932 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 20.2 tttm -48.42 -43.5 34.3 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.118 -0.989 . . . . 0.0 110.509 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -64.95 -41.86 95.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.326 -0.859 . . . . 0.0 109.805 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -71.2 -45.55 63.14 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.344 -0.848 . . . . 0.0 109.953 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' A' ' 208' ' ' LEU . 62.0 mt -53.92 -51.16 64.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.936 . . . . 0.0 109.778 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 69.6 mt -56.58 -31.27 64.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.314 -0.866 . . . . 0.0 109.349 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -76.88 -37.34 55.67 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.428 -0.795 . . . . 0.0 109.524 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.503 ' CZ ' ' HB2' ' A' ' 197' ' ' ASN . 5.9 t80 -54.22 -63.38 1.17 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.397 -0.815 . . . . 0.0 109.893 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 94.8 mt -48.91 -57.64 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.231 -0.918 . . . . 0.0 110.292 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.07 -34.5 56.81 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.331 -0.855 . . . . 0.0 110.243 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -89.64 -7.56 54.43 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.35 -0.844 . . . . 0.0 110.695 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 0.9 OUTLIER -88.48 -79.68 0.3 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.083 -1.011 . . . . 0.0 110.429 -179.325 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -64.97 -174.79 0.16 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.207 -0.933 . . . . 0.0 110.188 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 45.8 mt 52.81 89.76 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 0.0 110.2 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.417 ' HG2' HG23 ' A' ' 220' ' ' VAL . 46.4 Cg_endo -72.56 -173.07 1.05 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.685 1.36 . . . . 0.0 110.567 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 12.8 mt -92.6 72.96 5.08 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.279 -0.888 . . . . 0.0 110.476 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.417 HG23 ' HG2' ' A' ' 218' ' ' PRO . 54.8 t -96.73 74.86 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.858 . . . . 0.0 110.097 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 4.9 mt -88.04 87.7 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 110.279 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -128.43 -150.28 0.44 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 110.144 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.435 ' O ' ' N ' ' A' ' 225' ' ' GLU . 0.1 OUTLIER -73.78 -45.33 52.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.306 -0.871 . . . . 0.0 110.088 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 55.3 m 55.7 -86.17 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.628 -0.67 . . . . 0.0 110.729 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 223' ' ' PHE . 1.2 mt-10 55.7 79.67 0.16 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.943 -1.098 . . . . 0.0 110.068 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 52.92 -178.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.295 -0.878 . . . . 0.0 110.149 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 14.9 m -154.25 -43.51 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 110.061 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.182 179.819 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.291 0.567 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 167' ' ' PHE . . . -85.03 167.56 15.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 110.239 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.538 HG22 ' HA2' ' A' ' 168' ' ' GLY . 8.9 t -101.15 166.15 10.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.161 -0.962 . . . . 0.0 110.442 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.3 m -107.06 105.49 15.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.322 -0.861 . . . . 0.0 110.074 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.423 HD22 ' HB1' ' A' ' 128' ' ' ALA . 32.1 mt -77.67 134.41 65.42 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.213 -0.93 . . . . 0.0 110.096 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.459 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 47.5 Cg_endo -72.85 -32.31 9.22 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 123.52 1.274 . . . . 0.0 110.331 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -168.25 -170.77 1.35 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.255 -0.903 . . . . 0.0 110.805 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.41 ' HA3' ' HD2' ' A' ' 178' ' ' LYS . . . -61.32 -27.95 68.49 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -55.57 -29.24 58.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -1.123 . . . . 0.0 110.382 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.459 ' HB2' ' HD2' ' A' ' 124' ' ' PRO . . . -86.08 -30.86 22.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.146 -0.971 . . . . 0.0 110.178 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.04 -24.36 66.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.041 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -88.59 -38.11 15.13 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.258 -0.901 . . . . 0.0 110.168 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.0 m -72.67 -24.57 61.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.175 -0.953 . . . . 0.0 109.979 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.421 HD13 HD21 ' A' ' 123' ' ' LEU . 2.4 tp -70.44 -47.02 62.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.412 -0.805 . . . . 0.0 110.096 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 69.1 t -62.5 -45.0 99.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.374 -0.829 . . . . 0.0 110.294 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -72.84 -19.69 61.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.938 . . . . 0.0 110.237 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.5 m -72.66 -20.81 61.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.148 -0.97 . . . . 0.0 110.36 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.401 ' OG ' ' HG3' ' A' ' 166' ' ' PRO . 80.0 p -149.42 154.92 39.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.254 -0.904 . . . . 0.0 110.361 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.432 ' HA ' ' HD2' ' A' ' 191' ' ' LYS . 1.6 tt0 -57.44 -35.8 70.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.335 -0.853 . . . . 0.0 110.171 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.7 t -132.03 145.64 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.294 -0.879 . . . . 0.0 110.437 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.457 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -165.56 136.96 3.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.355 -0.841 . . . . 0.0 109.808 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.8 p -116.03 139.84 40.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 O-C-N 121.087 -1.008 . . . . 0.0 110.223 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 27.2 mt -128.4 110.26 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.315 -0.866 . . . . 0.0 109.87 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.55 127.64 8.22 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.491 ' CE2' HG12 ' A' ' 175' ' ' VAL . 50.3 m-85 -95.45 79.5 3.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.285 -1.127 . . . . 0.0 109.849 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.582 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 17.0 m-85 -100.73 141.53 33.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.088 -1.008 . . . . 0.0 111.097 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 21.4 pttt -91.11 -36.41 14.01 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.602 0.715 . . . . 0.0 109.261 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.485 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 0.4 OUTLIER -122.34 70.77 0.99 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.024 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.484 ' HA ' ' HB2' ' A' ' 152' ' ' ALA . 5.0 p -52.22 -20.94 2.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.71 -0.619 . . . . 0.0 111.16 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -76.63 1.33 17.23 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.966 -1.084 . . . . 0.0 110.86 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 51.5 p -86.27 -156.92 0.32 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.879 -1.138 . . . . 0.0 110.381 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -90.45 -46.63 8.23 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.317 -0.864 . . . . 0.0 110.794 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.4 t -46.08 -33.27 3.36 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.38 -0.825 . . . . 0.0 111.065 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 147' ' ' VAL . . . -80.79 -38.1 29.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.136 -0.977 . . . . 0.0 109.837 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.3 -51.3 59.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.0 109.911 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -52.9 -41.44 64.39 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.291 -0.88 . . . . 0.0 110.005 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -53.95 -57.19 11.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.402 -0.811 . . . . 0.0 109.918 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 15.2 mt -53.73 -53.95 44.92 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.502 -0.749 . . . . 0.0 110.365 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -54.52 -33.1 59.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.356 -0.84 . . . . 0.0 110.16 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.436 ' HB2' ' HA ' ' A' ' 205' ' ' LYS . . . -78.14 -35.62 48.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 110.148 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.511 ' HB2' ' CD2' ' A' ' 167' ' ' PHE . . . -72.95 -31.04 64.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.203 -0.936 . . . . 0.0 110.156 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -66.02 -20.97 66.36 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.192 -0.943 . . . . 0.0 110.285 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.479 ' HB3' HD21 ' A' ' 209' ' ' LEU . . . -79.63 -35.98 38.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.216 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.41 HG13 ' OD1' ' A' ' 164' ' ' ASP . 14.8 tt -97.51 154.96 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 110.119 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -142.28 21.92 2.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.184 -0.947 . . . . 0.0 110.493 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.554 ' O ' HD13 ' A' ' 165' ' ' ILE . 6.6 p-10 -120.92 12.91 11.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.182 -0.949 . . . . 0.0 110.629 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.595 HD11 ' OE1' ' A' ' 216' ' ' GLN . 49.7 mm -136.2 134.24 20.01 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.012 . . . . 0.0 110.267 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.457 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 48.8 Cg_endo -74.22 98.62 1.11 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.445 1.234 . . . . 0.0 110.371 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.511 ' CD2' ' HB2' ' A' ' 159' ' ' ALA . 3.3 m-85 -85.94 127.58 34.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 110.316 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.538 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -128.79 154.2 20.05 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.442 HD11 HG23 ' A' ' 147' ' ' VAL . 11.6 tt -150.26 149.93 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.154 -1.204 . . . . 0.0 110.595 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.475 HG21 HG21 ' A' ' 175' ' ' VAL . 2.1 t -161.06 156.99 25.41 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.069 0.938 . . . . 0.0 110.527 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.4 p -124.12 3.98 8.59 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -63.32 131.69 49.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 110.418 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 92.7 p -53.76 -31.46 48.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.211 -0.93 . . . . 0.0 110.189 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -53.48 -32.05 48.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.968 . . . . 0.0 109.848 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.491 HG12 ' CE2' ' A' ' 143' ' ' PHE . 60.0 t -82.61 -25.38 8.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.385 -0.822 . . . . 0.0 109.51 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -76.87 -52.52 9.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.421 -0.799 . . . . 0.0 109.717 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.23 -15.87 58.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.383 -0.823 . . . . 0.0 110.559 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.423 ' HG2' ' CD1' ' A' ' 179' ' ' TYR . 16.4 tttp -79.21 -52.51 8.06 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.04 -1.038 . . . . 0.0 110.09 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.446 ' HB2' ' CD1' ' A' ' 181' ' ' LEU . 81.4 m-85 -92.2 4.51 53.08 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.201 -0.937 . . . . 0.0 110.578 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.26 64.42 1.79 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.055 -1.028 . . . . 0.0 111.025 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.446 ' CD1' ' HB2' ' A' ' 179' ' ' TYR . 4.5 mt -115.6 115.19 26.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.152 -0.967 . . . . 0.0 109.81 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.429 ' O ' ' CG ' ' A' ' 183' ' ' LYS . 0.7 OUTLIER -83.48 7.77 15.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.135 -0.978 . . . . 0.0 110.501 179.716 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 182' ' ' ASP . 25.2 mttt -162.73 -163.91 0.94 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.065 -1.022 . . . . 0.0 109.658 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.409 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 44.1 m-20 -73.96 147.46 43.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.147 -0.971 . . . . 0.0 109.684 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -157.71 134.64 4.0 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.405 ' HB ' ' HB3' ' A' ' 199' ' ' PHE . 70.9 t -113.68 102.03 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.379 -1.071 . . . . 0.0 109.914 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.758 HG22 ' HA ' ' A' ' 198' ' ' ASN . 98.8 t -110.69 146.28 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.382 -0.823 . . . . 0.0 110.179 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.556 HD12 HD12 ' A' ' 212' ' ' ILE . 9.0 tt -109.91 127.9 55.02 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.158 -0.963 . . . . 0.0 108.53 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 189' ' ' PHE . 30.1 m-85 -100.43 120.43 39.97 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.832 -1.168 . . . . 0.0 111.179 -178.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.512 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -131.91 158.78 40.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.474 -0.766 . . . . 0.0 110.122 179.483 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.432 ' HD2' ' HA ' ' A' ' 137' ' ' GLU . 10.2 mttt -82.81 -24.9 33.15 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.217 -0.927 . . . . 0.0 110.259 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.512 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 1.3 p90 -91.69 -171.82 3.02 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.328 -0.858 . . . . 0.0 110.555 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 50.94 -159.1 0.09 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.616 0.722 . . . . 0.0 110.432 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -65.61 -45.52 82.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.655 -0.653 . . . . 0.0 110.222 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 142.09 -62.94 0.52 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -110.48 171.64 7.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.293 -1.122 . . . . 0.0 110.331 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ASN . . . . . 0.484 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 2.7 m-80 -127.71 -34.61 2.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.266 -0.896 . . . . 0.0 110.75 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.758 ' HA ' HG22 ' A' ' 187' ' ' VAL . 0.4 OUTLIER 58.11 83.93 0.11 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.203 -0.936 . . . . 0.0 110.091 -179.494 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.43 ' C ' ' CD1' ' A' ' 199' ' ' PHE . 12.1 t80 -56.78 121.31 9.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.343 -0.848 . . . . 0.0 110.21 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -118.14 100.24 7.4 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.231 -0.918 . . . . 0.0 110.345 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 160.27 -155.95 27.15 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.16 111.6 21.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.294 -1.121 . . . . 0.0 110.074 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.582 HG11 ' HZ ' ' A' ' 144' ' ' PHE . 75.7 t -63.82 109.05 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.938 . . . . 0.0 110.336 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 41.2 p -146.87 152.3 38.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.435 -0.79 . . . . 0.0 110.008 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.516 ' HG2' HD12 ' A' ' 209' ' ' LEU . 1.4 ttpt -46.85 -54.97 8.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.398 -0.814 . . . . 0.0 111.043 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 207' ' ' ASN . 17.0 pt-20 -55.1 -40.79 70.84 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.453 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.445 ' N ' ' HG3' ' A' ' 206' ' ' GLU . 72.8 m-20 -73.82 -49.26 26.04 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.226 -0.921 . . . . 0.0 110.12 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 208' ' ' LEU . 90.5 mt -56.33 -55.0 38.89 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.302 -0.874 . . . . 0.0 110.285 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.516 HD12 ' HG2' ' A' ' 205' ' ' LYS . 15.5 mt -53.29 -24.66 12.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 0.0 110.077 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.99 -43.82 13.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.87 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.422 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 11.9 t80 -56.96 -56.7 18.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.333 -0.854 . . . . 0.0 110.418 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.556 HD12 HD12 ' A' ' 188' ' ' LEU . 8.0 mm -51.6 -39.29 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.24 -0.912 . . . . 0.0 110.091 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -61.86 -41.41 97.8 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.628 -0.67 . . . . 0.0 110.283 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -78.64 -6.64 56.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 110.699 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.435 ' CB ' HD13 ' A' ' 188' ' ' LEU . 2.2 m-80 -89.27 -79.62 0.32 Allowed 'General case' 0 N--CA 1.484 1.265 0 O-C-N 120.914 -1.116 . . . . 0.0 110.583 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.595 ' OE1' HD11 ' A' ' 165' ' ' ILE . 28.6 pt20 -59.02 -171.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 110.36 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 12.5 mt 53.5 64.81 6.35 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.304 -0.873 . . . . 0.0 110.302 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.51 117.79 5.29 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.723 1.38 . . . . 0.0 110.351 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 2.7 mt -129.31 135.19 48.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.309 -0.869 . . . . 0.0 110.296 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 54.4 t -94.78 91.84 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 110.146 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 70.1 mt -103.77 98.15 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.869 . . . . 0.0 110.307 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -142.16 169.95 16.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.184 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -120.35 158.81 26.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.358 -0.839 . . . . 0.0 110.147 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 226' ' ' GLN . 60.8 m -106.35 105.41 15.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.203 -0.936 . . . . 0.0 110.263 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 56.98 -86.14 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.437 -0.79 . . . . 0.0 110.454 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 224' ' ' THR . 1.1 mt-30 -148.8 144.43 26.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.949 -1.095 . . . . 0.0 110.306 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 19.1 m 52.68 78.59 0.13 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 110.322 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.154 179.9 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.252 0.548 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.1 166.56 9.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.876 . . . . 0.0 110.17 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.581 HG22 ' HA2' ' A' ' 168' ' ' GLY . 10.0 t -94.21 164.78 12.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.241 -0.912 . . . . 0.0 110.166 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.2 m -104.63 106.43 16.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.237 -0.915 . . . . 0.0 110.108 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.758 HD21 HD12 ' A' ' 132' ' ' LEU . 26.4 mt -73.16 124.28 90.44 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.197 -0.939 . . . . 0.0 110.104 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -70.75 -22.61 27.32 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 123.393 1.207 . . . . 0.0 110.343 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.71 -171.13 0.17 Allowed 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 122.239 1.019 . . . . 0.0 111.479 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.23 -31.88 74.84 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -52.3 -31.85 34.84 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.336 -1.096 . . . . 0.0 110.299 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.39 -38.02 22.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.901 . . . . 0.0 110.227 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -52.14 -32.69 36.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.228 -0.92 . . . . 0.0 110.094 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -90.24 -46.66 8.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.357 -0.84 . . . . 0.0 110.016 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 10.1 t -64.19 -27.05 68.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.279 -0.888 . . . . 0.0 110.151 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.758 HD12 HD21 ' A' ' 123' ' ' LEU . 6.6 tt -70.53 -60.32 2.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.281 -0.887 . . . . 0.0 109.507 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.507 HG22 ' CB ' ' A' ' 189' ' ' PHE . 87.8 t -49.34 -27.67 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.553 -0.717 . . . . 0.0 110.355 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.15 7.19 25.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.279 -0.888 . . . . 0.0 110.726 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.2 t -90.29 -27.86 19.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.968 -1.083 . . . . 0.0 110.23 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.7 p -147.75 167.09 25.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 110.174 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -67.48 -12.17 59.65 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.216 -0.927 . . . . 0.0 110.136 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.9 t -137.84 150.69 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.066 -1.021 . . . . 0.0 110.063 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.47 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -174.42 142.05 0.74 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.959 . . . . 0.0 110.246 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.424 HG11 ' CZ ' ' A' ' 167' ' ' PHE . 7.2 p -129.7 148.18 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 121.108 -0.995 . . . . 0.0 110.188 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 2.9 mp -137.27 113.54 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -0.872 . . . . 0.0 110.181 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -80.91 131.69 10.63 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.817 ' CE2' HG12 ' A' ' 175' ' ' VAL . 35.1 m-85 -101.95 76.29 1.6 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -1.162 . . . . 0.0 110.091 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.636 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 18.6 m-85 -94.28 144.38 25.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.128 -0.983 . . . . 0.0 110.75 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.04 -26.94 20.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.611 -0.681 . . . . 0.0 109.412 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -134.1 76.3 1.64 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.672 -0.642 . . . . 0.0 109.306 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.556 ' O ' ' HB3' ' A' ' 152' ' ' ALA . 34.7 m -49.05 -23.64 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.377 -0.827 . . . . 0.0 111.042 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -80.02 4.88 15.66 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.048 -1.032 . . . . 0.0 111.175 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.2 p -78.93 -165.25 0.71 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.874 -1.142 . . . . 0.0 110.534 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.02 -23.49 20.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.558 -0.713 . . . . 0.0 110.238 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.5 m -80.27 -19.81 45.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.294 -0.879 . . . . 0.0 110.554 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 147' ' ' VAL . . . -84.34 -32.56 24.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.134 -0.979 . . . . 0.0 110.3 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.2 mtpt -58.89 -38.07 78.03 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 110.183 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.42 -47.48 81.78 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.207 -0.933 . . . . 0.0 110.065 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.435 ' O ' ' HB3' ' A' ' 158' ' ' ALA . 4.5 t80 -52.72 -54.69 30.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.315 -0.865 . . . . 0.0 110.103 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' A' ' 156' ' ' LEU . 22.1 mt -49.13 -55.04 13.55 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.308 -0.87 . . . . 0.0 110.378 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -54.22 -37.62 64.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.316 -0.865 . . . . 0.0 109.674 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 155' ' ' PHE . . . -65.85 -52.77 47.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.356 -0.84 . . . . 0.0 109.536 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.521 ' HB2' ' CD2' ' A' ' 167' ' ' PHE . . . -55.44 -35.21 65.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.288 -0.882 . . . . 0.0 109.602 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.58 -30.3 71.01 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.283 -0.886 . . . . 0.0 109.858 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.16 -48.97 79.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.356 -0.84 . . . . 0.0 109.801 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.434 HG22 ' H ' ' A' ' 164' ' ' ASP . 63.2 mt -95.42 149.52 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.338 -0.851 . . . . 0.0 109.882 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -126.69 8.98 6.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.178 -0.951 . . . . 0.0 110.819 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.434 ' H ' HG22 ' A' ' 162' ' ' ILE . 4.1 p30 -110.6 -17.25 13.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.967 -1.083 . . . . 0.0 110.339 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 51.0 mm -91.43 133.44 31.35 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.935 . . . . 0.0 110.185 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.507 ' HB2' HD21 ' A' ' 132' ' ' LEU . 50.6 Cg_endo -73.63 69.63 4.33 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.576 1.303 . . . . 0.0 110.253 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.521 ' CD2' ' HB2' ' A' ' 159' ' ' ALA . 3.3 m-85 -63.7 123.03 17.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.886 . . . . 0.0 109.932 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.581 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -125.19 151.07 17.38 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -141.83 148.18 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -1.146 . . . . 0.0 110.297 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.496 HG21 HG11 ' A' ' 175' ' ' VAL . 2.6 t -164.85 157.81 16.7 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.073 0.939 . . . . 0.0 110.913 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.7 t -123.39 2.31 9.06 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.394 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -60.92 120.79 10.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.121 -0.987 . . . . 0.0 110.171 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 3.0 p -51.29 -29.4 14.72 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -0.902 . . . . 0.0 110.35 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.22 -43.47 78.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 109.877 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.817 HG12 ' CE2' ' A' ' 143' ' ' PHE . 46.2 t -72.35 -26.31 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.239 -0.913 . . . . 0.0 109.832 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -75.46 -55.49 5.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.37 -0.831 . . . . 0.0 110.036 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -21.37 60.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.465 -0.772 . . . . 0.0 110.435 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.36 -56.06 26.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -0.972 . . . . 0.0 110.341 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -89.76 13.64 13.84 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.171 -0.956 . . . . 0.0 110.598 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 51.95 63.83 2.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 110.625 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 14.7 mt -96.06 124.27 40.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.412 -0.805 . . . . 0.0 109.911 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -61.29 -16.1 42.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.144 -0.973 . . . . 0.0 110.219 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -175.29 -142.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.569 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -86.71 159.81 19.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.995 -1.065 . . . . 0.0 110.365 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 176.76 179.74 47.33 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 186' ' ' VAL . 21.5 m -133.74 120.28 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -1.148 . . . . 0.0 110.297 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 188' ' ' LEU . 86.2 t -123.09 162.89 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.412 -0.805 . . . . 0.0 109.863 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.554 HD22 ' HB3' ' A' ' 215' ' ' ASN . 1.7 tt -113.36 148.79 35.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.078 -1.013 . . . . 0.0 109.761 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.507 ' CB ' HG22 ' A' ' 133' ' ' VAL . 40.0 m-85 -123.44 117.4 25.07 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.064 -1.022 . . . . 0.0 110.411 -179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.511 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -134.52 165.86 24.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.311 -0.868 . . . . 0.0 110.16 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -88.67 -22.71 23.28 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.0 110.373 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.511 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 1.4 p90 -90.87 -172.32 3.32 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.243 -0.911 . . . . 0.0 110.928 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 47.22 -159.46 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.663 0.744 . . . . 0.0 110.728 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -55.0 -53.62 53.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.641 -0.662 . . . . 0.0 110.321 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 139.5 -49.2 0.82 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.68 172.83 8.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.252 -1.146 . . . . 0.0 110.442 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ASN . . . . . 0.464 ' N ' ' ND2' ' A' ' 197' ' ' ASN . 0.6 OUTLIER -138.44 -152.67 0.44 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.292 -0.88 . . . . 0.0 109.598 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -175.57 76.69 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.32 -0.862 . . . . 0.0 110.309 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.41 ' CB ' HG23 ' A' ' 186' ' ' VAL . 70.5 t80 -51.39 118.57 3.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.349 -0.844 . . . . 0.0 110.409 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -113.3 95.14 5.21 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.289 -0.882 . . . . 0.0 110.301 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 162.5 -174.07 38.84 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -61.46 135.95 57.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.295 -1.121 . . . . 0.0 110.166 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.636 HG11 ' HZ ' ' A' ' 144' ' ' PHE . 74.7 t -91.15 104.43 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.885 . . . . 0.0 110.071 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 39.6 p -143.86 158.33 43.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.384 -0.822 . . . . 0.0 109.972 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.424 ' HG3' ' CA ' ' A' ' 158' ' ' ALA . 11.0 tttt -49.36 -51.54 34.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.287 -0.883 . . . . 0.0 110.916 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -59.54 -31.17 69.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 110.565 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -82.46 -38.94 23.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 110.344 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.548 ' O ' HD12 ' A' ' 212' ' ' ILE . 51.1 mt -61.38 -56.59 18.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.315 -0.866 . . . . 0.0 110.35 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 4.1 mp -52.96 -23.26 6.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.263 -0.898 . . . . 0.0 110.326 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.2 -49.89 12.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.888 . . . . 0.0 110.279 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -55.8 -59.35 4.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -0.918 . . . . 0.0 110.386 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.646 HG22 ' HG2' ' A' ' 216' ' ' GLN . 5.7 mt -50.07 -39.45 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.219 -0.926 . . . . 0.0 110.466 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -58.67 -18.42 30.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.304 -0.873 . . . . 0.0 110.305 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 17.5 t60 -99.47 -18.6 17.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.176 -0.953 . . . . 0.0 110.676 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.554 ' HB3' HD22 ' A' ' 188' ' ' LEU . 77.5 m-20 -97.66 -61.26 1.42 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.113 -0.992 . . . . 0.0 111.099 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.646 ' HG2' HG22 ' A' ' 212' ' ' ILE . 1.2 pt20 -61.11 -19.12 61.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.103 -0.998 . . . . 0.0 110.584 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.418 ' N ' ' HG3' ' A' ' 216' ' ' GLN . 12.6 mt -126.13 73.22 71.68 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.131 -0.981 . . . . 0.0 110.012 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.7 74.08 3.95 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.633 1.333 . . . . 0.0 110.82 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 41.9 mt 49.53 179.51 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.914 0.864 . . . . 0.0 111.279 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.613 HG22 ' O ' ' A' ' 220' ' ' VAL . 10.5 p -146.01 46.59 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.344 0.593 . . . . 0.0 109.647 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 39.4 mm -52.35 156.15 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.366 -0.834 . . . . 0.0 110.424 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -117.89 -171.76 2.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.346 -0.846 . . . . 0.0 110.094 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.6 t80 52.68 74.1 0.31 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.236 -0.915 . . . . 0.0 110.163 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 58.4 p -91.89 -159.49 0.65 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.332 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.93 -51.62 12.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 110.365 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -80.71 -161.02 0.35 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.203 -0.936 . . . . 0.0 110.207 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 18.5 p -119.3 93.78 4.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.326 -0.858 . . . . 0.0 110.194 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.32 179.962 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.291 0.567 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.55 159.12 6.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -0.944 . . . . 0.0 110.134 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.573 HG22 ' HA2' ' A' ' 168' ' ' GLY . 11.3 t -98.29 166.07 11.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 110.144 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.7 m -107.11 109.0 20.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.186 -0.946 . . . . 0.0 110.121 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 26.2 mt -92.12 131.31 35.28 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.225 -0.922 . . . . 0.0 109.986 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.437 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 45.9 Cg_endo -72.49 -36.3 5.33 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.401 1.211 . . . . 0.0 110.47 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.678 ' C ' HG22 ' A' ' 175' ' ' VAL . 1.7 p30 -154.96 -169.04 3.07 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.27 -0.894 . . . . 0.0 110.614 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.726 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -67.84 -30.94 74.75 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -54.26 -25.85 25.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -1.104 . . . . 0.0 110.362 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.437 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -89.51 -25.29 21.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 110.162 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.99 -26.06 65.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 109.977 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -79.14 -50.71 10.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.209 -0.932 . . . . 0.0 110.056 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.5 m -56.87 -24.32 50.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -0.895 . . . . 0.0 110.08 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.4 tp -67.64 -51.62 47.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 0.0 110.062 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.625 HG22 ' CB ' ' A' ' 189' ' ' PHE . 42.4 t -53.55 -46.95 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.871 . . . . 0.0 110.343 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.28 -18.89 63.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 0.0 110.427 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.4 t -56.16 -59.32 5.1 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.24 -0.913 . . . . 0.0 110.277 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.6 p -127.26 -171.13 2.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.257 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -74.2 -44.63 52.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.879 . . . . 0.0 110.328 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.483 ' CG2' HD12 ' A' ' 165' ' ' ILE . 30.5 m -116.1 151.91 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 0.0 110.535 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.432 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -176.03 139.52 0.38 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.344 -0.848 . . . . 0.0 109.827 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 188' ' ' LEU . 10.0 p -122.33 146.82 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.112 -0.993 . . . . 0.0 110.47 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.854 HD12 ' CD1' ' A' ' 189' ' ' PHE . 6.3 mt -128.18 112.65 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.424 -0.798 . . . . 0.0 109.928 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.07 125.35 7.16 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.436 ' CE2' ' O ' ' A' ' 141' ' ' ILE . 90.8 m-85 -103.2 66.56 0.9 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -1.134 . . . . 0.0 109.605 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.442 ' CD1' ' HB3' ' A' ' 184' ' ' ASP . 9.6 m-85 -93.92 140.1 30.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.351 -0.843 . . . . 0.0 111.03 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -26.83 43.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.462 -0.774 . . . . 0.0 109.775 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -122.32 90.69 3.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.51 -0.744 . . . . 0.0 109.913 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.15 -21.9 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 110.616 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -87.18 12.58 11.31 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.158 -0.964 . . . . 0.0 111.135 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 96.7 p -86.63 -164.26 1.03 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.094 -1.004 . . . . 0.0 110.118 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.53 -44.63 11.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.331 -0.856 . . . . 0.0 109.866 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 1.3 m -56.89 -21.31 28.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.317 -0.864 . . . . 0.0 110.085 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.29 -39.6 22.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.0 110.101 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -59.41 -39.91 84.95 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.268 -0.895 . . . . 0.0 110.339 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -63.97 -43.25 96.32 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.247 -0.908 . . . . 0.0 109.941 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.616 ' HE1' HG13 ' A' ' 186' ' ' VAL . 4.1 t80 -50.66 -55.81 14.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.333 -0.854 . . . . 0.0 110.307 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.415 ' HA ' HD23 ' A' ' 156' ' ' LEU . 75.2 mt -56.02 -51.53 67.45 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.374 -0.829 . . . . 0.0 110.08 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -51.17 -44.54 61.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.365 -0.834 . . . . 0.0 110.148 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -69.64 -34.18 73.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -0.885 . . . . 0.0 110.046 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.691 ' HB2' ' CD2' ' A' ' 167' ' ' PHE . . . -62.53 -30.98 71.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 110.136 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.97 -22.1 24.49 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.21 -0.931 . . . . 0.0 110.35 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -97.42 13.92 28.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.219 -0.926 . . . . 0.0 110.594 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.77 HD11 HG21 ' A' ' 212' ' ' ILE . 6.6 tt -103.78 174.67 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.093 -1.004 . . . . 0.0 110.211 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.42 62.89 0.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.37 -0.831 . . . . 0.0 110.25 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 162' ' ' ILE . 2.8 p-10 40.76 50.81 3.04 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.616 0.722 . . . . 0.0 111.56 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.576 HG23 ' HD2' ' A' ' 166' ' ' PRO . 39.1 mm -88.85 146.0 35.91 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.452 -0.78 . . . . 0.0 109.628 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.576 ' HD2' HG23 ' A' ' 165' ' ' ILE . 42.2 Cg_endo -68.63 100.8 0.71 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.58 1.305 . . . . 0.0 110.865 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.691 ' CD2' ' HB2' ' A' ' 159' ' ' ALA . 2.7 m-85 -97.6 136.32 38.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.42 -0.8 . . . . 0.0 110.158 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.573 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -129.47 143.81 14.92 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 11.1 tt -141.18 135.9 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.13 -1.218 . . . . 0.0 110.572 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.0 t -153.08 156.88 39.56 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.031 0.919 . . . . 0.0 110.571 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.4 t -122.68 2.59 9.53 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -64.31 123.23 18.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -0.945 . . . . 0.0 110.322 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 27.7 m -53.15 -28.36 25.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.229 -0.92 . . . . 0.0 110.131 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.45 -31.84 56.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -0.929 . . . . 0.0 109.764 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.726 HG22 ' N ' ' A' ' 126' ' ' GLY . 28.0 t -81.91 -26.21 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.429 -0.795 . . . . 0.0 109.32 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -76.24 -53.05 8.8 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.481 -0.762 . . . . 0.0 109.75 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 2.0 t -56.06 -21.93 24.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.402 -0.811 . . . . 0.0 110.08 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.51 -48.27 61.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 109.244 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -96.87 -0.67 47.4 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.432 -0.793 . . . . 0.0 110.352 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 53.83 70.63 0.58 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.103 -0.998 . . . . 0.0 110.589 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.549 HD22 ' HA3' ' A' ' 185' ' ' GLY . 1.1 mt -105.64 129.11 53.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.314 -0.866 . . . . 0.0 110.045 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.422 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 24.6 p-10 -60.65 -16.21 36.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.251 -0.905 . . . . 0.0 110.512 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.2 -145.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.175 -0.953 . . . . 0.0 109.649 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.442 ' HB3' ' CD1' ' A' ' 144' ' ' PHE . 43.0 m-20 -54.3 151.54 7.3 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.04 -1.038 . . . . 0.0 109.62 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.549 ' HA3' HD22 ' A' ' 181' ' ' LEU . . . -152.19 129.94 2.94 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.416 -1.374 . . . . 0.0 110.108 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.616 HG13 ' HE1' ' A' ' 155' ' ' PHE . 75.0 t -117.09 80.93 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.364 -1.08 . . . . 0.0 109.777 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 61.3 t -106.39 158.88 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 110.063 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.683 HD23 ' N ' ' A' ' 189' ' ' PHE . 9.8 tt -116.25 163.61 15.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.032 -1.043 . . . . 0.0 109.87 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.854 ' CD1' HD12 ' A' ' 141' ' ' ILE . 64.4 m-85 -128.88 132.08 47.68 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.009 -1.057 . . . . 0.0 110.892 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.481 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.3 OUTLIER -140.49 163.69 32.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.242 -0.911 . . . . 0.0 110.122 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -83.43 -29.13 28.34 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.273 -0.892 . . . . 0.0 110.083 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.8 OUTLIER -91.5 -175.04 4.09 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.533 -0.73 . . . . 0.0 110.955 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 50.43 -160.15 0.07 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.697 0.76 . . . . 0.0 110.608 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -59.24 -28.36 66.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.774 -0.579 . . . . 0.0 110.552 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.405 ' HA2' ' HG2' ' A' ' 190' ' ' LYS . . . 107.33 -28.04 13.86 Favored Glycine 0 N--CA 1.483 1.779 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.06 -179.98 5.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.129 -1.218 . . . . 0.0 110.599 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ASN . . . . . 0.441 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.4 m-80 -141.96 -152.39 0.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.575 -0.703 . . . . 0.0 109.712 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -171.57 79.81 0.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.355 -0.84 . . . . 0.0 110.474 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.482 ' CE1' HG22 ' A' ' 203' ' ' VAL . 26.7 t80 -60.3 143.05 53.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.172 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -146.51 129.95 16.8 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.341 -0.85 . . . . 0.0 109.717 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 121.79 -172.58 15.51 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -66.03 117.31 8.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -1.131 . . . . 0.0 110.349 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.484 ' C ' HG23 ' A' ' 204' ' ' THR . 71.7 t -74.14 118.88 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.887 . . . . 0.0 109.987 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.484 HG23 ' C ' ' A' ' 203' ' ' VAL . 72.6 p -150.07 157.11 42.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.318 -0.863 . . . . 0.0 110.433 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -49.26 -52.98 23.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.392 -0.818 . . . . 0.0 110.456 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -55.78 -36.21 67.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.354 -0.841 . . . . 0.0 110.332 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 -77.56 -51.98 9.8 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.193 -0.942 . . . . 0.0 110.454 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' A' ' 208' ' ' LEU . 70.8 mt -52.34 -56.35 15.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.322 -0.861 . . . . 0.0 110.429 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 18.7 mt -51.11 -24.13 3.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.169 -0.957 . . . . 0.0 110.57 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -84.71 -41.8 15.89 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.195 -0.941 . . . . 0.0 110.073 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -63.29 -57.82 9.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.352 -0.843 . . . . 0.0 110.67 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.77 HG21 HD11 ' A' ' 162' ' ' ILE . 9.4 mt -52.8 -47.22 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.134 -0.979 . . . . 0.0 110.388 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.56 -21.13 51.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.228 -0.92 . . . . 0.0 110.222 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -90.01 -19.35 24.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.309 -0.869 . . . . 0.0 110.438 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -94.73 -49.98 5.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.2 -0.938 . . . . 0.0 110.418 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.758 ' OE1' HG22 ' A' ' 212' ' ' ILE . 17.5 pt20 -58.05 -18.93 27.84 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.213 -0.93 . . . . 0.0 110.485 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 22.8 mt -109.17 92.94 11.99 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 0.0 110.305 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.64 167.12 27.36 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.667 1.351 . . . . 0.0 110.257 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.26 53.75 0.76 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.158 -0.963 . . . . 0.0 110.364 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.633 ' O ' HG12 ' A' ' 220' ' ' VAL . 95.5 t -122.43 60.16 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.331 -0.856 . . . . 0.0 110.013 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 221' ' ' ILE . 2.7 mp -99.2 18.63 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 0.0 110.459 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 52.26 29.76 7.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.177 -0.952 . . . . 0.0 110.354 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -168.88 60.29 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -0.918 . . . . 0.0 110.272 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 12.7 m -129.2 151.63 49.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -113.91 117.7 32.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.152 -0.967 . . . . 0.0 110.258 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.54 -71.94 0.73 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.212 -0.93 . . . . 0.0 110.256 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 20.4 p -75.55 128.49 35.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.235 -0.916 . . . . 0.0 110.198 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.291 179.984 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.238 0.542 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.53 179.71 7.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.181 -0.949 . . . . 0.0 110.154 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 51.9 m -101.56 125.51 48.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 110.149 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 87.0 m -76.84 126.91 31.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.25 -0.906 . . . . 0.0 110.169 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.618 HD22 ' HB1' ' A' ' 128' ' ' ALA . 45.7 mt -103.45 137.98 19.41 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.932 . . . . 0.0 109.95 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 46.8 Cg_endo -73.09 -26.21 15.23 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.554 1.292 . . . . 0.0 110.546 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -172.76 -170.33 0.66 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.159 -0.963 . . . . 0.0 110.912 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.462 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -61.8 -34.07 87.46 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -51.48 -28.2 12.67 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.276 -1.132 . . . . 0.0 110.4 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.618 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -86.06 -37.22 19.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 110.161 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.16 -30.15 48.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.197 -0.939 . . . . 0.0 110.118 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -81.62 -46.45 14.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.146 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 92.0 p -56.74 -33.34 66.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.894 . . . . 0.0 110.095 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.5 tp -61.09 -47.84 84.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -0.884 . . . . 0.0 110.165 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.842 HG22 ' HB3' ' A' ' 189' ' ' PHE . 39.4 t -54.67 -41.2 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.193 -0.942 . . . . 0.0 109.961 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -82.74 3.38 29.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.274 -0.891 . . . . 0.0 110.796 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.8 t -75.61 -41.92 53.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.934 -1.104 . . . . 0.0 110.111 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 28.2 p -147.24 -172.63 4.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 110.13 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.443 ' OE2' ' CD2' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -70.65 -44.76 66.43 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.205 -0.934 . . . . 0.0 110.163 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.4 t -116.26 150.51 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.276 -0.89 . . . . 0.0 110.191 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.455 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -172.15 146.0 1.85 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.843 . . . . 0.0 109.926 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.583 ' CG1' HD12 ' A' ' 188' ' ' LEU . 2.8 m -128.19 164.66 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.117 -0.99 . . . . 0.0 110.764 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 31.2 mt -149.96 114.4 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.753 -0.592 . . . . 0.0 110.173 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -87.06 133.05 11.53 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.546 ' CE2' HG12 ' A' ' 175' ' ' VAL . 76.1 m-85 -99.37 77.31 2.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.113 -1.228 . . . . 0.0 110.069 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.41 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 25.6 m-85 -95.24 143.65 26.47 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.992 0.901 . . . . 0.0 110.939 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.4 -25.36 20.43 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.815 0.817 . . . . 0.0 109.167 179.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -137.3 78.85 1.72 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.576 ' HA ' ' HB1' ' A' ' 152' ' ' ALA . 19.5 m -46.02 -25.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.457 -0.777 . . . . 0.0 111.167 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -84.73 10.31 11.7 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.106 -0.996 . . . . 0.0 110.937 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 68.6 p -81.0 -159.36 0.25 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.967 -1.083 . . . . 0.0 110.182 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -89.87 -54.18 4.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 110.207 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.87 -23.38 63.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 0.0 110.268 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.576 ' HB1' ' HA ' ' A' ' 147' ' ' VAL . . . -81.12 -23.43 38.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 0.0 110.286 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.18 -41.05 77.69 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.216 -0.928 . . . . 0.0 110.115 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.403 ' OE1' HG22 ' A' ' 204' ' ' THR . 1.1 mm-40 -60.43 -46.03 91.48 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.314 -0.867 . . . . 0.0 109.956 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -51.79 -55.35 20.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 110.268 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 156' ' ' LEU . 41.2 mt -54.13 -55.75 24.69 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.383 -0.823 . . . . 0.0 110.152 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -52.45 -38.02 58.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.347 -0.845 . . . . 0.0 110.13 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.729 ' HB2' ' HG3' ' A' ' 205' ' ' LYS . . . -76.8 -41.61 43.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.198 -0.939 . . . . 0.0 109.841 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -58.73 -37.61 76.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.828 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -66.59 -28.21 68.33 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.243 -0.91 . . . . 0.0 110.113 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 158' ' ' ALA . . . -60.36 -50.43 73.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.798 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.54 HG21 ' CG1' ' A' ' 165' ' ' ILE . 71.4 mt -90.31 152.17 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.367 -0.833 . . . . 0.0 109.891 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -127.6 -40.27 1.77 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.136 -0.978 . . . . 0.0 110.43 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -63.77 -16.25 60.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.249 -0.907 . . . . 0.0 110.615 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.54 ' CG1' HG21 ' A' ' 162' ' ' ILE . 46.2 mm -93.63 128.86 40.37 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.075 -1.016 . . . . 0.0 110.327 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.455 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 51.0 Cg_endo -77.31 82.55 2.35 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 O-C-N 123.538 1.283 . . . . 0.0 110.546 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -71.44 137.57 48.38 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.173 -0.954 . . . . 0.0 110.238 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 141' ' ' ILE . . . -128.9 145.07 15.91 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 4.8 tt -146.58 137.48 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -1.157 . . . . 0.0 110.439 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.2 t -159.49 156.94 29.13 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.001 0.905 . . . . 0.0 110.895 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 56.7 p -122.24 3.43 9.79 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.527 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -57.74 126.76 28.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.219 -0.926 . . . . 0.0 110.535 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.88 -35.88 58.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.244 -0.91 . . . . 0.0 110.143 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -53.09 -30.75 38.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.978 . . . . 0.0 109.815 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.546 HG12 ' CE2' ' A' ' 143' ' ' PHE . 57.3 t -81.29 -26.86 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.325 -0.859 . . . . 0.0 109.546 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -77.6 -52.86 8.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.351 -0.843 . . . . 0.0 109.345 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.4 m -58.96 -18.6 35.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.443 -0.786 . . . . 0.0 109.997 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -71.48 -53.91 12.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.559 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -91.11 4.6 51.76 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.41 -0.807 . . . . 0.0 110.292 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.13 64.64 1.76 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -0.946 . . . . 0.0 110.713 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 40.0 mt -102.7 122.41 44.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.256 -0.902 . . . . 0.0 110.17 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -62.83 -18.87 63.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 110.422 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 18.9 pttt -163.75 -148.22 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 109.983 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -70.71 150.98 45.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -0.933 . . . . 0.0 109.889 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -170.16 156.05 26.33 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 97.8 t -127.8 141.2 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.172 -1.193 . . . . 0.0 110.344 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.49 HG13 ' H ' ' A' ' 197' ' ' ASN . 70.6 t -143.06 149.24 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.337 -0.852 . . . . 0.0 109.646 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.69 HD23 ' HD3' ' A' ' 190' ' ' LYS . 3.7 tt -101.29 145.59 28.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.951 -1.093 . . . . 0.0 109.681 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.842 ' HB3' HG22 ' A' ' 133' ' ' VAL . 58.8 m-85 -121.87 108.34 13.34 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.131 -0.981 . . . . 0.0 110.624 -178.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.69 ' HD3' HD23 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -124.06 174.68 7.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.31 -0.869 . . . . 0.0 110.27 179.782 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -94.41 -26.22 16.6 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.321 -0.862 . . . . 0.0 110.007 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.493 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.5 OUTLIER -91.43 -170.92 2.76 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.833 179.577 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 49.87 -159.92 0.07 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.661 0.743 . . . . 0.0 110.595 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -56.05 -46.32 78.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.632 -0.667 . . . . 0.0 110.25 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 126.07 -32.86 3.67 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -136.55 173.14 12.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.193 -1.18 . . . . 0.0 110.429 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ASN . . . . . 0.49 ' H ' HG13 ' A' ' 187' ' ' VAL . 0.7 OUTLIER -144.22 -155.21 0.58 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.37 -0.831 . . . . 0.0 109.631 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.435 ' HA ' HG22 ' A' ' 187' ' ' VAL . 0.2 OUTLIER -169.52 86.93 0.15 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.53 -0.731 . . . . 0.0 110.206 179.612 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -49.85 130.83 22.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.272 -0.893 . . . . 0.0 110.441 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -127.95 115.38 18.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.327 -0.858 . . . . 0.0 109.942 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 132.93 -158.74 23.25 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -84.43 132.28 34.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.298 -1.119 . . . . 0.0 110.167 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.644 HG13 HD21 ' A' ' 208' ' ' LEU . 92.3 t -81.46 116.17 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.33 -0.856 . . . . 0.0 110.376 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.403 HG22 ' OE1' ' A' ' 154' ' ' GLN . 15.6 p -143.56 159.73 41.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 109.988 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.769 ' O ' HD12 ' A' ' 209' ' ' LEU . 2.9 ttpt -51.31 -49.24 61.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.12 -0.987 . . . . 0.0 110.584 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -62.98 -39.72 95.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.276 -0.89 . . . . 0.0 110.549 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -70.16 -48.79 55.86 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.197 -0.939 . . . . 0.0 110.374 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.644 HD21 HG13 ' A' ' 203' ' ' VAL . 95.3 mt -56.06 -49.87 72.55 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.257 -0.902 . . . . 0.0 110.428 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.769 HD12 ' O ' ' A' ' 205' ' ' LYS . 0.7 OUTLIER -59.26 -26.99 65.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.892 . . . . 0.0 110.298 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -78.28 -45.49 22.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.281 -0.887 . . . . 0.0 110.274 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -53.29 -60.92 2.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.318 -0.864 . . . . 0.0 110.393 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 9.9 mt -51.69 -46.47 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.242 -0.911 . . . . 0.0 110.586 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -18.85 13.79 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.258 -0.902 . . . . 0.0 110.956 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -96.52 -24.38 16.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.064 -1.022 . . . . 0.0 110.922 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.555 ' HB3' HD22 ' A' ' 188' ' ' LEU . 72.1 m-20 -89.34 -48.58 7.25 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.922 -1.111 . . . . 0.0 111.139 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -57.37 -21.55 36.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.956 -1.09 . . . . 0.0 110.212 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 1.7 mt -104.97 124.99 34.86 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.899 . . . . 0.0 109.949 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.66 -177.08 2.6 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.404 1.213 . . . . 0.0 110.426 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 5.1 mp -116.57 131.17 57.02 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.237 -0.915 . . . . 0.0 110.001 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 220' ' ' VAL . 33.0 m -89.39 59.27 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.275 -0.891 . . . . 0.0 110.212 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 2.2 pt -111.85 54.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.864 . . . . 0.0 110.069 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -161.18 142.58 11.68 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 110.397 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -150.63 46.65 0.87 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.082 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.438 ' O ' HG22 ' A' ' 224' ' ' THR . 25.4 m 54.95 48.84 19.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.29 -0.881 . . . . 0.0 110.293 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 52.52 -166.54 0.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.186 -0.947 . . . . 0.0 110.238 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.47 90.99 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.911 . . . . 0.0 110.204 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.48 HG22 ' N ' ' A' ' 228' ' ' ALA . 26.7 m 55.86 170.49 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.217 -0.927 . . . . 0.0 110.227 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.48 ' N ' HG22 ' A' ' 227' ' ' THR . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.237 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.315 0.578 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 167' ' ' PHE . . . -91.12 175.07 7.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 0.0 110.178 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.554 HG22 ' HA2' ' A' ' 168' ' ' GLY . 7.7 t -102.19 171.11 7.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.139 -0.976 . . . . 0.0 110.516 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.2 m -113.95 103.47 11.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.357 -0.839 . . . . 0.0 110.193 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.655 HD21 HD12 ' A' ' 132' ' ' LEU . 57.7 mt -79.47 111.95 24.87 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.924 . . . . 0.0 110.04 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.433 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 44.7 Cg_endo -69.61 -21.57 34.02 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 O-C-N 123.561 1.295 . . . . 0.0 110.869 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.577 ' OD2' ' HB3' ' A' ' 127' ' ' ALA . 0.4 OUTLIER -163.13 -170.03 2.19 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.052 -1.03 . . . . 0.0 111.076 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.452 ' HA3' ' HD3' ' A' ' 178' ' ' LYS . . . -67.69 -39.92 90.25 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.577 ' HB3' ' OD2' ' A' ' 125' ' ' ASP . . . -53.25 -22.56 7.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -1.15 . . . . 0.0 110.031 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.433 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -88.32 -23.91 23.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.205 -0.935 . . . . 0.0 109.301 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.0 -20.48 32.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.454 -0.779 . . . . 0.0 110.118 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 131' ' ' SER . 19.2 pt-20 -86.9 -37.61 17.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.177 -0.952 . . . . 0.0 110.228 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.44 ' N ' ' HG3' ' A' ' 130' ' ' GLU . 3.0 m -75.48 -31.45 60.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 0.0 109.998 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.655 HD12 HD21 ' A' ' 123' ' ' LEU . 2.4 tt -56.51 -59.47 4.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.336 -0.852 . . . . 0.0 110.067 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.54 HG22 ' CB ' ' A' ' 189' ' ' PHE . 51.4 t -53.63 -35.88 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 110.513 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.81 -19.86 57.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.125 -0.984 . . . . 0.0 110.581 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 68.4 m -68.56 -57.47 5.73 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.129 -0.982 . . . . 0.0 110.304 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 46.1 p -111.84 165.06 12.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.316 -0.865 . . . . 0.0 110.252 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.879 ' HG3' HG23 ' A' ' 138' ' ' VAL . 14.6 pt-20 -64.86 -40.39 95.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 110.035 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.879 HG23 ' HG3' ' A' ' 137' ' ' GLU . 94.1 t -121.67 147.7 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.429 -0.794 . . . . 0.0 110.17 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.501 ' HB1' HD22 ' A' ' 132' ' ' LEU . . . -173.99 133.26 0.43 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.298 -0.876 . . . . 0.0 110.061 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 187' ' ' VAL . 7.3 p -111.86 149.54 14.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.136 -0.977 . . . . 0.0 110.064 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.451 HG23 HD12 ' A' ' 123' ' ' LEU . 66.5 mt -131.37 111.1 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 110.253 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -77.28 133.24 12.96 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.733 ' CE2' HG12 ' A' ' 175' ' ' VAL . 51.4 m-85 -105.36 67.2 0.76 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.26 -1.141 . . . . 0.0 109.735 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -91.76 130.33 37.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 111.228 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.456 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 26.0 pttt -80.07 -30.62 39.32 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.923 0.868 . . . . 0.0 108.828 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.456 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 5.2 m-20 -123.19 70.93 1.04 Allowed 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.323 0.582 . . . . 0.0 109.449 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.46 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 25.6 m -49.17 -23.89 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.27 -0.894 . . . . 0.0 110.808 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -78.33 2.55 18.2 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.08 -1.012 . . . . 0.0 111.032 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 21.5 p -80.45 -161.0 0.34 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.901 -1.124 . . . . 0.0 110.243 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -90.41 -51.59 5.34 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.21 -0.931 . . . . 0.0 110.582 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 66.4 m -52.25 -26.07 10.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.2 -0.938 . . . . 0.0 110.507 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.46 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -86.24 -32.1 21.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 110.353 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -60.23 -41.32 92.84 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.22 -0.925 . . . . 0.0 110.189 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -66.32 -36.91 84.12 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.169 -0.957 . . . . 0.0 109.93 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.453 ' HA ' HD13 ' A' ' 208' ' ' LEU . 4.3 t80 -51.97 -57.78 8.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.286 -0.884 . . . . 0.0 110.097 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 19.2 mt -52.01 -50.57 61.11 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.45 -0.781 . . . . 0.0 110.245 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -52.1 -41.61 62.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.356 -0.84 . . . . 0.0 110.152 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.613 ' HB2' ' HA ' ' A' ' 205' ' ' LYS . . . -73.29 -35.47 66.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.335 -0.853 . . . . 0.0 109.889 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.58 -43.16 94.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 110.013 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -60.13 -35.62 75.68 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.256 -0.903 . . . . 0.0 110.139 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.3 -46.54 86.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.87 . . . . 0.0 110.182 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 49.8 mm -90.7 104.98 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.064 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.37 -20.54 20.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.122 -0.986 . . . . 0.0 110.373 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -76.88 -6.05 50.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.221 -0.925 . . . . 0.0 110.807 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 44.7 mm -116.3 130.35 24.54 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.941 -1.1 . . . . 0.0 110.132 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.445 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 50.6 Cg_endo -75.09 81.2 2.28 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.475 1.25 . . . . 0.0 110.549 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 120' ' ' ALA . 2.9 m-85 -68.23 132.38 47.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 110.316 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.554 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -126.54 153.34 18.71 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 7.2 tt -148.43 147.33 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -1.154 . . . . 0.0 110.329 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.507 HG21 HG11 ' A' ' 175' ' ' VAL . 2.4 t -164.01 156.96 17.86 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.065 0.936 . . . . 0.0 110.809 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.415 ' HA ' ' CE1' ' A' ' 176' ' ' PHE . 76.1 p -121.14 1.08 10.28 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.16 119.98 6.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.191 -0.943 . . . . 0.0 110.506 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.1 p -53.72 -32.48 52.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.229 -0.919 . . . . 0.0 110.095 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.404 ' O ' ' HE2' ' A' ' 178' ' ' LYS . 0.4 OUTLIER -56.47 -44.31 80.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.141 -0.975 . . . . 0.0 109.344 179.543 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.733 HG12 ' CE2' ' A' ' 143' ' ' PHE . 39.0 t -69.22 -29.84 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.346 -0.846 . . . . 0.0 109.41 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.415 ' CE1' ' HA ' ' A' ' 171' ' ' SER . 5.5 m-85 -68.57 -60.86 2.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.407 -0.808 . . . . 0.0 109.528 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 2.9 m -51.36 -36.62 43.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.61 -0.682 . . . . 0.0 110.562 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.452 ' HD3' ' HA3' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -48.44 -55.78 9.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.17 -0.956 . . . . 0.0 110.895 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -89.9 18.73 5.4 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.315 -0.866 . . . . 0.0 110.51 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.46 65.75 1.39 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.163 -0.961 . . . . 0.0 110.402 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 85.5 mt -112.92 92.29 3.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -0.836 . . . . 0.0 110.235 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.56 -26.98 9.65 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.038 -1.038 . . . . 0.0 109.53 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -138.66 177.73 7.67 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 3.7 p-10 -58.65 -173.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.08 -1.012 . . . . 0.0 110.262 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 165.27 171.86 32.01 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 186' ' ' VAL . 32.8 m -139.92 108.15 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.294 -1.121 . . . . 0.0 109.97 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.495 ' O ' HG23 ' A' ' 140' ' ' VAL . 97.2 t -117.04 160.9 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.287 -0.883 . . . . 0.0 109.851 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.785 HD12 HD13 ' A' ' 212' ' ' ILE . 8.3 tt -110.3 150.79 28.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.026 -1.046 . . . . 0.0 109.941 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.54 ' CB ' HG22 ' A' ' 133' ' ' VAL . 40.6 m-85 -121.87 127.19 50.2 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.991 -1.068 . . . . 0.0 110.196 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.28 167.39 22.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -0.885 . . . . 0.0 110.358 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.0 mtpt -90.87 -27.09 19.02 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.244 -0.91 . . . . 0.0 110.596 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -90.96 -175.69 4.41 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.381 -0.824 . . . . 0.0 111.023 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 50.01 -160.0 0.07 Allowed 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.666 0.746 . . . . 0.0 110.667 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -53.86 -54.68 35.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.666 -0.646 . . . . 0.0 110.191 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 133.12 -24.31 3.79 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -140.85 176.81 8.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.051 -1.264 . . . . 0.0 110.781 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ASN . . . . . 0.456 ' N ' ' ND2' ' A' ' 197' ' ' ASN . 1.1 m-80 -142.53 -151.76 0.38 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.549 -0.719 . . . . 0.0 109.509 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -176.51 79.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 0.0 109.97 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.574 ' CB ' HG23 ' A' ' 186' ' ' VAL . 17.1 t80 -51.26 120.1 4.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.285 -0.884 . . . . 0.0 110.52 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -119.56 104.91 10.72 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.248 -0.907 . . . . 0.0 110.111 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 152.21 -160.62 28.99 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -81.94 111.11 17.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -1.178 . . . . 0.0 110.16 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.453 ' C ' HG23 ' A' ' 204' ' ' THR . 86.9 t -61.82 116.68 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 110.173 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.453 HG23 ' C ' ' A' ' 203' ' ' VAL . 67.9 p -149.63 155.72 40.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 110.284 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.613 ' HA ' ' HB2' ' A' ' 158' ' ' ALA . 1.5 ttpt -52.62 -52.66 54.46 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.357 -0.839 . . . . 0.0 110.567 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -56.35 -25.83 50.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.0 110.293 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -87.47 -46.29 9.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.291 -0.881 . . . . 0.0 110.17 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 155' ' ' PHE . 19.4 mt -59.02 -47.27 85.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.283 -0.886 . . . . 0.0 110.315 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 14.6 mt -52.31 -30.99 31.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.226 -0.921 . . . . 0.0 110.287 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.53 -42.06 14.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 0.0 110.089 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.428 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 18.5 t80 -51.31 -51.7 51.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.162 -0.961 . . . . 0.0 109.705 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.785 HD13 HD12 ' A' ' 188' ' ' LEU . 25.4 mm -48.53 -72.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.427 -0.796 . . . . 0.0 110.423 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.459 ' HA ' ' CG ' ' A' ' 216' ' ' GLN . 18.0 mttt -45.9 -37.08 5.94 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.779 -0.575 . . . . 0.0 111.132 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.61 -25.46 67.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.13 -0.981 . . . . 0.0 110.793 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 74.8 m-80 -102.18 -31.53 10.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.103 -0.998 . . . . 0.0 110.977 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.459 ' CG ' ' HA ' ' A' ' 213' ' ' LYS . 0.0 OUTLIER -90.49 25.17 2.36 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.016 -1.053 . . . . 0.0 111.001 -179.414 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.42 HD12 ' O ' ' A' ' 213' ' ' LYS . 30.3 mt -126.69 57.78 23.83 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.072 -1.017 . . . . 0.0 110.035 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.34 151.67 48.68 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.611 1.322 . . . . 0.0 110.668 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 44.5 mt 44.99 69.06 0.47 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.562 -0.711 . . . . 0.0 111.241 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 220' ' ' VAL . 9.6 p -94.12 134.18 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 110.164 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 30.0 pt -87.99 -176.01 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.192 -0.942 . . . . 0.0 110.351 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.88 -152.7 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.267 -0.895 . . . . 0.0 110.174 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 53.47 -151.37 0.34 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.263 -0.898 . . . . 0.0 110.125 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.3 m -49.88 156.37 0.74 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.135 -0.978 . . . . 0.0 110.491 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -167.41 71.4 0.11 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 110.185 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.714 ' O ' HG23 ' A' ' 227' ' ' THR . 4.7 tt0 -60.36 -55.61 31.53 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.239 -0.913 . . . . 0.0 110.136 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.714 HG23 ' O ' ' A' ' 226' ' ' GLN . 1.0 OUTLIER -161.15 160.79 30.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.323 -0.861 . . . . 0.0 110.12 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.216 -179.998 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.21 0.529 . . . . 0.0 110.261 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.22 170.84 6.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.34 -0.85 . . . . 0.0 110.38 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.4 t -103.89 168.9 8.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 110.318 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.6 m -108.1 118.4 36.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 0.0 109.94 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.765 HD22 ' HB1' ' A' ' 128' ' ' ALA . 49.5 mt -90.88 138.35 26.28 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.218 -0.926 . . . . 0.0 110.378 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 46.5 Cg_endo -72.61 -36.63 4.78 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.565 1.297 . . . . 0.0 110.366 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.662 ' C ' HG22 ' A' ' 175' ' ' VAL . 0.9 OUTLIER -167.2 -170.24 1.45 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.222 -0.924 . . . . 0.0 110.805 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.5 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -57.56 -33.67 67.43 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.52 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -51.11 -26.72 6.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.22 -1.165 . . . . 0.0 110.406 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.765 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -88.12 -37.16 16.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 110.093 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.24 -25.88 25.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 0.0 109.995 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -88.88 -57.36 2.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.271 -0.893 . . . . 0.0 110.062 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.2 m -58.77 -27.87 65.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.233 -0.917 . . . . 0.0 110.205 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 20.6 tp -60.71 -54.31 46.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 109.988 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 98.4 t -57.39 -33.25 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.459 -0.776 . . . . 0.0 110.336 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -72.97 -17.69 61.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.903 . . . . 0.0 110.528 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.85 -27.12 57.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.189 -0.944 . . . . 0.0 110.393 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.404 ' OG ' ' HG3' ' A' ' 166' ' ' PRO . 31.1 p -141.58 163.55 32.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.188 -0.945 . . . . 0.0 110.391 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.855 ' HG3' HG23 ' A' ' 138' ' ' VAL . 18.3 pt-20 -63.8 -40.93 97.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 110.043 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.855 HG23 ' HG3' ' A' ' 137' ' ' GLU . 57.9 t -127.76 155.88 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.412 -0.805 . . . . 0.0 110.172 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.434 ' HB2' ' HG2' ' A' ' 166' ' ' PRO . . . -176.75 138.51 0.28 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.245 -0.91 . . . . 0.0 109.788 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 187' ' ' VAL . 7.5 p -112.78 151.78 14.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.085 -1.01 . . . . 0.0 110.245 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 71.9 mt -132.65 117.36 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.377 -0.827 . . . . 0.0 110.163 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -84.22 126.72 7.74 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.713 ' CE2' HG12 ' A' ' 175' ' ' VAL . 83.7 m-85 -100.24 70.03 1.51 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.356 -1.085 . . . . 0.0 109.924 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -94.99 141.5 28.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -0.875 . . . . 0.0 110.952 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.53 -27.96 18.83 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.501 -0.749 . . . . 0.0 110.554 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.587 ' C ' HG23 ' A' ' 147' ' ' VAL . 0.7 OUTLIER -90.69 -39.51 12.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.17 -0.956 . . . . 0.0 110.445 -179.875 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.587 HG23 ' C ' ' A' ' 146' ' ' ASP . 2.4 t 73.1 -51.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.743 -0.598 . . . . 0.0 110.634 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -90.83 8.96 32.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.067 -1.021 . . . . 0.0 110.507 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 7.5 p -70.01 -163.87 0.07 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.986 -1.071 . . . . 0.0 110.066 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.51 -41.31 13.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.338 -0.851 . . . . 0.0 110.431 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.7 p -59.55 -24.26 63.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.197 -0.94 . . . . 0.0 110.19 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -85.02 -37.17 20.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.253 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.88 -45.83 67.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 110.387 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -62.49 -39.48 93.61 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.219 -0.925 . . . . 0.0 110.355 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -51.6 -56.63 12.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 110.418 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.7 mt -51.21 -54.31 26.82 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.324 -0.86 . . . . 0.0 110.534 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -51.91 -40.46 60.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.254 -0.903 . . . . 0.0 110.252 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.468 ' HB2' ' HG3' ' A' ' 205' ' ' LYS . . . -69.47 -49.61 53.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.93 . . . . 0.0 109.885 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.456 ' HB1' ' CD2' ' A' ' 167' ' ' PHE . . . -55.61 -35.93 66.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 110.011 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -68.48 -22.76 64.54 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.329 -0.857 . . . . 0.0 110.435 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.89 -56.42 17.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.168 -0.957 . . . . 0.0 110.333 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 98.8 mt -90.02 151.1 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 0.0 110.177 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -119.67 -16.39 8.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 110.597 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -91.2 19.7 5.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.073 -1.017 . . . . 0.0 110.519 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.551 ' CG2' ' CE1' ' A' ' 167' ' ' PHE . 31.8 mm -132.21 125.1 19.75 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.135 -0.978 . . . . 0.0 109.899 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.434 ' HG2' ' HB2' ' A' ' 139' ' ' ALA . 50.0 Cg_endo -81.5 101.56 1.22 Allowed 'Trans proline' 0 C--N 1.315 -1.228 0 O-C-N 123.443 1.233 . . . . 0.0 110.697 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.551 ' CE1' ' CG2' ' A' ' 165' ' ' ILE . 1.1 m-85 -92.85 140.07 29.88 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.249 -0.907 . . . . 0.0 109.487 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 141' ' ' ILE . . . -132.58 156.37 22.04 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.3 tt -146.0 150.86 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.096 -1.237 . . . . 0.0 110.282 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.917 HG21 HG11 ' A' ' 175' ' ' VAL . 2.4 t -162.01 158.55 25.2 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.11 0.957 . . . . 0.0 110.891 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.421 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . 26.3 t -125.09 2.12 7.94 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.319 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -67.98 123.39 20.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.22 -0.925 . . . . 0.0 110.31 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 14.9 m -50.53 -25.43 4.07 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.224 -0.922 . . . . 0.0 110.445 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -59.91 -29.06 68.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.194 -0.941 . . . . 0.0 109.848 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.917 HG11 HG21 ' A' ' 170' ' ' THR . 39.2 t -88.87 -22.16 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.358 -0.839 . . . . 0.0 109.734 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -80.69 -44.31 18.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.347 -0.846 . . . . 0.0 109.711 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.0 -25.23 67.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.431 -0.793 . . . . 0.0 110.107 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.82 -61.42 2.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -0.852 . . . . 0.0 110.44 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.49 ' CZ ' ' CZ ' ' A' ' 189' ' ' PHE . 88.9 m-85 -89.59 12.24 17.29 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.181 -0.949 . . . . 0.0 110.675 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 50.34 60.62 3.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.143 -0.973 . . . . 0.0 110.719 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 83.8 mt -91.75 124.18 35.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.142 -0.974 . . . . 0.0 109.965 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -60.0 -19.32 51.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.244 -0.91 . . . . 0.0 110.615 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -168.84 -146.96 0.06 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.211 -0.931 . . . . 0.0 110.168 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -75.32 150.06 38.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.229 -0.92 . . . . 0.0 110.171 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -171.54 154.01 21.28 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 186' ' ' VAL . 33.3 m -126.04 104.71 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.278 -1.131 . . . . 0.0 110.174 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.479 HG22 ' HA ' ' A' ' 198' ' ' ASN . 95.2 t -111.27 157.91 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 0.0 109.494 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.785 HD22 ' HB3' ' A' ' 215' ' ' ASN . 9.1 tt -107.15 148.45 28.83 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.887 -1.133 . . . . 0.0 108.926 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.49 ' CZ ' ' CZ ' ' A' ' 179' ' ' TYR . 39.0 m-85 -113.78 129.06 56.63 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.756 -1.215 . . . . 0.0 111.304 -178.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.517 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -137.97 151.95 48.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.274 -0.891 . . . . 0.0 110.269 179.578 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp -83.27 -25.26 31.78 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.337 -0.852 . . . . 0.0 110.252 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.517 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 1.7 p90 -91.77 -176.99 4.63 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.397 -0.814 . . . . 0.0 110.976 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 193' ' ' ASP . 11.1 m-20 48.91 -158.37 0.06 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.574 0.702 . . . . 0.0 110.624 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.25 -46.94 46.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.553 -0.717 . . . . 0.0 110.55 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 133.37 -33.45 2.57 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.6 ptt180 -147.4 -165.84 2.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.188 -1.183 . . . . 0.0 110.593 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ASN . . . . . 0.526 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.0 OUTLIER -142.7 -153.7 0.48 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.549 -0.719 . . . . 0.0 109.895 -179.273 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.479 ' HA ' HG22 ' A' ' 187' ' ' VAL . 8.3 p-10 -171.94 80.93 0.06 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.467 -0.77 . . . . 0.0 109.935 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -53.92 119.49 5.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.833 . . . . 0.0 110.27 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -120.69 89.15 3.07 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.417 -0.802 . . . . 0.0 110.354 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 164.66 -165.68 37.58 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -73.17 126.32 29.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -1.132 . . . . 0.0 110.243 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 97.2 t -76.0 110.19 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 110.139 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 77.6 p -145.79 151.28 37.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.491 -0.756 . . . . 0.0 109.979 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.468 ' HG3' ' HB2' ' A' ' 158' ' ' ALA . 6.4 ttpt -48.69 -52.28 24.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.277 -0.889 . . . . 0.0 110.413 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -52.77 -39.86 62.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.324 -0.86 . . . . 0.0 110.19 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -77.31 -44.51 29.35 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.36 -0.838 . . . . 0.0 110.39 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 71.6 mt -53.97 -46.54 71.68 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.317 -0.864 . . . . 0.0 110.29 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 24.6 mt -59.09 -31.64 69.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 0.0 110.027 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -72.19 -28.18 63.04 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.217 -0.927 . . . . 0.0 109.864 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -65.09 -66.67 0.51 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.424 -0.798 . . . . 0.0 110.328 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 5.6 mt -46.37 -42.19 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.436 -0.79 . . . . 0.0 110.778 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -24.73 37.08 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.238 -0.914 . . . . 0.0 110.156 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -113.12 3.74 16.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.331 -0.855 . . . . 0.0 110.832 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.785 ' HB3' HD22 ' A' ' 188' ' ' LEU . 8.1 m120 -92.25 -60.06 1.94 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.882 -1.136 . . . . 0.0 110.195 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.491 ' HA ' ' CZ ' ' A' ' 192' ' ' PHE . 7.4 pt20 -85.09 -143.56 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.335 -0.853 . . . . 0.0 110.407 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.484 ' HA ' HD23 ' A' ' 217' ' ' LEU . 18.0 mt 54.92 57.96 11.3 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.137 -0.977 . . . . 0.0 110.299 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.58 111.92 3.35 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 O-C-N 123.692 1.364 . . . . 0.0 110.337 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 23.1 mt 50.93 92.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 110.427 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.415 ' H ' HG22 ' A' ' 220' ' ' VAL . 33.1 m -90.29 41.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.289 -0.882 . . . . 0.0 110.554 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.587 HG22 ' O ' ' A' ' 221' ' ' ILE . 53.1 mt -140.65 27.92 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.12 -0.988 . . . . 0.0 110.018 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -136.0 59.25 1.72 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.91 . . . . 0.0 110.308 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -119.04 108.99 15.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.258 -0.901 . . . . 0.0 110.239 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 30.1 m -147.11 95.9 2.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.209 -0.932 . . . . 0.0 110.293 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -105.05 -25.48 12.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 0.0 110.033 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.15 106.94 2.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.924 . . . . 0.0 110.123 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 41.7 m -136.86 148.28 47.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.262 -0.899 . . . . 0.0 110.162 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.181 179.977 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.201 0.524 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.47 -166.36 1.35 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.281 -0.887 . . . . 0.0 110.432 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.639 HG22 ' HA2' ' A' ' 168' ' ' GLY . 10.0 t -124.95 171.7 9.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.375 -0.828 . . . . 0.0 110.113 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 50.6 m -109.2 108.76 19.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.34 -0.85 . . . . 0.0 110.095 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.581 HD22 ' HB1' ' A' ' 128' ' ' ALA . 39.0 mt -84.4 125.7 71.19 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.892 . . . . 0.0 109.973 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -71.23 -42.82 1.79 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.53 1.279 . . . . 0.0 110.468 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.476 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 1.3 p30 -152.57 -170.05 3.52 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.301 -0.874 . . . . 0.0 110.807 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.427 ' HA3' ' HD2' ' A' ' 178' ' ' LYS . . . -62.09 -26.51 67.59 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.476 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -53.26 -34.53 57.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.338 -1.095 . . . . 0.0 110.4 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.581 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -79.26 -33.1 43.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.06 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.35 -32.25 64.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -0.881 . . . . 0.0 110.193 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -90.22 -41.17 11.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.348 -0.845 . . . . 0.0 110.406 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.0 m -62.62 -34.75 77.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.935 . . . . 0.0 110.079 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.1 tp -60.74 -45.29 94.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 110.246 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.723 HG22 ' HB3' ' A' ' 189' ' ' PHE . 43.8 t -56.11 -41.59 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.231 -0.918 . . . . 0.0 110.596 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -85.29 -19.9 30.84 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.219 -0.926 . . . . 0.0 110.496 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.5 m -55.48 -36.97 67.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.202 -0.936 . . . . 0.0 110.3 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.8 p -145.16 -178.82 6.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.159 -0.963 . . . . 0.0 110.288 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.15 -30.54 60.79 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.289 -0.882 . . . . 0.0 110.276 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 92.9 t -130.95 144.99 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 110.129 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -174.95 136.75 0.4 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 110.208 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.503 HG11 ' CE1' ' A' ' 167' ' ' PHE . 7.5 p -123.7 150.61 28.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.198 -0.938 . . . . 0.0 110.009 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.458 HG23 ' CD1' ' A' ' 123' ' ' LEU . 5.7 mt -131.17 116.42 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.232 -0.918 . . . . 0.0 110.067 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -87.13 121.63 5.88 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 184' ' ' ASP . 65.4 m-85 -99.08 98.25 9.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -1.161 . . . . 0.0 109.53 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.618 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 19.8 m-85 -115.67 147.33 40.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.026 -1.046 . . . . 0.0 111.357 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.4 ptmt -91.17 -27.38 18.55 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.643 0.735 . . . . 0.0 109.345 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.03 72.34 1.36 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.603 -0.685 . . . . 0.0 109.502 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.578 ' HA ' ' HB2' ' A' ' 152' ' ' ALA . 23.9 m -54.8 -19.77 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.283 -0.886 . . . . 0.0 110.617 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -76.33 0.96 17.53 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.111 -0.993 . . . . 0.0 110.927 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' A' ' 153' ' ' LYS . 83.6 p -88.06 -170.19 2.88 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.827 -1.17 . . . . 0.0 109.949 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -81.35 -30.8 33.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.289 -0.882 . . . . 0.0 110.167 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.43 ' HB2' ' CE1' ' A' ' 144' ' ' PHE . 94.9 p -56.92 -28.92 62.59 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.138 -0.976 . . . . 0.0 110.134 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.578 ' HB2' ' HA ' ' A' ' 147' ' ' VAL . . . -83.34 -43.16 16.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 109.935 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 149' ' ' SER . 0.1 OUTLIER -52.6 -53.05 52.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.265 -0.897 . . . . 0.0 110.255 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -56.32 -43.3 78.86 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.386 -0.821 . . . . 0.0 109.974 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.49 ' HE2' HG13 ' A' ' 186' ' ' VAL . 3.9 t80 -53.3 -57.45 10.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.384 -0.823 . . . . 0.0 110.175 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.9 mt -53.44 -54.33 38.46 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.208 -0.932 . . . . 0.0 110.349 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -50.57 -30.98 14.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.33 -0.856 . . . . 0.0 110.466 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.516 ' HB2' ' HG3' ' A' ' 205' ' ' LYS . . . -77.71 -33.18 53.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 0.0 110.021 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.878 ' O ' HG22 ' A' ' 162' ' ' ILE . . . -59.33 -44.72 92.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.27 -0.894 . . . . 0.0 110.166 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -79.84 -29.24 40.07 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.36 -0.837 . . . . 0.0 110.307 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -80.62 -6.51 58.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.267 -0.896 . . . . 0.0 110.743 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.878 HG22 ' O ' ' A' ' 159' ' ' ALA . 4.7 tt -92.44 179.66 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.964 -1.085 . . . . 0.0 109.967 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -70.33 62.34 0.23 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.035 -1.04 . . . . 0.0 110.429 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 162' ' ' ILE . 3.9 p-10 40.3 52.33 2.85 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.478 0.656 . . . . 0.0 111.194 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.555 HG23 ' HD2' ' A' ' 166' ' ' PRO . 34.6 mm -88.25 145.41 35.87 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.497 -0.752 . . . . 0.0 109.835 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.555 ' HD2' HG23 ' A' ' 165' ' ' ILE . 43.5 Cg_endo -68.59 91.3 0.41 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.639 1.336 . . . . 0.0 110.759 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.519 ' CZ ' HD13 ' A' ' 162' ' ' ILE . 2.9 m-85 -88.83 133.91 34.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 0.0 110.133 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.639 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -122.43 150.74 16.91 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 5.9 tt -150.04 142.01 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -1.118 . . . . 0.0 110.65 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.1 t -159.23 155.36 26.89 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.125 0.964 . . . . 0.0 110.755 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 85.0 p -116.01 1.04 13.2 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.608 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.404 ' ND2' ' HB2' ' A' ' 174' ' ' ASP . 56.2 t30 -57.56 128.28 36.27 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.085 -1.009 . . . . 0.0 110.34 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.14 -28.05 66.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.271 -0.893 . . . . 0.0 110.224 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.404 ' HB2' ' ND2' ' A' ' 172' ' ' ASN . 0.1 OUTLIER -55.41 -45.61 76.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.112 -0.992 . . . . 0.0 109.838 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 42.8 t -67.68 -29.79 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.2 -0.938 . . . . 0.0 109.573 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -76.5 -44.15 36.45 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.376 -0.828 . . . . 0.0 109.357 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 12.1 t -71.59 -5.75 35.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.539 -0.726 . . . . 0.0 110.499 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.427 ' HD2' ' HA3' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -88.59 -47.12 8.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.993 -1.067 . . . . 0.0 108.888 179.516 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -90.28 8.4 33.49 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.685 -0.634 . . . . 0.0 110.235 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 53.6 67.29 1.03 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.088 -1.007 . . . . 0.0 110.587 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 42.0 mt -117.27 107.5 14.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.112 -0.992 . . . . 0.0 109.88 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.74 -19.49 17.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.0 110.135 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.53 -164.72 2.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.166 -0.959 . . . . 0.0 109.492 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 3.3 p30 -61.51 164.23 6.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.074 -1.016 . . . . 0.0 109.958 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -158.55 153.84 24.96 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.49 HG13 ' HE2' ' A' ' 155' ' ' PHE . 92.8 t -129.59 98.73 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.301 -1.117 . . . . 0.0 109.982 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 140' ' ' VAL . 94.6 t -119.74 158.54 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.275 -0.89 . . . . 0.0 110.111 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.578 HD12 HG12 ' A' ' 212' ' ' ILE . 6.8 tt -109.21 150.48 27.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.085 -1.009 . . . . 0.0 109.572 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.723 ' HB3' HG22 ' A' ' 133' ' ' VAL . 44.4 m-85 -124.63 123.86 40.96 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.938 -1.101 . . . . 0.0 110.511 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.31 174.23 10.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.44 -0.788 . . . . 0.0 110.105 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -94.37 -34.24 12.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.174 -0.954 . . . . 0.0 110.263 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.27 -170.58 2.68 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.388 -0.82 . . . . 0.0 110.948 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 54.68 -160.34 0.16 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.544 0.687 . . . . 0.0 110.5 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -55.02 -53.68 52.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.701 -0.625 . . . . 0.0 110.14 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 130.93 -24.79 4.23 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 24.4 mtm-85 -144.48 178.93 7.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.12 -1.223 . . . . 0.0 110.686 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ASN . . . . . 0.468 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.0 OUTLIER -147.63 -155.11 0.6 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.343 -0.848 . . . . 0.0 109.687 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -169.44 85.48 0.14 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.486 -0.759 . . . . 0.0 110.187 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.419 ' CB ' ' O ' ' A' ' 186' ' ' VAL . 12.5 t80 -57.74 122.32 12.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.279 -0.888 . . . . 0.0 110.433 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -123.33 104.55 9.19 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.251 -0.905 . . . . 0.0 110.24 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 148.79 -167.0 29.31 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.79 134.87 49.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -1.128 . . . . 0.0 110.222 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.618 HG11 ' HZ ' ' A' ' 144' ' ' PHE . 70.7 t -86.04 111.17 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.904 . . . . 0.0 110.348 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.481 HG23 ' C ' ' A' ' 203' ' ' VAL . 68.8 p -149.18 153.96 38.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.472 -0.768 . . . . 0.0 110.097 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.756 ' O ' HD12 ' A' ' 209' ' ' LEU . 0.9 OUTLIER -48.06 -54.35 13.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.937 -179.806 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -54.21 -41.36 68.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.447 -0.783 . . . . 0.0 110.484 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -71.44 -42.87 67.68 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.425 -0.797 . . . . 0.0 110.687 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 71.0 mt -59.7 -51.75 68.43 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.145 -0.972 . . . . 0.0 110.711 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.756 HD12 ' O ' ' A' ' 205' ' ' LYS . 0.7 OUTLIER -54.68 -33.33 60.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.171 -0.955 . . . . 0.0 110.337 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -71.57 -47.62 53.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.216 -0.928 . . . . 0.0 110.3 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -57.95 -55.18 38.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.286 -0.884 . . . . 0.0 110.315 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.578 HG12 HD12 ' A' ' 188' ' ' LEU . 82.3 mt -54.42 -52.89 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.0 110.447 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.486 ' HA ' ' CD1' ' A' ' 217' ' ' LEU . 0.0 OUTLIER -48.21 -23.77 0.97 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.422 -0.799 . . . . 0.0 111.285 -179.391 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -92.19 -20.74 20.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.928 -1.108 . . . . 0.0 110.733 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -93.19 -53.12 4.24 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.034 -1.041 . . . . 0.0 111.516 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.843 ' HG3' HD12 ' A' ' 217' ' ' LEU . 6.9 pt20 -85.57 43.87 1.06 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.033 -1.042 . . . . 0.0 111.306 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.843 HD12 ' HG3' ' A' ' 216' ' ' GLN . 0.2 OUTLIER -154.92 57.11 1.58 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.124 -0.985 . . . . 0.0 110.286 179.776 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.77 80.63 1.44 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.557 1.293 . . . . 0.0 110.59 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 51.59 69.31 0.68 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.899 . . . . 0.0 110.639 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 220' ' ' VAL . 34.1 m -91.24 82.5 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.255 -0.903 . . . . 0.0 110.21 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 8.9 pt -110.04 -178.59 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.169 -0.957 . . . . 0.0 110.407 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.02 65.99 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.267 -0.896 . . . . 0.0 110.352 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.436 ' C ' HG23 ' A' ' 224' ' ' THR . 0.2 OUTLIER -53.64 -36.21 61.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.11 -0.994 . . . . 0.0 110.267 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.436 HG23 ' C ' ' A' ' 223' ' ' PHE . 23.0 p -151.98 161.07 43.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.911 . . . . 0.0 110.121 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.33 -66.82 1.03 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 110.308 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -78.28 85.03 4.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.23 -0.919 . . . . 0.0 110.177 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 7.7 p -89.23 149.76 22.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.871 . . . . 0.0 110.208 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.274 -179.915 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.211 0.529 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -107.05 164.84 11.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.234 -0.916 . . . . 0.0 110.308 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.656 HG22 ' HA2' ' A' ' 168' ' ' GLY . 7.9 t -89.71 170.72 10.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.891 . . . . 0.0 110.257 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 96.1 m -109.14 104.4 13.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 0.0 110.192 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.888 HD21 HD12 ' A' ' 132' ' ' LEU . 85.5 mt -76.78 139.83 66.8 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.261 -0.899 . . . . 0.0 110.191 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 46.4 Cg_endo -72.15 -35.15 7.22 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 O-C-N 123.556 1.292 . . . . 0.0 110.41 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.557 ' C ' HG22 ' A' ' 175' ' ' VAL . 1.0 OUTLIER -165.86 -170.37 1.75 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.235 -0.915 . . . . 0.0 110.932 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.51 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -66.7 -38.03 92.87 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -51.64 -32.97 31.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.231 -1.158 . . . . 0.0 110.4 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.431 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -82.13 -32.21 30.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.896 . . . . 0.0 110.242 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.59 -25.51 26.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.997 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -89.93 -44.63 9.76 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.312 -0.867 . . . . 0.0 109.058 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.3 m -60.51 -28.31 68.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.225 -0.922 . . . . 0.0 109.675 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.888 HD12 HD21 ' A' ' 123' ' ' LEU . 5.8 tt -65.14 -61.74 1.96 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.354 -0.842 . . . . 0.0 109.967 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.493 HG21 ' CB ' ' A' ' 189' ' ' PHE . 86.8 t -50.95 -31.11 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.404 -0.81 . . . . 0.0 110.253 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.34 -12.65 61.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.294 -0.879 . . . . 0.0 110.673 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 35.8 m -75.83 -21.97 56.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.015 -1.053 . . . . 0.0 110.25 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.14 168.98 22.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.296 -0.878 . . . . 0.0 110.432 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -72.05 -19.51 61.82 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.396 -0.815 . . . . 0.0 109.724 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 26.0 m -129.9 141.83 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.279 -0.888 . . . . 0.0 110.311 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.408 ' HB3' ' HA ' ' A' ' 133' ' ' VAL . . . -175.85 137.36 0.34 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.252 -0.905 . . . . 0.0 110.086 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.467 HG11 ' CZ ' ' A' ' 167' ' ' PHE . 14.5 p -123.57 150.49 27.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.18 -0.95 . . . . 0.0 110.351 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 69.9 mt -132.86 110.39 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.371 -0.831 . . . . 0.0 110.099 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.8 123.94 6.84 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.351 -1.499 . . . . 0.0 109.351 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.462 ' CD2' HD12 ' A' ' 181' ' ' LEU . 47.0 m-85 -93.9 80.56 4.15 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.229 -1.159 . . . . 0.0 110.141 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -105.8 140.99 37.99 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.059 -1.026 . . . . 0.0 111.128 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.462 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 61.3 pttt -91.48 -36.18 13.9 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.75 0.785 . . . . 0.0 109.165 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.462 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 4.7 m-20 -122.78 79.97 1.7 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.744 -0.598 . . . . 0.0 109.642 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.433 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 29.7 m -55.26 -19.37 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.239 -0.913 . . . . 0.0 110.708 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.79 11.81 8.49 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.092 -1.005 . . . . 0.0 110.9 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.407 ' O ' ' HG2' ' A' ' 153' ' ' LYS . 91.9 p -87.81 -163.7 0.99 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.912 -1.118 . . . . 0.0 110.102 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -90.17 -42.43 11.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.328 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 55.5 m -62.03 -28.82 69.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 110.493 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.433 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -79.8 -25.66 40.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.183 -0.948 . . . . 0.0 110.265 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 149' ' ' SER . 19.6 mmtt -63.16 -44.83 94.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 110.08 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -62.2 -40.78 97.22 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.275 -0.891 . . . . 0.0 110.214 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.506 ' HE1' HG13 ' A' ' 186' ' ' VAL . 4.6 t80 -50.86 -54.89 19.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.198 -0.939 . . . . 0.0 110.256 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 32.0 mt -52.4 -56.14 16.99 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.397 -0.815 . . . . 0.0 110.233 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -52.74 -49.85 64.61 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.322 -0.862 . . . . 0.0 110.257 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.81 -45.58 82.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.892 . . . . 0.0 110.114 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.451 ' HB2' ' CD2' ' A' ' 167' ' ' PHE . . . -64.71 -31.83 73.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 110.1 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.77 -31.26 72.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.359 -0.838 . . . . 0.0 110.157 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.23 -41.53 88.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 110.245 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 76.0 mt -99.72 140.33 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.929 . . . . 0.0 110.274 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -122.66 16.29 10.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.296 -0.877 . . . . 0.0 110.48 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.403 ' O ' HD13 ' A' ' 165' ' ' ILE . 3.7 p30 -120.35 19.67 12.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.156 -0.965 . . . . 0.0 110.323 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.403 HD13 ' O ' ' A' ' 164' ' ' ASP . 48.1 mm -128.98 132.58 24.46 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.17 -0.956 . . . . 0.0 110.014 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.54 ' HB2' HD21 ' A' ' 132' ' ' LEU . 48.6 Cg_endo -72.72 70.83 3.4 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.515 1.271 . . . . 0.0 110.281 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.467 ' CZ ' HG11 ' A' ' 140' ' ' VAL . 2.2 m-85 -65.54 125.46 25.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 109.954 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.656 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -125.0 149.12 16.93 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 12.4 tt -146.76 144.77 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.286 -1.126 . . . . 0.0 110.318 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.425 ' CG2' HG11 ' A' ' 175' ' ' VAL . 2.2 t -158.15 156.97 31.85 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.022 0.915 . . . . 0.0 110.789 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.5 m -124.17 3.54 8.57 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -60.81 129.89 43.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 0.0 110.279 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 84.4 p -53.52 -29.21 35.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.217 -0.927 . . . . 0.0 110.045 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -56.55 -26.77 55.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.904 . . . . 0.0 109.684 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.557 HG22 ' C ' ' A' ' 125' ' ' ASP . 42.9 t -86.93 -24.75 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.416 -0.803 . . . . 0.0 109.558 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 176' ' ' PHE . 10.6 m-85 -80.0 -47.9 14.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.295 -0.878 . . . . 0.0 109.403 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.81 -11.25 60.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.391 -0.818 . . . . 0.0 110.693 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.426 ' CD ' ' HA3' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -85.55 -50.54 7.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.061 -1.025 . . . . 0.0 109.697 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 179' ' ' TYR . 32.8 m-85 -89.35 13.62 13.12 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.485 -0.759 . . . . 0.0 110.196 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 49.81 65.3 1.45 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.123 -0.985 . . . . 0.0 110.482 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.462 HD12 ' CD2' ' A' ' 143' ' ' PHE . 79.4 mt -118.33 106.4 12.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 110.249 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.41 -30.27 70.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.061 -1.024 . . . . 0.0 109.825 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.17 -149.24 0.35 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.364 -0.835 . . . . 0.0 109.697 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.411 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 45.3 m-20 -78.16 175.42 10.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.007 -1.058 . . . . 0.0 109.748 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -167.63 139.75 5.87 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.459 -1.353 . . . . 0.0 109.924 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.506 HG13 ' HE1' ' A' ' 155' ' ' PHE . 95.0 t -121.33 85.75 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.477 -1.014 . . . . 0.0 109.799 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.7 t -109.86 160.26 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.399 -0.813 . . . . 0.0 110.45 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.649 HD22 ' HB3' ' A' ' 215' ' ' ASN . 2.2 tt -113.15 147.05 38.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.19 -0.944 . . . . 0.0 109.447 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.493 ' CB ' HG21 ' A' ' 133' ' ' VAL . 45.2 m-85 -118.7 125.15 49.05 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.981 -1.075 . . . . 0.0 110.651 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.595 ' HD3' HD23 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -139.92 161.75 36.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.888 . . . . 0.0 109.907 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.0 mmpp? -87.24 -20.65 26.59 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.181 -0.949 . . . . 0.0 110.563 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 190' ' ' LYS . 3.4 p90 -90.87 179.73 5.7 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.292 -0.88 . . . . 0.0 110.823 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 44.55 -158.24 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.551 0.691 . . . . 0.0 111.035 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -50.99 -43.74 60.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.577 -0.702 . . . . 0.0 110.235 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.405 ' HA2' ' HG2' ' A' ' 190' ' ' LYS . . . 112.37 -21.07 20.22 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -137.9 174.26 10.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.099 -1.236 . . . . 0.0 110.735 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ASN . . . . . 0.46 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.0 OUTLIER -144.54 -152.29 0.41 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.502 -0.749 . . . . 0.0 109.515 -179.827 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 27.8 p30 -173.77 76.06 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 0.0 110.548 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -54.01 125.47 18.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -0.938 . . . . 0.0 109.92 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -132.72 33.01 3.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.928 . . . . 0.0 110.096 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -117.96 175.74 15.84 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.77 122.74 10.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -1.157 . . . . 0.0 110.161 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.492 ' C ' HG23 ' A' ' 204' ' ' THR . 78.4 t -65.55 102.75 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.157 -0.965 . . . . 0.0 110.18 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.492 HG23 ' C ' ' A' ' 203' ' ' VAL . 82.1 p -150.11 151.91 33.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.389 -0.819 . . . . 0.0 110.24 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 23.2 tttt -50.44 -50.1 53.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 0.0 110.491 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -53.28 -35.44 60.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.203 -0.936 . . . . 0.0 110.388 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -79.03 -46.76 17.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 0.0 110.147 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.43 ' CD2' HG11 ' A' ' 186' ' ' VAL . 82.8 mt -62.53 -31.02 71.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 110.263 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 19.0 mt -70.44 -26.67 63.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 110.187 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -86.9 -47.69 8.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.166 -0.959 . . . . 0.0 110.039 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -49.45 -50.15 42.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.317 -0.865 . . . . 0.0 110.213 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.498 HD13 HD12 ' A' ' 188' ' ' LEU . 28.2 mm -55.38 -69.26 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.533 -0.729 . . . . 0.0 110.185 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.34 -36.81 4.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.759 -0.588 . . . . 0.0 111.063 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -40.04 95.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.137 -0.977 . . . . 0.0 110.121 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.649 ' HB3' HD22 ' A' ' 188' ' ' LEU . 79.5 m-20 -89.71 -45.04 9.6 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.3 -0.875 . . . . 0.0 110.451 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -41.18 -72.6 0.06 Allowed 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 1.2 mt -112.69 94.62 29.28 Favored Pre-proline 0 C--N 1.301 -1.521 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.662 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.29 110.95 3.2 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.578 1.304 . . . . 0.0 110.359 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.451 ' HA ' HD13 ' A' ' 219' ' ' LEU . 4.1 mm? -103.4 128.23 50.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.146 -0.971 . . . . 0.0 110.152 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.627 ' O ' HG12 ' A' ' 220' ' ' VAL . 45.4 t -125.54 31.67 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.468 -0.77 . . . . 0.0 110.02 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.464 HD12 ' H ' ' A' ' 220' ' ' VAL . 3.9 mp -126.73 146.71 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 110.392 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.52 -29.18 13.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.89 . . . . 0.0 110.268 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -55.79 -38.1 69.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.249 -0.907 . . . . 0.0 110.269 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.2 m 52.11 86.5 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.262 -0.899 . . . . 0.0 110.433 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -152.17 98.32 2.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 110.293 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -75.31 165.42 25.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.239 -0.913 . . . . 0.0 110.214 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 17.1 m -154.67 56.32 0.68 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.884 . . . . 0.0 110.233 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.114 -179.951 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.282 0.563 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -89.04 -174.04 4.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -0.885 . . . . 0.0 110.387 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.432 ' HB ' ' HA2' ' A' ' 168' ' ' GLY . 7.9 m -104.68 116.7 32.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.336 -0.853 . . . . 0.0 109.706 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 79.8 m -69.17 142.01 54.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 0.0 110.191 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.7 mt -124.29 144.41 45.63 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 110.148 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.432 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 45.8 Cg_endo -72.48 -37.42 4.25 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.713 1.375 . . . . 0.0 110.372 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.68 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.9 OUTLIER -173.27 -170.46 0.62 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.205 -0.934 . . . . 0.0 110.687 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.488 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -57.8 -30.59 63.11 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.68 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -51.49 -35.55 40.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.257 -1.143 . . . . 0.0 110.498 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.432 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -82.85 -38.19 23.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.108 -0.995 . . . . 0.0 110.203 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.73 -24.86 24.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.108 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -77.66 -64.16 1.21 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 110.165 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.0 -23.14 12.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 110.139 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.717 HD22 ' HB1' ' A' ' 139' ' ' ALA . 2.1 tt -64.76 -59.48 4.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 0.0 109.946 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.74 HG22 ' HB3' ' A' ' 189' ' ' PHE . 56.4 t -50.49 -41.53 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.37 -0.831 . . . . 0.0 110.562 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -80.22 1.72 27.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.919 . . . . 0.0 110.931 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 17.5 t -82.71 -27.38 31.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.898 -1.126 . . . . 0.0 110.051 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.42 171.59 16.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.262 -0.899 . . . . 0.0 110.168 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.25 -20.15 63.94 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.335 -0.853 . . . . 0.0 109.583 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 18.2 m -135.13 149.15 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.259 -0.901 . . . . 0.0 110.169 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.717 ' HB1' HD22 ' A' ' 132' ' ' LEU . . . -173.64 138.06 0.65 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.233 -0.917 . . . . 0.0 110.232 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.43 ' CG1' ' HA ' ' A' ' 167' ' ' PHE . 7.2 p -125.99 153.67 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 121.072 -1.017 . . . . 0.0 110.365 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.422 ' O ' ' CE1' ' A' ' 143' ' ' PHE . 52.9 mt -137.96 114.5 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 109.905 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.56 136.69 18.33 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.715 ' CE2' HG12 ' A' ' 175' ' ' VAL . 67.6 m-85 -112.97 72.84 0.79 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.299 -1.118 . . . . 0.0 110.014 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.417 ' CE1' ' HB3' ' A' ' 184' ' ' ASP . 10.8 m-85 -102.35 142.7 33.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 111.051 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.88 -27.38 23.46 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.765 0.793 . . . . 0.0 109.494 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.7 p30 -126.24 69.63 1.22 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.694 -0.629 . . . . 0.0 109.616 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.499 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 31.4 m -50.41 -23.27 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.725 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.16 -9.47 57.81 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.115 -0.991 . . . . 0.0 111.296 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 52.7 p -69.95 -159.69 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.894 -1.129 . . . . 0.0 110.333 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -90.35 -45.74 8.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.386 -0.822 . . . . 0.0 110.267 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.9 p -52.32 -30.0 26.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.318 -0.864 . . . . 0.0 110.224 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.499 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -83.24 -34.99 25.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.372 -0.83 . . . . 0.0 110.174 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.2 mmtt -49.89 -40.1 41.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.309 -0.87 . . . . 0.0 110.357 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -65.8 -45.03 83.9 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.288 -0.882 . . . . 0.0 110.002 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.44 ' HE1' HG13 ' A' ' 186' ' ' VAL . 5.7 t80 -48.05 -55.4 10.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.273 -0.892 . . . . 0.0 110.597 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.0 mt -48.59 -54.6 13.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.277 -0.89 . . . . 0.0 110.667 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -52.23 -51.61 57.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.217 -0.927 . . . . 0.0 110.171 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' A' ' 205' ' ' LYS . . . -60.0 -39.37 85.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.145 -0.972 . . . . 0.0 109.824 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.39 -32.21 71.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.343 -0.848 . . . . 0.0 110.066 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -80.62 -29.48 36.8 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.314 -0.866 . . . . 0.0 110.277 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.468 ' HB3' HD21 ' A' ' 209' ' ' LEU . . . -54.16 -52.21 61.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -0.893 . . . . 0.0 110.365 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.401 HG13 ' OD2' ' A' ' 164' ' ' ASP . 19.0 tt -89.79 150.04 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 110.064 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -132.57 35.77 3.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.108 -0.995 . . . . 0.0 110.661 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.722 ' O ' HD13 ' A' ' 165' ' ' ILE . 3.5 p30 -136.05 17.79 3.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.169 -0.957 . . . . 0.0 110.228 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.722 HD13 ' O ' ' A' ' 164' ' ' ASP . 39.5 mm -135.17 146.5 58.53 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.238 -0.914 . . . . 0.0 109.923 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.467 ' HD2' ' CG2' ' A' ' 165' ' ' ILE . 47.6 Cg_endo -84.18 90.83 0.85 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.779 1.41 . . . . 0.0 110.248 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.43 ' HA ' ' CG1' ' A' ' 140' ' ' VAL . 3.9 m-85 -85.81 130.93 34.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.29 -0.882 . . . . 0.0 110.554 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.432 ' HA2' ' HB ' ' A' ' 121' ' ' THR . . . -120.01 153.07 16.86 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 14.7 tt -147.42 144.36 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -1.125 . . . . 0.0 110.305 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.707 HG21 HG11 ' A' ' 175' ' ' VAL . 2.5 t -162.17 157.58 23.36 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.064 0.935 . . . . 0.0 110.693 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.1 1.58 9.2 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.411 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -59.41 121.52 11.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.115 -0.991 . . . . 0.0 110.259 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 79.4 p -51.65 -29.99 20.02 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.096 -1.002 . . . . 0.0 110.296 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -59.19 -35.6 73.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.136 -0.978 . . . . 0.0 109.842 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.715 HG12 ' CE2' ' A' ' 143' ' ' PHE . 60.3 t -76.85 -26.54 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.39 -0.819 . . . . 0.0 109.812 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -79.59 -53.26 7.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.395 -0.816 . . . . 0.0 109.865 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -25.45 63.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.955 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.43 -53.01 62.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 110.037 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -92.83 16.99 11.21 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.222 -0.923 . . . . 0.0 110.409 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 53.54 69.47 0.7 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.249 -0.907 . . . . 0.0 110.603 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 77.6 mt -115.02 123.01 47.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.212 -0.93 . . . . 0.0 110.024 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -86.39 -21.01 27.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.166 -0.959 . . . . 0.0 110.19 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -148.84 -166.14 2.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.329 -0.857 . . . . 0.0 109.914 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.417 ' HB3' ' CE1' ' A' ' 144' ' ' PHE . 71.2 m-20 -53.46 152.33 4.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.938 . . . . 0.0 109.997 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -157.77 131.74 2.96 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.44 HG13 ' HE1' ' A' ' 155' ' ' PHE . 72.8 t -115.21 85.69 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.356 -1.085 . . . . 0.0 109.619 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.555 HG13 ' H ' ' A' ' 197' ' ' ASN . 85.5 t -102.72 149.25 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.371 -0.831 . . . . 0.0 110.18 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.696 HD23 ' HD3' ' A' ' 190' ' ' LYS . 5.3 tt -105.53 150.59 25.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.122 -0.986 . . . . 0.0 109.627 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.74 ' HB3' HG22 ' A' ' 133' ' ' VAL . 46.1 m-85 -119.52 121.19 38.85 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.931 -1.106 . . . . 0.0 110.554 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.696 ' HD3' HD23 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -136.33 160.76 37.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 0.0 110.171 179.815 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -85.53 -22.94 27.91 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.312 -0.868 . . . . 0.0 110.556 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 190' ' ' LYS . 2.5 p90 -90.45 -176.29 4.73 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.392 -0.817 . . . . 0.0 110.865 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 193' ' ' ASP . 0.7 OUTLIER 46.52 -157.97 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.481 0.658 . . . . 0.0 110.511 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -54.83 -54.96 35.53 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.475 -0.766 . . . . 0.0 110.094 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 134.47 -31.61 2.74 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -131.56 173.09 11.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.157 -1.202 . . . . 0.0 110.66 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ASN . . . . . 0.555 ' H ' HG13 ' A' ' 187' ' ' VAL . 1.6 m-80 -138.21 -151.51 0.39 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.515 -0.741 . . . . 0.0 109.673 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -175.6 77.0 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.356 -0.84 . . . . 0.0 110.051 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -48.41 142.84 5.3 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.329 -0.857 . . . . 0.0 110.915 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -150.29 134.98 17.48 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.31 -0.869 . . . . 0.0 109.649 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 125.08 -178.39 16.55 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -54.98 121.15 8.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -1.139 . . . . 0.0 110.232 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 75.8 t -74.91 102.57 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.191 -0.943 . . . . 0.0 110.212 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.3 p -136.6 145.26 44.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.367 -0.833 . . . . 0.0 109.705 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.521 ' HA ' HD12 ' A' ' 208' ' ' LEU . 0.1 OUTLIER -48.08 -47.53 34.05 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.157 -0.964 . . . . 0.0 110.838 -179.722 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -59.11 -40.49 85.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.24 -0.912 . . . . 0.0 110.458 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -67.68 -39.53 84.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.123 -0.986 . . . . 0.0 110.407 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.812 ' O ' HD12 ' A' ' 212' ' ' ILE . 36.7 mt -63.42 -52.63 60.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 110.41 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.468 HD21 ' HB3' ' A' ' 161' ' ' ALA . 6.9 mt -51.69 -24.39 5.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.172 -0.955 . . . . 0.0 110.407 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -82.4 -48.76 10.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.17 -0.956 . . . . 0.0 110.031 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -53.27 -57.22 11.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 110.474 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.812 HD12 ' O ' ' A' ' 208' ' ' LEU . 4.4 mt -49.79 -54.2 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.179 -0.95 . . . . 0.0 110.61 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.29 -29.45 9.74 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.286 -0.884 . . . . 0.0 110.66 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -81.45 -15.97 53.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.31 -0.869 . . . . 0.0 110.782 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.664 ' HB3' HD22 ' A' ' 188' ' ' LEU . 74.5 m-20 -104.77 -35.52 7.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.08 -1.013 . . . . 0.0 110.849 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.443 ' OE1' HG22 ' A' ' 212' ' ' ILE . 13.7 pt20 -78.42 -9.0 59.11 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.13 -0.982 . . . . 0.0 110.949 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.44 HD23 HG21 ' A' ' 220' ' ' VAL . 19.6 mt -136.99 69.28 57.52 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 120.973 -1.079 . . . . 0.0 110.466 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.26 93.34 0.98 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.615 1.324 . . . . 0.0 110.571 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 48.1 mt 42.63 76.58 0.07 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.677 -0.639 . . . . 0.0 111.379 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.44 HG21 HD23 ' A' ' 217' ' ' LEU . 96.6 t -92.71 131.03 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.335 -0.853 . . . . 0.0 110.256 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 36.1 pt -135.24 160.24 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.192 -0.942 . . . . 0.0 110.341 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -131.29 -77.15 0.52 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.882 . . . . 0.0 110.137 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -100.26 74.58 1.76 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 0.0 110.044 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 41.1 p -121.43 -177.11 3.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 110.317 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -122.69 154.82 37.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -0.892 . . . . 0.0 110.176 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -105.98 113.33 26.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.0 110.258 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 15.6 m -138.47 55.23 1.75 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.193 -0.942 . . . . 0.0 110.181 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.193 179.997 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.165 0.507 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 167' ' ' PHE . . . -97.31 -169.04 1.79 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -0.881 . . . . 0.0 110.111 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.576 ' O ' HG22 ' A' ' 169' ' ' ILE . 7.2 t -145.31 152.32 39.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.154 -0.966 . . . . 0.0 110.048 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 169' ' ' ILE . 1.5 m -86.15 125.49 33.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.067 -1.02 . . . . 0.0 109.891 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.955 ' HB2' HG23 ' A' ' 170' ' ' THR . 71.0 mt -88.47 130.87 43.94 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.88 -1.137 . . . . 0.0 110.297 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.44 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 48.6 Cg_endo -72.68 -51.21 0.19 Allowed 'Trans proline' 0 C--N 1.315 -1.207 0 O-C-N 123.422 1.222 . . . . 0.0 110.556 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.687 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.5 OUTLIER -141.9 -169.43 2.91 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.247 -0.908 . . . . 0.0 110.778 -179.84 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.94 -27.04 72.87 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.687 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -59.13 -27.48 65.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.205 -1.173 . . . . 0.0 110.237 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.44 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -90.05 -21.28 22.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.944 . . . . 0.0 110.227 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.95 -21.88 50.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 110.252 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -90.31 -40.75 11.93 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.27 -0.894 . . . . 0.0 109.623 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.83 -31.18 66.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.147 -0.971 . . . . 0.0 110.385 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.4 tp -68.69 -43.98 74.95 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.296 -0.877 . . . . 0.0 110.391 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.837 HG22 ' HB3' ' A' ' 189' ' ' PHE . 46.2 t -51.56 -53.99 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.339 -0.85 . . . . 0.0 110.519 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.27 -17.84 60.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.196 -0.94 . . . . 0.0 110.471 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.6 p -53.3 -38.6 63.27 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.126 -0.984 . . . . 0.0 110.331 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.401 ' OG ' ' HG3' ' A' ' 166' ' ' PRO . 2.3 p -147.27 -172.77 4.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.301 -0.875 . . . . 0.0 110.249 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.06 -45.8 47.17 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.341 -0.85 . . . . 0.0 110.362 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.4 m -116.76 151.63 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.938 . . . . 0.0 110.464 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.434 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -175.26 127.11 0.26 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.911 . . . . 0.0 109.934 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.83 153.03 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.102 -0.999 . . . . 0.0 110.02 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.683 HG23 HD11 ' A' ' 123' ' ' LEU . 56.8 mt -139.98 114.74 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.144 -0.972 . . . . 0.0 110.47 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.0 132.4 11.06 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.709 ' CE2' HG12 ' A' ' 175' ' ' VAL . 18.7 m-85 -100.68 92.3 5.03 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.243 -1.151 . . . . 0.0 109.679 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.555 ' HZ ' HG21 ' A' ' 203' ' ' VAL . 25.1 m-85 -114.78 147.31 39.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.065 -1.022 . . . . 0.0 111.536 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.76 -26.85 19.28 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.57 0.7 . . . . 0.0 109.652 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.03 78.49 1.68 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.607 -0.683 . . . . 0.0 109.603 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.499 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 22.2 m -50.77 -23.2 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.289 -0.882 . . . . 0.0 110.69 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -72.5 -3.59 25.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.0 110.899 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 7.4 p -78.61 -164.73 0.61 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.851 -1.155 . . . . 0.0 110.161 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.2 -47.52 7.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.277 -0.889 . . . . 0.0 110.436 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.2 m -51.14 -27.34 8.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.24 -0.913 . . . . 0.0 110.541 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.499 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -81.16 -40.48 23.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.931 . . . . 0.0 110.026 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.8 mtpt -50.95 -47.07 61.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.354 -0.841 . . . . 0.0 110.317 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -53.63 -33.73 56.11 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.118 -0.989 . . . . 0.0 109.689 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.424 ' CE1' HG11 ' A' ' 186' ' ' VAL . 4.0 t80 -66.96 -56.65 9.26 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.405 -0.809 . . . . 0.0 109.935 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 152' ' ' ALA . 1.3 mp -46.71 -55.98 6.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.535 -0.728 . . . . 0.0 110.649 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -51.17 -46.73 62.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.35 -0.844 . . . . 0.0 110.292 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.544 ' HB2' ' HG3' ' A' ' 205' ' ' LYS . . . -65.27 -45.59 83.88 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.944 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.79 -38.03 71.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.21 -0.931 . . . . 0.0 109.971 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.35 -28.2 59.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.193 -0.942 . . . . 0.0 110.051 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.21 -42.09 76.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.869 . . . . 0.0 110.201 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.46 ' CD1' HG13 ' A' ' 165' ' ' ILE . 5.5 tt -96.41 152.06 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 110.343 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -131.22 15.35 5.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.272 -0.892 . . . . 0.0 110.558 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.696 ' O ' HD13 ' A' ' 165' ' ' ILE . 4.1 p30 -124.05 16.14 9.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.077 -1.014 . . . . 0.0 110.415 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.696 HD13 ' O ' ' A' ' 164' ' ' ASP . 39.4 mm -132.49 146.27 60.77 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.176 -0.952 . . . . 0.0 110.016 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.472 ' HD2' ' CG2' ' A' ' 165' ' ' ILE . 46.4 Cg_endo -84.34 78.93 2.7 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.747 1.393 . . . . 0.0 110.495 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 120' ' ' ALA . 3.6 m-85 -77.29 135.03 38.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 0.0 110.221 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 141' ' ' ILE . . . -136.06 153.62 21.55 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.576 HG22 ' O ' ' A' ' 121' ' ' THR . 1.7 tt -130.85 151.09 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.173 -1.192 . . . . 0.0 109.451 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' THR . . . . . 1.063 HG21 HG11 ' A' ' 175' ' ' VAL . 0.7 OUTLIER -119.36 144.61 46.78 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.1 -1.0 . . . . 0.0 110.94 -178.577 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 144' ' ' PHE . 2.5 t -130.85 12.89 5.29 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.503 -0.748 . . . . 0.0 109.814 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.437 ' ND2' ' HB2' ' A' ' 174' ' ' ASP . 50.8 t30 -112.36 160.76 17.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.068 -1.02 . . . . 0.0 110.893 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 39.6 t -83.29 -28.43 29.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.448 -0.782 . . . . 0.0 109.966 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.437 ' HB2' ' ND2' ' A' ' 172' ' ' ASN . 1.7 m-20 -53.8 -32.01 51.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -0.947 . . . . 0.0 109.519 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 1.063 HG11 HG21 ' A' ' 170' ' ' THR . 38.4 t -76.89 -32.17 19.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -69.83 -59.13 3.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.477 -0.765 . . . . 0.0 109.215 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.6 m -53.18 -23.76 9.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.444 -0.785 . . . . 0.0 109.514 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.474 ' HD2' ' CE1' ' A' ' 179' ' ' TYR . 3.4 tmtt? -61.31 -61.38 2.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.525 -0.734 . . . . 0.0 110.067 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.474 ' CE1' ' HD2' ' A' ' 178' ' ' LYS . 94.1 m-85 -89.58 8.39 31.52 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.47 -0.769 . . . . 0.0 110.645 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.9 62.68 2.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.039 -1.038 . . . . 0.0 110.55 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 mt -92.83 134.41 35.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.282 -0.886 . . . . 0.0 110.11 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -73.67 -9.72 58.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 110.587 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -175.94 -165.91 0.17 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.022 -1.049 . . . . 0.0 110.067 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -70.01 152.33 44.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.21 -0.931 . . . . 0.0 110.015 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -177.21 166.86 37.71 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 186' ' ' VAL . 18.6 m -126.22 121.88 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -1.154 . . . . 0.0 110.328 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 89.8 t -118.39 158.84 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.452 -0.78 . . . . 0.0 109.5 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.673 HD13 ' HB2' ' A' ' 215' ' ' ASN . 7.1 tt -107.27 140.2 40.54 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.826 -1.171 . . . . 0.0 109.8 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.837 ' HB3' HG22 ' A' ' 133' ' ' VAL . 49.6 m-85 -117.38 111.15 18.94 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.995 -1.066 . . . . 0.0 110.598 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.625 ' HD3' HD23 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -124.22 -172.81 2.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.27 -0.894 . . . . 0.0 110.06 179.852 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 11.5 mttt -106.62 -26.04 11.53 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.128 -0.983 . . . . 0.0 110.526 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -90.83 -175.89 4.51 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.381 -0.824 . . . . 0.0 110.829 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 47.68 -159.06 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.54 -0.725 . . . . 0.0 110.887 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -52.98 -43.54 66.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.662 -0.649 . . . . 0.0 110.294 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 113.9 -27.08 9.43 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 11.8 mtm180 -135.76 163.98 28.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.184 -1.186 . . . . 0.0 110.386 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ASN . . . . . 0.486 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 0.8 OUTLIER -136.49 -153.82 0.52 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.342 -0.848 . . . . 0.0 109.796 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -172.89 80.84 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.421 -0.799 . . . . 0.0 110.267 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -48.61 119.67 3.24 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.341 -0.849 . . . . 0.0 110.634 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -113.77 90.2 3.28 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.275 -0.89 . . . . 0.0 110.288 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 164.4 -165.44 37.3 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -74.85 117.88 17.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -1.145 . . . . 0.0 110.278 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.609 HG13 ' O ' ' A' ' 203' ' ' VAL . 6.9 p -66.95 83.28 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 110.091 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 81.4 p -121.24 153.83 37.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 0.0 110.212 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.544 ' HG3' ' HB2' ' A' ' 158' ' ' ALA . 0.6 OUTLIER -46.93 -55.18 8.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.372 -0.83 . . . . 0.0 110.543 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -54.74 -30.67 56.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.477 -0.764 . . . . 0.0 110.236 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -86.95 -23.96 24.92 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.228 -0.92 . . . . 0.0 110.248 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.881 ' O ' HD12 ' A' ' 212' ' ' ILE . 18.7 mt -75.54 -53.46 8.6 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.295 -0.878 . . . . 0.0 110.541 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 4.7 mp -57.58 -20.57 33.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.88 . . . . 0.0 110.633 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -81.94 -53.74 5.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.152 -0.968 . . . . 0.0 110.15 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -60.69 -55.64 30.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.33 -0.856 . . . . 0.0 110.677 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.881 HD12 ' O ' ' A' ' 208' ' ' LEU . 8.1 mt -51.57 -41.98 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.227 -0.921 . . . . 0.0 110.695 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -69.58 -15.01 63.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.122 -0.986 . . . . 0.0 110.836 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.64 -16.83 27.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.129 -0.982 . . . . 0.0 110.795 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.673 ' HB2' HD13 ' A' ' 188' ' ' LEU . 73.5 m-80 -103.69 -39.63 6.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.995 -1.066 . . . . 0.0 110.862 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.515 ' OE1' HG22 ' A' ' 212' ' ' ILE . 15.1 pt20 -64.29 -17.54 63.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.071 -1.018 . . . . 0.0 110.519 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.1 mt -119.32 93.49 47.21 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.131 -0.98 . . . . 0.0 110.248 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -72.95 171.1 18.18 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.657 1.346 . . . . 0.0 110.42 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.1 mt 50.57 96.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.227 -0.921 . . . . 0.0 110.584 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.584 ' O ' HG12 ' A' ' 220' ' ' VAL . 43.1 t -105.03 42.24 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 110.112 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.649 ' O ' HG23 ' A' ' 221' ' ' ILE . 5.1 tt -155.73 101.22 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.237 -0.914 . . . . 0.0 110.363 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 51.88 -170.21 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.277 -0.889 . . . . 0.0 110.529 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 223' ' ' PHE . 28.9 p90 -146.56 -170.7 3.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.315 -0.865 . . . . 0.0 110.107 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 7.2 t -160.71 -176.84 5.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.202 -0.936 . . . . 0.0 110.305 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.458 ' O ' HG23 ' A' ' 227' ' ' THR . 36.4 mt-10 -117.24 -161.5 0.82 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.208 -0.932 . . . . 0.0 110.213 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 53.15 44.17 30.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.191 -0.943 . . . . 0.0 110.327 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 225' ' ' GLU . 13.1 p -128.15 162.01 27.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 110.241 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.284 179.895 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.218 0.532 . . . . 0.0 110.084 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 167' ' ' PHE . . . -83.4 145.9 28.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.181 -0.949 . . . . 0.0 110.197 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.515 HG22 ' HA2' ' A' ' 168' ' ' GLY . 11.6 t -92.14 164.71 13.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 110.305 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 91.1 m -101.91 100.72 11.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.928 . . . . 0.0 110.149 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.54 HD12 HG23 ' A' ' 141' ' ' ILE . 45.4 mt -75.93 131.68 75.71 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.284 -0.885 . . . . 0.0 110.081 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.402 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 47.6 Cg_endo -72.34 -36.95 4.83 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 O-C-N 123.52 1.273 . . . . 0.0 110.485 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.593 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.0 OUTLIER -163.26 -169.5 2.0 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 122.073 0.939 . . . . 0.0 111.262 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.4 ' HA3' ' HD2' ' A' ' 178' ' ' LYS . . . -60.67 -27.2 65.95 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.593 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -55.62 -29.26 58.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -1.141 . . . . 0.0 110.278 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.524 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -90.43 -26.02 20.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.278 -0.888 . . . . 0.0 110.171 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.09 68.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.866 . . . . 0.0 110.119 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -90.26 -40.97 11.84 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.23 -0.918 . . . . 0.0 109.188 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 41.4 m -66.71 -22.68 66.06 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.233 -0.917 . . . . 0.0 110.147 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.58 HD23 HD11 ' A' ' 141' ' ' ILE . 9.0 tp -69.95 -50.76 38.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 110.429 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 91.3 t -58.21 -37.82 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.298 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -77.86 -17.36 57.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 110.419 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.5 p -63.84 -44.76 92.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.035 -1.041 . . . . 0.0 110.303 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 89.4 p -138.2 -173.72 3.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -0.882 . . . . 0.0 110.26 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.19 -44.93 74.75 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.273 -0.892 . . . . 0.0 110.258 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.624 HG21 HD12 ' A' ' 165' ' ' ILE . 33.6 m -120.53 163.71 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.261 -0.899 . . . . 0.0 110.453 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -176.38 125.42 0.18 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.411 -0.806 . . . . 0.0 109.634 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.509 HG11 ' CE2' ' A' ' 167' ' ' PHE . 8.2 p -112.29 139.64 36.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.049 -1.032 . . . . 0.0 110.781 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.58 HD11 HD23 ' A' ' 132' ' ' LEU . 3.4 mt -130.97 113.58 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.316 -0.865 . . . . 0.0 109.671 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.76 136.68 20.34 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.771 ' CE2' HG12 ' A' ' 175' ' ' VAL . 28.6 m-85 -105.87 69.07 0.8 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -1.134 . . . . 0.0 109.715 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.571 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 22.6 m-85 -95.37 145.79 24.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 110.835 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.04 -27.15 24.95 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.51 -0.744 . . . . 0.0 109.724 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.85 78.56 1.75 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.528 -0.733 . . . . 0.0 109.677 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.521 ' O ' ' HB3' ' A' ' 152' ' ' ALA . 22.6 m -51.12 -23.08 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.242 -0.911 . . . . 0.0 110.561 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -76.94 1.01 18.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.06 -1.025 . . . . 0.0 110.933 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 95.1 p -75.55 -164.89 0.37 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.835 -1.166 . . . . 0.0 110.31 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.435 ' HA ' ' HG3' ' A' ' 153' ' ' LYS . 0.3 OUTLIER -90.63 -34.36 15.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.324 -0.86 . . . . 0.0 110.603 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 38.6 t -68.32 -27.88 66.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.263 -0.898 . . . . 0.0 110.269 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.684 ' O ' HD12 ' A' ' 156' ' ' LEU . . . -78.47 -34.04 47.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.142 -0.973 . . . . 0.0 109.939 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.435 ' HG3' ' HA ' ' A' ' 150' ' ' ASP . 2.7 mmmt -53.78 -52.06 61.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 0.0 110.065 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -54.94 -33.68 62.49 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.263 -0.898 . . . . 0.0 109.787 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.652 ' CE1' HG11 ' A' ' 186' ' ' VAL . 4.3 t80 -60.06 -57.4 13.01 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.457 -0.777 . . . . 0.0 109.903 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.684 HD12 ' O ' ' A' ' 152' ' ' ALA . 3.6 mp -46.74 -57.04 5.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.508 -0.745 . . . . 0.0 110.591 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -52.36 -52.42 53.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.292 -0.88 . . . . 0.0 110.093 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.02 -38.64 79.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 0.0 109.907 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -68.11 -31.88 71.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -0.872 . . . . 0.0 109.813 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -80.82 -24.17 38.67 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.3 -0.875 . . . . 0.0 110.045 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.78 -40.34 94.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.31 -0.869 . . . . 0.0 110.072 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.416 HG21 ' CE1' ' A' ' 167' ' ' PHE . 1.5 tt -89.98 151.04 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.33 -0.856 . . . . 0.0 109.978 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.59 16.28 4.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.157 -0.965 . . . . 0.0 110.665 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.62 ' O ' HD13 ' A' ' 165' ' ' ILE . 5.8 p-10 -125.5 14.21 8.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.029 -1.045 . . . . 0.0 110.604 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.624 HD12 HG21 ' A' ' 138' ' ' VAL . 47.8 mm -134.91 135.53 23.35 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.018 -1.051 . . . . 0.0 110.15 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -78.3 81.62 2.68 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.543 1.286 . . . . 0.0 110.873 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.509 ' CE2' HG11 ' A' ' 140' ' ' VAL . 5.4 m-85 -71.14 145.19 49.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.133 -0.979 . . . . 0.0 109.857 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.515 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -137.65 159.29 24.88 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 121' ' ' THR . 4.4 tt -150.75 149.34 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -1.165 . . . . 0.0 110.304 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.447 HG21 HG11 ' A' ' 175' ' ' VAL . 3.3 t -168.82 157.12 8.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.188 -0.945 . . . . 0.0 111.005 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.447 ' HA ' ' CE1' ' A' ' 176' ' ' PHE . 87.6 p -125.54 2.84 7.62 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.378 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -61.73 124.2 20.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.171 -0.956 . . . . 0.0 110.248 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.06 -31.52 7.96 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.189 -0.945 . . . . 0.0 110.553 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.43 -41.78 66.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 110.023 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.771 HG12 ' CE2' ' A' ' 143' ' ' PHE . 61.3 t -75.54 -24.01 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.299 -0.875 . . . . 0.0 109.963 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.447 ' CE1' ' HA ' ' A' ' 171' ' ' SER . 10.6 m-85 -77.28 -54.29 6.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.891 . . . . 0.0 109.721 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.34 -21.86 60.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.367 -0.833 . . . . 0.0 110.085 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.4 ' HD2' ' HA3' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -62.95 -58.79 6.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 110.086 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.42 ' O ' ' HG2' ' A' ' 180' ' ' GLN . 96.3 m-85 -94.78 30.47 2.06 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.194 -0.941 . . . . 0.0 110.456 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 0.1 OUTLIER 29.57 62.02 0.16 Allowed 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 179.728 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.9 mt -89.61 128.24 36.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.073 -1.017 . . . . 0.0 109.962 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.29 -3.86 29.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.933 . . . . 0.0 110.74 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -174.77 -147.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.99 -1.069 . . . . 0.0 109.876 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -89.14 150.32 22.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.191 -0.943 . . . . 0.0 109.974 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -179.82 137.61 3.13 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.652 HG11 ' CE1' ' A' ' 155' ' ' PHE . 18.8 m -100.59 119.27 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.274 -1.133 . . . . 0.0 110.357 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.831 HG22 ' HA ' ' A' ' 198' ' ' ASN . 98.0 t -121.39 150.35 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.924 . . . . 0.0 110.029 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.91 HD22 ' HB3' ' A' ' 215' ' ' ASN . 6.3 tt -106.39 144.29 33.28 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.217 -0.927 . . . . 0.0 108.903 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -119.83 122.0 40.36 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.896 -1.127 . . . . 0.0 110.545 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.504 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -130.14 165.4 22.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 110.116 179.687 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.4 mmtm -84.32 -33.29 23.94 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.297 -0.877 . . . . 0.0 110.396 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.504 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.2 OUTLIER -90.9 -173.65 3.76 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.54 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 56.11 -153.86 0.34 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.23 -0.919 . . . . 0.0 110.076 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -71.93 -24.87 61.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.7 -0.625 . . . . 0.0 110.378 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 103.4 -30.53 10.16 Favored Glycine 0 N--CA 1.484 1.861 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -130.3 175.75 8.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.125 -1.221 . . . . 0.0 110.454 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ASN . . . . . 0.509 ' HB3' ' CZ ' ' A' ' 211' ' ' PHE . 1.7 m-80 -139.7 -44.64 0.44 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.322 -0.861 . . . . 0.0 110.227 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.831 ' HA ' HG22 ' A' ' 187' ' ' VAL . 0.3 OUTLIER 63.66 87.42 0.11 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.346 -0.846 . . . . 0.0 109.839 -179.308 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -57.85 134.74 56.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.448 -0.783 . . . . 0.0 110.472 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -130.63 114.84 15.93 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.273 -0.892 . . . . 0.0 109.831 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 139.95 -128.61 3.96 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -115.16 125.3 53.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.238 -1.154 . . . . 0.0 110.272 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.571 HG11 ' HZ ' ' A' ' 144' ' ' PHE . 70.8 t -74.78 107.02 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 110.029 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.452 HG23 ' C ' ' A' ' 203' ' ' VAL . 50.0 p -148.0 158.69 44.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.326 -0.859 . . . . 0.0 110.161 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.54 ' O ' HD12 ' A' ' 209' ' ' LEU . 5.1 tttt -49.22 -52.61 25.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.216 -0.927 . . . . 0.0 110.804 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -57.56 -37.15 72.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.315 -0.866 . . . . 0.0 110.429 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 45.2 m-20 -81.65 -42.89 19.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.435 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.839 ' O ' HD12 ' A' ' 212' ' ' ILE . 51.1 mt -57.86 -54.71 43.83 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.226 -0.921 . . . . 0.0 110.257 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.54 HD12 ' O ' ' A' ' 205' ' ' LYS . 0.4 OUTLIER -54.54 -28.19 43.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.148 -0.97 . . . . 0.0 109.748 179.732 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -77.05 -43.62 33.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.414 -0.804 . . . . 0.0 109.691 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.509 ' CZ ' ' HB3' ' A' ' 197' ' ' ASN . 8.4 t80 -62.01 -59.85 4.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.418 -0.801 . . . . 0.0 110.025 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.839 HD12 ' O ' ' A' ' 208' ' ' LEU . 4.7 mt -50.1 -40.47 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.306 -0.871 . . . . 0.0 110.375 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -66.04 -32.3 73.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.332 -0.855 . . . . 0.0 110.07 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' HIS . . . . . 0.656 ' HA ' HD12 ' A' ' 217' ' ' LEU . 60.2 t-80 -90.44 8.38 34.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.275 -0.89 . . . . 0.0 110.716 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.91 ' HB3' HD22 ' A' ' 188' ' ' LEU . 6.8 m120 -95.55 -61.99 1.37 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.892 -1.13 . . . . 0.0 110.165 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -70.34 62.04 0.23 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.308 -0.87 . . . . 0.0 110.557 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.656 HD12 ' HA ' ' A' ' 214' ' ' HIS . 24.7 mt -138.06 97.39 9.82 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.881 . . . . 0.0 110.2 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.57 99.2 0.92 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.676 1.356 . . . . 0.0 110.326 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 37.4 mt -80.27 56.21 2.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.274 -0.891 . . . . 0.0 110.388 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.555 ' O ' HG13 ' A' ' 220' ' ' VAL . 14.5 p -96.58 57.01 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.927 . . . . 0.0 110.258 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 3.1 mt -70.24 92.97 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 110.237 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -138.32 25.78 2.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.135 -0.978 . . . . 0.0 110.104 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -74.63 -175.54 2.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.396 -0.815 . . . . 0.0 110.267 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 224' ' ' THR . 5.9 t -106.28 33.67 3.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.218 -0.926 . . . . 0.0 110.249 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -104.1 -50.32 3.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.875 . . . . 0.0 110.13 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 53.01 58.27 5.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.29 -0.881 . . . . 0.0 110.329 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 57.6 m -137.92 -51.59 0.61 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 110.336 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.206 179.98 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.548 ' HB1' ' HB3' ' A' ' 159' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.304 0.573 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.502 ' HB1' ' CA ' ' A' ' 168' ' ' GLY . . . -129.06 166.54 19.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.255 -0.903 . . . . 0.0 110.051 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.525 HG22 ' HA2' ' A' ' 168' ' ' GLY . 12.8 t -82.54 162.03 22.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.093 -1.004 . . . . 0.0 109.917 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.1 m -97.42 119.87 36.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.951 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.669 HD22 ' HB1' ' A' ' 128' ' ' ALA . 40.7 mt -105.92 134.13 19.88 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.95 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.22 -39.16 1.72 Allowed 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.466 1.245 . . . . 0.0 110.054 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.47 ' C ' HG22 ' A' ' 175' ' ' VAL . 0.4 OUTLIER -158.37 -169.31 2.72 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.056 0.932 . . . . 0.0 110.873 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.408 ' HA3' ' HD3' ' A' ' 178' ' ' LYS . . . -63.11 -21.92 64.4 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.77 -27.78 63.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -1.113 . . . . 0.0 110.389 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.669 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -88.45 -31.95 18.52 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.093 -1.004 . . . . 0.0 110.061 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -55.17 -22.02 15.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 109.913 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -89.17 -35.61 16.14 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.299 -0.875 . . . . 0.0 109.025 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.0 m -69.89 -23.94 63.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 109.967 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.2 tp -72.73 -48.64 36.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.337 -0.852 . . . . 0.0 110.072 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.9 HG22 ' HB3' ' A' ' 189' ' ' PHE . 46.9 t -52.74 -43.77 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.338 -0.851 . . . . 0.0 110.31 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -78.84 -20.82 48.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.238 -0.914 . . . . 0.0 110.429 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 25.3 t -56.72 -56.36 22.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -0.927 . . . . 0.0 110.165 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 86.8 p -128.97 165.75 20.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 0.0 110.301 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.627 ' HG3' HG23 ' A' ' 138' ' ' VAL . 18.3 pt-20 -57.94 -40.77 81.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.27 -0.894 . . . . 0.0 110.098 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.627 HG23 ' HG3' ' A' ' 137' ' ' GLU . 74.6 t -124.01 144.8 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.405 -0.809 . . . . 0.0 110.154 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -170.47 144.55 2.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.328 -0.858 . . . . 0.0 109.709 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.624 HG11 ' CE2' ' A' ' 167' ' ' PHE . 7.3 p -129.35 153.05 38.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 121.011 -1.056 . . . . 0.0 110.252 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 20.5 mt -131.41 123.07 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.88 . . . . 0.0 109.9 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -85.81 129.01 9.09 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.62 ' CE2' HG12 ' A' ' 175' ' ' VAL . 28.8 m-85 -101.74 78.98 1.88 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -1.159 . . . . 0.0 109.898 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.483 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 10.9 m-85 -106.17 146.4 30.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.199 -0.938 . . . . 0.0 111.051 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.11 -27.12 18.77 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.617 0.722 . . . . 0.0 109.522 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.55 73.72 1.55 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.664 -0.647 . . . . 0.0 109.405 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.526 ' O ' ' HB3' ' A' ' 152' ' ' ALA . 21.7 m -49.3 -23.35 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.397 -0.815 . . . . 0.0 111.02 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -81.57 7.12 12.91 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.965 -1.084 . . . . 0.0 111.255 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.6 p -78.52 -164.37 0.56 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.864 -1.148 . . . . 0.0 110.506 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -91.04 -24.41 20.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.521 -0.737 . . . . 0.0 110.282 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.64 -30.66 46.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.29 -0.881 . . . . 0.0 109.974 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 147' ' ' VAL . . . -80.26 -19.96 45.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 0.0 110.196 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -38.83 92.72 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.309 -0.869 . . . . 0.0 109.925 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -69.97 -42.14 73.54 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.396 -0.815 . . . . 0.0 110.027 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.423 ' HE1' HG13 ' A' ' 186' ' ' VAL . 4.3 t80 -50.86 -57.75 7.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.359 -0.838 . . . . 0.0 110.337 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.442 ' HA ' ' HB1' ' A' ' 119' ' ' ALA . 74.9 mt -57.43 -49.7 75.39 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.435 -0.79 . . . . 0.0 110.095 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -52.33 -52.98 50.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.511 -0.743 . . . . 0.0 110.304 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.623 ' HB2' ' HG3' ' A' ' 205' ' ' LYS . . . -66.64 -46.0 77.2 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.192 -0.942 . . . . 0.0 110.173 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.548 ' HB3' ' HB1' ' A' ' 119' ' ' ALA . . . -53.15 -32.41 47.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.209 -0.932 . . . . 0.0 110.223 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -66.84 -38.42 86.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 110.2 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.81 -40.79 92.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.263 -0.898 . . . . 0.0 110.162 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 72.3 mt -91.53 92.53 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.292 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -90.62 -27.83 18.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -0.872 . . . . 0.0 110.308 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 164' ' ' ASP . 16.2 p-10 -57.79 -26.62 62.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.915 . . . . 0.0 110.221 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.411 HD12 ' CG1' ' A' ' 138' ' ' VAL . 45.9 mm -104.75 127.24 29.26 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.175 -0.953 . . . . 0.0 109.953 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -78.24 85.84 1.76 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.448 1.236 . . . . 0.0 110.675 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.624 ' CE2' HG11 ' A' ' 140' ' ' VAL . 3.8 m-85 -66.16 174.88 2.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.087 -1.008 . . . . 0.0 109.996 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.525 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -150.11 151.37 23.45 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 6.3 tt -150.47 142.46 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.939 -1.33 . . . . 0.0 110.539 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.493 ' CG2' HG11 ' A' ' 175' ' ' VAL . 2.2 t -160.78 155.67 24.08 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.013 0.911 . . . . 0.0 110.759 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 24.5 p -115.57 -1.9 12.64 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.589 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.416 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 7.5 t-20 -52.65 164.24 0.37 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.195 -0.941 . . . . 0.0 110.161 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 26.2 p -91.44 -33.41 15.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.221 -0.924 . . . . 0.0 109.958 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -57.29 -27.4 62.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.229 -0.919 . . . . 0.0 109.826 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.62 HG12 ' CE2' ' A' ' 143' ' ' PHE . 47.6 t -78.08 -29.14 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.336 -0.852 . . . . 0.0 109.725 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.425 ' N ' ' CD1' ' A' ' 176' ' ' PHE . 16.7 m-85 -85.27 -50.2 7.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.4 -0.812 . . . . 0.0 109.685 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 32.6 m -62.34 -18.05 60.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.433 -0.792 . . . . 0.0 110.361 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.408 ' HD3' ' HA3' ' A' ' 126' ' ' GLY . 5.3 tttp -74.61 -50.59 17.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.16 -0.963 . . . . 0.0 109.922 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -89.55 14.46 11.46 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.147 -0.97 . . . . 0.0 110.37 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 49.11 65.01 1.5 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.214 -0.928 . . . . 0.0 110.848 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 14.2 mt -112.75 100.95 9.08 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.061 -1.024 . . . . 0.0 109.794 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -57.96 -19.0 27.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.032 -1.042 . . . . 0.0 110.089 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt -147.38 -165.2 2.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -0.959 . . . . 0.0 109.661 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -60.31 156.81 14.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.089 -1.007 . . . . 0.0 109.855 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -159.98 118.83 0.85 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.54 HG21 ' CG2' ' A' ' 203' ' ' VAL . 79.7 t -99.21 95.75 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -1.128 . . . . 0.0 110.111 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.502 ' O ' HG23 ' A' ' 140' ' ' VAL . 94.9 t -113.71 152.66 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.299 -0.875 . . . . 0.0 109.862 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.706 ' CD1' HD13 ' A' ' 212' ' ' ILE . 7.7 tt -108.27 155.45 20.47 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.052 -1.03 . . . . 0.0 109.868 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.9 ' HB3' HG22 ' A' ' 133' ' ' VAL . 60.5 m-85 -125.0 126.38 45.35 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.943 -1.098 . . . . 0.0 110.466 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.445 ' HD2' ' CD2' ' A' ' 188' ' ' LEU . 0.0 OUTLIER -134.8 179.18 6.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.379 -0.826 . . . . 0.0 110.074 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -102.52 -29.57 11.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.171 -0.955 . . . . 0.0 110.311 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -90.96 -174.39 3.99 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.446 -0.784 . . . . 0.0 110.811 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 48.0 -159.11 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.643 0.735 . . . . 0.0 110.863 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -50.94 -51.8 48.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.568 -0.707 . . . . 0.0 110.359 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 123.47 -21.58 7.18 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -141.42 177.51 8.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -1.186 . . . . 0.0 110.399 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' ASN . . . . . 0.454 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.1 m-80 -141.89 -152.73 0.42 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.364 -0.835 . . . . 0.0 109.527 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.462 ' HA ' HG22 ' A' ' 187' ' ' VAL . 11.5 p-10 -175.43 79.1 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.274 -0.891 . . . . 0.0 110.496 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -64.34 117.54 7.38 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.384 -0.822 . . . . 0.0 109.88 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -122.64 28.88 7.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 110.571 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -110.92 -123.1 4.4 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 204' ' ' THR . 6.4 mt-10 -119.07 100.45 7.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.292 -1.122 . . . . 0.0 109.885 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.67 HG13 ' O ' ' A' ' 203' ' ' VAL . 7.3 p -51.17 93.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 110.699 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.42 ' N ' ' O ' ' A' ' 202' ' ' GLU . 21.9 p -136.03 160.88 37.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 109.995 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.623 ' HG3' ' HB2' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -50.46 -50.21 53.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.292 -0.88 . . . . 0.0 110.662 -179.823 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 206' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 207' ' ' ASN . 16.6 pt-20 -61.89 -41.22 97.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.24 -0.912 . . . . 0.0 110.552 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.425 ' N ' ' HG3' ' A' ' 206' ' ' GLU . 70.2 m-20 -73.24 -40.08 64.95 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.142 -0.974 . . . . 0.0 110.113 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.418 ' HA ' HD23 ' A' ' 208' ' ' LEU . 54.7 mt -61.9 -45.95 91.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.868 . . . . 0.0 110.066 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.534 HD12 ' O ' ' A' ' 205' ' ' LYS . 12.0 mt -59.45 -25.68 64.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.861 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -85.05 -46.11 11.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.292 -0.88 . . . . 0.0 109.901 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.422 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 22.3 t80 -48.22 -53.27 17.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.388 -0.82 . . . . 0.0 110.169 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.706 HD13 ' CD1' ' A' ' 188' ' ' LEU . 21.4 mm -48.92 -71.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.409 -0.807 . . . . 0.0 110.085 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.445 ' HA ' ' HG2' ' A' ' 216' ' ' GLN . 20.8 mttt -46.2 -34.38 4.29 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.71 -0.619 . . . . 0.0 110.965 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -71.64 -27.91 63.41 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.216 -0.927 . . . . 0.0 110.587 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 79.7 m-20 -97.84 -51.36 4.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.082 -1.012 . . . . 0.0 110.988 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.467 ' NE2' HG22 ' A' ' 212' ' ' ILE . 3.5 pt20 -52.39 -24.05 7.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.042 -1.036 . . . . 0.0 110.53 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 16.5 mt -129.94 101.97 17.91 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.316 -0.865 . . . . 0.0 110.286 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.46 134.61 24.8 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.532 1.28 . . . . 0.0 110.494 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.7 48.43 1.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.272 -0.893 . . . . 0.0 110.308 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.665 ' O ' HG12 ' A' ' 220' ' ' VAL . 59.4 t -120.93 31.46 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 110.102 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.53 ' O ' HG23 ' A' ' 221' ' ' ILE . 0.5 OUTLIER -172.01 124.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.4 -0.813 . . . . 0.0 109.967 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -127.04 116.53 20.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.23 -0.918 . . . . 0.0 110.281 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -145.09 37.2 1.14 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.196 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 6.6 p -121.81 37.54 4.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.23 -0.919 . . . . 0.0 110.103 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -94.02 126.25 39.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.184 -0.947 . . . . 0.0 110.318 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 52.55 46.27 27.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 110.36 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.492 HG22 ' N ' ' A' ' 228' ' ' ALA . 29.3 m -156.98 170.8 21.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.311 -0.868 . . . . 0.0 110.232 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.492 ' N ' HG22 ' A' ' 227' ' ' THR . . . . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.251 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.252 0.548 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -92.34 -178.94 5.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.9 . . . . 0.0 110.338 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.449 HG22 ' HA2' ' A' ' 168' ' ' GLY . 14.6 t -118.61 161.14 20.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 110.219 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.8 m -99.85 110.16 22.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 0.0 109.835 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.421 ' HB2' ' HB ' ' A' ' 170' ' ' THR . 34.9 mt -87.66 113.01 52.43 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.231 -0.918 . . . . 0.0 110.072 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.17 -24.13 23.79 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.491 1.258 . . . . 0.0 110.373 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.61 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 1.1 p30 -173.77 -169.88 0.53 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.307 -0.871 . . . . 0.0 110.541 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.406 ' HA3' ' HD2' ' A' ' 178' ' ' LYS . . . -59.24 -25.24 59.89 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.61 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -53.5 -34.24 57.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -1.132 . . . . 0.0 110.222 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.31 -36.27 14.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 110.149 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.13 -19.94 62.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 110.271 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -88.5 -60.03 2.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 0.0 110.262 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.5 t -55.27 -21.56 14.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.198 -0.939 . . . . 0.0 110.243 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.669 HD23 HD11 ' A' ' 141' ' ' ILE . 18.0 tp -69.92 -48.69 57.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 0.0 110.035 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.641 HG22 ' CB ' ' A' ' 189' ' ' PHE . 60.7 t -65.46 -37.82 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.834 . . . . 0.0 110.398 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -83.75 5.85 23.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.114 -0.991 . . . . 0.0 110.816 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.9 t -90.19 -27.83 19.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.95 -1.094 . . . . 0.0 110.353 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.53 165.06 33.34 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.208 -0.933 . . . . 0.0 110.523 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -65.17 -19.03 65.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.395 -0.816 . . . . 0.0 109.859 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 43.4 t -136.96 149.71 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.9 . . . . 0.0 110.201 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.455 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -175.32 142.61 0.61 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.379 -0.826 . . . . 0.0 109.551 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.673 HG11 HD11 ' A' ' 212' ' ' ILE . 3.6 m -124.15 158.38 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 118.979 -1.089 . . . . 0.0 111.07 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.669 HD11 HD23 ' A' ' 132' ' ' LEU . 60.5 mt -148.22 104.31 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.651 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.82 128.04 9.9 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.834 ' CE2' HG12 ' A' ' 175' ' ' VAL . 37.8 m-85 -98.8 84.56 3.13 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.139 -1.212 . . . . 0.0 109.488 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.673 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 16.4 m-85 -105.85 141.35 37.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.087 -1.008 . . . . 0.0 111.361 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.61 -28.94 26.18 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.959 -0.696 . . . . 0.0 110.015 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.04 87.0 2.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.367 -0.833 . . . . 0.0 109.895 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 98.0 t -60.18 -21.41 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.39 -0.819 . . . . 0.0 110.713 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -82.26 1.01 38.73 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.163 -0.961 . . . . 0.0 111.06 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 82.4 p -81.17 -168.08 1.69 Allowed 'General case' 0 C--N 1.307 -1.271 0 O-C-N 120.921 -1.112 . . . . 0.0 110.379 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -90.22 -18.08 26.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.423 -0.798 . . . . 0.0 110.168 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.476 ' CB ' ' CE1' ' A' ' 144' ' ' PHE . 1.4 m -71.4 -33.15 69.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.193 -0.942 . . . . 0.0 110.235 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.36 -37.64 27.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.141 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -55.92 -40.05 72.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.894 . . . . 0.0 110.094 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -64.19 -42.47 96.64 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.271 -0.893 . . . . 0.0 110.054 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.423 ' HA ' HD13 ' A' ' 208' ' ' LEU . 3.9 t80 -51.44 -55.45 18.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.362 -0.836 . . . . 0.0 110.18 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 156' ' ' LEU . 25.8 mt -54.58 -55.18 32.08 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.298 -0.876 . . . . 0.0 110.244 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.406 ' HB3' ' HD2' ' A' ' 205' ' ' LYS . 89.5 mt-30 -51.31 -49.65 60.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.329 -0.857 . . . . 0.0 110.129 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.601 ' HB2' ' HA ' ' A' ' 205' ' ' LYS . . . -63.52 -36.99 85.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 109.78 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.747 ' HB1' ' CD2' ' A' ' 167' ' ' PHE . . . -68.84 -29.61 67.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.301 -0.874 . . . . 0.0 109.947 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -67.7 -39.86 84.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.342 -0.849 . . . . 0.0 110.12 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.68 -50.35 66.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.863 . . . . 0.0 110.034 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.427 ' CG2' ' OD1' ' A' ' 164' ' ' ASP . 96.7 mt -97.38 163.4 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 109.806 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.425 ' N ' HG22 ' A' ' 162' ' ' ILE . 22.1 m-20 -136.73 -40.61 0.62 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.118 -0.989 . . . . 0.0 110.548 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.427 ' OD1' ' CG2' ' A' ' 162' ' ' ILE . 26.3 p-10 -55.29 -24.75 30.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 110.593 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.485 ' HB ' ' CE1' ' A' ' 167' ' ' PHE . 31.3 mm -92.59 129.78 39.34 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.073 -1.017 . . . . 0.0 110.226 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.455 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 55.2 Cg_endo -79.06 117.67 3.91 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 123.466 1.245 . . . . 0.0 110.274 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.747 ' CD2' ' HB1' ' A' ' 159' ' ' ALA . 6.1 m-85 -107.32 124.3 49.61 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.089 -1.007 . . . . 0.0 109.427 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.449 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -120.74 154.95 16.33 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 6.7 tt -150.43 140.94 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.124 -1.221 . . . . 0.0 110.78 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.421 ' HB ' ' HB2' ' A' ' 123' ' ' LEU . 1.8 t -155.12 156.93 36.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.307 -0.871 . . . . 0.0 110.414 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.1 t -119.87 1.35 10.98 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.468 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 41.4 p30 -67.93 151.29 47.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.117 -0.989 . . . . 0.0 109.985 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.8 p -78.44 -18.7 54.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.188 -0.945 . . . . 0.0 110.66 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.01 -39.14 84.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.933 . . . . 0.0 110.254 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.834 HG12 ' CE2' ' A' ' 143' ' ' PHE . 46.4 t -79.61 -24.45 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -0.956 . . . . 0.0 109.922 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.468 ' CD1' ' O ' ' A' ' 172' ' ' ASN . 9.0 m-85 -75.44 -50.59 15.33 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.32 -0.863 . . . . 0.0 109.878 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.18 -19.19 64.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.473 -0.767 . . . . 0.0 110.45 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.406 ' HD2' ' HA3' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -62.66 -56.47 17.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.971 . . . . 0.0 110.282 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.52 ' HB2' HD13 ' A' ' 181' ' ' LEU . 92.3 m-85 -92.83 26.28 2.81 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.18 -0.95 . . . . 0.0 110.374 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.552 ' C ' HD12 ' A' ' 181' ' ' LEU . 2.2 mm-40 55.97 67.06 1.06 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.498 -0.751 . . . . 0.0 110.712 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.552 HD12 ' C ' ' A' ' 180' ' ' GLN . 6.6 mp -124.7 102.98 7.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.555 -0.715 . . . . 0.0 110.227 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.405 ' O ' ' HG3' ' A' ' 183' ' ' LYS . 0.8 OUTLIER -88.74 14.7 9.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -0.935 . . . . 0.0 110.147 179.366 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 182' ' ' ASP . 6.2 mtmm -162.49 -165.3 1.15 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.276 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 10.6 p-10 -82.86 157.87 22.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.949 -1.094 . . . . 0.0 110.138 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 179.14 121.71 0.73 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.418 ' O ' ' CB ' ' A' ' 199' ' ' PHE . 94.7 t -92.8 121.62 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.329 -1.101 . . . . 0.0 110.049 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.858 HG22 ' HA ' ' A' ' 198' ' ' ASN . 90.6 t -128.97 149.77 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 0.0 109.83 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.804 HD12 HD13 ' A' ' 212' ' ' ILE . 8.5 tt -104.61 131.5 51.96 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.995 -1.066 . . . . 0.0 108.458 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.641 ' CB ' HG22 ' A' ' 133' ' ' VAL . 57.3 m-85 -102.95 121.64 42.95 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.899 -1.126 . . . . 0.0 110.902 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.402 ' HD3' HD23 ' A' ' 188' ' ' LEU . 0.1 OUTLIER -131.5 168.02 18.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.545 -0.722 . . . . 0.0 110.213 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -89.58 -24.9 21.6 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.293 -0.879 . . . . 0.0 110.579 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -90.71 -175.45 4.4 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.43 -0.794 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 47.08 -159.24 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.53 -0.732 . . . . 0.0 110.724 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -59.67 -44.25 93.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.642 -0.661 . . . . 0.0 110.265 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 128.99 -31.5 3.48 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.08 171.48 11.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -1.21 . . . . 0.0 110.532 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' ASN . . . . . 0.536 ' H ' HG13 ' A' ' 187' ' ' VAL . 7.8 m120 -131.66 -35.12 1.3 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.317 -0.864 . . . . 0.0 111.188 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.858 ' HA ' HG22 ' A' ' 187' ' ' VAL . 0.8 OUTLIER 63.71 85.45 0.13 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.152 -0.968 . . . . 0.0 110.015 -179.193 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.432 ' C ' ' CD1' ' A' ' 199' ' ' PHE . 9.4 t80 -62.16 118.73 7.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.398 -0.814 . . . . 0.0 110.161 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -113.63 101.5 9.38 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.264 -0.897 . . . . 0.0 110.511 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 157.13 -140.11 6.91 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -107.48 113.47 26.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.309 -1.113 . . . . 0.0 110.102 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.673 HG11 ' HZ ' ' A' ' 144' ' ' PHE . 7.5 p -64.29 110.74 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 110.218 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 70.5 p -143.13 157.14 44.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.167 -0.958 . . . . 0.0 110.376 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.855 ' O ' HD12 ' A' ' 209' ' ' LEU . 12.2 tttt -51.1 -49.59 60.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.322 -0.861 . . . . 0.0 110.397 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -61.13 -34.67 75.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 110.097 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -78.72 -47.69 16.39 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.207 -0.933 . . . . 0.0 110.084 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 155' ' ' PHE . 80.7 mt -52.78 -37.95 60.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.196 -0.94 . . . . 0.0 110.054 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.855 HD12 ' O ' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -71.08 -23.07 62.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.29 -0.881 . . . . 0.0 109.924 179.755 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.66 -45.81 9.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.362 -0.836 . . . . 0.0 109.88 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.421 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 25.6 t80 -49.66 -50.15 44.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.213 -0.929 . . . . 0.0 109.822 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.804 HD13 HD12 ' A' ' 188' ' ' LEU . 23.5 mm -50.72 -73.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.467 -0.771 . . . . 0.0 110.296 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -46.21 -25.87 0.68 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.705 -0.622 . . . . 0.0 111.114 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -76.51 -23.19 53.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 110.568 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.484 ' CG ' ' ND2' ' A' ' 197' ' ' ASN . 78.2 m-20 -101.42 -57.62 2.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.182 -0.949 . . . . 0.0 110.866 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 212' ' ' ILE . 2.9 pt20 -51.52 178.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.1 -1.0 . . . . 0.0 110.588 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 81.4 mt 53.32 72.88 1.03 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 110.428 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.58 168.45 24.38 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.684 1.36 . . . . 0.0 110.282 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.37 -168.76 1.35 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -0.937 . . . . 0.0 110.233 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 95.1 t -105.12 134.16 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.931 . . . . 0.0 110.189 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 73.1 mt -105.19 77.45 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.907 . . . . 0.0 110.173 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.92 32.77 3.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 0.0 110.192 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -152.62 145.0 24.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.906 . . . . 0.0 110.213 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 18.1 m -135.31 123.23 22.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 109.969 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -89.46 -179.16 5.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.318 -0.864 . . . . 0.0 110.383 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.35 -45.65 5.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.329 -0.857 . . . . 0.0 110.107 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.8 p -128.17 99.89 5.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.298 -0.877 . . . . 0.0 110.216 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.102 -0.952 . . . . 0.0 110.299 179.933 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.293 0.568 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 167' ' ' PHE . . . -59.44 -178.27 0.06 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.159 -0.963 . . . . 0.0 110.112 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.546 HG22 ' HA2' ' A' ' 168' ' ' GLY . 9.9 t -108.49 167.65 9.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.106 -0.996 . . . . 0.0 110.246 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.3 m -110.48 109.25 19.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 110.115 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.9 mt -87.14 126.4 62.93 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.334 -0.853 . . . . 0.0 110.097 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 46.0 Cg_endo -71.73 -22.45 23.89 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.457 1.241 . . . . 0.0 110.462 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.495 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.8 OUTLIER -174.31 -170.64 0.54 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.183 -0.948 . . . . 0.0 110.938 179.885 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.82 -34.79 90.79 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.495 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -51.63 -24.93 6.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -1.159 . . . . 0.0 110.343 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.431 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -90.13 -27.14 19.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.941 . . . . 0.0 110.191 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.17 -18.53 65.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 110.266 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -89.75 -48.7 7.09 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.158 -0.964 . . . . 0.0 109.21 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 32.4 p -63.35 -19.75 64.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.28 -0.888 . . . . 0.0 110.253 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.459 HD22 ' HB1' ' A' ' 139' ' ' ALA . 1.6 tt -73.83 -58.96 2.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.209 -0.932 . . . . 0.0 110.262 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.651 HG13 ' HB3' ' A' ' 189' ' ' PHE . 48.1 t -50.03 -25.34 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.268 -0.895 . . . . 0.0 110.581 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.96 -20.11 23.7 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.253 -0.905 . . . . 0.0 109.846 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.7 m -54.45 -50.67 67.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.162 -0.961 . . . . 0.0 110.362 -179.82 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.4 p -130.87 -173.52 3.11 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.12 -0.987 . . . . 0.0 110.487 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.01 -45.12 28.39 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.22 -0.925 . . . . 0.0 109.988 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.3 m -115.22 130.07 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.353 -0.842 . . . . 0.0 109.97 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.459 ' HB1' HD22 ' A' ' 132' ' ' LEU . . . -152.76 148.22 26.98 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.123 -0.986 . . . . 0.0 110.015 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.499 ' CG1' ' CD1' ' A' ' 167' ' ' PHE . 7.1 p -130.9 149.97 34.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.104 -0.998 . . . . 0.0 110.437 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.42 ' CG1' HD13 ' A' ' 132' ' ' LEU . 45.7 mt -133.9 124.13 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.424 -0.797 . . . . 0.0 109.682 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -90.74 131.75 10.93 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.587 ' CD2' HG12 ' A' ' 175' ' ' VAL . 22.0 m-85 -103.95 69.69 0.96 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -1.149 . . . . 0.0 109.643 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -94.9 139.02 31.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.145 -0.972 . . . . 0.0 110.769 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -76.2 -27.84 57.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.427 -0.796 . . . . 0.0 110.136 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -126.89 88.46 2.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 0.0 109.908 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 45.1 t -55.55 -21.03 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.449 -0.782 . . . . 0.0 110.36 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -91.79 18.39 7.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -0.897 . . . . 0.0 110.622 -179.782 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 86.8 p -87.2 -164.64 1.12 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.948 . . . . 0.0 110.169 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.409 ' HA ' ' HG3' ' A' ' 153' ' ' LYS . 28.0 t70 -90.13 -34.09 16.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.348 -0.845 . . . . 0.0 110.141 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 49.3 m -63.81 -31.7 72.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.3 -0.875 . . . . 0.0 110.245 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.55 -28.58 59.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.824 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.409 ' HG3' ' HA ' ' A' ' 150' ' ' ASP . 3.6 mmtt -58.66 -52.0 67.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.418 -0.801 . . . . 0.0 110.184 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' A' ' 204' ' ' THR . 7.0 mm-40 -61.22 -39.73 91.36 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.182 -0.949 . . . . 0.0 110.083 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.475 ' HE1' HG13 ' A' ' 186' ' ' VAL . 5.1 t80 -47.62 -54.9 10.56 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.304 -0.873 . . . . 0.0 110.606 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.411 ' O ' ' HB3' ' A' ' 159' ' ' ALA . 17.2 mt -55.57 -53.35 57.54 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.414 -0.804 . . . . 0.0 110.33 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.419 ' HB3' ' HD2' ' A' ' 205' ' ' LYS . 4.2 mt-30 -49.78 -50.22 45.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.325 -0.859 . . . . 0.0 110.464 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -64.24 -25.03 67.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.18 -0.95 . . . . 0.0 110.052 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.721 ' HB2' ' CD2' ' A' ' 167' ' ' PHE . . . -76.1 -41.06 51.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.309 -0.87 . . . . 0.0 110.324 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -76.02 -9.64 58.78 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.291 -0.88 . . . . 0.0 110.909 -179.69 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -118.0 28.12 8.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.971 -1.081 . . . . 0.0 110.565 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.655 HD13 ' CZ ' ' A' ' 167' ' ' PHE . 5.7 tt -113.44 176.76 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.077 -1.014 . . . . 0.0 110.25 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.48 63.36 0.16 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.896 . . . . 0.0 110.511 -179.566 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 162' ' ' ILE . 3.7 p-10 40.92 50.91 3.16 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.535 0.683 . . . . 0.0 111.628 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.512 ' CG2' ' HD2' ' A' ' 166' ' ' PRO . 42.7 mm -88.77 149.2 43.33 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.472 -0.767 . . . . 0.0 109.097 179.044 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.512 ' HD2' ' CG2' ' A' ' 165' ' ' ILE . 43.8 Cg_endo -81.43 99.75 1.09 Allowed 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.555 1.292 . . . . 0.0 110.772 -179.063 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.721 ' CD2' ' HB2' ' A' ' 159' ' ' ALA . 3.2 m-85 -92.12 131.05 37.68 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.524 -0.735 . . . . 0.0 110.109 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.546 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -121.61 144.53 16.52 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.979 -1.649 . . . . 0.0 108.979 179.244 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.402 ' O ' HG23 ' A' ' 169' ' ' ILE . 13.5 tt -140.75 135.36 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.268 -1.136 . . . . 0.0 110.86 -179.357 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.502 HG21 HG21 ' A' ' 175' ' ' VAL . 2.1 t -151.82 155.85 39.01 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.999 0.904 . . . . 0.0 110.386 179.189 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.9 t -125.3 4.62 7.76 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.028 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -65.72 132.32 48.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.223 -0.923 . . . . 0.0 110.409 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 88.6 p -54.26 -29.04 45.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.163 -0.961 . . . . 0.0 110.047 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -54.49 -35.48 63.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.939 . . . . 0.0 109.867 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.587 HG12 ' CD2' ' A' ' 143' ' ' PHE . 61.4 t -78.71 -25.67 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.409 -0.807 . . . . 0.0 109.728 179.599 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -79.13 -50.1 11.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 109.758 179.638 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 75.1 m -60.68 -19.19 57.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.863 . . . . 0.0 110.116 179.621 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.437 ' HD3' ' CE1' ' A' ' 179' ' ' TYR . 7.2 tttp -74.43 -51.46 14.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.132 -0.98 . . . . 0.0 109.653 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.437 ' CE1' ' HD3' ' A' ' 178' ' ' LYS . 78.3 m-85 -92.7 -5.34 51.53 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.436 -0.79 . . . . 0.0 110.427 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 56.77 63.61 1.89 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.128 -0.982 . . . . 0.0 111.079 179.457 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.0 mt -102.52 119.53 38.97 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.12 -0.988 . . . . 0.0 109.679 178.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.412 ' O ' ' CG ' ' A' ' 183' ' ' LYS . 5.8 t0 -65.2 -11.78 44.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 110.333 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.412 ' CG ' ' O ' ' A' ' 182' ' ' ASP . 0.5 OUTLIER -156.42 -165.78 1.98 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.175 -0.953 . . . . 0.0 109.545 -179.977 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.422 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 3.9 p30 -62.22 164.17 7.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.062 -1.024 . . . . 0.0 109.44 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -161.4 150.05 19.36 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.231 -179.761 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.475 HG13 ' HE1' ' A' ' 155' ' ' PHE . 77.3 t -132.09 84.95 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.49 -1.006 . . . . 0.0 109.506 179.58 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 47.6 t -101.31 159.8 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.336 -0.853 . . . . 0.0 110.472 -179.599 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.435 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 4.3 tt -116.44 155.08 29.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.866 . . . . 0.0 109.374 179.721 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.651 ' HB3' HG13 ' A' ' 133' ' ' VAL . 51.6 m-85 -125.03 127.21 46.62 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.898 -1.126 . . . . 0.0 110.659 -179.051 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.501 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.5 OUTLIER -141.03 166.86 23.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.315 -0.866 . . . . 0.0 110.235 179.751 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -91.21 -22.59 20.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 110.329 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.501 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.9 OUTLIER -91.08 -176.55 4.64 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.362 -0.837 . . . . 0.0 111.069 -179.988 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 48.04 -154.77 0.08 Allowed 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.802 0.81 . . . . 0.0 110.649 -179.782 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -57.37 -54.52 45.93 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.694 -0.629 . . . . 0.0 110.325 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 133.01 -24.21 3.83 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -139.41 176.34 8.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.208 -1.172 . . . . 0.0 110.548 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 197' ' ' ASN . . . . . 0.449 ' N ' ' ND2' ' A' ' 197' ' ' ASN . 0.7 OUTLIER -145.36 -155.33 0.6 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.389 -0.819 . . . . 0.0 109.786 -179.776 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -171.02 81.77 0.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.377 -0.827 . . . . 0.0 110.083 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -64.97 126.99 29.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.377 -0.827 . . . . 0.0 110.287 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -140.82 124.12 16.67 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.236 -0.915 . . . . 0.0 109.901 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 141.7 -167.62 25.84 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -62.67 109.02 1.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.339 -1.095 . . . . 0.0 110.26 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.456 ' C ' HG23 ' A' ' 204' ' ' THR . 91.7 t -65.88 112.24 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.226 -0.921 . . . . 0.0 110.203 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.456 HG23 ' C ' ' A' ' 203' ' ' VAL . 41.7 p -150.2 152.39 34.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.36 -0.838 . . . . 0.0 110.314 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.453 ' CE ' HD11 ' A' ' 209' ' ' LEU . 3.1 tttt -49.76 -52.67 30.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.3 -0.875 . . . . 0.0 110.487 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -54.34 -32.5 56.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 110.157 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -83.96 -41.46 17.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.27 -0.894 . . . . 0.0 110.044 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.452 ' CD2' HG11 ' A' ' 186' ' ' VAL . 27.4 mt -65.83 -41.79 91.35 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.311 -0.868 . . . . 0.0 110.061 179.86 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.453 HD11 ' CE ' ' A' ' 205' ' ' LYS . 85.7 mt -69.39 -21.74 63.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 0.0 110.128 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -83.81 -56.38 3.73 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.292 -0.88 . . . . 0.0 110.076 179.828 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.401 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 20.5 t80 -51.52 -53.02 42.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.237 -0.914 . . . . 0.0 110.146 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.627 HG21 HD11 ' A' ' 162' ' ' ILE . 84.6 mt -52.78 -58.5 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.348 -0.845 . . . . 0.0 110.178 179.753 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.443 ' HA ' ' CG ' ' A' ' 216' ' ' GLN . 14.4 tttt -49.24 -38.74 27.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 110.132 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.27 -22.81 67.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.399 -0.813 . . . . 0.0 109.826 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.401 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 75.7 m-80 -96.77 -42.51 7.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.296 -0.878 . . . . 0.0 110.359 -179.682 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.443 ' CG ' ' HA ' ' A' ' 213' ' ' LYS . 2.1 pt20 -85.06 -176.83 6.36 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.2 -0.937 . . . . 0.0 110.205 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 19.0 mt 52.67 68.69 2.85 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.254 -0.904 . . . . 0.0 110.289 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.605 ' C ' HD22 ' A' ' 219' ' ' LEU . 47.0 Cg_endo -73.35 152.56 49.78 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.631 1.332 . . . . 0.0 110.303 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.605 HD22 ' C ' ' A' ' 218' ' ' PRO . 4.5 mm? -112.09 170.82 7.89 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.248 -0.908 . . . . 0.0 109.967 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.439 ' H ' HG22 ' A' ' 220' ' ' VAL . 29.1 m -103.39 38.57 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.521 -0.737 . . . . 0.0 110.561 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 59.8 mt 53.74 98.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.198 -0.939 . . . . 0.0 110.287 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -62.4 156.03 23.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.288 -0.883 . . . . 0.0 109.953 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -131.01 131.07 44.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.168 -0.957 . . . . 0.0 110.449 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 226' ' ' GLN . 2.8 m -143.86 42.38 1.45 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.364 -0.835 . . . . 0.0 110.006 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.424 ' HG2' ' N ' ' A' ' 226' ' ' GLN . 38.4 tt0 54.49 -90.32 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.381 -0.825 . . . . 0.0 110.311 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.424 ' N ' ' HG2' ' A' ' 225' ' ' GLU . 0.0 OUTLIER 178.79 -63.73 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.858 -1.151 . . . . 0.0 110.035 179.931 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.4 m -71.55 88.54 0.94 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -0.88 . . . . 0.0 110.3 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.129 179.95 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.224 0.535 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -155.96 166.47 33.39 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.312 -0.867 . . . . 0.0 110.275 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.618 HG22 ' HA2' ' A' ' 168' ' ' GLY . 10.1 t -97.85 171.07 8.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.922 . . . . 0.0 110.353 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.3 m -111.68 111.9 23.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.91 . . . . 0.0 110.065 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.9 mt -94.64 130.39 33.51 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.173 -0.954 . . . . 0.0 110.068 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.439 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 43.5 Cg_endo -69.69 -53.09 0.29 Allowed 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.442 1.233 . . . . 0.0 111.015 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.4 ' HB2' ' OD1' ' A' ' 174' ' ' ASP . 1.4 p30 -146.65 -170.45 3.52 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.099 -1.001 . . . . 0.0 111.184 -179.673 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -57.31 -39.91 91.05 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.715 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -49.62 -25.29 2.71 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.268 -1.137 . . . . 0.0 110.714 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.439 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -90.07 -35.31 15.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.138 -0.976 . . . . 0.0 110.067 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.409 ' O ' HG23 ' A' ' 133' ' ' VAL . . . -56.23 -24.68 43.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.359 -0.838 . . . . 0.0 110.177 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -84.53 -54.37 4.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.227 -0.921 . . . . 0.0 110.248 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.7 t -52.65 -26.49 13.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.256 -0.903 . . . . 0.0 110.324 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.1 tp -70.07 -46.04 65.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.291 -0.88 . . . . 0.0 110.398 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.667 HG13 ' HB3' ' A' ' 189' ' ' PHE . 40.5 t -56.88 -38.64 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.267 -0.896 . . . . 0.0 110.583 -179.629 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -85.29 -15.97 41.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.281 -0.887 . . . . 0.0 110.761 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.2 m -56.68 -45.81 81.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.025 -1.047 . . . . 0.0 110.288 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 92.3 p -133.35 -175.59 3.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.342 -0.849 . . . . 0.0 110.215 -179.847 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.59 -35.22 62.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.318 -0.864 . . . . 0.0 110.249 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 87.6 t -129.33 147.27 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.064 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.42 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -173.76 134.13 0.47 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.244 -0.91 . . . . 0.0 110.048 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 187' ' ' VAL . 9.4 p -120.46 147.33 24.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.097 -1.002 . . . . 0.0 110.371 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.628 HD12 ' CD2' ' A' ' 189' ' ' PHE . 7.4 mt -125.76 113.83 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.361 -0.837 . . . . 0.0 109.912 179.726 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -80.81 120.96 5.28 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.542 ' CE2' HG12 ' A' ' 175' ' ' VAL . 46.5 m-85 -91.22 80.86 5.56 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.193 -1.181 . . . . 0.0 109.753 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -100.06 140.39 34.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.079 -1.013 . . . . 0.0 111.033 -179.317 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.12 -27.83 18.3 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.671 0.748 . . . . 0.0 109.473 179.028 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.26 69.03 1.48 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.024 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.504 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 4.6 p -48.25 -24.0 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.717 -0.614 . . . . 0.0 111.327 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -78.91 3.45 16.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.102 -0.999 . . . . 0.0 110.873 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 94.5 p -85.56 -163.16 0.81 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.843 -1.161 . . . . 0.0 110.23 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.19 -49.65 6.44 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.327 -0.858 . . . . 0.0 110.353 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.21 -28.85 8.23 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.299 -0.876 . . . . 0.0 110.448 -179.83 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.504 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -88.5 -29.25 20.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.346 -0.846 . . . . 0.0 110.136 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.82 -36.11 78.23 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.215 -0.928 . . . . 0.0 109.639 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -59.26 -49.09 79.19 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.103 -0.998 . . . . 0.0 108.607 178.762 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -50.96 -47.77 61.13 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.538 -0.726 . . . . 0.0 110.04 178.862 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.7 mt -47.4 -59.51 3.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.512 -0.743 . . . . 0.0 110.375 179.655 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -58.21 -50.53 73.21 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.424 -0.797 . . . . 0.0 110.057 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -53.82 -43.74 69.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.333 -0.854 . . . . 0.0 109.948 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.95 -24.41 63.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.86 . . . . 0.0 110.074 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -77.76 -40.58 40.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.871 . . . . 0.0 110.303 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.8 -39.9 68.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 0.0 110.334 -179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.449 HG21 ' CE1' ' A' ' 167' ' ' PHE . 0.7 OUTLIER -89.81 144.76 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.296 -0.877 . . . . 0.0 110.262 -179.862 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -132.29 18.6 4.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.215 -0.928 . . . . 0.0 110.394 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.461 ' O ' HD13 ' A' ' 165' ' ' ILE . 6.0 p-10 -125.51 21.36 7.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -0.959 . . . . 0.0 110.266 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.461 HD13 ' O ' ' A' ' 164' ' ' ASP . 45.0 mm -136.43 134.05 19.61 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.172 -0.955 . . . . 0.0 110.175 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.42 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 48.2 Cg_endo -74.67 75.2 3.61 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 O-C-N 123.542 1.285 . . . . 0.0 110.474 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.449 ' CE1' HG21 ' A' ' 162' ' ' ILE . 5.7 m-85 -67.9 134.0 50.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.303 -0.873 . . . . 0.0 110.323 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.618 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -124.72 149.23 16.93 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.54 HG23 ' O ' ' A' ' 169' ' ' ILE . 9.2 tt -148.27 125.03 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.206 -1.173 . . . . 0.0 110.29 -179.82 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.626 ' CG2' HG11 ' A' ' 175' ' ' VAL . 2.3 t -141.5 157.14 45.52 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 122.196 0.998 . . . . 0.0 110.933 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 94.9 p -124.77 3.41 8.17 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.47 178.803 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 124' ' ' PRO . 64.1 t30 -63.5 127.66 32.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.194 -0.941 . . . . 0.0 110.32 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.27 -32.78 11.47 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.241 -0.912 . . . . 0.0 110.597 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.4 ' OD1' ' HB2' ' A' ' 125' ' ' ASP . 0.8 OUTLIER -54.22 -31.82 54.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.098 -1.001 . . . . 0.0 109.88 179.84 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.626 HG11 ' CG2' ' A' ' 170' ' ' THR . 39.8 t -79.08 -27.02 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 109.692 179.593 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -84.32 -39.81 18.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 109.14 179.328 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 46.5 t -72.89 -4.78 34.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.464 -0.772 . . . . 0.0 110.231 178.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.67 -52.19 5.13 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.067 -1.021 . . . . 0.0 109.171 179.609 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -89.84 4.5 49.65 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.749 -0.595 . . . . 0.0 110.532 179.769 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 53.56 59.99 3.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.078 -1.014 . . . . 0.0 110.451 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 60.0 mt -102.82 102.77 12.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 110.13 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -53.47 -26.76 21.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.194 -0.941 . . . . 0.0 109.992 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -141.54 -175.44 4.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.406 -0.808 . . . . 0.0 109.839 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.409 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 11.8 p-10 -72.25 165.09 25.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.093 -1.004 . . . . 0.0 110.131 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -172.18 160.19 31.57 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 186' ' ' VAL . 34.2 m -123.91 97.25 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -1.18 . . . . 0.0 110.158 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.68 ' O ' HG23 ' A' ' 140' ' ' VAL . 89.1 t -108.81 155.77 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 109.96 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.751 HD22 ' HB3' ' A' ' 215' ' ' ASN . 6.6 tt -107.96 159.47 16.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.023 -1.048 . . . . 0.0 109.709 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.667 ' HB3' HG13 ' A' ' 133' ' ' VAL . 45.0 m-85 -130.11 121.26 26.0 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.901 -1.124 . . . . 0.0 110.349 -179.313 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.432 ' HD3' HD23 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -132.86 164.05 27.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.381 -0.824 . . . . 0.0 110.163 179.876 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -82.63 -26.15 32.48 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.206 -0.933 . . . . 0.0 110.845 -179.624 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.429 ' CD1' ' HG3' ' A' ' 190' ' ' LYS . 1.6 p90 -90.86 -176.81 4.78 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.287 -0.883 . . . . 0.0 110.988 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 47.01 -159.67 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.632 0.729 . . . . 0.0 110.928 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.91 -29.48 60.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.667 -0.646 . . . . 0.0 110.4 -179.731 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.4 ' HA2' ' HG2' ' A' ' 190' ' ' LYS . . . 96.09 -16.92 60.23 Favored Glycine 0 N--CA 1.483 1.822 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.494 ' HG3' ' CE1' ' A' ' 189' ' ' PHE . 4.2 ttp180 -138.34 154.31 48.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.018 -1.283 . . . . 0.0 110.479 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 197' ' ' ASN . . . . . 0.455 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.5 m-80 -125.15 -153.91 0.59 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.312 -0.867 . . . . 0.0 110.038 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.574 ' HA ' HG22 ' A' ' 187' ' ' VAL . 18.1 p30 -178.77 78.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.511 -0.743 . . . . 0.0 109.998 179.61 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -46.21 142.68 2.74 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.367 -0.833 . . . . 0.0 111.062 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 198' ' ' ASN . 6.5 mt-10 -140.94 123.62 16.09 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.299 -0.876 . . . . 0.0 109.819 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 133.38 -121.64 2.89 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -120.04 104.61 10.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.203 -1.174 . . . . 0.0 110.213 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.637 HG13 ' O ' ' A' ' 203' ' ' VAL . 6.5 p -58.84 91.38 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.15 -0.968 . . . . 0.0 110.224 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 66.0 p -126.12 160.1 31.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 110.079 179.84 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.554 ' O ' HD12 ' A' ' 209' ' ' LEU . 0.2 OUTLIER -49.87 -47.46 51.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 0.0 110.648 -179.956 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -63.25 -41.63 99.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.283 -0.885 . . . . 0.0 110.652 -179.694 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -79.04 -26.61 43.12 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.159 -0.963 . . . . 0.0 110.474 -179.713 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.59 HD21 HG23 ' A' ' 203' ' ' VAL . 19.1 mt -73.52 -59.25 2.8 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.248 -0.908 . . . . 0.0 110.499 -179.622 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.554 HD12 ' O ' ' A' ' 205' ' ' LYS . 5.5 mt -49.13 -40.16 31.39 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.303 -0.873 . . . . 0.0 110.886 -179.635 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -67.83 -45.14 75.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.12 -0.987 . . . . 0.0 110.451 -179.746 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.406 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 16.6 t80 -58.57 -54.41 47.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.933 . . . . 0.0 110.8 -179.624 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.503 HD12 HD12 ' A' ' 188' ' ' LEU . 6.4 mm -58.09 -47.96 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.155 -0.966 . . . . 0.0 110.026 -179.624 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.408 ' HA ' ' NE2' ' A' ' 216' ' ' GLN . 0.3 OUTLIER -58.04 -21.92 47.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.507 -0.746 . . . . 0.0 110.429 -179.766 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -90.03 -25.36 20.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.098 -1.001 . . . . 0.0 110.57 -179.716 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.751 ' HB3' HD22 ' A' ' 188' ' ' LEU . 76.1 m-20 -90.61 -39.81 12.29 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.169 -0.957 . . . . 0.0 110.893 -179.361 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.415 ' HG3' ' N ' ' A' ' 217' ' ' LEU . 5.6 pt20 -58.47 -28.89 65.76 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.196 -0.94 . . . . 0.0 110.813 -179.512 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.415 ' N ' ' HG3' ' A' ' 216' ' ' GLN . 48.1 mt -136.17 94.6 13.98 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.091 -1.006 . . . . 0.0 110.753 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -74.33 111.65 3.36 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.725 1.381 . . . . 0.0 110.189 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 219' ' ' LEU . 4.2 mm? -94.43 56.45 2.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.155 -0.966 . . . . 0.0 110.192 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 220' ' ' VAL . 11.5 p -111.9 29.46 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 110.096 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 2.9 mp -127.94 -42.27 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.297 -0.877 . . . . 0.0 110.338 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.32 132.75 34.58 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.684 -0.635 . . . . 0.0 110.215 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -88.12 -45.48 10.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.193 -0.942 . . . . 0.0 110.283 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 224' ' ' THR . 10.2 t -57.44 134.92 56.48 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.267 -0.896 . . . . 0.0 110.237 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -116.29 73.48 0.85 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.942 . . . . 0.0 110.357 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -164.35 66.63 0.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.927 . . . . 0.0 110.193 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.6 m -117.13 130.01 56.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.904 . . . . 0.0 110.207 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.186 -179.97 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.24 0.543 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.98 161.44 23.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 110.183 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.674 HG22 ' HA2' ' A' ' 168' ' ' GLY . 9.9 t -85.8 169.39 13.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 110.249 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.7 m -108.66 104.41 13.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 110.342 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.999 HD21 HD12 ' A' ' 132' ' ' LEU . 67.3 mt -80.65 133.67 55.34 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.192 -0.942 . . . . 0.0 110.048 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.513 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 45.3 Cg_endo -71.23 -35.13 9.01 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.387 1.204 . . . . 0.0 110.556 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.421 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.3 OUTLIER -167.75 -170.76 1.45 Allowed 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.169 0.985 . . . . 0.0 111.487 -179.919 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -58.09 -31.77 65.91 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.421 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -54.63 -28.81 49.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -1.141 . . . . 0.0 110.295 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.653 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -84.08 -35.02 24.03 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.931 . . . . 0.0 110.103 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -53.46 -29.16 34.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 0.0 109.98 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -90.15 -29.98 17.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.426 -0.796 . . . . 0.0 110.22 179.911 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.56 -35.19 30.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.195 -0.94 . . . . 0.0 110.263 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.999 HD12 HD21 ' A' ' 123' ' ' LEU . 3.2 tt -59.9 -58.26 9.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.316 -0.865 . . . . 0.0 109.739 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 97.9 t -51.98 -24.61 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.45 -0.781 . . . . 0.0 110.212 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -82.38 -21.81 35.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.311 -0.868 . . . . 0.0 110.262 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.8 m -53.14 -58.85 5.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.221 -0.924 . . . . 0.0 110.203 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 82.6 p -121.9 -179.03 4.0 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.288 -0.882 . . . . 0.0 110.296 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -69.56 -39.96 77.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.287 -0.883 . . . . 0.0 110.179 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.6 t -117.94 143.44 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.389 -0.82 . . . . 0.0 110.275 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.456 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -165.95 147.54 6.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.241 -0.912 . . . . 0.0 109.957 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.498 HG11 ' CZ ' ' A' ' 167' ' ' PHE . 7.3 p -127.11 150.09 32.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 O-C-N 121.103 -0.998 . . . . 0.0 110.205 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.433 HD11 ' HB3' ' A' ' 132' ' ' LEU . 75.5 mt -143.48 120.19 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.41 -0.806 . . . . 0.0 109.647 179.599 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.411 ' C ' ' CD1' ' A' ' 143' ' ' PHE . . . -85.89 166.68 39.37 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.507 ' CE2' HG12 ' A' ' 175' ' ' VAL . 26.5 m-85 -129.86 76.56 1.73 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.405 -1.056 . . . . 0.0 109.85 179.833 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.73 ' HZ ' HG21 ' A' ' 203' ' ' VAL . 19.6 m-85 -104.1 145.82 29.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.99 -1.069 . . . . 0.0 111.099 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.26 -27.75 19.26 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.786 0.803 . . . . 0.0 109.464 179.523 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.407 ' HB3' ' HB3' ' A' ' 149' ' ' SER . 0.3 OUTLIER -131.0 73.0 1.52 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.687 -0.633 . . . . 0.0 109.511 179.014 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.522 ' O ' ' HB3' ' A' ' 152' ' ' ALA . 18.4 m -48.36 -24.54 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.262 -0.899 . . . . 0.0 110.869 -179.543 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -83.95 5.53 25.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.063 -1.023 . . . . 0.0 110.844 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.407 ' HB3' ' HB3' ' A' ' 146' ' ' ASP . 33.5 p -75.19 -166.29 0.49 Allowed 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.905 -1.122 . . . . 0.0 110.34 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -90.45 -19.95 23.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.537 -0.727 . . . . 0.0 110.159 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 10.5 t -81.93 -31.62 31.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.163 -0.961 . . . . 0.0 110.078 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 147' ' ' VAL . . . -80.67 -20.05 43.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 110.2 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -61.45 -39.16 89.86 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.221 -0.924 . . . . 0.0 109.751 179.471 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -67.09 -41.18 86.74 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.358 -0.839 . . . . 0.0 109.619 179.436 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -48.96 -57.09 7.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.397 -0.814 . . . . 0.0 110.607 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 156' ' ' LEU . 52.8 mt -53.87 -54.76 34.07 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.449 -0.782 . . . . 0.0 110.289 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -54.2 -46.67 72.51 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.42 -0.8 . . . . 0.0 110.347 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.09 -45.36 85.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.148 -0.97 . . . . 0.0 110.379 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.82 -31.11 72.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.939 . . . . 0.0 110.435 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -63.69 -29.59 70.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.183 -0.948 . . . . 0.0 110.232 -179.833 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -57.33 -48.38 79.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.907 . . . . 0.0 110.227 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.401 HG13 ' OD1' ' A' ' 164' ' ' ASP . 8.9 tt -90.85 158.27 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.175 -0.953 . . . . 0.0 110.01 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.11 19.16 1.24 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.033 -1.042 . . . . 0.0 110.609 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.524 ' O ' HD13 ' A' ' 165' ' ' ILE . 5.9 p-10 -116.25 16.3 15.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.141 -0.974 . . . . 0.0 110.495 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.524 HD13 ' O ' ' A' ' 164' ' ' ASP . 49.7 mm -134.41 140.35 35.49 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.126 -0.984 . . . . 0.0 110.11 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.456 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 48.0 Cg_endo -74.77 79.5 2.58 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.618 1.325 . . . . 0.0 110.508 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.498 ' CZ ' HG11 ' A' ' 140' ' ' VAL . 3.6 m-85 -68.79 135.64 51.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.33 -0.856 . . . . 0.0 109.933 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.674 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -131.35 151.99 19.88 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.564 -1.303 . . . . 0.0 109.942 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 169' ' ' ILE . 11.7 tt -150.19 140.34 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -1.105 . . . . 0.0 109.979 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.568 HG21 HG21 ' A' ' 175' ' ' VAL . 2.9 t -153.77 158.05 40.35 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.118 0.961 . . . . 0.0 111.069 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.1 m -119.97 0.97 10.9 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.44 178.859 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -60.53 145.97 46.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.138 -0.976 . . . . 0.0 110.174 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 37.8 t -70.41 -30.91 67.91 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.167 -0.958 . . . . 0.0 110.471 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -54.56 -40.88 69.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.073 -1.017 . . . . 0.0 109.955 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.568 HG21 HG21 ' A' ' 170' ' ' THR . 58.8 t -69.82 -30.69 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 0.0 109.546 179.481 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.405 ' N ' ' CD1' ' A' ' 176' ' ' PHE . 10.6 m-85 -80.34 -41.17 25.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.445 -0.784 . . . . 0.0 109.751 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.87 -6.34 37.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.416 -0.802 . . . . 0.0 110.551 179.531 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 15.0 tttp -90.03 -45.39 9.2 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.014 -1.054 . . . . 0.0 109.382 179.7 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -91.5 0.78 57.47 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.562 -0.711 . . . . 0.0 110.642 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 53.97 66.47 1.22 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.985 -1.072 . . . . 0.0 110.728 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 55.3 mt -107.97 114.34 28.19 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.236 -0.915 . . . . 0.0 109.945 179.62 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.423 ' O ' ' CG ' ' A' ' 183' ' ' LYS . 45.2 m-20 -61.81 -17.26 55.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.936 . . . . 0.0 110.33 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 182' ' ' ASP . 22.6 mtmt -157.75 -166.39 1.98 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.206 -0.934 . . . . 0.0 110.012 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 3.5 p30 -63.9 162.98 12.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.184 -0.947 . . . . 0.0 110.049 179.814 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -176.32 152.28 12.52 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 70.4 t -118.75 133.97 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.383 -1.069 . . . . 0.0 109.697 179.629 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.739 HG22 ' HA ' ' A' ' 198' ' ' ASN . 77.3 t -141.92 145.06 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.223 -0.923 . . . . 0.0 110.468 -179.738 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.513 HD13 ' CB ' ' A' ' 215' ' ' ASN . 7.1 tt -105.03 146.85 28.51 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -118.81 127.18 53.28 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.722 -1.236 . . . . 0.0 110.834 -178.689 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.509 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -138.47 158.06 44.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.389 -0.819 . . . . 0.0 110.222 179.827 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.1 mmmm -84.3 -21.3 31.06 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.244 -0.91 . . . . 0.0 110.433 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.509 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 1.7 p90 -90.55 -176.23 4.68 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.244 -0.91 . . . . 0.0 110.883 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 46.79 -158.76 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.684 0.754 . . . . 0.0 110.74 -179.73 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.46 -54.0 49.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.634 -0.666 . . . . 0.0 110.313 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 137.81 -31.11 2.51 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.82 173.88 10.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.172 -1.193 . . . . 0.0 110.156 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 197' ' ' ASN . . . . . 0.451 ' N ' ' ND2' ' A' ' 197' ' ' ASN . 1.3 m-80 -134.14 -40.36 0.83 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.121 -0.987 . . . . 0.0 110.811 -179.181 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.739 ' HA ' HG22 ' A' ' 187' ' ' VAL . 0.6 OUTLIER 63.98 94.23 0.05 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.248 -0.907 . . . . 0.0 110.202 -179.273 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.506 ' HB2' ' CZ ' ' A' ' 211' ' ' PHE . 41.0 t80 -88.96 136.73 32.86 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.338 -0.851 . . . . 0.0 110.201 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.477 ' O ' ' CE1' ' A' ' 199' ' ' PHE . 5.1 mt-10 -121.0 -147.38 0.39 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.209 -0.932 . . . . 0.0 109.678 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 58.15 -128.27 47.14 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.03 130.39 53.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.316 -1.108 . . . . 0.0 110.35 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.73 HG21 ' HZ ' ' A' ' 144' ' ' PHE . 28.2 m -77.49 59.13 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.383 -0.823 . . . . 0.0 110.073 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.403 ' OG1' ' ND2' ' A' ' 207' ' ' ASN . 7.6 p -93.76 156.18 16.82 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.587 -0.695 . . . . 0.0 110.354 -179.826 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.471 ' O ' HD12 ' A' ' 209' ' ' LEU . 9.6 tttt -48.64 -48.24 39.73 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.24 -0.913 . . . . 0.0 110.532 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 206' ' ' GLU . . . . . 0.423 ' HG3' ' N ' ' A' ' 207' ' ' ASN . 14.2 pt-20 -54.34 -41.15 68.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.941 . . . . 0.0 110.42 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.423 ' N ' ' HG3' ' A' ' 206' ' ' GLU . 79.9 m-20 -83.21 -28.41 29.28 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.287 -0.883 . . . . 0.0 110.149 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.45 ' HA ' HD23 ' A' ' 208' ' ' LEU . 19.9 mt -72.16 -48.58 42.36 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.267 -0.896 . . . . 0.0 110.264 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.471 HD12 ' O ' ' A' ' 205' ' ' LYS . 9.1 mt -53.56 -38.92 64.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 109.899 179.719 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -74.17 -49.11 25.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.84 . . . . 0.0 109.925 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.506 ' CZ ' ' HB2' ' A' ' 199' ' ' PHE . 23.8 t80 -47.94 -58.14 4.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 110.79 179.752 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 21.6 mt -52.83 -47.61 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -0.867 . . . . 0.0 110.212 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.55 -41.37 88.78 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.24 -0.912 . . . . 0.0 109.939 179.722 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -62.03 -19.87 63.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.383 -0.823 . . . . 0.0 109.945 179.649 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.513 ' CB ' HD13 ' A' ' 188' ' ' LEU . 2.3 m-80 -89.23 -60.71 1.88 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.253 -0.905 . . . . 0.0 109.553 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.55 156.1 0.2 Allowed 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.395 -0.816 . . . . 0.0 111.18 179.84 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 8.0 mt 54.94 92.7 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.524 -0.735 . . . . 0.0 110.01 179.237 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.74 73.35 2.39 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.607 1.32 . . . . 0.0 110.414 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 87.2 mt -125.72 67.89 1.17 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 110.191 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.667 ' O ' HG13 ' A' ' 220' ' ' VAL . 7.8 p -120.84 77.9 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.955 . . . . 0.0 110.333 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.506 ' O ' HG23 ' A' ' 221' ' ' ILE . 7.4 tt -160.05 123.88 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -0.914 . . . . 0.0 110.155 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.33 -57.6 0.2 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.28 -0.888 . . . . 0.0 110.18 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -128.08 -52.58 1.31 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 110.098 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.2 p -93.52 152.24 19.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 110.231 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -116.88 33.53 5.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 110.29 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 53.42 69.26 0.72 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.289 -0.882 . . . . 0.0 110.198 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.5 m -60.7 -27.59 67.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 110.216 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.195 -179.918 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.307 0.575 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -79.86 167.01 21.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.218 -0.926 . . . . 0.0 110.366 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.616 HG22 ' HA2' ' A' ' 168' ' ' GLY . 10.1 t -96.31 169.69 9.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.119 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.6 m -109.15 107.89 18.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 110.249 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 24.8 mt -85.43 128.86 57.59 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.361 -0.837 . . . . 0.0 109.98 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.419 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 46.6 Cg_endo -72.05 -43.61 1.12 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.425 1.223 . . . . 0.0 110.431 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.425 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.3 OUTLIER -158.2 -170.42 3.12 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 122.108 0.956 . . . . 0.0 111.242 179.936 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -58.5 -27.97 61.7 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.425 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -54.04 -32.27 53.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -1.129 . . . . 0.0 110.096 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.419 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -87.11 -34.93 18.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 110.016 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.0 -22.75 61.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.349 -0.844 . . . . 0.0 110.033 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -84.69 -57.88 2.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 110.134 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.5 p -61.06 -18.2 56.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.312 -0.867 . . . . 0.0 110.377 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.55 HD23 HD11 ' A' ' 141' ' ' ILE . 17.2 tp -71.05 -49.44 44.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.151 -0.968 . . . . 0.0 109.891 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.619 HG22 ' HB3' ' A' ' 189' ' ' PHE . 59.1 t -64.83 -28.59 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.478 -0.764 . . . . 0.0 110.262 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -90.0 -0.74 57.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.276 -0.89 . . . . 0.0 110.96 -179.836 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 46.9 t -86.44 -23.19 26.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.915 -1.115 . . . . 0.0 110.31 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.401 ' OG ' ' HG3' ' A' ' 166' ' ' PRO . 0.6 OUTLIER -148.44 160.0 43.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.236 -0.915 . . . . 0.0 110.495 -179.94 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.77 -22.85 59.06 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.401 -0.812 . . . . 0.0 109.592 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.8 m -138.43 152.22 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.315 -0.866 . . . . 0.0 110.377 -179.773 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -173.41 134.48 0.52 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 0.0 109.862 179.799 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.89 149.8 23.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 120.994 -1.067 . . . . 0.0 110.271 -179.685 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.55 HD11 HD23 ' A' ' 132' ' ' LEU . 2.8 mp -134.9 117.26 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.342 -0.849 . . . . 0.0 110.139 179.733 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.21 126.12 7.34 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.649 ' CE2' HG12 ' A' ' 175' ' ' VAL . 65.7 m-85 -100.74 78.77 2.0 Allowed 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.102 -1.234 . . . . 0.0 110.206 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -104.52 146.32 29.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.061 -1.024 . . . . 0.0 110.835 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.43 -27.89 21.25 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.575 -0.703 . . . . 0.0 109.827 179.375 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.422 ' HB3' ' HB3' ' A' ' 149' ' ' SER . 0.5 OUTLIER -130.15 74.35 1.59 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.502 -0.749 . . . . 0.0 109.525 179.506 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.596 ' O ' ' HB3' ' A' ' 152' ' ' ALA . 23.5 m -52.82 -21.4 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.367 -0.833 . . . . 0.0 110.846 -179.542 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -82.65 8.41 12.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.125 -0.984 . . . . 0.0 110.838 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.422 ' HB3' ' HB3' ' A' ' 146' ' ' ASP . 7.5 p -84.67 -161.71 0.6 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.869 -1.144 . . . . 0.0 110.37 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -90.74 -21.31 21.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 0.0 110.269 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.36 -37.13 68.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.214 -0.929 . . . . 0.0 110.255 -179.803 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 147' ' ' VAL . . . -74.04 -26.85 60.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.207 -0.933 . . . . 0.0 109.722 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 149' ' ' SER . 25.1 mmtt -54.05 -49.83 68.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.887 . . . . 0.0 109.858 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -64.42 -39.71 94.36 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.343 -0.848 . . . . 0.0 109.782 179.511 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -52.07 -55.7 19.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.356 -0.84 . . . . 0.0 110.161 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.43 -56.66 16.46 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.382 -0.824 . . . . 0.0 110.169 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -49.38 -57.97 5.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.33 -0.856 . . . . 0.0 110.489 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.582 ' HB2' ' HA ' ' A' ' 205' ' ' LYS . . . -57.72 -36.34 71.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.806 179.652 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.9 -32.63 73.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.993 179.655 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -67.63 -31.77 72.02 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.224 -0.923 . . . . 0.0 110.098 179.683 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.77 -32.54 63.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 109.961 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.464 HG21 ' CG1' ' A' ' 165' ' ' ILE . 58.1 mt -102.76 139.41 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.33 -0.856 . . . . 0.0 110.111 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.81 15.61 8.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.921 . . . . 0.0 110.539 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -119.86 -10.21 9.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.194 -0.941 . . . . 0.0 110.549 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.464 ' CG1' HG21 ' A' ' 162' ' ' ILE . 39.7 mm -101.51 146.06 31.54 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.045 -1.034 . . . . 0.0 110.249 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.45 ' HD2' ' CG2' ' A' ' 165' ' ' ILE . 47.6 Cg_endo -85.53 72.86 4.16 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 O-C-N 123.722 1.38 . . . . 0.0 110.458 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.609 ' HZ ' HD13 ' A' ' 212' ' ' ILE . 5.6 m-85 -65.61 124.69 23.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.303 -0.873 . . . . 0.0 110.19 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.616 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -121.09 153.05 16.68 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 8.1 tt -150.16 137.69 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -1.12 . . . . 0.0 110.159 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.6 HG21 HG11 ' A' ' 175' ' ' VAL . 2.5 t -154.17 156.89 37.99 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.116 0.96 . . . . 0.0 110.884 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 13.7 m -115.09 -2.08 12.87 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.506 178.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -59.19 118.72 6.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.182 -0.949 . . . . 0.0 110.252 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.4 m -50.46 -33.09 19.86 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.153 -0.967 . . . . 0.0 110.458 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.32 -35.81 60.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.208 -0.932 . . . . 0.0 110.076 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.649 HG12 ' CE2' ' A' ' 143' ' ' PHE . 40.6 t -79.25 -24.91 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.338 -0.851 . . . . 0.0 109.734 179.66 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.41 ' N ' ' CD1' ' A' ' 176' ' ' PHE . 12.2 m-85 -80.97 -45.87 15.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.37 -0.831 . . . . 0.0 109.704 179.75 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 41.4 t -67.74 -22.76 65.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.353 -0.842 . . . . 0.0 110.066 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.5 tttm -52.68 -57.49 9.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.247 -0.908 . . . . 0.0 110.207 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -89.7 13.97 12.9 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.266 -0.896 . . . . 0.0 110.565 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 51.99 61.0 3.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.132 -0.98 . . . . 0.0 110.423 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 68.0 mt -96.85 -26.65 15.02 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.125 -0.984 . . . . 0.0 110.417 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 52.71 21.1 1.76 Allowed 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.896 -0.503 . . . . 0.0 110.684 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.403 ' HD3' ' O ' ' A' ' 184' ' ' ASP . 0.3 OUTLIER -178.6 -163.37 0.06 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.208 -0.932 . . . . 0.0 109.764 179.888 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 4.1 m-20 -90.57 152.6 20.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.12 -0.987 . . . . 0.0 109.838 179.468 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -164.93 149.52 16.29 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.46 -1.352 . . . . 0.0 109.917 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 199' ' ' PHE . 82.3 t -117.55 94.46 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.403 -1.057 . . . . 0.0 109.484 179.561 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 84.9 t -113.71 156.39 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.141 -0.974 . . . . 0.0 110.682 -179.294 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.656 HD13 ' CB ' ' A' ' 215' ' ' ASN . 8.2 tt -108.91 157.73 18.35 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.195 -0.941 . . . . 0.0 109.275 179.674 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.619 ' HB3' HG22 ' A' ' 133' ' ' VAL . 46.7 m-85 -129.9 124.85 34.15 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.924 -1.11 . . . . 0.0 110.733 -179.099 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.33 179.11 6.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.369 -0.832 . . . . 0.0 109.964 179.475 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -95.96 -29.7 14.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.131 -0.98 . . . . 0.0 110.74 -179.36 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.11 -172.01 3.17 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.964 0.888 . . . . 0.0 111.211 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 47.89 -155.42 0.07 Allowed 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.733 0.777 . . . . 0.0 110.654 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.61 -26.12 68.54 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.668 -0.645 . . . . 0.0 110.214 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 100.42 -34.93 5.16 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.63 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.36 172.31 8.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.072 -1.252 . . . . 0.0 110.743 -179.716 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 197' ' ' ASN . . . . . 0.458 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 0.9 OUTLIER -139.45 -148.16 0.25 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.6 -0.688 . . . . 0.0 109.494 -179.44 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -175.54 84.27 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.189 -0.944 . . . . 0.0 110.259 179.397 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 186' ' ' VAL . 83.4 t80 -51.28 119.73 4.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.196 -0.94 . . . . 0.0 110.535 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -117.45 95.98 5.2 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.299 -0.875 . . . . 0.0 110.31 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 156.11 -178.41 32.65 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.8 119.73 16.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -1.15 . . . . 0.0 110.137 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 80.0 t -60.06 108.25 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.195 -0.94 . . . . 0.0 110.137 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.415 ' OG1' ' ND2' ' A' ' 207' ' ' ASN . 10.6 p -147.68 157.67 43.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.365 -0.835 . . . . 0.0 110.11 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.582 ' HA ' ' HB2' ' A' ' 158' ' ' ALA . 27.0 tttt -52.16 -48.15 65.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.282 -0.886 . . . . 0.0 110.587 -179.752 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -63.87 -24.85 67.91 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.184 -0.947 . . . . 0.0 110.483 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.415 ' ND2' ' OG1' ' A' ' 204' ' ' THR . 75.9 m-20 -90.31 -44.65 9.56 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.184 -0.948 . . . . 0.0 110.333 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' A' ' 208' ' ' LEU . 46.4 mt -58.96 -55.83 30.09 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.224 -0.923 . . . . 0.0 110.277 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 205' ' ' LYS . 0.9 OUTLIER -54.74 -23.69 18.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 0.0 110.094 179.899 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -80.81 -57.98 3.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 110.048 179.91 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -54.98 -54.04 48.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.898 . . . . 0.0 109.974 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.609 HD13 ' HZ ' ' A' ' 167' ' ' PHE . 82.0 mt -49.15 -55.64 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.274 -0.891 . . . . 0.0 110.284 179.676 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.06 -30.48 6.37 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.432 -0.792 . . . . 0.0 110.352 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -87.78 -7.12 57.72 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.202 -0.936 . . . . 0.0 110.626 179.765 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.656 ' CB ' HD13 ' A' ' 188' ' ' LEU . 2.1 m-80 -89.31 -70.41 0.66 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.029 -1.044 . . . . 0.0 109.935 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -59.25 161.44 5.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.18 -0.95 . . . . 0.0 109.68 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 19.2 mt 53.59 99.34 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.29 -0.881 . . . . 0.0 110.368 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.6 111.85 2.89 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.578 1.304 . . . . 0.0 110.38 179.803 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.1 mt -94.42 115.93 28.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 0.0 110.383 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.482 ' O ' HG12 ' A' ' 220' ' ' VAL . 54.9 t -102.16 60.16 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.25 -0.906 . . . . 0.0 109.967 179.751 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.401 ' O ' ' CG1' ' A' ' 221' ' ' ILE . 1.3 tt -90.3 17.86 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.247 -0.908 . . . . 0.0 110.606 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -149.69 26.02 0.84 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.061 -1.024 . . . . 0.0 110.183 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 59.22 157.4 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.448 -0.783 . . . . 0.0 110.434 -180.0 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 4.1 m -136.87 106.25 6.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 0.0 110.144 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -56.61 126.93 28.88 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.317 -0.864 . . . . 0.0 110.249 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -145.23 126.79 15.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.285 -0.884 . . . . 0.0 110.133 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 6.1 t -144.74 151.97 39.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.246 -0.909 . . . . 0.0 110.263 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.185 179.921 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 167' ' ' PHE . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.235 0.541 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.542 HG22 ' HA2' ' A' ' 168' ' ' GLY . 13.2 t -86.26 170.53 12.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.277 -0.889 . . . . 0.0 110.3 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.8 m -104.13 105.03 15.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.105 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.619 ' CD1' HG23 ' A' ' 141' ' ' ILE . 17.8 mt -79.65 129.24 71.99 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.9 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 49.1 Cg_endo -72.85 -44.84 0.56 Allowed 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.421 1.222 . . . . 0.0 110.39 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 127' ' ' ALA . 0.9 OUTLIER -157.44 -169.3 2.85 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.325 -0.86 . . . . 0.0 110.572 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.44 -23.4 60.28 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 125' ' ' ASP . . . -57.24 -29.7 64.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.263 -1.139 . . . . 0.0 110.25 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.446 ' HB2' ' HD2' ' A' ' 124' ' ' PRO . . . -88.26 -31.15 19.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 110.035 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.457 ' HA ' HD13 ' A' ' 141' ' ' ILE . . . -59.3 -30.7 68.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -0.901 . . . . 0.0 110.002 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -87.88 -37.99 16.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.343 -0.848 . . . . 0.0 110.09 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 10.1 p -73.95 -29.65 62.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 110.106 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.549 HD23 ' CG1' ' A' ' 141' ' ' ILE . 15.1 tp -61.9 -55.55 28.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.212 -0.93 . . . . 0.0 110.082 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.596 HG22 ' HB3' ' A' ' 189' ' ' PHE . 55.5 t -55.37 -25.87 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.895 . . . . 0.0 110.155 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -83.33 -29.21 28.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.319 -0.863 . . . . 0.0 110.422 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.5 m -61.05 -31.2 70.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.236 -0.915 . . . . 0.0 110.312 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.401 ' OG ' ' HG3' ' A' ' 166' ' ' PRO . 95.8 p -146.34 159.21 43.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.219 -0.925 . . . . 0.0 110.25 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.937 ' HG3' HG23 ' A' ' 138' ' ' VAL . 12.7 pt-20 -64.38 -40.65 96.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.879 . . . . 0.0 110.155 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.937 HG23 ' HG3' ' A' ' 137' ' ' GLU . 95.1 t -113.24 128.32 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.477 -0.764 . . . . 0.0 110.194 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -158.11 145.31 18.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.859 . . . . 0.0 109.839 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.467 HG11 ' CE2' ' A' ' 167' ' ' PHE . 7.5 p -124.63 151.29 29.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.125 -0.985 . . . . 0.0 110.298 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.619 HG23 ' CD1' ' A' ' 123' ' ' LEU . 66.7 mt -143.11 119.52 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.441 -0.787 . . . . 0.0 109.576 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -90.62 164.95 30.67 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.831 ' CE2' HG12 ' A' ' 175' ' ' VAL . 46.7 m-85 -130.72 69.09 1.46 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.52 -0.988 . . . . 0.0 109.375 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.408 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 11.5 m-85 -89.03 132.63 34.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.139 -0.975 . . . . 0.0 111.379 -178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.3 -28.52 59.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.582 -0.699 . . . . 0.0 110.077 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -127.38 73.87 1.47 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.392 -0.817 . . . . 0.0 109.923 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.485 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 24.0 m -53.21 -21.8 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.348 -0.845 . . . . 0.0 110.611 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.49 13.39 8.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.134 -0.979 . . . . 0.0 110.801 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 85.3 p -98.6 -163.53 1.05 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.04 -1.038 . . . . 0.0 110.131 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.43 -43.67 14.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.114 -0.991 . . . . 0.0 110.293 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 85.6 p -52.74 -27.65 18.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -0.928 . . . . 0.0 110.25 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.485 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -85.48 -35.17 21.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 110.057 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.6 mmmt -54.28 -50.04 68.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 110.216 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -57.74 -38.9 76.16 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.261 -0.899 . . . . 0.0 110.085 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -52.41 -63.24 1.2 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 0.0 110.278 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.4 mt -53.86 -52.13 61.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.346 -0.846 . . . . 0.0 110.205 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.407 ' HB3' ' HD2' ' A' ' 205' ' ' LYS . 36.3 mt-30 -52.01 -50.44 61.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.369 -0.832 . . . . 0.0 110.12 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.714 ' HB2' ' HA ' ' A' ' 205' ' ' LYS . . . -66.15 -29.13 69.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.127 -0.983 . . . . 0.0 109.738 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.12 -34.3 66.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.389 -0.819 . . . . 0.0 109.995 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -57.11 -22.84 42.79 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.296 -0.877 . . . . 0.0 110.125 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.13 -51.47 69.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.896 . . . . 0.0 110.134 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.462 HG21 ' CG1' ' A' ' 165' ' ' ILE . 76.8 mt -100.96 139.76 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.32 -0.862 . . . . 0.0 110.246 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -117.51 -21.87 8.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 0.0 110.47 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -74.17 -11.0 60.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.184 -0.947 . . . . 0.0 110.729 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.462 ' CG1' HG21 ' A' ' 162' ' ' ILE . 49.4 mm -100.02 130.96 25.11 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 120.995 -1.066 . . . . 0.0 110.107 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.401 ' HG3' ' OG ' ' A' ' 136' ' ' SER . 50.3 Cg_endo -75.88 78.38 3.15 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.409 1.216 . . . . 0.0 110.683 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.467 ' CE2' HG11 ' A' ' 140' ' ' VAL . 5.8 m-85 -68.87 138.78 54.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.212 -0.93 . . . . 0.0 109.813 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.542 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -133.02 150.34 19.77 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 14.6 tt -149.67 137.81 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -1.191 . . . . 0.0 110.693 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.665 HG21 HG11 ' A' ' 175' ' ' VAL . 2.6 t -150.88 157.37 42.83 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.092 0.948 . . . . 0.0 110.774 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 79.7 p -118.78 0.78 11.5 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.581 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.48 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 43.3 t30 -53.56 -177.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.216 -0.928 . . . . 0.0 110.136 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 18.3 m -106.8 -35.96 6.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.137 -0.977 . . . . 0.0 110.077 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -57.91 -31.52 66.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -0.914 . . . . 0.0 109.819 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.831 HG12 ' CE2' ' A' ' 143' ' ' PHE . 40.2 t -76.42 -30.03 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.282 -0.886 . . . . 0.0 109.562 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 172' ' ' ASN . 11.4 m-85 -77.33 -57.36 3.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 109.613 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.2 m -53.2 -23.58 8.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.342 -0.849 . . . . 0.0 110.052 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -58.69 -57.91 10.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.873 . . . . 0.0 110.288 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -89.98 17.41 6.87 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.237 -0.914 . . . . 0.0 110.445 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 53.84 65.53 1.49 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.045 -1.035 . . . . 0.0 110.347 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 83.3 mt -108.29 100.79 10.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.316 -0.865 . . . . 0.0 110.194 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.97 -26.12 46.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 109.978 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -144.3 -165.5 2.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.362 -0.837 . . . . 0.0 110.122 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 9.7 p-10 -68.89 163.56 24.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.171 -0.956 . . . . 0.0 110.233 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 175.81 144.75 5.21 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.548 HG23 ' CB ' ' A' ' 199' ' ' PHE . 11.5 m -114.32 128.47 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -1.131 . . . . 0.0 110.283 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 188' ' ' LEU . 94.8 t -132.75 163.3 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.389 -0.819 . . . . 0.0 109.326 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.498 HD23 ' N ' ' A' ' 189' ' ' PHE . 6.6 tt -110.79 161.55 15.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.939 -1.101 . . . . 0.0 109.907 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.596 ' HB3' HG22 ' A' ' 133' ' ' VAL . 52.6 m-85 -128.53 124.85 37.05 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.989 -1.07 . . . . 0.0 110.418 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.426 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -138.14 161.24 37.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.265 -0.897 . . . . 0.0 110.378 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -90.87 -27.89 18.5 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.342 -0.849 . . . . 0.0 110.552 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.426 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.8 OUTLIER -90.75 -176.39 4.68 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.435 -0.79 . . . . 0.0 110.873 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 48.02 -154.52 0.08 Allowed 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.718 0.77 . . . . 0.0 110.587 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.04 -55.6 22.51 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.72 -0.613 . . . . 0.0 110.243 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 121.52 -25.69 6.85 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -134.89 161.56 34.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.268 -1.137 . . . . 0.0 110.203 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ASN . . . . . 0.462 ' N ' ' ND2' ' A' ' 197' ' ' ASN . 0.6 OUTLIER -133.34 -153.57 0.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.151 -0.968 . . . . 0.0 109.998 -179.481 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.41 ' HA ' HG22 ' A' ' 187' ' ' VAL . 5.1 p30 -174.57 88.3 0.05 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.446 -0.784 . . . . 0.0 110.217 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.548 ' CB ' HG23 ' A' ' 186' ' ' VAL . 29.3 t80 -60.75 139.97 57.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.334 -0.854 . . . . 0.0 110.398 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.468 ' O ' ' CE1' ' A' ' 199' ' ' PHE . 55.7 mt-10 -130.0 -151.33 0.47 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.141 -0.974 . . . . 0.0 109.679 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 51.34 -146.66 10.96 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.08 158.45 16.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -1.157 . . . . 0.0 110.016 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.445 ' C ' HG23 ' A' ' 204' ' ' THR . 73.2 t -89.13 114.69 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.255 -0.903 . . . . 0.0 110.251 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.445 HG23 ' C ' ' A' ' 203' ' ' VAL . 38.8 p -150.27 147.78 28.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.329 -0.857 . . . . 0.0 110.165 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.714 ' HA ' ' HB2' ' A' ' 158' ' ' ALA . 13.2 tttm -46.78 -50.26 18.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.25 -0.906 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . 0.439 ' HG3' ' N ' ' A' ' 207' ' ' ASN . 17.7 pt-20 -56.77 -39.36 73.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 110.191 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.439 ' N ' ' HG3' ' A' ' 206' ' ' GLU . 54.8 m-20 -72.33 -45.63 59.1 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.315 -0.865 . . . . 0.0 110.165 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.412 HD13 ' HB3' ' A' ' 158' ' ' ALA . 89.7 mt -54.52 -54.54 39.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 110.285 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.69 HD12 ' O ' ' A' ' 205' ' ' LYS . 1.4 mt -52.69 -29.09 24.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 0.0 110.002 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -77.72 -48.18 17.31 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.34 -0.85 . . . . 0.0 109.651 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.428 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 18.3 t80 -52.22 -56.04 17.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.865 . . . . 0.0 109.763 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.462 HD13 HD12 ' A' ' 188' ' ' LEU . 36.9 mm -51.24 -65.4 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.319 -0.863 . . . . 0.0 110.001 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -50.86 -25.31 4.38 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.755 -0.591 . . . . 0.0 110.452 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -89.57 -14.77 34.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.176 -0.952 . . . . 0.0 110.565 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.477 ' CB ' HD13 ' A' ' 188' ' ' LEU . 1.7 m-80 -89.06 -81.99 0.26 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.074 -1.016 . . . . 0.0 110.27 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 . . . . . 0 N--CA 1.487 1.379 0 O-C-N 121.157 -0.965 . . . . 0.0 110.164 -179.943 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 167' ' ' PHE . . . . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.263 0.554 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.451 HG22 ' HA2' ' A' ' 168' ' ' GLY . 7.8 t -99.38 169.95 8.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.124 -0.985 . . . . 0.0 110.318 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 92.8 m -108.18 121.12 44.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.288 -0.882 . . . . 0.0 110.119 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.618 HD22 ' HB1' ' A' ' 128' ' ' ALA . 28.1 mt -100.06 136.49 20.12 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.241 -0.912 . . . . 0.0 110.08 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.88 -51.76 0.14 Allowed 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.509 1.268 . . . . 0.0 110.44 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.653 ' C ' HG22 ' A' ' 175' ' ' VAL . 0.6 OUTLIER -146.08 -170.42 3.48 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.224 -0.922 . . . . 0.0 110.788 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.589 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -58.86 -28.8 63.81 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -51.2 -36.69 42.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.176 -1.191 . . . . 0.0 110.472 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.618 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -83.68 -29.19 27.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.145 -0.972 . . . . 0.0 110.03 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.2 -27.3 68.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.131 -0.98 . . . . 0.0 109.95 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -89.07 -49.74 6.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.893 . . . . 0.0 109.971 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.3 t -58.7 -32.22 68.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.893 . . . . 0.0 110.197 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 27.0 tp -59.91 -52.52 65.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.321 -0.862 . . . . 0.0 110.011 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.487 HG22 ' CB ' ' A' ' 189' ' ' PHE . 47.7 t -58.56 -37.62 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.295 -0.878 . . . . 0.0 110.033 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -74.13 -5.69 43.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.32 -0.862 . . . . 0.0 110.909 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.35 -21.98 25.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.903 -1.123 . . . . 0.0 110.615 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.405 ' OG ' ' HG3' ' A' ' 166' ' ' PRO . 0.7 OUTLIER -150.08 162.24 40.79 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.196 -0.94 . . . . 0.0 110.571 -179.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.06 -17.39 62.01 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.314 -0.866 . . . . 0.0 109.912 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 99.2 t -135.13 139.6 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.976 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.449 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -173.13 146.9 1.51 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 0.0 110.121 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.543 HG11 ' CZ ' ' A' ' 167' ' ' PHE . 7.7 p -129.13 152.74 37.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.089 -1.007 . . . . 0.0 109.919 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.477 ' O ' ' CE1' ' A' ' 143' ' ' PHE . 62.5 mt -139.47 117.68 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.209 -0.932 . . . . 0.0 110.204 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -81.85 139.68 20.2 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.477 ' CE1' ' O ' ' A' ' 141' ' ' ILE . 70.9 m-85 -114.07 79.38 1.25 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.154 -1.204 . . . . 0.0 109.971 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' A' ' 151' ' ' SER . 15.9 m-85 -107.15 148.35 28.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.109 -0.994 . . . . 0.0 110.842 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.32 -28.59 18.65 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.3 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.418 ' HB3' ' HB3' ' A' ' 149' ' ' SER . 0.9 OUTLIER -119.69 82.88 1.95 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -0.837 . . . . 0.0 109.638 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 87.6 t -52.87 -21.93 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.366 -0.833 . . . . 0.0 110.76 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.81 18.39 6.59 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.218 -0.926 . . . . 0.0 110.563 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.418 ' HB3' ' HB3' ' A' ' 146' ' ' ASP . 10.3 p -90.8 -162.84 0.95 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.139 -0.976 . . . . 0.0 110.245 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -90.27 -47.94 7.46 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.267 -0.896 . . . . 0.0 110.489 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.413 ' HB3' ' CE1' ' A' ' 144' ' ' PHE . 62.5 m -52.35 -29.97 26.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.167 -0.958 . . . . 0.0 110.245 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.53 -29.08 41.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 109.975 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 149' ' ' SER . 1.0 OUTLIER -61.1 -54.36 45.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -0.907 . . . . 0.0 109.865 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -58.21 -37.91 75.74 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.309 -0.87 . . . . 0.0 109.864 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.45 ' HE1' HG13 ' A' ' 186' ' ' VAL . 4.8 t80 -50.22 -59.84 3.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.315 -0.866 . . . . 0.0 110.32 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' A' ' 156' ' ' LEU . 17.4 mt -50.44 -50.23 52.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.328 -0.858 . . . . 0.0 110.39 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -52.83 -54.76 29.61 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.392 -0.818 . . . . 0.0 110.113 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.58 -40.94 93.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.051 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.452 ' CB ' ' CD2' ' A' ' 167' ' ' PHE . . . -67.46 -25.67 66.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.307 -0.87 . . . . 0.0 110.158 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -82.94 -31.19 27.82 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.304 -0.873 . . . . 0.0 110.214 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.77 -38.64 64.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 0.0 110.195 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.8 tt -96.37 156.36 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.914 . . . . 0.0 110.339 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -133.93 16.01 3.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.93 . . . . 0.0 110.481 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.483 ' O ' HD13 ' A' ' 165' ' ' ILE . 4.5 p30 -123.68 10.43 9.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.08 -1.013 . . . . 0.0 110.716 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.483 HD13 ' O ' ' A' ' 164' ' ' ASP . 50.0 mm -126.67 136.52 28.85 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.0 -1.062 . . . . 0.0 110.189 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.449 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 49.9 Cg_endo -77.13 91.94 1.15 Allowed 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.499 1.262 . . . . 0.0 110.915 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.543 ' CZ ' HG11 ' A' ' 140' ' ' VAL . 4.1 m-85 -86.66 130.75 34.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.288 -0.882 . . . . 0.0 109.823 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.451 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -133.56 156.06 22.07 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.402 HD12 ' CD2' ' A' ' 155' ' ' PHE . 12.6 tt -150.84 150.78 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.094 -1.239 . . . . 0.0 110.418 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.515 HG21 HG11 ' A' ' 175' ' ' VAL . 2.3 t -157.65 157.78 34.24 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.06 0.933 . . . . 0.0 110.819 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.2 t -120.13 -0.18 10.57 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.389 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.455 ' ND2' ' HB2' ' A' ' 174' ' ' ASP . 23.8 t30 -61.55 129.47 41.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.096 -1.002 . . . . 0.0 110.24 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.6 t -58.83 -29.36 66.85 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.261 -0.9 . . . . 0.0 110.448 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.455 ' HB2' ' ND2' ' A' ' 172' ' ' ASN . 1.0 OUTLIER -56.36 -33.66 65.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.125 -0.984 . . . . 0.0 110.206 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.653 HG22 ' C ' ' A' ' 125' ' ' ASP . 42.3 t -80.03 -25.29 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.913 . . . . 0.0 109.947 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 176' ' ' PHE . 11.9 m-85 -80.39 -53.06 6.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.304 -0.873 . . . . 0.0 109.777 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 14.2 m -54.45 -23.19 15.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.886 . . . . 0.0 109.932 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.71 -50.28 45.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.361 -0.837 . . . . 0.0 110.025 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -89.84 8.21 33.21 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.319 -0.863 . . . . 0.0 110.735 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 52.51 57.94 5.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.991 -1.068 . . . . 0.0 110.4 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 83.7 mt -99.45 100.27 11.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.197 -0.939 . . . . 0.0 110.351 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 3.7 m-20 -54.07 -26.74 28.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.96 . . . . 0.0 110.198 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -146.94 -165.29 2.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.217 -0.927 . . . . 0.0 109.914 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.43 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 2.7 p30 -64.1 162.49 14.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.14 -0.975 . . . . 0.0 109.91 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -170.57 140.3 5.92 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.466 -1.35 . . . . 0.0 110.064 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.45 HG13 ' HE1' ' A' ' 155' ' ' PHE . 53.3 t -109.46 90.32 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.423 -1.045 . . . . 0.0 109.448 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.517 HG13 ' H ' ' A' ' 197' ' ' ASN . 94.0 t -102.55 147.75 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.338 -0.851 . . . . 0.0 110.277 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.552 HD22 ' HB3' ' A' ' 215' ' ' ASN . 7.7 tt -107.46 158.98 16.75 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.292 -0.88 . . . . 0.0 109.306 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.487 ' CB ' HG22 ' A' ' 133' ' ' VAL . 71.2 m-85 -123.86 139.76 53.65 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.995 -1.066 . . . . 0.0 110.707 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.402 ' HG2' ' HA2' ' A' ' 195' ' ' GLY . 0.0 OUTLIER -145.91 166.16 26.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.399 -0.813 . . . . 0.0 109.796 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -84.4 -36.55 22.35 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.138 -0.976 . . . . 0.0 110.409 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.07 -170.98 2.83 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.743 0.782 . . . . 0.0 110.782 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 53.54 -160.58 0.13 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.666 0.746 . . . . 0.0 110.575 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -60.79 -29.59 69.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.668 -0.645 . . . . 0.0 110.241 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.402 ' HA2' ' HG2' ' A' ' 190' ' ' LYS . . . 105.38 -21.87 34.05 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.71 172.84 12.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.083 -1.245 . . . . 0.0 110.616 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ASN . . . . . 0.517 ' H ' HG13 ' A' ' 187' ' ' VAL . 1.8 m-80 -134.65 -148.9 0.33 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.585 -0.697 . . . . 0.0 109.48 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -173.73 81.25 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.228 -0.92 . . . . 0.0 110.393 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.431 ' HB3' ' HB ' ' A' ' 186' ' ' VAL . 12.1 t80 -69.64 123.55 21.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.372 -0.83 . . . . 0.0 109.96 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -138.26 122.0 17.55 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.214 -0.929 . . . . 0.0 109.949 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 144.01 -145.2 14.61 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.53 112.92 19.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -1.132 . . . . 0.0 110.333 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.435 ' C ' HG23 ' A' ' 204' ' ' THR . 83.6 t -74.72 109.57 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.103 -0.998 . . . . 0.0 110.03 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.435 HG23 ' C ' ' A' ' 203' ' ' VAL . 71.9 p -147.95 151.67 36.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.315 -0.865 . . . . 0.0 110.47 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 12.5 tttm -46.84 -55.14 8.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.468 -0.77 . . . . 0.0 110.928 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -54.65 -28.14 44.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.357 -0.839 . . . . 0.0 110.479 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 24.8 m-20 -86.18 -44.38 12.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 0.0 110.396 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 80.4 mt -57.28 -55.02 40.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.938 . . . . 0.0 110.695 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 8.0 mp -50.99 -50.32 58.61 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.116 -0.99 . . . . 0.0 110.653 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.01 -37.16 76.26 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.251 -0.906 . . . . 0.0 110.497 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.417 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 8.9 t80 -64.36 -60.46 3.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.145 -0.972 . . . . 0.0 110.472 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 8.9 mt -53.77 -47.37 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.337 -0.852 . . . . 0.0 110.697 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.6 mmtt -50.79 -23.21 2.57 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.235 -0.916 . . . . 0.0 110.863 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -96.69 -16.13 21.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.167 -0.958 . . . . 0.0 110.862 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.552 ' HB3' HD22 ' A' ' 188' ' ' LEU . 77.6 m-20 -94.66 -40.04 10.01 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.108 -0.995 . . . . 0.0 111.33 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 . . . . . 0 N--CA 1.493 1.715 0 O-C-N 120.897 -1.127 . . . . 0.0 110.662 -179.674 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.183 0.515 . . . . 0.0 110.301 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.593 HG22 ' HA2' ' A' ' 168' ' ' GLY . 9.3 t -74.66 169.23 18.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.288 -0.883 . . . . 0.0 110.093 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.4 m -101.66 121.32 41.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.262 -0.899 . . . . 0.0 110.548 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.3 mt -102.34 118.33 59.12 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.336 -0.853 . . . . 0.0 109.619 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.411 ' O ' ' ND2' ' A' ' 172' ' ' ASN . 46.1 Cg_endo -71.0 -18.34 31.27 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.453 1.239 . . . . 0.0 110.848 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.61 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.0 OUTLIER 179.4 -170.03 0.12 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.088 -1.007 . . . . 0.0 111.466 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.96 -29.43 70.72 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.61 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -53.47 -29.9 38.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -1.12 . . . . 0.0 110.159 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.75 -35.17 15.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.906 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.59 -39.16 79.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.327 -0.858 . . . . 0.0 109.996 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.49 -51.11 12.38 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.249 -0.907 . . . . 0.0 110.253 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.0 m -57.27 -20.46 28.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.35 -0.844 . . . . 0.0 110.408 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.9 tp -79.15 -48.14 14.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 110.381 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.699 HG22 ' CB ' ' A' ' 189' ' ' PHE . 90.9 t -60.02 -31.39 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.142 -0.974 . . . . 0.0 110.38 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -85.79 -23.69 27.12 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.238 -0.913 . . . . 0.0 109.582 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.12 -63.41 1.19 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.143 -0.973 . . . . 0.0 110.12 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.4 p -115.7 -176.63 2.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.927 . . . . 0.0 110.259 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.5 -35.56 58.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.872 . . . . 0.0 110.248 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.5 t -120.86 149.29 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.247 -0.908 . . . . 0.0 110.261 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -175.27 130.45 0.29 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.316 -0.865 . . . . 0.0 109.907 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.529 HG11 ' CZ ' ' A' ' 167' ' ' PHE . 9.6 p -119.13 147.99 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.142 -0.974 . . . . 0.0 110.329 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.2 mt -134.83 113.92 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.342 -0.849 . . . . 0.0 109.945 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -80.98 128.23 8.33 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.665 ' CE2' HG12 ' A' ' 175' ' ' VAL . 32.0 m-85 -94.89 76.57 3.6 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.235 -1.156 . . . . 0.0 109.904 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -96.63 139.21 33.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 110.965 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.39 -26.89 26.16 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.425 -0.797 . . . . 0.0 109.576 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -137.96 78.39 1.68 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.51 -0.744 . . . . 0.0 109.508 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.431 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 27.3 m -50.36 -23.86 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.349 -0.844 . . . . 0.0 110.717 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -84.66 10.59 10.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 110.892 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 11.2 p -88.11 -161.65 0.75 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.963 -1.085 . . . . 0.0 110.187 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.05 -42.81 10.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.262 -0.899 . . . . 0.0 110.344 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.0 m -59.4 -28.66 67.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.158 -0.964 . . . . 0.0 110.355 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.431 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -78.8 -31.26 45.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.309 -0.87 . . . . 0.0 110.174 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -58.94 -25.43 63.48 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.21 -0.931 . . . . 0.0 109.96 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -75.37 -46.31 33.84 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.394 -0.816 . . . . 0.0 110.133 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -49.97 -56.56 10.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 110.476 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 156' ' ' LEU . 64.9 mt -49.36 -52.29 29.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.42 -0.8 . . . . 0.0 110.584 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.414 ' HB3' ' HD2' ' A' ' 205' ' ' LYS . 1.6 mm100 -51.82 -46.49 64.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.422 -0.799 . . . . 0.0 110.36 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.4 -39.81 74.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 110.261 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.25 -27.61 69.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 110.298 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -60.42 -47.44 86.1 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.208 -0.932 . . . . 0.0 110.38 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.76 -35.65 56.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.165 -0.959 . . . . 0.0 110.342 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.7 mm -89.8 112.26 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 109.89 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -114.0 13.9 18.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 110.446 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.583 ' O ' HD13 ' A' ' 165' ' ' ILE . 8.4 p-10 -124.32 17.35 9.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.086 -1.009 . . . . 0.0 110.366 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.583 HD13 ' O ' ' A' ' 164' ' ' ASP . 42.2 mm -128.22 141.03 40.01 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.162 -0.961 . . . . 0.0 110.057 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -75.32 73.68 4.42 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.533 1.281 . . . . 0.0 110.409 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.529 ' CZ ' HG11 ' A' ' 140' ' ' VAL . 2.6 m-85 -66.32 132.67 48.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.23 -0.919 . . . . 0.0 110.09 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.593 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -123.99 154.08 17.59 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 16.9 tt -149.2 138.96 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -1.14 . . . . 0.0 110.283 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.3 t -159.46 157.35 29.96 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.113 0.958 . . . . 0.0 110.753 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.2 t -122.79 2.15 9.43 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.495 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 124' ' ' PRO . 60.8 t30 -57.08 123.77 16.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.135 -0.978 . . . . 0.0 110.277 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 77.2 p -49.65 -33.18 14.86 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.253 -0.905 . . . . 0.0 110.504 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -54.1 -32.61 55.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 109.887 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.665 HG12 ' CE2' ' A' ' 143' ' ' PHE . 41.4 t -78.83 -24.45 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -0.872 . . . . 0.0 109.861 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 176' ' ' PHE . 20.6 m-85 -86.64 -44.91 11.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -0.871 . . . . 0.0 109.891 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 5.6 m -70.83 -7.22 43.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -0.844 . . . . 0.0 110.777 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 45.7 tttp -88.09 -47.49 8.46 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.058 -1.026 . . . . 0.0 109.563 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -90.06 12.19 18.47 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.371 -0.831 . . . . 0.0 110.385 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.93 68.6 0.78 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.054 -1.028 . . . . 0.0 110.483 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 62.2 mt -116.23 103.35 10.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 110.143 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -51.57 -26.14 8.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.27 -0.894 . . . . 0.0 110.226 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -149.93 -169.0 3.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 110.023 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 2.1 p30 -63.43 162.94 11.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.202 -0.936 . . . . 0.0 110.137 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -169.18 166.73 39.93 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 186' ' ' VAL . 21.4 m -135.19 114.68 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.247 -1.149 . . . . 0.0 110.11 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.828 HG22 ' HA ' ' A' ' 198' ' ' ASN . 99.5 t -127.29 153.67 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.924 . . . . 0.0 110.082 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.922 HD22 ' HB3' ' A' ' 215' ' ' ASN . 6.1 tt -109.27 137.96 46.36 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.285 -0.884 . . . . 0.0 108.668 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.699 ' CB ' HG22 ' A' ' 133' ' ' VAL . 62.4 m-85 -111.28 135.87 51.2 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.726 -1.234 . . . . 0.0 111.19 -178.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.535 ' HD2' HD23 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -150.16 159.76 44.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.453 -0.779 . . . . 0.0 109.967 179.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -83.97 -22.18 31.51 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.242 -0.911 . . . . 0.0 110.491 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.518 ' CZ ' ' HA ' ' A' ' 216' ' ' GLN . 2.4 p90 -90.7 -178.91 5.4 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.284 -0.885 . . . . 0.0 110.633 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 48.79 -159.17 0.05 Allowed 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.659 0.742 . . . . 0.0 110.509 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -60.61 -31.05 70.24 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.583 -0.698 . . . . 0.0 110.293 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 114.58 -42.74 1.85 Allowed Glycine 0 N--CA 1.483 1.822 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.09 177.95 5.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.147 -1.208 . . . . 0.0 110.462 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ASN . . . . . 0.487 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 2.5 m-80 -134.47 -37.3 0.85 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 0.0 110.55 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.828 ' HA ' HG22 ' A' ' 187' ' ' VAL . 4.0 m-80 57.73 83.29 0.11 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.171 -0.955 . . . . 0.0 109.991 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.494 ' HB3' HG23 ' A' ' 186' ' ' VAL . 84.3 t80 -66.61 115.27 6.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.396 -0.815 . . . . 0.0 110.433 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -115.6 80.16 1.4 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.368 -0.832 . . . . 0.0 110.12 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -169.12 -157.6 11.92 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -79.36 122.47 26.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -1.154 . . . . 0.0 110.305 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.467 ' C ' HG23 ' A' ' 204' ' ' THR . 70.6 t -71.87 101.36 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 110.076 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.467 HG23 ' C ' ' A' ' 203' ' ' VAL . 57.9 p -150.27 152.08 33.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.388 -0.82 . . . . 0.0 110.268 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.426 ' HG2' ' CD1' ' A' ' 209' ' ' LEU . 3.9 tttm -49.49 -48.54 47.82 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.321 -0.862 . . . . 0.0 110.426 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -57.1 -39.81 75.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.342 -0.849 . . . . 0.0 110.283 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -80.03 -48.48 13.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.231 -0.918 . . . . 0.0 110.368 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.542 ' O ' HD12 ' A' ' 212' ' ' ILE . 98.8 mt -54.19 -55.44 27.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.935 . . . . 0.0 110.257 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.426 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 8.2 mt -54.35 -29.88 49.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.283 -0.885 . . . . 0.0 110.221 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -76.42 -45.88 29.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.911 . . . . 0.0 110.065 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 197' ' ' ASN . 6.9 t80 -56.46 -62.79 1.48 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.411 -0.806 . . . . 0.0 110.462 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.542 HD12 ' O ' ' A' ' 208' ' ' LEU . 5.8 mt -52.42 -42.56 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.0 110.593 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -56.15 -19.74 14.73 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.218 -0.926 . . . . 0.0 110.786 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -110.92 11.64 22.27 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.198 -0.939 . . . . 0.0 110.755 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.922 ' HB3' HD22 ' A' ' 188' ' ' LEU . 1.3 m120 -91.89 -64.41 1.12 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.946 -1.096 . . . . 0.0 110.611 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' GLN . . . . . 0.518 ' HA ' ' CZ ' ' A' ' 192' ' ' PHE . 5.9 pt20 . . . . . 0 C--N 1.303 -1.427 0 O-C-N 121.289 -0.882 . . . . 0.0 111.002 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.289 0.566 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.558 HG22 ' HA2' ' A' ' 168' ' ' GLY . 8.9 t -97.87 166.89 11.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.182 -0.949 . . . . 0.0 110.15 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.8 m -115.02 103.92 11.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.942 . . . . 0.0 110.346 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.566 HD22 ' HB1' ' A' ' 128' ' ' ALA . 39.3 mt -77.85 126.2 84.43 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.299 -0.876 . . . . 0.0 110.015 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.27 -40.25 2.47 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.418 1.22 . . . . 0.0 110.508 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.541 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.9 OUTLIER -153.82 -170.59 3.62 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.308 -0.87 . . . . 0.0 110.813 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.02 -29.93 72.19 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.541 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -52.15 -30.36 26.29 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.157 -1.202 . . . . 0.0 110.371 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.566 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -89.79 -38.7 13.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.947 . . . . 0.0 110.032 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.53 -25.22 24.5 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.283 -0.885 . . . . 0.0 110.036 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -86.62 -54.49 4.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.353 -0.842 . . . . 0.0 110.115 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.07 -18.31 33.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.912 . . . . 0.0 110.291 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.535 HD21 ' HB2' ' A' ' 166' ' ' PRO . 3.3 tt -73.25 -59.35 2.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 0.0 109.747 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.59 HG22 ' CB ' ' A' ' 189' ' ' PHE . 49.8 t -53.01 -37.21 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.414 -0.803 . . . . 0.0 110.257 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -73.16 -25.58 60.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.274 -0.891 . . . . 0.0 110.313 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.81 -48.82 69.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 110.28 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 78.0 p -135.65 173.86 11.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.224 -0.922 . . . . 0.0 110.338 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.91 -41.22 91.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -0.862 . . . . 0.0 110.309 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 95.7 t -112.97 151.02 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.283 -0.886 . . . . 0.0 110.371 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.526 ' HB1' HD22 ' A' ' 132' ' ' LEU . . . -174.4 137.79 0.52 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.854 . . . . 0.0 109.845 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.484 HG11 ' CZ ' ' A' ' 167' ' ' PHE . 9.1 p -123.38 147.09 27.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.203 -0.936 . . . . 0.0 110.302 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.486 HD12 ' CD1' ' A' ' 189' ' ' PHE . 3.4 mt -135.79 115.82 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.265 -0.897 . . . . 0.0 109.666 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -79.82 134.25 13.39 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.908 ' CE2' HG12 ' A' ' 175' ' ' VAL . 11.5 m-85 -103.48 71.25 1.08 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.181 -1.188 . . . . 0.0 109.615 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.529 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 15.1 m-85 -91.74 137.45 32.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.026 -1.046 . . . . 0.0 110.992 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.483 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -91.19 -31.94 15.98 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 121.614 0.721 . . . . 0.0 109.846 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.566 ' C ' HG23 ' A' ' 147' ' ' VAL . 1.7 t70 -89.5 -41.49 12.01 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.534 0.683 . . . . 0.0 110.166 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.566 HG23 ' C ' ' A' ' 146' ' ' ASP . 2.5 t 72.97 -51.08 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.859 -0.526 . . . . 0.0 110.714 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -90.72 8.87 32.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.093 -1.005 . . . . 0.0 110.551 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 19.8 p -70.34 -164.68 0.09 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.863 -1.148 . . . . 0.0 109.971 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.41 -31.18 16.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.895 . . . . 0.0 110.277 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.5 p -68.49 -25.6 65.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.906 . . . . 0.0 110.123 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.39 -34.01 25.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.9 . . . . 0.0 110.173 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -53.2 -44.77 68.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.355 -0.841 . . . . 0.0 110.4 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -66.89 -36.83 83.17 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.221 -0.925 . . . . 0.0 110.316 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.434 ' O ' ' HB3' ' A' ' 158' ' ' ALA . 4.5 t80 -51.58 -58.22 6.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.392 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.6 mt -50.52 -54.25 23.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.4 -0.813 . . . . 0.0 110.45 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -50.88 -29.93 13.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.258 -0.901 . . . . 0.0 110.342 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 155' ' ' PHE . . . -75.63 -56.47 4.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.338 -0.852 . . . . 0.0 110.006 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.623 ' HB2' ' CD2' ' A' ' 167' ' ' PHE . . . -54.86 -33.58 62.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 110.059 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -66.69 -28.7 68.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.331 -0.856 . . . . 0.0 110.226 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -64.67 -42.88 95.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.285 -0.884 . . . . 0.0 110.231 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.402 HG13 ' OD1' ' A' ' 164' ' ' ASP . 4.1 tt -93.12 164.42 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.254 -0.904 . . . . 0.0 110.209 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 163' ' ' ASP . 17.1 p-10 -145.23 19.2 1.57 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.101 -0.999 . . . . 0.0 110.467 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.402 ' OD1' HG13 ' A' ' 162' ' ' ILE . 5.0 p-10 -125.57 8.82 7.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.196 -0.94 . . . . 0.0 110.652 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 45.8 mm -125.53 137.21 29.46 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.04 -1.037 . . . . 0.0 109.798 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.535 ' HB2' HD21 ' A' ' 132' ' ' LEU . 48.2 Cg_endo -73.69 78.97 2.33 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.568 1.299 . . . . 0.0 110.724 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.623 ' CD2' ' HB2' ' A' ' 159' ' ' ALA . 2.9 m-85 -71.4 125.64 27.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.186 -0.946 . . . . 0.0 109.694 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.558 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -123.33 156.15 17.59 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.134 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 14.7 tt -150.17 142.95 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.459 -1.024 . . . . 0.0 109.912 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.4 t -164.98 157.57 16.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.117 -0.989 . . . . 0.0 110.892 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . 0.4 ' HB3' ' CG2' ' A' ' 147' ' ' VAL . 91.2 p -122.97 3.58 9.38 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.375 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -54.98 122.05 10.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.158 -0.964 . . . . 0.0 110.306 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 83.9 p -51.52 -31.85 25.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.321 -0.862 . . . . 0.0 110.477 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -54.32 -33.8 59.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.142 -0.974 . . . . 0.0 109.809 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.908 HG12 ' CE2' ' A' ' 143' ' ' PHE . 41.0 t -79.78 -24.46 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.44 -0.788 . . . . 0.0 109.642 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 176' ' ' PHE . 10.8 m-85 -79.44 -54.96 5.41 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.441 -0.787 . . . . 0.0 109.907 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 29.9 t -66.53 -14.27 62.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.366 -0.834 . . . . 0.0 110.562 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 11.3 tttt -82.01 -44.94 15.99 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.086 -1.009 . . . . 0.0 110.034 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -90.7 8.08 36.25 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.15 -0.969 . . . . 0.0 110.674 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.69 67.81 0.87 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.05 -1.032 . . . . 0.0 110.676 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.454 HD13 ' CD2' ' A' ' 143' ' ' PHE . 3.4 mt -109.06 124.43 50.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.226 -0.921 . . . . 0.0 110.137 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -62.08 -15.83 47.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.108 -0.995 . . . . 0.0 110.012 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -175.26 -157.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.233 -0.917 . . . . 0.0 109.551 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 8.4 p-10 -71.57 160.45 32.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.087 -1.008 . . . . 0.0 109.945 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -177.33 172.97 45.82 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 74.9 t -126.5 107.54 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.385 -1.068 . . . . 0.0 110.006 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 197' ' ' ASN . 75.0 t -111.57 148.22 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.339 -0.851 . . . . 0.0 109.94 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.805 HD22 ' HB3' ' A' ' 215' ' ' ASN . 6.3 tt -108.16 143.74 36.54 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.008 -1.057 . . . . 0.0 109.421 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.59 ' CB ' HG22 ' A' ' 133' ' ' VAL . 59.9 m-85 -115.62 118.6 33.56 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.017 -1.052 . . . . 0.0 110.874 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.458 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -130.55 164.02 25.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.279 -0.888 . . . . 0.0 109.996 179.513 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -88.86 -24.9 22.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.165 -0.959 . . . . 0.0 110.148 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.458 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 1.6 p90 -91.01 -176.17 4.55 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.46 -0.775 . . . . 0.0 110.741 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 46.22 -159.13 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.605 0.717 . . . . 0.0 110.966 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -50.9 -56.33 12.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.66 -0.65 . . . . 0.0 110.284 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 125.17 -21.71 6.43 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.4 mtm180 -143.63 156.91 44.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.132 -1.216 . . . . 0.0 110.571 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ASN . . . . . 0.473 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.1 m-80 -131.46 -167.35 1.84 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.36 -0.837 . . . . 0.0 109.84 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -156.82 80.69 0.94 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.442 -0.787 . . . . 0.0 109.892 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.534 ' CE2' HG22 ' A' ' 203' ' ' VAL . 84.7 t80 -51.3 121.87 6.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.138 -0.976 . . . . 0.0 110.484 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.03 91.72 3.49 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.344 -0.847 . . . . 0.0 110.271 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 165.34 177.41 37.71 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -55.96 107.52 0.36 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.25 -1.147 . . . . 0.0 110.237 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.534 HG22 ' CE2' ' A' ' 199' ' ' PHE . 93.1 t -64.84 113.66 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -0.879 . . . . 0.0 110.071 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 12.5 p -150.33 157.36 42.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.87 . . . . 0.0 110.475 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.469 ' O ' HD12 ' A' ' 209' ' ' LEU . 11.4 tttt -50.09 -52.25 36.26 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.196 -0.94 . . . . 0.0 110.597 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . 0.448 ' HG3' ' N ' ' A' ' 207' ' ' ASN . 12.3 pt-20 -55.91 -40.04 72.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.221 -0.924 . . . . 0.0 110.329 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.448 ' N ' ' HG3' ' A' ' 206' ' ' GLU . 87.6 m-20 -78.12 -48.01 16.93 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.271 -0.893 . . . . 0.0 110.253 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.667 ' O ' HD12 ' A' ' 212' ' ' ILE . 68.2 mt -53.53 -57.99 8.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.221 -0.924 . . . . 0.0 110.346 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 205' ' ' LYS . 0.4 OUTLIER -53.54 -22.83 9.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.293 -0.88 . . . . 0.0 110.467 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -81.76 -49.62 10.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.099 -1.001 . . . . 0.0 110.093 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -58.97 -56.92 16.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.317 -0.864 . . . . 0.0 110.428 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.667 HD12 ' O ' ' A' ' 208' ' ' LEU . 6.9 mt -55.22 -49.03 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.267 -0.896 . . . . 0.0 110.621 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -50.33 -27.35 6.04 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.173 -0.954 . . . . 0.0 110.598 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -88.0 -24.67 23.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -0.925 . . . . 0.0 110.412 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.805 ' HB3' HD22 ' A' ' 188' ' ' LEU . 70.8 m-80 -89.58 -33.59 16.65 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.263 -0.898 . . . . 0.0 110.753 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 O-C-N 121.13 -0.981 . . . . 0.0 110.63 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.209 0.528 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.434 ' HB ' ' HA2' ' A' ' 168' ' ' GLY . 28.6 m -97.53 95.7 7.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 110.172 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 95.9 m -61.34 104.24 0.38 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -0.9 . . . . 0.0 109.88 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.411 ' HB2' ' HB ' ' A' ' 170' ' ' THR . 0.8 OUTLIER -82.98 137.1 43.5 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.124 -0.985 . . . . 0.0 110.169 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.437 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 48.9 Cg_endo -73.33 -39.62 2.0 Allowed 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.532 1.28 . . . . 0.0 110.206 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.46 ' C ' HG22 ' A' ' 175' ' ' VAL . 0.4 OUTLIER -157.06 -169.11 2.84 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.992 0.901 . . . . 0.0 111.085 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.429 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -66.4 -31.7 79.66 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -53.21 -27.14 20.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.233 -1.157 . . . . 0.0 110.119 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.437 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -88.2 -32.75 18.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.87 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.431 ' O ' HG23 ' A' ' 133' ' ' VAL . . . -56.85 -41.54 78.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.349 -0.844 . . . . 0.0 109.946 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.77 -52.79 11.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.331 -0.856 . . . . 0.0 110.086 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.96 -40.31 63.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.333 -0.854 . . . . 0.0 110.099 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.779 HD23 HD11 ' A' ' 141' ' ' ILE . 21.3 tp -53.55 -50.72 64.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.247 -0.908 . . . . 0.0 109.961 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.76 HG22 ' HB3' ' A' ' 189' ' ' PHE . 39.9 t -53.63 -32.71 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.459 -0.775 . . . . 0.0 110.186 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -87.54 -32.11 19.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.186 -0.946 . . . . 0.0 110.377 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 59.7 p -52.0 -46.29 64.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.193 -0.942 . . . . 0.0 110.382 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.2 p -132.29 163.94 27.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.145 -0.972 . . . . 0.0 110.109 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -63.4 -43.66 96.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.902 . . . . 0.0 110.166 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 28.1 m -117.63 147.99 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.215 -0.928 . . . . 0.0 110.422 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -175.27 126.34 0.26 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.364 -0.835 . . . . 0.0 110.031 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.566 HG12 ' HA ' ' A' ' 167' ' ' PHE . 13.7 p -97.91 147.96 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 121.119 -0.988 . . . . 0.0 110.535 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.779 HD11 HD23 ' A' ' 132' ' ' LEU . 44.7 mt -141.43 107.71 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.91 . . . . 0.0 109.734 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -84.36 163.15 38.89 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.562 ' CE2' HG12 ' A' ' 175' ' ' VAL . 26.2 m-85 -126.72 70.42 1.27 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.632 -0.923 . . . . 0.0 109.647 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.5 ' CZ ' HG21 ' A' ' 203' ' ' VAL . 23.9 m-85 -97.21 146.02 25.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 111.071 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.61 -28.22 18.57 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.145 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.89 84.17 1.94 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -0.833 . . . . 0.0 109.94 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.9 t -66.89 -12.45 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.345 -0.847 . . . . 0.0 110.8 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -99.07 4.03 46.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.009 -1.057 . . . . 0.0 110.805 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 38.7 p -85.97 -159.52 0.47 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.824 -1.173 . . . . 0.0 110.27 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -88.82 -35.34 16.66 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.232 -0.918 . . . . 0.0 110.135 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.1 t -54.89 -33.24 61.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.34 -0.85 . . . . 0.0 110.226 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.495 ' O ' HD12 ' A' ' 156' ' ' LEU . . . -82.49 -33.51 28.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.917 . . . . 0.0 110.203 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -53.46 -50.48 65.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.879 . . . . 0.0 110.128 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -57.34 -41.96 81.02 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.369 -0.832 . . . . 0.0 110.124 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.412 ' CD2' HD12 ' A' ' 169' ' ' ILE . 4.2 t80 -52.22 -57.31 10.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 110.1 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.495 HD12 ' O ' ' A' ' 152' ' ' ALA . 0.6 OUTLIER -52.65 -55.13 24.68 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.42 -0.8 . . . . 0.0 110.207 179.569 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -47.64 -48.58 28.7 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.414 -0.804 . . . . 0.0 110.551 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.702 ' HB2' ' HA ' ' A' ' 205' ' ' LYS . . . -64.84 -43.6 92.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 109.766 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.05 -35.28 74.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.372 -0.83 . . . . 0.0 109.862 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -68.16 -29.09 67.89 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.319 -0.863 . . . . 0.0 110.301 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.32 -61.61 2.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.197 -0.939 . . . . 0.0 110.171 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 73.6 mt -89.67 149.28 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.928 . . . . 0.0 109.95 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.47 -31.06 4.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.205 -0.934 . . . . 0.0 110.375 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -68.74 -14.51 63.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.22 -0.925 . . . . 0.0 110.698 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.531 ' CG2' ' CE1' ' A' ' 167' ' ' PHE . 37.1 mm -98.46 123.98 48.31 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.08 -1.013 . . . . 0.0 110.263 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -83.38 107.6 1.44 Allowed 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.471 1.248 . . . . 0.0 110.064 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.566 ' HA ' HG12 ' A' ' 140' ' ' VAL . 0.4 OUTLIER -99.25 154.46 18.15 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.12 -0.988 . . . . 0.0 109.969 -179.489 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.434 ' HA2' ' HB ' ' A' ' 121' ' ' THR . . . -137.71 145.03 16.57 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.52 ' O ' HG23 ' A' ' 169' ' ' ILE . 16.8 tt -143.27 126.31 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.269 -1.136 . . . . 0.0 110.231 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.502 ' CG2' HG11 ' A' ' 175' ' ' VAL . 2.8 t -143.77 157.96 44.01 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.146 0.974 . . . . 0.0 111.131 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.7 t -127.09 5.37 6.46 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.181 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.428 ' ND2' ' HB2' ' A' ' 174' ' ' ASP . 43.4 t30 -62.0 128.32 35.58 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.182 -0.949 . . . . 0.0 110.231 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 9.0 t -52.23 -33.88 43.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.187 -0.946 . . . . 0.0 110.323 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.428 ' HB2' ' ND2' ' A' ' 172' ' ' ASN . 0.3 OUTLIER -54.67 -34.23 61.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.949 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.562 HG12 ' CE2' ' A' ' 143' ' ' PHE . 57.3 t -78.35 -27.19 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.537 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.401 ' N ' ' CD1' ' A' ' 176' ' ' PHE . 12.5 m-85 -81.54 -42.45 20.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.424 -0.798 . . . . 0.0 109.805 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.03 -7.47 46.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.343 -0.848 . . . . 0.0 110.629 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.86 -45.11 9.98 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.901 -1.124 . . . . 0.0 109.304 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -89.59 5.07 47.25 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.742 -0.599 . . . . 0.0 110.555 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.42 ' CG ' ' O ' ' A' ' 180' ' ' GLN . 0.0 OUTLIER 51.81 58.81 5.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.1 -1.0 . . . . 0.0 110.722 179.587 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.4 mt -98.66 130.35 45.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.063 -1.023 . . . . 0.0 109.824 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -87.06 12.22 11.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.1 -1.0 . . . . 0.0 110.295 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 13.8 pttp 179.13 -163.34 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.227 -0.921 . . . . 0.0 109.618 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.411 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 8.2 p-10 -87.47 156.63 19.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.287 -0.883 . . . . 0.0 110.133 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -177.54 152.09 11.58 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.426 HG11 ' CD2' ' A' ' 208' ' ' LEU . 88.2 t -103.65 128.4 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.317 -1.108 . . . . 0.0 110.468 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 83.1 t -134.56 151.48 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.363 -0.836 . . . . 0.0 109.655 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.504 HD22 ' HB3' ' A' ' 215' ' ' ASN . 7.8 tt -113.21 158.67 20.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.996 -1.065 . . . . 0.0 109.915 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.76 ' HB3' HG22 ' A' ' 133' ' ' VAL . 52.6 m-85 -128.67 130.03 46.63 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.078 -1.014 . . . . 0.0 110.459 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.21 166.61 23.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.877 . . . . 0.0 110.069 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.01 -33.73 18.27 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.199 -0.938 . . . . 0.0 110.128 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -90.91 -173.4 3.68 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.443 -0.786 . . . . 0.0 110.647 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 51.95 -159.73 0.11 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.434 -0.792 . . . . 0.0 110.458 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -54.93 -54.17 46.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.634 -0.666 . . . . 0.0 110.271 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 128.65 -38.49 2.04 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.18 165.31 21.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -1.166 . . . . 0.0 110.359 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ASN . . . . . 0.463 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.8 m-80 -128.72 -151.31 0.47 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.3 -0.875 . . . . 0.0 109.865 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -174.37 78.37 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.279 -0.888 . . . . 0.0 110.381 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.417 ' CB ' ' O ' ' A' ' 186' ' ' VAL . 28.3 t80 -57.95 118.7 5.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 109.838 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -125.53 38.8 4.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.302 -0.874 . . . . 0.0 110.413 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -128.83 -149.24 6.86 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -90.71 97.38 11.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.149 -1.206 . . . . 0.0 109.928 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.667 ' O ' HG13 ' A' ' 203' ' ' VAL . 7.4 p -51.33 102.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.212 -0.93 . . . . 0.0 110.373 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 26.2 p -140.93 150.59 43.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.357 -0.84 . . . . 0.0 110.323 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.881 ' O ' HD12 ' A' ' 209' ' ' LEU . 3.7 tttp -47.21 -31.31 3.56 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.359 -0.838 . . . . 0.0 110.946 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -79.42 -33.06 42.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.178 -0.951 . . . . 0.0 110.316 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 59.9 m-20 -83.57 -47.06 11.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 110.289 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.667 HD21 HG23 ' A' ' 203' ' ' VAL . 65.6 mt -52.87 -48.65 66.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 110.33 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.881 HD12 ' O ' ' A' ' 205' ' ' LYS . 13.6 mt -59.26 -29.13 67.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 110.095 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.47 -34.42 41.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 0.0 110.144 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.412 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 7.1 t80 -62.88 -62.98 1.35 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.306 -0.871 . . . . 0.0 110.192 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.404 HG22 ' OE1' ' A' ' 216' ' ' GLN . 7.0 mt -51.03 -49.75 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.391 -0.818 . . . . 0.0 110.473 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -48.7 -25.08 1.62 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.364 -0.835 . . . . 0.0 110.868 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.75 -14.77 21.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.125 -0.984 . . . . 0.0 110.815 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.504 ' HB3' HD22 ' A' ' 188' ' ' LEU . 73.4 m-80 -102.27 -24.29 13.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.078 -1.014 . . . . 0.0 110.767 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' GLN . . . . . 0.404 ' OE1' HG22 ' A' ' 212' ' ' ILE . 16.1 pt20 . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.066 -1.021 . . . . 0.0 110.736 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.33 0.586 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.444 ' HB ' ' HA2' ' A' ' 168' ' ' GLY . 3.9 m -119.92 112.69 19.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.348 -0.845 . . . . 0.0 109.729 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 169' ' ' ILE . 53.5 m -68.57 144.04 54.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 110.047 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.607 HD22 ' HB1' ' A' ' 128' ' ' ALA . 20.5 mt -125.3 143.98 46.17 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.0 110.106 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.06 -40.33 2.58 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.705 1.371 . . . . 0.0 110.293 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.534 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.2 OUTLIER -170.5 -169.93 0.87 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.346 -0.846 . . . . 0.0 110.636 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.543 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -54.74 -27.77 44.35 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.534 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -52.88 -31.51 39.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.194 -1.18 . . . . 0.0 110.434 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.607 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -89.77 -37.5 14.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.177 -0.952 . . . . 0.0 109.912 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.591 ' O ' HG23 ' A' ' 133' ' ' VAL . . . -58.0 -33.19 68.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.332 -0.855 . . . . 0.0 110.004 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -74.28 -51.2 15.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.06 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.14 -30.71 71.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.307 -0.871 . . . . 0.0 110.07 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.1 tp -59.74 -48.68 80.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.207 -0.933 . . . . 0.0 109.961 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 129' ' ' ALA . 38.5 t -56.05 -52.13 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 110.07 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -65.59 -20.21 66.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.234 -0.916 . . . . 0.0 110.243 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.2 t -52.49 -51.43 59.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.146 -0.971 . . . . 0.0 110.351 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 53.7 p -137.31 -171.88 3.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.252 -0.905 . . . . 0.0 110.313 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -75.57 -39.74 57.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -0.878 . . . . 0.0 110.169 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 87.1 t -119.43 147.29 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.25 -0.906 . . . . 0.0 110.175 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.423 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -170.89 121.94 0.57 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.201 -0.937 . . . . 0.0 110.203 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.43 ' CG1' ' HA ' ' A' ' 167' ' ' PHE . 14.8 p -104.41 148.78 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.311 -0.868 . . . . 0.0 110.361 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.47 ' O ' ' CE2' ' A' ' 143' ' ' PHE . 51.1 mt -133.79 107.71 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.258 -0.902 . . . . 0.0 109.992 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.49 122.81 6.91 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.47 ' CE2' ' O ' ' A' ' 141' ' ' ILE . 93.0 m-85 -101.63 67.48 1.12 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.273 -1.134 . . . . 0.0 109.961 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -95.48 146.34 24.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.091 -1.006 . . . . 0.0 110.418 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.46 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -91.08 -32.5 15.85 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.586 -0.696 . . . . 0.0 109.585 179.083 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.46 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 88.5 m-20 -122.32 69.7 0.97 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.517 -0.739 . . . . 0.0 109.862 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.502 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 26.4 m -53.8 -21.31 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.206 -0.934 . . . . 0.0 110.51 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -79.74 4.32 16.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.09 -1.006 . . . . 0.0 111.008 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 32.9 p -87.34 -163.72 0.97 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.904 -1.122 . . . . 0.0 110.284 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.87 -40.83 12.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.0 110.103 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.83 -28.99 59.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.187 -0.946 . . . . 0.0 109.807 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.767 ' O ' HD12 ' A' ' 156' ' ' LEU . . . -79.68 -35.26 39.44 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.332 -0.855 . . . . 0.0 109.849 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -51.32 -44.99 62.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.277 -0.89 . . . . 0.0 110.192 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.412 ' OE1' ' HA ' ' A' ' 204' ' ' THR . 21.5 mm-40 -54.7 -47.36 73.78 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.156 -0.965 . . . . 0.0 109.514 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.568 ' HE1' HG13 ' A' ' 186' ' ' VAL . 4.7 t80 -52.48 -56.44 15.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 0.0 109.831 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.767 HD12 ' O ' ' A' ' 152' ' ' ALA . 2.6 mp -51.44 -58.27 6.71 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.362 -0.836 . . . . 0.0 110.095 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -49.61 -41.79 43.12 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.343 -0.848 . . . . 0.0 110.313 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 205' ' ' LYS . . . -74.61 -26.88 60.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.995 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.2 -29.03 42.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 0.0 110.067 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -63.4 -37.82 88.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 110.111 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.97 -29.82 69.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.358 -0.838 . . . . 0.0 109.961 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.571 HG21 ' CE1' ' A' ' 167' ' ' PHE . 18.2 mm -90.1 122.48 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.423 -0.798 . . . . 0.0 109.634 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -123.88 2.07 8.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.243 -0.91 . . . . 0.0 110.727 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -109.36 -19.85 13.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.952 -1.092 . . . . 0.0 110.252 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.468 ' CG2' ' HD2' ' A' ' 166' ' ' PRO . 41.4 mm -91.4 146.1 32.69 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.146 -0.971 . . . . 0.0 110.182 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.468 ' HD2' ' CG2' ' A' ' 165' ' ' ILE . 44.9 Cg_endo -84.25 79.26 2.64 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.807 1.425 . . . . 0.0 110.089 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.571 ' CE1' HG21 ' A' ' 162' ' ' ILE . 3.6 m-85 -71.92 126.94 31.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.406 -0.809 . . . . 0.0 110.589 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.444 ' HA2' ' HB ' ' A' ' 121' ' ' THR . . . -118.69 157.24 15.33 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 122' ' ' THR . 6.3 tt -150.42 141.96 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.255 -1.144 . . . . 0.0 110.618 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.2 t -158.25 155.52 29.07 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.004 0.907 . . . . 0.0 110.463 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . 0.429 ' HB2' ' HA ' ' A' ' 145' ' ' LYS . 78.8 p -127.47 7.83 6.41 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.38 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -67.39 119.84 12.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.073 -1.017 . . . . 0.0 110.383 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.431 ' HA ' ' HB2' ' A' ' 176' ' ' PHE . 10.5 p -49.02 -28.17 3.76 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.211 -0.93 . . . . 0.0 110.535 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -54.8 -41.09 70.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.115 -0.991 . . . . 0.0 109.734 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.543 HG22 ' N ' ' A' ' 126' ' ' GLY . 45.1 t -78.77 -23.68 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.381 -0.824 . . . . 0.0 109.691 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.431 ' HB2' ' HA ' ' A' ' 173' ' ' SER . 9.0 m-85 -72.43 -51.81 18.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.394 -0.816 . . . . 0.0 109.531 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 33.9 t -70.58 -17.06 62.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.482 -0.761 . . . . 0.0 110.366 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 23.9 tttm -73.52 -52.43 13.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.137 -0.977 . . . . 0.0 109.96 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -90.53 22.55 3.4 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.221 -0.924 . . . . 0.0 110.53 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 54.56 56.96 6.19 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.129 -0.982 . . . . 0.0 110.176 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 86.1 mt -113.13 96.63 6.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 110.181 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -63.18 -19.15 64.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.291 -0.881 . . . . 0.0 110.427 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.51 -159.74 1.05 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.194 -0.941 . . . . 0.0 110.152 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 32.1 m-20 -53.52 152.31 5.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.182 -0.949 . . . . 0.0 109.896 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -153.4 136.74 5.44 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.59 -1.29 . . . . 0.0 110.008 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.568 HG13 ' HE1' ' A' ' 155' ' ' PHE . 59.0 t -121.53 84.43 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.367 -1.079 . . . . 0.0 109.479 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.924 HG22 ' HA ' ' A' ' 198' ' ' ASN . 98.2 t -111.55 150.11 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.111 -0.993 . . . . 0.0 110.352 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.597 HD12 HD12 ' A' ' 212' ' ' ILE . 6.0 tt -106.55 150.88 25.7 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.182 -0.949 . . . . 0.0 108.833 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -120.64 116.58 25.6 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.863 -1.148 . . . . 0.0 110.438 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.527 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -124.6 170.62 10.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.0 110.153 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.26 -24.12 19.1 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.316 -0.865 . . . . 0.0 110.339 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.527 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.4 OUTLIER -91.25 -171.71 3.05 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.881 179.666 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 47.23 -154.67 0.06 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.699 0.761 . . . . 0.0 110.502 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.45 -44.45 91.1 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.619 -0.675 . . . . 0.0 110.191 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 131.19 -39.88 1.72 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.409 ' HG2' HG11 ' A' ' 187' ' ' VAL . 2.6 mtm180 -116.65 175.55 5.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.16 -1.2 . . . . 0.0 110.248 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ASN . . . . . 0.465 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 2.7 m-80 -134.93 -44.99 0.72 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.271 -0.893 . . . . 0.0 110.952 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.924 ' HA ' HG22 ' A' ' 187' ' ' VAL . 0.9 OUTLIER 65.46 89.04 0.1 Allowed 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.27 -0.894 . . . . 0.0 110.196 -179.251 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' A' ' 186' ' ' VAL . 45.5 t80 -56.62 123.79 16.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.464 -0.772 . . . . 0.0 110.501 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -120.65 101.37 7.69 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.212 -0.93 . . . . 0.0 110.269 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 152.99 -159.32 28.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -81.51 118.66 22.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -1.1 . . . . 0.0 110.357 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 78.2 t -68.07 103.5 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.93 . . . . 0.0 110.056 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.412 ' HA ' ' OE1' ' A' ' 154' ' ' GLN . 14.0 p -138.68 149.03 44.69 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.444 -0.785 . . . . 0.0 109.858 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.508 ' HA ' ' HB2' ' A' ' 158' ' ' ALA . 31.4 tttt -51.05 -39.19 55.37 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.223 -0.923 . . . . 0.0 110.321 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . 0.412 ' CG ' ' N ' ' A' ' 207' ' ' ASN . 11.5 pt-20 -66.11 -40.32 90.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.295 -0.878 . . . . 0.0 110.001 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.412 ' N ' ' CG ' ' A' ' 206' ' ' GLU . 79.3 m-20 -78.33 -30.83 48.38 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.384 -0.822 . . . . 0.0 109.923 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.427 HD13 ' HA ' ' A' ' 155' ' ' PHE . 64.0 mt -65.5 -55.84 15.62 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.459 -0.776 . . . . 0.0 110.272 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.494 HD12 ' O ' ' A' ' 205' ' ' LYS . 5.9 mt -56.03 -25.65 45.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 110.289 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -80.49 -48.58 12.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.324 -0.86 . . . . 0.0 110.029 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.421 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 10.8 t80 -51.55 -57.67 8.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.341 -0.849 . . . . 0.0 110.468 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.597 HD12 HD12 ' A' ' 188' ' ' LEU . 6.9 mm -53.32 -52.37 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.329 -0.857 . . . . 0.0 110.133 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.439 ' HA ' ' HG2' ' A' ' 216' ' ' GLN . 3.7 tmtt? -52.99 -31.51 41.29 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.624 -0.673 . . . . 0.0 110.586 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -77.44 -15.6 59.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.884 . . . . 0.0 110.702 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.483 ' HB3' HD22 ' A' ' 188' ' ' LEU . 74.3 m-20 -105.8 -40.31 5.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.119 -0.988 . . . . 0.0 110.55 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' GLN . . . . . 0.439 ' HG2' ' HA ' ' A' ' 213' ' ' LYS . 10.2 pt20 . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.095 -1.003 . . . . 0.0 110.133 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.289 0.566 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.429 ' HB ' ' HA2' ' A' ' 168' ' ' GLY . 23.8 m -104.91 116.82 32.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.291 -0.88 . . . . 0.0 109.833 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.6 m -78.86 118.49 20.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.302 -0.874 . . . . 0.0 110.221 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.556 HD23 ' HB1' ' A' ' 128' ' ' ALA . 0.9 OUTLIER -101.84 128.8 27.93 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.171 -0.956 . . . . 0.0 110.027 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.494 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 47.7 Cg_endo -73.22 -27.87 13.18 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.447 1.235 . . . . 0.0 110.107 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.535 ' C ' HG22 ' A' ' 175' ' ' VAL . 0.2 OUTLIER -164.93 -170.49 1.97 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.063 0.935 . . . . 0.0 111.077 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.495 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -64.53 -25.93 70.49 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.441 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -58.72 -30.56 67.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.298 -1.119 . . . . 0.0 110.183 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.556 ' HB1' HD23 ' A' ' 123' ' ' LEU . . . -84.45 -20.92 30.98 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.004 -1.06 . . . . 0.0 109.625 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.529 ' HA ' HD13 ' A' ' 141' ' ' ILE . . . -81.36 -23.98 37.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.426 -0.796 . . . . 0.0 110.266 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 127' ' ' ALA . 13.9 pt-20 -84.78 -36.47 21.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.94 . . . . 0.0 110.171 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.57 -32.45 53.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.334 -0.854 . . . . 0.0 110.552 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.451 ' HB3' HD11 ' A' ' 141' ' ' ILE . 6.3 tp -59.05 -52.97 63.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.058 -1.026 . . . . 0.0 110.045 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.745 HG22 ' CB ' ' A' ' 189' ' ' PHE . 87.9 t -55.49 -37.04 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 110.085 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -83.93 -22.04 31.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.391 -0.818 . . . . 0.0 110.192 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.29 -54.34 25.99 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.376 -0.828 . . . . 0.0 110.199 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.9 p -115.77 157.9 23.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -0.91 . . . . 0.0 110.259 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -59.47 -45.75 90.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.169 -0.957 . . . . 0.0 110.196 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.5 t -119.71 123.77 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 110.262 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -152.2 120.24 6.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 109.599 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.49 HG23 ' HA ' ' A' ' 188' ' ' LEU . 11.6 p -98.51 143.05 13.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.093 -1.005 . . . . 0.0 110.664 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.529 HD13 ' HA ' ' A' ' 129' ' ' ALA . 77.2 mt -133.84 115.13 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.463 -0.773 . . . . 0.0 109.446 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -82.97 163.45 41.72 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.132 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.755 ' CE2' HG12 ' A' ' 175' ' ' VAL . 30.3 m-85 -127.7 63.18 1.38 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.723 -0.869 . . . . 0.0 109.421 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.616 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 12.4 m-85 -81.34 133.3 35.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 111.311 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.403 ' HD2' ' HB2' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -78.96 -26.69 43.47 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.729 0.776 . . . . 0.0 109.582 179.451 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.403 ' HB2' ' HD2' ' A' ' 145' ' ' LYS . 0.3 OUTLIER -127.45 98.79 5.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.73 -0.606 . . . . 0.0 109.624 179.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.4 t -63.67 -12.82 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.0 110.903 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -103.01 14.83 31.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.968 -1.083 . . . . 0.0 110.776 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 21.9 p -83.29 -164.89 0.96 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.054 -1.029 . . . . 0.0 110.165 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -90.33 -18.2 25.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 110.317 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.522 ' CB ' ' CE1' ' A' ' 144' ' ' PHE . 6.1 m -83.36 -26.13 30.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 110.326 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.63 -32.75 36.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -0.915 . . . . 0.0 110.089 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.83 -49.85 75.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 109.993 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -57.69 -41.66 82.09 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.37 -0.831 . . . . 0.0 110.278 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -50.68 -55.68 15.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.181 -0.949 . . . . 0.0 110.523 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 16.4 mt -51.01 -55.85 15.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.167 -0.958 . . . . 0.0 110.427 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -53.09 -49.24 66.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.26 -0.9 . . . . 0.0 110.007 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.87 -48.11 80.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 109.977 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.602 ' HB1' ' CD2' ' A' ' 167' ' ' PHE . . . -63.66 -27.09 68.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 110.011 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -75.15 -27.37 59.69 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.367 -0.833 . . . . 0.0 110.297 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.87 -47.84 73.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.902 . . . . 0.0 110.254 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.445 HG23 ' OD1' ' A' ' 164' ' ' ASP . 68.4 mt -98.38 150.25 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -0.899 . . . . 0.0 110.133 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -125.0 -12.57 6.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.253 -0.904 . . . . 0.0 111.105 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.445 ' OD1' HG23 ' A' ' 162' ' ' ILE . 7.9 p-10 -86.99 5.81 35.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.861 -1.149 . . . . 0.0 110.843 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.536 ' CG2' ' CE1' ' A' ' 167' ' ' PHE . 32.6 mm -128.31 126.04 23.47 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.857 -1.152 . . . . 0.0 110.186 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -81.32 110.65 2.27 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.428 1.225 . . . . 0.0 110.585 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.602 ' CD2' ' HB1' ' A' ' 159' ' ' ALA . 1.1 m-85 -102.63 126.49 49.73 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.218 -0.926 . . . . 0.0 109.49 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.429 ' HA2' ' HB ' ' A' ' 121' ' ' THR . . . -106.85 155.52 16.4 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.419 ' O ' HG23 ' A' ' 169' ' ' ILE . 9.5 tt -149.49 133.04 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.374 -1.074 . . . . 0.0 110.378 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.568 HG21 HG11 ' A' ' 175' ' ' VAL . 2.6 t -152.82 157.24 40.47 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 122.003 0.906 . . . . 0.0 110.889 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.6 t -125.51 2.68 7.64 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -64.42 129.21 39.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 0.0 110.3 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.4 m -53.42 -28.06 27.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.301 -0.875 . . . . 0.0 110.225 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -54.89 -39.96 69.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.887 . . . . 0.0 110.024 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.755 HG12 ' CE2' ' A' ' 143' ' ' PHE . 34.0 t -77.15 -24.92 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.81 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -77.54 -49.69 14.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.201 -0.937 . . . . 0.0 109.942 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.88 -34.21 40.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.278 -0.889 . . . . 0.0 110.023 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.408 ' CE ' ' HA3' ' A' ' 126' ' ' GLY . 0.2 OUTLIER -55.34 -55.68 28.71 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.359 -0.838 . . . . 0.0 110.202 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -92.88 6.84 46.28 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.15 -0.969 . . . . 0.0 110.629 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 49.59 65.24 1.46 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.02 -1.05 . . . . 0.0 110.495 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 92.6 mt -101.84 124.33 47.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.263 -0.898 . . . . 0.0 110.282 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.68 0.13 31.64 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.2 -0.937 . . . . 0.0 110.665 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -171.09 -174.67 1.54 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.094 -1.004 . . . . 0.0 109.827 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 21.4 p30 -54.61 156.95 3.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.17 -0.956 . . . . 0.0 110.247 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -172.94 118.78 0.73 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 96.4 t -95.18 128.99 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -1.154 . . . . 0.0 110.152 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.629 HG22 ' HA ' ' A' ' 198' ' ' ASN . 98.7 t -138.06 149.28 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 110.148 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.502 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 9.3 tt -109.75 139.25 45.03 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.105 -0.997 . . . . 0.0 108.437 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.745 ' CB ' HG22 ' A' ' 133' ' ' VAL . 50.7 m-85 -112.66 126.18 55.1 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.768 -1.207 . . . . 0.0 110.866 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.9 166.1 23.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.338 -0.851 . . . . 0.0 110.211 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -89.29 -31.4 17.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.913 . . . . 0.0 110.422 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -90.56 -173.32 3.72 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.443 -0.786 . . . . 0.0 110.729 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 51.93 -159.43 0.11 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.431 -0.793 . . . . 0.0 110.456 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.06 -48.9 78.17 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.633 -0.667 . . . . 0.0 110.238 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 136.58 -58.94 0.65 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 17.6 mtm-85 -108.7 175.21 5.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.183 -1.187 . . . . 0.0 110.329 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ASN . . . . . 0.503 ' HB2' ' CZ ' ' A' ' 211' ' ' PHE . 1.8 m-80 -132.49 -34.7 1.18 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.263 -0.898 . . . . 0.0 110.996 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.629 ' HA ' HG22 ' A' ' 187' ' ' VAL . 0.7 OUTLIER 61.89 87.81 0.09 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.162 -0.961 . . . . 0.0 110.021 -179.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.431 ' HA ' ' CE1' ' A' ' 211' ' ' PHE . 28.6 t80 -57.83 124.11 18.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.379 -0.826 . . . . 0.0 110.265 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -118.15 103.37 9.8 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.318 -0.864 . . . . 0.0 110.337 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 147.52 -148.72 20.54 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -97.66 123.74 41.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -1.147 . . . . 0.0 110.129 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.616 HG11 ' HZ ' ' A' ' 144' ' ' PHE . 79.2 t -70.6 113.65 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.182 -0.949 . . . . 0.0 110.261 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.3 p -145.88 152.43 39.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.43 -0.794 . . . . 0.0 109.932 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 20.2 tttm -48.42 -43.5 34.3 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.118 -0.989 . . . . 0.0 110.509 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -64.95 -41.86 95.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.326 -0.859 . . . . 0.0 109.805 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -71.2 -45.55 63.14 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.344 -0.848 . . . . 0.0 109.953 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 208' ' ' LEU . 62.0 mt -53.92 -51.16 64.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.936 . . . . 0.0 109.778 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 69.6 mt -56.58 -31.27 64.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.314 -0.866 . . . . 0.0 109.349 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -76.88 -37.34 55.67 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.428 -0.795 . . . . 0.0 109.524 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.503 ' CZ ' ' HB2' ' A' ' 197' ' ' ASN . 5.9 t80 -54.22 -63.38 1.17 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.397 -0.815 . . . . 0.0 109.893 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 94.8 mt -48.91 -57.64 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.231 -0.918 . . . . 0.0 110.292 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.07 -34.5 56.81 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.331 -0.855 . . . . 0.0 110.243 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -89.64 -7.56 54.43 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.35 -0.844 . . . . 0.0 110.695 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 0.9 OUTLIER -88.48 -79.68 0.3 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.083 -1.011 . . . . 0.0 110.429 -179.325 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.207 -0.933 . . . . 0.0 110.188 -179.848 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 167' ' ' PHE . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.252 0.548 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.538 HG22 ' HA2' ' A' ' 168' ' ' GLY . 8.9 t -101.15 166.15 10.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.161 -0.962 . . . . 0.0 110.442 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.3 m -107.06 105.49 15.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.322 -0.861 . . . . 0.0 110.074 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.423 HD22 ' HB1' ' A' ' 128' ' ' ALA . 32.1 mt -77.67 134.41 65.42 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.213 -0.93 . . . . 0.0 110.096 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.459 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 47.5 Cg_endo -72.85 -32.31 9.22 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 123.52 1.274 . . . . 0.0 110.331 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -168.25 -170.77 1.35 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.255 -0.903 . . . . 0.0 110.805 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.41 ' HA3' ' HD2' ' A' ' 178' ' ' LYS . . . -61.32 -27.95 68.49 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -55.57 -29.24 58.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -1.123 . . . . 0.0 110.382 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.459 ' HB2' ' HD2' ' A' ' 124' ' ' PRO . . . -86.08 -30.86 22.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.146 -0.971 . . . . 0.0 110.178 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.04 -24.36 66.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.041 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -88.59 -38.11 15.13 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.258 -0.901 . . . . 0.0 110.168 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.0 m -72.67 -24.57 61.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.175 -0.953 . . . . 0.0 109.979 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.421 HD13 HD21 ' A' ' 123' ' ' LEU . 2.4 tp -70.44 -47.02 62.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.412 -0.805 . . . . 0.0 110.096 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 69.1 t -62.5 -45.0 99.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.374 -0.829 . . . . 0.0 110.294 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -72.84 -19.69 61.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.938 . . . . 0.0 110.237 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.5 m -72.66 -20.81 61.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.148 -0.97 . . . . 0.0 110.36 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.401 ' OG ' ' HG3' ' A' ' 166' ' ' PRO . 80.0 p -149.42 154.92 39.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.254 -0.904 . . . . 0.0 110.361 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.432 ' HA ' ' HD2' ' A' ' 191' ' ' LYS . 1.6 tt0 -57.44 -35.8 70.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.335 -0.853 . . . . 0.0 110.171 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.7 t -132.03 145.64 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.294 -0.879 . . . . 0.0 110.437 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.457 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -165.56 136.96 3.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.355 -0.841 . . . . 0.0 109.808 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.8 p -116.03 139.84 40.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 O-C-N 121.087 -1.008 . . . . 0.0 110.223 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 27.2 mt -128.4 110.26 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.315 -0.866 . . . . 0.0 109.87 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.55 127.64 8.22 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.491 ' CE2' HG12 ' A' ' 175' ' ' VAL . 50.3 m-85 -95.45 79.5 3.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.285 -1.127 . . . . 0.0 109.849 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.582 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 17.0 m-85 -100.73 141.53 33.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.088 -1.008 . . . . 0.0 111.097 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 21.4 pttt -91.11 -36.41 14.01 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.602 0.715 . . . . 0.0 109.261 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.485 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 0.4 OUTLIER -122.34 70.77 0.99 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.024 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.484 ' HA ' ' HB2' ' A' ' 152' ' ' ALA . 5.0 p -52.22 -20.94 2.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.71 -0.619 . . . . 0.0 111.16 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -76.63 1.33 17.23 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.966 -1.084 . . . . 0.0 110.86 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 51.5 p -86.27 -156.92 0.32 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.879 -1.138 . . . . 0.0 110.381 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -90.45 -46.63 8.23 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.317 -0.864 . . . . 0.0 110.794 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.4 t -46.08 -33.27 3.36 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.38 -0.825 . . . . 0.0 111.065 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 147' ' ' VAL . . . -80.79 -38.1 29.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.136 -0.977 . . . . 0.0 109.837 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.3 -51.3 59.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.0 109.911 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -52.9 -41.44 64.39 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.291 -0.88 . . . . 0.0 110.005 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -53.95 -57.19 11.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.402 -0.811 . . . . 0.0 109.918 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 15.2 mt -53.73 -53.95 44.92 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.502 -0.749 . . . . 0.0 110.365 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -54.52 -33.1 59.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.356 -0.84 . . . . 0.0 110.16 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.436 ' HB2' ' HA ' ' A' ' 205' ' ' LYS . . . -78.14 -35.62 48.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 110.148 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.511 ' HB2' ' CD2' ' A' ' 167' ' ' PHE . . . -72.95 -31.04 64.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.203 -0.936 . . . . 0.0 110.156 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -66.02 -20.97 66.36 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.192 -0.943 . . . . 0.0 110.285 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.479 ' HB3' HD21 ' A' ' 209' ' ' LEU . . . -79.63 -35.98 38.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.216 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.41 HG13 ' OD1' ' A' ' 164' ' ' ASP . 14.8 tt -97.51 154.96 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 110.119 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -142.28 21.92 2.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.184 -0.947 . . . . 0.0 110.493 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.554 ' O ' HD13 ' A' ' 165' ' ' ILE . 6.6 p-10 -120.92 12.91 11.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.182 -0.949 . . . . 0.0 110.629 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.595 HD11 ' OE1' ' A' ' 216' ' ' GLN . 49.7 mm -136.2 134.24 20.01 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.012 . . . . 0.0 110.267 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.457 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 48.8 Cg_endo -74.22 98.62 1.11 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.445 1.234 . . . . 0.0 110.371 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.511 ' CD2' ' HB2' ' A' ' 159' ' ' ALA . 3.3 m-85 -85.94 127.58 34.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 110.316 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.538 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -128.79 154.2 20.05 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.442 HD11 HG23 ' A' ' 147' ' ' VAL . 11.6 tt -150.26 149.93 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.154 -1.204 . . . . 0.0 110.595 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.475 HG21 HG21 ' A' ' 175' ' ' VAL . 2.1 t -161.06 156.99 25.41 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.069 0.938 . . . . 0.0 110.527 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.4 p -124.12 3.98 8.59 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -63.32 131.69 49.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 110.418 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 92.7 p -53.76 -31.46 48.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.211 -0.93 . . . . 0.0 110.189 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -53.48 -32.05 48.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.968 . . . . 0.0 109.848 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.491 HG12 ' CE2' ' A' ' 143' ' ' PHE . 60.0 t -82.61 -25.38 8.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.385 -0.822 . . . . 0.0 109.51 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -76.87 -52.52 9.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.421 -0.799 . . . . 0.0 109.717 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.23 -15.87 58.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.383 -0.823 . . . . 0.0 110.559 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.423 ' HG2' ' CD1' ' A' ' 179' ' ' TYR . 16.4 tttp -79.21 -52.51 8.06 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.04 -1.038 . . . . 0.0 110.09 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.446 ' HB2' ' CD1' ' A' ' 181' ' ' LEU . 81.4 m-85 -92.2 4.51 53.08 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.201 -0.937 . . . . 0.0 110.578 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.26 64.42 1.79 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.055 -1.028 . . . . 0.0 111.025 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.446 ' CD1' ' HB2' ' A' ' 179' ' ' TYR . 4.5 mt -115.6 115.19 26.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.152 -0.967 . . . . 0.0 109.81 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.429 ' O ' ' CG ' ' A' ' 183' ' ' LYS . 0.7 OUTLIER -83.48 7.77 15.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.135 -0.978 . . . . 0.0 110.501 179.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 182' ' ' ASP . 25.2 mttt -162.73 -163.91 0.94 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.065 -1.022 . . . . 0.0 109.658 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.409 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 44.1 m-20 -73.96 147.46 43.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.147 -0.971 . . . . 0.0 109.684 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -157.71 134.64 4.0 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.405 ' HB ' ' HB3' ' A' ' 199' ' ' PHE . 70.9 t -113.68 102.03 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.379 -1.071 . . . . 0.0 109.914 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.758 HG22 ' HA ' ' A' ' 198' ' ' ASN . 98.8 t -110.69 146.28 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.382 -0.823 . . . . 0.0 110.179 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.556 HD12 HD12 ' A' ' 212' ' ' ILE . 9.0 tt -109.91 127.9 55.02 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.158 -0.963 . . . . 0.0 108.53 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 189' ' ' PHE . 30.1 m-85 -100.43 120.43 39.97 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.832 -1.168 . . . . 0.0 111.179 -178.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.512 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -131.91 158.78 40.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.474 -0.766 . . . . 0.0 110.122 179.483 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.432 ' HD2' ' HA ' ' A' ' 137' ' ' GLU . 10.2 mttt -82.81 -24.9 33.15 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.217 -0.927 . . . . 0.0 110.259 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.512 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 1.3 p90 -91.69 -171.82 3.02 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.328 -0.858 . . . . 0.0 110.555 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 50.94 -159.1 0.09 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.616 0.722 . . . . 0.0 110.432 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -65.61 -45.52 82.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.655 -0.653 . . . . 0.0 110.222 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 142.09 -62.94 0.52 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -110.48 171.64 7.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.293 -1.122 . . . . 0.0 110.331 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ASN . . . . . 0.484 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 2.7 m-80 -127.71 -34.61 2.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.266 -0.896 . . . . 0.0 110.75 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.758 ' HA ' HG22 ' A' ' 187' ' ' VAL . 0.4 OUTLIER 58.11 83.93 0.11 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.203 -0.936 . . . . 0.0 110.091 -179.494 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.43 ' C ' ' CD1' ' A' ' 199' ' ' PHE . 12.1 t80 -56.78 121.31 9.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.343 -0.848 . . . . 0.0 110.21 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -118.14 100.24 7.4 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.231 -0.918 . . . . 0.0 110.345 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 160.27 -155.95 27.15 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.16 111.6 21.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.294 -1.121 . . . . 0.0 110.074 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.582 HG11 ' HZ ' ' A' ' 144' ' ' PHE . 75.7 t -63.82 109.05 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.938 . . . . 0.0 110.336 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 41.2 p -146.87 152.3 38.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.435 -0.79 . . . . 0.0 110.008 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.516 ' HG2' HD12 ' A' ' 209' ' ' LEU . 1.4 ttpt -46.85 -54.97 8.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.398 -0.814 . . . . 0.0 111.043 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 207' ' ' ASN . 17.0 pt-20 -55.1 -40.79 70.84 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.453 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.445 ' N ' ' HG3' ' A' ' 206' ' ' GLU . 72.8 m-20 -73.82 -49.26 26.04 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.226 -0.921 . . . . 0.0 110.12 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 208' ' ' LEU . 90.5 mt -56.33 -55.0 38.89 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.302 -0.874 . . . . 0.0 110.285 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.516 HD12 ' HG2' ' A' ' 205' ' ' LYS . 15.5 mt -53.29 -24.66 12.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 0.0 110.077 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.99 -43.82 13.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.87 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.422 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 11.9 t80 -56.96 -56.7 18.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.333 -0.854 . . . . 0.0 110.418 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.556 HD12 HD12 ' A' ' 188' ' ' LEU . 8.0 mm -51.6 -39.29 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.24 -0.912 . . . . 0.0 110.091 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -61.86 -41.41 97.8 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.628 -0.67 . . . . 0.0 110.283 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -78.64 -6.64 56.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 110.699 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.435 ' CB ' HD13 ' A' ' 188' ' ' LEU . 2.2 m-80 -89.27 -79.62 0.32 Allowed 'General case' 0 N--CA 1.484 1.265 0 O-C-N 120.914 -1.116 . . . . 0.0 110.583 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' GLN . . . . . 0.595 ' OE1' HD11 ' A' ' 165' ' ' ILE . 28.6 pt20 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 110.36 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.261 0.553 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.581 HG22 ' HA2' ' A' ' 168' ' ' GLY . 10.0 t -94.21 164.78 12.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.241 -0.912 . . . . 0.0 110.166 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.2 m -104.63 106.43 16.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.237 -0.915 . . . . 0.0 110.108 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.758 HD21 HD12 ' A' ' 132' ' ' LEU . 26.4 mt -73.16 124.28 90.44 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.197 -0.939 . . . . 0.0 110.104 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -70.75 -22.61 27.32 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 123.393 1.207 . . . . 0.0 110.343 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.71 -171.13 0.17 Allowed 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 122.239 1.019 . . . . 0.0 111.479 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.23 -31.88 74.84 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -52.3 -31.85 34.84 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.336 -1.096 . . . . 0.0 110.299 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.39 -38.02 22.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.901 . . . . 0.0 110.227 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -52.14 -32.69 36.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.228 -0.92 . . . . 0.0 110.094 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -90.24 -46.66 8.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.357 -0.84 . . . . 0.0 110.016 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 10.1 t -64.19 -27.05 68.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.279 -0.888 . . . . 0.0 110.151 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.758 HD12 HD21 ' A' ' 123' ' ' LEU . 6.6 tt -70.53 -60.32 2.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.281 -0.887 . . . . 0.0 109.507 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.507 HG22 ' CB ' ' A' ' 189' ' ' PHE . 87.8 t -49.34 -27.67 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.553 -0.717 . . . . 0.0 110.355 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.15 7.19 25.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.279 -0.888 . . . . 0.0 110.726 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.2 t -90.29 -27.86 19.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.968 -1.083 . . . . 0.0 110.23 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.7 p -147.75 167.09 25.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 110.174 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -67.48 -12.17 59.65 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.216 -0.927 . . . . 0.0 110.136 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.9 t -137.84 150.69 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.066 -1.021 . . . . 0.0 110.063 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.47 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -174.42 142.05 0.74 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.959 . . . . 0.0 110.246 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.424 HG11 ' CZ ' ' A' ' 167' ' ' PHE . 7.2 p -129.7 148.18 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 121.108 -0.995 . . . . 0.0 110.188 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 2.9 mp -137.27 113.54 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -0.872 . . . . 0.0 110.181 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -80.91 131.69 10.63 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.817 ' CE2' HG12 ' A' ' 175' ' ' VAL . 35.1 m-85 -101.95 76.29 1.6 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -1.162 . . . . 0.0 110.091 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.636 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 18.6 m-85 -94.28 144.38 25.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.128 -0.983 . . . . 0.0 110.75 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.04 -26.94 20.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.611 -0.681 . . . . 0.0 109.412 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -134.1 76.3 1.64 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.672 -0.642 . . . . 0.0 109.306 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.556 ' O ' ' HB3' ' A' ' 152' ' ' ALA . 34.7 m -49.05 -23.64 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.377 -0.827 . . . . 0.0 111.042 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -80.02 4.88 15.66 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.048 -1.032 . . . . 0.0 111.175 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.2 p -78.93 -165.25 0.71 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.874 -1.142 . . . . 0.0 110.534 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.02 -23.49 20.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.558 -0.713 . . . . 0.0 110.238 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.5 m -80.27 -19.81 45.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.294 -0.879 . . . . 0.0 110.554 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 147' ' ' VAL . . . -84.34 -32.56 24.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.134 -0.979 . . . . 0.0 110.3 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.2 mtpt -58.89 -38.07 78.03 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 110.183 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.42 -47.48 81.78 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.207 -0.933 . . . . 0.0 110.065 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.435 ' O ' ' HB3' ' A' ' 158' ' ' ALA . 4.5 t80 -52.72 -54.69 30.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.315 -0.865 . . . . 0.0 110.103 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' A' ' 156' ' ' LEU . 22.1 mt -49.13 -55.04 13.55 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.308 -0.87 . . . . 0.0 110.378 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -54.22 -37.62 64.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.316 -0.865 . . . . 0.0 109.674 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 155' ' ' PHE . . . -65.85 -52.77 47.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.356 -0.84 . . . . 0.0 109.536 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.521 ' HB2' ' CD2' ' A' ' 167' ' ' PHE . . . -55.44 -35.21 65.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.288 -0.882 . . . . 0.0 109.602 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.58 -30.3 71.01 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.283 -0.886 . . . . 0.0 109.858 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.16 -48.97 79.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.356 -0.84 . . . . 0.0 109.801 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.434 HG22 ' H ' ' A' ' 164' ' ' ASP . 63.2 mt -95.42 149.52 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.338 -0.851 . . . . 0.0 109.882 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -126.69 8.98 6.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.178 -0.951 . . . . 0.0 110.819 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.434 ' H ' HG22 ' A' ' 162' ' ' ILE . 4.1 p30 -110.6 -17.25 13.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.967 -1.083 . . . . 0.0 110.339 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 51.0 mm -91.43 133.44 31.35 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.935 . . . . 0.0 110.185 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.507 ' HB2' HD21 ' A' ' 132' ' ' LEU . 50.6 Cg_endo -73.63 69.63 4.33 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.576 1.303 . . . . 0.0 110.253 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.521 ' CD2' ' HB2' ' A' ' 159' ' ' ALA . 3.3 m-85 -63.7 123.03 17.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.886 . . . . 0.0 109.932 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.581 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -125.19 151.07 17.38 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -141.83 148.18 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -1.146 . . . . 0.0 110.297 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.496 HG21 HG11 ' A' ' 175' ' ' VAL . 2.6 t -164.85 157.81 16.7 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.073 0.939 . . . . 0.0 110.913 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.7 t -123.39 2.31 9.06 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.394 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -60.92 120.79 10.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.121 -0.987 . . . . 0.0 110.171 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 3.0 p -51.29 -29.4 14.72 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -0.902 . . . . 0.0 110.35 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.22 -43.47 78.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 109.877 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.817 HG12 ' CE2' ' A' ' 143' ' ' PHE . 46.2 t -72.35 -26.31 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.239 -0.913 . . . . 0.0 109.832 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -75.46 -55.49 5.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.37 -0.831 . . . . 0.0 110.036 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -21.37 60.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.465 -0.772 . . . . 0.0 110.435 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.36 -56.06 26.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -0.972 . . . . 0.0 110.341 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -89.76 13.64 13.84 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.171 -0.956 . . . . 0.0 110.598 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 51.95 63.83 2.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 110.625 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 14.7 mt -96.06 124.27 40.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.412 -0.805 . . . . 0.0 109.911 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -61.29 -16.1 42.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.144 -0.973 . . . . 0.0 110.219 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -175.29 -142.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.569 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -86.71 159.81 19.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.995 -1.065 . . . . 0.0 110.365 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 176.76 179.74 47.33 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 186' ' ' VAL . 21.5 m -133.74 120.28 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -1.148 . . . . 0.0 110.297 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 188' ' ' LEU . 86.2 t -123.09 162.89 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.412 -0.805 . . . . 0.0 109.863 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.554 HD22 ' HB3' ' A' ' 215' ' ' ASN . 1.7 tt -113.36 148.79 35.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.078 -1.013 . . . . 0.0 109.761 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.507 ' CB ' HG22 ' A' ' 133' ' ' VAL . 40.0 m-85 -123.44 117.4 25.07 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.064 -1.022 . . . . 0.0 110.411 -179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.511 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -134.52 165.86 24.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.311 -0.868 . . . . 0.0 110.16 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -88.67 -22.71 23.28 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.0 110.373 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.511 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 1.4 p90 -90.87 -172.32 3.32 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.243 -0.911 . . . . 0.0 110.928 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 47.22 -159.46 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.663 0.744 . . . . 0.0 110.728 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -55.0 -53.62 53.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.641 -0.662 . . . . 0.0 110.321 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 139.5 -49.2 0.82 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.68 172.83 8.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.252 -1.146 . . . . 0.0 110.442 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ASN . . . . . 0.464 ' N ' ' ND2' ' A' ' 197' ' ' ASN . 0.6 OUTLIER -138.44 -152.67 0.44 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.292 -0.88 . . . . 0.0 109.598 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -175.57 76.69 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.32 -0.862 . . . . 0.0 110.309 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.41 ' CB ' HG23 ' A' ' 186' ' ' VAL . 70.5 t80 -51.39 118.57 3.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.349 -0.844 . . . . 0.0 110.409 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -113.3 95.14 5.21 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.289 -0.882 . . . . 0.0 110.301 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 162.5 -174.07 38.84 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -61.46 135.95 57.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.295 -1.121 . . . . 0.0 110.166 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.636 HG11 ' HZ ' ' A' ' 144' ' ' PHE . 74.7 t -91.15 104.43 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.885 . . . . 0.0 110.071 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 39.6 p -143.86 158.33 43.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.384 -0.822 . . . . 0.0 109.972 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.424 ' HG3' ' CA ' ' A' ' 158' ' ' ALA . 11.0 tttt -49.36 -51.54 34.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.287 -0.883 . . . . 0.0 110.916 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -59.54 -31.17 69.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 110.565 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -82.46 -38.94 23.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 110.344 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.548 ' O ' HD12 ' A' ' 212' ' ' ILE . 51.1 mt -61.38 -56.59 18.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.315 -0.866 . . . . 0.0 110.35 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 4.1 mp -52.96 -23.26 6.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.263 -0.898 . . . . 0.0 110.326 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.2 -49.89 12.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.888 . . . . 0.0 110.279 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -55.8 -59.35 4.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -0.918 . . . . 0.0 110.386 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.646 HG22 ' HG2' ' A' ' 216' ' ' GLN . 5.7 mt -50.07 -39.45 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.219 -0.926 . . . . 0.0 110.466 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -58.67 -18.42 30.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.304 -0.873 . . . . 0.0 110.305 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 17.5 t60 -99.47 -18.6 17.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.176 -0.953 . . . . 0.0 110.676 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.554 ' HB3' HD22 ' A' ' 188' ' ' LEU . 77.5 m-20 -97.66 -61.26 1.42 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.113 -0.992 . . . . 0.0 111.099 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' GLN . . . . . 0.646 ' HG2' HG22 ' A' ' 212' ' ' ILE . 1.2 pt20 . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.103 -0.998 . . . . 0.0 110.584 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.202 0.525 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.573 HG22 ' HA2' ' A' ' 168' ' ' GLY . 11.3 t -98.29 166.07 11.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 110.144 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.7 m -107.11 109.0 20.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.186 -0.946 . . . . 0.0 110.121 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 26.2 mt -92.12 131.31 35.28 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.225 -0.922 . . . . 0.0 109.986 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.437 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 45.9 Cg_endo -72.49 -36.3 5.33 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.401 1.211 . . . . 0.0 110.47 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.678 ' C ' HG22 ' A' ' 175' ' ' VAL . 1.7 p30 -154.96 -169.04 3.07 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.27 -0.894 . . . . 0.0 110.614 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.726 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -67.84 -30.94 74.75 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -54.26 -25.85 25.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -1.104 . . . . 0.0 110.362 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.437 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -89.51 -25.29 21.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 110.162 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.99 -26.06 65.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 109.977 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -79.14 -50.71 10.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.209 -0.932 . . . . 0.0 110.056 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.5 m -56.87 -24.32 50.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -0.895 . . . . 0.0 110.08 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.4 tp -67.64 -51.62 47.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 0.0 110.062 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.625 HG22 ' CB ' ' A' ' 189' ' ' PHE . 42.4 t -53.55 -46.95 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.871 . . . . 0.0 110.343 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.28 -18.89 63.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 0.0 110.427 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.4 t -56.16 -59.32 5.1 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.24 -0.913 . . . . 0.0 110.277 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.6 p -127.26 -171.13 2.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.257 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -74.2 -44.63 52.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.879 . . . . 0.0 110.328 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.483 ' CG2' HD12 ' A' ' 165' ' ' ILE . 30.5 m -116.1 151.91 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 0.0 110.535 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.432 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -176.03 139.52 0.38 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.344 -0.848 . . . . 0.0 109.827 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 188' ' ' LEU . 10.0 p -122.33 146.82 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.112 -0.993 . . . . 0.0 110.47 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.854 HD12 ' CD1' ' A' ' 189' ' ' PHE . 6.3 mt -128.18 112.65 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.424 -0.798 . . . . 0.0 109.928 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.07 125.35 7.16 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.436 ' CE2' ' O ' ' A' ' 141' ' ' ILE . 90.8 m-85 -103.2 66.56 0.9 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -1.134 . . . . 0.0 109.605 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.442 ' CD1' ' HB3' ' A' ' 184' ' ' ASP . 9.6 m-85 -93.92 140.1 30.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.351 -0.843 . . . . 0.0 111.03 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -26.83 43.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.462 -0.774 . . . . 0.0 109.775 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -122.32 90.69 3.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.51 -0.744 . . . . 0.0 109.913 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.15 -21.9 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 110.616 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -87.18 12.58 11.31 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.158 -0.964 . . . . 0.0 111.135 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 96.7 p -86.63 -164.26 1.03 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.094 -1.004 . . . . 0.0 110.118 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.53 -44.63 11.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.331 -0.856 . . . . 0.0 109.866 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 1.3 m -56.89 -21.31 28.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.317 -0.864 . . . . 0.0 110.085 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.29 -39.6 22.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.0 110.101 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -59.41 -39.91 84.95 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.268 -0.895 . . . . 0.0 110.339 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -63.97 -43.25 96.32 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.247 -0.908 . . . . 0.0 109.941 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.616 ' HE1' HG13 ' A' ' 186' ' ' VAL . 4.1 t80 -50.66 -55.81 14.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.333 -0.854 . . . . 0.0 110.307 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.415 ' HA ' HD23 ' A' ' 156' ' ' LEU . 75.2 mt -56.02 -51.53 67.45 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.374 -0.829 . . . . 0.0 110.08 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -51.17 -44.54 61.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.365 -0.834 . . . . 0.0 110.148 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -69.64 -34.18 73.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -0.885 . . . . 0.0 110.046 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.691 ' HB2' ' CD2' ' A' ' 167' ' ' PHE . . . -62.53 -30.98 71.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 110.136 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.97 -22.1 24.49 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.21 -0.931 . . . . 0.0 110.35 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -97.42 13.92 28.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.219 -0.926 . . . . 0.0 110.594 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.77 HD11 HG21 ' A' ' 212' ' ' ILE . 6.6 tt -103.78 174.67 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.093 -1.004 . . . . 0.0 110.211 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.42 62.89 0.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.37 -0.831 . . . . 0.0 110.25 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 162' ' ' ILE . 2.8 p-10 40.76 50.81 3.04 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.616 0.722 . . . . 0.0 111.56 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.576 HG23 ' HD2' ' A' ' 166' ' ' PRO . 39.1 mm -88.85 146.0 35.91 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.452 -0.78 . . . . 0.0 109.628 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.576 ' HD2' HG23 ' A' ' 165' ' ' ILE . 42.2 Cg_endo -68.63 100.8 0.71 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.58 1.305 . . . . 0.0 110.865 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.691 ' CD2' ' HB2' ' A' ' 159' ' ' ALA . 2.7 m-85 -97.6 136.32 38.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.42 -0.8 . . . . 0.0 110.158 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.573 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -129.47 143.81 14.92 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 11.1 tt -141.18 135.9 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.13 -1.218 . . . . 0.0 110.572 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.0 t -153.08 156.88 39.56 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.031 0.919 . . . . 0.0 110.571 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.4 t -122.68 2.59 9.53 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -64.31 123.23 18.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -0.945 . . . . 0.0 110.322 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 27.7 m -53.15 -28.36 25.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.229 -0.92 . . . . 0.0 110.131 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.45 -31.84 56.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -0.929 . . . . 0.0 109.764 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.726 HG22 ' N ' ' A' ' 126' ' ' GLY . 28.0 t -81.91 -26.21 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.429 -0.795 . . . . 0.0 109.32 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -76.24 -53.05 8.8 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.481 -0.762 . . . . 0.0 109.75 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 2.0 t -56.06 -21.93 24.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.402 -0.811 . . . . 0.0 110.08 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.51 -48.27 61.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 109.244 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -96.87 -0.67 47.4 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.432 -0.793 . . . . 0.0 110.352 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 53.83 70.63 0.58 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.103 -0.998 . . . . 0.0 110.589 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.549 HD22 ' HA3' ' A' ' 185' ' ' GLY . 1.1 mt -105.64 129.11 53.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.314 -0.866 . . . . 0.0 110.045 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.422 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 24.6 p-10 -60.65 -16.21 36.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.251 -0.905 . . . . 0.0 110.512 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.2 -145.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.175 -0.953 . . . . 0.0 109.649 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.442 ' HB3' ' CD1' ' A' ' 144' ' ' PHE . 43.0 m-20 -54.3 151.54 7.3 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.04 -1.038 . . . . 0.0 109.62 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.549 ' HA3' HD22 ' A' ' 181' ' ' LEU . . . -152.19 129.94 2.94 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.416 -1.374 . . . . 0.0 110.108 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.616 HG13 ' HE1' ' A' ' 155' ' ' PHE . 75.0 t -117.09 80.93 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.364 -1.08 . . . . 0.0 109.777 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 61.3 t -106.39 158.88 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 110.063 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.683 HD23 ' N ' ' A' ' 189' ' ' PHE . 9.8 tt -116.25 163.61 15.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.032 -1.043 . . . . 0.0 109.87 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.854 ' CD1' HD12 ' A' ' 141' ' ' ILE . 64.4 m-85 -128.88 132.08 47.68 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.009 -1.057 . . . . 0.0 110.892 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.481 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.3 OUTLIER -140.49 163.69 32.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.242 -0.911 . . . . 0.0 110.122 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -83.43 -29.13 28.34 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.273 -0.892 . . . . 0.0 110.083 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.8 OUTLIER -91.5 -175.04 4.09 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.533 -0.73 . . . . 0.0 110.955 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 50.43 -160.15 0.07 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.697 0.76 . . . . 0.0 110.608 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -59.24 -28.36 66.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.774 -0.579 . . . . 0.0 110.552 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.405 ' HA2' ' HG2' ' A' ' 190' ' ' LYS . . . 107.33 -28.04 13.86 Favored Glycine 0 N--CA 1.483 1.779 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.06 -179.98 5.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.129 -1.218 . . . . 0.0 110.599 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ASN . . . . . 0.441 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.4 m-80 -141.96 -152.39 0.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.575 -0.703 . . . . 0.0 109.712 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -171.57 79.81 0.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.355 -0.84 . . . . 0.0 110.474 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.482 ' CE1' HG22 ' A' ' 203' ' ' VAL . 26.7 t80 -60.3 143.05 53.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.172 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -146.51 129.95 16.8 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.341 -0.85 . . . . 0.0 109.717 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 121.79 -172.58 15.51 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -66.03 117.31 8.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -1.131 . . . . 0.0 110.349 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.484 ' C ' HG23 ' A' ' 204' ' ' THR . 71.7 t -74.14 118.88 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.887 . . . . 0.0 109.987 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.484 HG23 ' C ' ' A' ' 203' ' ' VAL . 72.6 p -150.07 157.11 42.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.318 -0.863 . . . . 0.0 110.433 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -49.26 -52.98 23.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.392 -0.818 . . . . 0.0 110.456 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -55.78 -36.21 67.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.354 -0.841 . . . . 0.0 110.332 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 -77.56 -51.98 9.8 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.193 -0.942 . . . . 0.0 110.454 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 208' ' ' LEU . 70.8 mt -52.34 -56.35 15.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.322 -0.861 . . . . 0.0 110.429 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 18.7 mt -51.11 -24.13 3.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.169 -0.957 . . . . 0.0 110.57 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -84.71 -41.8 15.89 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.195 -0.941 . . . . 0.0 110.073 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -63.29 -57.82 9.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.352 -0.843 . . . . 0.0 110.67 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.77 HG21 HD11 ' A' ' 162' ' ' ILE . 9.4 mt -52.8 -47.22 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.134 -0.979 . . . . 0.0 110.388 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.56 -21.13 51.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.228 -0.92 . . . . 0.0 110.222 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -90.01 -19.35 24.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.309 -0.869 . . . . 0.0 110.438 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -94.73 -49.98 5.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.2 -0.938 . . . . 0.0 110.418 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' GLN . . . . . 0.758 ' OE1' HG22 ' A' ' 212' ' ' ILE . 17.5 pt20 . . . . . 0 N--CA 1.486 1.327 0 O-C-N 121.213 -0.93 . . . . 0.0 110.485 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.26 0.552 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 51.9 m -101.56 125.51 48.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 110.149 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 87.0 m -76.84 126.91 31.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.25 -0.906 . . . . 0.0 110.169 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.618 HD22 ' HB1' ' A' ' 128' ' ' ALA . 45.7 mt -103.45 137.98 19.41 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.932 . . . . 0.0 109.95 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 46.8 Cg_endo -73.09 -26.21 15.23 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.554 1.292 . . . . 0.0 110.546 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -172.76 -170.33 0.66 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.159 -0.963 . . . . 0.0 110.912 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.462 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -61.8 -34.07 87.46 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -51.48 -28.2 12.67 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.276 -1.132 . . . . 0.0 110.4 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.618 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -86.06 -37.22 19.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 110.161 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.16 -30.15 48.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.197 -0.939 . . . . 0.0 110.118 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -81.62 -46.45 14.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.146 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 92.0 p -56.74 -33.34 66.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.894 . . . . 0.0 110.095 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.5 tp -61.09 -47.84 84.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -0.884 . . . . 0.0 110.165 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.842 HG22 ' HB3' ' A' ' 189' ' ' PHE . 39.4 t -54.67 -41.2 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.193 -0.942 . . . . 0.0 109.961 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -82.74 3.38 29.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.274 -0.891 . . . . 0.0 110.796 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.8 t -75.61 -41.92 53.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.934 -1.104 . . . . 0.0 110.111 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 28.2 p -147.24 -172.63 4.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 110.13 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.443 ' OE2' ' CD2' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -70.65 -44.76 66.43 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.205 -0.934 . . . . 0.0 110.163 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.4 t -116.26 150.51 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.276 -0.89 . . . . 0.0 110.191 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.455 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -172.15 146.0 1.85 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.843 . . . . 0.0 109.926 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.583 ' CG1' HD12 ' A' ' 188' ' ' LEU . 2.8 m -128.19 164.66 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.117 -0.99 . . . . 0.0 110.764 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 31.2 mt -149.96 114.4 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.753 -0.592 . . . . 0.0 110.173 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -87.06 133.05 11.53 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.546 ' CE2' HG12 ' A' ' 175' ' ' VAL . 76.1 m-85 -99.37 77.31 2.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.113 -1.228 . . . . 0.0 110.069 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.41 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 25.6 m-85 -95.24 143.65 26.47 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.992 0.901 . . . . 0.0 110.939 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.4 -25.36 20.43 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.815 0.817 . . . . 0.0 109.167 179.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -137.3 78.85 1.72 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.576 ' HA ' ' HB1' ' A' ' 152' ' ' ALA . 19.5 m -46.02 -25.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.457 -0.777 . . . . 0.0 111.167 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -84.73 10.31 11.7 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.106 -0.996 . . . . 0.0 110.937 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 68.6 p -81.0 -159.36 0.25 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.967 -1.083 . . . . 0.0 110.182 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -89.87 -54.18 4.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 110.207 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.87 -23.38 63.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 0.0 110.268 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.576 ' HB1' ' HA ' ' A' ' 147' ' ' VAL . . . -81.12 -23.43 38.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 0.0 110.286 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.18 -41.05 77.69 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.216 -0.928 . . . . 0.0 110.115 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.403 ' OE1' HG22 ' A' ' 204' ' ' THR . 1.1 mm-40 -60.43 -46.03 91.48 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.314 -0.867 . . . . 0.0 109.956 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -51.79 -55.35 20.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 110.268 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 156' ' ' LEU . 41.2 mt -54.13 -55.75 24.69 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.383 -0.823 . . . . 0.0 110.152 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -52.45 -38.02 58.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.347 -0.845 . . . . 0.0 110.13 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.729 ' HB2' ' HG3' ' A' ' 205' ' ' LYS . . . -76.8 -41.61 43.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.198 -0.939 . . . . 0.0 109.841 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -58.73 -37.61 76.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.828 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -66.59 -28.21 68.33 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.243 -0.91 . . . . 0.0 110.113 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 158' ' ' ALA . . . -60.36 -50.43 73.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.798 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.54 HG21 ' CG1' ' A' ' 165' ' ' ILE . 71.4 mt -90.31 152.17 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.367 -0.833 . . . . 0.0 109.891 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -127.6 -40.27 1.77 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.136 -0.978 . . . . 0.0 110.43 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -63.77 -16.25 60.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.249 -0.907 . . . . 0.0 110.615 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.54 ' CG1' HG21 ' A' ' 162' ' ' ILE . 46.2 mm -93.63 128.86 40.37 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.075 -1.016 . . . . 0.0 110.327 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.455 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 51.0 Cg_endo -77.31 82.55 2.35 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 O-C-N 123.538 1.283 . . . . 0.0 110.546 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -71.44 137.57 48.38 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.173 -0.954 . . . . 0.0 110.238 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 141' ' ' ILE . . . -128.9 145.07 15.91 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 4.8 tt -146.58 137.48 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -1.157 . . . . 0.0 110.439 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.2 t -159.49 156.94 29.13 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.001 0.905 . . . . 0.0 110.895 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 56.7 p -122.24 3.43 9.79 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.527 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -57.74 126.76 28.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.219 -0.926 . . . . 0.0 110.535 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.88 -35.88 58.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.244 -0.91 . . . . 0.0 110.143 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -53.09 -30.75 38.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.978 . . . . 0.0 109.815 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.546 HG12 ' CE2' ' A' ' 143' ' ' PHE . 57.3 t -81.29 -26.86 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.325 -0.859 . . . . 0.0 109.546 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -77.6 -52.86 8.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.351 -0.843 . . . . 0.0 109.345 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.4 m -58.96 -18.6 35.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.443 -0.786 . . . . 0.0 109.997 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -71.48 -53.91 12.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.559 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -91.11 4.6 51.76 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.41 -0.807 . . . . 0.0 110.292 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.13 64.64 1.76 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -0.946 . . . . 0.0 110.713 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 40.0 mt -102.7 122.41 44.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.256 -0.902 . . . . 0.0 110.17 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -62.83 -18.87 63.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 110.422 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 18.9 pttt -163.75 -148.22 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 109.983 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -70.71 150.98 45.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -0.933 . . . . 0.0 109.889 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -170.16 156.05 26.33 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 97.8 t -127.8 141.2 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.172 -1.193 . . . . 0.0 110.344 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.49 HG13 ' H ' ' A' ' 197' ' ' ASN . 70.6 t -143.06 149.24 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.337 -0.852 . . . . 0.0 109.646 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.69 HD23 ' HD3' ' A' ' 190' ' ' LYS . 3.7 tt -101.29 145.59 28.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.951 -1.093 . . . . 0.0 109.681 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.842 ' HB3' HG22 ' A' ' 133' ' ' VAL . 58.8 m-85 -121.87 108.34 13.34 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.131 -0.981 . . . . 0.0 110.624 -178.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.69 ' HD3' HD23 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -124.06 174.68 7.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.31 -0.869 . . . . 0.0 110.27 179.782 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -94.41 -26.22 16.6 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.321 -0.862 . . . . 0.0 110.007 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.493 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.5 OUTLIER -91.43 -170.92 2.76 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.833 179.577 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 49.87 -159.92 0.07 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.661 0.743 . . . . 0.0 110.595 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -56.05 -46.32 78.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.632 -0.667 . . . . 0.0 110.25 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 126.07 -32.86 3.67 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -136.55 173.14 12.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.193 -1.18 . . . . 0.0 110.429 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' ASN . . . . . 0.49 ' H ' HG13 ' A' ' 187' ' ' VAL . 0.7 OUTLIER -144.22 -155.21 0.58 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.37 -0.831 . . . . 0.0 109.631 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.435 ' HA ' HG22 ' A' ' 187' ' ' VAL . 0.2 OUTLIER -169.52 86.93 0.15 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.53 -0.731 . . . . 0.0 110.206 179.612 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -49.85 130.83 22.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.272 -0.893 . . . . 0.0 110.441 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -127.95 115.38 18.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.327 -0.858 . . . . 0.0 109.942 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 132.93 -158.74 23.25 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -84.43 132.28 34.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.298 -1.119 . . . . 0.0 110.167 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.644 HG13 HD21 ' A' ' 208' ' ' LEU . 92.3 t -81.46 116.17 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.33 -0.856 . . . . 0.0 110.376 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.403 HG22 ' OE1' ' A' ' 154' ' ' GLN . 15.6 p -143.56 159.73 41.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 109.988 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.769 ' O ' HD12 ' A' ' 209' ' ' LEU . 2.9 ttpt -51.31 -49.24 61.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.12 -0.987 . . . . 0.0 110.584 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -62.98 -39.72 95.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.276 -0.89 . . . . 0.0 110.549 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -70.16 -48.79 55.86 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.197 -0.939 . . . . 0.0 110.374 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.644 HD21 HG13 ' A' ' 203' ' ' VAL . 95.3 mt -56.06 -49.87 72.55 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.257 -0.902 . . . . 0.0 110.428 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.769 HD12 ' O ' ' A' ' 205' ' ' LYS . 0.7 OUTLIER -59.26 -26.99 65.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.892 . . . . 0.0 110.298 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -78.28 -45.49 22.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.281 -0.887 . . . . 0.0 110.274 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -53.29 -60.92 2.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.318 -0.864 . . . . 0.0 110.393 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 9.9 mt -51.69 -46.47 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.242 -0.911 . . . . 0.0 110.586 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -18.85 13.79 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.258 -0.902 . . . . 0.0 110.956 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -96.52 -24.38 16.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.064 -1.022 . . . . 0.0 110.922 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.555 ' HB3' HD22 ' A' ' 188' ' ' LEU . 72.1 m-20 -89.34 -48.58 7.25 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.922 -1.111 . . . . 0.0 111.139 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 . . . . . 0 N--CA 1.493 1.676 0 O-C-N 120.956 -1.09 . . . . 0.0 110.212 -179.777 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 167' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.106 0.479 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.554 HG22 ' HA2' ' A' ' 168' ' ' GLY . 7.7 t -102.19 171.11 7.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.139 -0.976 . . . . 0.0 110.516 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.2 m -113.95 103.47 11.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.357 -0.839 . . . . 0.0 110.193 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.655 HD21 HD12 ' A' ' 132' ' ' LEU . 57.7 mt -79.47 111.95 24.87 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.924 . . . . 0.0 110.04 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.433 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 44.7 Cg_endo -69.61 -21.57 34.02 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 O-C-N 123.561 1.295 . . . . 0.0 110.869 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.577 ' OD2' ' HB3' ' A' ' 127' ' ' ALA . 0.4 OUTLIER -163.13 -170.03 2.19 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.052 -1.03 . . . . 0.0 111.076 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.452 ' HA3' ' HD3' ' A' ' 178' ' ' LYS . . . -67.69 -39.92 90.25 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.577 ' HB3' ' OD2' ' A' ' 125' ' ' ASP . . . -53.25 -22.56 7.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -1.15 . . . . 0.0 110.031 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.433 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -88.32 -23.91 23.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.205 -0.935 . . . . 0.0 109.301 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.0 -20.48 32.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.454 -0.779 . . . . 0.0 110.118 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 131' ' ' SER . 19.2 pt-20 -86.9 -37.61 17.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.177 -0.952 . . . . 0.0 110.228 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.44 ' N ' ' HG3' ' A' ' 130' ' ' GLU . 3.0 m -75.48 -31.45 60.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 0.0 109.998 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.655 HD12 HD21 ' A' ' 123' ' ' LEU . 2.4 tt -56.51 -59.47 4.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.336 -0.852 . . . . 0.0 110.067 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.54 HG22 ' CB ' ' A' ' 189' ' ' PHE . 51.4 t -53.63 -35.88 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 110.513 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.81 -19.86 57.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.125 -0.984 . . . . 0.0 110.581 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 68.4 m -68.56 -57.47 5.73 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.129 -0.982 . . . . 0.0 110.304 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 46.1 p -111.84 165.06 12.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.316 -0.865 . . . . 0.0 110.252 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.879 ' HG3' HG23 ' A' ' 138' ' ' VAL . 14.6 pt-20 -64.86 -40.39 95.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 110.035 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.879 HG23 ' HG3' ' A' ' 137' ' ' GLU . 94.1 t -121.67 147.7 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.429 -0.794 . . . . 0.0 110.17 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.501 ' HB1' HD22 ' A' ' 132' ' ' LEU . . . -173.99 133.26 0.43 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.298 -0.876 . . . . 0.0 110.061 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 187' ' ' VAL . 7.3 p -111.86 149.54 14.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.136 -0.977 . . . . 0.0 110.064 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.451 HG23 HD12 ' A' ' 123' ' ' LEU . 66.5 mt -131.37 111.1 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 110.253 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -77.28 133.24 12.96 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.733 ' CE2' HG12 ' A' ' 175' ' ' VAL . 51.4 m-85 -105.36 67.2 0.76 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.26 -1.141 . . . . 0.0 109.735 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -91.76 130.33 37.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 111.228 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.456 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 26.0 pttt -80.07 -30.62 39.32 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.923 0.868 . . . . 0.0 108.828 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.456 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 5.2 m-20 -123.19 70.93 1.04 Allowed 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.323 0.582 . . . . 0.0 109.449 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.46 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 25.6 m -49.17 -23.89 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.27 -0.894 . . . . 0.0 110.808 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -78.33 2.55 18.2 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.08 -1.012 . . . . 0.0 111.032 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 21.5 p -80.45 -161.0 0.34 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.901 -1.124 . . . . 0.0 110.243 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -90.41 -51.59 5.34 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.21 -0.931 . . . . 0.0 110.582 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 66.4 m -52.25 -26.07 10.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.2 -0.938 . . . . 0.0 110.507 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.46 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -86.24 -32.1 21.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 110.353 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -60.23 -41.32 92.84 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.22 -0.925 . . . . 0.0 110.189 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -66.32 -36.91 84.12 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.169 -0.957 . . . . 0.0 109.93 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.453 ' HA ' HD13 ' A' ' 208' ' ' LEU . 4.3 t80 -51.97 -57.78 8.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.286 -0.884 . . . . 0.0 110.097 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 19.2 mt -52.01 -50.57 61.11 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.45 -0.781 . . . . 0.0 110.245 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -52.1 -41.61 62.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.356 -0.84 . . . . 0.0 110.152 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.613 ' HB2' ' HA ' ' A' ' 205' ' ' LYS . . . -73.29 -35.47 66.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.335 -0.853 . . . . 0.0 109.889 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.58 -43.16 94.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 110.013 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -60.13 -35.62 75.68 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.256 -0.903 . . . . 0.0 110.139 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.3 -46.54 86.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.87 . . . . 0.0 110.182 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 49.8 mm -90.7 104.98 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.064 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.37 -20.54 20.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.122 -0.986 . . . . 0.0 110.373 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -76.88 -6.05 50.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.221 -0.925 . . . . 0.0 110.807 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 44.7 mm -116.3 130.35 24.54 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.941 -1.1 . . . . 0.0 110.132 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.445 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 50.6 Cg_endo -75.09 81.2 2.28 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.475 1.25 . . . . 0.0 110.549 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 120' ' ' ALA . 2.9 m-85 -68.23 132.38 47.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 110.316 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.554 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -126.54 153.34 18.71 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 7.2 tt -148.43 147.33 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -1.154 . . . . 0.0 110.329 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.507 HG21 HG11 ' A' ' 175' ' ' VAL . 2.4 t -164.01 156.96 17.86 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.065 0.936 . . . . 0.0 110.809 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . 0.415 ' HA ' ' CE1' ' A' ' 176' ' ' PHE . 76.1 p -121.14 1.08 10.28 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.16 119.98 6.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.191 -0.943 . . . . 0.0 110.506 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.1 p -53.72 -32.48 52.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.229 -0.919 . . . . 0.0 110.095 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.404 ' O ' ' HE2' ' A' ' 178' ' ' LYS . 0.4 OUTLIER -56.47 -44.31 80.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.141 -0.975 . . . . 0.0 109.344 179.543 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.733 HG12 ' CE2' ' A' ' 143' ' ' PHE . 39.0 t -69.22 -29.84 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.346 -0.846 . . . . 0.0 109.41 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.415 ' CE1' ' HA ' ' A' ' 171' ' ' SER . 5.5 m-85 -68.57 -60.86 2.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.407 -0.808 . . . . 0.0 109.528 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 2.9 m -51.36 -36.62 43.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.61 -0.682 . . . . 0.0 110.562 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.452 ' HD3' ' HA3' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -48.44 -55.78 9.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.17 -0.956 . . . . 0.0 110.895 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -89.9 18.73 5.4 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.315 -0.866 . . . . 0.0 110.51 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.46 65.75 1.39 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.163 -0.961 . . . . 0.0 110.402 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 85.5 mt -112.92 92.29 3.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -0.836 . . . . 0.0 110.235 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.56 -26.98 9.65 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.038 -1.038 . . . . 0.0 109.53 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -138.66 177.73 7.67 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 3.7 p-10 -58.65 -173.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.08 -1.012 . . . . 0.0 110.262 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 165.27 171.86 32.01 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 186' ' ' VAL . 32.8 m -139.92 108.15 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.294 -1.121 . . . . 0.0 109.97 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.495 ' O ' HG23 ' A' ' 140' ' ' VAL . 97.2 t -117.04 160.9 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.287 -0.883 . . . . 0.0 109.851 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.785 HD12 HD13 ' A' ' 212' ' ' ILE . 8.3 tt -110.3 150.79 28.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.026 -1.046 . . . . 0.0 109.941 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.54 ' CB ' HG22 ' A' ' 133' ' ' VAL . 40.6 m-85 -121.87 127.19 50.2 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.991 -1.068 . . . . 0.0 110.196 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.28 167.39 22.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -0.885 . . . . 0.0 110.358 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.0 mtpt -90.87 -27.09 19.02 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.244 -0.91 . . . . 0.0 110.596 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -90.96 -175.69 4.41 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.381 -0.824 . . . . 0.0 111.023 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 50.01 -160.0 0.07 Allowed 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.666 0.746 . . . . 0.0 110.667 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -53.86 -54.68 35.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.666 -0.646 . . . . 0.0 110.191 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 133.12 -24.31 3.79 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -140.85 176.81 8.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.051 -1.264 . . . . 0.0 110.781 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' ASN . . . . . 0.456 ' N ' ' ND2' ' A' ' 197' ' ' ASN . 1.1 m-80 -142.53 -151.76 0.38 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.549 -0.719 . . . . 0.0 109.509 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -176.51 79.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 0.0 109.97 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.574 ' CB ' HG23 ' A' ' 186' ' ' VAL . 17.1 t80 -51.26 120.1 4.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.285 -0.884 . . . . 0.0 110.52 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -119.56 104.91 10.72 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.248 -0.907 . . . . 0.0 110.111 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 152.21 -160.62 28.99 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -81.94 111.11 17.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -1.178 . . . . 0.0 110.16 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.453 ' C ' HG23 ' A' ' 204' ' ' THR . 86.9 t -61.82 116.68 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 110.173 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.453 HG23 ' C ' ' A' ' 203' ' ' VAL . 67.9 p -149.63 155.72 40.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 110.284 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.613 ' HA ' ' HB2' ' A' ' 158' ' ' ALA . 1.5 ttpt -52.62 -52.66 54.46 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.357 -0.839 . . . . 0.0 110.567 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -56.35 -25.83 50.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.0 110.293 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -87.47 -46.29 9.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.291 -0.881 . . . . 0.0 110.17 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 155' ' ' PHE . 19.4 mt -59.02 -47.27 85.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.283 -0.886 . . . . 0.0 110.315 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 14.6 mt -52.31 -30.99 31.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.226 -0.921 . . . . 0.0 110.287 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.53 -42.06 14.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 0.0 110.089 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.428 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 18.5 t80 -51.31 -51.7 51.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.162 -0.961 . . . . 0.0 109.705 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.785 HD13 HD12 ' A' ' 188' ' ' LEU . 25.4 mm -48.53 -72.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.427 -0.796 . . . . 0.0 110.423 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.459 ' HA ' ' CG ' ' A' ' 216' ' ' GLN . 18.0 mttt -45.9 -37.08 5.94 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.779 -0.575 . . . . 0.0 111.132 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.61 -25.46 67.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.13 -0.981 . . . . 0.0 110.793 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 74.8 m-80 -102.18 -31.53 10.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.103 -0.998 . . . . 0.0 110.977 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' GLN . . . . . 0.459 ' CG ' ' HA ' ' A' ' 213' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 O-C-N 121.016 -1.053 . . . . 0.0 111.001 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.269 0.557 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.4 t -103.89 168.9 8.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 110.318 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.6 m -108.1 118.4 36.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 0.0 109.94 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.765 HD22 ' HB1' ' A' ' 128' ' ' ALA . 49.5 mt -90.88 138.35 26.28 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.218 -0.926 . . . . 0.0 110.378 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 46.5 Cg_endo -72.61 -36.63 4.78 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.565 1.297 . . . . 0.0 110.366 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.662 ' C ' HG22 ' A' ' 175' ' ' VAL . 0.9 OUTLIER -167.2 -170.24 1.45 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.222 -0.924 . . . . 0.0 110.805 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.5 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -57.56 -33.67 67.43 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.52 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -51.11 -26.72 6.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.22 -1.165 . . . . 0.0 110.406 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.765 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -88.12 -37.16 16.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 110.093 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.24 -25.88 25.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 0.0 109.995 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -88.88 -57.36 2.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.271 -0.893 . . . . 0.0 110.062 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.2 m -58.77 -27.87 65.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.233 -0.917 . . . . 0.0 110.205 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 20.6 tp -60.71 -54.31 46.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 109.988 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 98.4 t -57.39 -33.25 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.459 -0.776 . . . . 0.0 110.336 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -72.97 -17.69 61.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.903 . . . . 0.0 110.528 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.85 -27.12 57.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.189 -0.944 . . . . 0.0 110.393 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.404 ' OG ' ' HG3' ' A' ' 166' ' ' PRO . 31.1 p -141.58 163.55 32.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.188 -0.945 . . . . 0.0 110.391 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.855 ' HG3' HG23 ' A' ' 138' ' ' VAL . 18.3 pt-20 -63.8 -40.93 97.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 110.043 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.855 HG23 ' HG3' ' A' ' 137' ' ' GLU . 57.9 t -127.76 155.88 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.412 -0.805 . . . . 0.0 110.172 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.434 ' HB2' ' HG2' ' A' ' 166' ' ' PRO . . . -176.75 138.51 0.28 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.245 -0.91 . . . . 0.0 109.788 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 187' ' ' VAL . 7.5 p -112.78 151.78 14.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.085 -1.01 . . . . 0.0 110.245 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 71.9 mt -132.65 117.36 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.377 -0.827 . . . . 0.0 110.163 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -84.22 126.72 7.74 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.713 ' CE2' HG12 ' A' ' 175' ' ' VAL . 83.7 m-85 -100.24 70.03 1.51 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.356 -1.085 . . . . 0.0 109.924 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -94.99 141.5 28.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -0.875 . . . . 0.0 110.952 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.53 -27.96 18.83 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.501 -0.749 . . . . 0.0 110.554 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.587 ' C ' HG23 ' A' ' 147' ' ' VAL . 0.7 OUTLIER -90.69 -39.51 12.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.17 -0.956 . . . . 0.0 110.445 -179.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.587 HG23 ' C ' ' A' ' 146' ' ' ASP . 2.4 t 73.1 -51.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.743 -0.598 . . . . 0.0 110.634 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -90.83 8.96 32.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.067 -1.021 . . . . 0.0 110.507 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 7.5 p -70.01 -163.87 0.07 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.986 -1.071 . . . . 0.0 110.066 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.51 -41.31 13.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.338 -0.851 . . . . 0.0 110.431 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.7 p -59.55 -24.26 63.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.197 -0.94 . . . . 0.0 110.19 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -85.02 -37.17 20.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.253 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.88 -45.83 67.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 110.387 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -62.49 -39.48 93.61 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.219 -0.925 . . . . 0.0 110.355 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -51.6 -56.63 12.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 110.418 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.7 mt -51.21 -54.31 26.82 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.324 -0.86 . . . . 0.0 110.534 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -51.91 -40.46 60.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.254 -0.903 . . . . 0.0 110.252 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.468 ' HB2' ' HG3' ' A' ' 205' ' ' LYS . . . -69.47 -49.61 53.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.93 . . . . 0.0 109.885 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.456 ' HB1' ' CD2' ' A' ' 167' ' ' PHE . . . -55.61 -35.93 66.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 110.011 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -68.48 -22.76 64.54 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.329 -0.857 . . . . 0.0 110.435 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.89 -56.42 17.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.168 -0.957 . . . . 0.0 110.333 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 98.8 mt -90.02 151.1 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 0.0 110.177 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -119.67 -16.39 8.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 110.597 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -91.2 19.7 5.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.073 -1.017 . . . . 0.0 110.519 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.551 ' CG2' ' CE1' ' A' ' 167' ' ' PHE . 31.8 mm -132.21 125.1 19.75 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.135 -0.978 . . . . 0.0 109.899 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.434 ' HG2' ' HB2' ' A' ' 139' ' ' ALA . 50.0 Cg_endo -81.5 101.56 1.22 Allowed 'Trans proline' 0 C--N 1.315 -1.228 0 O-C-N 123.443 1.233 . . . . 0.0 110.697 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.551 ' CE1' ' CG2' ' A' ' 165' ' ' ILE . 1.1 m-85 -92.85 140.07 29.88 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.249 -0.907 . . . . 0.0 109.487 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 141' ' ' ILE . . . -132.58 156.37 22.04 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.3 tt -146.0 150.86 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.096 -1.237 . . . . 0.0 110.282 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.917 HG21 HG11 ' A' ' 175' ' ' VAL . 2.4 t -162.01 158.55 25.2 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.11 0.957 . . . . 0.0 110.891 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . 0.421 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . 26.3 t -125.09 2.12 7.94 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.319 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -67.98 123.39 20.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.22 -0.925 . . . . 0.0 110.31 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 14.9 m -50.53 -25.43 4.07 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.224 -0.922 . . . . 0.0 110.445 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -59.91 -29.06 68.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.194 -0.941 . . . . 0.0 109.848 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.917 HG11 HG21 ' A' ' 170' ' ' THR . 39.2 t -88.87 -22.16 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.358 -0.839 . . . . 0.0 109.734 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -80.69 -44.31 18.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.347 -0.846 . . . . 0.0 109.711 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.0 -25.23 67.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.431 -0.793 . . . . 0.0 110.107 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.82 -61.42 2.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -0.852 . . . . 0.0 110.44 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.49 ' CZ ' ' CZ ' ' A' ' 189' ' ' PHE . 88.9 m-85 -89.59 12.24 17.29 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.181 -0.949 . . . . 0.0 110.675 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 50.34 60.62 3.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.143 -0.973 . . . . 0.0 110.719 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 83.8 mt -91.75 124.18 35.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.142 -0.974 . . . . 0.0 109.965 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -60.0 -19.32 51.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.244 -0.91 . . . . 0.0 110.615 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -168.84 -146.96 0.06 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.211 -0.931 . . . . 0.0 110.168 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -75.32 150.06 38.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.229 -0.92 . . . . 0.0 110.171 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -171.54 154.01 21.28 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 186' ' ' VAL . 33.3 m -126.04 104.71 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.278 -1.131 . . . . 0.0 110.174 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.479 HG22 ' HA ' ' A' ' 198' ' ' ASN . 95.2 t -111.27 157.91 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 0.0 109.494 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.785 HD22 ' HB3' ' A' ' 215' ' ' ASN . 9.1 tt -107.15 148.45 28.83 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.887 -1.133 . . . . 0.0 108.926 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.49 ' CZ ' ' CZ ' ' A' ' 179' ' ' TYR . 39.0 m-85 -113.78 129.06 56.63 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.756 -1.215 . . . . 0.0 111.304 -178.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.517 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -137.97 151.95 48.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.274 -0.891 . . . . 0.0 110.269 179.578 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp -83.27 -25.26 31.78 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.337 -0.852 . . . . 0.0 110.252 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.517 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 1.7 p90 -91.77 -176.99 4.63 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.397 -0.814 . . . . 0.0 110.976 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 193' ' ' ASP . 11.1 m-20 48.91 -158.37 0.06 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.574 0.702 . . . . 0.0 110.624 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.25 -46.94 46.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.553 -0.717 . . . . 0.0 110.55 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 133.37 -33.45 2.57 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.6 ptt180 -147.4 -165.84 2.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.188 -1.183 . . . . 0.0 110.593 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' ASN . . . . . 0.526 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.0 OUTLIER -142.7 -153.7 0.48 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.549 -0.719 . . . . 0.0 109.895 -179.273 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.479 ' HA ' HG22 ' A' ' 187' ' ' VAL . 8.3 p-10 -171.94 80.93 0.06 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.467 -0.77 . . . . 0.0 109.935 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -53.92 119.49 5.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.833 . . . . 0.0 110.27 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -120.69 89.15 3.07 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.417 -0.802 . . . . 0.0 110.354 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 164.66 -165.68 37.58 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -73.17 126.32 29.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -1.132 . . . . 0.0 110.243 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 97.2 t -76.0 110.19 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 110.139 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 77.6 p -145.79 151.28 37.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.491 -0.756 . . . . 0.0 109.979 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.468 ' HG3' ' HB2' ' A' ' 158' ' ' ALA . 6.4 ttpt -48.69 -52.28 24.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.277 -0.889 . . . . 0.0 110.413 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -52.77 -39.86 62.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.324 -0.86 . . . . 0.0 110.19 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -77.31 -44.51 29.35 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.36 -0.838 . . . . 0.0 110.39 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 71.6 mt -53.97 -46.54 71.68 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.317 -0.864 . . . . 0.0 110.29 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 24.6 mt -59.09 -31.64 69.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 0.0 110.027 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -72.19 -28.18 63.04 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.217 -0.927 . . . . 0.0 109.864 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -65.09 -66.67 0.51 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.424 -0.798 . . . . 0.0 110.328 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 5.6 mt -46.37 -42.19 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.436 -0.79 . . . . 0.0 110.778 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -24.73 37.08 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.238 -0.914 . . . . 0.0 110.156 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -113.12 3.74 16.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.331 -0.855 . . . . 0.0 110.832 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.785 ' HB3' HD22 ' A' ' 188' ' ' LEU . 8.1 m120 -92.25 -60.06 1.94 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.882 -1.136 . . . . 0.0 110.195 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' GLN . . . . . 0.491 ' HA ' ' CZ ' ' A' ' 192' ' ' PHE . 7.4 pt20 . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.335 -0.853 . . . . 0.0 110.407 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.26 0.552 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.639 HG22 ' HA2' ' A' ' 168' ' ' GLY . 10.0 t -124.95 171.7 9.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.375 -0.828 . . . . 0.0 110.113 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 50.6 m -109.2 108.76 19.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.34 -0.85 . . . . 0.0 110.095 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.581 HD22 ' HB1' ' A' ' 128' ' ' ALA . 39.0 mt -84.4 125.7 71.19 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.892 . . . . 0.0 109.973 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -71.23 -42.82 1.79 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.53 1.279 . . . . 0.0 110.468 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.476 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 1.3 p30 -152.57 -170.05 3.52 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.301 -0.874 . . . . 0.0 110.807 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.427 ' HA3' ' HD2' ' A' ' 178' ' ' LYS . . . -62.09 -26.51 67.59 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.476 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -53.26 -34.53 57.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.338 -1.095 . . . . 0.0 110.4 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.581 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -79.26 -33.1 43.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.06 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.35 -32.25 64.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -0.881 . . . . 0.0 110.193 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -90.22 -41.17 11.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.348 -0.845 . . . . 0.0 110.406 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.0 m -62.62 -34.75 77.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.935 . . . . 0.0 110.079 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.1 tp -60.74 -45.29 94.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 110.246 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.723 HG22 ' HB3' ' A' ' 189' ' ' PHE . 43.8 t -56.11 -41.59 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.231 -0.918 . . . . 0.0 110.596 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -85.29 -19.9 30.84 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.219 -0.926 . . . . 0.0 110.496 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.5 m -55.48 -36.97 67.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.202 -0.936 . . . . 0.0 110.3 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.8 p -145.16 -178.82 6.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.159 -0.963 . . . . 0.0 110.288 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.15 -30.54 60.79 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.289 -0.882 . . . . 0.0 110.276 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 92.9 t -130.95 144.99 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 110.129 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -174.95 136.75 0.4 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 110.208 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.503 HG11 ' CE1' ' A' ' 167' ' ' PHE . 7.5 p -123.7 150.61 28.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.198 -0.938 . . . . 0.0 110.009 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.458 HG23 ' CD1' ' A' ' 123' ' ' LEU . 5.7 mt -131.17 116.42 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.232 -0.918 . . . . 0.0 110.067 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -87.13 121.63 5.88 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 184' ' ' ASP . 65.4 m-85 -99.08 98.25 9.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -1.161 . . . . 0.0 109.53 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.618 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 19.8 m-85 -115.67 147.33 40.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.026 -1.046 . . . . 0.0 111.357 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.4 ptmt -91.17 -27.38 18.55 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.643 0.735 . . . . 0.0 109.345 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.03 72.34 1.36 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.603 -0.685 . . . . 0.0 109.502 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.578 ' HA ' ' HB2' ' A' ' 152' ' ' ALA . 23.9 m -54.8 -19.77 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.283 -0.886 . . . . 0.0 110.617 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -76.33 0.96 17.53 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.111 -0.993 . . . . 0.0 110.927 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' A' ' 153' ' ' LYS . 83.6 p -88.06 -170.19 2.88 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.827 -1.17 . . . . 0.0 109.949 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -81.35 -30.8 33.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.289 -0.882 . . . . 0.0 110.167 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.43 ' HB2' ' CE1' ' A' ' 144' ' ' PHE . 94.9 p -56.92 -28.92 62.59 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.138 -0.976 . . . . 0.0 110.134 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.578 ' HB2' ' HA ' ' A' ' 147' ' ' VAL . . . -83.34 -43.16 16.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 109.935 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 149' ' ' SER . 0.1 OUTLIER -52.6 -53.05 52.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.265 -0.897 . . . . 0.0 110.255 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -56.32 -43.3 78.86 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.386 -0.821 . . . . 0.0 109.974 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.49 ' HE2' HG13 ' A' ' 186' ' ' VAL . 3.9 t80 -53.3 -57.45 10.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.384 -0.823 . . . . 0.0 110.175 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.9 mt -53.44 -54.33 38.46 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.208 -0.932 . . . . 0.0 110.349 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -50.57 -30.98 14.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.33 -0.856 . . . . 0.0 110.466 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.516 ' HB2' ' HG3' ' A' ' 205' ' ' LYS . . . -77.71 -33.18 53.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 0.0 110.021 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.878 ' O ' HG22 ' A' ' 162' ' ' ILE . . . -59.33 -44.72 92.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.27 -0.894 . . . . 0.0 110.166 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -79.84 -29.24 40.07 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.36 -0.837 . . . . 0.0 110.307 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -80.62 -6.51 58.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.267 -0.896 . . . . 0.0 110.743 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.878 HG22 ' O ' ' A' ' 159' ' ' ALA . 4.7 tt -92.44 179.66 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.964 -1.085 . . . . 0.0 109.967 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -70.33 62.34 0.23 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.035 -1.04 . . . . 0.0 110.429 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 162' ' ' ILE . 3.9 p-10 40.3 52.33 2.85 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.478 0.656 . . . . 0.0 111.194 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.555 HG23 ' HD2' ' A' ' 166' ' ' PRO . 34.6 mm -88.25 145.41 35.87 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.497 -0.752 . . . . 0.0 109.835 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.555 ' HD2' HG23 ' A' ' 165' ' ' ILE . 43.5 Cg_endo -68.59 91.3 0.41 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.639 1.336 . . . . 0.0 110.759 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.519 ' CZ ' HD13 ' A' ' 162' ' ' ILE . 2.9 m-85 -88.83 133.91 34.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 0.0 110.133 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.639 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -122.43 150.74 16.91 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 5.9 tt -150.04 142.01 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -1.118 . . . . 0.0 110.65 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.1 t -159.23 155.36 26.89 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.125 0.964 . . . . 0.0 110.755 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 85.0 p -116.01 1.04 13.2 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.608 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.404 ' ND2' ' HB2' ' A' ' 174' ' ' ASP . 56.2 t30 -57.56 128.28 36.27 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.085 -1.009 . . . . 0.0 110.34 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.14 -28.05 66.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.271 -0.893 . . . . 0.0 110.224 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.404 ' HB2' ' ND2' ' A' ' 172' ' ' ASN . 0.1 OUTLIER -55.41 -45.61 76.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.112 -0.992 . . . . 0.0 109.838 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 42.8 t -67.68 -29.79 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.2 -0.938 . . . . 0.0 109.573 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -76.5 -44.15 36.45 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.376 -0.828 . . . . 0.0 109.357 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 12.1 t -71.59 -5.75 35.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.539 -0.726 . . . . 0.0 110.499 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.427 ' HD2' ' HA3' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -88.59 -47.12 8.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.993 -1.067 . . . . 0.0 108.888 179.516 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -90.28 8.4 33.49 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.685 -0.634 . . . . 0.0 110.235 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 53.6 67.29 1.03 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.088 -1.007 . . . . 0.0 110.587 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 42.0 mt -117.27 107.5 14.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.112 -0.992 . . . . 0.0 109.88 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.74 -19.49 17.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.0 110.135 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.53 -164.72 2.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.166 -0.959 . . . . 0.0 109.492 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 3.3 p30 -61.51 164.23 6.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.074 -1.016 . . . . 0.0 109.958 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -158.55 153.84 24.96 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.49 HG13 ' HE2' ' A' ' 155' ' ' PHE . 92.8 t -129.59 98.73 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.301 -1.117 . . . . 0.0 109.982 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 140' ' ' VAL . 94.6 t -119.74 158.54 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.275 -0.89 . . . . 0.0 110.111 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.578 HD12 HG12 ' A' ' 212' ' ' ILE . 6.8 tt -109.21 150.48 27.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.085 -1.009 . . . . 0.0 109.572 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.723 ' HB3' HG22 ' A' ' 133' ' ' VAL . 44.4 m-85 -124.63 123.86 40.96 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.938 -1.101 . . . . 0.0 110.511 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.31 174.23 10.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.44 -0.788 . . . . 0.0 110.105 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -94.37 -34.24 12.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.174 -0.954 . . . . 0.0 110.263 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.27 -170.58 2.68 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.388 -0.82 . . . . 0.0 110.948 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 54.68 -160.34 0.16 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.544 0.687 . . . . 0.0 110.5 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -55.02 -53.68 52.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.701 -0.625 . . . . 0.0 110.14 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 130.93 -24.79 4.23 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 24.4 mtm-85 -144.48 178.93 7.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.12 -1.223 . . . . 0.0 110.686 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' ASN . . . . . 0.468 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.0 OUTLIER -147.63 -155.11 0.6 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.343 -0.848 . . . . 0.0 109.687 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 197' ' ' ASN . 6.4 m-80 -169.44 85.48 0.14 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.486 -0.759 . . . . 0.0 110.187 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.419 ' CB ' ' O ' ' A' ' 186' ' ' VAL . 12.5 t80 -57.74 122.32 12.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.279 -0.888 . . . . 0.0 110.433 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -123.33 104.55 9.19 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.251 -0.905 . . . . 0.0 110.24 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 148.79 -167.0 29.31 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.79 134.87 49.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -1.128 . . . . 0.0 110.222 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.618 HG11 ' HZ ' ' A' ' 144' ' ' PHE . 70.7 t -86.04 111.17 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.904 . . . . 0.0 110.348 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.481 HG23 ' C ' ' A' ' 203' ' ' VAL . 68.8 p -149.18 153.96 38.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.472 -0.768 . . . . 0.0 110.097 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.756 ' O ' HD12 ' A' ' 209' ' ' LEU . 0.9 OUTLIER -48.06 -54.35 13.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.937 -179.806 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -54.21 -41.36 68.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.447 -0.783 . . . . 0.0 110.484 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -71.44 -42.87 67.68 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.425 -0.797 . . . . 0.0 110.687 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 71.0 mt -59.7 -51.75 68.43 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.145 -0.972 . . . . 0.0 110.711 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.756 HD12 ' O ' ' A' ' 205' ' ' LYS . 0.7 OUTLIER -54.68 -33.33 60.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.171 -0.955 . . . . 0.0 110.337 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -71.57 -47.62 53.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.216 -0.928 . . . . 0.0 110.3 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -57.95 -55.18 38.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.286 -0.884 . . . . 0.0 110.315 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.578 HG12 HD12 ' A' ' 188' ' ' LEU . 82.3 mt -54.42 -52.89 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.0 110.447 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.21 -23.77 0.97 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.422 -0.799 . . . . 0.0 111.285 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 214' ' ' HIS . 21.3 m170 -92.19 -20.74 20.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.928 -1.108 . . . . 0.0 110.733 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -93.19 -53.12 4.24 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.034 -1.041 . . . . 0.0 111.516 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 . . . . . 0 N--CA 1.488 1.471 0 O-C-N 121.033 -1.042 . . . . 0.0 111.306 -179.048 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.231 0.539 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.656 HG22 ' HA2' ' A' ' 168' ' ' GLY . 7.9 t -89.71 170.72 10.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.891 . . . . 0.0 110.257 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 96.1 m -109.14 104.4 13.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 0.0 110.192 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.888 HD21 HD12 ' A' ' 132' ' ' LEU . 85.5 mt -76.78 139.83 66.8 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.261 -0.899 . . . . 0.0 110.191 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 46.4 Cg_endo -72.15 -35.15 7.22 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 O-C-N 123.556 1.292 . . . . 0.0 110.41 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.557 ' C ' HG22 ' A' ' 175' ' ' VAL . 1.0 OUTLIER -165.86 -170.37 1.75 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.235 -0.915 . . . . 0.0 110.932 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.51 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -66.7 -38.03 92.87 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -51.64 -32.97 31.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.231 -1.158 . . . . 0.0 110.4 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.431 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -82.13 -32.21 30.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.896 . . . . 0.0 110.242 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.59 -25.51 26.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.997 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -89.93 -44.63 9.76 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.312 -0.867 . . . . 0.0 109.058 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.3 m -60.51 -28.31 68.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.225 -0.922 . . . . 0.0 109.675 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.888 HD12 HD21 ' A' ' 123' ' ' LEU . 5.8 tt -65.14 -61.74 1.96 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.354 -0.842 . . . . 0.0 109.967 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.493 HG21 ' CB ' ' A' ' 189' ' ' PHE . 86.8 t -50.95 -31.11 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.404 -0.81 . . . . 0.0 110.253 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.34 -12.65 61.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.294 -0.879 . . . . 0.0 110.673 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 35.8 m -75.83 -21.97 56.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.015 -1.053 . . . . 0.0 110.25 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.14 168.98 22.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.296 -0.878 . . . . 0.0 110.432 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -72.05 -19.51 61.82 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.396 -0.815 . . . . 0.0 109.724 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 26.0 m -129.9 141.83 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.279 -0.888 . . . . 0.0 110.311 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.408 ' HB3' ' HA ' ' A' ' 133' ' ' VAL . . . -175.85 137.36 0.34 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.252 -0.905 . . . . 0.0 110.086 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.467 HG11 ' CZ ' ' A' ' 167' ' ' PHE . 14.5 p -123.57 150.49 27.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.18 -0.95 . . . . 0.0 110.351 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 69.9 mt -132.86 110.39 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.371 -0.831 . . . . 0.0 110.099 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.8 123.94 6.84 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.351 -1.499 . . . . 0.0 109.351 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.462 ' CD2' HD12 ' A' ' 181' ' ' LEU . 47.0 m-85 -93.9 80.56 4.15 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.229 -1.159 . . . . 0.0 110.141 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -105.8 140.99 37.99 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.059 -1.026 . . . . 0.0 111.128 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.462 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 61.3 pttt -91.48 -36.18 13.9 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.75 0.785 . . . . 0.0 109.165 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.462 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 4.7 m-20 -122.78 79.97 1.7 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.744 -0.598 . . . . 0.0 109.642 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.433 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 29.7 m -55.26 -19.37 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.239 -0.913 . . . . 0.0 110.708 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.79 11.81 8.49 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.092 -1.005 . . . . 0.0 110.9 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.407 ' O ' ' HG2' ' A' ' 153' ' ' LYS . 91.9 p -87.81 -163.7 0.99 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.912 -1.118 . . . . 0.0 110.102 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -90.17 -42.43 11.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.328 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 55.5 m -62.03 -28.82 69.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 110.493 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.433 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -79.8 -25.66 40.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.183 -0.948 . . . . 0.0 110.265 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 149' ' ' SER . 19.6 mmtt -63.16 -44.83 94.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 110.08 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -62.2 -40.78 97.22 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.275 -0.891 . . . . 0.0 110.214 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.506 ' HE1' HG13 ' A' ' 186' ' ' VAL . 4.6 t80 -50.86 -54.89 19.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.198 -0.939 . . . . 0.0 110.256 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 32.0 mt -52.4 -56.14 16.99 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.397 -0.815 . . . . 0.0 110.233 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -52.74 -49.85 64.61 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.322 -0.862 . . . . 0.0 110.257 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.81 -45.58 82.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.892 . . . . 0.0 110.114 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.451 ' HB2' ' CD2' ' A' ' 167' ' ' PHE . . . -64.71 -31.83 73.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 110.1 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.77 -31.26 72.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.359 -0.838 . . . . 0.0 110.157 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.23 -41.53 88.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 110.245 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 76.0 mt -99.72 140.33 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.929 . . . . 0.0 110.274 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -122.66 16.29 10.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.296 -0.877 . . . . 0.0 110.48 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.403 ' O ' HD13 ' A' ' 165' ' ' ILE . 3.7 p30 -120.35 19.67 12.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.156 -0.965 . . . . 0.0 110.323 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.403 HD13 ' O ' ' A' ' 164' ' ' ASP . 48.1 mm -128.98 132.58 24.46 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.17 -0.956 . . . . 0.0 110.014 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.54 ' HB2' HD21 ' A' ' 132' ' ' LEU . 48.6 Cg_endo -72.72 70.83 3.4 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.515 1.271 . . . . 0.0 110.281 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.467 ' CZ ' HG11 ' A' ' 140' ' ' VAL . 2.2 m-85 -65.54 125.46 25.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 109.954 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.656 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -125.0 149.12 16.93 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 12.4 tt -146.76 144.77 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.286 -1.126 . . . . 0.0 110.318 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.425 ' CG2' HG11 ' A' ' 175' ' ' VAL . 2.2 t -158.15 156.97 31.85 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.022 0.915 . . . . 0.0 110.789 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.5 m -124.17 3.54 8.57 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -60.81 129.89 43.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 0.0 110.279 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 84.4 p -53.52 -29.21 35.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.217 -0.927 . . . . 0.0 110.045 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -56.55 -26.77 55.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.904 . . . . 0.0 109.684 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.557 HG22 ' C ' ' A' ' 125' ' ' ASP . 42.9 t -86.93 -24.75 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.416 -0.803 . . . . 0.0 109.558 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 176' ' ' PHE . 10.6 m-85 -80.0 -47.9 14.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.295 -0.878 . . . . 0.0 109.403 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.81 -11.25 60.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.391 -0.818 . . . . 0.0 110.693 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.426 ' CD ' ' HA3' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -85.55 -50.54 7.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.061 -1.025 . . . . 0.0 109.697 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 179' ' ' TYR . 32.8 m-85 -89.35 13.62 13.12 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.485 -0.759 . . . . 0.0 110.196 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 49.81 65.3 1.45 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.123 -0.985 . . . . 0.0 110.482 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.462 HD12 ' CD2' ' A' ' 143' ' ' PHE . 79.4 mt -118.33 106.4 12.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 110.249 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.41 -30.27 70.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.061 -1.024 . . . . 0.0 109.825 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.17 -149.24 0.35 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.364 -0.835 . . . . 0.0 109.697 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.411 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 45.3 m-20 -78.16 175.42 10.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.007 -1.058 . . . . 0.0 109.748 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -167.63 139.75 5.87 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.459 -1.353 . . . . 0.0 109.924 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.506 HG13 ' HE1' ' A' ' 155' ' ' PHE . 95.0 t -121.33 85.75 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.477 -1.014 . . . . 0.0 109.799 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.7 t -109.86 160.26 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.399 -0.813 . . . . 0.0 110.45 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.649 HD22 ' HB3' ' A' ' 215' ' ' ASN . 2.2 tt -113.15 147.05 38.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.19 -0.944 . . . . 0.0 109.447 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.493 ' CB ' HG21 ' A' ' 133' ' ' VAL . 45.2 m-85 -118.7 125.15 49.05 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.981 -1.075 . . . . 0.0 110.651 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.595 ' HD3' HD23 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -139.92 161.75 36.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.888 . . . . 0.0 109.907 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.0 mmpp? -87.24 -20.65 26.59 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.181 -0.949 . . . . 0.0 110.563 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 190' ' ' LYS . 3.4 p90 -90.87 179.73 5.7 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.292 -0.88 . . . . 0.0 110.823 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 44.55 -158.24 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.551 0.691 . . . . 0.0 111.035 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -50.99 -43.74 60.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.577 -0.702 . . . . 0.0 110.235 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.405 ' HA2' ' HG2' ' A' ' 190' ' ' LYS . . . 112.37 -21.07 20.22 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -137.9 174.26 10.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.099 -1.236 . . . . 0.0 110.735 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' ASN . . . . . 0.46 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.0 OUTLIER -144.54 -152.29 0.41 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.502 -0.749 . . . . 0.0 109.515 -179.827 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 27.8 p30 -173.77 76.06 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 0.0 110.548 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -54.01 125.47 18.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -0.938 . . . . 0.0 109.92 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -132.72 33.01 3.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.928 . . . . 0.0 110.096 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -117.96 175.74 15.84 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.77 122.74 10.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -1.157 . . . . 0.0 110.161 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.492 ' C ' HG23 ' A' ' 204' ' ' THR . 78.4 t -65.55 102.75 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.157 -0.965 . . . . 0.0 110.18 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.492 HG23 ' C ' ' A' ' 203' ' ' VAL . 82.1 p -150.11 151.91 33.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.389 -0.819 . . . . 0.0 110.24 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 23.2 tttt -50.44 -50.1 53.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 0.0 110.491 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -53.28 -35.44 60.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.203 -0.936 . . . . 0.0 110.388 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -79.03 -46.76 17.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 0.0 110.147 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.43 ' CD2' HG11 ' A' ' 186' ' ' VAL . 82.8 mt -62.53 -31.02 71.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 110.263 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 19.0 mt -70.44 -26.67 63.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 110.187 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -86.9 -47.69 8.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.166 -0.959 . . . . 0.0 110.039 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -49.45 -50.15 42.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.317 -0.865 . . . . 0.0 110.213 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.498 HD13 HD12 ' A' ' 188' ' ' LEU . 28.2 mm -55.38 -69.26 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.533 -0.729 . . . . 0.0 110.185 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.34 -36.81 4.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.759 -0.588 . . . . 0.0 111.063 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -40.04 95.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.137 -0.977 . . . . 0.0 110.121 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.649 ' HB3' HD22 ' A' ' 188' ' ' LEU . 79.5 m-20 -89.71 -45.04 9.6 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.3 -0.875 . . . . 0.0 110.451 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.221 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.299 0.571 . . . . 0.0 110.387 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.432 ' HB ' ' HA2' ' A' ' 168' ' ' GLY . 7.9 m -104.68 116.7 32.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.336 -0.853 . . . . 0.0 109.706 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 79.8 m -69.17 142.01 54.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 0.0 110.191 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.7 mt -124.29 144.41 45.63 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 110.148 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.432 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 45.8 Cg_endo -72.48 -37.42 4.25 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.713 1.375 . . . . 0.0 110.372 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.68 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.9 OUTLIER -173.27 -170.46 0.62 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.205 -0.934 . . . . 0.0 110.687 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.488 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -57.8 -30.59 63.11 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.68 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -51.49 -35.55 40.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.257 -1.143 . . . . 0.0 110.498 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.432 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -82.85 -38.19 23.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.108 -0.995 . . . . 0.0 110.203 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.73 -24.86 24.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.108 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -77.66 -64.16 1.21 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 110.165 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.0 -23.14 12.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 110.139 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.717 HD22 ' HB1' ' A' ' 139' ' ' ALA . 2.1 tt -64.76 -59.48 4.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 0.0 109.946 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.74 HG22 ' HB3' ' A' ' 189' ' ' PHE . 56.4 t -50.49 -41.53 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.37 -0.831 . . . . 0.0 110.562 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -80.22 1.72 27.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.919 . . . . 0.0 110.931 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 17.5 t -82.71 -27.38 31.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.898 -1.126 . . . . 0.0 110.051 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.42 171.59 16.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.262 -0.899 . . . . 0.0 110.168 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.25 -20.15 63.94 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.335 -0.853 . . . . 0.0 109.583 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 18.2 m -135.13 149.15 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.259 -0.901 . . . . 0.0 110.169 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.717 ' HB1' HD22 ' A' ' 132' ' ' LEU . . . -173.64 138.06 0.65 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.233 -0.917 . . . . 0.0 110.232 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.43 ' CG1' ' HA ' ' A' ' 167' ' ' PHE . 7.2 p -125.99 153.67 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 121.072 -1.017 . . . . 0.0 110.365 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.422 ' O ' ' CE1' ' A' ' 143' ' ' PHE . 52.9 mt -137.96 114.5 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 109.905 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.56 136.69 18.33 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.715 ' CE2' HG12 ' A' ' 175' ' ' VAL . 67.6 m-85 -112.97 72.84 0.79 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.299 -1.118 . . . . 0.0 110.014 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.417 ' CE1' ' HB3' ' A' ' 184' ' ' ASP . 10.8 m-85 -102.35 142.7 33.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 111.051 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.88 -27.38 23.46 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.765 0.793 . . . . 0.0 109.494 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.7 p30 -126.24 69.63 1.22 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.694 -0.629 . . . . 0.0 109.616 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.499 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 31.4 m -50.41 -23.27 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.725 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.16 -9.47 57.81 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.115 -0.991 . . . . 0.0 111.296 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 52.7 p -69.95 -159.69 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.894 -1.129 . . . . 0.0 110.333 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -90.35 -45.74 8.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.386 -0.822 . . . . 0.0 110.267 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.9 p -52.32 -30.0 26.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.318 -0.864 . . . . 0.0 110.224 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.499 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -83.24 -34.99 25.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.372 -0.83 . . . . 0.0 110.174 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.2 mmtt -49.89 -40.1 41.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.309 -0.87 . . . . 0.0 110.357 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.8 -45.03 83.9 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.288 -0.882 . . . . 0.0 110.002 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.44 ' HE1' HG13 ' A' ' 186' ' ' VAL . 5.7 t80 -48.05 -55.4 10.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.273 -0.892 . . . . 0.0 110.597 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.0 mt -48.59 -54.6 13.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.277 -0.89 . . . . 0.0 110.667 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -52.23 -51.61 57.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.217 -0.927 . . . . 0.0 110.171 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' A' ' 205' ' ' LYS . . . -60.0 -39.37 85.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.145 -0.972 . . . . 0.0 109.824 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.39 -32.21 71.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.343 -0.848 . . . . 0.0 110.066 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -80.62 -29.48 36.8 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.314 -0.866 . . . . 0.0 110.277 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.468 ' HB3' HD21 ' A' ' 209' ' ' LEU . . . -54.16 -52.21 61.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -0.893 . . . . 0.0 110.365 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.401 HG13 ' OD2' ' A' ' 164' ' ' ASP . 19.0 tt -89.79 150.04 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 110.064 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -132.57 35.77 3.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.108 -0.995 . . . . 0.0 110.661 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.722 ' O ' HD13 ' A' ' 165' ' ' ILE . 3.5 p30 -136.05 17.79 3.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.169 -0.957 . . . . 0.0 110.228 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.722 HD13 ' O ' ' A' ' 164' ' ' ASP . 39.5 mm -135.17 146.5 58.53 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.238 -0.914 . . . . 0.0 109.923 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.467 ' HD2' ' CG2' ' A' ' 165' ' ' ILE . 47.6 Cg_endo -84.18 90.83 0.85 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.779 1.41 . . . . 0.0 110.248 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.43 ' HA ' ' CG1' ' A' ' 140' ' ' VAL . 3.9 m-85 -85.81 130.93 34.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.29 -0.882 . . . . 0.0 110.554 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.432 ' HA2' ' HB ' ' A' ' 121' ' ' THR . . . -120.01 153.07 16.86 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 14.7 tt -147.42 144.36 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -1.125 . . . . 0.0 110.305 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.707 HG21 HG11 ' A' ' 175' ' ' VAL . 2.5 t -162.17 157.58 23.36 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.064 0.935 . . . . 0.0 110.693 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.1 1.58 9.2 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.411 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -59.41 121.52 11.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.115 -0.991 . . . . 0.0 110.259 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 79.4 p -51.65 -29.99 20.02 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.096 -1.002 . . . . 0.0 110.296 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -59.19 -35.6 73.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.136 -0.978 . . . . 0.0 109.842 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.715 HG12 ' CE2' ' A' ' 143' ' ' PHE . 60.3 t -76.85 -26.54 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.39 -0.819 . . . . 0.0 109.812 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -79.59 -53.26 7.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.395 -0.816 . . . . 0.0 109.865 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -25.45 63.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.955 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.43 -53.01 62.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 110.037 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -92.83 16.99 11.21 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.222 -0.923 . . . . 0.0 110.409 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 53.54 69.47 0.7 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.249 -0.907 . . . . 0.0 110.603 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 77.6 mt -115.02 123.01 47.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.212 -0.93 . . . . 0.0 110.024 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -86.39 -21.01 27.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.166 -0.959 . . . . 0.0 110.19 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -148.84 -166.14 2.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.329 -0.857 . . . . 0.0 109.914 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.417 ' HB3' ' CE1' ' A' ' 144' ' ' PHE . 71.2 m-20 -53.46 152.33 4.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.938 . . . . 0.0 109.997 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -157.77 131.74 2.96 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.44 HG13 ' HE1' ' A' ' 155' ' ' PHE . 72.8 t -115.21 85.69 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.356 -1.085 . . . . 0.0 109.619 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.555 HG13 ' H ' ' A' ' 197' ' ' ASN . 85.5 t -102.72 149.25 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.371 -0.831 . . . . 0.0 110.18 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.696 HD23 ' HD3' ' A' ' 190' ' ' LYS . 5.3 tt -105.53 150.59 25.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.122 -0.986 . . . . 0.0 109.627 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.74 ' HB3' HG22 ' A' ' 133' ' ' VAL . 46.1 m-85 -119.52 121.19 38.85 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.931 -1.106 . . . . 0.0 110.554 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.696 ' HD3' HD23 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -136.33 160.76 37.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 0.0 110.171 179.815 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -85.53 -22.94 27.91 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.312 -0.868 . . . . 0.0 110.556 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 190' ' ' LYS . 2.5 p90 -90.45 -176.29 4.73 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.392 -0.817 . . . . 0.0 110.865 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 193' ' ' ASP . 0.7 OUTLIER 46.52 -157.97 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.481 0.658 . . . . 0.0 110.511 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -54.83 -54.96 35.53 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.475 -0.766 . . . . 0.0 110.094 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 134.47 -31.61 2.74 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -131.56 173.09 11.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.157 -1.202 . . . . 0.0 110.66 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' ASN . . . . . 0.555 ' H ' HG13 ' A' ' 187' ' ' VAL . 1.6 m-80 -138.21 -151.51 0.39 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.515 -0.741 . . . . 0.0 109.673 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -175.6 77.0 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.356 -0.84 . . . . 0.0 110.051 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -48.41 142.84 5.3 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.329 -0.857 . . . . 0.0 110.915 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -150.29 134.98 17.48 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.31 -0.869 . . . . 0.0 109.649 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 125.08 -178.39 16.55 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -54.98 121.15 8.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -1.139 . . . . 0.0 110.232 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 75.8 t -74.91 102.57 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.191 -0.943 . . . . 0.0 110.212 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.3 p -136.6 145.26 44.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.367 -0.833 . . . . 0.0 109.705 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.521 ' HA ' HD12 ' A' ' 208' ' ' LEU . 0.1 OUTLIER -48.08 -47.53 34.05 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.157 -0.964 . . . . 0.0 110.838 -179.722 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -59.11 -40.49 85.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.24 -0.912 . . . . 0.0 110.458 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -67.68 -39.53 84.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.123 -0.986 . . . . 0.0 110.407 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.812 ' O ' HD12 ' A' ' 212' ' ' ILE . 36.7 mt -63.42 -52.63 60.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 110.41 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.468 HD21 ' HB3' ' A' ' 161' ' ' ALA . 6.9 mt -51.69 -24.39 5.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.172 -0.955 . . . . 0.0 110.407 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -82.4 -48.76 10.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.17 -0.956 . . . . 0.0 110.031 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -53.27 -57.22 11.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 110.474 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.812 HD12 ' O ' ' A' ' 208' ' ' LEU . 4.4 mt -49.79 -54.2 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.179 -0.95 . . . . 0.0 110.61 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.29 -29.45 9.74 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.286 -0.884 . . . . 0.0 110.66 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -81.45 -15.97 53.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.31 -0.869 . . . . 0.0 110.782 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.664 ' HB3' HD22 ' A' ' 188' ' ' LEU . 74.5 m-20 -104.77 -35.52 7.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.08 -1.013 . . . . 0.0 110.849 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' GLN . . . . . 0.443 ' OE1' HG22 ' A' ' 212' ' ' ILE . 13.7 pt20 . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.13 -0.982 . . . . 0.0 110.949 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 167' ' ' PHE . . . . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.191 0.52 . . . . 0.0 110.111 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.576 ' O ' HG22 ' A' ' 169' ' ' ILE . 7.2 t -145.31 152.32 39.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.154 -0.966 . . . . 0.0 110.048 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 169' ' ' ILE . 1.5 m -86.15 125.49 33.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.067 -1.02 . . . . 0.0 109.891 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.955 ' HB2' HG23 ' A' ' 170' ' ' THR . 71.0 mt -88.47 130.87 43.94 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.88 -1.137 . . . . 0.0 110.297 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.44 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 48.6 Cg_endo -72.68 -51.21 0.19 Allowed 'Trans proline' 0 C--N 1.315 -1.207 0 O-C-N 123.422 1.222 . . . . 0.0 110.556 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.687 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.5 OUTLIER -141.9 -169.43 2.91 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.247 -0.908 . . . . 0.0 110.778 -179.84 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.94 -27.04 72.87 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.687 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -59.13 -27.48 65.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.205 -1.173 . . . . 0.0 110.237 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.44 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -90.05 -21.28 22.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.944 . . . . 0.0 110.227 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.95 -21.88 50.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 110.252 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -90.31 -40.75 11.93 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.27 -0.894 . . . . 0.0 109.623 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.83 -31.18 66.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.147 -0.971 . . . . 0.0 110.385 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.4 tp -68.69 -43.98 74.95 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.296 -0.877 . . . . 0.0 110.391 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.837 HG22 ' HB3' ' A' ' 189' ' ' PHE . 46.2 t -51.56 -53.99 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.339 -0.85 . . . . 0.0 110.519 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.27 -17.84 60.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.196 -0.94 . . . . 0.0 110.471 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.6 p -53.3 -38.6 63.27 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.126 -0.984 . . . . 0.0 110.331 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.401 ' OG ' ' HG3' ' A' ' 166' ' ' PRO . 2.3 p -147.27 -172.77 4.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.301 -0.875 . . . . 0.0 110.249 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.06 -45.8 47.17 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.341 -0.85 . . . . 0.0 110.362 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.4 m -116.76 151.63 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.938 . . . . 0.0 110.464 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.434 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -175.26 127.11 0.26 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.911 . . . . 0.0 109.934 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.83 153.03 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.102 -0.999 . . . . 0.0 110.02 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.683 HG23 HD11 ' A' ' 123' ' ' LEU . 56.8 mt -139.98 114.74 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.144 -0.972 . . . . 0.0 110.47 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.0 132.4 11.06 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.709 ' CE2' HG12 ' A' ' 175' ' ' VAL . 18.7 m-85 -100.68 92.3 5.03 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.243 -1.151 . . . . 0.0 109.679 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.555 ' HZ ' HG21 ' A' ' 203' ' ' VAL . 25.1 m-85 -114.78 147.31 39.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.065 -1.022 . . . . 0.0 111.536 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.76 -26.85 19.28 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.57 0.7 . . . . 0.0 109.652 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.03 78.49 1.68 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.607 -0.683 . . . . 0.0 109.603 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.499 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 22.2 m -50.77 -23.2 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.289 -0.882 . . . . 0.0 110.69 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -72.5 -3.59 25.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.0 110.899 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 7.4 p -78.61 -164.73 0.61 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.851 -1.155 . . . . 0.0 110.161 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.2 -47.52 7.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.277 -0.889 . . . . 0.0 110.436 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.2 m -51.14 -27.34 8.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.24 -0.913 . . . . 0.0 110.541 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.499 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -81.16 -40.48 23.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.931 . . . . 0.0 110.026 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.8 mtpt -50.95 -47.07 61.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.354 -0.841 . . . . 0.0 110.317 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -53.63 -33.73 56.11 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.118 -0.989 . . . . 0.0 109.689 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.424 ' CE1' HG11 ' A' ' 186' ' ' VAL . 4.0 t80 -66.96 -56.65 9.26 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.405 -0.809 . . . . 0.0 109.935 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 152' ' ' ALA . 1.3 mp -46.71 -55.98 6.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.535 -0.728 . . . . 0.0 110.649 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -51.17 -46.73 62.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.35 -0.844 . . . . 0.0 110.292 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.544 ' HB2' ' HG3' ' A' ' 205' ' ' LYS . . . -65.27 -45.59 83.88 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.944 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.79 -38.03 71.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.21 -0.931 . . . . 0.0 109.971 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.35 -28.2 59.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.193 -0.942 . . . . 0.0 110.051 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.21 -42.09 76.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.869 . . . . 0.0 110.201 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.46 ' CD1' HG13 ' A' ' 165' ' ' ILE . 5.5 tt -96.41 152.06 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 110.343 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -131.22 15.35 5.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.272 -0.892 . . . . 0.0 110.558 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.696 ' O ' HD13 ' A' ' 165' ' ' ILE . 4.1 p30 -124.05 16.14 9.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.077 -1.014 . . . . 0.0 110.415 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.696 HD13 ' O ' ' A' ' 164' ' ' ASP . 39.4 mm -132.49 146.27 60.77 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.176 -0.952 . . . . 0.0 110.016 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.472 ' HD2' ' CG2' ' A' ' 165' ' ' ILE . 46.4 Cg_endo -84.34 78.93 2.7 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.747 1.393 . . . . 0.0 110.495 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 120' ' ' ALA . 3.6 m-85 -77.29 135.03 38.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 0.0 110.221 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 141' ' ' ILE . . . -136.06 153.62 21.55 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.576 HG22 ' O ' ' A' ' 121' ' ' THR . 1.7 tt -130.85 151.09 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.173 -1.192 . . . . 0.0 109.451 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 1.063 HG21 HG11 ' A' ' 175' ' ' VAL . 0.7 OUTLIER -119.36 144.61 46.78 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.1 -1.0 . . . . 0.0 110.94 -178.577 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 144' ' ' PHE . 2.5 t -130.85 12.89 5.29 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.503 -0.748 . . . . 0.0 109.814 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.437 ' ND2' ' HB2' ' A' ' 174' ' ' ASP . 50.8 t30 -112.36 160.76 17.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.068 -1.02 . . . . 0.0 110.893 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 39.6 t -83.29 -28.43 29.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.448 -0.782 . . . . 0.0 109.966 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.437 ' HB2' ' ND2' ' A' ' 172' ' ' ASN . 1.7 m-20 -53.8 -32.01 51.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -0.947 . . . . 0.0 109.519 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 1.063 HG11 HG21 ' A' ' 170' ' ' THR . 38.4 t -76.89 -32.17 19.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -69.83 -59.13 3.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.477 -0.765 . . . . 0.0 109.215 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.6 m -53.18 -23.76 9.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.444 -0.785 . . . . 0.0 109.514 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.474 ' HD2' ' CE1' ' A' ' 179' ' ' TYR . 3.4 tmtt? -61.31 -61.38 2.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.525 -0.734 . . . . 0.0 110.067 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.474 ' CE1' ' HD2' ' A' ' 178' ' ' LYS . 94.1 m-85 -89.58 8.39 31.52 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.47 -0.769 . . . . 0.0 110.645 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.9 62.68 2.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.039 -1.038 . . . . 0.0 110.55 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 mt -92.83 134.41 35.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.282 -0.886 . . . . 0.0 110.11 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -73.67 -9.72 58.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 110.587 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -175.94 -165.91 0.17 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.022 -1.049 . . . . 0.0 110.067 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -70.01 152.33 44.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.21 -0.931 . . . . 0.0 110.015 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -177.21 166.86 37.71 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 186' ' ' VAL . 18.6 m -126.22 121.88 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -1.154 . . . . 0.0 110.328 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 89.8 t -118.39 158.84 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.452 -0.78 . . . . 0.0 109.5 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.673 HD13 ' HB2' ' A' ' 215' ' ' ASN . 7.1 tt -107.27 140.2 40.54 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.826 -1.171 . . . . 0.0 109.8 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.837 ' HB3' HG22 ' A' ' 133' ' ' VAL . 49.6 m-85 -117.38 111.15 18.94 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.995 -1.066 . . . . 0.0 110.598 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.625 ' HD3' HD23 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -124.22 -172.81 2.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.27 -0.894 . . . . 0.0 110.06 179.852 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 11.5 mttt -106.62 -26.04 11.53 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.128 -0.983 . . . . 0.0 110.526 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -90.83 -175.89 4.51 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.381 -0.824 . . . . 0.0 110.829 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 47.68 -159.06 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.54 -0.725 . . . . 0.0 110.887 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -52.98 -43.54 66.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.662 -0.649 . . . . 0.0 110.294 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 113.9 -27.08 9.43 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 11.8 mtm180 -135.76 163.98 28.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.184 -1.186 . . . . 0.0 110.386 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' ASN . . . . . 0.486 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 0.8 OUTLIER -136.49 -153.82 0.52 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.342 -0.848 . . . . 0.0 109.796 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -172.89 80.84 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.421 -0.799 . . . . 0.0 110.267 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -48.61 119.67 3.24 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.341 -0.849 . . . . 0.0 110.634 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -113.77 90.2 3.28 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.275 -0.89 . . . . 0.0 110.288 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 164.4 -165.44 37.3 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -74.85 117.88 17.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -1.145 . . . . 0.0 110.278 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.609 ' O ' HG13 ' A' ' 203' ' ' VAL . 6.9 p -66.95 83.28 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 110.091 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 81.4 p -121.24 153.83 37.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 0.0 110.212 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.544 ' HG3' ' HB2' ' A' ' 158' ' ' ALA . 0.6 OUTLIER -46.93 -55.18 8.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.372 -0.83 . . . . 0.0 110.543 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -54.74 -30.67 56.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.477 -0.764 . . . . 0.0 110.236 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -86.95 -23.96 24.92 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.228 -0.92 . . . . 0.0 110.248 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.881 ' O ' HD12 ' A' ' 212' ' ' ILE . 18.7 mt -75.54 -53.46 8.6 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.295 -0.878 . . . . 0.0 110.541 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 4.7 mp -57.58 -20.57 33.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.88 . . . . 0.0 110.633 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -81.94 -53.74 5.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.152 -0.968 . . . . 0.0 110.15 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -60.69 -55.64 30.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.33 -0.856 . . . . 0.0 110.677 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.881 HD12 ' O ' ' A' ' 208' ' ' LEU . 8.1 mt -51.57 -41.98 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.227 -0.921 . . . . 0.0 110.695 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -69.58 -15.01 63.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.122 -0.986 . . . . 0.0 110.836 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.64 -16.83 27.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.129 -0.982 . . . . 0.0 110.795 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.673 ' HB2' HD13 ' A' ' 188' ' ' LEU . 73.5 m-80 -103.69 -39.63 6.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.995 -1.066 . . . . 0.0 110.862 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' GLN . . . . . 0.515 ' OE1' HG22 ' A' ' 212' ' ' ILE . 15.1 pt20 . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.071 -1.018 . . . . 0.0 110.519 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 167' ' ' PHE . . . . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.207 0.527 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.515 HG22 ' HA2' ' A' ' 168' ' ' GLY . 11.6 t -92.14 164.71 13.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 110.305 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 91.1 m -101.91 100.72 11.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.928 . . . . 0.0 110.149 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.54 HD12 HG23 ' A' ' 141' ' ' ILE . 45.4 mt -75.93 131.68 75.71 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.284 -0.885 . . . . 0.0 110.081 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.402 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 47.6 Cg_endo -72.34 -36.95 4.83 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 O-C-N 123.52 1.273 . . . . 0.0 110.485 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.593 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.0 OUTLIER -163.26 -169.5 2.0 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 122.073 0.939 . . . . 0.0 111.262 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.4 ' HA3' ' HD2' ' A' ' 178' ' ' LYS . . . -60.67 -27.2 65.95 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.593 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -55.62 -29.26 58.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -1.141 . . . . 0.0 110.278 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.524 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -90.43 -26.02 20.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.278 -0.888 . . . . 0.0 110.171 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.09 68.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.866 . . . . 0.0 110.119 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -90.26 -40.97 11.84 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.23 -0.918 . . . . 0.0 109.188 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 41.4 m -66.71 -22.68 66.06 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.233 -0.917 . . . . 0.0 110.147 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.58 HD23 HD11 ' A' ' 141' ' ' ILE . 9.0 tp -69.95 -50.76 38.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 110.429 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 91.3 t -58.21 -37.82 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.298 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -77.86 -17.36 57.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 110.419 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.5 p -63.84 -44.76 92.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.035 -1.041 . . . . 0.0 110.303 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 89.4 p -138.2 -173.72 3.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -0.882 . . . . 0.0 110.26 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.19 -44.93 74.75 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.273 -0.892 . . . . 0.0 110.258 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.624 HG21 HD12 ' A' ' 165' ' ' ILE . 33.6 m -120.53 163.71 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.261 -0.899 . . . . 0.0 110.453 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -176.38 125.42 0.18 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.411 -0.806 . . . . 0.0 109.634 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.509 HG11 ' CE2' ' A' ' 167' ' ' PHE . 8.2 p -112.29 139.64 36.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.049 -1.032 . . . . 0.0 110.781 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.58 HD11 HD23 ' A' ' 132' ' ' LEU . 3.4 mt -130.97 113.58 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.316 -0.865 . . . . 0.0 109.671 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.76 136.68 20.34 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.771 ' CE2' HG12 ' A' ' 175' ' ' VAL . 28.6 m-85 -105.87 69.07 0.8 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -1.134 . . . . 0.0 109.715 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.571 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 22.6 m-85 -95.37 145.79 24.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 110.835 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.04 -27.15 24.95 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.51 -0.744 . . . . 0.0 109.724 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.85 78.56 1.75 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.528 -0.733 . . . . 0.0 109.677 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.521 ' O ' ' HB3' ' A' ' 152' ' ' ALA . 22.6 m -51.12 -23.08 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.242 -0.911 . . . . 0.0 110.561 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -76.94 1.01 18.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.06 -1.025 . . . . 0.0 110.933 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 95.1 p -75.55 -164.89 0.37 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.835 -1.166 . . . . 0.0 110.31 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.435 ' HA ' ' HG3' ' A' ' 153' ' ' LYS . 0.3 OUTLIER -90.63 -34.36 15.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.324 -0.86 . . . . 0.0 110.603 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 38.6 t -68.32 -27.88 66.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.263 -0.898 . . . . 0.0 110.269 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.684 ' O ' HD12 ' A' ' 156' ' ' LEU . . . -78.47 -34.04 47.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.142 -0.973 . . . . 0.0 109.939 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.435 ' HG3' ' HA ' ' A' ' 150' ' ' ASP . 2.7 mmmt -53.78 -52.06 61.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 0.0 110.065 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -54.94 -33.68 62.49 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.263 -0.898 . . . . 0.0 109.787 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.652 ' CE1' HG11 ' A' ' 186' ' ' VAL . 4.3 t80 -60.06 -57.4 13.01 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.457 -0.777 . . . . 0.0 109.903 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.684 HD12 ' O ' ' A' ' 152' ' ' ALA . 3.6 mp -46.74 -57.04 5.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.508 -0.745 . . . . 0.0 110.591 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -52.36 -52.42 53.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.292 -0.88 . . . . 0.0 110.093 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.02 -38.64 79.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 0.0 109.907 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -68.11 -31.88 71.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -0.872 . . . . 0.0 109.813 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -80.82 -24.17 38.67 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.3 -0.875 . . . . 0.0 110.045 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.78 -40.34 94.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.31 -0.869 . . . . 0.0 110.072 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.416 HG21 ' CE1' ' A' ' 167' ' ' PHE . 1.5 tt -89.98 151.04 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.33 -0.856 . . . . 0.0 109.978 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.59 16.28 4.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.157 -0.965 . . . . 0.0 110.665 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.62 ' O ' HD13 ' A' ' 165' ' ' ILE . 5.8 p-10 -125.5 14.21 8.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.029 -1.045 . . . . 0.0 110.604 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.624 HD12 HG21 ' A' ' 138' ' ' VAL . 47.8 mm -134.91 135.53 23.35 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.018 -1.051 . . . . 0.0 110.15 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -78.3 81.62 2.68 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.543 1.286 . . . . 0.0 110.873 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.509 ' CE2' HG11 ' A' ' 140' ' ' VAL . 5.4 m-85 -71.14 145.19 49.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.133 -0.979 . . . . 0.0 109.857 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.515 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -137.65 159.29 24.88 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 121' ' ' THR . 4.4 tt -150.75 149.34 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -1.165 . . . . 0.0 110.304 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.447 HG21 HG11 ' A' ' 175' ' ' VAL . 3.3 t -168.82 157.12 8.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.188 -0.945 . . . . 0.0 111.005 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . 0.447 ' HA ' ' CE1' ' A' ' 176' ' ' PHE . 87.6 p -125.54 2.84 7.62 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.378 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -61.73 124.2 20.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.171 -0.956 . . . . 0.0 110.248 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.06 -31.52 7.96 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.189 -0.945 . . . . 0.0 110.553 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.43 -41.78 66.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 110.023 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.771 HG12 ' CE2' ' A' ' 143' ' ' PHE . 61.3 t -75.54 -24.01 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.299 -0.875 . . . . 0.0 109.963 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.447 ' CE1' ' HA ' ' A' ' 171' ' ' SER . 10.6 m-85 -77.28 -54.29 6.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.891 . . . . 0.0 109.721 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.34 -21.86 60.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.367 -0.833 . . . . 0.0 110.085 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.4 ' HD2' ' HA3' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -62.95 -58.79 6.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 110.086 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.42 ' O ' ' HG2' ' A' ' 180' ' ' GLN . 96.3 m-85 -94.78 30.47 2.06 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.194 -0.941 . . . . 0.0 110.456 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 0.1 OUTLIER 29.57 62.02 0.16 Allowed 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 179.728 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.9 mt -89.61 128.24 36.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.073 -1.017 . . . . 0.0 109.962 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.29 -3.86 29.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.933 . . . . 0.0 110.74 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -174.77 -147.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.99 -1.069 . . . . 0.0 109.876 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -89.14 150.32 22.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.191 -0.943 . . . . 0.0 109.974 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -179.82 137.61 3.13 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.652 HG11 ' CE1' ' A' ' 155' ' ' PHE . 18.8 m -100.59 119.27 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.274 -1.133 . . . . 0.0 110.357 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.831 HG22 ' HA ' ' A' ' 198' ' ' ASN . 98.0 t -121.39 150.35 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.924 . . . . 0.0 110.029 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.91 HD22 ' HB3' ' A' ' 215' ' ' ASN . 6.3 tt -106.39 144.29 33.28 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.217 -0.927 . . . . 0.0 108.903 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -119.83 122.0 40.36 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.896 -1.127 . . . . 0.0 110.545 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.504 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -130.14 165.4 22.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 110.116 179.687 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.4 mmtm -84.32 -33.29 23.94 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.297 -0.877 . . . . 0.0 110.396 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.504 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.2 OUTLIER -90.9 -173.65 3.76 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.54 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 56.11 -153.86 0.34 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.23 -0.919 . . . . 0.0 110.076 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -71.93 -24.87 61.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.7 -0.625 . . . . 0.0 110.378 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 103.4 -30.53 10.16 Favored Glycine 0 N--CA 1.484 1.861 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -130.3 175.75 8.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.125 -1.221 . . . . 0.0 110.454 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' ASN . . . . . 0.509 ' HB3' ' CZ ' ' A' ' 211' ' ' PHE . 1.7 m-80 -139.7 -44.64 0.44 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.322 -0.861 . . . . 0.0 110.227 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.831 ' HA ' HG22 ' A' ' 187' ' ' VAL . 0.3 OUTLIER 63.66 87.42 0.11 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.346 -0.846 . . . . 0.0 109.839 -179.308 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -57.85 134.74 56.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.448 -0.783 . . . . 0.0 110.472 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -130.63 114.84 15.93 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.273 -0.892 . . . . 0.0 109.831 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 139.95 -128.61 3.96 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -115.16 125.3 53.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.238 -1.154 . . . . 0.0 110.272 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.571 HG11 ' HZ ' ' A' ' 144' ' ' PHE . 70.8 t -74.78 107.02 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 110.029 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.452 HG23 ' C ' ' A' ' 203' ' ' VAL . 50.0 p -148.0 158.69 44.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.326 -0.859 . . . . 0.0 110.161 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.54 ' O ' HD12 ' A' ' 209' ' ' LEU . 5.1 tttt -49.22 -52.61 25.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.216 -0.927 . . . . 0.0 110.804 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -57.56 -37.15 72.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.315 -0.866 . . . . 0.0 110.429 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 45.2 m-20 -81.65 -42.89 19.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.435 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.839 ' O ' HD12 ' A' ' 212' ' ' ILE . 51.1 mt -57.86 -54.71 43.83 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.226 -0.921 . . . . 0.0 110.257 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.54 HD12 ' O ' ' A' ' 205' ' ' LYS . 0.4 OUTLIER -54.54 -28.19 43.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.148 -0.97 . . . . 0.0 109.748 179.732 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -77.05 -43.62 33.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.414 -0.804 . . . . 0.0 109.691 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.509 ' CZ ' ' HB3' ' A' ' 197' ' ' ASN . 8.4 t80 -62.01 -59.85 4.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.418 -0.801 . . . . 0.0 110.025 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.839 HD12 ' O ' ' A' ' 208' ' ' LEU . 4.7 mt -50.1 -40.47 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.306 -0.871 . . . . 0.0 110.375 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -66.04 -32.3 73.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.332 -0.855 . . . . 0.0 110.07 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . 0.424 ' O ' ' CD2' ' A' ' 214' ' ' HIS . 16.8 t60 -90.44 8.38 34.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.275 -0.89 . . . . 0.0 110.716 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.91 ' HB3' HD22 ' A' ' 188' ' ' LEU . 6.8 m120 -95.55 -61.99 1.37 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.892 -1.13 . . . . 0.0 110.165 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.308 -0.87 . . . . 0.0 110.557 -179.841 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.502 ' HB1' ' CA ' ' A' ' 168' ' ' GLY . . . . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.014 0.435 . . . . 0.0 110.051 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.525 HG22 ' HA2' ' A' ' 168' ' ' GLY . 12.8 t -82.54 162.03 22.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.093 -1.004 . . . . 0.0 109.917 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.1 m -97.42 119.87 36.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.951 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.669 HD22 ' HB1' ' A' ' 128' ' ' ALA . 40.7 mt -105.92 134.13 19.88 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.95 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.22 -39.16 1.72 Allowed 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.466 1.245 . . . . 0.0 110.054 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.47 ' C ' HG22 ' A' ' 175' ' ' VAL . 0.4 OUTLIER -158.37 -169.31 2.72 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.056 0.932 . . . . 0.0 110.873 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.408 ' HA3' ' HD3' ' A' ' 178' ' ' LYS . . . -63.11 -21.92 64.4 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.77 -27.78 63.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -1.113 . . . . 0.0 110.389 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.669 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -88.45 -31.95 18.52 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.093 -1.004 . . . . 0.0 110.061 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -55.17 -22.02 15.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 109.913 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -89.17 -35.61 16.14 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.299 -0.875 . . . . 0.0 109.025 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.0 m -69.89 -23.94 63.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 109.967 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.2 tp -72.73 -48.64 36.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.337 -0.852 . . . . 0.0 110.072 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.9 HG22 ' HB3' ' A' ' 189' ' ' PHE . 46.9 t -52.74 -43.77 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.338 -0.851 . . . . 0.0 110.31 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -78.84 -20.82 48.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.238 -0.914 . . . . 0.0 110.429 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 25.3 t -56.72 -56.36 22.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -0.927 . . . . 0.0 110.165 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 86.8 p -128.97 165.75 20.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 0.0 110.301 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.627 ' HG3' HG23 ' A' ' 138' ' ' VAL . 18.3 pt-20 -57.94 -40.77 81.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.27 -0.894 . . . . 0.0 110.098 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.627 HG23 ' HG3' ' A' ' 137' ' ' GLU . 74.6 t -124.01 144.8 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.405 -0.809 . . . . 0.0 110.154 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -170.47 144.55 2.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.328 -0.858 . . . . 0.0 109.709 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.624 HG11 ' CE2' ' A' ' 167' ' ' PHE . 7.3 p -129.35 153.05 38.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 121.011 -1.056 . . . . 0.0 110.252 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 20.5 mt -131.41 123.07 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.88 . . . . 0.0 109.9 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -85.81 129.01 9.09 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.62 ' CE2' HG12 ' A' ' 175' ' ' VAL . 28.8 m-85 -101.74 78.98 1.88 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -1.159 . . . . 0.0 109.898 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.483 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 10.9 m-85 -106.17 146.4 30.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.199 -0.938 . . . . 0.0 111.051 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.11 -27.12 18.77 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.617 0.722 . . . . 0.0 109.522 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.55 73.72 1.55 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.664 -0.647 . . . . 0.0 109.405 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.526 ' O ' ' HB3' ' A' ' 152' ' ' ALA . 21.7 m -49.3 -23.35 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.397 -0.815 . . . . 0.0 111.02 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -81.57 7.12 12.91 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.965 -1.084 . . . . 0.0 111.255 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.6 p -78.52 -164.37 0.56 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.864 -1.148 . . . . 0.0 110.506 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -91.04 -24.41 20.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.521 -0.737 . . . . 0.0 110.282 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.64 -30.66 46.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.29 -0.881 . . . . 0.0 109.974 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 147' ' ' VAL . . . -80.26 -19.96 45.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 0.0 110.196 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -38.83 92.72 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.309 -0.869 . . . . 0.0 109.925 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -69.97 -42.14 73.54 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.396 -0.815 . . . . 0.0 110.027 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.423 ' HE1' HG13 ' A' ' 186' ' ' VAL . 4.3 t80 -50.86 -57.75 7.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.359 -0.838 . . . . 0.0 110.337 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 74.9 mt -57.43 -49.7 75.39 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.435 -0.79 . . . . 0.0 110.095 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -52.33 -52.98 50.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.511 -0.743 . . . . 0.0 110.304 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.623 ' HB2' ' HG3' ' A' ' 205' ' ' LYS . . . -66.64 -46.0 77.2 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.192 -0.942 . . . . 0.0 110.173 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -53.15 -32.41 47.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.209 -0.932 . . . . 0.0 110.223 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -66.84 -38.42 86.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 110.2 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.81 -40.79 92.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.263 -0.898 . . . . 0.0 110.162 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 72.3 mt -91.53 92.53 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.292 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -90.62 -27.83 18.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -0.872 . . . . 0.0 110.308 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 164' ' ' ASP . 16.2 p-10 -57.79 -26.62 62.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.915 . . . . 0.0 110.221 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.411 HD12 ' CG1' ' A' ' 138' ' ' VAL . 45.9 mm -104.75 127.24 29.26 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.175 -0.953 . . . . 0.0 109.953 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -78.24 85.84 1.76 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.448 1.236 . . . . 0.0 110.675 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.624 ' CE2' HG11 ' A' ' 140' ' ' VAL . 3.8 m-85 -66.16 174.88 2.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.087 -1.008 . . . . 0.0 109.996 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.525 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -150.11 151.37 23.45 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 6.3 tt -150.47 142.46 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.939 -1.33 . . . . 0.0 110.539 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.493 ' CG2' HG11 ' A' ' 175' ' ' VAL . 2.2 t -160.78 155.67 24.08 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.013 0.911 . . . . 0.0 110.759 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 24.5 p -115.57 -1.9 12.64 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.589 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.416 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 20.4 t30 -52.65 164.24 0.37 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.195 -0.941 . . . . 0.0 110.161 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 26.2 p -91.44 -33.41 15.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.221 -0.924 . . . . 0.0 109.958 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -57.29 -27.4 62.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.229 -0.919 . . . . 0.0 109.826 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.62 HG12 ' CE2' ' A' ' 143' ' ' PHE . 47.6 t -78.08 -29.14 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.336 -0.852 . . . . 0.0 109.725 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 176' ' ' PHE . 16.7 m-85 -85.27 -50.2 7.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.4 -0.812 . . . . 0.0 109.685 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 32.6 m -62.34 -18.05 60.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.433 -0.792 . . . . 0.0 110.361 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.408 ' HD3' ' HA3' ' A' ' 126' ' ' GLY . 5.3 tttp -74.61 -50.59 17.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.16 -0.963 . . . . 0.0 109.922 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -89.55 14.46 11.46 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.147 -0.97 . . . . 0.0 110.37 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 49.11 65.01 1.5 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.214 -0.928 . . . . 0.0 110.848 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 14.2 mt -112.75 100.95 9.08 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.061 -1.024 . . . . 0.0 109.794 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -57.96 -19.0 27.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.032 -1.042 . . . . 0.0 110.089 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt -147.38 -165.2 2.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -0.959 . . . . 0.0 109.661 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -60.31 156.81 14.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.089 -1.007 . . . . 0.0 109.855 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -159.98 118.83 0.85 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.54 HG21 ' CG2' ' A' ' 203' ' ' VAL . 79.7 t -99.21 95.75 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -1.128 . . . . 0.0 110.111 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.502 ' O ' HG23 ' A' ' 140' ' ' VAL . 94.9 t -113.71 152.66 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.299 -0.875 . . . . 0.0 109.862 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.706 ' CD1' HD13 ' A' ' 212' ' ' ILE . 7.7 tt -108.27 155.45 20.47 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.052 -1.03 . . . . 0.0 109.868 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.9 ' HB3' HG22 ' A' ' 133' ' ' VAL . 60.5 m-85 -125.0 126.38 45.35 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.943 -1.098 . . . . 0.0 110.466 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.445 ' HD2' ' CD2' ' A' ' 188' ' ' LEU . 0.0 OUTLIER -134.8 179.18 6.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.379 -0.826 . . . . 0.0 110.074 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -102.52 -29.57 11.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.171 -0.955 . . . . 0.0 110.311 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -90.96 -174.39 3.99 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.446 -0.784 . . . . 0.0 110.811 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 48.0 -159.11 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.643 0.735 . . . . 0.0 110.863 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -50.94 -51.8 48.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.568 -0.707 . . . . 0.0 110.359 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 123.47 -21.58 7.18 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -141.42 177.51 8.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -1.186 . . . . 0.0 110.399 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' ASN . . . . . 0.454 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.1 m-80 -141.89 -152.73 0.42 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.364 -0.835 . . . . 0.0 109.527 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.462 ' HA ' HG22 ' A' ' 187' ' ' VAL . 11.5 p-10 -175.43 79.1 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.274 -0.891 . . . . 0.0 110.496 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -64.34 117.54 7.38 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.384 -0.822 . . . . 0.0 109.88 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -122.64 28.88 7.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 110.571 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -110.92 -123.1 4.4 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 204' ' ' THR . 6.4 mt-10 -119.07 100.45 7.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.292 -1.122 . . . . 0.0 109.885 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.67 ' O ' HG13 ' A' ' 203' ' ' VAL . 7.3 p -51.17 93.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 110.699 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.42 ' N ' ' O ' ' A' ' 202' ' ' GLU . 21.9 p -136.03 160.88 37.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 109.995 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.623 ' HG3' ' HB2' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -50.46 -50.21 53.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.292 -0.88 . . . . 0.0 110.662 -179.823 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 207' ' ' ASN . 16.6 pt-20 -61.89 -41.22 97.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.24 -0.912 . . . . 0.0 110.552 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.425 ' N ' ' HG3' ' A' ' 206' ' ' GLU . 70.2 m-20 -73.24 -40.08 64.95 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.142 -0.974 . . . . 0.0 110.113 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 208' ' ' LEU . 54.7 mt -61.9 -45.95 91.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.868 . . . . 0.0 110.066 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.534 HD12 ' O ' ' A' ' 205' ' ' LYS . 12.0 mt -59.45 -25.68 64.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.861 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -85.05 -46.11 11.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.292 -0.88 . . . . 0.0 109.901 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.422 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 22.3 t80 -48.22 -53.27 17.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.388 -0.82 . . . . 0.0 110.169 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.706 HD13 ' CD1' ' A' ' 188' ' ' LEU . 21.4 mm -48.92 -71.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.409 -0.807 . . . . 0.0 110.085 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.445 ' HA ' ' HG2' ' A' ' 216' ' ' GLN . 20.8 mttt -46.2 -34.38 4.29 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.71 -0.619 . . . . 0.0 110.965 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -71.64 -27.91 63.41 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.216 -0.927 . . . . 0.0 110.587 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 79.7 m-20 -97.84 -51.36 4.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.082 -1.012 . . . . 0.0 110.988 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' GLN . . . . . 0.467 ' NE2' HG22 ' A' ' 212' ' ' ILE . 3.5 pt20 . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.042 -1.036 . . . . 0.0 110.53 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.2 0.524 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.449 HG22 ' HA2' ' A' ' 168' ' ' GLY . 14.6 t -118.61 161.14 20.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 110.219 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.8 m -99.85 110.16 22.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 0.0 109.835 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.421 ' HB2' ' HB ' ' A' ' 170' ' ' THR . 34.9 mt -87.66 113.01 52.43 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.231 -0.918 . . . . 0.0 110.072 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.17 -24.13 23.79 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.491 1.258 . . . . 0.0 110.373 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.61 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 1.1 p30 -173.77 -169.88 0.53 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.307 -0.871 . . . . 0.0 110.541 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.406 ' HA3' ' HD2' ' A' ' 178' ' ' LYS . . . -59.24 -25.24 59.89 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.61 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -53.5 -34.24 57.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -1.132 . . . . 0.0 110.222 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.31 -36.27 14.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 110.149 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.13 -19.94 62.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 110.271 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -88.5 -60.03 2.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 0.0 110.262 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.5 t -55.27 -21.56 14.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.198 -0.939 . . . . 0.0 110.243 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.669 HD23 HD11 ' A' ' 141' ' ' ILE . 18.0 tp -69.92 -48.69 57.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 0.0 110.035 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.641 HG22 ' CB ' ' A' ' 189' ' ' PHE . 60.7 t -65.46 -37.82 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.834 . . . . 0.0 110.398 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -83.75 5.85 23.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.114 -0.991 . . . . 0.0 110.816 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.9 t -90.19 -27.83 19.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.95 -1.094 . . . . 0.0 110.353 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.53 165.06 33.34 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.208 -0.933 . . . . 0.0 110.523 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -65.17 -19.03 65.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.395 -0.816 . . . . 0.0 109.859 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 43.4 t -136.96 149.71 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.9 . . . . 0.0 110.201 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.455 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -175.32 142.61 0.61 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.379 -0.826 . . . . 0.0 109.551 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.673 HG11 HD11 ' A' ' 212' ' ' ILE . 3.6 m -124.15 158.38 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 118.979 -1.089 . . . . 0.0 111.07 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.669 HD11 HD23 ' A' ' 132' ' ' LEU . 60.5 mt -148.22 104.31 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.651 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.82 128.04 9.9 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.834 ' CE2' HG12 ' A' ' 175' ' ' VAL . 37.8 m-85 -98.8 84.56 3.13 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.139 -1.212 . . . . 0.0 109.488 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.673 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 16.4 m-85 -105.85 141.35 37.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.087 -1.008 . . . . 0.0 111.361 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.61 -28.94 26.18 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.959 -0.696 . . . . 0.0 110.015 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.04 87.0 2.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.367 -0.833 . . . . 0.0 109.895 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 98.0 t -60.18 -21.41 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.39 -0.819 . . . . 0.0 110.713 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -82.26 1.01 38.73 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.163 -0.961 . . . . 0.0 111.06 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 82.4 p -81.17 -168.08 1.69 Allowed 'General case' 0 C--N 1.307 -1.271 0 O-C-N 120.921 -1.112 . . . . 0.0 110.379 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -90.22 -18.08 26.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.423 -0.798 . . . . 0.0 110.168 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.476 ' CB ' ' CE1' ' A' ' 144' ' ' PHE . 1.4 m -71.4 -33.15 69.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.193 -0.942 . . . . 0.0 110.235 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.36 -37.64 27.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.141 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -55.92 -40.05 72.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.894 . . . . 0.0 110.094 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -64.19 -42.47 96.64 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.271 -0.893 . . . . 0.0 110.054 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.423 ' HA ' HD13 ' A' ' 208' ' ' LEU . 3.9 t80 -51.44 -55.45 18.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.362 -0.836 . . . . 0.0 110.18 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 156' ' ' LEU . 25.8 mt -54.58 -55.18 32.08 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.298 -0.876 . . . . 0.0 110.244 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.406 ' HB3' ' HD2' ' A' ' 205' ' ' LYS . 89.5 mt-30 -51.31 -49.65 60.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.329 -0.857 . . . . 0.0 110.129 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.601 ' HB2' ' HA ' ' A' ' 205' ' ' LYS . . . -63.52 -36.99 85.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 109.78 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.747 ' HB1' ' CD2' ' A' ' 167' ' ' PHE . . . -68.84 -29.61 67.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.301 -0.874 . . . . 0.0 109.947 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -67.7 -39.86 84.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.342 -0.849 . . . . 0.0 110.12 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.68 -50.35 66.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.863 . . . . 0.0 110.034 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.427 ' CG2' ' OD1' ' A' ' 164' ' ' ASP . 96.7 mt -97.38 163.4 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 109.806 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.425 ' N ' HG22 ' A' ' 162' ' ' ILE . 22.1 m-20 -136.73 -40.61 0.62 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.118 -0.989 . . . . 0.0 110.548 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.427 ' OD1' ' CG2' ' A' ' 162' ' ' ILE . 26.3 p-10 -55.29 -24.75 30.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 110.593 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.485 ' HB ' ' CE1' ' A' ' 167' ' ' PHE . 31.3 mm -92.59 129.78 39.34 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.073 -1.017 . . . . 0.0 110.226 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.455 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 55.2 Cg_endo -79.06 117.67 3.91 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 123.466 1.245 . . . . 0.0 110.274 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.747 ' CD2' ' HB1' ' A' ' 159' ' ' ALA . 6.1 m-85 -107.32 124.3 49.61 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.089 -1.007 . . . . 0.0 109.427 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.449 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -120.74 154.95 16.33 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 6.7 tt -150.43 140.94 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.124 -1.221 . . . . 0.0 110.78 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.421 ' HB ' ' HB2' ' A' ' 123' ' ' LEU . 1.8 t -155.12 156.93 36.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.307 -0.871 . . . . 0.0 110.414 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.1 t -119.87 1.35 10.98 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.468 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 41.4 p30 -67.93 151.29 47.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.117 -0.989 . . . . 0.0 109.985 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.8 p -78.44 -18.7 54.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.188 -0.945 . . . . 0.0 110.66 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.01 -39.14 84.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.933 . . . . 0.0 110.254 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.834 HG12 ' CE2' ' A' ' 143' ' ' PHE . 46.4 t -79.61 -24.45 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -0.956 . . . . 0.0 109.922 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.468 ' CD1' ' O ' ' A' ' 172' ' ' ASN . 9.0 m-85 -75.44 -50.59 15.33 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.32 -0.863 . . . . 0.0 109.878 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.18 -19.19 64.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.473 -0.767 . . . . 0.0 110.45 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.406 ' HD2' ' HA3' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -62.66 -56.47 17.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.971 . . . . 0.0 110.282 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.52 ' HB2' HD13 ' A' ' 181' ' ' LEU . 92.3 m-85 -92.83 26.28 2.81 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.18 -0.95 . . . . 0.0 110.374 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.552 ' C ' HD12 ' A' ' 181' ' ' LEU . 2.2 mm-40 55.97 67.06 1.06 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.498 -0.751 . . . . 0.0 110.712 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.552 HD12 ' C ' ' A' ' 180' ' ' GLN . 6.6 mp -124.7 102.98 7.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.555 -0.715 . . . . 0.0 110.227 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.405 ' O ' ' HG3' ' A' ' 183' ' ' LYS . 0.8 OUTLIER -88.74 14.7 9.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -0.935 . . . . 0.0 110.147 179.366 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 182' ' ' ASP . 6.2 mtmm -162.49 -165.3 1.15 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.276 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 10.6 p-10 -82.86 157.87 22.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.949 -1.094 . . . . 0.0 110.138 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 179.14 121.71 0.73 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.418 ' O ' ' CB ' ' A' ' 199' ' ' PHE . 94.7 t -92.8 121.62 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.329 -1.101 . . . . 0.0 110.049 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.858 HG22 ' HA ' ' A' ' 198' ' ' ASN . 90.6 t -128.97 149.77 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 0.0 109.83 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.804 HD12 HD13 ' A' ' 212' ' ' ILE . 8.5 tt -104.61 131.5 51.96 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.995 -1.066 . . . . 0.0 108.458 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.641 ' CB ' HG22 ' A' ' 133' ' ' VAL . 57.3 m-85 -102.95 121.64 42.95 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.899 -1.126 . . . . 0.0 110.902 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.402 ' HD3' HD23 ' A' ' 188' ' ' LEU . 0.1 OUTLIER -131.5 168.02 18.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.545 -0.722 . . . . 0.0 110.213 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -89.58 -24.9 21.6 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.293 -0.879 . . . . 0.0 110.579 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -90.71 -175.45 4.4 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.43 -0.794 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 47.08 -159.24 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.53 -0.732 . . . . 0.0 110.724 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -59.67 -44.25 93.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.642 -0.661 . . . . 0.0 110.265 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 128.99 -31.5 3.48 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.08 171.48 11.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -1.21 . . . . 0.0 110.532 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' ASN . . . . . 0.536 ' H ' HG13 ' A' ' 187' ' ' VAL . 3.5 m-80 -131.66 -35.12 1.3 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.317 -0.864 . . . . 0.0 111.188 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.858 ' HA ' HG22 ' A' ' 187' ' ' VAL . 0.8 OUTLIER 63.71 85.45 0.13 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.152 -0.968 . . . . 0.0 110.015 -179.193 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.432 ' C ' ' CD1' ' A' ' 199' ' ' PHE . 9.4 t80 -62.16 118.73 7.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.398 -0.814 . . . . 0.0 110.161 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -113.63 101.5 9.38 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.264 -0.897 . . . . 0.0 110.511 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 157.13 -140.11 6.91 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -107.48 113.47 26.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.309 -1.113 . . . . 0.0 110.102 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.673 HG11 ' HZ ' ' A' ' 144' ' ' PHE . 7.5 p -64.29 110.74 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 110.218 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 70.5 p -143.13 157.14 44.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.167 -0.958 . . . . 0.0 110.376 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.855 ' O ' HD12 ' A' ' 209' ' ' LEU . 12.2 tttt -51.1 -49.59 60.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.322 -0.861 . . . . 0.0 110.397 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -61.13 -34.67 75.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 110.097 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -78.72 -47.69 16.39 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.207 -0.933 . . . . 0.0 110.084 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 155' ' ' PHE . 80.7 mt -52.78 -37.95 60.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.196 -0.94 . . . . 0.0 110.054 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.855 HD12 ' O ' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -71.08 -23.07 62.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.29 -0.881 . . . . 0.0 109.924 179.755 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.66 -45.81 9.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.362 -0.836 . . . . 0.0 109.88 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.421 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 25.6 t80 -49.66 -50.15 44.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.213 -0.929 . . . . 0.0 109.822 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.804 HD13 HD12 ' A' ' 188' ' ' LEU . 23.5 mm -50.72 -73.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.467 -0.771 . . . . 0.0 110.296 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -46.21 -25.87 0.68 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.705 -0.622 . . . . 0.0 111.114 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -76.51 -23.19 53.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 110.568 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.421 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 78.2 m-20 -101.42 -57.62 2.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.182 -0.949 . . . . 0.0 110.866 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 212' ' ' ILE . 2.9 pt20 . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.1 -1.0 . . . . 0.0 110.588 -179.573 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 167' ' ' PHE . . . . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.096 0.474 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.546 HG22 ' HA2' ' A' ' 168' ' ' GLY . 9.9 t -108.49 167.65 9.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.106 -0.996 . . . . 0.0 110.246 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.3 m -110.48 109.25 19.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 110.115 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.9 mt -87.14 126.4 62.93 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.334 -0.853 . . . . 0.0 110.097 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 46.0 Cg_endo -71.73 -22.45 23.89 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.457 1.241 . . . . 0.0 110.462 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.495 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.8 OUTLIER -174.31 -170.64 0.54 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.183 -0.948 . . . . 0.0 110.938 179.885 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.82 -34.79 90.79 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.495 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -51.63 -24.93 6.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -1.159 . . . . 0.0 110.343 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.431 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -90.13 -27.14 19.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.941 . . . . 0.0 110.191 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.17 -18.53 65.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 110.266 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -89.75 -48.7 7.09 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.158 -0.964 . . . . 0.0 109.21 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 32.4 p -63.35 -19.75 64.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.28 -0.888 . . . . 0.0 110.253 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.459 HD22 ' HB1' ' A' ' 139' ' ' ALA . 1.6 tt -73.83 -58.96 2.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.209 -0.932 . . . . 0.0 110.262 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.651 HG13 ' HB3' ' A' ' 189' ' ' PHE . 48.1 t -50.03 -25.34 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.268 -0.895 . . . . 0.0 110.581 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.96 -20.11 23.7 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.253 -0.905 . . . . 0.0 109.846 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.7 m -54.45 -50.67 67.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.162 -0.961 . . . . 0.0 110.362 -179.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.4 p -130.87 -173.52 3.11 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.12 -0.987 . . . . 0.0 110.487 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.01 -45.12 28.39 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.22 -0.925 . . . . 0.0 109.988 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.3 m -115.22 130.07 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.353 -0.842 . . . . 0.0 109.97 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.459 ' HB1' HD22 ' A' ' 132' ' ' LEU . . . -152.76 148.22 26.98 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.123 -0.986 . . . . 0.0 110.015 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.499 ' CG1' ' CD1' ' A' ' 167' ' ' PHE . 7.1 p -130.9 149.97 34.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.104 -0.998 . . . . 0.0 110.437 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.42 ' CG1' HD13 ' A' ' 132' ' ' LEU . 45.7 mt -133.9 124.13 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.424 -0.797 . . . . 0.0 109.682 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -90.74 131.75 10.93 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.587 ' CD2' HG12 ' A' ' 175' ' ' VAL . 22.0 m-85 -103.95 69.69 0.96 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -1.149 . . . . 0.0 109.643 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -94.9 139.02 31.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.145 -0.972 . . . . 0.0 110.769 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -76.2 -27.84 57.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.427 -0.796 . . . . 0.0 110.136 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -126.89 88.46 2.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 0.0 109.908 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 45.1 t -55.55 -21.03 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.449 -0.782 . . . . 0.0 110.36 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -91.79 18.39 7.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -0.897 . . . . 0.0 110.622 -179.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 86.8 p -87.2 -164.64 1.12 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.948 . . . . 0.0 110.169 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.409 ' HA ' ' HG3' ' A' ' 153' ' ' LYS . 28.0 t70 -90.13 -34.09 16.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.348 -0.845 . . . . 0.0 110.141 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 49.3 m -63.81 -31.7 72.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.3 -0.875 . . . . 0.0 110.245 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.55 -28.58 59.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.824 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.409 ' HG3' ' HA ' ' A' ' 150' ' ' ASP . 3.6 mmtt -58.66 -52.0 67.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.418 -0.801 . . . . 0.0 110.184 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' A' ' 204' ' ' THR . 7.0 mm-40 -61.22 -39.73 91.36 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.182 -0.949 . . . . 0.0 110.083 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.475 ' HE1' HG13 ' A' ' 186' ' ' VAL . 5.1 t80 -47.62 -54.9 10.56 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.304 -0.873 . . . . 0.0 110.606 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.411 ' O ' ' HB3' ' A' ' 159' ' ' ALA . 17.2 mt -55.57 -53.35 57.54 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.414 -0.804 . . . . 0.0 110.33 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.419 ' HB3' ' HD2' ' A' ' 205' ' ' LYS . 4.2 mt-30 -49.78 -50.22 45.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.325 -0.859 . . . . 0.0 110.464 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -64.24 -25.03 67.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.18 -0.95 . . . . 0.0 110.052 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.721 ' HB2' ' CD2' ' A' ' 167' ' ' PHE . . . -76.1 -41.06 51.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.309 -0.87 . . . . 0.0 110.324 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -76.02 -9.64 58.78 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.291 -0.88 . . . . 0.0 110.909 -179.69 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -118.0 28.12 8.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.971 -1.081 . . . . 0.0 110.565 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.655 HD13 ' CZ ' ' A' ' 167' ' ' PHE . 5.7 tt -113.44 176.76 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.077 -1.014 . . . . 0.0 110.25 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.48 63.36 0.16 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.896 . . . . 0.0 110.511 -179.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 162' ' ' ILE . 3.7 p-10 40.92 50.91 3.16 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.535 0.683 . . . . 0.0 111.628 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.512 ' CG2' ' HD2' ' A' ' 166' ' ' PRO . 42.7 mm -88.77 149.2 43.33 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.472 -0.767 . . . . 0.0 109.097 179.044 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.512 ' HD2' ' CG2' ' A' ' 165' ' ' ILE . 43.8 Cg_endo -81.43 99.75 1.09 Allowed 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.555 1.292 . . . . 0.0 110.772 -179.063 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.721 ' CD2' ' HB2' ' A' ' 159' ' ' ALA . 3.2 m-85 -92.12 131.05 37.68 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.524 -0.735 . . . . 0.0 110.109 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.546 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -121.61 144.53 16.52 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.979 -1.649 . . . . 0.0 108.979 179.244 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.402 ' O ' HG23 ' A' ' 169' ' ' ILE . 13.5 tt -140.75 135.36 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.268 -1.136 . . . . 0.0 110.86 -179.357 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.502 HG21 HG21 ' A' ' 175' ' ' VAL . 2.1 t -151.82 155.85 39.01 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.999 0.904 . . . . 0.0 110.386 179.189 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.9 t -125.3 4.62 7.76 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -65.72 132.32 48.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.223 -0.923 . . . . 0.0 110.409 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 88.6 p -54.26 -29.04 45.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.163 -0.961 . . . . 0.0 110.047 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -54.49 -35.48 63.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.939 . . . . 0.0 109.867 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.587 HG12 ' CD2' ' A' ' 143' ' ' PHE . 61.4 t -78.71 -25.67 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.409 -0.807 . . . . 0.0 109.728 179.599 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -79.13 -50.1 11.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 109.758 179.638 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 75.1 m -60.68 -19.19 57.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.863 . . . . 0.0 110.116 179.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.437 ' HD3' ' CE1' ' A' ' 179' ' ' TYR . 7.2 tttp -74.43 -51.46 14.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.132 -0.98 . . . . 0.0 109.653 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.437 ' CE1' ' HD3' ' A' ' 178' ' ' LYS . 78.3 m-85 -92.7 -5.34 51.53 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.436 -0.79 . . . . 0.0 110.427 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 56.77 63.61 1.89 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.128 -0.982 . . . . 0.0 111.079 179.457 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.0 mt -102.52 119.53 38.97 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.12 -0.988 . . . . 0.0 109.679 178.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.412 ' O ' ' CG ' ' A' ' 183' ' ' LYS . 5.8 t0 -65.2 -11.78 44.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 110.333 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.412 ' CG ' ' O ' ' A' ' 182' ' ' ASP . 0.5 OUTLIER -156.42 -165.78 1.98 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.175 -0.953 . . . . 0.0 109.545 -179.977 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.422 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 3.9 p30 -62.22 164.17 7.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.062 -1.024 . . . . 0.0 109.44 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -161.4 150.05 19.36 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.231 -179.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.475 HG13 ' HE1' ' A' ' 155' ' ' PHE . 77.3 t -132.09 84.95 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.49 -1.006 . . . . 0.0 109.506 179.58 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 47.6 t -101.31 159.8 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.336 -0.853 . . . . 0.0 110.472 -179.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.435 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 4.3 tt -116.44 155.08 29.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.866 . . . . 0.0 109.374 179.721 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.651 ' HB3' HG13 ' A' ' 133' ' ' VAL . 51.6 m-85 -125.03 127.21 46.62 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.898 -1.126 . . . . 0.0 110.659 -179.051 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.501 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.5 OUTLIER -141.03 166.86 23.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.315 -0.866 . . . . 0.0 110.235 179.751 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -91.21 -22.59 20.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 110.329 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.501 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.9 OUTLIER -91.08 -176.55 4.64 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.362 -0.837 . . . . 0.0 111.069 -179.988 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 48.04 -154.77 0.08 Allowed 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.802 0.81 . . . . 0.0 110.649 -179.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -57.37 -54.52 45.93 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.694 -0.629 . . . . 0.0 110.325 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 133.01 -24.21 3.83 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -139.41 176.34 8.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.208 -1.172 . . . . 0.0 110.548 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 197' ' ' ASN . . . . . 0.449 ' N ' ' ND2' ' A' ' 197' ' ' ASN . 0.7 OUTLIER -145.36 -155.33 0.6 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.389 -0.819 . . . . 0.0 109.786 -179.776 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -171.02 81.77 0.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.377 -0.827 . . . . 0.0 110.083 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -64.97 126.99 29.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.377 -0.827 . . . . 0.0 110.287 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -140.82 124.12 16.67 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.236 -0.915 . . . . 0.0 109.901 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 141.7 -167.62 25.84 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -62.67 109.02 1.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.339 -1.095 . . . . 0.0 110.26 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.456 ' C ' HG23 ' A' ' 204' ' ' THR . 91.7 t -65.88 112.24 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.226 -0.921 . . . . 0.0 110.203 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.456 HG23 ' C ' ' A' ' 203' ' ' VAL . 41.7 p -150.2 152.39 34.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.36 -0.838 . . . . 0.0 110.314 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.453 ' CE ' HD11 ' A' ' 209' ' ' LEU . 3.1 tttt -49.76 -52.67 30.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.3 -0.875 . . . . 0.0 110.487 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -54.34 -32.5 56.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 110.157 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -83.96 -41.46 17.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.27 -0.894 . . . . 0.0 110.044 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.452 ' CD2' HG11 ' A' ' 186' ' ' VAL . 27.4 mt -65.83 -41.79 91.35 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.311 -0.868 . . . . 0.0 110.061 179.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.453 HD11 ' CE ' ' A' ' 205' ' ' LYS . 85.7 mt -69.39 -21.74 63.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 0.0 110.128 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -83.81 -56.38 3.73 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.292 -0.88 . . . . 0.0 110.076 179.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.401 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 20.5 t80 -51.52 -53.02 42.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.237 -0.914 . . . . 0.0 110.146 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.627 HG21 HD11 ' A' ' 162' ' ' ILE . 84.6 mt -52.78 -58.5 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.348 -0.845 . . . . 0.0 110.178 179.753 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.443 ' HA ' ' CG ' ' A' ' 216' ' ' GLN . 14.4 tttt -49.24 -38.74 27.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 110.132 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.27 -22.81 67.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.399 -0.813 . . . . 0.0 109.826 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.401 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 75.7 m-80 -96.77 -42.51 7.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.296 -0.878 . . . . 0.0 110.359 -179.682 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 216' ' ' GLN . . . . . 0.443 ' CG ' ' HA ' ' A' ' 213' ' ' LYS . 2.1 pt20 . . . . . 0 N--CA 1.493 1.675 0 O-C-N 121.2 -0.937 . . . . 0.0 110.205 179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.257 0.551 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.618 HG22 ' HA2' ' A' ' 168' ' ' GLY . 10.1 t -97.85 171.07 8.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.922 . . . . 0.0 110.353 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.3 m -111.68 111.9 23.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.91 . . . . 0.0 110.065 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.9 mt -94.64 130.39 33.51 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.173 -0.954 . . . . 0.0 110.068 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.439 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 43.5 Cg_endo -69.69 -53.09 0.29 Allowed 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.442 1.233 . . . . 0.0 111.015 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.4 ' HB2' ' OD1' ' A' ' 174' ' ' ASP . 1.4 p30 -146.65 -170.45 3.52 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.099 -1.001 . . . . 0.0 111.184 -179.673 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -57.31 -39.91 91.05 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.715 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -49.62 -25.29 2.71 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.268 -1.137 . . . . 0.0 110.714 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.439 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -90.07 -35.31 15.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.138 -0.976 . . . . 0.0 110.067 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.409 ' O ' HG23 ' A' ' 133' ' ' VAL . . . -56.23 -24.68 43.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.359 -0.838 . . . . 0.0 110.177 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -84.53 -54.37 4.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.227 -0.921 . . . . 0.0 110.248 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.7 t -52.65 -26.49 13.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.256 -0.903 . . . . 0.0 110.324 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.1 tp -70.07 -46.04 65.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.291 -0.88 . . . . 0.0 110.398 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.667 HG13 ' HB3' ' A' ' 189' ' ' PHE . 40.5 t -56.88 -38.64 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.267 -0.896 . . . . 0.0 110.583 -179.629 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -85.29 -15.97 41.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.281 -0.887 . . . . 0.0 110.761 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.2 m -56.68 -45.81 81.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.025 -1.047 . . . . 0.0 110.288 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 92.3 p -133.35 -175.59 3.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.342 -0.849 . . . . 0.0 110.215 -179.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.59 -35.22 62.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.318 -0.864 . . . . 0.0 110.249 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 87.6 t -129.33 147.27 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.064 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.42 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -173.76 134.13 0.47 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.244 -0.91 . . . . 0.0 110.048 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 187' ' ' VAL . 9.4 p -120.46 147.33 24.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.097 -1.002 . . . . 0.0 110.371 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.628 HD12 ' CD2' ' A' ' 189' ' ' PHE . 7.4 mt -125.76 113.83 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.361 -0.837 . . . . 0.0 109.912 179.726 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -80.81 120.96 5.28 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.542 ' CE2' HG12 ' A' ' 175' ' ' VAL . 46.5 m-85 -91.22 80.86 5.56 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.193 -1.181 . . . . 0.0 109.753 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -100.06 140.39 34.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.079 -1.013 . . . . 0.0 111.033 -179.317 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.12 -27.83 18.3 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.671 0.748 . . . . 0.0 109.473 179.028 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.26 69.03 1.48 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.024 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.504 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 4.6 p -48.25 -24.0 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.717 -0.614 . . . . 0.0 111.327 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -78.91 3.45 16.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.102 -0.999 . . . . 0.0 110.873 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 94.5 p -85.56 -163.16 0.81 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.843 -1.161 . . . . 0.0 110.23 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.19 -49.65 6.44 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.327 -0.858 . . . . 0.0 110.353 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.21 -28.85 8.23 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.299 -0.876 . . . . 0.0 110.448 -179.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.504 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -88.5 -29.25 20.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.346 -0.846 . . . . 0.0 110.136 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.82 -36.11 78.23 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.215 -0.928 . . . . 0.0 109.639 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -59.26 -49.09 79.19 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.103 -0.998 . . . . 0.0 108.607 178.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -50.96 -47.77 61.13 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.538 -0.726 . . . . 0.0 110.04 178.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.7 mt -47.4 -59.51 3.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.512 -0.743 . . . . 0.0 110.375 179.655 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -58.21 -50.53 73.21 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.424 -0.797 . . . . 0.0 110.057 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -53.82 -43.74 69.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.333 -0.854 . . . . 0.0 109.948 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.95 -24.41 63.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.86 . . . . 0.0 110.074 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -77.76 -40.58 40.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.871 . . . . 0.0 110.303 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.8 -39.9 68.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 0.0 110.334 -179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.449 HG21 ' CE1' ' A' ' 167' ' ' PHE . 0.7 OUTLIER -89.81 144.76 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.296 -0.877 . . . . 0.0 110.262 -179.862 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -132.29 18.6 4.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.215 -0.928 . . . . 0.0 110.394 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.461 ' O ' HD13 ' A' ' 165' ' ' ILE . 6.0 p-10 -125.51 21.36 7.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -0.959 . . . . 0.0 110.266 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.461 HD13 ' O ' ' A' ' 164' ' ' ASP . 45.0 mm -136.43 134.05 19.61 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.172 -0.955 . . . . 0.0 110.175 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.42 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 48.2 Cg_endo -74.67 75.2 3.61 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 O-C-N 123.542 1.285 . . . . 0.0 110.474 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.449 ' CE1' HG21 ' A' ' 162' ' ' ILE . 5.7 m-85 -67.9 134.0 50.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.303 -0.873 . . . . 0.0 110.323 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.618 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -124.72 149.23 16.93 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.54 ' O ' HG23 ' A' ' 169' ' ' ILE . 9.2 tt -148.27 125.03 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.206 -1.173 . . . . 0.0 110.29 -179.82 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.626 ' CG2' HG11 ' A' ' 175' ' ' VAL . 2.3 t -141.5 157.14 45.52 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 122.196 0.998 . . . . 0.0 110.933 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 94.9 p -124.77 3.41 8.17 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.47 178.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 124' ' ' PRO . 64.1 t30 -63.5 127.66 32.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.194 -0.941 . . . . 0.0 110.32 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.27 -32.78 11.47 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.241 -0.912 . . . . 0.0 110.597 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.4 ' OD1' ' HB2' ' A' ' 125' ' ' ASP . 0.8 OUTLIER -54.22 -31.82 54.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.098 -1.001 . . . . 0.0 109.88 179.84 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.626 HG11 ' CG2' ' A' ' 170' ' ' THR . 39.8 t -79.08 -27.02 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 109.692 179.593 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -84.32 -39.81 18.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 109.14 179.328 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 46.5 t -72.89 -4.78 34.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.464 -0.772 . . . . 0.0 110.231 178.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.67 -52.19 5.13 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.067 -1.021 . . . . 0.0 109.171 179.609 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -89.84 4.5 49.65 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.749 -0.595 . . . . 0.0 110.532 179.769 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 53.56 59.99 3.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.078 -1.014 . . . . 0.0 110.451 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 60.0 mt -102.82 102.77 12.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 110.13 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -53.47 -26.76 21.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.194 -0.941 . . . . 0.0 109.992 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -141.54 -175.44 4.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.406 -0.808 . . . . 0.0 109.839 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.409 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 11.8 p-10 -72.25 165.09 25.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.093 -1.004 . . . . 0.0 110.131 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -172.18 160.19 31.57 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 186' ' ' VAL . 34.2 m -123.91 97.25 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -1.18 . . . . 0.0 110.158 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.68 ' O ' HG23 ' A' ' 140' ' ' VAL . 89.1 t -108.81 155.77 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 109.96 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.751 HD22 ' HB3' ' A' ' 215' ' ' ASN . 6.6 tt -107.96 159.47 16.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.023 -1.048 . . . . 0.0 109.709 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.667 ' HB3' HG13 ' A' ' 133' ' ' VAL . 45.0 m-85 -130.11 121.26 26.0 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.901 -1.124 . . . . 0.0 110.349 -179.313 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.432 ' HD3' HD23 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -132.86 164.05 27.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.381 -0.824 . . . . 0.0 110.163 179.876 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -82.63 -26.15 32.48 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.206 -0.933 . . . . 0.0 110.845 -179.624 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.429 ' CD1' ' HG3' ' A' ' 190' ' ' LYS . 1.6 p90 -90.86 -176.81 4.78 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.287 -0.883 . . . . 0.0 110.988 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 47.01 -159.67 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.632 0.729 . . . . 0.0 110.928 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.91 -29.48 60.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.667 -0.646 . . . . 0.0 110.4 -179.731 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.4 ' HA2' ' HG2' ' A' ' 190' ' ' LYS . . . 96.09 -16.92 60.23 Favored Glycine 0 N--CA 1.483 1.822 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.494 ' HG3' ' CE1' ' A' ' 189' ' ' PHE . 4.2 ttp180 -138.34 154.31 48.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.018 -1.283 . . . . 0.0 110.479 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 197' ' ' ASN . . . . . 0.455 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.5 m-80 -125.15 -153.91 0.59 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.312 -0.867 . . . . 0.0 110.038 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.574 ' HA ' HG22 ' A' ' 187' ' ' VAL . 18.1 p30 -178.77 78.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.511 -0.743 . . . . 0.0 109.998 179.61 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -46.21 142.68 2.74 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.367 -0.833 . . . . 0.0 111.062 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 198' ' ' ASN . 6.5 mt-10 -140.94 123.62 16.09 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.299 -0.876 . . . . 0.0 109.819 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 133.38 -121.64 2.89 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -120.04 104.61 10.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.203 -1.174 . . . . 0.0 110.213 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.637 ' O ' HG13 ' A' ' 203' ' ' VAL . 6.5 p -58.84 91.38 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.15 -0.968 . . . . 0.0 110.224 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 66.0 p -126.12 160.1 31.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 110.079 179.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.554 ' O ' HD12 ' A' ' 209' ' ' LEU . 0.2 OUTLIER -49.87 -47.46 51.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 0.0 110.648 -179.956 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -63.25 -41.63 99.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.283 -0.885 . . . . 0.0 110.652 -179.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -79.04 -26.61 43.12 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.159 -0.963 . . . . 0.0 110.474 -179.713 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.59 HD21 HG23 ' A' ' 203' ' ' VAL . 19.1 mt -73.52 -59.25 2.8 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.248 -0.908 . . . . 0.0 110.499 -179.622 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.554 HD12 ' O ' ' A' ' 205' ' ' LYS . 5.5 mt -49.13 -40.16 31.39 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.303 -0.873 . . . . 0.0 110.886 -179.635 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -67.83 -45.14 75.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.12 -0.987 . . . . 0.0 110.451 -179.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.406 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 16.6 t80 -58.57 -54.41 47.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.933 . . . . 0.0 110.8 -179.624 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.503 HD12 HD12 ' A' ' 188' ' ' LEU . 6.4 mm -58.09 -47.96 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.155 -0.966 . . . . 0.0 110.026 -179.624 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.408 ' HA ' ' NE2' ' A' ' 216' ' ' GLN . 0.3 OUTLIER -58.04 -21.92 47.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.507 -0.746 . . . . 0.0 110.429 -179.766 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -90.03 -25.36 20.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.098 -1.001 . . . . 0.0 110.57 -179.716 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.751 ' HB3' HD22 ' A' ' 188' ' ' LEU . 76.1 m-20 -90.61 -39.81 12.29 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.169 -0.957 . . . . 0.0 110.893 -179.361 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 216' ' ' GLN . . . . . 0.408 ' NE2' ' HA ' ' A' ' 213' ' ' LYS . 5.6 pt20 . . . . . 0 N--CA 1.487 1.391 0 O-C-N 121.196 -0.94 . . . . 0.0 110.813 -179.512 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.208 0.528 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.674 HG22 ' HA2' ' A' ' 168' ' ' GLY . 9.9 t -85.8 169.39 13.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 110.249 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.7 m -108.66 104.41 13.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 110.342 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.999 HD21 HD12 ' A' ' 132' ' ' LEU . 67.3 mt -80.65 133.67 55.34 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.192 -0.942 . . . . 0.0 110.048 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.513 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 45.3 Cg_endo -71.23 -35.13 9.01 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.387 1.204 . . . . 0.0 110.556 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.421 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.3 OUTLIER -167.75 -170.76 1.45 Allowed 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.169 0.985 . . . . 0.0 111.487 -179.919 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -58.09 -31.77 65.91 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.421 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -54.63 -28.81 49.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -1.141 . . . . 0.0 110.295 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.653 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -84.08 -35.02 24.03 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.931 . . . . 0.0 110.103 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -53.46 -29.16 34.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 0.0 109.98 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -90.15 -29.98 17.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.426 -0.796 . . . . 0.0 110.22 179.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.56 -35.19 30.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.195 -0.94 . . . . 0.0 110.263 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.999 HD12 HD21 ' A' ' 123' ' ' LEU . 3.2 tt -59.9 -58.26 9.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.316 -0.865 . . . . 0.0 109.739 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 97.9 t -51.98 -24.61 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.45 -0.781 . . . . 0.0 110.212 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -82.38 -21.81 35.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.311 -0.868 . . . . 0.0 110.262 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.8 m -53.14 -58.85 5.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.221 -0.924 . . . . 0.0 110.203 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 82.6 p -121.9 -179.03 4.0 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.288 -0.882 . . . . 0.0 110.296 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -69.56 -39.96 77.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.287 -0.883 . . . . 0.0 110.179 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.6 t -117.94 143.44 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.389 -0.82 . . . . 0.0 110.275 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.456 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -165.95 147.54 6.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.241 -0.912 . . . . 0.0 109.957 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.498 HG11 ' CZ ' ' A' ' 167' ' ' PHE . 7.3 p -127.11 150.09 32.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 O-C-N 121.103 -0.998 . . . . 0.0 110.205 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.433 HD11 ' HB3' ' A' ' 132' ' ' LEU . 75.5 mt -143.48 120.19 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.41 -0.806 . . . . 0.0 109.647 179.599 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.411 ' C ' ' CD1' ' A' ' 143' ' ' PHE . . . -85.89 166.68 39.37 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.507 ' CE2' HG12 ' A' ' 175' ' ' VAL . 26.5 m-85 -129.86 76.56 1.73 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.405 -1.056 . . . . 0.0 109.85 179.833 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.73 ' HZ ' HG21 ' A' ' 203' ' ' VAL . 19.6 m-85 -104.1 145.82 29.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.99 -1.069 . . . . 0.0 111.099 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.26 -27.75 19.26 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.786 0.803 . . . . 0.0 109.464 179.523 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.407 ' HB3' ' HB3' ' A' ' 149' ' ' SER . 0.3 OUTLIER -131.0 73.0 1.52 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.687 -0.633 . . . . 0.0 109.511 179.014 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.522 ' O ' ' HB3' ' A' ' 152' ' ' ALA . 18.4 m -48.36 -24.54 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.262 -0.899 . . . . 0.0 110.869 -179.543 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -83.95 5.53 25.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.063 -1.023 . . . . 0.0 110.844 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.407 ' HB3' ' HB3' ' A' ' 146' ' ' ASP . 33.5 p -75.19 -166.29 0.49 Allowed 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.905 -1.122 . . . . 0.0 110.34 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -90.45 -19.95 23.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.537 -0.727 . . . . 0.0 110.159 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 10.5 t -81.93 -31.62 31.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.163 -0.961 . . . . 0.0 110.078 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 147' ' ' VAL . . . -80.67 -20.05 43.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 110.2 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -61.45 -39.16 89.86 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.221 -0.924 . . . . 0.0 109.751 179.471 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -67.09 -41.18 86.74 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.358 -0.839 . . . . 0.0 109.619 179.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -48.96 -57.09 7.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.397 -0.814 . . . . 0.0 110.607 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 156' ' ' LEU . 52.8 mt -53.87 -54.76 34.07 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.449 -0.782 . . . . 0.0 110.289 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -54.2 -46.67 72.51 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.42 -0.8 . . . . 0.0 110.347 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.09 -45.36 85.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.148 -0.97 . . . . 0.0 110.379 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.82 -31.11 72.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.939 . . . . 0.0 110.435 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -63.69 -29.59 70.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.183 -0.948 . . . . 0.0 110.232 -179.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -57.33 -48.38 79.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.907 . . . . 0.0 110.227 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.401 HG13 ' OD1' ' A' ' 164' ' ' ASP . 8.9 tt -90.85 158.27 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.175 -0.953 . . . . 0.0 110.01 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.11 19.16 1.24 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.033 -1.042 . . . . 0.0 110.609 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.524 ' O ' HD13 ' A' ' 165' ' ' ILE . 5.9 p-10 -116.25 16.3 15.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.141 -0.974 . . . . 0.0 110.495 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.524 HD13 ' O ' ' A' ' 164' ' ' ASP . 49.7 mm -134.41 140.35 35.49 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.126 -0.984 . . . . 0.0 110.11 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.456 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 48.0 Cg_endo -74.77 79.5 2.58 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.618 1.325 . . . . 0.0 110.508 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.498 ' CZ ' HG11 ' A' ' 140' ' ' VAL . 3.6 m-85 -68.79 135.64 51.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.33 -0.856 . . . . 0.0 109.933 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.674 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -131.35 151.99 19.88 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.564 -1.303 . . . . 0.0 109.942 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 169' ' ' ILE . 11.7 tt -150.19 140.34 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -1.105 . . . . 0.0 109.979 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.568 HG21 HG21 ' A' ' 175' ' ' VAL . 2.9 t -153.77 158.05 40.35 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.118 0.961 . . . . 0.0 111.069 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.1 m -119.97 0.97 10.9 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.44 178.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.402 ' ND2' ' HB2' ' A' ' 174' ' ' ASP . 56.2 t30 -60.53 145.97 46.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.138 -0.976 . . . . 0.0 110.174 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 37.8 t -70.41 -30.91 67.91 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.167 -0.958 . . . . 0.0 110.471 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.402 ' HB2' ' ND2' ' A' ' 172' ' ' ASN . 1.2 t70 -54.56 -40.88 69.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.073 -1.017 . . . . 0.0 109.955 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.568 HG21 HG21 ' A' ' 170' ' ' THR . 58.8 t -69.82 -30.69 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 0.0 109.546 179.481 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 176' ' ' PHE . 10.6 m-85 -80.34 -41.17 25.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.445 -0.784 . . . . 0.0 109.751 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.87 -6.34 37.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.416 -0.802 . . . . 0.0 110.551 179.531 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 15.0 tttp -90.03 -45.39 9.2 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.014 -1.054 . . . . 0.0 109.382 179.7 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -91.5 0.78 57.47 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.562 -0.711 . . . . 0.0 110.642 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 53.97 66.47 1.22 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.985 -1.072 . . . . 0.0 110.728 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 55.3 mt -107.97 114.34 28.19 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.236 -0.915 . . . . 0.0 109.945 179.62 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.423 ' O ' ' CG ' ' A' ' 183' ' ' LYS . 45.2 m-20 -61.81 -17.26 55.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.936 . . . . 0.0 110.33 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 182' ' ' ASP . 22.6 mtmt -157.75 -166.39 1.98 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.206 -0.934 . . . . 0.0 110.012 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 3.5 p30 -63.9 162.98 12.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.184 -0.947 . . . . 0.0 110.049 179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -176.32 152.28 12.52 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 70.4 t -118.75 133.97 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.383 -1.069 . . . . 0.0 109.697 179.629 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.739 HG22 ' HA ' ' A' ' 198' ' ' ASN . 77.3 t -141.92 145.06 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.223 -0.923 . . . . 0.0 110.468 -179.738 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.513 HD13 ' CB ' ' A' ' 215' ' ' ASN . 7.1 tt -105.03 146.85 28.51 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -118.81 127.18 53.28 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.722 -1.236 . . . . 0.0 110.834 -178.689 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.509 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -138.47 158.06 44.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.389 -0.819 . . . . 0.0 110.222 179.827 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.1 mmmm -84.3 -21.3 31.06 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.244 -0.91 . . . . 0.0 110.433 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.509 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 1.7 p90 -90.55 -176.23 4.68 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.244 -0.91 . . . . 0.0 110.883 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 46.79 -158.76 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.684 0.754 . . . . 0.0 110.74 -179.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.46 -54.0 49.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.634 -0.666 . . . . 0.0 110.313 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 137.81 -31.11 2.51 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.82 173.88 10.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.172 -1.193 . . . . 0.0 110.156 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 197' ' ' ASN . . . . . 0.451 ' N ' ' ND2' ' A' ' 197' ' ' ASN . 1.3 m-80 -134.14 -40.36 0.83 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.121 -0.987 . . . . 0.0 110.811 -179.181 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.739 ' HA ' HG22 ' A' ' 187' ' ' VAL . 0.6 OUTLIER 63.98 94.23 0.05 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.248 -0.907 . . . . 0.0 110.202 -179.273 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.506 ' HB2' ' CZ ' ' A' ' 211' ' ' PHE . 41.0 t80 -88.96 136.73 32.86 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.338 -0.851 . . . . 0.0 110.201 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.477 ' O ' ' CE1' ' A' ' 199' ' ' PHE . 5.1 mt-10 -121.0 -147.38 0.39 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.209 -0.932 . . . . 0.0 109.678 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 58.15 -128.27 47.14 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.03 130.39 53.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.316 -1.108 . . . . 0.0 110.35 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.73 HG21 ' HZ ' ' A' ' 144' ' ' PHE . 28.2 m -77.49 59.13 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.383 -0.823 . . . . 0.0 110.073 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.403 ' OG1' ' ND2' ' A' ' 207' ' ' ASN . 7.6 p -93.76 156.18 16.82 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.587 -0.695 . . . . 0.0 110.354 -179.826 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.471 ' O ' HD12 ' A' ' 209' ' ' LEU . 9.6 tttt -48.64 -48.24 39.73 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.24 -0.913 . . . . 0.0 110.532 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . 0.423 ' HG3' ' N ' ' A' ' 207' ' ' ASN . 14.2 pt-20 -54.34 -41.15 68.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.941 . . . . 0.0 110.42 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.423 ' N ' ' HG3' ' A' ' 206' ' ' GLU . 79.9 m-20 -83.21 -28.41 29.28 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.287 -0.883 . . . . 0.0 110.149 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 208' ' ' LEU . 19.9 mt -72.16 -48.58 42.36 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.267 -0.896 . . . . 0.0 110.264 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.471 HD12 ' O ' ' A' ' 205' ' ' LYS . 9.1 mt -53.56 -38.92 64.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 109.899 179.719 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -74.17 -49.11 25.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.84 . . . . 0.0 109.925 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.506 ' CZ ' ' HB2' ' A' ' 199' ' ' PHE . 23.8 t80 -47.94 -58.14 4.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 110.79 179.752 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 21.6 mt -52.83 -47.61 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -0.867 . . . . 0.0 110.212 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.55 -41.37 88.78 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.24 -0.912 . . . . 0.0 109.939 179.722 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -62.03 -19.87 63.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.383 -0.823 . . . . 0.0 109.945 179.649 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.513 ' CB ' HD13 ' A' ' 188' ' ' LEU . 2.3 m-80 -89.23 -60.71 1.88 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.253 -0.905 . . . . 0.0 109.553 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 O-C-N 121.395 -0.816 . . . . 0.0 111.18 179.84 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.238 0.542 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.616 HG22 ' HA2' ' A' ' 168' ' ' GLY . 10.1 t -96.31 169.69 9.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.119 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.6 m -109.15 107.89 18.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 110.249 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 24.8 mt -85.43 128.86 57.59 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.361 -0.837 . . . . 0.0 109.98 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.419 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 46.6 Cg_endo -72.05 -43.61 1.12 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.425 1.223 . . . . 0.0 110.431 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.425 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.3 OUTLIER -158.2 -170.42 3.12 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 122.108 0.956 . . . . 0.0 111.242 179.936 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -58.5 -27.97 61.7 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.425 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -54.04 -32.27 53.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -1.129 . . . . 0.0 110.096 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.419 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -87.11 -34.93 18.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 110.016 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.0 -22.75 61.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.349 -0.844 . . . . 0.0 110.033 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -84.69 -57.88 2.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 110.134 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.5 p -61.06 -18.2 56.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.312 -0.867 . . . . 0.0 110.377 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.55 HD23 HD11 ' A' ' 141' ' ' ILE . 17.2 tp -71.05 -49.44 44.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.151 -0.968 . . . . 0.0 109.891 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.619 HG22 ' HB3' ' A' ' 189' ' ' PHE . 59.1 t -64.83 -28.59 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.478 -0.764 . . . . 0.0 110.262 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -90.0 -0.74 57.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.276 -0.89 . . . . 0.0 110.96 -179.836 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 46.9 t -86.44 -23.19 26.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.915 -1.115 . . . . 0.0 110.31 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.401 ' OG ' ' HG3' ' A' ' 166' ' ' PRO . 0.6 OUTLIER -148.44 160.0 43.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.236 -0.915 . . . . 0.0 110.495 -179.94 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.77 -22.85 59.06 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.401 -0.812 . . . . 0.0 109.592 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.8 m -138.43 152.22 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.315 -0.866 . . . . 0.0 110.377 -179.773 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -173.41 134.48 0.52 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 0.0 109.862 179.799 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.89 149.8 23.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 120.994 -1.067 . . . . 0.0 110.271 -179.685 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.55 HD11 HD23 ' A' ' 132' ' ' LEU . 2.8 mp -134.9 117.26 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.342 -0.849 . . . . 0.0 110.139 179.733 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.21 126.12 7.34 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.649 ' CE2' HG12 ' A' ' 175' ' ' VAL . 65.7 m-85 -100.74 78.77 2.0 Allowed 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.102 -1.234 . . . . 0.0 110.206 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -104.52 146.32 29.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.061 -1.024 . . . . 0.0 110.835 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.43 -27.89 21.25 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.575 -0.703 . . . . 0.0 109.827 179.375 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.422 ' HB3' ' HB3' ' A' ' 149' ' ' SER . 0.5 OUTLIER -130.15 74.35 1.59 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.502 -0.749 . . . . 0.0 109.525 179.506 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.596 ' O ' ' HB3' ' A' ' 152' ' ' ALA . 23.5 m -52.82 -21.4 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.367 -0.833 . . . . 0.0 110.846 -179.542 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -82.65 8.41 12.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.125 -0.984 . . . . 0.0 110.838 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.422 ' HB3' ' HB3' ' A' ' 146' ' ' ASP . 7.5 p -84.67 -161.71 0.6 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.869 -1.144 . . . . 0.0 110.37 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -90.74 -21.31 21.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 0.0 110.269 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.36 -37.13 68.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.214 -0.929 . . . . 0.0 110.255 -179.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 147' ' ' VAL . . . -74.04 -26.85 60.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.207 -0.933 . . . . 0.0 109.722 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 149' ' ' SER . 25.1 mmtt -54.05 -49.83 68.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.887 . . . . 0.0 109.858 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -64.42 -39.71 94.36 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.343 -0.848 . . . . 0.0 109.782 179.511 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -52.07 -55.7 19.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.356 -0.84 . . . . 0.0 110.161 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.43 -56.66 16.46 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.382 -0.824 . . . . 0.0 110.169 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -49.38 -57.97 5.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.33 -0.856 . . . . 0.0 110.489 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.582 ' HB2' ' HA ' ' A' ' 205' ' ' LYS . . . -57.72 -36.34 71.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.806 179.652 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.9 -32.63 73.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.993 179.655 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -67.63 -31.77 72.02 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.224 -0.923 . . . . 0.0 110.098 179.683 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.77 -32.54 63.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 109.961 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.464 HG21 ' CG1' ' A' ' 165' ' ' ILE . 58.1 mt -102.76 139.41 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.33 -0.856 . . . . 0.0 110.111 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.81 15.61 8.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.921 . . . . 0.0 110.539 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -119.86 -10.21 9.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.194 -0.941 . . . . 0.0 110.549 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.464 ' CG1' HG21 ' A' ' 162' ' ' ILE . 39.7 mm -101.51 146.06 31.54 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.045 -1.034 . . . . 0.0 110.249 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.45 ' HD2' ' CG2' ' A' ' 165' ' ' ILE . 47.6 Cg_endo -85.53 72.86 4.16 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 O-C-N 123.722 1.38 . . . . 0.0 110.458 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.609 ' HZ ' HD13 ' A' ' 212' ' ' ILE . 5.6 m-85 -65.61 124.69 23.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.303 -0.873 . . . . 0.0 110.19 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.616 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -121.09 153.05 16.68 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 8.1 tt -150.16 137.69 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -1.12 . . . . 0.0 110.159 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.6 HG21 HG11 ' A' ' 175' ' ' VAL . 2.5 t -154.17 156.89 37.99 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.116 0.96 . . . . 0.0 110.884 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 13.7 m -115.09 -2.08 12.87 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.506 178.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -59.19 118.72 6.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.182 -0.949 . . . . 0.0 110.252 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.4 m -50.46 -33.09 19.86 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.153 -0.967 . . . . 0.0 110.458 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.32 -35.81 60.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.208 -0.932 . . . . 0.0 110.076 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.649 HG12 ' CE2' ' A' ' 143' ' ' PHE . 40.6 t -79.25 -24.91 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.338 -0.851 . . . . 0.0 109.734 179.66 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 176' ' ' PHE . 12.2 m-85 -80.97 -45.87 15.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.37 -0.831 . . . . 0.0 109.704 179.75 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 41.4 t -67.74 -22.76 65.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.353 -0.842 . . . . 0.0 110.066 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.5 tttm -52.68 -57.49 9.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.247 -0.908 . . . . 0.0 110.207 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -89.7 13.97 12.9 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.266 -0.896 . . . . 0.0 110.565 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 51.99 61.0 3.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.132 -0.98 . . . . 0.0 110.423 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 68.0 mt -96.85 -26.65 15.02 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.125 -0.984 . . . . 0.0 110.417 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 52.71 21.1 1.76 Allowed 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.896 -0.503 . . . . 0.0 110.684 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.403 ' HD3' ' O ' ' A' ' 184' ' ' ASP . 0.3 OUTLIER -178.6 -163.37 0.06 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.208 -0.932 . . . . 0.0 109.764 179.888 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 4.1 m-20 -90.57 152.6 20.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.12 -0.987 . . . . 0.0 109.838 179.468 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -164.93 149.52 16.29 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.46 -1.352 . . . . 0.0 109.917 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 199' ' ' PHE . 82.3 t -117.55 94.46 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.403 -1.057 . . . . 0.0 109.484 179.561 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 84.9 t -113.71 156.39 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.141 -0.974 . . . . 0.0 110.682 -179.294 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.656 HD13 ' CB ' ' A' ' 215' ' ' ASN . 8.2 tt -108.91 157.73 18.35 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.195 -0.941 . . . . 0.0 109.275 179.674 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.619 ' HB3' HG22 ' A' ' 133' ' ' VAL . 46.7 m-85 -129.9 124.85 34.15 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.924 -1.11 . . . . 0.0 110.733 -179.099 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.33 179.11 6.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.369 -0.832 . . . . 0.0 109.964 179.475 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -95.96 -29.7 14.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.131 -0.98 . . . . 0.0 110.74 -179.36 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.11 -172.01 3.17 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.964 0.888 . . . . 0.0 111.211 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 47.89 -155.42 0.07 Allowed 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.733 0.777 . . . . 0.0 110.654 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.61 -26.12 68.54 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.668 -0.645 . . . . 0.0 110.214 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 100.42 -34.93 5.16 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.63 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.36 172.31 8.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.072 -1.252 . . . . 0.0 110.743 -179.716 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 197' ' ' ASN . . . . . 0.458 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 0.9 OUTLIER -139.45 -148.16 0.25 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.6 -0.688 . . . . 0.0 109.494 -179.44 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -175.54 84.27 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.189 -0.944 . . . . 0.0 110.259 179.397 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 186' ' ' VAL . 83.4 t80 -51.28 119.73 4.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.196 -0.94 . . . . 0.0 110.535 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -117.45 95.98 5.2 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.299 -0.875 . . . . 0.0 110.31 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 156.11 -178.41 32.65 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.8 119.73 16.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -1.15 . . . . 0.0 110.137 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 80.0 t -60.06 108.25 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.195 -0.94 . . . . 0.0 110.137 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.415 ' OG1' ' ND2' ' A' ' 207' ' ' ASN . 10.6 p -147.68 157.67 43.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.365 -0.835 . . . . 0.0 110.11 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.582 ' HA ' ' HB2' ' A' ' 158' ' ' ALA . 27.0 tttt -52.16 -48.15 65.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.282 -0.886 . . . . 0.0 110.587 -179.752 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -63.87 -24.85 67.91 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.184 -0.947 . . . . 0.0 110.483 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.415 ' ND2' ' OG1' ' A' ' 204' ' ' THR . 75.9 m-20 -90.31 -44.65 9.56 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.184 -0.948 . . . . 0.0 110.333 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' A' ' 208' ' ' LEU . 46.4 mt -58.96 -55.83 30.09 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.224 -0.923 . . . . 0.0 110.277 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 205' ' ' LYS . 0.9 OUTLIER -54.74 -23.69 18.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 0.0 110.094 179.899 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -80.81 -57.98 3.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 110.048 179.91 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -54.98 -54.04 48.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.898 . . . . 0.0 109.974 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.609 HD13 ' HZ ' ' A' ' 167' ' ' PHE . 82.0 mt -49.15 -55.64 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.274 -0.891 . . . . 0.0 110.284 179.676 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.06 -30.48 6.37 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.432 -0.792 . . . . 0.0 110.352 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . 0.448 ' CD2' ' N ' ' A' ' 214' ' ' HIS . 29.2 m170 -87.78 -7.12 57.72 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.202 -0.936 . . . . 0.0 110.626 179.765 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.656 ' CB ' HD13 ' A' ' 188' ' ' LEU . 2.1 m-80 -89.31 -70.41 0.66 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.029 -1.044 . . . . 0.0 109.935 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.18 -0.95 . . . . 0.0 109.68 179.607 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.239 0.542 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 167' ' ' PHE . . . -105.22 141.83 36.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 110.239 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.542 HG22 ' HA2' ' A' ' 168' ' ' GLY . 13.2 t -86.26 170.53 12.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.277 -0.889 . . . . 0.0 110.3 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.8 m -104.13 105.03 15.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.105 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.619 ' CD1' HG23 ' A' ' 141' ' ' ILE . 17.8 mt -79.65 129.24 71.99 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.9 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 49.1 Cg_endo -72.85 -44.84 0.56 Allowed 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.421 1.222 . . . . 0.0 110.39 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 127' ' ' ALA . 0.9 OUTLIER -157.44 -169.3 2.85 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.325 -0.86 . . . . 0.0 110.572 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.44 -23.4 60.28 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 125' ' ' ASP . . . -57.24 -29.7 64.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.263 -1.139 . . . . 0.0 110.25 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.446 ' HB2' ' HD2' ' A' ' 124' ' ' PRO . . . -88.26 -31.15 19.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 110.035 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.457 ' HA ' HD13 ' A' ' 141' ' ' ILE . . . -59.3 -30.7 68.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -0.901 . . . . 0.0 110.002 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -87.88 -37.99 16.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.343 -0.848 . . . . 0.0 110.09 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 10.1 p -73.95 -29.65 62.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 110.106 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.549 HD23 ' CG1' ' A' ' 141' ' ' ILE . 15.1 tp -61.9 -55.55 28.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.212 -0.93 . . . . 0.0 110.082 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.596 HG22 ' HB3' ' A' ' 189' ' ' PHE . 55.5 t -55.37 -25.87 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.895 . . . . 0.0 110.155 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -83.33 -29.21 28.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.319 -0.863 . . . . 0.0 110.422 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.5 m -61.05 -31.2 70.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.236 -0.915 . . . . 0.0 110.312 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.401 ' OG ' ' HG3' ' A' ' 166' ' ' PRO . 95.8 p -146.34 159.21 43.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.219 -0.925 . . . . 0.0 110.25 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.937 ' HG3' HG23 ' A' ' 138' ' ' VAL . 12.7 pt-20 -64.38 -40.65 96.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.879 . . . . 0.0 110.155 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.937 HG23 ' HG3' ' A' ' 137' ' ' GLU . 95.1 t -113.24 128.32 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.477 -0.764 . . . . 0.0 110.194 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -158.11 145.31 18.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.859 . . . . 0.0 109.839 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.467 HG11 ' CE2' ' A' ' 167' ' ' PHE . 7.5 p -124.63 151.29 29.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.125 -0.985 . . . . 0.0 110.298 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.619 HG23 ' CD1' ' A' ' 123' ' ' LEU . 66.7 mt -143.11 119.52 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.441 -0.787 . . . . 0.0 109.576 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -90.62 164.95 30.67 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.831 ' CE2' HG12 ' A' ' 175' ' ' VAL . 46.7 m-85 -130.72 69.09 1.46 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.52 -0.988 . . . . 0.0 109.375 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.408 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 11.5 m-85 -89.03 132.63 34.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.139 -0.975 . . . . 0.0 111.379 -178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.3 -28.52 59.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.582 -0.699 . . . . 0.0 110.077 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -127.38 73.87 1.47 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.392 -0.817 . . . . 0.0 109.923 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.485 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 24.0 m -53.21 -21.8 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.348 -0.845 . . . . 0.0 110.611 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.49 13.39 8.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.134 -0.979 . . . . 0.0 110.801 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 85.3 p -98.6 -163.53 1.05 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.04 -1.038 . . . . 0.0 110.131 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.43 -43.67 14.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.114 -0.991 . . . . 0.0 110.293 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 85.6 p -52.74 -27.65 18.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -0.928 . . . . 0.0 110.25 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.485 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -85.48 -35.17 21.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 110.057 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.6 mmmt -54.28 -50.04 68.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 110.216 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -57.74 -38.9 76.16 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.261 -0.899 . . . . 0.0 110.085 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -52.41 -63.24 1.2 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 0.0 110.278 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.4 mt -53.86 -52.13 61.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.346 -0.846 . . . . 0.0 110.205 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.407 ' HB3' ' HD2' ' A' ' 205' ' ' LYS . 36.3 mt-30 -52.01 -50.44 61.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.369 -0.832 . . . . 0.0 110.12 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.714 ' HB2' ' HA ' ' A' ' 205' ' ' LYS . . . -66.15 -29.13 69.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.127 -0.983 . . . . 0.0 109.738 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.12 -34.3 66.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.389 -0.819 . . . . 0.0 109.995 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -57.11 -22.84 42.79 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.296 -0.877 . . . . 0.0 110.125 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.13 -51.47 69.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.896 . . . . 0.0 110.134 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.462 HG21 ' CG1' ' A' ' 165' ' ' ILE . 76.8 mt -100.96 139.76 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.32 -0.862 . . . . 0.0 110.246 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -117.51 -21.87 8.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 0.0 110.47 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -74.17 -11.0 60.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.184 -0.947 . . . . 0.0 110.729 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.462 ' CG1' HG21 ' A' ' 162' ' ' ILE . 49.4 mm -100.02 130.96 25.11 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 120.995 -1.066 . . . . 0.0 110.107 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.401 ' HG3' ' OG ' ' A' ' 136' ' ' SER . 50.3 Cg_endo -75.88 78.38 3.15 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.409 1.216 . . . . 0.0 110.683 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.467 ' CE2' HG11 ' A' ' 140' ' ' VAL . 5.8 m-85 -68.87 138.78 54.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.212 -0.93 . . . . 0.0 109.813 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.542 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -133.02 150.34 19.77 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 14.6 tt -149.67 137.81 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -1.191 . . . . 0.0 110.693 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.665 HG21 HG11 ' A' ' 175' ' ' VAL . 2.6 t -150.88 157.37 42.83 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.092 0.948 . . . . 0.0 110.774 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 79.7 p -118.78 0.78 11.5 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.581 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.48 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 43.3 t30 -53.56 -177.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.216 -0.928 . . . . 0.0 110.136 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 18.3 m -106.8 -35.96 6.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.137 -0.977 . . . . 0.0 110.077 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -57.91 -31.52 66.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -0.914 . . . . 0.0 109.819 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.831 HG12 ' CE2' ' A' ' 143' ' ' PHE . 40.2 t -76.42 -30.03 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.282 -0.886 . . . . 0.0 109.562 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 172' ' ' ASN . 11.4 m-85 -77.33 -57.36 3.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 109.613 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.2 m -53.2 -23.58 8.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.342 -0.849 . . . . 0.0 110.052 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -58.69 -57.91 10.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.873 . . . . 0.0 110.288 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -89.98 17.41 6.87 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.237 -0.914 . . . . 0.0 110.445 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 53.84 65.53 1.49 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.045 -1.035 . . . . 0.0 110.347 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 83.3 mt -108.29 100.79 10.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.316 -0.865 . . . . 0.0 110.194 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.97 -26.12 46.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 109.978 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -144.3 -165.5 2.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.362 -0.837 . . . . 0.0 110.122 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 9.7 p-10 -68.89 163.56 24.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.171 -0.956 . . . . 0.0 110.233 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 175.81 144.75 5.21 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.548 HG23 ' CB ' ' A' ' 199' ' ' PHE . 11.5 m -114.32 128.47 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -1.131 . . . . 0.0 110.283 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 188' ' ' LEU . 94.8 t -132.75 163.3 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.389 -0.819 . . . . 0.0 109.326 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.498 HD23 ' N ' ' A' ' 189' ' ' PHE . 6.6 tt -110.79 161.55 15.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.939 -1.101 . . . . 0.0 109.907 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.596 ' HB3' HG22 ' A' ' 133' ' ' VAL . 52.6 m-85 -128.53 124.85 37.05 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.989 -1.07 . . . . 0.0 110.418 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.426 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -138.14 161.24 37.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.265 -0.897 . . . . 0.0 110.378 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -90.87 -27.89 18.5 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.342 -0.849 . . . . 0.0 110.552 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.426 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.8 OUTLIER -90.75 -176.39 4.68 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.435 -0.79 . . . . 0.0 110.873 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 48.02 -154.52 0.08 Allowed 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.718 0.77 . . . . 0.0 110.587 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.04 -55.6 22.51 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.72 -0.613 . . . . 0.0 110.243 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 121.52 -25.69 6.85 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -134.89 161.56 34.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.268 -1.137 . . . . 0.0 110.203 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . 0.462 ' N ' ' ND2' ' A' ' 197' ' ' ASN . 0.6 OUTLIER -133.34 -153.57 0.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.151 -0.968 . . . . 0.0 109.998 -179.481 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.41 ' HA ' HG22 ' A' ' 187' ' ' VAL . 5.1 p30 -174.57 88.3 0.05 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.446 -0.784 . . . . 0.0 110.217 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.548 ' CB ' HG23 ' A' ' 186' ' ' VAL . 29.3 t80 -60.75 139.97 57.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.334 -0.854 . . . . 0.0 110.398 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.468 ' O ' ' CE1' ' A' ' 199' ' ' PHE . 55.7 mt-10 -130.0 -151.33 0.47 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.141 -0.974 . . . . 0.0 109.679 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 51.34 -146.66 10.96 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.08 158.45 16.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -1.157 . . . . 0.0 110.016 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.445 ' C ' HG23 ' A' ' 204' ' ' THR . 73.2 t -89.13 114.69 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.255 -0.903 . . . . 0.0 110.251 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.445 HG23 ' C ' ' A' ' 203' ' ' VAL . 38.8 p -150.27 147.78 28.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.329 -0.857 . . . . 0.0 110.165 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.714 ' HA ' ' HB2' ' A' ' 158' ' ' ALA . 13.2 tttm -46.78 -50.26 18.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.25 -0.906 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . 0.439 ' HG3' ' N ' ' A' ' 207' ' ' ASN . 17.7 pt-20 -56.77 -39.36 73.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 110.191 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.439 ' N ' ' HG3' ' A' ' 206' ' ' GLU . 54.8 m-20 -72.33 -45.63 59.1 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.315 -0.865 . . . . 0.0 110.165 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.412 HD13 ' HB3' ' A' ' 158' ' ' ALA . 89.7 mt -54.52 -54.54 39.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 110.285 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.69 HD12 ' O ' ' A' ' 205' ' ' LYS . 1.4 mt -52.69 -29.09 24.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 0.0 110.002 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -77.72 -48.18 17.31 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.34 -0.85 . . . . 0.0 109.651 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.428 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 18.3 t80 -52.22 -56.04 17.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.865 . . . . 0.0 109.763 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.462 HD13 HD12 ' A' ' 188' ' ' LEU . 36.9 mm -51.24 -65.4 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.319 -0.863 . . . . 0.0 110.001 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -50.86 -25.31 4.38 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.755 -0.591 . . . . 0.0 110.452 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -89.57 -14.77 34.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.176 -0.952 . . . . 0.0 110.565 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.477 ' CB ' HD13 ' A' ' 188' ' ' LEU . 1.7 m-80 -89.06 -81.99 0.26 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.074 -1.016 . . . . 0.0 110.27 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.49 177.9 0.35 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.157 -0.965 . . . . 0.0 110.164 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 28.9 mt 54.59 100.03 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.391 -0.818 . . . . 0.0 110.314 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.23 -176.75 1.72 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.586 1.308 . . . . 0.0 110.294 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.0 -165.32 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.191 -0.943 . . . . 0.0 109.917 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 8.7 p -149.48 137.85 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 110.241 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 7.2 mt -70.42 78.22 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.205 -0.934 . . . . 0.0 110.202 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -157.99 144.38 17.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.34 -0.85 . . . . 0.0 110.143 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 53.83 -170.12 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.194 -0.941 . . . . 0.0 110.119 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.1 t -154.61 22.44 0.46 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.228 -0.92 . . . . 0.0 110.223 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 52.88 62.0 2.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.258 -0.901 . . . . 0.0 110.269 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -59.54 96.31 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.218 -0.926 . . . . 0.0 110.17 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 72.2 m -140.1 -61.33 0.52 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 110.132 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.224 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.256 0.55 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 167' ' ' PHE . . . -94.15 160.71 14.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.0 110.195 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.451 HG22 ' HA2' ' A' ' 168' ' ' GLY . 7.8 t -99.38 169.95 8.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.124 -0.985 . . . . 0.0 110.318 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 92.8 m -108.18 121.12 44.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.288 -0.882 . . . . 0.0 110.119 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.618 HD22 ' HB1' ' A' ' 128' ' ' ALA . 28.1 mt -100.06 136.49 20.12 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.241 -0.912 . . . . 0.0 110.08 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.88 -51.76 0.14 Allowed 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.509 1.268 . . . . 0.0 110.44 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.653 ' C ' HG22 ' A' ' 175' ' ' VAL . 0.6 OUTLIER -146.08 -170.42 3.48 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.224 -0.922 . . . . 0.0 110.788 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.589 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -58.86 -28.8 63.81 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -51.2 -36.69 42.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.176 -1.191 . . . . 0.0 110.472 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.618 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -83.68 -29.19 27.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.145 -0.972 . . . . 0.0 110.03 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.2 -27.3 68.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.131 -0.98 . . . . 0.0 109.95 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -89.07 -49.74 6.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.893 . . . . 0.0 109.971 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.3 t -58.7 -32.22 68.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.893 . . . . 0.0 110.197 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 27.0 tp -59.91 -52.52 65.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.321 -0.862 . . . . 0.0 110.011 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.487 HG22 ' CB ' ' A' ' 189' ' ' PHE . 47.7 t -58.56 -37.62 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.295 -0.878 . . . . 0.0 110.033 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -74.13 -5.69 43.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.32 -0.862 . . . . 0.0 110.909 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.35 -21.98 25.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.903 -1.123 . . . . 0.0 110.615 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.405 ' OG ' ' HG3' ' A' ' 166' ' ' PRO . 0.7 OUTLIER -150.08 162.24 40.79 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.196 -0.94 . . . . 0.0 110.571 -179.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.06 -17.39 62.01 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.314 -0.866 . . . . 0.0 109.912 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 99.2 t -135.13 139.6 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.976 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.449 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -173.13 146.9 1.51 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 0.0 110.121 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.543 HG11 ' CZ ' ' A' ' 167' ' ' PHE . 7.7 p -129.13 152.74 37.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.089 -1.007 . . . . 0.0 109.919 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.477 ' O ' ' CE1' ' A' ' 143' ' ' PHE . 62.5 mt -139.47 117.68 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.209 -0.932 . . . . 0.0 110.204 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -81.85 139.68 20.2 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.477 ' CE1' ' O ' ' A' ' 141' ' ' ILE . 70.9 m-85 -114.07 79.38 1.25 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.154 -1.204 . . . . 0.0 109.971 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' A' ' 151' ' ' SER . 15.9 m-85 -107.15 148.35 28.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.109 -0.994 . . . . 0.0 110.842 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.32 -28.59 18.65 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.3 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.418 ' HB3' ' HB3' ' A' ' 149' ' ' SER . 0.9 OUTLIER -119.69 82.88 1.95 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -0.837 . . . . 0.0 109.638 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 87.6 t -52.87 -21.93 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.366 -0.833 . . . . 0.0 110.76 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.81 18.39 6.59 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.218 -0.926 . . . . 0.0 110.563 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.418 ' HB3' ' HB3' ' A' ' 146' ' ' ASP . 10.3 p -90.8 -162.84 0.95 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.139 -0.976 . . . . 0.0 110.245 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -90.27 -47.94 7.46 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.267 -0.896 . . . . 0.0 110.489 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.413 ' HB3' ' CE1' ' A' ' 144' ' ' PHE . 62.5 m -52.35 -29.97 26.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.167 -0.958 . . . . 0.0 110.245 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.53 -29.08 41.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 109.975 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 149' ' ' SER . 1.0 OUTLIER -61.1 -54.36 45.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -0.907 . . . . 0.0 109.865 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -58.21 -37.91 75.74 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.309 -0.87 . . . . 0.0 109.864 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.45 ' HE1' HG13 ' A' ' 186' ' ' VAL . 4.8 t80 -50.22 -59.84 3.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.315 -0.866 . . . . 0.0 110.32 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' A' ' 156' ' ' LEU . 17.4 mt -50.44 -50.23 52.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.328 -0.858 . . . . 0.0 110.39 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -52.83 -54.76 29.61 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.392 -0.818 . . . . 0.0 110.113 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.58 -40.94 93.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.051 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.452 ' CB ' ' CD2' ' A' ' 167' ' ' PHE . . . -67.46 -25.67 66.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.307 -0.87 . . . . 0.0 110.158 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -82.94 -31.19 27.82 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.304 -0.873 . . . . 0.0 110.214 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.77 -38.64 64.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 0.0 110.195 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.8 tt -96.37 156.36 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.914 . . . . 0.0 110.339 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -133.93 16.01 3.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.93 . . . . 0.0 110.481 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.483 ' O ' HD13 ' A' ' 165' ' ' ILE . 4.5 p30 -123.68 10.43 9.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.08 -1.013 . . . . 0.0 110.716 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.483 HD13 ' O ' ' A' ' 164' ' ' ASP . 50.0 mm -126.67 136.52 28.85 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.0 -1.062 . . . . 0.0 110.189 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.449 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 49.9 Cg_endo -77.13 91.94 1.15 Allowed 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.499 1.262 . . . . 0.0 110.915 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.543 ' CZ ' HG11 ' A' ' 140' ' ' VAL . 4.1 m-85 -86.66 130.75 34.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.288 -0.882 . . . . 0.0 109.823 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.451 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -133.56 156.06 22.07 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.402 HD12 ' CD2' ' A' ' 155' ' ' PHE . 12.6 tt -150.84 150.78 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.094 -1.239 . . . . 0.0 110.418 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.515 HG21 HG11 ' A' ' 175' ' ' VAL . 2.3 t -157.65 157.78 34.24 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.06 0.933 . . . . 0.0 110.819 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.2 t -120.13 -0.18 10.57 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.389 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.455 ' ND2' ' HB2' ' A' ' 174' ' ' ASP . 23.8 t30 -61.55 129.47 41.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.096 -1.002 . . . . 0.0 110.24 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.6 t -58.83 -29.36 66.85 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.261 -0.9 . . . . 0.0 110.448 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.455 ' HB2' ' ND2' ' A' ' 172' ' ' ASN . 1.0 OUTLIER -56.36 -33.66 65.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.125 -0.984 . . . . 0.0 110.206 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.653 HG22 ' C ' ' A' ' 125' ' ' ASP . 42.3 t -80.03 -25.29 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.913 . . . . 0.0 109.947 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 176' ' ' PHE . 11.9 m-85 -80.39 -53.06 6.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.304 -0.873 . . . . 0.0 109.777 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 14.2 m -54.45 -23.19 15.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.886 . . . . 0.0 109.932 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.71 -50.28 45.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.361 -0.837 . . . . 0.0 110.025 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -89.84 8.21 33.21 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.319 -0.863 . . . . 0.0 110.735 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 52.51 57.94 5.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.991 -1.068 . . . . 0.0 110.4 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 83.7 mt -99.45 100.27 11.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.197 -0.939 . . . . 0.0 110.351 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 3.7 m-20 -54.07 -26.74 28.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.96 . . . . 0.0 110.198 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -146.94 -165.29 2.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.217 -0.927 . . . . 0.0 109.914 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.43 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 2.7 p30 -64.1 162.49 14.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.14 -0.975 . . . . 0.0 109.91 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -170.57 140.3 5.92 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.466 -1.35 . . . . 0.0 110.064 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.45 HG13 ' HE1' ' A' ' 155' ' ' PHE . 53.3 t -109.46 90.32 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.423 -1.045 . . . . 0.0 109.448 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.517 HG13 ' H ' ' A' ' 197' ' ' ASN . 94.0 t -102.55 147.75 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.338 -0.851 . . . . 0.0 110.277 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.552 HD22 ' HB3' ' A' ' 215' ' ' ASN . 7.7 tt -107.46 158.98 16.75 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.292 -0.88 . . . . 0.0 109.306 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.487 ' CB ' HG22 ' A' ' 133' ' ' VAL . 71.2 m-85 -123.86 139.76 53.65 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.995 -1.066 . . . . 0.0 110.707 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.402 ' HG2' ' HA2' ' A' ' 195' ' ' GLY . 0.0 OUTLIER -145.91 166.16 26.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.399 -0.813 . . . . 0.0 109.796 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -84.4 -36.55 22.35 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.138 -0.976 . . . . 0.0 110.409 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.07 -170.98 2.83 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.743 0.782 . . . . 0.0 110.782 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 53.54 -160.58 0.13 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.666 0.746 . . . . 0.0 110.575 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -60.79 -29.59 69.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.668 -0.645 . . . . 0.0 110.241 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.402 ' HA2' ' HG2' ' A' ' 190' ' ' LYS . . . 105.38 -21.87 34.05 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.71 172.84 12.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.083 -1.245 . . . . 0.0 110.616 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . 0.517 ' H ' HG13 ' A' ' 187' ' ' VAL . 1.8 m-80 -134.65 -148.9 0.33 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.585 -0.697 . . . . 0.0 109.48 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -173.73 81.25 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.228 -0.92 . . . . 0.0 110.393 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.431 ' HB3' ' HB ' ' A' ' 186' ' ' VAL . 12.1 t80 -69.64 123.55 21.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.372 -0.83 . . . . 0.0 109.96 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -138.26 122.0 17.55 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.214 -0.929 . . . . 0.0 109.949 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 144.01 -145.2 14.61 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.53 112.92 19.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -1.132 . . . . 0.0 110.333 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.435 ' C ' HG23 ' A' ' 204' ' ' THR . 83.6 t -74.72 109.57 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.103 -0.998 . . . . 0.0 110.03 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.435 HG23 ' C ' ' A' ' 203' ' ' VAL . 71.9 p -147.95 151.67 36.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.315 -0.865 . . . . 0.0 110.47 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 12.5 tttm -46.84 -55.14 8.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.468 -0.77 . . . . 0.0 110.928 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -54.65 -28.14 44.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.357 -0.839 . . . . 0.0 110.479 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 24.8 m-20 -86.18 -44.38 12.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 0.0 110.396 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 80.4 mt -57.28 -55.02 40.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.938 . . . . 0.0 110.695 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 8.0 mp -50.99 -50.32 58.61 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.116 -0.99 . . . . 0.0 110.653 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.01 -37.16 76.26 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.251 -0.906 . . . . 0.0 110.497 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.417 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 8.9 t80 -64.36 -60.46 3.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.145 -0.972 . . . . 0.0 110.472 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 8.9 mt -53.77 -47.37 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.337 -0.852 . . . . 0.0 110.697 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.6 mmtt -50.79 -23.21 2.57 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.235 -0.916 . . . . 0.0 110.863 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -96.69 -16.13 21.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.167 -0.958 . . . . 0.0 110.862 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.552 ' HB3' HD22 ' A' ' 188' ' ' LEU . 77.6 m-20 -94.66 -40.04 10.01 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.108 -0.995 . . . . 0.0 111.33 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -91.09 19.94 5.36 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.897 -1.127 . . . . 0.0 110.662 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 217' ' ' LEU . 14.4 mt -145.53 57.95 4.59 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.146 -0.971 . . . . 0.0 109.949 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.455 ' C ' HD22 ' A' ' 219' ' ' LEU . 45.6 Cg_endo -71.93 150.16 54.58 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.718 1.378 . . . . 0.0 110.215 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.544 HD22 ' N ' ' A' ' 219' ' ' LEU . 4.5 mm? -98.02 118.0 33.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.887 . . . . 0.0 110.228 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 34.0 m -90.55 156.48 3.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.471 -0.768 . . . . 0.0 110.152 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 94.5 mt -118.18 150.37 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.177 -0.952 . . . . 0.0 110.181 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 52.9 89.27 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.287 -0.883 . . . . 0.0 110.361 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -55.39 171.37 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.909 . . . . 0.0 110.251 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.665 HG23 ' HB2' ' A' ' 226' ' ' GLN . 9.9 t -110.94 175.4 5.44 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.253 -0.904 . . . . 0.0 110.23 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.54 61.68 0.36 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.915 . . . . 0.0 110.172 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.665 ' HB2' HG23 ' A' ' 224' ' ' THR . 0.0 OUTLIER -146.17 -55.82 0.28 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.934 . . . . 0.0 110.131 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 6.6 t -150.67 167.74 26.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.293 -0.879 . . . . 0.0 110.188 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.232 -179.942 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.301 0.572 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -103.99 157.79 16.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 110.301 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.593 HG22 ' HA2' ' A' ' 168' ' ' GLY . 9.3 t -74.66 169.23 18.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.288 -0.883 . . . . 0.0 110.093 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.4 m -101.66 121.32 41.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.262 -0.899 . . . . 0.0 110.548 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.3 mt -102.34 118.33 59.12 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.336 -0.853 . . . . 0.0 109.619 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.411 ' O ' ' ND2' ' A' ' 172' ' ' ASN . 46.1 Cg_endo -71.0 -18.34 31.27 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.453 1.239 . . . . 0.0 110.848 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.61 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.0 OUTLIER 179.4 -170.03 0.12 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.088 -1.007 . . . . 0.0 111.466 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.96 -29.43 70.72 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.61 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -53.47 -29.9 38.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -1.12 . . . . 0.0 110.159 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.75 -35.17 15.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.906 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.59 -39.16 79.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.327 -0.858 . . . . 0.0 109.996 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.49 -51.11 12.38 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.249 -0.907 . . . . 0.0 110.253 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.0 m -57.27 -20.46 28.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.35 -0.844 . . . . 0.0 110.408 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.9 tp -79.15 -48.14 14.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 110.381 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.699 HG22 ' CB ' ' A' ' 189' ' ' PHE . 90.9 t -60.02 -31.39 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.142 -0.974 . . . . 0.0 110.38 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -85.79 -23.69 27.12 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.238 -0.913 . . . . 0.0 109.582 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.12 -63.41 1.19 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.143 -0.973 . . . . 0.0 110.12 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.4 p -115.7 -176.63 2.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.927 . . . . 0.0 110.259 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.5 -35.56 58.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.872 . . . . 0.0 110.248 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.5 t -120.86 149.29 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.247 -0.908 . . . . 0.0 110.261 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -175.27 130.45 0.29 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.316 -0.865 . . . . 0.0 109.907 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.529 HG11 ' CZ ' ' A' ' 167' ' ' PHE . 9.6 p -119.13 147.99 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.142 -0.974 . . . . 0.0 110.329 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.2 mt -134.83 113.92 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.342 -0.849 . . . . 0.0 109.945 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -80.98 128.23 8.33 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.665 ' CE2' HG12 ' A' ' 175' ' ' VAL . 32.0 m-85 -94.89 76.57 3.6 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.235 -1.156 . . . . 0.0 109.904 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -96.63 139.21 33.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 110.965 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.39 -26.89 26.16 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.425 -0.797 . . . . 0.0 109.576 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -137.96 78.39 1.68 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.51 -0.744 . . . . 0.0 109.508 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.431 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 27.3 m -50.36 -23.86 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.349 -0.844 . . . . 0.0 110.717 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -84.66 10.59 10.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 110.892 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 11.2 p -88.11 -161.65 0.75 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.963 -1.085 . . . . 0.0 110.187 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.05 -42.81 10.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.262 -0.899 . . . . 0.0 110.344 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.0 m -59.4 -28.66 67.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.158 -0.964 . . . . 0.0 110.355 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.431 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -78.8 -31.26 45.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.309 -0.87 . . . . 0.0 110.174 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -58.94 -25.43 63.48 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.21 -0.931 . . . . 0.0 109.96 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -75.37 -46.31 33.84 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.394 -0.816 . . . . 0.0 110.133 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -49.97 -56.56 10.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 110.476 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 156' ' ' LEU . 64.9 mt -49.36 -52.29 29.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.42 -0.8 . . . . 0.0 110.584 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.414 ' HB3' ' HD2' ' A' ' 205' ' ' LYS . 1.6 mm100 -51.82 -46.49 64.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.422 -0.799 . . . . 0.0 110.36 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.4 -39.81 74.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 110.261 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.25 -27.61 69.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 110.298 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -60.42 -47.44 86.1 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.208 -0.932 . . . . 0.0 110.38 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.76 -35.65 56.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.165 -0.959 . . . . 0.0 110.342 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.7 mm -89.8 112.26 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 109.89 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -114.0 13.9 18.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 110.446 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.583 ' O ' HD13 ' A' ' 165' ' ' ILE . 8.4 p-10 -124.32 17.35 9.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.086 -1.009 . . . . 0.0 110.366 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.583 HD13 ' O ' ' A' ' 164' ' ' ASP . 42.2 mm -128.22 141.03 40.01 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.162 -0.961 . . . . 0.0 110.057 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -75.32 73.68 4.42 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.533 1.281 . . . . 0.0 110.409 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.529 ' CZ ' HG11 ' A' ' 140' ' ' VAL . 2.6 m-85 -66.32 132.67 48.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.23 -0.919 . . . . 0.0 110.09 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.593 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -123.99 154.08 17.59 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 16.9 tt -149.2 138.96 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -1.14 . . . . 0.0 110.283 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.3 t -159.46 157.35 29.96 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.113 0.958 . . . . 0.0 110.753 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.2 t -122.79 2.15 9.43 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.495 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 124' ' ' PRO . 60.8 t30 -57.08 123.77 16.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.135 -0.978 . . . . 0.0 110.277 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 77.2 p -49.65 -33.18 14.86 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.253 -0.905 . . . . 0.0 110.504 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -54.1 -32.61 55.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 109.887 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.665 HG12 ' CE2' ' A' ' 143' ' ' PHE . 41.4 t -78.83 -24.45 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -0.872 . . . . 0.0 109.861 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 176' ' ' PHE . 20.6 m-85 -86.64 -44.91 11.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -0.871 . . . . 0.0 109.891 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 5.6 m -70.83 -7.22 43.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -0.844 . . . . 0.0 110.777 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 45.7 tttp -88.09 -47.49 8.46 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.058 -1.026 . . . . 0.0 109.563 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -90.06 12.19 18.47 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.371 -0.831 . . . . 0.0 110.385 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.93 68.6 0.78 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.054 -1.028 . . . . 0.0 110.483 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 62.2 mt -116.23 103.35 10.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 110.143 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -51.57 -26.14 8.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.27 -0.894 . . . . 0.0 110.226 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -149.93 -169.0 3.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 110.023 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 2.1 p30 -63.43 162.94 11.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.202 -0.936 . . . . 0.0 110.137 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -169.18 166.73 39.93 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 186' ' ' VAL . 21.4 m -135.19 114.68 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.247 -1.149 . . . . 0.0 110.11 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.828 HG22 ' HA ' ' A' ' 198' ' ' ASN . 99.5 t -127.29 153.67 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.924 . . . . 0.0 110.082 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.922 HD22 ' HB3' ' A' ' 215' ' ' ASN . 6.1 tt -109.27 137.96 46.36 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.285 -0.884 . . . . 0.0 108.668 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.699 ' CB ' HG22 ' A' ' 133' ' ' VAL . 62.4 m-85 -111.28 135.87 51.2 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.726 -1.234 . . . . 0.0 111.19 -178.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.535 ' HD2' HD23 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -150.16 159.76 44.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.453 -0.779 . . . . 0.0 109.967 179.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -83.97 -22.18 31.51 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.242 -0.911 . . . . 0.0 110.491 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.518 ' CZ ' ' HA ' ' A' ' 216' ' ' GLN . 2.4 p90 -90.7 -178.91 5.4 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.284 -0.885 . . . . 0.0 110.633 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 48.79 -159.17 0.05 Allowed 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.659 0.742 . . . . 0.0 110.509 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -60.61 -31.05 70.24 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.583 -0.698 . . . . 0.0 110.293 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 114.58 -42.74 1.85 Allowed Glycine 0 N--CA 1.483 1.822 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.09 177.95 5.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.147 -1.208 . . . . 0.0 110.462 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . 0.487 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 2.5 m-80 -134.47 -37.3 0.85 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 0.0 110.55 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.828 ' HA ' HG22 ' A' ' 187' ' ' VAL . 4.0 m-80 57.73 83.29 0.11 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.171 -0.955 . . . . 0.0 109.991 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.494 ' HB3' HG23 ' A' ' 186' ' ' VAL . 84.3 t80 -66.61 115.27 6.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.396 -0.815 . . . . 0.0 110.433 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -115.6 80.16 1.4 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.368 -0.832 . . . . 0.0 110.12 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -169.12 -157.6 11.92 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -79.36 122.47 26.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -1.154 . . . . 0.0 110.305 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.467 ' C ' HG23 ' A' ' 204' ' ' THR . 70.6 t -71.87 101.36 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 110.076 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.467 HG23 ' C ' ' A' ' 203' ' ' VAL . 57.9 p -150.27 152.08 33.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.388 -0.82 . . . . 0.0 110.268 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.426 ' HG2' ' CD1' ' A' ' 209' ' ' LEU . 3.9 tttm -49.49 -48.54 47.82 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.321 -0.862 . . . . 0.0 110.426 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -57.1 -39.81 75.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.342 -0.849 . . . . 0.0 110.283 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -80.03 -48.48 13.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.231 -0.918 . . . . 0.0 110.368 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.542 ' O ' HD12 ' A' ' 212' ' ' ILE . 98.8 mt -54.19 -55.44 27.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.935 . . . . 0.0 110.257 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.426 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 8.2 mt -54.35 -29.88 49.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.283 -0.885 . . . . 0.0 110.221 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -76.42 -45.88 29.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.911 . . . . 0.0 110.065 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 197' ' ' ASN . 6.9 t80 -56.46 -62.79 1.48 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.411 -0.806 . . . . 0.0 110.462 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.542 HD12 ' O ' ' A' ' 208' ' ' LEU . 5.8 mt -52.42 -42.56 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.0 110.593 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.41 ' O ' HD12 ' A' ' 217' ' ' LEU . 12.1 mttp -56.15 -19.74 14.73 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.218 -0.926 . . . . 0.0 110.786 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -110.92 11.64 22.27 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.198 -0.939 . . . . 0.0 110.755 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.922 ' HB3' HD22 ' A' ' 188' ' ' LEU . 1.3 m120 -91.89 -64.41 1.12 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.946 -1.096 . . . . 0.0 110.611 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.518 ' HA ' ' CZ ' ' A' ' 192' ' ' PHE . 5.9 pt20 -53.11 -41.41 64.97 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.289 -0.882 . . . . 0.0 111.002 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 213' ' ' LYS . 3.4 mt -63.84 111.9 6.25 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.165 -0.96 . . . . 0.0 110.53 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -77.39 -168.54 0.6 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 O-C-N 123.454 1.239 . . . . 0.0 110.382 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 3.5 mt -84.75 104.97 15.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.289 -0.882 . . . . 0.0 110.194 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.65 HG22 ' O ' ' A' ' 220' ' ' VAL . 8.3 p -137.3 47.05 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.374 -0.829 . . . . 0.0 110.135 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 47.9 mm -79.25 89.32 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.318 -0.864 . . . . 0.0 110.252 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -136.0 -72.63 0.45 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.888 . . . . 0.0 110.119 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -108.5 -169.4 1.5 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.0 110.05 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 55.9 m -120.26 134.86 55.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.0 110.193 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -101.07 -38.19 8.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.225 -0.922 . . . . 0.0 110.077 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -86.7 97.87 10.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.283 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 18.2 p -75.43 116.94 16.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.185 -0.947 . . . . 0.0 110.15 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.216 179.976 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.282 0.563 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -105.9 176.12 5.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -0.911 . . . . 0.0 110.178 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.558 HG22 ' HA2' ' A' ' 168' ' ' GLY . 8.9 t -97.87 166.89 11.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.182 -0.949 . . . . 0.0 110.15 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.8 m -115.02 103.92 11.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.942 . . . . 0.0 110.346 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.566 HD22 ' HB1' ' A' ' 128' ' ' ALA . 39.3 mt -77.85 126.2 84.43 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.299 -0.876 . . . . 0.0 110.015 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.27 -40.25 2.47 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.418 1.22 . . . . 0.0 110.508 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.541 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.9 OUTLIER -153.82 -170.59 3.62 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.308 -0.87 . . . . 0.0 110.813 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.02 -29.93 72.19 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.541 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -52.15 -30.36 26.29 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.157 -1.202 . . . . 0.0 110.371 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.566 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -89.79 -38.7 13.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.947 . . . . 0.0 110.032 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.53 -25.22 24.5 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.283 -0.885 . . . . 0.0 110.036 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -86.62 -54.49 4.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.353 -0.842 . . . . 0.0 110.115 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.07 -18.31 33.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.912 . . . . 0.0 110.291 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.535 HD21 ' HB2' ' A' ' 166' ' ' PRO . 3.3 tt -73.25 -59.35 2.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 0.0 109.747 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.59 HG22 ' CB ' ' A' ' 189' ' ' PHE . 49.8 t -53.01 -37.21 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.414 -0.803 . . . . 0.0 110.257 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -73.16 -25.58 60.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.274 -0.891 . . . . 0.0 110.313 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.81 -48.82 69.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 110.28 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 78.0 p -135.65 173.86 11.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.224 -0.922 . . . . 0.0 110.338 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.91 -41.22 91.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -0.862 . . . . 0.0 110.309 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 95.7 t -112.97 151.02 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.283 -0.886 . . . . 0.0 110.371 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.526 ' HB1' HD22 ' A' ' 132' ' ' LEU . . . -174.4 137.79 0.52 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.854 . . . . 0.0 109.845 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.484 HG11 ' CZ ' ' A' ' 167' ' ' PHE . 9.1 p -123.38 147.09 27.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.203 -0.936 . . . . 0.0 110.302 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.486 HD12 ' CD1' ' A' ' 189' ' ' PHE . 3.4 mt -135.79 115.82 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.265 -0.897 . . . . 0.0 109.666 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -79.82 134.25 13.39 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.908 ' CE2' HG12 ' A' ' 175' ' ' VAL . 11.5 m-85 -103.48 71.25 1.08 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.181 -1.188 . . . . 0.0 109.615 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.529 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 15.1 m-85 -91.74 137.45 32.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.026 -1.046 . . . . 0.0 110.992 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.483 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -91.19 -31.94 15.98 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 121.614 0.721 . . . . 0.0 109.846 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.566 ' C ' HG23 ' A' ' 147' ' ' VAL . 1.7 t70 -89.5 -41.49 12.01 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.534 0.683 . . . . 0.0 110.166 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.566 HG23 ' C ' ' A' ' 146' ' ' ASP . 2.5 t 72.97 -51.08 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.859 -0.526 . . . . 0.0 110.714 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -90.72 8.87 32.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.093 -1.005 . . . . 0.0 110.551 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 19.8 p -70.34 -164.68 0.09 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.863 -1.148 . . . . 0.0 109.971 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.41 -31.18 16.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.895 . . . . 0.0 110.277 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.5 p -68.49 -25.6 65.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.906 . . . . 0.0 110.123 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.39 -34.01 25.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.9 . . . . 0.0 110.173 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -53.2 -44.77 68.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.355 -0.841 . . . . 0.0 110.4 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -66.89 -36.83 83.17 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.221 -0.925 . . . . 0.0 110.316 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.434 ' O ' ' HB3' ' A' ' 158' ' ' ALA . 4.5 t80 -51.58 -58.22 6.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.392 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.6 mt -50.52 -54.25 23.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.4 -0.813 . . . . 0.0 110.45 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -50.88 -29.93 13.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.258 -0.901 . . . . 0.0 110.342 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 155' ' ' PHE . . . -75.63 -56.47 4.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.338 -0.852 . . . . 0.0 110.006 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.623 ' HB2' ' CD2' ' A' ' 167' ' ' PHE . . . -54.86 -33.58 62.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 110.059 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -66.69 -28.7 68.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.331 -0.856 . . . . 0.0 110.226 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -64.67 -42.88 95.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.285 -0.884 . . . . 0.0 110.231 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.402 HG13 ' OD1' ' A' ' 164' ' ' ASP . 4.1 tt -93.12 164.42 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.254 -0.904 . . . . 0.0 110.209 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 163' ' ' ASP . 17.1 p-10 -145.23 19.2 1.57 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.101 -0.999 . . . . 0.0 110.467 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.402 ' OD1' HG13 ' A' ' 162' ' ' ILE . 5.0 p-10 -125.57 8.82 7.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.196 -0.94 . . . . 0.0 110.652 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 45.8 mm -125.53 137.21 29.46 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.04 -1.037 . . . . 0.0 109.798 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.535 ' HB2' HD21 ' A' ' 132' ' ' LEU . 48.2 Cg_endo -73.69 78.97 2.33 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.568 1.299 . . . . 0.0 110.724 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.623 ' CD2' ' HB2' ' A' ' 159' ' ' ALA . 2.9 m-85 -71.4 125.64 27.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.186 -0.946 . . . . 0.0 109.694 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.558 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -123.33 156.15 17.59 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.134 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 14.7 tt -150.17 142.95 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.459 -1.024 . . . . 0.0 109.912 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.4 t -164.98 157.57 16.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.117 -0.989 . . . . 0.0 110.892 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.4 ' HB3' ' CG2' ' A' ' 147' ' ' VAL . 91.2 p -122.97 3.58 9.38 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.375 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -54.98 122.05 10.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.158 -0.964 . . . . 0.0 110.306 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 83.9 p -51.52 -31.85 25.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.321 -0.862 . . . . 0.0 110.477 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -54.32 -33.8 59.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.142 -0.974 . . . . 0.0 109.809 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.908 HG12 ' CE2' ' A' ' 143' ' ' PHE . 41.0 t -79.78 -24.46 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.44 -0.788 . . . . 0.0 109.642 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 176' ' ' PHE . 10.8 m-85 -79.44 -54.96 5.41 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.441 -0.787 . . . . 0.0 109.907 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 29.9 t -66.53 -14.27 62.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.366 -0.834 . . . . 0.0 110.562 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 11.3 tttt -82.01 -44.94 15.99 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.086 -1.009 . . . . 0.0 110.034 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -90.7 8.08 36.25 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.15 -0.969 . . . . 0.0 110.674 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.69 67.81 0.87 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.05 -1.032 . . . . 0.0 110.676 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.454 HD13 ' CD2' ' A' ' 143' ' ' PHE . 3.4 mt -109.06 124.43 50.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.226 -0.921 . . . . 0.0 110.137 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -62.08 -15.83 47.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.108 -0.995 . . . . 0.0 110.012 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -175.26 -157.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.233 -0.917 . . . . 0.0 109.551 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 8.4 p-10 -71.57 160.45 32.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.087 -1.008 . . . . 0.0 109.945 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -177.33 172.97 45.82 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 74.9 t -126.5 107.54 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.385 -1.068 . . . . 0.0 110.006 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 197' ' ' ASN . 75.0 t -111.57 148.22 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.339 -0.851 . . . . 0.0 109.94 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.805 HD22 ' HB3' ' A' ' 215' ' ' ASN . 6.3 tt -108.16 143.74 36.54 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.008 -1.057 . . . . 0.0 109.421 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.59 ' CB ' HG22 ' A' ' 133' ' ' VAL . 59.9 m-85 -115.62 118.6 33.56 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.017 -1.052 . . . . 0.0 110.874 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.458 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -130.55 164.02 25.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.279 -0.888 . . . . 0.0 109.996 179.513 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -88.86 -24.9 22.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.165 -0.959 . . . . 0.0 110.148 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.458 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 1.6 p90 -91.01 -176.17 4.55 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.46 -0.775 . . . . 0.0 110.741 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 46.22 -159.13 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.605 0.717 . . . . 0.0 110.966 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -50.9 -56.33 12.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.66 -0.65 . . . . 0.0 110.284 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 125.17 -21.71 6.43 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.4 mtm180 -143.63 156.91 44.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.132 -1.216 . . . . 0.0 110.571 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . 0.473 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.1 m-80 -131.46 -167.35 1.84 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.36 -0.837 . . . . 0.0 109.84 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -156.82 80.69 0.94 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.442 -0.787 . . . . 0.0 109.892 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.534 ' CE2' HG22 ' A' ' 203' ' ' VAL . 84.7 t80 -51.3 121.87 6.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.138 -0.976 . . . . 0.0 110.484 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.03 91.72 3.49 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.344 -0.847 . . . . 0.0 110.271 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 165.34 177.41 37.71 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -55.96 107.52 0.36 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.25 -1.147 . . . . 0.0 110.237 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.534 HG22 ' CE2' ' A' ' 199' ' ' PHE . 93.1 t -64.84 113.66 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -0.879 . . . . 0.0 110.071 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 12.5 p -150.33 157.36 42.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.87 . . . . 0.0 110.475 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.469 ' O ' HD12 ' A' ' 209' ' ' LEU . 11.4 tttt -50.09 -52.25 36.26 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.196 -0.94 . . . . 0.0 110.597 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . 0.448 ' HG3' ' N ' ' A' ' 207' ' ' ASN . 12.3 pt-20 -55.91 -40.04 72.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.221 -0.924 . . . . 0.0 110.329 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.448 ' N ' ' HG3' ' A' ' 206' ' ' GLU . 87.6 m-20 -78.12 -48.01 16.93 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.271 -0.893 . . . . 0.0 110.253 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.667 ' O ' HD12 ' A' ' 212' ' ' ILE . 68.2 mt -53.53 -57.99 8.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.221 -0.924 . . . . 0.0 110.346 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 205' ' ' LYS . 0.4 OUTLIER -53.54 -22.83 9.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.293 -0.88 . . . . 0.0 110.467 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -81.76 -49.62 10.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.099 -1.001 . . . . 0.0 110.093 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -58.97 -56.92 16.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.317 -0.864 . . . . 0.0 110.428 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.667 HD12 ' O ' ' A' ' 208' ' ' LEU . 6.9 mt -55.22 -49.03 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.267 -0.896 . . . . 0.0 110.621 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.76 ' O ' HD12 ' A' ' 217' ' ' LEU . 1.8 mtpt -50.33 -27.35 6.04 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.173 -0.954 . . . . 0.0 110.598 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -88.0 -24.67 23.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -0.925 . . . . 0.0 110.412 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.805 ' HB3' HD22 ' A' ' 188' ' ' LEU . 70.8 m-80 -89.58 -33.59 16.65 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.263 -0.898 . . . . 0.0 110.753 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.87 19.78 4.59 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.13 -0.981 . . . . 0.0 110.63 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.76 HD12 ' O ' ' A' ' 213' ' ' LYS . 25.8 mt -140.4 74.52 28.9 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.068 -1.02 . . . . 0.0 110.211 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.17 179.55 4.86 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.619 1.326 . . . . 0.0 110.41 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.2 mp -111.57 118.22 35.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.344 -0.848 . . . . 0.0 110.289 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.697 HG22 HG12 ' A' ' 221' ' ' ILE . 8.5 p -100.0 147.91 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.912 . . . . 0.0 110.035 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.697 HG12 HG22 ' A' ' 220' ' ' VAL . 34.5 mm 52.67 85.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.181 -0.949 . . . . 0.0 110.11 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -162.52 104.33 1.08 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.18 -0.95 . . . . 0.0 110.218 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.02 131.78 45.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 109.978 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.1 p -125.74 98.48 5.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.913 . . . . 0.0 110.369 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -99.0 -69.99 0.74 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.875 . . . . 0.0 110.068 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -116.41 150.15 38.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.188 -0.945 . . . . 0.0 110.205 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 98.9 m -83.97 -30.93 25.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.29 -0.881 . . . . 0.0 110.25 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.252 179.951 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.16 0.505 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -112.39 -171.23 1.81 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 0.0 110.317 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.434 ' HB ' ' HA2' ' A' ' 168' ' ' GLY . 28.6 m -97.53 95.7 7.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 110.172 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 95.9 m -61.34 104.24 0.38 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -0.9 . . . . 0.0 109.88 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.411 ' HB2' ' HB ' ' A' ' 170' ' ' THR . 0.8 OUTLIER -82.98 137.1 43.5 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.124 -0.985 . . . . 0.0 110.169 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.437 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 48.9 Cg_endo -73.33 -39.62 2.0 Allowed 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.532 1.28 . . . . 0.0 110.206 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.46 ' C ' HG22 ' A' ' 175' ' ' VAL . 0.4 OUTLIER -157.06 -169.11 2.84 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.992 0.901 . . . . 0.0 111.085 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.429 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -66.4 -31.7 79.66 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -53.21 -27.14 20.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.233 -1.157 . . . . 0.0 110.119 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.437 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -88.2 -32.75 18.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.87 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.431 ' O ' HG23 ' A' ' 133' ' ' VAL . . . -56.85 -41.54 78.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.349 -0.844 . . . . 0.0 109.946 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.77 -52.79 11.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.331 -0.856 . . . . 0.0 110.086 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.96 -40.31 63.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.333 -0.854 . . . . 0.0 110.099 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.779 HD23 HD11 ' A' ' 141' ' ' ILE . 21.3 tp -53.55 -50.72 64.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.247 -0.908 . . . . 0.0 109.961 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.76 HG22 ' HB3' ' A' ' 189' ' ' PHE . 39.9 t -53.63 -32.71 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.459 -0.775 . . . . 0.0 110.186 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -87.54 -32.11 19.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.186 -0.946 . . . . 0.0 110.377 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 59.7 p -52.0 -46.29 64.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.193 -0.942 . . . . 0.0 110.382 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.2 p -132.29 163.94 27.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.145 -0.972 . . . . 0.0 110.109 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -63.4 -43.66 96.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.902 . . . . 0.0 110.166 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 28.1 m -117.63 147.99 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.215 -0.928 . . . . 0.0 110.422 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -175.27 126.34 0.26 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.364 -0.835 . . . . 0.0 110.031 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.566 HG12 ' HA ' ' A' ' 167' ' ' PHE . 13.7 p -97.91 147.96 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 121.119 -0.988 . . . . 0.0 110.535 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.779 HD11 HD23 ' A' ' 132' ' ' LEU . 44.7 mt -141.43 107.71 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.91 . . . . 0.0 109.734 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -84.36 163.15 38.89 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.562 ' CE2' HG12 ' A' ' 175' ' ' VAL . 26.2 m-85 -126.72 70.42 1.27 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.632 -0.923 . . . . 0.0 109.647 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.5 ' CZ ' HG21 ' A' ' 203' ' ' VAL . 23.9 m-85 -97.21 146.02 25.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 111.071 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.61 -28.22 18.57 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.145 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.89 84.17 1.94 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -0.833 . . . . 0.0 109.94 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.9 t -66.89 -12.45 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.345 -0.847 . . . . 0.0 110.8 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -99.07 4.03 46.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.009 -1.057 . . . . 0.0 110.805 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 38.7 p -85.97 -159.52 0.47 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.824 -1.173 . . . . 0.0 110.27 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -88.82 -35.34 16.66 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.232 -0.918 . . . . 0.0 110.135 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.1 t -54.89 -33.24 61.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.34 -0.85 . . . . 0.0 110.226 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.495 ' O ' HD12 ' A' ' 156' ' ' LEU . . . -82.49 -33.51 28.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.917 . . . . 0.0 110.203 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -53.46 -50.48 65.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.879 . . . . 0.0 110.128 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -57.34 -41.96 81.02 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.369 -0.832 . . . . 0.0 110.124 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.412 ' CD2' HD12 ' A' ' 169' ' ' ILE . 4.2 t80 -52.22 -57.31 10.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 110.1 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.495 HD12 ' O ' ' A' ' 152' ' ' ALA . 0.6 OUTLIER -52.65 -55.13 24.68 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.42 -0.8 . . . . 0.0 110.207 179.569 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -47.64 -48.58 28.7 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.414 -0.804 . . . . 0.0 110.551 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.702 ' HB2' ' HA ' ' A' ' 205' ' ' LYS . . . -64.84 -43.6 92.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 109.766 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.05 -35.28 74.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.372 -0.83 . . . . 0.0 109.862 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -68.16 -29.09 67.89 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.319 -0.863 . . . . 0.0 110.301 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.32 -61.61 2.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.197 -0.939 . . . . 0.0 110.171 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 73.6 mt -89.67 149.28 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.928 . . . . 0.0 109.95 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.47 -31.06 4.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.205 -0.934 . . . . 0.0 110.375 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -68.74 -14.51 63.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.22 -0.925 . . . . 0.0 110.698 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.531 ' CG2' ' CE1' ' A' ' 167' ' ' PHE . 37.1 mm -98.46 123.98 48.31 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.08 -1.013 . . . . 0.0 110.263 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -83.38 107.6 1.44 Allowed 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.471 1.248 . . . . 0.0 110.064 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.566 ' HA ' HG12 ' A' ' 140' ' ' VAL . 0.4 OUTLIER -99.25 154.46 18.15 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.12 -0.988 . . . . 0.0 109.969 -179.489 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.434 ' HA2' ' HB ' ' A' ' 121' ' ' THR . . . -137.71 145.03 16.57 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.52 ' O ' HG23 ' A' ' 169' ' ' ILE . 16.8 tt -143.27 126.31 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.269 -1.136 . . . . 0.0 110.231 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.502 ' CG2' HG11 ' A' ' 175' ' ' VAL . 2.8 t -143.77 157.96 44.01 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.146 0.974 . . . . 0.0 111.131 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.7 t -127.09 5.37 6.46 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.181 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.428 ' ND2' ' HB2' ' A' ' 174' ' ' ASP . 43.4 t30 -62.0 128.32 35.58 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.182 -0.949 . . . . 0.0 110.231 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 9.0 t -52.23 -33.88 43.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.187 -0.946 . . . . 0.0 110.323 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.428 ' HB2' ' ND2' ' A' ' 172' ' ' ASN . 0.3 OUTLIER -54.67 -34.23 61.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.949 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.562 HG12 ' CE2' ' A' ' 143' ' ' PHE . 57.3 t -78.35 -27.19 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.537 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.401 ' N ' ' CD1' ' A' ' 176' ' ' PHE . 12.5 m-85 -81.54 -42.45 20.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.424 -0.798 . . . . 0.0 109.805 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.03 -7.47 46.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.343 -0.848 . . . . 0.0 110.629 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.86 -45.11 9.98 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.901 -1.124 . . . . 0.0 109.304 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -89.59 5.07 47.25 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.742 -0.599 . . . . 0.0 110.555 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.42 ' CG ' ' O ' ' A' ' 180' ' ' GLN . 0.0 OUTLIER 51.81 58.81 5.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.1 -1.0 . . . . 0.0 110.722 179.587 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.4 mt -98.66 130.35 45.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.063 -1.023 . . . . 0.0 109.824 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -87.06 12.22 11.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.1 -1.0 . . . . 0.0 110.295 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 13.8 pttp 179.13 -163.34 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.227 -0.921 . . . . 0.0 109.618 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.411 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 8.2 p-10 -87.47 156.63 19.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.287 -0.883 . . . . 0.0 110.133 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -177.54 152.09 11.58 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.426 HG11 ' CD2' ' A' ' 208' ' ' LEU . 88.2 t -103.65 128.4 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.317 -1.108 . . . . 0.0 110.468 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 83.1 t -134.56 151.48 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.363 -0.836 . . . . 0.0 109.655 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.504 HD22 ' HB3' ' A' ' 215' ' ' ASN . 7.8 tt -113.21 158.67 20.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.996 -1.065 . . . . 0.0 109.915 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.76 ' HB3' HG22 ' A' ' 133' ' ' VAL . 52.6 m-85 -128.67 130.03 46.63 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.078 -1.014 . . . . 0.0 110.459 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.21 166.61 23.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.877 . . . . 0.0 110.069 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.01 -33.73 18.27 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.199 -0.938 . . . . 0.0 110.128 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -90.91 -173.4 3.68 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.443 -0.786 . . . . 0.0 110.647 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 51.95 -159.73 0.11 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.434 -0.792 . . . . 0.0 110.458 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -54.93 -54.17 46.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.634 -0.666 . . . . 0.0 110.271 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 128.65 -38.49 2.04 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.18 165.31 21.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -1.166 . . . . 0.0 110.359 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . 0.463 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.8 m-80 -128.72 -151.31 0.47 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.3 -0.875 . . . . 0.0 109.865 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -174.37 78.37 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.279 -0.888 . . . . 0.0 110.381 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.417 ' CB ' ' O ' ' A' ' 186' ' ' VAL . 28.3 t80 -57.95 118.7 5.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 109.838 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -125.53 38.8 4.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.302 -0.874 . . . . 0.0 110.413 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -128.83 -149.24 6.86 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -90.71 97.38 11.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.149 -1.206 . . . . 0.0 109.928 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.667 ' O ' HG13 ' A' ' 203' ' ' VAL . 7.4 p -51.33 102.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.212 -0.93 . . . . 0.0 110.373 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 26.2 p -140.93 150.59 43.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.357 -0.84 . . . . 0.0 110.323 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.881 ' O ' HD12 ' A' ' 209' ' ' LEU . 3.7 tttp -47.21 -31.31 3.56 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.359 -0.838 . . . . 0.0 110.946 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -79.42 -33.06 42.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.178 -0.951 . . . . 0.0 110.316 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 59.9 m-20 -83.57 -47.06 11.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 110.289 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.667 HD21 HG23 ' A' ' 203' ' ' VAL . 65.6 mt -52.87 -48.65 66.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 110.33 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.881 HD12 ' O ' ' A' ' 205' ' ' LYS . 13.6 mt -59.26 -29.13 67.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 110.095 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.47 -34.42 41.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 0.0 110.144 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.412 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 7.1 t80 -62.88 -62.98 1.35 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.306 -0.871 . . . . 0.0 110.192 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.404 HG22 ' OE1' ' A' ' 216' ' ' GLN . 7.0 mt -51.03 -49.75 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.391 -0.818 . . . . 0.0 110.473 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.523 ' O ' HD12 ' A' ' 217' ' ' LEU . 7.1 mtmt -48.7 -25.08 1.62 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.364 -0.835 . . . . 0.0 110.868 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.75 -14.77 21.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.125 -0.984 . . . . 0.0 110.815 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.504 ' HB3' HD22 ' A' ' 188' ' ' LEU . 73.4 m-80 -102.27 -24.29 13.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.078 -1.014 . . . . 0.0 110.767 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.404 ' OE1' HG22 ' A' ' 212' ' ' ILE . 16.1 pt20 -86.75 5.74 34.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.066 -1.021 . . . . 0.0 110.736 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 213' ' ' LYS . 14.0 mt -126.59 106.92 23.37 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.954 -1.091 . . . . 0.0 110.094 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.56 144.31 44.48 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.594 1.313 . . . . 0.0 110.281 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 18.3 mt -91.93 -167.02 1.68 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.233 -0.917 . . . . 0.0 109.969 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.532 ' O ' HG13 ' A' ' 220' ' ' VAL . 11.3 p -150.14 59.31 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.37 -0.832 . . . . 0.0 110.33 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 15.2 tt -114.79 162.36 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 110.19 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -108.12 141.49 39.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.088 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -106.17 -178.86 3.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.165 -0.959 . . . . 0.0 110.191 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 37.9 p -104.36 81.85 1.86 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.0 110.306 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -96.61 62.73 2.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.341 -0.85 . . . . 0.0 110.087 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 53.94 82.49 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 0.0 110.098 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 19.7 p -56.69 94.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.905 . . . . 0.0 110.265 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.19 179.996 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.252 0.548 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -133.96 -176.56 4.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.271 -0.893 . . . . 0.0 110.366 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.444 ' HB ' ' HA2' ' A' ' 168' ' ' GLY . 3.9 m -119.92 112.69 19.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.348 -0.845 . . . . 0.0 109.729 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 169' ' ' ILE . 53.5 m -68.57 144.04 54.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 110.047 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.607 HD22 ' HB1' ' A' ' 128' ' ' ALA . 20.5 mt -125.3 143.98 46.17 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.0 110.106 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.06 -40.33 2.58 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.705 1.371 . . . . 0.0 110.293 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.534 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.2 OUTLIER -170.5 -169.93 0.87 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.346 -0.846 . . . . 0.0 110.636 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.543 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -54.74 -27.77 44.35 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.534 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -52.88 -31.51 39.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.194 -1.18 . . . . 0.0 110.434 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.607 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -89.77 -37.5 14.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.177 -0.952 . . . . 0.0 109.912 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.591 ' O ' HG23 ' A' ' 133' ' ' VAL . . . -58.0 -33.19 68.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.332 -0.855 . . . . 0.0 110.004 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -74.28 -51.2 15.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.06 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.14 -30.71 71.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.307 -0.871 . . . . 0.0 110.07 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.1 tp -59.74 -48.68 80.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.207 -0.933 . . . . 0.0 109.961 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 129' ' ' ALA . 38.5 t -56.05 -52.13 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 110.07 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -65.59 -20.21 66.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.234 -0.916 . . . . 0.0 110.243 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.2 t -52.49 -51.43 59.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.146 -0.971 . . . . 0.0 110.351 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 53.7 p -137.31 -171.88 3.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.252 -0.905 . . . . 0.0 110.313 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -75.57 -39.74 57.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -0.878 . . . . 0.0 110.169 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 87.1 t -119.43 147.29 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.25 -0.906 . . . . 0.0 110.175 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.423 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -170.89 121.94 0.57 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.201 -0.937 . . . . 0.0 110.203 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.43 ' CG1' ' HA ' ' A' ' 167' ' ' PHE . 14.8 p -104.41 148.78 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.311 -0.868 . . . . 0.0 110.361 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.47 ' O ' ' CE2' ' A' ' 143' ' ' PHE . 51.1 mt -133.79 107.71 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.258 -0.902 . . . . 0.0 109.992 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.49 122.81 6.91 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.47 ' CE2' ' O ' ' A' ' 141' ' ' ILE . 93.0 m-85 -101.63 67.48 1.12 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.273 -1.134 . . . . 0.0 109.961 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -95.48 146.34 24.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.091 -1.006 . . . . 0.0 110.418 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.46 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -91.08 -32.5 15.85 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.586 -0.696 . . . . 0.0 109.585 179.083 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.46 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 88.5 m-20 -122.32 69.7 0.97 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.517 -0.739 . . . . 0.0 109.862 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.502 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 26.4 m -53.8 -21.31 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.206 -0.934 . . . . 0.0 110.51 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -79.74 4.32 16.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.09 -1.006 . . . . 0.0 111.008 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 32.9 p -87.34 -163.72 0.97 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.904 -1.122 . . . . 0.0 110.284 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.87 -40.83 12.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.0 110.103 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.83 -28.99 59.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.187 -0.946 . . . . 0.0 109.807 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.767 ' O ' HD12 ' A' ' 156' ' ' LEU . . . -79.68 -35.26 39.44 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.332 -0.855 . . . . 0.0 109.849 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -51.32 -44.99 62.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.277 -0.89 . . . . 0.0 110.192 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.412 ' OE1' ' HA ' ' A' ' 204' ' ' THR . 21.5 mm-40 -54.7 -47.36 73.78 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.156 -0.965 . . . . 0.0 109.514 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.568 ' HE1' HG13 ' A' ' 186' ' ' VAL . 4.7 t80 -52.48 -56.44 15.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 0.0 109.831 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.767 HD12 ' O ' ' A' ' 152' ' ' ALA . 2.6 mp -51.44 -58.27 6.71 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.362 -0.836 . . . . 0.0 110.095 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -49.61 -41.79 43.12 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.343 -0.848 . . . . 0.0 110.313 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 205' ' ' LYS . . . -74.61 -26.88 60.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.995 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.2 -29.03 42.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 0.0 110.067 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -63.4 -37.82 88.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 110.111 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.97 -29.82 69.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.358 -0.838 . . . . 0.0 109.961 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.571 HG21 ' CE1' ' A' ' 167' ' ' PHE . 18.2 mm -90.1 122.48 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.423 -0.798 . . . . 0.0 109.634 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -123.88 2.07 8.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.243 -0.91 . . . . 0.0 110.727 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -109.36 -19.85 13.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.952 -1.092 . . . . 0.0 110.252 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.468 ' CG2' ' HD2' ' A' ' 166' ' ' PRO . 41.4 mm -91.4 146.1 32.69 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.146 -0.971 . . . . 0.0 110.182 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.468 ' HD2' ' CG2' ' A' ' 165' ' ' ILE . 44.9 Cg_endo -84.25 79.26 2.64 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.807 1.425 . . . . 0.0 110.089 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.571 ' CE1' HG21 ' A' ' 162' ' ' ILE . 3.6 m-85 -71.92 126.94 31.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.406 -0.809 . . . . 0.0 110.589 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.444 ' HA2' ' HB ' ' A' ' 121' ' ' THR . . . -118.69 157.24 15.33 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 122' ' ' THR . 6.3 tt -150.42 141.96 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.255 -1.144 . . . . 0.0 110.618 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.2 t -158.25 155.52 29.07 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.004 0.907 . . . . 0.0 110.463 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.429 ' HB2' ' HA ' ' A' ' 145' ' ' LYS . 78.8 p -127.47 7.83 6.41 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.38 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -67.39 119.84 12.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.073 -1.017 . . . . 0.0 110.383 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.431 ' HA ' ' HB2' ' A' ' 176' ' ' PHE . 10.5 p -49.02 -28.17 3.76 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.211 -0.93 . . . . 0.0 110.535 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -54.8 -41.09 70.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.115 -0.991 . . . . 0.0 109.734 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.543 HG22 ' N ' ' A' ' 126' ' ' GLY . 45.1 t -78.77 -23.68 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.381 -0.824 . . . . 0.0 109.691 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.431 ' HB2' ' HA ' ' A' ' 173' ' ' SER . 9.0 m-85 -72.43 -51.81 18.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.394 -0.816 . . . . 0.0 109.531 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 33.9 t -70.58 -17.06 62.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.482 -0.761 . . . . 0.0 110.366 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 23.9 tttm -73.52 -52.43 13.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.137 -0.977 . . . . 0.0 109.96 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -90.53 22.55 3.4 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.221 -0.924 . . . . 0.0 110.53 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 54.56 56.96 6.19 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.129 -0.982 . . . . 0.0 110.176 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 86.1 mt -113.13 96.63 6.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 110.181 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -63.18 -19.15 64.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.291 -0.881 . . . . 0.0 110.427 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.51 -159.74 1.05 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.194 -0.941 . . . . 0.0 110.152 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 32.1 m-20 -53.52 152.31 5.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.182 -0.949 . . . . 0.0 109.896 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -153.4 136.74 5.44 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.59 -1.29 . . . . 0.0 110.008 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.568 HG13 ' HE1' ' A' ' 155' ' ' PHE . 59.0 t -121.53 84.43 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.367 -1.079 . . . . 0.0 109.479 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.924 HG22 ' HA ' ' A' ' 198' ' ' ASN . 98.2 t -111.55 150.11 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.111 -0.993 . . . . 0.0 110.352 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.597 HD12 HD12 ' A' ' 212' ' ' ILE . 6.0 tt -106.55 150.88 25.7 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.182 -0.949 . . . . 0.0 108.833 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -120.64 116.58 25.6 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.863 -1.148 . . . . 0.0 110.438 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.527 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -124.6 170.62 10.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.0 110.153 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.26 -24.12 19.1 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.316 -0.865 . . . . 0.0 110.339 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.527 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.4 OUTLIER -91.25 -171.71 3.05 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.881 179.666 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 47.23 -154.67 0.06 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.699 0.761 . . . . 0.0 110.502 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.45 -44.45 91.1 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.619 -0.675 . . . . 0.0 110.191 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 131.19 -39.88 1.72 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.409 ' HG2' HG11 ' A' ' 187' ' ' VAL . 2.6 mtm180 -116.65 175.55 5.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.16 -1.2 . . . . 0.0 110.248 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . 0.465 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 2.7 m-80 -134.93 -44.99 0.72 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.271 -0.893 . . . . 0.0 110.952 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.924 ' HA ' HG22 ' A' ' 187' ' ' VAL . 0.9 OUTLIER 65.46 89.04 0.1 Allowed 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.27 -0.894 . . . . 0.0 110.196 -179.251 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' A' ' 186' ' ' VAL . 45.5 t80 -56.62 123.79 16.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.464 -0.772 . . . . 0.0 110.501 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -120.65 101.37 7.69 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.212 -0.93 . . . . 0.0 110.269 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 152.99 -159.32 28.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -81.51 118.66 22.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -1.1 . . . . 0.0 110.357 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 78.2 t -68.07 103.5 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.93 . . . . 0.0 110.056 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.412 ' HA ' ' OE1' ' A' ' 154' ' ' GLN . 14.0 p -138.68 149.03 44.69 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.444 -0.785 . . . . 0.0 109.858 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.508 ' HA ' ' HB2' ' A' ' 158' ' ' ALA . 31.4 tttt -51.05 -39.19 55.37 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.223 -0.923 . . . . 0.0 110.321 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . 0.412 ' CG ' ' N ' ' A' ' 207' ' ' ASN . 11.5 pt-20 -66.11 -40.32 90.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.295 -0.878 . . . . 0.0 110.001 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.412 ' N ' ' CG ' ' A' ' 206' ' ' GLU . 79.3 m-20 -78.33 -30.83 48.38 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.384 -0.822 . . . . 0.0 109.923 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.427 HD13 ' HA ' ' A' ' 155' ' ' PHE . 64.0 mt -65.5 -55.84 15.62 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.459 -0.776 . . . . 0.0 110.272 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.494 HD12 ' O ' ' A' ' 205' ' ' LYS . 5.9 mt -56.03 -25.65 45.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 110.289 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -80.49 -48.58 12.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.324 -0.86 . . . . 0.0 110.029 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.421 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 10.8 t80 -51.55 -57.67 8.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.341 -0.849 . . . . 0.0 110.468 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.597 HD12 HD12 ' A' ' 188' ' ' LEU . 6.9 mm -53.32 -52.37 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.329 -0.857 . . . . 0.0 110.133 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.439 ' HA ' ' HG2' ' A' ' 216' ' ' GLN . 3.7 tmtt? -52.99 -31.51 41.29 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.624 -0.673 . . . . 0.0 110.586 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -77.44 -15.6 59.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.884 . . . . 0.0 110.702 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.483 ' HB3' HD22 ' A' ' 188' ' ' LEU . 74.3 m-20 -105.8 -40.31 5.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.119 -0.988 . . . . 0.0 110.55 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.439 ' HG2' ' HA ' ' A' ' 213' ' ' LYS . 10.2 pt20 -63.38 -25.88 68.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.095 -1.003 . . . . 0.0 110.133 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.6 mt -130.5 76.13 77.98 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.995 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.753 ' O ' HG23 ' A' ' 220' ' ' VAL . 45.8 Cg_endo -72.38 130.53 16.33 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.672 1.354 . . . . 0.0 110.376 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.74 104.07 0.26 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.364 -0.835 . . . . 0.0 109.989 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 218' ' ' PRO . 50.0 t -119.09 120.79 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 0.0 110.358 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 2.0 pt -110.21 -178.22 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.22 -0.925 . . . . 0.0 110.23 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -170.28 165.3 8.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.195 -0.94 . . . . 0.0 110.294 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 1.5 t80 56.53 168.23 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.235 -0.915 . . . . 0.0 110.259 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 68.5 p -109.71 72.36 0.8 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.222 -0.924 . . . . 0.0 110.129 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -152.18 64.03 0.83 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.281 -0.887 . . . . 0.0 110.186 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -60.64 174.86 0.53 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.266 -0.896 . . . . 0.0 110.294 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 6.0 t -143.4 47.06 1.5 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.906 . . . . 0.0 110.226 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.228 -179.949 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.221 0.534 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -113.44 -176.64 2.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.147 -0.97 . . . . 0.0 110.296 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.429 ' HB ' ' HA2' ' A' ' 168' ' ' GLY . 23.8 m -104.91 116.82 32.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.291 -0.88 . . . . 0.0 109.833 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.6 m -78.86 118.49 20.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.302 -0.874 . . . . 0.0 110.221 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.556 HD23 ' HB1' ' A' ' 128' ' ' ALA . 0.9 OUTLIER -101.84 128.8 27.93 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.171 -0.956 . . . . 0.0 110.027 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.494 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 47.7 Cg_endo -73.22 -27.87 13.18 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.447 1.235 . . . . 0.0 110.107 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.535 ' C ' HG22 ' A' ' 175' ' ' VAL . 0.2 OUTLIER -164.93 -170.49 1.97 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.063 0.935 . . . . 0.0 111.077 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.495 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -64.53 -25.93 70.49 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.441 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -58.72 -30.56 67.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.298 -1.119 . . . . 0.0 110.183 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.556 ' HB1' HD23 ' A' ' 123' ' ' LEU . . . -84.45 -20.92 30.98 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.004 -1.06 . . . . 0.0 109.625 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.529 ' HA ' HD13 ' A' ' 141' ' ' ILE . . . -81.36 -23.98 37.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.426 -0.796 . . . . 0.0 110.266 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 127' ' ' ALA . 13.9 pt-20 -84.78 -36.47 21.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.94 . . . . 0.0 110.171 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.57 -32.45 53.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.334 -0.854 . . . . 0.0 110.552 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.451 ' HB3' HD11 ' A' ' 141' ' ' ILE . 6.3 tp -59.05 -52.97 63.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.058 -1.026 . . . . 0.0 110.045 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.745 HG22 ' CB ' ' A' ' 189' ' ' PHE . 87.9 t -55.49 -37.04 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 110.085 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -83.93 -22.04 31.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.391 -0.818 . . . . 0.0 110.192 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.29 -54.34 25.99 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.376 -0.828 . . . . 0.0 110.199 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.9 p -115.77 157.9 23.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -0.91 . . . . 0.0 110.259 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -59.47 -45.75 90.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.169 -0.957 . . . . 0.0 110.196 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.5 t -119.71 123.77 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 110.262 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -152.2 120.24 6.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 109.599 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.49 HG23 ' HA ' ' A' ' 188' ' ' LEU . 11.6 p -98.51 143.05 13.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.093 -1.005 . . . . 0.0 110.664 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.529 HD13 ' HA ' ' A' ' 129' ' ' ALA . 77.2 mt -133.84 115.13 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.463 -0.773 . . . . 0.0 109.446 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -82.97 163.45 41.72 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.132 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.755 ' CE2' HG12 ' A' ' 175' ' ' VAL . 30.3 m-85 -127.7 63.18 1.38 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.723 -0.869 . . . . 0.0 109.421 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.616 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 12.4 m-85 -81.34 133.3 35.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 111.311 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.403 ' HD2' ' HB2' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -78.96 -26.69 43.47 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.729 0.776 . . . . 0.0 109.582 179.451 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.403 ' HB2' ' HD2' ' A' ' 145' ' ' LYS . 0.3 OUTLIER -127.45 98.79 5.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.73 -0.606 . . . . 0.0 109.624 179.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.4 t -63.67 -12.82 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.0 110.903 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -103.01 14.83 31.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.968 -1.083 . . . . 0.0 110.776 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 21.9 p -83.29 -164.89 0.96 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.054 -1.029 . . . . 0.0 110.165 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -90.33 -18.2 25.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 110.317 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.522 ' CB ' ' CE1' ' A' ' 144' ' ' PHE . 6.1 m -83.36 -26.13 30.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 110.326 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.63 -32.75 36.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -0.915 . . . . 0.0 110.089 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.83 -49.85 75.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 109.993 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -57.69 -41.66 82.09 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.37 -0.831 . . . . 0.0 110.278 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -50.68 -55.68 15.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.181 -0.949 . . . . 0.0 110.523 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 16.4 mt -51.01 -55.85 15.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.167 -0.958 . . . . 0.0 110.427 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -53.09 -49.24 66.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.26 -0.9 . . . . 0.0 110.007 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.87 -48.11 80.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 109.977 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.602 ' HB1' ' CD2' ' A' ' 167' ' ' PHE . . . -63.66 -27.09 68.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 110.011 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -75.15 -27.37 59.69 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.367 -0.833 . . . . 0.0 110.297 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.87 -47.84 73.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.902 . . . . 0.0 110.254 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.445 HG23 ' OD1' ' A' ' 164' ' ' ASP . 68.4 mt -98.38 150.25 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -0.899 . . . . 0.0 110.133 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -125.0 -12.57 6.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.253 -0.904 . . . . 0.0 111.105 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.445 ' OD1' HG23 ' A' ' 162' ' ' ILE . 7.9 p-10 -86.99 5.81 35.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.861 -1.149 . . . . 0.0 110.843 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.536 ' CG2' ' CE1' ' A' ' 167' ' ' PHE . 32.6 mm -128.31 126.04 23.47 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.857 -1.152 . . . . 0.0 110.186 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -81.32 110.65 2.27 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.428 1.225 . . . . 0.0 110.585 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.602 ' CD2' ' HB1' ' A' ' 159' ' ' ALA . 1.1 m-85 -102.63 126.49 49.73 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.218 -0.926 . . . . 0.0 109.49 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.429 ' HA2' ' HB ' ' A' ' 121' ' ' THR . . . -106.85 155.52 16.4 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.419 ' O ' HG23 ' A' ' 169' ' ' ILE . 9.5 tt -149.49 133.04 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.374 -1.074 . . . . 0.0 110.378 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.568 HG21 HG11 ' A' ' 175' ' ' VAL . 2.6 t -152.82 157.24 40.47 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 122.003 0.906 . . . . 0.0 110.889 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.6 t -125.51 2.68 7.64 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -64.42 129.21 39.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 0.0 110.3 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.4 m -53.42 -28.06 27.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.301 -0.875 . . . . 0.0 110.225 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -54.89 -39.96 69.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.887 . . . . 0.0 110.024 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.755 HG12 ' CE2' ' A' ' 143' ' ' PHE . 34.0 t -77.15 -24.92 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.81 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -77.54 -49.69 14.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.201 -0.937 . . . . 0.0 109.942 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.88 -34.21 40.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.278 -0.889 . . . . 0.0 110.023 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.408 ' CE ' ' HA3' ' A' ' 126' ' ' GLY . 0.2 OUTLIER -55.34 -55.68 28.71 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.359 -0.838 . . . . 0.0 110.202 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -92.88 6.84 46.28 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.15 -0.969 . . . . 0.0 110.629 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 49.59 65.24 1.46 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.02 -1.05 . . . . 0.0 110.495 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 92.6 mt -101.84 124.33 47.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.263 -0.898 . . . . 0.0 110.282 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.68 0.13 31.64 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.2 -0.937 . . . . 0.0 110.665 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -171.09 -174.67 1.54 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.094 -1.004 . . . . 0.0 109.827 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 21.4 p30 -54.61 156.95 3.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.17 -0.956 . . . . 0.0 110.247 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -172.94 118.78 0.73 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 96.4 t -95.18 128.99 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -1.154 . . . . 0.0 110.152 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.629 HG22 ' HA ' ' A' ' 198' ' ' ASN . 98.7 t -138.06 149.28 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 110.148 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.502 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 9.3 tt -109.75 139.25 45.03 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.105 -0.997 . . . . 0.0 108.437 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.745 ' CB ' HG22 ' A' ' 133' ' ' VAL . 50.7 m-85 -112.66 126.18 55.1 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.768 -1.207 . . . . 0.0 110.866 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.9 166.1 23.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.338 -0.851 . . . . 0.0 110.211 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -89.29 -31.4 17.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.913 . . . . 0.0 110.422 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -90.56 -173.32 3.72 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.443 -0.786 . . . . 0.0 110.729 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 51.93 -159.43 0.11 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.431 -0.793 . . . . 0.0 110.456 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.06 -48.9 78.17 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.633 -0.667 . . . . 0.0 110.238 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 136.58 -58.94 0.65 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 17.6 mtm-85 -108.7 175.21 5.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.183 -1.187 . . . . 0.0 110.329 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . 0.503 ' HB2' ' CZ ' ' A' ' 211' ' ' PHE . 1.8 m-80 -132.49 -34.7 1.18 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.263 -0.898 . . . . 0.0 110.996 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.629 ' HA ' HG22 ' A' ' 187' ' ' VAL . 0.7 OUTLIER 61.89 87.81 0.09 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.162 -0.961 . . . . 0.0 110.021 -179.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.431 ' HA ' ' CE1' ' A' ' 211' ' ' PHE . 28.6 t80 -57.83 124.11 18.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.379 -0.826 . . . . 0.0 110.265 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -118.15 103.37 9.8 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.318 -0.864 . . . . 0.0 110.337 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 147.52 -148.72 20.54 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -97.66 123.74 41.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -1.147 . . . . 0.0 110.129 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.616 HG11 ' HZ ' ' A' ' 144' ' ' PHE . 79.2 t -70.6 113.65 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.182 -0.949 . . . . 0.0 110.261 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.3 p -145.88 152.43 39.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.43 -0.794 . . . . 0.0 109.932 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 20.2 tttm -48.42 -43.5 34.3 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.118 -0.989 . . . . 0.0 110.509 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -64.95 -41.86 95.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.326 -0.859 . . . . 0.0 109.805 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -71.2 -45.55 63.14 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.344 -0.848 . . . . 0.0 109.953 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 208' ' ' LEU . 62.0 mt -53.92 -51.16 64.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.936 . . . . 0.0 109.778 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 69.6 mt -56.58 -31.27 64.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.314 -0.866 . . . . 0.0 109.349 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -76.88 -37.34 55.67 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.428 -0.795 . . . . 0.0 109.524 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.503 ' CZ ' ' HB2' ' A' ' 197' ' ' ASN . 5.9 t80 -54.22 -63.38 1.17 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.397 -0.815 . . . . 0.0 109.893 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 94.8 mt -48.91 -57.64 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.231 -0.918 . . . . 0.0 110.292 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.07 -34.5 56.81 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.331 -0.855 . . . . 0.0 110.243 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -89.64 -7.56 54.43 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.35 -0.844 . . . . 0.0 110.695 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 0.9 OUTLIER -88.48 -79.68 0.3 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.083 -1.011 . . . . 0.0 110.429 -179.325 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -64.97 -174.79 0.16 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.207 -0.933 . . . . 0.0 110.188 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 45.8 mt 52.81 89.76 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 0.0 110.2 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.417 ' HG2' HG23 ' A' ' 220' ' ' VAL . 46.4 Cg_endo -72.56 -173.07 1.05 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.685 1.36 . . . . 0.0 110.567 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 12.8 mt -92.6 72.96 5.08 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.279 -0.888 . . . . 0.0 110.476 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.417 HG23 ' HG2' ' A' ' 218' ' ' PRO . 54.8 t -96.73 74.86 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.858 . . . . 0.0 110.097 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 4.9 mt -88.04 87.7 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 110.279 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -128.43 -150.28 0.44 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 110.144 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.435 ' O ' ' N ' ' A' ' 225' ' ' GLU . 0.1 OUTLIER -73.78 -45.33 52.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.306 -0.871 . . . . 0.0 110.088 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 55.3 m 55.7 -86.17 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.628 -0.67 . . . . 0.0 110.729 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 223' ' ' PHE . 1.2 mt-10 55.7 79.67 0.16 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.943 -1.098 . . . . 0.0 110.068 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 52.92 -178.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.295 -0.878 . . . . 0.0 110.149 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 14.9 m -154.25 -43.51 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 110.061 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.182 179.819 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.291 0.567 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 167' ' ' PHE . . . -85.03 167.56 15.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 110.239 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.538 HG22 ' HA2' ' A' ' 168' ' ' GLY . 8.9 t -101.15 166.15 10.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.161 -0.962 . . . . 0.0 110.442 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.3 m -107.06 105.49 15.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.322 -0.861 . . . . 0.0 110.074 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.423 HD22 ' HB1' ' A' ' 128' ' ' ALA . 32.1 mt -77.67 134.41 65.42 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.213 -0.93 . . . . 0.0 110.096 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.459 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 47.5 Cg_endo -72.85 -32.31 9.22 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 123.52 1.274 . . . . 0.0 110.331 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -168.25 -170.77 1.35 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.255 -0.903 . . . . 0.0 110.805 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.41 ' HA3' ' HD2' ' A' ' 178' ' ' LYS . . . -61.32 -27.95 68.49 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -55.57 -29.24 58.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -1.123 . . . . 0.0 110.382 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.459 ' HB2' ' HD2' ' A' ' 124' ' ' PRO . . . -86.08 -30.86 22.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.146 -0.971 . . . . 0.0 110.178 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.04 -24.36 66.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.041 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -88.59 -38.11 15.13 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.258 -0.901 . . . . 0.0 110.168 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.0 m -72.67 -24.57 61.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.175 -0.953 . . . . 0.0 109.979 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.421 HD13 HD21 ' A' ' 123' ' ' LEU . 2.4 tp -70.44 -47.02 62.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.412 -0.805 . . . . 0.0 110.096 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 69.1 t -62.5 -45.0 99.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.374 -0.829 . . . . 0.0 110.294 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -72.84 -19.69 61.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.938 . . . . 0.0 110.237 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.5 m -72.66 -20.81 61.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.148 -0.97 . . . . 0.0 110.36 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.401 ' OG ' ' HG3' ' A' ' 166' ' ' PRO . 80.0 p -149.42 154.92 39.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.254 -0.904 . . . . 0.0 110.361 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.432 ' HA ' ' HD2' ' A' ' 191' ' ' LYS . 1.6 tt0 -57.44 -35.8 70.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.335 -0.853 . . . . 0.0 110.171 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.7 t -132.03 145.64 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.294 -0.879 . . . . 0.0 110.437 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.457 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -165.56 136.96 3.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.355 -0.841 . . . . 0.0 109.808 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.8 p -116.03 139.84 40.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 O-C-N 121.087 -1.008 . . . . 0.0 110.223 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 27.2 mt -128.4 110.26 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.315 -0.866 . . . . 0.0 109.87 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.55 127.64 8.22 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.491 ' CE2' HG12 ' A' ' 175' ' ' VAL . 50.3 m-85 -95.45 79.5 3.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.285 -1.127 . . . . 0.0 109.849 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.582 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 17.0 m-85 -100.73 141.53 33.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.088 -1.008 . . . . 0.0 111.097 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 21.4 pttt -91.11 -36.41 14.01 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.602 0.715 . . . . 0.0 109.261 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.485 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 0.4 OUTLIER -122.34 70.77 0.99 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.024 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.484 ' HA ' ' HB2' ' A' ' 152' ' ' ALA . 5.0 p -52.22 -20.94 2.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.71 -0.619 . . . . 0.0 111.16 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -76.63 1.33 17.23 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.966 -1.084 . . . . 0.0 110.86 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 51.5 p -86.27 -156.92 0.32 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.879 -1.138 . . . . 0.0 110.381 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -90.45 -46.63 8.23 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.317 -0.864 . . . . 0.0 110.794 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.4 t -46.08 -33.27 3.36 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.38 -0.825 . . . . 0.0 111.065 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 147' ' ' VAL . . . -80.79 -38.1 29.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.136 -0.977 . . . . 0.0 109.837 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.3 -51.3 59.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.0 109.911 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -52.9 -41.44 64.39 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.291 -0.88 . . . . 0.0 110.005 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -53.95 -57.19 11.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.402 -0.811 . . . . 0.0 109.918 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 15.2 mt -53.73 -53.95 44.92 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.502 -0.749 . . . . 0.0 110.365 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -54.52 -33.1 59.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.356 -0.84 . . . . 0.0 110.16 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.436 ' HB2' ' HA ' ' A' ' 205' ' ' LYS . . . -78.14 -35.62 48.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 110.148 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.511 ' HB2' ' CD2' ' A' ' 167' ' ' PHE . . . -72.95 -31.04 64.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.203 -0.936 . . . . 0.0 110.156 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -66.02 -20.97 66.36 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.192 -0.943 . . . . 0.0 110.285 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.479 ' HB3' HD21 ' A' ' 209' ' ' LEU . . . -79.63 -35.98 38.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.216 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.41 HG13 ' OD1' ' A' ' 164' ' ' ASP . 14.8 tt -97.51 154.96 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 110.119 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -142.28 21.92 2.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.184 -0.947 . . . . 0.0 110.493 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.554 ' O ' HD13 ' A' ' 165' ' ' ILE . 6.6 p-10 -120.92 12.91 11.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.182 -0.949 . . . . 0.0 110.629 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.595 HD11 ' OE1' ' A' ' 216' ' ' GLN . 49.7 mm -136.2 134.24 20.01 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.012 . . . . 0.0 110.267 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.457 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 48.8 Cg_endo -74.22 98.62 1.11 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.445 1.234 . . . . 0.0 110.371 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.511 ' CD2' ' HB2' ' A' ' 159' ' ' ALA . 3.3 m-85 -85.94 127.58 34.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 110.316 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.538 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -128.79 154.2 20.05 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.442 HD11 HG23 ' A' ' 147' ' ' VAL . 11.6 tt -150.26 149.93 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.154 -1.204 . . . . 0.0 110.595 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.475 HG21 HG21 ' A' ' 175' ' ' VAL . 2.1 t -161.06 156.99 25.41 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.069 0.938 . . . . 0.0 110.527 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.4 p -124.12 3.98 8.59 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -63.32 131.69 49.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 110.418 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 92.7 p -53.76 -31.46 48.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.211 -0.93 . . . . 0.0 110.189 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -53.48 -32.05 48.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.968 . . . . 0.0 109.848 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.491 HG12 ' CE2' ' A' ' 143' ' ' PHE . 60.0 t -82.61 -25.38 8.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.385 -0.822 . . . . 0.0 109.51 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -76.87 -52.52 9.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.421 -0.799 . . . . 0.0 109.717 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.23 -15.87 58.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.383 -0.823 . . . . 0.0 110.559 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.423 ' HG2' ' CD1' ' A' ' 179' ' ' TYR . 16.4 tttp -79.21 -52.51 8.06 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.04 -1.038 . . . . 0.0 110.09 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.446 ' HB2' ' CD1' ' A' ' 181' ' ' LEU . 81.4 m-85 -92.2 4.51 53.08 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.201 -0.937 . . . . 0.0 110.578 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.26 64.42 1.79 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.055 -1.028 . . . . 0.0 111.025 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.446 ' CD1' ' HB2' ' A' ' 179' ' ' TYR . 4.5 mt -115.6 115.19 26.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.152 -0.967 . . . . 0.0 109.81 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.429 ' O ' ' CG ' ' A' ' 183' ' ' LYS . 0.7 OUTLIER -83.48 7.77 15.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.135 -0.978 . . . . 0.0 110.501 179.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 182' ' ' ASP . 25.2 mttt -162.73 -163.91 0.94 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.065 -1.022 . . . . 0.0 109.658 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.409 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 44.1 m-20 -73.96 147.46 43.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.147 -0.971 . . . . 0.0 109.684 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -157.71 134.64 4.0 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.405 ' HB ' ' HB3' ' A' ' 199' ' ' PHE . 70.9 t -113.68 102.03 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.379 -1.071 . . . . 0.0 109.914 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.758 HG22 ' HA ' ' A' ' 198' ' ' ASN . 98.8 t -110.69 146.28 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.382 -0.823 . . . . 0.0 110.179 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.556 HD12 HD12 ' A' ' 212' ' ' ILE . 9.0 tt -109.91 127.9 55.02 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.158 -0.963 . . . . 0.0 108.53 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 189' ' ' PHE . 30.1 m-85 -100.43 120.43 39.97 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.832 -1.168 . . . . 0.0 111.179 -178.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.512 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -131.91 158.78 40.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.474 -0.766 . . . . 0.0 110.122 179.483 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.432 ' HD2' ' HA ' ' A' ' 137' ' ' GLU . 10.2 mttt -82.81 -24.9 33.15 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.217 -0.927 . . . . 0.0 110.259 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.512 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 1.3 p90 -91.69 -171.82 3.02 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.328 -0.858 . . . . 0.0 110.555 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 50.94 -159.1 0.09 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.616 0.722 . . . . 0.0 110.432 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -65.61 -45.52 82.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.655 -0.653 . . . . 0.0 110.222 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 142.09 -62.94 0.52 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -110.48 171.64 7.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.293 -1.122 . . . . 0.0 110.331 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . 0.484 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 2.7 m-80 -127.71 -34.61 2.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.266 -0.896 . . . . 0.0 110.75 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.758 ' HA ' HG22 ' A' ' 187' ' ' VAL . 0.4 OUTLIER 58.11 83.93 0.11 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.203 -0.936 . . . . 0.0 110.091 -179.494 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.43 ' C ' ' CD1' ' A' ' 199' ' ' PHE . 12.1 t80 -56.78 121.31 9.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.343 -0.848 . . . . 0.0 110.21 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -118.14 100.24 7.4 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.231 -0.918 . . . . 0.0 110.345 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 160.27 -155.95 27.15 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.16 111.6 21.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.294 -1.121 . . . . 0.0 110.074 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.582 HG11 ' HZ ' ' A' ' 144' ' ' PHE . 75.7 t -63.82 109.05 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.938 . . . . 0.0 110.336 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 41.2 p -146.87 152.3 38.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.435 -0.79 . . . . 0.0 110.008 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.516 ' HG2' HD12 ' A' ' 209' ' ' LEU . 1.4 ttpt -46.85 -54.97 8.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.398 -0.814 . . . . 0.0 111.043 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 207' ' ' ASN . 17.0 pt-20 -55.1 -40.79 70.84 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.453 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.445 ' N ' ' HG3' ' A' ' 206' ' ' GLU . 72.8 m-20 -73.82 -49.26 26.04 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.226 -0.921 . . . . 0.0 110.12 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 208' ' ' LEU . 90.5 mt -56.33 -55.0 38.89 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.302 -0.874 . . . . 0.0 110.285 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.516 HD12 ' HG2' ' A' ' 205' ' ' LYS . 15.5 mt -53.29 -24.66 12.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 0.0 110.077 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.99 -43.82 13.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.87 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.422 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 11.9 t80 -56.96 -56.7 18.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.333 -0.854 . . . . 0.0 110.418 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.556 HD12 HD12 ' A' ' 188' ' ' LEU . 8.0 mm -51.6 -39.29 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.24 -0.912 . . . . 0.0 110.091 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -61.86 -41.41 97.8 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.628 -0.67 . . . . 0.0 110.283 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -78.64 -6.64 56.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 110.699 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.435 ' CB ' HD13 ' A' ' 188' ' ' LEU . 2.2 m-80 -89.27 -79.62 0.32 Allowed 'General case' 0 N--CA 1.484 1.265 0 O-C-N 120.914 -1.116 . . . . 0.0 110.583 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.595 ' OE1' HD11 ' A' ' 165' ' ' ILE . 28.6 pt20 -59.02 -171.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 110.36 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 12.5 mt 53.5 64.81 6.35 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.304 -0.873 . . . . 0.0 110.302 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.51 117.79 5.29 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.723 1.38 . . . . 0.0 110.351 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 2.7 mt -129.31 135.19 48.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.309 -0.869 . . . . 0.0 110.296 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 54.4 t -94.78 91.84 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 110.146 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 70.1 mt -103.77 98.15 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.869 . . . . 0.0 110.307 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -142.16 169.95 16.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.184 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -120.35 158.81 26.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.358 -0.839 . . . . 0.0 110.147 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 226' ' ' GLN . 60.8 m -106.35 105.41 15.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.203 -0.936 . . . . 0.0 110.263 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 56.98 -86.14 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.437 -0.79 . . . . 0.0 110.454 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 224' ' ' THR . 1.1 mt-30 -148.8 144.43 26.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.949 -1.095 . . . . 0.0 110.306 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 19.1 m 52.68 78.59 0.13 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 110.322 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.154 179.9 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.252 0.548 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.1 166.56 9.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.876 . . . . 0.0 110.17 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.581 HG22 ' HA2' ' A' ' 168' ' ' GLY . 10.0 t -94.21 164.78 12.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.241 -0.912 . . . . 0.0 110.166 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.2 m -104.63 106.43 16.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.237 -0.915 . . . . 0.0 110.108 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.758 HD21 HD12 ' A' ' 132' ' ' LEU . 26.4 mt -73.16 124.28 90.44 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.197 -0.939 . . . . 0.0 110.104 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -70.75 -22.61 27.32 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 123.393 1.207 . . . . 0.0 110.343 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.71 -171.13 0.17 Allowed 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 122.239 1.019 . . . . 0.0 111.479 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.23 -31.88 74.84 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -52.3 -31.85 34.84 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.336 -1.096 . . . . 0.0 110.299 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.39 -38.02 22.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.901 . . . . 0.0 110.227 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -52.14 -32.69 36.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.228 -0.92 . . . . 0.0 110.094 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -90.24 -46.66 8.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.357 -0.84 . . . . 0.0 110.016 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 10.1 t -64.19 -27.05 68.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.279 -0.888 . . . . 0.0 110.151 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.758 HD12 HD21 ' A' ' 123' ' ' LEU . 6.6 tt -70.53 -60.32 2.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.281 -0.887 . . . . 0.0 109.507 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.507 HG22 ' CB ' ' A' ' 189' ' ' PHE . 87.8 t -49.34 -27.67 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.553 -0.717 . . . . 0.0 110.355 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.15 7.19 25.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.279 -0.888 . . . . 0.0 110.726 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.2 t -90.29 -27.86 19.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.968 -1.083 . . . . 0.0 110.23 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.7 p -147.75 167.09 25.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 110.174 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -67.48 -12.17 59.65 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.216 -0.927 . . . . 0.0 110.136 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.9 t -137.84 150.69 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.066 -1.021 . . . . 0.0 110.063 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.47 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -174.42 142.05 0.74 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.959 . . . . 0.0 110.246 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.424 HG11 ' CZ ' ' A' ' 167' ' ' PHE . 7.2 p -129.7 148.18 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 121.108 -0.995 . . . . 0.0 110.188 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 2.9 mp -137.27 113.54 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -0.872 . . . . 0.0 110.181 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -80.91 131.69 10.63 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.817 ' CE2' HG12 ' A' ' 175' ' ' VAL . 35.1 m-85 -101.95 76.29 1.6 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -1.162 . . . . 0.0 110.091 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.636 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 18.6 m-85 -94.28 144.38 25.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.128 -0.983 . . . . 0.0 110.75 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.04 -26.94 20.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.611 -0.681 . . . . 0.0 109.412 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -134.1 76.3 1.64 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.672 -0.642 . . . . 0.0 109.306 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.556 ' O ' ' HB3' ' A' ' 152' ' ' ALA . 34.7 m -49.05 -23.64 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.377 -0.827 . . . . 0.0 111.042 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -80.02 4.88 15.66 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.048 -1.032 . . . . 0.0 111.175 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.2 p -78.93 -165.25 0.71 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.874 -1.142 . . . . 0.0 110.534 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.02 -23.49 20.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.558 -0.713 . . . . 0.0 110.238 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.5 m -80.27 -19.81 45.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.294 -0.879 . . . . 0.0 110.554 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 147' ' ' VAL . . . -84.34 -32.56 24.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.134 -0.979 . . . . 0.0 110.3 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.2 mtpt -58.89 -38.07 78.03 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 110.183 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.42 -47.48 81.78 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.207 -0.933 . . . . 0.0 110.065 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.435 ' O ' ' HB3' ' A' ' 158' ' ' ALA . 4.5 t80 -52.72 -54.69 30.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.315 -0.865 . . . . 0.0 110.103 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' A' ' 156' ' ' LEU . 22.1 mt -49.13 -55.04 13.55 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.308 -0.87 . . . . 0.0 110.378 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -54.22 -37.62 64.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.316 -0.865 . . . . 0.0 109.674 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 155' ' ' PHE . . . -65.85 -52.77 47.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.356 -0.84 . . . . 0.0 109.536 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.521 ' HB2' ' CD2' ' A' ' 167' ' ' PHE . . . -55.44 -35.21 65.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.288 -0.882 . . . . 0.0 109.602 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.58 -30.3 71.01 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.283 -0.886 . . . . 0.0 109.858 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.16 -48.97 79.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.356 -0.84 . . . . 0.0 109.801 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.434 HG22 ' H ' ' A' ' 164' ' ' ASP . 63.2 mt -95.42 149.52 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.338 -0.851 . . . . 0.0 109.882 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -126.69 8.98 6.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.178 -0.951 . . . . 0.0 110.819 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.434 ' H ' HG22 ' A' ' 162' ' ' ILE . 4.1 p30 -110.6 -17.25 13.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.967 -1.083 . . . . 0.0 110.339 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 51.0 mm -91.43 133.44 31.35 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.935 . . . . 0.0 110.185 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.507 ' HB2' HD21 ' A' ' 132' ' ' LEU . 50.6 Cg_endo -73.63 69.63 4.33 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.576 1.303 . . . . 0.0 110.253 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.521 ' CD2' ' HB2' ' A' ' 159' ' ' ALA . 3.3 m-85 -63.7 123.03 17.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.886 . . . . 0.0 109.932 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.581 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -125.19 151.07 17.38 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -141.83 148.18 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -1.146 . . . . 0.0 110.297 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.496 HG21 HG11 ' A' ' 175' ' ' VAL . 2.6 t -164.85 157.81 16.7 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.073 0.939 . . . . 0.0 110.913 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.7 t -123.39 2.31 9.06 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.394 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -60.92 120.79 10.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.121 -0.987 . . . . 0.0 110.171 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 3.0 p -51.29 -29.4 14.72 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -0.902 . . . . 0.0 110.35 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.22 -43.47 78.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 109.877 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.817 HG12 ' CE2' ' A' ' 143' ' ' PHE . 46.2 t -72.35 -26.31 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.239 -0.913 . . . . 0.0 109.832 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -75.46 -55.49 5.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.37 -0.831 . . . . 0.0 110.036 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -21.37 60.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.465 -0.772 . . . . 0.0 110.435 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.36 -56.06 26.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -0.972 . . . . 0.0 110.341 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -89.76 13.64 13.84 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.171 -0.956 . . . . 0.0 110.598 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 51.95 63.83 2.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 110.625 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 14.7 mt -96.06 124.27 40.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.412 -0.805 . . . . 0.0 109.911 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -61.29 -16.1 42.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.144 -0.973 . . . . 0.0 110.219 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -175.29 -142.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.569 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -86.71 159.81 19.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.995 -1.065 . . . . 0.0 110.365 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 176.76 179.74 47.33 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 186' ' ' VAL . 21.5 m -133.74 120.28 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -1.148 . . . . 0.0 110.297 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 188' ' ' LEU . 86.2 t -123.09 162.89 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.412 -0.805 . . . . 0.0 109.863 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.554 HD22 ' HB3' ' A' ' 215' ' ' ASN . 1.7 tt -113.36 148.79 35.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.078 -1.013 . . . . 0.0 109.761 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.507 ' CB ' HG22 ' A' ' 133' ' ' VAL . 40.0 m-85 -123.44 117.4 25.07 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.064 -1.022 . . . . 0.0 110.411 -179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.511 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -134.52 165.86 24.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.311 -0.868 . . . . 0.0 110.16 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -88.67 -22.71 23.28 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.0 110.373 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.511 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 1.4 p90 -90.87 -172.32 3.32 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.243 -0.911 . . . . 0.0 110.928 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 47.22 -159.46 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.663 0.744 . . . . 0.0 110.728 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -55.0 -53.62 53.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.641 -0.662 . . . . 0.0 110.321 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 139.5 -49.2 0.82 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.68 172.83 8.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.252 -1.146 . . . . 0.0 110.442 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . 0.464 ' N ' ' ND2' ' A' ' 197' ' ' ASN . 0.6 OUTLIER -138.44 -152.67 0.44 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.292 -0.88 . . . . 0.0 109.598 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -175.57 76.69 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.32 -0.862 . . . . 0.0 110.309 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.41 ' CB ' HG23 ' A' ' 186' ' ' VAL . 70.5 t80 -51.39 118.57 3.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.349 -0.844 . . . . 0.0 110.409 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -113.3 95.14 5.21 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.289 -0.882 . . . . 0.0 110.301 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 162.5 -174.07 38.84 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -61.46 135.95 57.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.295 -1.121 . . . . 0.0 110.166 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.636 HG11 ' HZ ' ' A' ' 144' ' ' PHE . 74.7 t -91.15 104.43 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.885 . . . . 0.0 110.071 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 39.6 p -143.86 158.33 43.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.384 -0.822 . . . . 0.0 109.972 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.424 ' HG3' ' CA ' ' A' ' 158' ' ' ALA . 11.0 tttt -49.36 -51.54 34.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.287 -0.883 . . . . 0.0 110.916 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -59.54 -31.17 69.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 110.565 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -82.46 -38.94 23.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 110.344 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.548 ' O ' HD12 ' A' ' 212' ' ' ILE . 51.1 mt -61.38 -56.59 18.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.315 -0.866 . . . . 0.0 110.35 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 4.1 mp -52.96 -23.26 6.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.263 -0.898 . . . . 0.0 110.326 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.2 -49.89 12.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.888 . . . . 0.0 110.279 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -55.8 -59.35 4.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -0.918 . . . . 0.0 110.386 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.646 HG22 ' HG2' ' A' ' 216' ' ' GLN . 5.7 mt -50.07 -39.45 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.219 -0.926 . . . . 0.0 110.466 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -58.67 -18.42 30.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.304 -0.873 . . . . 0.0 110.305 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 17.5 t60 -99.47 -18.6 17.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.176 -0.953 . . . . 0.0 110.676 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.554 ' HB3' HD22 ' A' ' 188' ' ' LEU . 77.5 m-20 -97.66 -61.26 1.42 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.113 -0.992 . . . . 0.0 111.099 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.646 ' HG2' HG22 ' A' ' 212' ' ' ILE . 1.2 pt20 -61.11 -19.12 61.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.103 -0.998 . . . . 0.0 110.584 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.418 ' N ' ' HG3' ' A' ' 216' ' ' GLN . 12.6 mt -126.13 73.22 71.68 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.131 -0.981 . . . . 0.0 110.012 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.7 74.08 3.95 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.633 1.333 . . . . 0.0 110.82 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 41.9 mt 49.53 179.51 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.914 0.864 . . . . 0.0 111.279 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.613 HG22 ' O ' ' A' ' 220' ' ' VAL . 10.5 p -146.01 46.59 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.344 0.593 . . . . 0.0 109.647 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 39.4 mm -52.35 156.15 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.366 -0.834 . . . . 0.0 110.424 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -117.89 -171.76 2.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.346 -0.846 . . . . 0.0 110.094 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.6 t80 52.68 74.1 0.31 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.236 -0.915 . . . . 0.0 110.163 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 58.4 p -91.89 -159.49 0.65 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.332 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.93 -51.62 12.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 110.365 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -80.71 -161.02 0.35 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.203 -0.936 . . . . 0.0 110.207 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 18.5 p -119.3 93.78 4.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.326 -0.858 . . . . 0.0 110.194 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.32 179.962 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.291 0.567 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.55 159.12 6.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -0.944 . . . . 0.0 110.134 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.573 HG22 ' HA2' ' A' ' 168' ' ' GLY . 11.3 t -98.29 166.07 11.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 110.144 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.7 m -107.11 109.0 20.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.186 -0.946 . . . . 0.0 110.121 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 26.2 mt -92.12 131.31 35.28 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.225 -0.922 . . . . 0.0 109.986 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.437 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 45.9 Cg_endo -72.49 -36.3 5.33 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.401 1.211 . . . . 0.0 110.47 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.678 ' C ' HG22 ' A' ' 175' ' ' VAL . 1.7 p30 -154.96 -169.04 3.07 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.27 -0.894 . . . . 0.0 110.614 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.726 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -67.84 -30.94 74.75 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -54.26 -25.85 25.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -1.104 . . . . 0.0 110.362 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.437 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -89.51 -25.29 21.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 110.162 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.99 -26.06 65.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 109.977 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -79.14 -50.71 10.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.209 -0.932 . . . . 0.0 110.056 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.5 m -56.87 -24.32 50.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -0.895 . . . . 0.0 110.08 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.4 tp -67.64 -51.62 47.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 0.0 110.062 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.625 HG22 ' CB ' ' A' ' 189' ' ' PHE . 42.4 t -53.55 -46.95 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.871 . . . . 0.0 110.343 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.28 -18.89 63.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 0.0 110.427 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.4 t -56.16 -59.32 5.1 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.24 -0.913 . . . . 0.0 110.277 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.6 p -127.26 -171.13 2.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.257 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -74.2 -44.63 52.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.879 . . . . 0.0 110.328 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.483 ' CG2' HD12 ' A' ' 165' ' ' ILE . 30.5 m -116.1 151.91 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 0.0 110.535 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.432 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -176.03 139.52 0.38 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.344 -0.848 . . . . 0.0 109.827 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 188' ' ' LEU . 10.0 p -122.33 146.82 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.112 -0.993 . . . . 0.0 110.47 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.854 HD12 ' CD1' ' A' ' 189' ' ' PHE . 6.3 mt -128.18 112.65 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.424 -0.798 . . . . 0.0 109.928 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.07 125.35 7.16 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.436 ' CE2' ' O ' ' A' ' 141' ' ' ILE . 90.8 m-85 -103.2 66.56 0.9 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -1.134 . . . . 0.0 109.605 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.442 ' CD1' ' HB3' ' A' ' 184' ' ' ASP . 9.6 m-85 -93.92 140.1 30.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.351 -0.843 . . . . 0.0 111.03 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -26.83 43.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.462 -0.774 . . . . 0.0 109.775 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -122.32 90.69 3.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.51 -0.744 . . . . 0.0 109.913 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.15 -21.9 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 110.616 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -87.18 12.58 11.31 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.158 -0.964 . . . . 0.0 111.135 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 96.7 p -86.63 -164.26 1.03 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.094 -1.004 . . . . 0.0 110.118 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.53 -44.63 11.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.331 -0.856 . . . . 0.0 109.866 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 1.3 m -56.89 -21.31 28.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.317 -0.864 . . . . 0.0 110.085 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.29 -39.6 22.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.0 110.101 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -59.41 -39.91 84.95 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.268 -0.895 . . . . 0.0 110.339 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -63.97 -43.25 96.32 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.247 -0.908 . . . . 0.0 109.941 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.616 ' HE1' HG13 ' A' ' 186' ' ' VAL . 4.1 t80 -50.66 -55.81 14.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.333 -0.854 . . . . 0.0 110.307 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.415 ' HA ' HD23 ' A' ' 156' ' ' LEU . 75.2 mt -56.02 -51.53 67.45 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.374 -0.829 . . . . 0.0 110.08 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -51.17 -44.54 61.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.365 -0.834 . . . . 0.0 110.148 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -69.64 -34.18 73.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -0.885 . . . . 0.0 110.046 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.691 ' HB2' ' CD2' ' A' ' 167' ' ' PHE . . . -62.53 -30.98 71.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 110.136 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.97 -22.1 24.49 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.21 -0.931 . . . . 0.0 110.35 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -97.42 13.92 28.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.219 -0.926 . . . . 0.0 110.594 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.77 HD11 HG21 ' A' ' 212' ' ' ILE . 6.6 tt -103.78 174.67 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.093 -1.004 . . . . 0.0 110.211 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.42 62.89 0.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.37 -0.831 . . . . 0.0 110.25 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 162' ' ' ILE . 2.8 p-10 40.76 50.81 3.04 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.616 0.722 . . . . 0.0 111.56 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.576 HG23 ' HD2' ' A' ' 166' ' ' PRO . 39.1 mm -88.85 146.0 35.91 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.452 -0.78 . . . . 0.0 109.628 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.576 ' HD2' HG23 ' A' ' 165' ' ' ILE . 42.2 Cg_endo -68.63 100.8 0.71 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.58 1.305 . . . . 0.0 110.865 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.691 ' CD2' ' HB2' ' A' ' 159' ' ' ALA . 2.7 m-85 -97.6 136.32 38.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.42 -0.8 . . . . 0.0 110.158 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.573 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -129.47 143.81 14.92 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 11.1 tt -141.18 135.9 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.13 -1.218 . . . . 0.0 110.572 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.0 t -153.08 156.88 39.56 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.031 0.919 . . . . 0.0 110.571 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.4 t -122.68 2.59 9.53 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -64.31 123.23 18.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -0.945 . . . . 0.0 110.322 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 27.7 m -53.15 -28.36 25.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.229 -0.92 . . . . 0.0 110.131 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.45 -31.84 56.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -0.929 . . . . 0.0 109.764 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.726 HG22 ' N ' ' A' ' 126' ' ' GLY . 28.0 t -81.91 -26.21 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.429 -0.795 . . . . 0.0 109.32 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -76.24 -53.05 8.8 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.481 -0.762 . . . . 0.0 109.75 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 2.0 t -56.06 -21.93 24.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.402 -0.811 . . . . 0.0 110.08 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.51 -48.27 61.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 109.244 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -96.87 -0.67 47.4 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.432 -0.793 . . . . 0.0 110.352 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 53.83 70.63 0.58 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.103 -0.998 . . . . 0.0 110.589 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.549 HD22 ' HA3' ' A' ' 185' ' ' GLY . 1.1 mt -105.64 129.11 53.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.314 -0.866 . . . . 0.0 110.045 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.422 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 24.6 p-10 -60.65 -16.21 36.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.251 -0.905 . . . . 0.0 110.512 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.2 -145.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.175 -0.953 . . . . 0.0 109.649 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.442 ' HB3' ' CD1' ' A' ' 144' ' ' PHE . 43.0 m-20 -54.3 151.54 7.3 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.04 -1.038 . . . . 0.0 109.62 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.549 ' HA3' HD22 ' A' ' 181' ' ' LEU . . . -152.19 129.94 2.94 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.416 -1.374 . . . . 0.0 110.108 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.616 HG13 ' HE1' ' A' ' 155' ' ' PHE . 75.0 t -117.09 80.93 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.364 -1.08 . . . . 0.0 109.777 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 61.3 t -106.39 158.88 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 110.063 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.683 HD23 ' N ' ' A' ' 189' ' ' PHE . 9.8 tt -116.25 163.61 15.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.032 -1.043 . . . . 0.0 109.87 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.854 ' CD1' HD12 ' A' ' 141' ' ' ILE . 64.4 m-85 -128.88 132.08 47.68 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.009 -1.057 . . . . 0.0 110.892 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.481 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.3 OUTLIER -140.49 163.69 32.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.242 -0.911 . . . . 0.0 110.122 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -83.43 -29.13 28.34 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.273 -0.892 . . . . 0.0 110.083 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.8 OUTLIER -91.5 -175.04 4.09 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.533 -0.73 . . . . 0.0 110.955 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 50.43 -160.15 0.07 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.697 0.76 . . . . 0.0 110.608 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -59.24 -28.36 66.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.774 -0.579 . . . . 0.0 110.552 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.405 ' HA2' ' HG2' ' A' ' 190' ' ' LYS . . . 107.33 -28.04 13.86 Favored Glycine 0 N--CA 1.483 1.779 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.06 -179.98 5.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.129 -1.218 . . . . 0.0 110.599 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . 0.441 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.4 m-80 -141.96 -152.39 0.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.575 -0.703 . . . . 0.0 109.712 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -171.57 79.81 0.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.355 -0.84 . . . . 0.0 110.474 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.482 ' CE1' HG22 ' A' ' 203' ' ' VAL . 26.7 t80 -60.3 143.05 53.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.172 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -146.51 129.95 16.8 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.341 -0.85 . . . . 0.0 109.717 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 121.79 -172.58 15.51 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -66.03 117.31 8.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -1.131 . . . . 0.0 110.349 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.484 ' C ' HG23 ' A' ' 204' ' ' THR . 71.7 t -74.14 118.88 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.887 . . . . 0.0 109.987 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.484 HG23 ' C ' ' A' ' 203' ' ' VAL . 72.6 p -150.07 157.11 42.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.318 -0.863 . . . . 0.0 110.433 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -49.26 -52.98 23.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.392 -0.818 . . . . 0.0 110.456 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -55.78 -36.21 67.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.354 -0.841 . . . . 0.0 110.332 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 -77.56 -51.98 9.8 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.193 -0.942 . . . . 0.0 110.454 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 208' ' ' LEU . 70.8 mt -52.34 -56.35 15.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.322 -0.861 . . . . 0.0 110.429 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 18.7 mt -51.11 -24.13 3.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.169 -0.957 . . . . 0.0 110.57 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -84.71 -41.8 15.89 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.195 -0.941 . . . . 0.0 110.073 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -63.29 -57.82 9.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.352 -0.843 . . . . 0.0 110.67 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.77 HG21 HD11 ' A' ' 162' ' ' ILE . 9.4 mt -52.8 -47.22 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.134 -0.979 . . . . 0.0 110.388 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.56 -21.13 51.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.228 -0.92 . . . . 0.0 110.222 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -90.01 -19.35 24.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.309 -0.869 . . . . 0.0 110.438 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -94.73 -49.98 5.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.2 -0.938 . . . . 0.0 110.418 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.758 ' OE1' HG22 ' A' ' 212' ' ' ILE . 17.5 pt20 -58.05 -18.93 27.84 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.213 -0.93 . . . . 0.0 110.485 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 22.8 mt -109.17 92.94 11.99 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 0.0 110.305 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.64 167.12 27.36 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.667 1.351 . . . . 0.0 110.257 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.26 53.75 0.76 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.158 -0.963 . . . . 0.0 110.364 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.633 ' O ' HG12 ' A' ' 220' ' ' VAL . 95.5 t -122.43 60.16 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.331 -0.856 . . . . 0.0 110.013 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.649 ' O ' HG22 ' A' ' 221' ' ' ILE . 2.7 mp -99.2 18.63 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 0.0 110.459 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 52.26 29.76 7.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.177 -0.952 . . . . 0.0 110.354 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -168.88 60.29 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -0.918 . . . . 0.0 110.272 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 12.7 m -129.2 151.63 49.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 110.256 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -113.91 117.7 32.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.152 -0.967 . . . . 0.0 110.258 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.54 -71.94 0.73 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.212 -0.93 . . . . 0.0 110.256 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 20.4 p -75.55 128.49 35.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.235 -0.916 . . . . 0.0 110.198 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.291 179.984 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.238 0.542 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.53 179.71 7.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.181 -0.949 . . . . 0.0 110.154 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 51.9 m -101.56 125.51 48.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 110.149 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 87.0 m -76.84 126.91 31.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.25 -0.906 . . . . 0.0 110.169 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.618 HD22 ' HB1' ' A' ' 128' ' ' ALA . 45.7 mt -103.45 137.98 19.41 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.932 . . . . 0.0 109.95 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 46.8 Cg_endo -73.09 -26.21 15.23 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.554 1.292 . . . . 0.0 110.546 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -172.76 -170.33 0.66 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.159 -0.963 . . . . 0.0 110.912 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.462 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -61.8 -34.07 87.46 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -51.48 -28.2 12.67 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.276 -1.132 . . . . 0.0 110.4 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.618 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -86.06 -37.22 19.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 110.161 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.16 -30.15 48.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.197 -0.939 . . . . 0.0 110.118 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -81.62 -46.45 14.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.146 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 92.0 p -56.74 -33.34 66.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.894 . . . . 0.0 110.095 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.5 tp -61.09 -47.84 84.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -0.884 . . . . 0.0 110.165 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.842 HG22 ' HB3' ' A' ' 189' ' ' PHE . 39.4 t -54.67 -41.2 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.193 -0.942 . . . . 0.0 109.961 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -82.74 3.38 29.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.274 -0.891 . . . . 0.0 110.796 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.8 t -75.61 -41.92 53.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.934 -1.104 . . . . 0.0 110.111 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 28.2 p -147.24 -172.63 4.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 110.13 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.443 ' OE2' ' CD2' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -70.65 -44.76 66.43 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.205 -0.934 . . . . 0.0 110.163 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.4 t -116.26 150.51 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.276 -0.89 . . . . 0.0 110.191 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.455 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -172.15 146.0 1.85 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.843 . . . . 0.0 109.926 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.583 ' CG1' HD12 ' A' ' 188' ' ' LEU . 2.8 m -128.19 164.66 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.117 -0.99 . . . . 0.0 110.764 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 31.2 mt -149.96 114.4 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.753 -0.592 . . . . 0.0 110.173 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -87.06 133.05 11.53 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.546 ' CE2' HG12 ' A' ' 175' ' ' VAL . 76.1 m-85 -99.37 77.31 2.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.113 -1.228 . . . . 0.0 110.069 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.41 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 25.6 m-85 -95.24 143.65 26.47 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.992 0.901 . . . . 0.0 110.939 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.4 -25.36 20.43 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.815 0.817 . . . . 0.0 109.167 179.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -137.3 78.85 1.72 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.576 ' HA ' ' HB1' ' A' ' 152' ' ' ALA . 19.5 m -46.02 -25.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.457 -0.777 . . . . 0.0 111.167 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -84.73 10.31 11.7 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.106 -0.996 . . . . 0.0 110.937 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 68.6 p -81.0 -159.36 0.25 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.967 -1.083 . . . . 0.0 110.182 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -89.87 -54.18 4.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 110.207 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.87 -23.38 63.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 0.0 110.268 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.576 ' HB1' ' HA ' ' A' ' 147' ' ' VAL . . . -81.12 -23.43 38.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 0.0 110.286 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.18 -41.05 77.69 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.216 -0.928 . . . . 0.0 110.115 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.403 ' OE1' HG22 ' A' ' 204' ' ' THR . 1.1 mm-40 -60.43 -46.03 91.48 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.314 -0.867 . . . . 0.0 109.956 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -51.79 -55.35 20.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 110.268 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 156' ' ' LEU . 41.2 mt -54.13 -55.75 24.69 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.383 -0.823 . . . . 0.0 110.152 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -52.45 -38.02 58.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.347 -0.845 . . . . 0.0 110.13 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.729 ' HB2' ' HG3' ' A' ' 205' ' ' LYS . . . -76.8 -41.61 43.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.198 -0.939 . . . . 0.0 109.841 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -58.73 -37.61 76.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.828 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -66.59 -28.21 68.33 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.243 -0.91 . . . . 0.0 110.113 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 158' ' ' ALA . . . -60.36 -50.43 73.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.798 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.54 HG21 ' CG1' ' A' ' 165' ' ' ILE . 71.4 mt -90.31 152.17 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.367 -0.833 . . . . 0.0 109.891 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -127.6 -40.27 1.77 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.136 -0.978 . . . . 0.0 110.43 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -63.77 -16.25 60.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.249 -0.907 . . . . 0.0 110.615 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.54 ' CG1' HG21 ' A' ' 162' ' ' ILE . 46.2 mm -93.63 128.86 40.37 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.075 -1.016 . . . . 0.0 110.327 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.455 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 51.0 Cg_endo -77.31 82.55 2.35 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 O-C-N 123.538 1.283 . . . . 0.0 110.546 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -71.44 137.57 48.38 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.173 -0.954 . . . . 0.0 110.238 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 141' ' ' ILE . . . -128.9 145.07 15.91 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 4.8 tt -146.58 137.48 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -1.157 . . . . 0.0 110.439 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.2 t -159.49 156.94 29.13 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.001 0.905 . . . . 0.0 110.895 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 56.7 p -122.24 3.43 9.79 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.527 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -57.74 126.76 28.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.219 -0.926 . . . . 0.0 110.535 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.88 -35.88 58.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.244 -0.91 . . . . 0.0 110.143 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -53.09 -30.75 38.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.978 . . . . 0.0 109.815 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.546 HG12 ' CE2' ' A' ' 143' ' ' PHE . 57.3 t -81.29 -26.86 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.325 -0.859 . . . . 0.0 109.546 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -77.6 -52.86 8.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.351 -0.843 . . . . 0.0 109.345 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.4 m -58.96 -18.6 35.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.443 -0.786 . . . . 0.0 109.997 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -71.48 -53.91 12.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.559 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -91.11 4.6 51.76 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.41 -0.807 . . . . 0.0 110.292 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.13 64.64 1.76 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -0.946 . . . . 0.0 110.713 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 40.0 mt -102.7 122.41 44.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.256 -0.902 . . . . 0.0 110.17 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -62.83 -18.87 63.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 110.422 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 18.9 pttt -163.75 -148.22 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 109.983 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -70.71 150.98 45.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -0.933 . . . . 0.0 109.889 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -170.16 156.05 26.33 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 97.8 t -127.8 141.2 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.172 -1.193 . . . . 0.0 110.344 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.49 HG13 ' H ' ' A' ' 197' ' ' ASN . 70.6 t -143.06 149.24 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.337 -0.852 . . . . 0.0 109.646 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.69 HD23 ' HD3' ' A' ' 190' ' ' LYS . 3.7 tt -101.29 145.59 28.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.951 -1.093 . . . . 0.0 109.681 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.842 ' HB3' HG22 ' A' ' 133' ' ' VAL . 58.8 m-85 -121.87 108.34 13.34 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.131 -0.981 . . . . 0.0 110.624 -178.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.69 ' HD3' HD23 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -124.06 174.68 7.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.31 -0.869 . . . . 0.0 110.27 179.782 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -94.41 -26.22 16.6 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.321 -0.862 . . . . 0.0 110.007 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.493 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.5 OUTLIER -91.43 -170.92 2.76 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.833 179.577 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 49.87 -159.92 0.07 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.661 0.743 . . . . 0.0 110.595 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -56.05 -46.32 78.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.632 -0.667 . . . . 0.0 110.25 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 126.07 -32.86 3.67 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -136.55 173.14 12.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.193 -1.18 . . . . 0.0 110.429 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . 0.49 ' H ' HG13 ' A' ' 187' ' ' VAL . 0.7 OUTLIER -144.22 -155.21 0.58 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.37 -0.831 . . . . 0.0 109.631 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.435 ' HA ' HG22 ' A' ' 187' ' ' VAL . 0.2 OUTLIER -169.52 86.93 0.15 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.53 -0.731 . . . . 0.0 110.206 179.612 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -49.85 130.83 22.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.272 -0.893 . . . . 0.0 110.441 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -127.95 115.38 18.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.327 -0.858 . . . . 0.0 109.942 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 132.93 -158.74 23.25 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -84.43 132.28 34.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.298 -1.119 . . . . 0.0 110.167 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.644 HG13 HD21 ' A' ' 208' ' ' LEU . 92.3 t -81.46 116.17 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.33 -0.856 . . . . 0.0 110.376 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.403 HG22 ' OE1' ' A' ' 154' ' ' GLN . 15.6 p -143.56 159.73 41.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 109.988 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.769 ' O ' HD12 ' A' ' 209' ' ' LEU . 2.9 ttpt -51.31 -49.24 61.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.12 -0.987 . . . . 0.0 110.584 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -62.98 -39.72 95.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.276 -0.89 . . . . 0.0 110.549 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -70.16 -48.79 55.86 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.197 -0.939 . . . . 0.0 110.374 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.644 HD21 HG13 ' A' ' 203' ' ' VAL . 95.3 mt -56.06 -49.87 72.55 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.257 -0.902 . . . . 0.0 110.428 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.769 HD12 ' O ' ' A' ' 205' ' ' LYS . 0.7 OUTLIER -59.26 -26.99 65.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.892 . . . . 0.0 110.298 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -78.28 -45.49 22.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.281 -0.887 . . . . 0.0 110.274 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -53.29 -60.92 2.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.318 -0.864 . . . . 0.0 110.393 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 9.9 mt -51.69 -46.47 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.242 -0.911 . . . . 0.0 110.586 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -18.85 13.79 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.258 -0.902 . . . . 0.0 110.956 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -96.52 -24.38 16.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.064 -1.022 . . . . 0.0 110.922 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.555 ' HB3' HD22 ' A' ' 188' ' ' LEU . 72.1 m-20 -89.34 -48.58 7.25 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.922 -1.111 . . . . 0.0 111.139 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -57.37 -21.55 36.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.956 -1.09 . . . . 0.0 110.212 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 1.7 mt -104.97 124.99 34.86 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.899 . . . . 0.0 109.949 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.66 -177.08 2.6 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.404 1.213 . . . . 0.0 110.426 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 5.1 mp -116.57 131.17 57.02 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.237 -0.915 . . . . 0.0 110.001 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.503 ' O ' HG23 ' A' ' 220' ' ' VAL . 33.0 m -89.39 59.27 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.275 -0.891 . . . . 0.0 110.212 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 2.2 pt -111.85 54.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.864 . . . . 0.0 110.069 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -161.18 142.58 11.68 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 110.397 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -150.63 46.65 0.87 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.082 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 224' ' ' THR . 25.4 m 54.95 48.84 19.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.29 -0.881 . . . . 0.0 110.293 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 52.52 -166.54 0.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.186 -0.947 . . . . 0.0 110.238 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.47 90.99 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.911 . . . . 0.0 110.204 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.48 HG22 ' N ' ' A' ' 228' ' ' ALA . 26.7 m 55.86 170.49 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.217 -0.927 . . . . 0.0 110.227 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.48 ' N ' HG22 ' A' ' 227' ' ' THR . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.237 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.315 0.578 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 167' ' ' PHE . . . -91.12 175.07 7.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 0.0 110.178 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.554 HG22 ' HA2' ' A' ' 168' ' ' GLY . 7.7 t -102.19 171.11 7.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.139 -0.976 . . . . 0.0 110.516 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.2 m -113.95 103.47 11.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.357 -0.839 . . . . 0.0 110.193 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.655 HD21 HD12 ' A' ' 132' ' ' LEU . 57.7 mt -79.47 111.95 24.87 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.924 . . . . 0.0 110.04 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.433 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 44.7 Cg_endo -69.61 -21.57 34.02 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 O-C-N 123.561 1.295 . . . . 0.0 110.869 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.577 ' OD2' ' HB3' ' A' ' 127' ' ' ALA . 0.4 OUTLIER -163.13 -170.03 2.19 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.052 -1.03 . . . . 0.0 111.076 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.452 ' HA3' ' HD3' ' A' ' 178' ' ' LYS . . . -67.69 -39.92 90.25 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.577 ' HB3' ' OD2' ' A' ' 125' ' ' ASP . . . -53.25 -22.56 7.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -1.15 . . . . 0.0 110.031 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.433 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -88.32 -23.91 23.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.205 -0.935 . . . . 0.0 109.301 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.0 -20.48 32.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.454 -0.779 . . . . 0.0 110.118 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 131' ' ' SER . 19.2 pt-20 -86.9 -37.61 17.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.177 -0.952 . . . . 0.0 110.228 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.44 ' N ' ' HG3' ' A' ' 130' ' ' GLU . 3.0 m -75.48 -31.45 60.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 0.0 109.998 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.655 HD12 HD21 ' A' ' 123' ' ' LEU . 2.4 tt -56.51 -59.47 4.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.336 -0.852 . . . . 0.0 110.067 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.54 HG22 ' CB ' ' A' ' 189' ' ' PHE . 51.4 t -53.63 -35.88 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 110.513 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.81 -19.86 57.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.125 -0.984 . . . . 0.0 110.581 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 68.4 m -68.56 -57.47 5.73 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.129 -0.982 . . . . 0.0 110.304 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 46.1 p -111.84 165.06 12.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.316 -0.865 . . . . 0.0 110.252 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.879 ' HG3' HG23 ' A' ' 138' ' ' VAL . 14.6 pt-20 -64.86 -40.39 95.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 110.035 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.879 HG23 ' HG3' ' A' ' 137' ' ' GLU . 94.1 t -121.67 147.7 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.429 -0.794 . . . . 0.0 110.17 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.501 ' HB1' HD22 ' A' ' 132' ' ' LEU . . . -173.99 133.26 0.43 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.298 -0.876 . . . . 0.0 110.061 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 187' ' ' VAL . 7.3 p -111.86 149.54 14.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.136 -0.977 . . . . 0.0 110.064 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.451 HG23 HD12 ' A' ' 123' ' ' LEU . 66.5 mt -131.37 111.1 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 110.253 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -77.28 133.24 12.96 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.733 ' CE2' HG12 ' A' ' 175' ' ' VAL . 51.4 m-85 -105.36 67.2 0.76 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.26 -1.141 . . . . 0.0 109.735 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -91.76 130.33 37.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 111.228 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.456 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 26.0 pttt -80.07 -30.62 39.32 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.923 0.868 . . . . 0.0 108.828 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.456 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 5.2 m-20 -123.19 70.93 1.04 Allowed 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.323 0.582 . . . . 0.0 109.449 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.46 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 25.6 m -49.17 -23.89 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.27 -0.894 . . . . 0.0 110.808 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -78.33 2.55 18.2 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.08 -1.012 . . . . 0.0 111.032 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 21.5 p -80.45 -161.0 0.34 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.901 -1.124 . . . . 0.0 110.243 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -90.41 -51.59 5.34 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.21 -0.931 . . . . 0.0 110.582 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 66.4 m -52.25 -26.07 10.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.2 -0.938 . . . . 0.0 110.507 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.46 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -86.24 -32.1 21.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 110.353 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -60.23 -41.32 92.84 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.22 -0.925 . . . . 0.0 110.189 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -66.32 -36.91 84.12 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.169 -0.957 . . . . 0.0 109.93 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.453 ' HA ' HD13 ' A' ' 208' ' ' LEU . 4.3 t80 -51.97 -57.78 8.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.286 -0.884 . . . . 0.0 110.097 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 19.2 mt -52.01 -50.57 61.11 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.45 -0.781 . . . . 0.0 110.245 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -52.1 -41.61 62.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.356 -0.84 . . . . 0.0 110.152 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.613 ' HB2' ' HA ' ' A' ' 205' ' ' LYS . . . -73.29 -35.47 66.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.335 -0.853 . . . . 0.0 109.889 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.58 -43.16 94.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 110.013 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -60.13 -35.62 75.68 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.256 -0.903 . . . . 0.0 110.139 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.3 -46.54 86.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.87 . . . . 0.0 110.182 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 49.8 mm -90.7 104.98 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.064 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.37 -20.54 20.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.122 -0.986 . . . . 0.0 110.373 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -76.88 -6.05 50.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.221 -0.925 . . . . 0.0 110.807 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 44.7 mm -116.3 130.35 24.54 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.941 -1.1 . . . . 0.0 110.132 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.445 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 50.6 Cg_endo -75.09 81.2 2.28 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.475 1.25 . . . . 0.0 110.549 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 120' ' ' ALA . 2.9 m-85 -68.23 132.38 47.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 110.316 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.554 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -126.54 153.34 18.71 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 7.2 tt -148.43 147.33 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -1.154 . . . . 0.0 110.329 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.507 HG21 HG11 ' A' ' 175' ' ' VAL . 2.4 t -164.01 156.96 17.86 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.065 0.936 . . . . 0.0 110.809 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.415 ' HA ' ' CE1' ' A' ' 176' ' ' PHE . 76.1 p -121.14 1.08 10.28 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.16 119.98 6.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.191 -0.943 . . . . 0.0 110.506 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.1 p -53.72 -32.48 52.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.229 -0.919 . . . . 0.0 110.095 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.404 ' O ' ' HE2' ' A' ' 178' ' ' LYS . 0.4 OUTLIER -56.47 -44.31 80.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.141 -0.975 . . . . 0.0 109.344 179.543 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.733 HG12 ' CE2' ' A' ' 143' ' ' PHE . 39.0 t -69.22 -29.84 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.346 -0.846 . . . . 0.0 109.41 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.415 ' CE1' ' HA ' ' A' ' 171' ' ' SER . 5.5 m-85 -68.57 -60.86 2.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.407 -0.808 . . . . 0.0 109.528 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 2.9 m -51.36 -36.62 43.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.61 -0.682 . . . . 0.0 110.562 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.452 ' HD3' ' HA3' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -48.44 -55.78 9.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.17 -0.956 . . . . 0.0 110.895 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -89.9 18.73 5.4 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.315 -0.866 . . . . 0.0 110.51 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.46 65.75 1.39 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.163 -0.961 . . . . 0.0 110.402 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 85.5 mt -112.92 92.29 3.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -0.836 . . . . 0.0 110.235 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.56 -26.98 9.65 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.038 -1.038 . . . . 0.0 109.53 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -138.66 177.73 7.67 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 3.7 p-10 -58.65 -173.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.08 -1.012 . . . . 0.0 110.262 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 165.27 171.86 32.01 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 186' ' ' VAL . 32.8 m -139.92 108.15 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.294 -1.121 . . . . 0.0 109.97 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.495 ' O ' HG23 ' A' ' 140' ' ' VAL . 97.2 t -117.04 160.9 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.287 -0.883 . . . . 0.0 109.851 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.785 HD12 HD13 ' A' ' 212' ' ' ILE . 8.3 tt -110.3 150.79 28.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.026 -1.046 . . . . 0.0 109.941 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.54 ' CB ' HG22 ' A' ' 133' ' ' VAL . 40.6 m-85 -121.87 127.19 50.2 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.991 -1.068 . . . . 0.0 110.196 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.28 167.39 22.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -0.885 . . . . 0.0 110.358 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.0 mtpt -90.87 -27.09 19.02 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.244 -0.91 . . . . 0.0 110.596 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -90.96 -175.69 4.41 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.381 -0.824 . . . . 0.0 111.023 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 50.01 -160.0 0.07 Allowed 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.666 0.746 . . . . 0.0 110.667 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -53.86 -54.68 35.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.666 -0.646 . . . . 0.0 110.191 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 133.12 -24.31 3.79 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -140.85 176.81 8.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.051 -1.264 . . . . 0.0 110.781 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . 0.456 ' N ' ' ND2' ' A' ' 197' ' ' ASN . 1.1 m-80 -142.53 -151.76 0.38 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.549 -0.719 . . . . 0.0 109.509 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -176.51 79.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 0.0 109.97 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.574 ' CB ' HG23 ' A' ' 186' ' ' VAL . 17.1 t80 -51.26 120.1 4.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.285 -0.884 . . . . 0.0 110.52 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -119.56 104.91 10.72 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.248 -0.907 . . . . 0.0 110.111 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 152.21 -160.62 28.99 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -81.94 111.11 17.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -1.178 . . . . 0.0 110.16 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.453 ' C ' HG23 ' A' ' 204' ' ' THR . 86.9 t -61.82 116.68 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 110.173 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.453 HG23 ' C ' ' A' ' 203' ' ' VAL . 67.9 p -149.63 155.72 40.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 110.284 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.613 ' HA ' ' HB2' ' A' ' 158' ' ' ALA . 1.5 ttpt -52.62 -52.66 54.46 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.357 -0.839 . . . . 0.0 110.567 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -56.35 -25.83 50.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.0 110.293 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -87.47 -46.29 9.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.291 -0.881 . . . . 0.0 110.17 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 155' ' ' PHE . 19.4 mt -59.02 -47.27 85.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.283 -0.886 . . . . 0.0 110.315 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 14.6 mt -52.31 -30.99 31.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.226 -0.921 . . . . 0.0 110.287 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.53 -42.06 14.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 0.0 110.089 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.428 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 18.5 t80 -51.31 -51.7 51.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.162 -0.961 . . . . 0.0 109.705 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.785 HD13 HD12 ' A' ' 188' ' ' LEU . 25.4 mm -48.53 -72.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.427 -0.796 . . . . 0.0 110.423 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.459 ' HA ' ' CG ' ' A' ' 216' ' ' GLN . 18.0 mttt -45.9 -37.08 5.94 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.779 -0.575 . . . . 0.0 111.132 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.61 -25.46 67.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.13 -0.981 . . . . 0.0 110.793 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 74.8 m-80 -102.18 -31.53 10.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.103 -0.998 . . . . 0.0 110.977 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.459 ' CG ' ' HA ' ' A' ' 213' ' ' LYS . 0.0 OUTLIER -90.49 25.17 2.36 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.016 -1.053 . . . . 0.0 111.001 -179.414 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.42 HD12 ' O ' ' A' ' 213' ' ' LYS . 30.3 mt -126.69 57.78 23.83 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.072 -1.017 . . . . 0.0 110.035 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.34 151.67 48.68 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.611 1.322 . . . . 0.0 110.668 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 44.5 mt 44.99 69.06 0.47 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.562 -0.711 . . . . 0.0 111.241 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 220' ' ' VAL . 9.6 p -94.12 134.18 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 110.164 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 30.0 pt -87.99 -176.01 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.192 -0.942 . . . . 0.0 110.351 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.88 -152.7 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.267 -0.895 . . . . 0.0 110.174 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 53.47 -151.37 0.34 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.263 -0.898 . . . . 0.0 110.125 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.3 m -49.88 156.37 0.74 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.135 -0.978 . . . . 0.0 110.491 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -167.41 71.4 0.11 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 110.185 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.714 ' O ' HG23 ' A' ' 227' ' ' THR . 4.7 tt0 -60.36 -55.61 31.53 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.239 -0.913 . . . . 0.0 110.136 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.714 HG23 ' O ' ' A' ' 226' ' ' GLN . 1.0 OUTLIER -161.15 160.79 30.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.323 -0.861 . . . . 0.0 110.12 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.216 -179.998 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.21 0.529 . . . . 0.0 110.261 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.22 170.84 6.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.34 -0.85 . . . . 0.0 110.38 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.4 t -103.89 168.9 8.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 110.318 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.6 m -108.1 118.4 36.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 0.0 109.94 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.765 HD22 ' HB1' ' A' ' 128' ' ' ALA . 49.5 mt -90.88 138.35 26.28 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.218 -0.926 . . . . 0.0 110.378 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 46.5 Cg_endo -72.61 -36.63 4.78 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.565 1.297 . . . . 0.0 110.366 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.662 ' C ' HG22 ' A' ' 175' ' ' VAL . 0.9 OUTLIER -167.2 -170.24 1.45 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.222 -0.924 . . . . 0.0 110.805 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.5 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -57.56 -33.67 67.43 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.52 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -51.11 -26.72 6.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.22 -1.165 . . . . 0.0 110.406 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.765 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -88.12 -37.16 16.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 110.093 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.24 -25.88 25.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 0.0 109.995 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -88.88 -57.36 2.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.271 -0.893 . . . . 0.0 110.062 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.2 m -58.77 -27.87 65.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.233 -0.917 . . . . 0.0 110.205 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 20.6 tp -60.71 -54.31 46.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 109.988 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 98.4 t -57.39 -33.25 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.459 -0.776 . . . . 0.0 110.336 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -72.97 -17.69 61.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.903 . . . . 0.0 110.528 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.85 -27.12 57.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.189 -0.944 . . . . 0.0 110.393 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.404 ' OG ' ' HG3' ' A' ' 166' ' ' PRO . 31.1 p -141.58 163.55 32.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.188 -0.945 . . . . 0.0 110.391 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.855 ' HG3' HG23 ' A' ' 138' ' ' VAL . 18.3 pt-20 -63.8 -40.93 97.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 110.043 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.855 HG23 ' HG3' ' A' ' 137' ' ' GLU . 57.9 t -127.76 155.88 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.412 -0.805 . . . . 0.0 110.172 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.434 ' HB2' ' HG2' ' A' ' 166' ' ' PRO . . . -176.75 138.51 0.28 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.245 -0.91 . . . . 0.0 109.788 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 187' ' ' VAL . 7.5 p -112.78 151.78 14.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.085 -1.01 . . . . 0.0 110.245 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 71.9 mt -132.65 117.36 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.377 -0.827 . . . . 0.0 110.163 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -84.22 126.72 7.74 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.713 ' CE2' HG12 ' A' ' 175' ' ' VAL . 83.7 m-85 -100.24 70.03 1.51 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.356 -1.085 . . . . 0.0 109.924 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -94.99 141.5 28.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -0.875 . . . . 0.0 110.952 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.53 -27.96 18.83 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.501 -0.749 . . . . 0.0 110.554 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.587 ' C ' HG23 ' A' ' 147' ' ' VAL . 0.7 OUTLIER -90.69 -39.51 12.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.17 -0.956 . . . . 0.0 110.445 -179.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.587 HG23 ' C ' ' A' ' 146' ' ' ASP . 2.4 t 73.1 -51.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.743 -0.598 . . . . 0.0 110.634 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -90.83 8.96 32.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.067 -1.021 . . . . 0.0 110.507 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 7.5 p -70.01 -163.87 0.07 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.986 -1.071 . . . . 0.0 110.066 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.51 -41.31 13.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.338 -0.851 . . . . 0.0 110.431 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.7 p -59.55 -24.26 63.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.197 -0.94 . . . . 0.0 110.19 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -85.02 -37.17 20.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.253 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.88 -45.83 67.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 110.387 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -62.49 -39.48 93.61 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.219 -0.925 . . . . 0.0 110.355 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -51.6 -56.63 12.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 110.418 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.7 mt -51.21 -54.31 26.82 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.324 -0.86 . . . . 0.0 110.534 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -51.91 -40.46 60.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.254 -0.903 . . . . 0.0 110.252 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.468 ' HB2' ' HG3' ' A' ' 205' ' ' LYS . . . -69.47 -49.61 53.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.93 . . . . 0.0 109.885 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.456 ' HB1' ' CD2' ' A' ' 167' ' ' PHE . . . -55.61 -35.93 66.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 110.011 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -68.48 -22.76 64.54 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.329 -0.857 . . . . 0.0 110.435 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.89 -56.42 17.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.168 -0.957 . . . . 0.0 110.333 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 98.8 mt -90.02 151.1 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 0.0 110.177 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -119.67 -16.39 8.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 110.597 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -91.2 19.7 5.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.073 -1.017 . . . . 0.0 110.519 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.551 ' CG2' ' CE1' ' A' ' 167' ' ' PHE . 31.8 mm -132.21 125.1 19.75 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.135 -0.978 . . . . 0.0 109.899 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.434 ' HG2' ' HB2' ' A' ' 139' ' ' ALA . 50.0 Cg_endo -81.5 101.56 1.22 Allowed 'Trans proline' 0 C--N 1.315 -1.228 0 O-C-N 123.443 1.233 . . . . 0.0 110.697 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.551 ' CE1' ' CG2' ' A' ' 165' ' ' ILE . 1.1 m-85 -92.85 140.07 29.88 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.249 -0.907 . . . . 0.0 109.487 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 141' ' ' ILE . . . -132.58 156.37 22.04 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.3 tt -146.0 150.86 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.096 -1.237 . . . . 0.0 110.282 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.917 HG21 HG11 ' A' ' 175' ' ' VAL . 2.4 t -162.01 158.55 25.2 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.11 0.957 . . . . 0.0 110.891 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.421 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . 26.3 t -125.09 2.12 7.94 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.319 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -67.98 123.39 20.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.22 -0.925 . . . . 0.0 110.31 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 14.9 m -50.53 -25.43 4.07 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.224 -0.922 . . . . 0.0 110.445 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -59.91 -29.06 68.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.194 -0.941 . . . . 0.0 109.848 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.917 HG11 HG21 ' A' ' 170' ' ' THR . 39.2 t -88.87 -22.16 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.358 -0.839 . . . . 0.0 109.734 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -80.69 -44.31 18.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.347 -0.846 . . . . 0.0 109.711 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.0 -25.23 67.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.431 -0.793 . . . . 0.0 110.107 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.82 -61.42 2.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -0.852 . . . . 0.0 110.44 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.49 ' CZ ' ' CZ ' ' A' ' 189' ' ' PHE . 88.9 m-85 -89.59 12.24 17.29 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.181 -0.949 . . . . 0.0 110.675 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 50.34 60.62 3.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.143 -0.973 . . . . 0.0 110.719 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 83.8 mt -91.75 124.18 35.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.142 -0.974 . . . . 0.0 109.965 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -60.0 -19.32 51.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.244 -0.91 . . . . 0.0 110.615 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -168.84 -146.96 0.06 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.211 -0.931 . . . . 0.0 110.168 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -75.32 150.06 38.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.229 -0.92 . . . . 0.0 110.171 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -171.54 154.01 21.28 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 186' ' ' VAL . 33.3 m -126.04 104.71 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.278 -1.131 . . . . 0.0 110.174 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.479 HG22 ' HA ' ' A' ' 198' ' ' ASN . 95.2 t -111.27 157.91 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 0.0 109.494 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.785 HD22 ' HB3' ' A' ' 215' ' ' ASN . 9.1 tt -107.15 148.45 28.83 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.887 -1.133 . . . . 0.0 108.926 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.49 ' CZ ' ' CZ ' ' A' ' 179' ' ' TYR . 39.0 m-85 -113.78 129.06 56.63 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.756 -1.215 . . . . 0.0 111.304 -178.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.517 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -137.97 151.95 48.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.274 -0.891 . . . . 0.0 110.269 179.578 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp -83.27 -25.26 31.78 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.337 -0.852 . . . . 0.0 110.252 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.517 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 1.7 p90 -91.77 -176.99 4.63 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.397 -0.814 . . . . 0.0 110.976 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 193' ' ' ASP . 11.1 m-20 48.91 -158.37 0.06 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.574 0.702 . . . . 0.0 110.624 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.25 -46.94 46.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.553 -0.717 . . . . 0.0 110.55 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 133.37 -33.45 2.57 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.6 ptt180 -147.4 -165.84 2.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.188 -1.183 . . . . 0.0 110.593 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . 0.526 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.0 OUTLIER -142.7 -153.7 0.48 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.549 -0.719 . . . . 0.0 109.895 -179.273 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.479 ' HA ' HG22 ' A' ' 187' ' ' VAL . 8.3 p-10 -171.94 80.93 0.06 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.467 -0.77 . . . . 0.0 109.935 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -53.92 119.49 5.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.833 . . . . 0.0 110.27 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -120.69 89.15 3.07 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.417 -0.802 . . . . 0.0 110.354 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 164.66 -165.68 37.58 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -73.17 126.32 29.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -1.132 . . . . 0.0 110.243 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 97.2 t -76.0 110.19 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 110.139 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 77.6 p -145.79 151.28 37.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.491 -0.756 . . . . 0.0 109.979 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.468 ' HG3' ' HB2' ' A' ' 158' ' ' ALA . 6.4 ttpt -48.69 -52.28 24.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.277 -0.889 . . . . 0.0 110.413 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -52.77 -39.86 62.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.324 -0.86 . . . . 0.0 110.19 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -77.31 -44.51 29.35 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.36 -0.838 . . . . 0.0 110.39 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 71.6 mt -53.97 -46.54 71.68 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.317 -0.864 . . . . 0.0 110.29 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 24.6 mt -59.09 -31.64 69.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 0.0 110.027 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -72.19 -28.18 63.04 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.217 -0.927 . . . . 0.0 109.864 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -65.09 -66.67 0.51 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.424 -0.798 . . . . 0.0 110.328 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 5.6 mt -46.37 -42.19 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.436 -0.79 . . . . 0.0 110.778 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -24.73 37.08 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.238 -0.914 . . . . 0.0 110.156 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -113.12 3.74 16.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.331 -0.855 . . . . 0.0 110.832 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.785 ' HB3' HD22 ' A' ' 188' ' ' LEU . 8.1 m120 -92.25 -60.06 1.94 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.882 -1.136 . . . . 0.0 110.195 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.491 ' HA ' ' CZ ' ' A' ' 192' ' ' PHE . 7.4 pt20 -85.09 -143.56 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.335 -0.853 . . . . 0.0 110.407 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.484 ' HA ' HD23 ' A' ' 217' ' ' LEU . 18.0 mt 54.92 57.96 11.3 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.137 -0.977 . . . . 0.0 110.299 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.58 111.92 3.35 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 O-C-N 123.692 1.364 . . . . 0.0 110.337 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 23.1 mt 50.93 92.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 110.427 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.415 ' H ' HG22 ' A' ' 220' ' ' VAL . 33.1 m -90.29 41.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.289 -0.882 . . . . 0.0 110.554 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.587 ' O ' HG22 ' A' ' 221' ' ' ILE . 53.1 mt -140.65 27.92 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.12 -0.988 . . . . 0.0 110.018 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -136.0 59.25 1.72 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.91 . . . . 0.0 110.308 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -119.04 108.99 15.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.258 -0.901 . . . . 0.0 110.239 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 30.1 m -147.11 95.9 2.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.209 -0.932 . . . . 0.0 110.293 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -105.05 -25.48 12.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 0.0 110.033 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.15 106.94 2.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.924 . . . . 0.0 110.123 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 41.7 m -136.86 148.28 47.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.262 -0.899 . . . . 0.0 110.162 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.181 179.977 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.201 0.524 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.47 -166.36 1.35 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.281 -0.887 . . . . 0.0 110.432 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.639 HG22 ' HA2' ' A' ' 168' ' ' GLY . 10.0 t -124.95 171.7 9.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.375 -0.828 . . . . 0.0 110.113 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 50.6 m -109.2 108.76 19.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.34 -0.85 . . . . 0.0 110.095 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.581 HD22 ' HB1' ' A' ' 128' ' ' ALA . 39.0 mt -84.4 125.7 71.19 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.892 . . . . 0.0 109.973 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -71.23 -42.82 1.79 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.53 1.279 . . . . 0.0 110.468 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.476 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 1.3 p30 -152.57 -170.05 3.52 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.301 -0.874 . . . . 0.0 110.807 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.427 ' HA3' ' HD2' ' A' ' 178' ' ' LYS . . . -62.09 -26.51 67.59 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.476 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -53.26 -34.53 57.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.338 -1.095 . . . . 0.0 110.4 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.581 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -79.26 -33.1 43.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.06 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.35 -32.25 64.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -0.881 . . . . 0.0 110.193 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -90.22 -41.17 11.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.348 -0.845 . . . . 0.0 110.406 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.0 m -62.62 -34.75 77.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.935 . . . . 0.0 110.079 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.1 tp -60.74 -45.29 94.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 110.246 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.723 HG22 ' HB3' ' A' ' 189' ' ' PHE . 43.8 t -56.11 -41.59 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.231 -0.918 . . . . 0.0 110.596 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -85.29 -19.9 30.84 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.219 -0.926 . . . . 0.0 110.496 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.5 m -55.48 -36.97 67.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.202 -0.936 . . . . 0.0 110.3 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.8 p -145.16 -178.82 6.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.159 -0.963 . . . . 0.0 110.288 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.15 -30.54 60.79 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.289 -0.882 . . . . 0.0 110.276 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 92.9 t -130.95 144.99 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 110.129 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -174.95 136.75 0.4 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 110.208 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.503 HG11 ' CE1' ' A' ' 167' ' ' PHE . 7.5 p -123.7 150.61 28.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.198 -0.938 . . . . 0.0 110.009 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.458 HG23 ' CD1' ' A' ' 123' ' ' LEU . 5.7 mt -131.17 116.42 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.232 -0.918 . . . . 0.0 110.067 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -87.13 121.63 5.88 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 184' ' ' ASP . 65.4 m-85 -99.08 98.25 9.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -1.161 . . . . 0.0 109.53 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.618 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 19.8 m-85 -115.67 147.33 40.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.026 -1.046 . . . . 0.0 111.357 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.4 ptmt -91.17 -27.38 18.55 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.643 0.735 . . . . 0.0 109.345 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.03 72.34 1.36 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.603 -0.685 . . . . 0.0 109.502 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.578 ' HA ' ' HB2' ' A' ' 152' ' ' ALA . 23.9 m -54.8 -19.77 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.283 -0.886 . . . . 0.0 110.617 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -76.33 0.96 17.53 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.111 -0.993 . . . . 0.0 110.927 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' A' ' 153' ' ' LYS . 83.6 p -88.06 -170.19 2.88 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.827 -1.17 . . . . 0.0 109.949 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -81.35 -30.8 33.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.289 -0.882 . . . . 0.0 110.167 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.43 ' HB2' ' CE1' ' A' ' 144' ' ' PHE . 94.9 p -56.92 -28.92 62.59 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.138 -0.976 . . . . 0.0 110.134 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.578 ' HB2' ' HA ' ' A' ' 147' ' ' VAL . . . -83.34 -43.16 16.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 109.935 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 149' ' ' SER . 0.1 OUTLIER -52.6 -53.05 52.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.265 -0.897 . . . . 0.0 110.255 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -56.32 -43.3 78.86 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.386 -0.821 . . . . 0.0 109.974 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.49 ' HE2' HG13 ' A' ' 186' ' ' VAL . 3.9 t80 -53.3 -57.45 10.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.384 -0.823 . . . . 0.0 110.175 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.9 mt -53.44 -54.33 38.46 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.208 -0.932 . . . . 0.0 110.349 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -50.57 -30.98 14.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.33 -0.856 . . . . 0.0 110.466 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.516 ' HB2' ' HG3' ' A' ' 205' ' ' LYS . . . -77.71 -33.18 53.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 0.0 110.021 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.878 ' O ' HG22 ' A' ' 162' ' ' ILE . . . -59.33 -44.72 92.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.27 -0.894 . . . . 0.0 110.166 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -79.84 -29.24 40.07 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.36 -0.837 . . . . 0.0 110.307 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -80.62 -6.51 58.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.267 -0.896 . . . . 0.0 110.743 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.878 HG22 ' O ' ' A' ' 159' ' ' ALA . 4.7 tt -92.44 179.66 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.964 -1.085 . . . . 0.0 109.967 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -70.33 62.34 0.23 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.035 -1.04 . . . . 0.0 110.429 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 162' ' ' ILE . 3.9 p-10 40.3 52.33 2.85 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.478 0.656 . . . . 0.0 111.194 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.555 HG23 ' HD2' ' A' ' 166' ' ' PRO . 34.6 mm -88.25 145.41 35.87 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.497 -0.752 . . . . 0.0 109.835 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.555 ' HD2' HG23 ' A' ' 165' ' ' ILE . 43.5 Cg_endo -68.59 91.3 0.41 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.639 1.336 . . . . 0.0 110.759 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.519 ' CZ ' HD13 ' A' ' 162' ' ' ILE . 2.9 m-85 -88.83 133.91 34.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 0.0 110.133 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.639 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -122.43 150.74 16.91 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 5.9 tt -150.04 142.01 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -1.118 . . . . 0.0 110.65 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.1 t -159.23 155.36 26.89 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.125 0.964 . . . . 0.0 110.755 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 85.0 p -116.01 1.04 13.2 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.608 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.404 ' ND2' ' HB2' ' A' ' 174' ' ' ASP . 56.2 t30 -57.56 128.28 36.27 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.085 -1.009 . . . . 0.0 110.34 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.14 -28.05 66.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.271 -0.893 . . . . 0.0 110.224 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.404 ' HB2' ' ND2' ' A' ' 172' ' ' ASN . 0.1 OUTLIER -55.41 -45.61 76.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.112 -0.992 . . . . 0.0 109.838 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 42.8 t -67.68 -29.79 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.2 -0.938 . . . . 0.0 109.573 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -76.5 -44.15 36.45 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.376 -0.828 . . . . 0.0 109.357 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 12.1 t -71.59 -5.75 35.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.539 -0.726 . . . . 0.0 110.499 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.427 ' HD2' ' HA3' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -88.59 -47.12 8.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.993 -1.067 . . . . 0.0 108.888 179.516 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -90.28 8.4 33.49 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.685 -0.634 . . . . 0.0 110.235 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 53.6 67.29 1.03 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.088 -1.007 . . . . 0.0 110.587 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 42.0 mt -117.27 107.5 14.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.112 -0.992 . . . . 0.0 109.88 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.74 -19.49 17.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.0 110.135 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.53 -164.72 2.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.166 -0.959 . . . . 0.0 109.492 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 3.3 p30 -61.51 164.23 6.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.074 -1.016 . . . . 0.0 109.958 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -158.55 153.84 24.96 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.49 HG13 ' HE2' ' A' ' 155' ' ' PHE . 92.8 t -129.59 98.73 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.301 -1.117 . . . . 0.0 109.982 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 140' ' ' VAL . 94.6 t -119.74 158.54 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.275 -0.89 . . . . 0.0 110.111 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.578 HD12 HG12 ' A' ' 212' ' ' ILE . 6.8 tt -109.21 150.48 27.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.085 -1.009 . . . . 0.0 109.572 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.723 ' HB3' HG22 ' A' ' 133' ' ' VAL . 44.4 m-85 -124.63 123.86 40.96 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.938 -1.101 . . . . 0.0 110.511 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.31 174.23 10.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.44 -0.788 . . . . 0.0 110.105 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -94.37 -34.24 12.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.174 -0.954 . . . . 0.0 110.263 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.27 -170.58 2.68 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.388 -0.82 . . . . 0.0 110.948 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 54.68 -160.34 0.16 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.544 0.687 . . . . 0.0 110.5 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -55.02 -53.68 52.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.701 -0.625 . . . . 0.0 110.14 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 130.93 -24.79 4.23 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 24.4 mtm-85 -144.48 178.93 7.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.12 -1.223 . . . . 0.0 110.686 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . 0.468 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.0 OUTLIER -147.63 -155.11 0.6 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.343 -0.848 . . . . 0.0 109.687 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 197' ' ' ASN . 6.4 m-80 -169.44 85.48 0.14 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.486 -0.759 . . . . 0.0 110.187 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.419 ' CB ' ' O ' ' A' ' 186' ' ' VAL . 12.5 t80 -57.74 122.32 12.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.279 -0.888 . . . . 0.0 110.433 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -123.33 104.55 9.19 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.251 -0.905 . . . . 0.0 110.24 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 148.79 -167.0 29.31 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.79 134.87 49.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -1.128 . . . . 0.0 110.222 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.618 HG11 ' HZ ' ' A' ' 144' ' ' PHE . 70.7 t -86.04 111.17 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.904 . . . . 0.0 110.348 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.481 HG23 ' C ' ' A' ' 203' ' ' VAL . 68.8 p -149.18 153.96 38.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.472 -0.768 . . . . 0.0 110.097 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.756 ' O ' HD12 ' A' ' 209' ' ' LEU . 0.9 OUTLIER -48.06 -54.35 13.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.937 -179.806 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -54.21 -41.36 68.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.447 -0.783 . . . . 0.0 110.484 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -71.44 -42.87 67.68 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.425 -0.797 . . . . 0.0 110.687 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 71.0 mt -59.7 -51.75 68.43 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.145 -0.972 . . . . 0.0 110.711 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.756 HD12 ' O ' ' A' ' 205' ' ' LYS . 0.7 OUTLIER -54.68 -33.33 60.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.171 -0.955 . . . . 0.0 110.337 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -71.57 -47.62 53.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.216 -0.928 . . . . 0.0 110.3 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -57.95 -55.18 38.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.286 -0.884 . . . . 0.0 110.315 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.578 HG12 HD12 ' A' ' 188' ' ' LEU . 82.3 mt -54.42 -52.89 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.0 110.447 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.486 ' HA ' ' CD1' ' A' ' 217' ' ' LEU . 0.0 OUTLIER -48.21 -23.77 0.97 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.422 -0.799 . . . . 0.0 111.285 -179.391 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 214' ' ' HIS . 21.3 m170 -92.19 -20.74 20.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.928 -1.108 . . . . 0.0 110.733 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -93.19 -53.12 4.24 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.034 -1.041 . . . . 0.0 111.516 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.843 ' HG3' HD12 ' A' ' 217' ' ' LEU . 6.9 pt20 -85.57 43.87 1.06 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.033 -1.042 . . . . 0.0 111.306 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.843 HD12 ' HG3' ' A' ' 216' ' ' GLN . 0.2 OUTLIER -154.92 57.11 1.58 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.124 -0.985 . . . . 0.0 110.286 179.776 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.77 80.63 1.44 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.557 1.293 . . . . 0.0 110.59 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 51.59 69.31 0.68 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.899 . . . . 0.0 110.639 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.675 ' O ' HG23 ' A' ' 220' ' ' VAL . 34.1 m -91.24 82.5 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.255 -0.903 . . . . 0.0 110.21 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 8.9 pt -110.04 -178.59 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.169 -0.957 . . . . 0.0 110.407 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.02 65.99 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.267 -0.896 . . . . 0.0 110.352 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.436 ' C ' HG23 ' A' ' 224' ' ' THR . 0.2 OUTLIER -53.64 -36.21 61.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.11 -0.994 . . . . 0.0 110.267 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.436 HG23 ' C ' ' A' ' 223' ' ' PHE . 23.0 p -151.98 161.07 43.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.911 . . . . 0.0 110.121 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.33 -66.82 1.03 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 110.308 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -78.28 85.03 4.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.23 -0.919 . . . . 0.0 110.177 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 7.7 p -89.23 149.76 22.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.871 . . . . 0.0 110.208 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.274 -179.915 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.211 0.529 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -107.05 164.84 11.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.234 -0.916 . . . . 0.0 110.308 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.656 HG22 ' HA2' ' A' ' 168' ' ' GLY . 7.9 t -89.71 170.72 10.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.891 . . . . 0.0 110.257 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 96.1 m -109.14 104.4 13.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 0.0 110.192 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.888 HD21 HD12 ' A' ' 132' ' ' LEU . 85.5 mt -76.78 139.83 66.8 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.261 -0.899 . . . . 0.0 110.191 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 46.4 Cg_endo -72.15 -35.15 7.22 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 O-C-N 123.556 1.292 . . . . 0.0 110.41 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.557 ' C ' HG22 ' A' ' 175' ' ' VAL . 1.0 OUTLIER -165.86 -170.37 1.75 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.235 -0.915 . . . . 0.0 110.932 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.51 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -66.7 -38.03 92.87 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -51.64 -32.97 31.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.231 -1.158 . . . . 0.0 110.4 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.431 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -82.13 -32.21 30.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.896 . . . . 0.0 110.242 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.59 -25.51 26.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.997 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -89.93 -44.63 9.76 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.312 -0.867 . . . . 0.0 109.058 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.3 m -60.51 -28.31 68.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.225 -0.922 . . . . 0.0 109.675 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.888 HD12 HD21 ' A' ' 123' ' ' LEU . 5.8 tt -65.14 -61.74 1.96 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.354 -0.842 . . . . 0.0 109.967 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.493 HG21 ' CB ' ' A' ' 189' ' ' PHE . 86.8 t -50.95 -31.11 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.404 -0.81 . . . . 0.0 110.253 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.34 -12.65 61.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.294 -0.879 . . . . 0.0 110.673 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 35.8 m -75.83 -21.97 56.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.015 -1.053 . . . . 0.0 110.25 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.14 168.98 22.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.296 -0.878 . . . . 0.0 110.432 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -72.05 -19.51 61.82 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.396 -0.815 . . . . 0.0 109.724 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 26.0 m -129.9 141.83 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.279 -0.888 . . . . 0.0 110.311 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.408 ' HB3' ' HA ' ' A' ' 133' ' ' VAL . . . -175.85 137.36 0.34 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.252 -0.905 . . . . 0.0 110.086 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.467 HG11 ' CZ ' ' A' ' 167' ' ' PHE . 14.5 p -123.57 150.49 27.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.18 -0.95 . . . . 0.0 110.351 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.421 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 69.9 mt -132.86 110.39 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.371 -0.831 . . . . 0.0 110.099 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.8 123.94 6.84 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.351 -1.499 . . . . 0.0 109.351 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.462 ' CD2' HD12 ' A' ' 181' ' ' LEU . 47.0 m-85 -93.9 80.56 4.15 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.229 -1.159 . . . . 0.0 110.141 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -105.8 140.99 37.99 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.059 -1.026 . . . . 0.0 111.128 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.462 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 61.3 pttt -91.48 -36.18 13.9 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.75 0.785 . . . . 0.0 109.165 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.462 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 4.7 m-20 -122.78 79.97 1.7 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.744 -0.598 . . . . 0.0 109.642 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.433 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 29.7 m -55.26 -19.37 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.239 -0.913 . . . . 0.0 110.708 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.79 11.81 8.49 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.092 -1.005 . . . . 0.0 110.9 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.407 ' O ' ' HG2' ' A' ' 153' ' ' LYS . 91.9 p -87.81 -163.7 0.99 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.912 -1.118 . . . . 0.0 110.102 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -90.17 -42.43 11.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.328 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 55.5 m -62.03 -28.82 69.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 110.493 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.433 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -79.8 -25.66 40.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.183 -0.948 . . . . 0.0 110.265 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 149' ' ' SER . 19.6 mmtt -63.16 -44.83 94.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 110.08 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -62.2 -40.78 97.22 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.275 -0.891 . . . . 0.0 110.214 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.506 ' HE1' HG13 ' A' ' 186' ' ' VAL . 4.6 t80 -50.86 -54.89 19.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.198 -0.939 . . . . 0.0 110.256 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 32.0 mt -52.4 -56.14 16.99 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.397 -0.815 . . . . 0.0 110.233 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -52.74 -49.85 64.61 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.322 -0.862 . . . . 0.0 110.257 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.81 -45.58 82.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.892 . . . . 0.0 110.114 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.451 ' HB2' ' CD2' ' A' ' 167' ' ' PHE . . . -64.71 -31.83 73.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 110.1 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.77 -31.26 72.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.359 -0.838 . . . . 0.0 110.157 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.23 -41.53 88.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 110.245 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 76.0 mt -99.72 140.33 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.929 . . . . 0.0 110.274 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -122.66 16.29 10.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.296 -0.877 . . . . 0.0 110.48 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.403 ' O ' HD13 ' A' ' 165' ' ' ILE . 3.7 p30 -120.35 19.67 12.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.156 -0.965 . . . . 0.0 110.323 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.403 HD13 ' O ' ' A' ' 164' ' ' ASP . 48.1 mm -128.98 132.58 24.46 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.17 -0.956 . . . . 0.0 110.014 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.54 ' HB2' HD21 ' A' ' 132' ' ' LEU . 48.6 Cg_endo -72.72 70.83 3.4 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.515 1.271 . . . . 0.0 110.281 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.467 ' CZ ' HG11 ' A' ' 140' ' ' VAL . 2.2 m-85 -65.54 125.46 25.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 109.954 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.656 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -125.0 149.12 16.93 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 12.4 tt -146.76 144.77 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.286 -1.126 . . . . 0.0 110.318 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.425 ' CG2' HG11 ' A' ' 175' ' ' VAL . 2.2 t -158.15 156.97 31.85 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.022 0.915 . . . . 0.0 110.789 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.5 m -124.17 3.54 8.57 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -60.81 129.89 43.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 0.0 110.279 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 84.4 p -53.52 -29.21 35.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.217 -0.927 . . . . 0.0 110.045 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -56.55 -26.77 55.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.904 . . . . 0.0 109.684 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.557 HG22 ' C ' ' A' ' 125' ' ' ASP . 42.9 t -86.93 -24.75 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.416 -0.803 . . . . 0.0 109.558 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 176' ' ' PHE . 10.6 m-85 -80.0 -47.9 14.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.295 -0.878 . . . . 0.0 109.403 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.81 -11.25 60.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.391 -0.818 . . . . 0.0 110.693 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.426 ' CD ' ' HA3' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -85.55 -50.54 7.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.061 -1.025 . . . . 0.0 109.697 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 179' ' ' TYR . 32.8 m-85 -89.35 13.62 13.12 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.485 -0.759 . . . . 0.0 110.196 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 49.81 65.3 1.45 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.123 -0.985 . . . . 0.0 110.482 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.462 HD12 ' CD2' ' A' ' 143' ' ' PHE . 79.4 mt -118.33 106.4 12.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 110.249 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.41 -30.27 70.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.061 -1.024 . . . . 0.0 109.825 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.17 -149.24 0.35 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.364 -0.835 . . . . 0.0 109.697 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.411 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 45.3 m-20 -78.16 175.42 10.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.007 -1.058 . . . . 0.0 109.748 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -167.63 139.75 5.87 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.459 -1.353 . . . . 0.0 109.924 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.506 HG13 ' HE1' ' A' ' 155' ' ' PHE . 95.0 t -121.33 85.75 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.477 -1.014 . . . . 0.0 109.799 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.7 t -109.86 160.26 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.399 -0.813 . . . . 0.0 110.45 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.649 HD22 ' HB3' ' A' ' 215' ' ' ASN . 2.2 tt -113.15 147.05 38.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.19 -0.944 . . . . 0.0 109.447 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.493 ' CB ' HG21 ' A' ' 133' ' ' VAL . 45.2 m-85 -118.7 125.15 49.05 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.981 -1.075 . . . . 0.0 110.651 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.595 ' HD3' HD23 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -139.92 161.75 36.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.888 . . . . 0.0 109.907 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.0 mmpp? -87.24 -20.65 26.59 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.181 -0.949 . . . . 0.0 110.563 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 190' ' ' LYS . 3.4 p90 -90.87 179.73 5.7 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.292 -0.88 . . . . 0.0 110.823 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 44.55 -158.24 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.551 0.691 . . . . 0.0 111.035 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -50.99 -43.74 60.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.577 -0.702 . . . . 0.0 110.235 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.405 ' HA2' ' HG2' ' A' ' 190' ' ' LYS . . . 112.37 -21.07 20.22 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -137.9 174.26 10.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.099 -1.236 . . . . 0.0 110.735 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . 0.46 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.0 OUTLIER -144.54 -152.29 0.41 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.502 -0.749 . . . . 0.0 109.515 -179.827 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 27.8 p30 -173.77 76.06 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 0.0 110.548 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -54.01 125.47 18.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -0.938 . . . . 0.0 109.92 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -132.72 33.01 3.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.928 . . . . 0.0 110.096 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -117.96 175.74 15.84 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.77 122.74 10.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -1.157 . . . . 0.0 110.161 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.492 ' C ' HG23 ' A' ' 204' ' ' THR . 78.4 t -65.55 102.75 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.157 -0.965 . . . . 0.0 110.18 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.492 HG23 ' C ' ' A' ' 203' ' ' VAL . 82.1 p -150.11 151.91 33.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.389 -0.819 . . . . 0.0 110.24 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 23.2 tttt -50.44 -50.1 53.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 0.0 110.491 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -53.28 -35.44 60.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.203 -0.936 . . . . 0.0 110.388 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -79.03 -46.76 17.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 0.0 110.147 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.43 ' CD2' HG11 ' A' ' 186' ' ' VAL . 82.8 mt -62.53 -31.02 71.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 110.263 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 19.0 mt -70.44 -26.67 63.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 110.187 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -86.9 -47.69 8.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.166 -0.959 . . . . 0.0 110.039 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -49.45 -50.15 42.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.317 -0.865 . . . . 0.0 110.213 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.498 HD13 HD12 ' A' ' 188' ' ' LEU . 28.2 mm -55.38 -69.26 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.533 -0.729 . . . . 0.0 110.185 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.34 -36.81 4.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.759 -0.588 . . . . 0.0 111.063 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -40.04 95.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.137 -0.977 . . . . 0.0 110.121 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.649 ' HB3' HD22 ' A' ' 188' ' ' LEU . 79.5 m-20 -89.71 -45.04 9.6 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.3 -0.875 . . . . 0.0 110.451 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -41.18 -72.6 0.06 Allowed 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 1.2 mt -112.69 94.62 29.28 Favored Pre-proline 0 C--N 1.301 -1.521 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.662 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.29 110.95 3.2 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.578 1.304 . . . . 0.0 110.359 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.451 HD13 ' HA ' ' A' ' 219' ' ' LEU . 4.1 mm? -103.4 128.23 50.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.146 -0.971 . . . . 0.0 110.152 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.627 ' O ' HG12 ' A' ' 220' ' ' VAL . 45.4 t -125.54 31.67 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.468 -0.77 . . . . 0.0 110.02 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.464 HD12 ' H ' ' A' ' 220' ' ' VAL . 3.9 mp -126.73 146.71 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 110.392 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.52 -29.18 13.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.89 . . . . 0.0 110.268 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -55.79 -38.1 69.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.249 -0.907 . . . . 0.0 110.269 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.2 m 52.11 86.5 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.262 -0.899 . . . . 0.0 110.433 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -152.17 98.32 2.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 110.293 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -75.31 165.42 25.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.239 -0.913 . . . . 0.0 110.214 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 17.1 m -154.67 56.32 0.68 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.884 . . . . 0.0 110.233 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.114 -179.951 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.282 0.563 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -89.04 -174.04 4.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -0.885 . . . . 0.0 110.387 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.432 ' HB ' ' HA2' ' A' ' 168' ' ' GLY . 7.9 m -104.68 116.7 32.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.336 -0.853 . . . . 0.0 109.706 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 79.8 m -69.17 142.01 54.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 0.0 110.191 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.7 mt -124.29 144.41 45.63 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 110.148 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.432 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 45.8 Cg_endo -72.48 -37.42 4.25 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.713 1.375 . . . . 0.0 110.372 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.68 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.9 OUTLIER -173.27 -170.46 0.62 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.205 -0.934 . . . . 0.0 110.687 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.488 ' N ' HG22 ' A' ' 175' ' ' VAL . . . -57.8 -30.59 63.11 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.68 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -51.49 -35.55 40.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.257 -1.143 . . . . 0.0 110.498 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.432 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -82.85 -38.19 23.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.108 -0.995 . . . . 0.0 110.203 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.73 -24.86 24.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.108 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -77.66 -64.16 1.21 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 110.165 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.0 -23.14 12.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 110.139 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.717 HD22 ' HB1' ' A' ' 139' ' ' ALA . 2.1 tt -64.76 -59.48 4.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 0.0 109.946 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.74 HG22 ' HB3' ' A' ' 189' ' ' PHE . 56.4 t -50.49 -41.53 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.37 -0.831 . . . . 0.0 110.562 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -80.22 1.72 27.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.919 . . . . 0.0 110.931 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 17.5 t -82.71 -27.38 31.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.898 -1.126 . . . . 0.0 110.051 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.42 171.59 16.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.262 -0.899 . . . . 0.0 110.168 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.25 -20.15 63.94 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.335 -0.853 . . . . 0.0 109.583 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 18.2 m -135.13 149.15 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.259 -0.901 . . . . 0.0 110.169 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.717 ' HB1' HD22 ' A' ' 132' ' ' LEU . . . -173.64 138.06 0.65 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.233 -0.917 . . . . 0.0 110.232 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.43 ' CG1' ' HA ' ' A' ' 167' ' ' PHE . 7.2 p -125.99 153.67 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 121.072 -1.017 . . . . 0.0 110.365 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.422 ' O ' ' CE1' ' A' ' 143' ' ' PHE . 52.9 mt -137.96 114.5 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 109.905 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.56 136.69 18.33 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.715 ' CE2' HG12 ' A' ' 175' ' ' VAL . 67.6 m-85 -112.97 72.84 0.79 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.299 -1.118 . . . . 0.0 110.014 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.417 ' CE1' ' HB3' ' A' ' 184' ' ' ASP . 10.8 m-85 -102.35 142.7 33.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 111.051 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.88 -27.38 23.46 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.765 0.793 . . . . 0.0 109.494 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.7 p30 -126.24 69.63 1.22 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.694 -0.629 . . . . 0.0 109.616 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.499 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 31.4 m -50.41 -23.27 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.725 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.16 -9.47 57.81 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.115 -0.991 . . . . 0.0 111.296 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 52.7 p -69.95 -159.69 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.894 -1.129 . . . . 0.0 110.333 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -90.35 -45.74 8.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.386 -0.822 . . . . 0.0 110.267 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.9 p -52.32 -30.0 26.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.318 -0.864 . . . . 0.0 110.224 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.499 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -83.24 -34.99 25.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.372 -0.83 . . . . 0.0 110.174 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.2 mmtt -49.89 -40.1 41.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.309 -0.87 . . . . 0.0 110.357 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.8 -45.03 83.9 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.288 -0.882 . . . . 0.0 110.002 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.44 ' HE1' HG13 ' A' ' 186' ' ' VAL . 5.7 t80 -48.05 -55.4 10.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.273 -0.892 . . . . 0.0 110.597 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.0 mt -48.59 -54.6 13.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.277 -0.89 . . . . 0.0 110.667 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -52.23 -51.61 57.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.217 -0.927 . . . . 0.0 110.171 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' A' ' 205' ' ' LYS . . . -60.0 -39.37 85.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.145 -0.972 . . . . 0.0 109.824 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.39 -32.21 71.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.343 -0.848 . . . . 0.0 110.066 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -80.62 -29.48 36.8 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.314 -0.866 . . . . 0.0 110.277 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.468 ' HB3' HD21 ' A' ' 209' ' ' LEU . . . -54.16 -52.21 61.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -0.893 . . . . 0.0 110.365 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.401 HG13 ' OD2' ' A' ' 164' ' ' ASP . 19.0 tt -89.79 150.04 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 110.064 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -132.57 35.77 3.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.108 -0.995 . . . . 0.0 110.661 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.722 ' O ' HD13 ' A' ' 165' ' ' ILE . 3.5 p30 -136.05 17.79 3.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.169 -0.957 . . . . 0.0 110.228 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.722 HD13 ' O ' ' A' ' 164' ' ' ASP . 39.5 mm -135.17 146.5 58.53 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.238 -0.914 . . . . 0.0 109.923 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.467 ' HD2' ' CG2' ' A' ' 165' ' ' ILE . 47.6 Cg_endo -84.18 90.83 0.85 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.779 1.41 . . . . 0.0 110.248 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.43 ' HA ' ' CG1' ' A' ' 140' ' ' VAL . 3.9 m-85 -85.81 130.93 34.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.29 -0.882 . . . . 0.0 110.554 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.432 ' HA2' ' HB ' ' A' ' 121' ' ' THR . . . -120.01 153.07 16.86 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 14.7 tt -147.42 144.36 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -1.125 . . . . 0.0 110.305 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.707 HG21 HG11 ' A' ' 175' ' ' VAL . 2.5 t -162.17 157.58 23.36 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.064 0.935 . . . . 0.0 110.693 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.1 1.58 9.2 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.411 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -59.41 121.52 11.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.115 -0.991 . . . . 0.0 110.259 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 79.4 p -51.65 -29.99 20.02 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.096 -1.002 . . . . 0.0 110.296 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -59.19 -35.6 73.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.136 -0.978 . . . . 0.0 109.842 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.715 HG12 ' CE2' ' A' ' 143' ' ' PHE . 60.3 t -76.85 -26.54 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.39 -0.819 . . . . 0.0 109.812 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -79.59 -53.26 7.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.395 -0.816 . . . . 0.0 109.865 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -25.45 63.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.955 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.43 -53.01 62.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 110.037 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -92.83 16.99 11.21 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.222 -0.923 . . . . 0.0 110.409 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 53.54 69.47 0.7 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.249 -0.907 . . . . 0.0 110.603 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 77.6 mt -115.02 123.01 47.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.212 -0.93 . . . . 0.0 110.024 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -86.39 -21.01 27.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.166 -0.959 . . . . 0.0 110.19 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -148.84 -166.14 2.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.329 -0.857 . . . . 0.0 109.914 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.417 ' HB3' ' CE1' ' A' ' 144' ' ' PHE . 71.2 m-20 -53.46 152.33 4.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.938 . . . . 0.0 109.997 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -157.77 131.74 2.96 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.44 HG13 ' HE1' ' A' ' 155' ' ' PHE . 72.8 t -115.21 85.69 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.356 -1.085 . . . . 0.0 109.619 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.555 HG13 ' H ' ' A' ' 197' ' ' ASN . 85.5 t -102.72 149.25 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.371 -0.831 . . . . 0.0 110.18 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.696 HD23 ' HD3' ' A' ' 190' ' ' LYS . 5.3 tt -105.53 150.59 25.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.122 -0.986 . . . . 0.0 109.627 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.74 ' HB3' HG22 ' A' ' 133' ' ' VAL . 46.1 m-85 -119.52 121.19 38.85 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.931 -1.106 . . . . 0.0 110.554 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.696 ' HD3' HD23 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -136.33 160.76 37.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 0.0 110.171 179.815 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -85.53 -22.94 27.91 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.312 -0.868 . . . . 0.0 110.556 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 190' ' ' LYS . 2.5 p90 -90.45 -176.29 4.73 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.392 -0.817 . . . . 0.0 110.865 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 193' ' ' ASP . 0.7 OUTLIER 46.52 -157.97 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.481 0.658 . . . . 0.0 110.511 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -54.83 -54.96 35.53 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.475 -0.766 . . . . 0.0 110.094 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 134.47 -31.61 2.74 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -131.56 173.09 11.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.157 -1.202 . . . . 0.0 110.66 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . 0.555 ' H ' HG13 ' A' ' 187' ' ' VAL . 1.6 m-80 -138.21 -151.51 0.39 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.515 -0.741 . . . . 0.0 109.673 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -175.6 77.0 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.356 -0.84 . . . . 0.0 110.051 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -48.41 142.84 5.3 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.329 -0.857 . . . . 0.0 110.915 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -150.29 134.98 17.48 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.31 -0.869 . . . . 0.0 109.649 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 125.08 -178.39 16.55 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -54.98 121.15 8.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -1.139 . . . . 0.0 110.232 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 75.8 t -74.91 102.57 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.191 -0.943 . . . . 0.0 110.212 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 72.3 p -136.6 145.26 44.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.367 -0.833 . . . . 0.0 109.705 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.521 ' HA ' HD12 ' A' ' 208' ' ' LEU . 0.1 OUTLIER -48.08 -47.53 34.05 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.157 -0.964 . . . . 0.0 110.838 -179.722 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -59.11 -40.49 85.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.24 -0.912 . . . . 0.0 110.458 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -67.68 -39.53 84.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.123 -0.986 . . . . 0.0 110.407 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.812 ' O ' HD12 ' A' ' 212' ' ' ILE . 36.7 mt -63.42 -52.63 60.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 110.41 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.468 HD21 ' HB3' ' A' ' 161' ' ' ALA . 6.9 mt -51.69 -24.39 5.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.172 -0.955 . . . . 0.0 110.407 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -82.4 -48.76 10.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.17 -0.956 . . . . 0.0 110.031 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -53.27 -57.22 11.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 110.474 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.812 HD12 ' O ' ' A' ' 208' ' ' LEU . 4.4 mt -49.79 -54.2 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.179 -0.95 . . . . 0.0 110.61 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.29 -29.45 9.74 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.286 -0.884 . . . . 0.0 110.66 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -81.45 -15.97 53.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.31 -0.869 . . . . 0.0 110.782 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.664 ' HB3' HD22 ' A' ' 188' ' ' LEU . 74.5 m-20 -104.77 -35.52 7.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.08 -1.013 . . . . 0.0 110.849 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.443 ' OE1' HG22 ' A' ' 212' ' ' ILE . 13.7 pt20 -78.42 -9.0 59.11 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.13 -0.982 . . . . 0.0 110.949 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.44 HD23 HG21 ' A' ' 220' ' ' VAL . 19.6 mt -136.99 69.28 57.52 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 120.973 -1.079 . . . . 0.0 110.466 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.26 93.34 0.98 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.615 1.324 . . . . 0.0 110.571 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 48.1 mt 42.63 76.58 0.07 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.677 -0.639 . . . . 0.0 111.379 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.44 HG21 HD23 ' A' ' 217' ' ' LEU . 96.6 t -92.71 131.03 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.335 -0.853 . . . . 0.0 110.256 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 36.1 pt -135.24 160.24 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.192 -0.942 . . . . 0.0 110.341 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -131.29 -77.15 0.52 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.882 . . . . 0.0 110.137 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -100.26 74.58 1.76 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 0.0 110.044 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 41.1 p -121.43 -177.11 3.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 110.317 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -122.69 154.82 37.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -0.892 . . . . 0.0 110.176 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -105.98 113.33 26.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.0 110.258 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 15.6 m -138.47 55.23 1.75 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.193 -0.942 . . . . 0.0 110.181 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.193 179.997 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.165 0.507 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 167' ' ' PHE . . . -97.31 -169.04 1.79 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -0.881 . . . . 0.0 110.111 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.576 ' O ' HG22 ' A' ' 169' ' ' ILE . 7.2 t -145.31 152.32 39.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.154 -0.966 . . . . 0.0 110.048 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 169' ' ' ILE . 1.5 m -86.15 125.49 33.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.067 -1.02 . . . . 0.0 109.891 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.955 ' HB2' HG23 ' A' ' 170' ' ' THR . 71.0 mt -88.47 130.87 43.94 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.88 -1.137 . . . . 0.0 110.297 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.44 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 48.6 Cg_endo -72.68 -51.21 0.19 Allowed 'Trans proline' 0 C--N 1.315 -1.207 0 O-C-N 123.422 1.222 . . . . 0.0 110.556 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.687 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.5 OUTLIER -141.9 -169.43 2.91 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.247 -0.908 . . . . 0.0 110.778 -179.84 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.94 -27.04 72.87 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.687 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -59.13 -27.48 65.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.205 -1.173 . . . . 0.0 110.237 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.44 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -90.05 -21.28 22.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.944 . . . . 0.0 110.227 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.95 -21.88 50.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 110.252 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -90.31 -40.75 11.93 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.27 -0.894 . . . . 0.0 109.623 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.83 -31.18 66.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.147 -0.971 . . . . 0.0 110.385 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.4 tp -68.69 -43.98 74.95 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.296 -0.877 . . . . 0.0 110.391 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.837 HG22 ' HB3' ' A' ' 189' ' ' PHE . 46.2 t -51.56 -53.99 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.339 -0.85 . . . . 0.0 110.519 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.27 -17.84 60.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.196 -0.94 . . . . 0.0 110.471 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.6 p -53.3 -38.6 63.27 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.126 -0.984 . . . . 0.0 110.331 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.401 ' OG ' ' HG3' ' A' ' 166' ' ' PRO . 2.3 p -147.27 -172.77 4.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.301 -0.875 . . . . 0.0 110.249 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.06 -45.8 47.17 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.341 -0.85 . . . . 0.0 110.362 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.4 m -116.76 151.63 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.938 . . . . 0.0 110.464 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.434 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -175.26 127.11 0.26 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.911 . . . . 0.0 109.934 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.83 153.03 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.102 -0.999 . . . . 0.0 110.02 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.683 HG23 HD11 ' A' ' 123' ' ' LEU . 56.8 mt -139.98 114.74 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.144 -0.972 . . . . 0.0 110.47 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.0 132.4 11.06 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.709 ' CE2' HG12 ' A' ' 175' ' ' VAL . 18.7 m-85 -100.68 92.3 5.03 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.243 -1.151 . . . . 0.0 109.679 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.555 ' HZ ' HG21 ' A' ' 203' ' ' VAL . 25.1 m-85 -114.78 147.31 39.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.065 -1.022 . . . . 0.0 111.536 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.76 -26.85 19.28 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.57 0.7 . . . . 0.0 109.652 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.03 78.49 1.68 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.607 -0.683 . . . . 0.0 109.603 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.499 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 22.2 m -50.77 -23.2 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.289 -0.882 . . . . 0.0 110.69 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -72.5 -3.59 25.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.0 110.899 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 7.4 p -78.61 -164.73 0.61 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.851 -1.155 . . . . 0.0 110.161 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.2 -47.52 7.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.277 -0.889 . . . . 0.0 110.436 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.2 m -51.14 -27.34 8.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.24 -0.913 . . . . 0.0 110.541 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.499 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -81.16 -40.48 23.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.931 . . . . 0.0 110.026 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.8 mtpt -50.95 -47.07 61.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.354 -0.841 . . . . 0.0 110.317 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -53.63 -33.73 56.11 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.118 -0.989 . . . . 0.0 109.689 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.424 ' CE1' HG11 ' A' ' 186' ' ' VAL . 4.0 t80 -66.96 -56.65 9.26 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.405 -0.809 . . . . 0.0 109.935 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 152' ' ' ALA . 1.3 mp -46.71 -55.98 6.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.535 -0.728 . . . . 0.0 110.649 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -51.17 -46.73 62.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.35 -0.844 . . . . 0.0 110.292 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.544 ' HB2' ' HG3' ' A' ' 205' ' ' LYS . . . -65.27 -45.59 83.88 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.944 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.79 -38.03 71.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.21 -0.931 . . . . 0.0 109.971 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.35 -28.2 59.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.193 -0.942 . . . . 0.0 110.051 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.21 -42.09 76.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.869 . . . . 0.0 110.201 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.46 ' CD1' HG13 ' A' ' 165' ' ' ILE . 5.5 tt -96.41 152.06 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 110.343 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -131.22 15.35 5.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.272 -0.892 . . . . 0.0 110.558 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.696 ' O ' HD13 ' A' ' 165' ' ' ILE . 4.1 p30 -124.05 16.14 9.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.077 -1.014 . . . . 0.0 110.415 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.696 HD13 ' O ' ' A' ' 164' ' ' ASP . 39.4 mm -132.49 146.27 60.77 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.176 -0.952 . . . . 0.0 110.016 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.472 ' HD2' ' CG2' ' A' ' 165' ' ' ILE . 46.4 Cg_endo -84.34 78.93 2.7 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.747 1.393 . . . . 0.0 110.495 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 120' ' ' ALA . 3.6 m-85 -77.29 135.03 38.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 0.0 110.221 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 141' ' ' ILE . . . -136.06 153.62 21.55 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.576 HG22 ' O ' ' A' ' 121' ' ' THR . 1.7 tt -130.85 151.09 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.173 -1.192 . . . . 0.0 109.451 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 1.063 HG21 HG11 ' A' ' 175' ' ' VAL . 0.7 OUTLIER -119.36 144.61 46.78 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.1 -1.0 . . . . 0.0 110.94 -178.577 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 144' ' ' PHE . 2.5 t -130.85 12.89 5.29 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.503 -0.748 . . . . 0.0 109.814 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.437 ' ND2' ' HB2' ' A' ' 174' ' ' ASP . 50.8 t30 -112.36 160.76 17.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.068 -1.02 . . . . 0.0 110.893 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 39.6 t -83.29 -28.43 29.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.448 -0.782 . . . . 0.0 109.966 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.437 ' HB2' ' ND2' ' A' ' 172' ' ' ASN . 1.7 m-20 -53.8 -32.01 51.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -0.947 . . . . 0.0 109.519 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 1.063 HG11 HG21 ' A' ' 170' ' ' THR . 38.4 t -76.89 -32.17 19.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -69.83 -59.13 3.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.477 -0.765 . . . . 0.0 109.215 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.6 m -53.18 -23.76 9.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.444 -0.785 . . . . 0.0 109.514 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.474 ' HD2' ' CE1' ' A' ' 179' ' ' TYR . 3.4 tmtt? -61.31 -61.38 2.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.525 -0.734 . . . . 0.0 110.067 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.474 ' CE1' ' HD2' ' A' ' 178' ' ' LYS . 94.1 m-85 -89.58 8.39 31.52 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.47 -0.769 . . . . 0.0 110.645 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.9 62.68 2.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.039 -1.038 . . . . 0.0 110.55 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 mt -92.83 134.41 35.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.282 -0.886 . . . . 0.0 110.11 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -73.67 -9.72 58.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 110.587 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -175.94 -165.91 0.17 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.022 -1.049 . . . . 0.0 110.067 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -70.01 152.33 44.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.21 -0.931 . . . . 0.0 110.015 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -177.21 166.86 37.71 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 186' ' ' VAL . 18.6 m -126.22 121.88 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -1.154 . . . . 0.0 110.328 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 89.8 t -118.39 158.84 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.452 -0.78 . . . . 0.0 109.5 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.673 HD13 ' HB2' ' A' ' 215' ' ' ASN . 7.1 tt -107.27 140.2 40.54 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.826 -1.171 . . . . 0.0 109.8 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.837 ' HB3' HG22 ' A' ' 133' ' ' VAL . 49.6 m-85 -117.38 111.15 18.94 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.995 -1.066 . . . . 0.0 110.598 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.625 ' HD3' HD23 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -124.22 -172.81 2.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.27 -0.894 . . . . 0.0 110.06 179.852 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 11.5 mttt -106.62 -26.04 11.53 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.128 -0.983 . . . . 0.0 110.526 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -90.83 -175.89 4.51 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.381 -0.824 . . . . 0.0 110.829 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 47.68 -159.06 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.54 -0.725 . . . . 0.0 110.887 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -52.98 -43.54 66.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.662 -0.649 . . . . 0.0 110.294 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 113.9 -27.08 9.43 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 11.8 mtm180 -135.76 163.98 28.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.184 -1.186 . . . . 0.0 110.386 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . 0.486 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 0.8 OUTLIER -136.49 -153.82 0.52 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.342 -0.848 . . . . 0.0 109.796 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -172.89 80.84 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.421 -0.799 . . . . 0.0 110.267 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -48.61 119.67 3.24 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.341 -0.849 . . . . 0.0 110.634 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -113.77 90.2 3.28 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.275 -0.89 . . . . 0.0 110.288 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 164.4 -165.44 37.3 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -74.85 117.88 17.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -1.145 . . . . 0.0 110.278 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.609 ' O ' HG13 ' A' ' 203' ' ' VAL . 6.9 p -66.95 83.28 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 110.091 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 81.4 p -121.24 153.83 37.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 0.0 110.212 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.544 ' HG3' ' HB2' ' A' ' 158' ' ' ALA . 0.6 OUTLIER -46.93 -55.18 8.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.372 -0.83 . . . . 0.0 110.543 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -54.74 -30.67 56.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.477 -0.764 . . . . 0.0 110.236 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -86.95 -23.96 24.92 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.228 -0.92 . . . . 0.0 110.248 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.881 ' O ' HD12 ' A' ' 212' ' ' ILE . 18.7 mt -75.54 -53.46 8.6 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.295 -0.878 . . . . 0.0 110.541 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 4.7 mp -57.58 -20.57 33.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.88 . . . . 0.0 110.633 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -81.94 -53.74 5.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.152 -0.968 . . . . 0.0 110.15 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -60.69 -55.64 30.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.33 -0.856 . . . . 0.0 110.677 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.881 HD12 ' O ' ' A' ' 208' ' ' LEU . 8.1 mt -51.57 -41.98 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.227 -0.921 . . . . 0.0 110.695 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -69.58 -15.01 63.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.122 -0.986 . . . . 0.0 110.836 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.64 -16.83 27.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.129 -0.982 . . . . 0.0 110.795 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.673 ' HB2' HD13 ' A' ' 188' ' ' LEU . 73.5 m-80 -103.69 -39.63 6.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.995 -1.066 . . . . 0.0 110.862 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.515 ' OE1' HG22 ' A' ' 212' ' ' ILE . 15.1 pt20 -64.29 -17.54 63.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.071 -1.018 . . . . 0.0 110.519 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.1 mt -119.32 93.49 47.21 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.131 -0.98 . . . . 0.0 110.248 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -72.95 171.1 18.18 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.657 1.346 . . . . 0.0 110.42 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.1 mt 50.57 96.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.227 -0.921 . . . . 0.0 110.584 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.584 ' O ' HG12 ' A' ' 220' ' ' VAL . 43.1 t -105.03 42.24 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 110.112 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.649 ' O ' HG23 ' A' ' 221' ' ' ILE . 5.1 tt -155.73 101.22 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.237 -0.914 . . . . 0.0 110.363 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 51.88 -170.21 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.277 -0.889 . . . . 0.0 110.529 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 223' ' ' PHE . 28.9 p90 -146.56 -170.7 3.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.315 -0.865 . . . . 0.0 110.107 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 7.2 t -160.71 -176.84 5.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.202 -0.936 . . . . 0.0 110.305 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.458 ' O ' HG23 ' A' ' 227' ' ' THR . 36.4 mt-10 -117.24 -161.5 0.82 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.208 -0.932 . . . . 0.0 110.213 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 53.15 44.17 30.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.191 -0.943 . . . . 0.0 110.327 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 225' ' ' GLU . 13.1 p -128.15 162.01 27.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 110.241 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.284 179.895 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.218 0.532 . . . . 0.0 110.084 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 167' ' ' PHE . . . -83.4 145.9 28.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.181 -0.949 . . . . 0.0 110.197 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.515 HG22 ' HA2' ' A' ' 168' ' ' GLY . 11.6 t -92.14 164.71 13.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 110.305 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 91.1 m -101.91 100.72 11.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.928 . . . . 0.0 110.149 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.54 HD12 HG23 ' A' ' 141' ' ' ILE . 45.4 mt -75.93 131.68 75.71 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.284 -0.885 . . . . 0.0 110.081 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.402 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 47.6 Cg_endo -72.34 -36.95 4.83 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 O-C-N 123.52 1.273 . . . . 0.0 110.485 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.593 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.0 OUTLIER -163.26 -169.5 2.0 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 122.073 0.939 . . . . 0.0 111.262 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.4 ' HA3' ' HD2' ' A' ' 178' ' ' LYS . . . -60.67 -27.2 65.95 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.593 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -55.62 -29.26 58.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -1.141 . . . . 0.0 110.278 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.524 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -90.43 -26.02 20.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.278 -0.888 . . . . 0.0 110.171 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.09 68.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.866 . . . . 0.0 110.119 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -90.26 -40.97 11.84 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.23 -0.918 . . . . 0.0 109.188 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 41.4 m -66.71 -22.68 66.06 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.233 -0.917 . . . . 0.0 110.147 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.58 HD23 HD11 ' A' ' 141' ' ' ILE . 9.0 tp -69.95 -50.76 38.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 110.429 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 91.3 t -58.21 -37.82 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.298 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -77.86 -17.36 57.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 110.419 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.5 p -63.84 -44.76 92.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.035 -1.041 . . . . 0.0 110.303 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 89.4 p -138.2 -173.72 3.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -0.882 . . . . 0.0 110.26 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.19 -44.93 74.75 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.273 -0.892 . . . . 0.0 110.258 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.624 HG21 HD12 ' A' ' 165' ' ' ILE . 33.6 m -120.53 163.71 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.261 -0.899 . . . . 0.0 110.453 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -176.38 125.42 0.18 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.411 -0.806 . . . . 0.0 109.634 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.509 HG11 ' CE2' ' A' ' 167' ' ' PHE . 8.2 p -112.29 139.64 36.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.049 -1.032 . . . . 0.0 110.781 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.58 HD11 HD23 ' A' ' 132' ' ' LEU . 3.4 mt -130.97 113.58 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.316 -0.865 . . . . 0.0 109.671 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.76 136.68 20.34 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.771 ' CE2' HG12 ' A' ' 175' ' ' VAL . 28.6 m-85 -105.87 69.07 0.8 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -1.134 . . . . 0.0 109.715 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.571 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 22.6 m-85 -95.37 145.79 24.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 110.835 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.04 -27.15 24.95 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.51 -0.744 . . . . 0.0 109.724 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.85 78.56 1.75 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.528 -0.733 . . . . 0.0 109.677 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.521 ' O ' ' HB3' ' A' ' 152' ' ' ALA . 22.6 m -51.12 -23.08 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.242 -0.911 . . . . 0.0 110.561 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -76.94 1.01 18.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.06 -1.025 . . . . 0.0 110.933 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 95.1 p -75.55 -164.89 0.37 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.835 -1.166 . . . . 0.0 110.31 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.435 ' HA ' ' HG3' ' A' ' 153' ' ' LYS . 0.3 OUTLIER -90.63 -34.36 15.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.324 -0.86 . . . . 0.0 110.603 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 38.6 t -68.32 -27.88 66.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.263 -0.898 . . . . 0.0 110.269 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.684 ' O ' HD12 ' A' ' 156' ' ' LEU . . . -78.47 -34.04 47.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.142 -0.973 . . . . 0.0 109.939 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.435 ' HG3' ' HA ' ' A' ' 150' ' ' ASP . 2.7 mmmt -53.78 -52.06 61.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 0.0 110.065 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -54.94 -33.68 62.49 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.263 -0.898 . . . . 0.0 109.787 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.652 ' CE1' HG11 ' A' ' 186' ' ' VAL . 4.3 t80 -60.06 -57.4 13.01 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.457 -0.777 . . . . 0.0 109.903 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.684 HD12 ' O ' ' A' ' 152' ' ' ALA . 3.6 mp -46.74 -57.04 5.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.508 -0.745 . . . . 0.0 110.591 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -52.36 -52.42 53.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.292 -0.88 . . . . 0.0 110.093 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.02 -38.64 79.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 0.0 109.907 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -68.11 -31.88 71.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -0.872 . . . . 0.0 109.813 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -80.82 -24.17 38.67 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.3 -0.875 . . . . 0.0 110.045 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.78 -40.34 94.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.31 -0.869 . . . . 0.0 110.072 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.416 HG21 ' CE1' ' A' ' 167' ' ' PHE . 1.5 tt -89.98 151.04 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.33 -0.856 . . . . 0.0 109.978 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.59 16.28 4.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.157 -0.965 . . . . 0.0 110.665 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.62 ' O ' HD13 ' A' ' 165' ' ' ILE . 5.8 p-10 -125.5 14.21 8.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.029 -1.045 . . . . 0.0 110.604 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.624 HD12 HG21 ' A' ' 138' ' ' VAL . 47.8 mm -134.91 135.53 23.35 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.018 -1.051 . . . . 0.0 110.15 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -78.3 81.62 2.68 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.543 1.286 . . . . 0.0 110.873 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.509 ' CE2' HG11 ' A' ' 140' ' ' VAL . 5.4 m-85 -71.14 145.19 49.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.133 -0.979 . . . . 0.0 109.857 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.515 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -137.65 159.29 24.88 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 121' ' ' THR . 4.4 tt -150.75 149.34 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -1.165 . . . . 0.0 110.304 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.447 HG21 HG11 ' A' ' 175' ' ' VAL . 3.3 t -168.82 157.12 8.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.188 -0.945 . . . . 0.0 111.005 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.447 ' HA ' ' CE1' ' A' ' 176' ' ' PHE . 87.6 p -125.54 2.84 7.62 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.378 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -61.73 124.2 20.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.171 -0.956 . . . . 0.0 110.248 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.06 -31.52 7.96 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.189 -0.945 . . . . 0.0 110.553 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.43 -41.78 66.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 110.023 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.771 HG12 ' CE2' ' A' ' 143' ' ' PHE . 61.3 t -75.54 -24.01 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.299 -0.875 . . . . 0.0 109.963 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.447 ' CE1' ' HA ' ' A' ' 171' ' ' SER . 10.6 m-85 -77.28 -54.29 6.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.891 . . . . 0.0 109.721 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.34 -21.86 60.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.367 -0.833 . . . . 0.0 110.085 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.4 ' HD2' ' HA3' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -62.95 -58.79 6.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 110.086 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.42 ' O ' ' HG2' ' A' ' 180' ' ' GLN . 96.3 m-85 -94.78 30.47 2.06 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.194 -0.941 . . . . 0.0 110.456 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 179' ' ' TYR . 0.1 OUTLIER 29.57 62.02 0.16 Allowed 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 179.728 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.9 mt -89.61 128.24 36.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.073 -1.017 . . . . 0.0 109.962 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.29 -3.86 29.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.933 . . . . 0.0 110.74 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -174.77 -147.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.99 -1.069 . . . . 0.0 109.876 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -89.14 150.32 22.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.191 -0.943 . . . . 0.0 109.974 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -179.82 137.61 3.13 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.652 HG11 ' CE1' ' A' ' 155' ' ' PHE . 18.8 m -100.59 119.27 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.274 -1.133 . . . . 0.0 110.357 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.831 HG22 ' HA ' ' A' ' 198' ' ' ASN . 98.0 t -121.39 150.35 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.924 . . . . 0.0 110.029 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.91 HD22 ' HB3' ' A' ' 215' ' ' ASN . 6.3 tt -106.39 144.29 33.28 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.217 -0.927 . . . . 0.0 108.903 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -119.83 122.0 40.36 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.896 -1.127 . . . . 0.0 110.545 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.504 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -130.14 165.4 22.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 110.116 179.687 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.4 mmtm -84.32 -33.29 23.94 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.297 -0.877 . . . . 0.0 110.396 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.504 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.2 OUTLIER -90.9 -173.65 3.76 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.54 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 56.11 -153.86 0.34 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.23 -0.919 . . . . 0.0 110.076 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -71.93 -24.87 61.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.7 -0.625 . . . . 0.0 110.378 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 103.4 -30.53 10.16 Favored Glycine 0 N--CA 1.484 1.861 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -130.3 175.75 8.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.125 -1.221 . . . . 0.0 110.454 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . 0.509 ' HB3' ' CZ ' ' A' ' 211' ' ' PHE . 1.7 m-80 -139.7 -44.64 0.44 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.322 -0.861 . . . . 0.0 110.227 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.831 ' HA ' HG22 ' A' ' 187' ' ' VAL . 0.3 OUTLIER 63.66 87.42 0.11 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.346 -0.846 . . . . 0.0 109.839 -179.308 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -57.85 134.74 56.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.448 -0.783 . . . . 0.0 110.472 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -130.63 114.84 15.93 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.273 -0.892 . . . . 0.0 109.831 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 139.95 -128.61 3.96 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -115.16 125.3 53.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.238 -1.154 . . . . 0.0 110.272 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.571 HG11 ' HZ ' ' A' ' 144' ' ' PHE . 70.8 t -74.78 107.02 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 110.029 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.452 HG23 ' C ' ' A' ' 203' ' ' VAL . 50.0 p -148.0 158.69 44.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.326 -0.859 . . . . 0.0 110.161 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.54 ' O ' HD12 ' A' ' 209' ' ' LEU . 5.1 tttt -49.22 -52.61 25.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.216 -0.927 . . . . 0.0 110.804 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -57.56 -37.15 72.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.315 -0.866 . . . . 0.0 110.429 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 45.2 m-20 -81.65 -42.89 19.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.435 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.839 ' O ' HD12 ' A' ' 212' ' ' ILE . 51.1 mt -57.86 -54.71 43.83 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.226 -0.921 . . . . 0.0 110.257 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.54 HD12 ' O ' ' A' ' 205' ' ' LYS . 0.4 OUTLIER -54.54 -28.19 43.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.148 -0.97 . . . . 0.0 109.748 179.732 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -77.05 -43.62 33.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.414 -0.804 . . . . 0.0 109.691 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.509 ' CZ ' ' HB3' ' A' ' 197' ' ' ASN . 8.4 t80 -62.01 -59.85 4.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.418 -0.801 . . . . 0.0 110.025 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.839 HD12 ' O ' ' A' ' 208' ' ' LEU . 4.7 mt -50.1 -40.47 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.306 -0.871 . . . . 0.0 110.375 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -66.04 -32.3 73.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.332 -0.855 . . . . 0.0 110.07 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.656 ' HA ' HD12 ' A' ' 217' ' ' LEU . 16.8 t60 -90.44 8.38 34.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.275 -0.89 . . . . 0.0 110.716 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.91 ' HB3' HD22 ' A' ' 188' ' ' LEU . 6.8 m120 -95.55 -61.99 1.37 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.892 -1.13 . . . . 0.0 110.165 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -70.34 62.04 0.23 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.308 -0.87 . . . . 0.0 110.557 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.656 HD12 ' HA ' ' A' ' 214' ' ' HIS . 24.7 mt -138.06 97.39 9.82 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.881 . . . . 0.0 110.2 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.57 99.2 0.92 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.676 1.356 . . . . 0.0 110.326 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 37.4 mt -80.27 56.21 2.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.274 -0.891 . . . . 0.0 110.388 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.555 ' O ' HG13 ' A' ' 220' ' ' VAL . 14.5 p -96.58 57.01 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.927 . . . . 0.0 110.258 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 3.1 mt -70.24 92.97 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 110.237 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -138.32 25.78 2.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.135 -0.978 . . . . 0.0 110.104 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -74.63 -175.54 2.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.396 -0.815 . . . . 0.0 110.267 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 224' ' ' THR . 5.9 t -106.28 33.67 3.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.218 -0.926 . . . . 0.0 110.249 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -104.1 -50.32 3.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.875 . . . . 0.0 110.13 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 53.01 58.27 5.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.29 -0.881 . . . . 0.0 110.329 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 57.6 m -137.92 -51.59 0.61 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 110.336 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.206 179.98 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.548 ' HB1' ' HB3' ' A' ' 159' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.304 0.573 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.502 ' HB1' ' CA ' ' A' ' 168' ' ' GLY . . . -129.06 166.54 19.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.255 -0.903 . . . . 0.0 110.051 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.525 HG22 ' HA2' ' A' ' 168' ' ' GLY . 12.8 t -82.54 162.03 22.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.093 -1.004 . . . . 0.0 109.917 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.1 m -97.42 119.87 36.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.951 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.669 HD22 ' HB1' ' A' ' 128' ' ' ALA . 40.7 mt -105.92 134.13 19.88 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.95 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.22 -39.16 1.72 Allowed 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.466 1.245 . . . . 0.0 110.054 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.47 ' C ' HG22 ' A' ' 175' ' ' VAL . 0.4 OUTLIER -158.37 -169.31 2.72 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.056 0.932 . . . . 0.0 110.873 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.408 ' HA3' ' HD3' ' A' ' 178' ' ' LYS . . . -63.11 -21.92 64.4 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.77 -27.78 63.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -1.113 . . . . 0.0 110.389 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.669 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -88.45 -31.95 18.52 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.093 -1.004 . . . . 0.0 110.061 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -55.17 -22.02 15.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 109.913 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -89.17 -35.61 16.14 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.299 -0.875 . . . . 0.0 109.025 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.0 m -69.89 -23.94 63.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 109.967 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.2 tp -72.73 -48.64 36.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.337 -0.852 . . . . 0.0 110.072 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.9 HG22 ' HB3' ' A' ' 189' ' ' PHE . 46.9 t -52.74 -43.77 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.338 -0.851 . . . . 0.0 110.31 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -78.84 -20.82 48.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.238 -0.914 . . . . 0.0 110.429 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 25.3 t -56.72 -56.36 22.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -0.927 . . . . 0.0 110.165 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 86.8 p -128.97 165.75 20.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 0.0 110.301 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.627 ' HG3' HG23 ' A' ' 138' ' ' VAL . 18.3 pt-20 -57.94 -40.77 81.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.27 -0.894 . . . . 0.0 110.098 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.627 HG23 ' HG3' ' A' ' 137' ' ' GLU . 74.6 t -124.01 144.8 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.405 -0.809 . . . . 0.0 110.154 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -170.47 144.55 2.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.328 -0.858 . . . . 0.0 109.709 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.624 HG11 ' CE2' ' A' ' 167' ' ' PHE . 7.3 p -129.35 153.05 38.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 121.011 -1.056 . . . . 0.0 110.252 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 20.5 mt -131.41 123.07 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.88 . . . . 0.0 109.9 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -85.81 129.01 9.09 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.62 ' CE2' HG12 ' A' ' 175' ' ' VAL . 28.8 m-85 -101.74 78.98 1.88 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -1.159 . . . . 0.0 109.898 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.483 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 10.9 m-85 -106.17 146.4 30.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.199 -0.938 . . . . 0.0 111.051 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.11 -27.12 18.77 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.617 0.722 . . . . 0.0 109.522 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.55 73.72 1.55 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.664 -0.647 . . . . 0.0 109.405 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.526 ' O ' ' HB3' ' A' ' 152' ' ' ALA . 21.7 m -49.3 -23.35 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.397 -0.815 . . . . 0.0 111.02 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -81.57 7.12 12.91 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.965 -1.084 . . . . 0.0 111.255 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.6 p -78.52 -164.37 0.56 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.864 -1.148 . . . . 0.0 110.506 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -91.04 -24.41 20.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.521 -0.737 . . . . 0.0 110.282 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.64 -30.66 46.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.29 -0.881 . . . . 0.0 109.974 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 147' ' ' VAL . . . -80.26 -19.96 45.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 0.0 110.196 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -38.83 92.72 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.309 -0.869 . . . . 0.0 109.925 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -69.97 -42.14 73.54 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.396 -0.815 . . . . 0.0 110.027 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.423 ' HE1' HG13 ' A' ' 186' ' ' VAL . 4.3 t80 -50.86 -57.75 7.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.359 -0.838 . . . . 0.0 110.337 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.442 ' HA ' ' HB1' ' A' ' 119' ' ' ALA . 74.9 mt -57.43 -49.7 75.39 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.435 -0.79 . . . . 0.0 110.095 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -52.33 -52.98 50.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.511 -0.743 . . . . 0.0 110.304 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.623 ' HB2' ' HG3' ' A' ' 205' ' ' LYS . . . -66.64 -46.0 77.2 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.192 -0.942 . . . . 0.0 110.173 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.548 ' HB3' ' HB1' ' A' ' 119' ' ' ALA . . . -53.15 -32.41 47.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.209 -0.932 . . . . 0.0 110.223 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -66.84 -38.42 86.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 110.2 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.81 -40.79 92.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.263 -0.898 . . . . 0.0 110.162 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 72.3 mt -91.53 92.53 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.292 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -90.62 -27.83 18.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -0.872 . . . . 0.0 110.308 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 164' ' ' ASP . 16.2 p-10 -57.79 -26.62 62.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.915 . . . . 0.0 110.221 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.411 HD12 ' CG1' ' A' ' 138' ' ' VAL . 45.9 mm -104.75 127.24 29.26 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.175 -0.953 . . . . 0.0 109.953 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -78.24 85.84 1.76 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.448 1.236 . . . . 0.0 110.675 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.624 ' CE2' HG11 ' A' ' 140' ' ' VAL . 3.8 m-85 -66.16 174.88 2.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.087 -1.008 . . . . 0.0 109.996 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.525 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -150.11 151.37 23.45 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 6.3 tt -150.47 142.46 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.939 -1.33 . . . . 0.0 110.539 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.493 ' CG2' HG11 ' A' ' 175' ' ' VAL . 2.2 t -160.78 155.67 24.08 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.013 0.911 . . . . 0.0 110.759 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 24.5 p -115.57 -1.9 12.64 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.589 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.416 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 20.4 t30 -52.65 164.24 0.37 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.195 -0.941 . . . . 0.0 110.161 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 26.2 p -91.44 -33.41 15.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.221 -0.924 . . . . 0.0 109.958 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -57.29 -27.4 62.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.229 -0.919 . . . . 0.0 109.826 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.62 HG12 ' CE2' ' A' ' 143' ' ' PHE . 47.6 t -78.08 -29.14 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.336 -0.852 . . . . 0.0 109.725 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 176' ' ' PHE . 16.7 m-85 -85.27 -50.2 7.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.4 -0.812 . . . . 0.0 109.685 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 32.6 m -62.34 -18.05 60.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.433 -0.792 . . . . 0.0 110.361 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.408 ' HD3' ' HA3' ' A' ' 126' ' ' GLY . 5.3 tttp -74.61 -50.59 17.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.16 -0.963 . . . . 0.0 109.922 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -89.55 14.46 11.46 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.147 -0.97 . . . . 0.0 110.37 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 49.11 65.01 1.5 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.214 -0.928 . . . . 0.0 110.848 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 14.2 mt -112.75 100.95 9.08 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.061 -1.024 . . . . 0.0 109.794 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -57.96 -19.0 27.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.032 -1.042 . . . . 0.0 110.089 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt -147.38 -165.2 2.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -0.959 . . . . 0.0 109.661 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -60.31 156.81 14.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.089 -1.007 . . . . 0.0 109.855 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -159.98 118.83 0.85 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.54 HG21 ' CG2' ' A' ' 203' ' ' VAL . 79.7 t -99.21 95.75 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -1.128 . . . . 0.0 110.111 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.502 ' O ' HG23 ' A' ' 140' ' ' VAL . 94.9 t -113.71 152.66 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.299 -0.875 . . . . 0.0 109.862 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.706 ' CD1' HD13 ' A' ' 212' ' ' ILE . 7.7 tt -108.27 155.45 20.47 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.052 -1.03 . . . . 0.0 109.868 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.9 ' HB3' HG22 ' A' ' 133' ' ' VAL . 60.5 m-85 -125.0 126.38 45.35 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.943 -1.098 . . . . 0.0 110.466 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.445 ' HD2' ' CD2' ' A' ' 188' ' ' LEU . 0.0 OUTLIER -134.8 179.18 6.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.379 -0.826 . . . . 0.0 110.074 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -102.52 -29.57 11.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.171 -0.955 . . . . 0.0 110.311 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -90.96 -174.39 3.99 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.446 -0.784 . . . . 0.0 110.811 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 48.0 -159.11 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.643 0.735 . . . . 0.0 110.863 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -50.94 -51.8 48.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.568 -0.707 . . . . 0.0 110.359 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 123.47 -21.58 7.18 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -141.42 177.51 8.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -1.186 . . . . 0.0 110.399 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . 0.454 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.1 m-80 -141.89 -152.73 0.42 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.364 -0.835 . . . . 0.0 109.527 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.462 ' HA ' HG22 ' A' ' 187' ' ' VAL . 11.5 p-10 -175.43 79.1 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.274 -0.891 . . . . 0.0 110.496 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -64.34 117.54 7.38 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.384 -0.822 . . . . 0.0 109.88 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -122.64 28.88 7.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 110.571 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -110.92 -123.1 4.4 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 204' ' ' THR . 6.4 mt-10 -119.07 100.45 7.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.292 -1.122 . . . . 0.0 109.885 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.67 ' O ' HG13 ' A' ' 203' ' ' VAL . 7.3 p -51.17 93.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 110.699 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.42 ' N ' ' O ' ' A' ' 202' ' ' GLU . 21.9 p -136.03 160.88 37.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 109.995 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.623 ' HG3' ' HB2' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -50.46 -50.21 53.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.292 -0.88 . . . . 0.0 110.662 -179.823 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 207' ' ' ASN . 16.6 pt-20 -61.89 -41.22 97.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.24 -0.912 . . . . 0.0 110.552 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.425 ' N ' ' HG3' ' A' ' 206' ' ' GLU . 70.2 m-20 -73.24 -40.08 64.95 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.142 -0.974 . . . . 0.0 110.113 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 208' ' ' LEU . 54.7 mt -61.9 -45.95 91.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.868 . . . . 0.0 110.066 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.534 HD12 ' O ' ' A' ' 205' ' ' LYS . 12.0 mt -59.45 -25.68 64.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.861 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -85.05 -46.11 11.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.292 -0.88 . . . . 0.0 109.901 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.422 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 22.3 t80 -48.22 -53.27 17.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.388 -0.82 . . . . 0.0 110.169 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.706 HD13 ' CD1' ' A' ' 188' ' ' LEU . 21.4 mm -48.92 -71.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.409 -0.807 . . . . 0.0 110.085 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.445 ' HA ' ' HG2' ' A' ' 216' ' ' GLN . 20.8 mttt -46.2 -34.38 4.29 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.71 -0.619 . . . . 0.0 110.965 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -71.64 -27.91 63.41 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.216 -0.927 . . . . 0.0 110.587 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 79.7 m-20 -97.84 -51.36 4.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.082 -1.012 . . . . 0.0 110.988 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.467 ' NE2' HG22 ' A' ' 212' ' ' ILE . 3.5 pt20 -52.39 -24.05 7.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.042 -1.036 . . . . 0.0 110.53 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 16.5 mt -129.94 101.97 17.91 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.316 -0.865 . . . . 0.0 110.286 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.46 134.61 24.8 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.532 1.28 . . . . 0.0 110.494 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.7 48.43 1.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.272 -0.893 . . . . 0.0 110.308 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.665 ' O ' HG12 ' A' ' 220' ' ' VAL . 59.4 t -120.93 31.46 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 110.102 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.53 ' O ' HG23 ' A' ' 221' ' ' ILE . 0.5 OUTLIER -172.01 124.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.4 -0.813 . . . . 0.0 109.967 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -127.04 116.53 20.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.23 -0.918 . . . . 0.0 110.281 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -145.09 37.2 1.14 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.196 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 6.6 p -121.81 37.54 4.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.23 -0.919 . . . . 0.0 110.103 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -94.02 126.25 39.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.184 -0.947 . . . . 0.0 110.318 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 52.55 46.27 27.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 110.36 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.492 HG22 ' N ' ' A' ' 228' ' ' ALA . 29.3 m -156.98 170.8 21.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.311 -0.868 . . . . 0.0 110.232 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.492 ' N ' HG22 ' A' ' 227' ' ' THR . . . . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.251 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.252 0.548 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -92.34 -178.94 5.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.9 . . . . 0.0 110.338 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.449 HG22 ' HA2' ' A' ' 168' ' ' GLY . 14.6 t -118.61 161.14 20.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 110.219 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.8 m -99.85 110.16 22.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 0.0 109.835 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.421 ' HB2' ' HB ' ' A' ' 170' ' ' THR . 34.9 mt -87.66 113.01 52.43 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.231 -0.918 . . . . 0.0 110.072 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.17 -24.13 23.79 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.491 1.258 . . . . 0.0 110.373 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.61 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 1.1 p30 -173.77 -169.88 0.53 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.307 -0.871 . . . . 0.0 110.541 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.406 ' HA3' ' HD2' ' A' ' 178' ' ' LYS . . . -59.24 -25.24 59.89 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.61 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -53.5 -34.24 57.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -1.132 . . . . 0.0 110.222 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.31 -36.27 14.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 110.149 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.13 -19.94 62.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 110.271 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -88.5 -60.03 2.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 0.0 110.262 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.5 t -55.27 -21.56 14.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.198 -0.939 . . . . 0.0 110.243 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.669 HD23 HD11 ' A' ' 141' ' ' ILE . 18.0 tp -69.92 -48.69 57.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 0.0 110.035 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.641 HG22 ' CB ' ' A' ' 189' ' ' PHE . 60.7 t -65.46 -37.82 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.834 . . . . 0.0 110.398 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -83.75 5.85 23.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.114 -0.991 . . . . 0.0 110.816 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.9 t -90.19 -27.83 19.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.95 -1.094 . . . . 0.0 110.353 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.53 165.06 33.34 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.208 -0.933 . . . . 0.0 110.523 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -65.17 -19.03 65.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.395 -0.816 . . . . 0.0 109.859 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 43.4 t -136.96 149.71 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.9 . . . . 0.0 110.201 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.455 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -175.32 142.61 0.61 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.379 -0.826 . . . . 0.0 109.551 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.673 HG11 HD11 ' A' ' 212' ' ' ILE . 3.6 m -124.15 158.38 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 118.979 -1.089 . . . . 0.0 111.07 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.669 HD11 HD23 ' A' ' 132' ' ' LEU . 60.5 mt -148.22 104.31 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.651 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.82 128.04 9.9 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.834 ' CE2' HG12 ' A' ' 175' ' ' VAL . 37.8 m-85 -98.8 84.56 3.13 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.139 -1.212 . . . . 0.0 109.488 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.673 ' HZ ' HG11 ' A' ' 203' ' ' VAL . 16.4 m-85 -105.85 141.35 37.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.087 -1.008 . . . . 0.0 111.361 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.61 -28.94 26.18 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.959 -0.696 . . . . 0.0 110.015 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.04 87.0 2.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.367 -0.833 . . . . 0.0 109.895 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 98.0 t -60.18 -21.41 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.39 -0.819 . . . . 0.0 110.713 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -82.26 1.01 38.73 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.163 -0.961 . . . . 0.0 111.06 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 82.4 p -81.17 -168.08 1.69 Allowed 'General case' 0 C--N 1.307 -1.271 0 O-C-N 120.921 -1.112 . . . . 0.0 110.379 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -90.22 -18.08 26.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.423 -0.798 . . . . 0.0 110.168 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.476 ' CB ' ' CE1' ' A' ' 144' ' ' PHE . 1.4 m -71.4 -33.15 69.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.193 -0.942 . . . . 0.0 110.235 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.36 -37.64 27.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.141 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -55.92 -40.05 72.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.894 . . . . 0.0 110.094 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -64.19 -42.47 96.64 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.271 -0.893 . . . . 0.0 110.054 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.423 ' HA ' HD13 ' A' ' 208' ' ' LEU . 3.9 t80 -51.44 -55.45 18.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.362 -0.836 . . . . 0.0 110.18 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 156' ' ' LEU . 25.8 mt -54.58 -55.18 32.08 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.298 -0.876 . . . . 0.0 110.244 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.406 ' HB3' ' HD2' ' A' ' 205' ' ' LYS . 89.5 mt-30 -51.31 -49.65 60.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.329 -0.857 . . . . 0.0 110.129 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.601 ' HB2' ' HA ' ' A' ' 205' ' ' LYS . . . -63.52 -36.99 85.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 109.78 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.747 ' HB1' ' CD2' ' A' ' 167' ' ' PHE . . . -68.84 -29.61 67.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.301 -0.874 . . . . 0.0 109.947 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -67.7 -39.86 84.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.342 -0.849 . . . . 0.0 110.12 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.68 -50.35 66.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.863 . . . . 0.0 110.034 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.427 ' CG2' ' OD1' ' A' ' 164' ' ' ASP . 96.7 mt -97.38 163.4 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 109.806 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.425 ' N ' HG22 ' A' ' 162' ' ' ILE . 22.1 m-20 -136.73 -40.61 0.62 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.118 -0.989 . . . . 0.0 110.548 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.427 ' OD1' ' CG2' ' A' ' 162' ' ' ILE . 26.3 p-10 -55.29 -24.75 30.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 110.593 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.485 ' HB ' ' CE1' ' A' ' 167' ' ' PHE . 31.3 mm -92.59 129.78 39.34 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.073 -1.017 . . . . 0.0 110.226 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.455 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 55.2 Cg_endo -79.06 117.67 3.91 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 123.466 1.245 . . . . 0.0 110.274 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.747 ' CD2' ' HB1' ' A' ' 159' ' ' ALA . 6.1 m-85 -107.32 124.3 49.61 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.089 -1.007 . . . . 0.0 109.427 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.449 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -120.74 154.95 16.33 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 6.7 tt -150.43 140.94 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.124 -1.221 . . . . 0.0 110.78 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.421 ' HB ' ' HB2' ' A' ' 123' ' ' LEU . 1.8 t -155.12 156.93 36.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.307 -0.871 . . . . 0.0 110.414 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.1 t -119.87 1.35 10.98 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.468 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 41.4 p30 -67.93 151.29 47.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.117 -0.989 . . . . 0.0 109.985 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.8 p -78.44 -18.7 54.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.188 -0.945 . . . . 0.0 110.66 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.01 -39.14 84.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.933 . . . . 0.0 110.254 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.834 HG12 ' CE2' ' A' ' 143' ' ' PHE . 46.4 t -79.61 -24.45 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -0.956 . . . . 0.0 109.922 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.468 ' CD1' ' O ' ' A' ' 172' ' ' ASN . 9.0 m-85 -75.44 -50.59 15.33 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.32 -0.863 . . . . 0.0 109.878 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.18 -19.19 64.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.473 -0.767 . . . . 0.0 110.45 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.406 ' HD2' ' HA3' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -62.66 -56.47 17.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.971 . . . . 0.0 110.282 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.52 ' HB2' HD13 ' A' ' 181' ' ' LEU . 92.3 m-85 -92.83 26.28 2.81 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.18 -0.95 . . . . 0.0 110.374 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.552 ' C ' HD12 ' A' ' 181' ' ' LEU . 2.2 mm-40 55.97 67.06 1.06 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.498 -0.751 . . . . 0.0 110.712 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.552 HD12 ' C ' ' A' ' 180' ' ' GLN . 6.6 mp -124.7 102.98 7.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.555 -0.715 . . . . 0.0 110.227 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.405 ' O ' ' HG3' ' A' ' 183' ' ' LYS . 0.8 OUTLIER -88.74 14.7 9.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -0.935 . . . . 0.0 110.147 179.366 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 182' ' ' ASP . 6.2 mtmm -162.49 -165.3 1.15 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.276 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 10.6 p-10 -82.86 157.87 22.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.949 -1.094 . . . . 0.0 110.138 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 179.14 121.71 0.73 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.418 ' O ' ' CB ' ' A' ' 199' ' ' PHE . 94.7 t -92.8 121.62 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.329 -1.101 . . . . 0.0 110.049 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.858 HG22 ' HA ' ' A' ' 198' ' ' ASN . 90.6 t -128.97 149.77 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 0.0 109.83 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.804 HD12 HD13 ' A' ' 212' ' ' ILE . 8.5 tt -104.61 131.5 51.96 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.995 -1.066 . . . . 0.0 108.458 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.641 ' CB ' HG22 ' A' ' 133' ' ' VAL . 57.3 m-85 -102.95 121.64 42.95 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.899 -1.126 . . . . 0.0 110.902 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.402 ' HD3' HD23 ' A' ' 188' ' ' LEU . 0.1 OUTLIER -131.5 168.02 18.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.545 -0.722 . . . . 0.0 110.213 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -89.58 -24.9 21.6 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.293 -0.879 . . . . 0.0 110.579 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -90.71 -175.45 4.4 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.43 -0.794 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 47.08 -159.24 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.53 -0.732 . . . . 0.0 110.724 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -59.67 -44.25 93.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.642 -0.661 . . . . 0.0 110.265 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 128.99 -31.5 3.48 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.08 171.48 11.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -1.21 . . . . 0.0 110.532 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . 0.536 ' H ' HG13 ' A' ' 187' ' ' VAL . 3.5 m-80 -131.66 -35.12 1.3 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.317 -0.864 . . . . 0.0 111.188 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.858 ' HA ' HG22 ' A' ' 187' ' ' VAL . 0.8 OUTLIER 63.71 85.45 0.13 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.152 -0.968 . . . . 0.0 110.015 -179.193 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.432 ' C ' ' CD1' ' A' ' 199' ' ' PHE . 9.4 t80 -62.16 118.73 7.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.398 -0.814 . . . . 0.0 110.161 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -113.63 101.5 9.38 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.264 -0.897 . . . . 0.0 110.511 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 157.13 -140.11 6.91 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -107.48 113.47 26.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.309 -1.113 . . . . 0.0 110.102 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.673 HG11 ' HZ ' ' A' ' 144' ' ' PHE . 7.5 p -64.29 110.74 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 110.218 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 70.5 p -143.13 157.14 44.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.167 -0.958 . . . . 0.0 110.376 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.855 ' O ' HD12 ' A' ' 209' ' ' LEU . 12.2 tttt -51.1 -49.59 60.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.322 -0.861 . . . . 0.0 110.397 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -61.13 -34.67 75.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 110.097 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -78.72 -47.69 16.39 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.207 -0.933 . . . . 0.0 110.084 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 155' ' ' PHE . 80.7 mt -52.78 -37.95 60.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.196 -0.94 . . . . 0.0 110.054 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.855 HD12 ' O ' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -71.08 -23.07 62.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.29 -0.881 . . . . 0.0 109.924 179.755 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.66 -45.81 9.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.362 -0.836 . . . . 0.0 109.88 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.421 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 25.6 t80 -49.66 -50.15 44.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.213 -0.929 . . . . 0.0 109.822 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.804 HD13 HD12 ' A' ' 188' ' ' LEU . 23.5 mm -50.72 -73.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.467 -0.771 . . . . 0.0 110.296 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -46.21 -25.87 0.68 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.705 -0.622 . . . . 0.0 111.114 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -76.51 -23.19 53.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 110.568 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.421 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 78.2 m-20 -101.42 -57.62 2.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.182 -0.949 . . . . 0.0 110.866 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 212' ' ' ILE . 2.9 pt20 -51.52 178.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.1 -1.0 . . . . 0.0 110.588 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 81.4 mt 53.32 72.88 1.03 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 110.428 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.58 168.45 24.38 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.684 1.36 . . . . 0.0 110.282 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.37 -168.76 1.35 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -0.937 . . . . 0.0 110.233 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 95.1 t -105.12 134.16 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.931 . . . . 0.0 110.189 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 73.1 mt -105.19 77.45 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.907 . . . . 0.0 110.173 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.92 32.77 3.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 0.0 110.192 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -152.62 145.0 24.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.906 . . . . 0.0 110.213 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 18.1 m -135.31 123.23 22.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 109.969 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -89.46 -179.16 5.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.318 -0.864 . . . . 0.0 110.383 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.35 -45.65 5.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.329 -0.857 . . . . 0.0 110.107 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.8 p -128.17 99.89 5.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.298 -0.877 . . . . 0.0 110.216 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.102 -0.952 . . . . 0.0 110.299 179.933 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.293 0.568 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 167' ' ' PHE . . . -59.44 -178.27 0.06 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.159 -0.963 . . . . 0.0 110.112 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.546 HG22 ' HA2' ' A' ' 168' ' ' GLY . 9.9 t -108.49 167.65 9.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.106 -0.996 . . . . 0.0 110.246 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.3 m -110.48 109.25 19.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 110.115 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.9 mt -87.14 126.4 62.93 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.334 -0.853 . . . . 0.0 110.097 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 46.0 Cg_endo -71.73 -22.45 23.89 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.457 1.241 . . . . 0.0 110.462 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.495 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.8 OUTLIER -174.31 -170.64 0.54 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.183 -0.948 . . . . 0.0 110.938 179.885 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.82 -34.79 90.79 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.495 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -51.63 -24.93 6.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -1.159 . . . . 0.0 110.343 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.431 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -90.13 -27.14 19.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.941 . . . . 0.0 110.191 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.17 -18.53 65.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 110.266 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -89.75 -48.7 7.09 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.158 -0.964 . . . . 0.0 109.21 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 32.4 p -63.35 -19.75 64.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.28 -0.888 . . . . 0.0 110.253 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.459 HD22 ' HB1' ' A' ' 139' ' ' ALA . 1.6 tt -73.83 -58.96 2.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.209 -0.932 . . . . 0.0 110.262 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.651 HG13 ' HB3' ' A' ' 189' ' ' PHE . 48.1 t -50.03 -25.34 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.268 -0.895 . . . . 0.0 110.581 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.96 -20.11 23.7 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.253 -0.905 . . . . 0.0 109.846 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.7 m -54.45 -50.67 67.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.162 -0.961 . . . . 0.0 110.362 -179.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.4 p -130.87 -173.52 3.11 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.12 -0.987 . . . . 0.0 110.487 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.01 -45.12 28.39 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.22 -0.925 . . . . 0.0 109.988 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.3 m -115.22 130.07 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.353 -0.842 . . . . 0.0 109.97 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.459 ' HB1' HD22 ' A' ' 132' ' ' LEU . . . -152.76 148.22 26.98 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.123 -0.986 . . . . 0.0 110.015 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.499 ' CG1' ' CD1' ' A' ' 167' ' ' PHE . 7.1 p -130.9 149.97 34.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.104 -0.998 . . . . 0.0 110.437 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.42 ' CG1' HD13 ' A' ' 132' ' ' LEU . 45.7 mt -133.9 124.13 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.424 -0.797 . . . . 0.0 109.682 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -90.74 131.75 10.93 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.587 ' CD2' HG12 ' A' ' 175' ' ' VAL . 22.0 m-85 -103.95 69.69 0.96 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -1.149 . . . . 0.0 109.643 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -94.9 139.02 31.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.145 -0.972 . . . . 0.0 110.769 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -76.2 -27.84 57.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.427 -0.796 . . . . 0.0 110.136 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -126.89 88.46 2.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 0.0 109.908 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 45.1 t -55.55 -21.03 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.449 -0.782 . . . . 0.0 110.36 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -91.79 18.39 7.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -0.897 . . . . 0.0 110.622 -179.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 86.8 p -87.2 -164.64 1.12 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.948 . . . . 0.0 110.169 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.409 ' HA ' ' HG3' ' A' ' 153' ' ' LYS . 28.0 t70 -90.13 -34.09 16.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.348 -0.845 . . . . 0.0 110.141 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 49.3 m -63.81 -31.7 72.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.3 -0.875 . . . . 0.0 110.245 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.55 -28.58 59.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.824 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.409 ' HG3' ' HA ' ' A' ' 150' ' ' ASP . 3.6 mmtt -58.66 -52.0 67.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.418 -0.801 . . . . 0.0 110.184 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' A' ' 204' ' ' THR . 7.0 mm-40 -61.22 -39.73 91.36 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.182 -0.949 . . . . 0.0 110.083 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.475 ' HE1' HG13 ' A' ' 186' ' ' VAL . 5.1 t80 -47.62 -54.9 10.56 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.304 -0.873 . . . . 0.0 110.606 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.411 ' O ' ' HB3' ' A' ' 159' ' ' ALA . 17.2 mt -55.57 -53.35 57.54 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.414 -0.804 . . . . 0.0 110.33 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.419 ' HB3' ' HD2' ' A' ' 205' ' ' LYS . 4.2 mt-30 -49.78 -50.22 45.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.325 -0.859 . . . . 0.0 110.464 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -64.24 -25.03 67.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.18 -0.95 . . . . 0.0 110.052 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.721 ' HB2' ' CD2' ' A' ' 167' ' ' PHE . . . -76.1 -41.06 51.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.309 -0.87 . . . . 0.0 110.324 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -76.02 -9.64 58.78 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.291 -0.88 . . . . 0.0 110.909 -179.69 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -118.0 28.12 8.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.971 -1.081 . . . . 0.0 110.565 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.655 HD13 ' CZ ' ' A' ' 167' ' ' PHE . 5.7 tt -113.44 176.76 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.077 -1.014 . . . . 0.0 110.25 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.48 63.36 0.16 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.896 . . . . 0.0 110.511 -179.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 162' ' ' ILE . 3.7 p-10 40.92 50.91 3.16 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.535 0.683 . . . . 0.0 111.628 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.512 ' CG2' ' HD2' ' A' ' 166' ' ' PRO . 42.7 mm -88.77 149.2 43.33 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.472 -0.767 . . . . 0.0 109.097 179.044 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.512 ' HD2' ' CG2' ' A' ' 165' ' ' ILE . 43.8 Cg_endo -81.43 99.75 1.09 Allowed 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.555 1.292 . . . . 0.0 110.772 -179.063 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.721 ' CD2' ' HB2' ' A' ' 159' ' ' ALA . 3.2 m-85 -92.12 131.05 37.68 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.524 -0.735 . . . . 0.0 110.109 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.546 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -121.61 144.53 16.52 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.979 -1.649 . . . . 0.0 108.979 179.244 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.402 ' O ' HG23 ' A' ' 169' ' ' ILE . 13.5 tt -140.75 135.36 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.268 -1.136 . . . . 0.0 110.86 -179.357 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.502 HG21 HG21 ' A' ' 175' ' ' VAL . 2.1 t -151.82 155.85 39.01 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.999 0.904 . . . . 0.0 110.386 179.189 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.9 t -125.3 4.62 7.76 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -65.72 132.32 48.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.223 -0.923 . . . . 0.0 110.409 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 88.6 p -54.26 -29.04 45.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.163 -0.961 . . . . 0.0 110.047 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -54.49 -35.48 63.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.939 . . . . 0.0 109.867 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.587 HG12 ' CD2' ' A' ' 143' ' ' PHE . 61.4 t -78.71 -25.67 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.409 -0.807 . . . . 0.0 109.728 179.599 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -79.13 -50.1 11.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 109.758 179.638 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 75.1 m -60.68 -19.19 57.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.863 . . . . 0.0 110.116 179.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.437 ' HD3' ' CE1' ' A' ' 179' ' ' TYR . 7.2 tttp -74.43 -51.46 14.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.132 -0.98 . . . . 0.0 109.653 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.437 ' CE1' ' HD3' ' A' ' 178' ' ' LYS . 78.3 m-85 -92.7 -5.34 51.53 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.436 -0.79 . . . . 0.0 110.427 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 56.77 63.61 1.89 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.128 -0.982 . . . . 0.0 111.079 179.457 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.0 mt -102.52 119.53 38.97 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.12 -0.988 . . . . 0.0 109.679 178.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.412 ' O ' ' CG ' ' A' ' 183' ' ' LYS . 5.8 t0 -65.2 -11.78 44.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 110.333 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.412 ' CG ' ' O ' ' A' ' 182' ' ' ASP . 0.5 OUTLIER -156.42 -165.78 1.98 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.175 -0.953 . . . . 0.0 109.545 -179.977 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.422 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 3.9 p30 -62.22 164.17 7.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.062 -1.024 . . . . 0.0 109.44 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -161.4 150.05 19.36 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.231 -179.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.475 HG13 ' HE1' ' A' ' 155' ' ' PHE . 77.3 t -132.09 84.95 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.49 -1.006 . . . . 0.0 109.506 179.58 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 47.6 t -101.31 159.8 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.336 -0.853 . . . . 0.0 110.472 -179.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.435 ' HB3' ' ND2' ' A' ' 197' ' ' ASN . 4.3 tt -116.44 155.08 29.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.866 . . . . 0.0 109.374 179.721 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.651 ' HB3' HG13 ' A' ' 133' ' ' VAL . 51.6 m-85 -125.03 127.21 46.62 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.898 -1.126 . . . . 0.0 110.659 -179.051 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.501 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.5 OUTLIER -141.03 166.86 23.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.315 -0.866 . . . . 0.0 110.235 179.751 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -91.21 -22.59 20.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 110.329 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.501 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 0.9 OUTLIER -91.08 -176.55 4.64 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.362 -0.837 . . . . 0.0 111.069 -179.988 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 48.04 -154.77 0.08 Allowed 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.802 0.81 . . . . 0.0 110.649 -179.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -57.37 -54.52 45.93 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.694 -0.629 . . . . 0.0 110.325 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 133.01 -24.21 3.83 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -139.41 176.34 8.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.208 -1.172 . . . . 0.0 110.548 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . 0.449 ' N ' ' ND2' ' A' ' 197' ' ' ASN . 0.7 OUTLIER -145.36 -155.33 0.6 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.389 -0.819 . . . . 0.0 109.786 -179.776 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -171.02 81.77 0.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.377 -0.827 . . . . 0.0 110.083 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -64.97 126.99 29.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.377 -0.827 . . . . 0.0 110.287 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -140.82 124.12 16.67 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.236 -0.915 . . . . 0.0 109.901 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 141.7 -167.62 25.84 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -62.67 109.02 1.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.339 -1.095 . . . . 0.0 110.26 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.456 ' C ' HG23 ' A' ' 204' ' ' THR . 91.7 t -65.88 112.24 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.226 -0.921 . . . . 0.0 110.203 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.456 HG23 ' C ' ' A' ' 203' ' ' VAL . 41.7 p -150.2 152.39 34.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.36 -0.838 . . . . 0.0 110.314 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.453 ' CE ' HD11 ' A' ' 209' ' ' LEU . 3.1 tttt -49.76 -52.67 30.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.3 -0.875 . . . . 0.0 110.487 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -54.34 -32.5 56.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 110.157 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -83.96 -41.46 17.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.27 -0.894 . . . . 0.0 110.044 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.452 ' CD2' HG11 ' A' ' 186' ' ' VAL . 27.4 mt -65.83 -41.79 91.35 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.311 -0.868 . . . . 0.0 110.061 179.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.453 HD11 ' CE ' ' A' ' 205' ' ' LYS . 85.7 mt -69.39 -21.74 63.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 0.0 110.128 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -83.81 -56.38 3.73 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.292 -0.88 . . . . 0.0 110.076 179.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.401 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 20.5 t80 -51.52 -53.02 42.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.237 -0.914 . . . . 0.0 110.146 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.627 HG21 HD11 ' A' ' 162' ' ' ILE . 84.6 mt -52.78 -58.5 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.348 -0.845 . . . . 0.0 110.178 179.753 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.443 ' HA ' ' CG ' ' A' ' 216' ' ' GLN . 14.4 tttt -49.24 -38.74 27.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 110.132 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.27 -22.81 67.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.399 -0.813 . . . . 0.0 109.826 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.401 ' ND2' ' O ' ' A' ' 211' ' ' PHE . 75.7 m-80 -96.77 -42.51 7.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.296 -0.878 . . . . 0.0 110.359 -179.682 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.443 ' CG ' ' HA ' ' A' ' 213' ' ' LYS . 2.1 pt20 -85.06 -176.83 6.36 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.2 -0.937 . . . . 0.0 110.205 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 19.0 mt 52.67 68.69 2.85 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.254 -0.904 . . . . 0.0 110.289 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.605 ' C ' HD22 ' A' ' 219' ' ' LEU . 47.0 Cg_endo -73.35 152.56 49.78 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.631 1.332 . . . . 0.0 110.303 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.605 HD22 ' C ' ' A' ' 218' ' ' PRO . 4.5 mm? -112.09 170.82 7.89 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.248 -0.908 . . . . 0.0 109.967 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.439 ' H ' HG22 ' A' ' 220' ' ' VAL . 29.1 m -103.39 38.57 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.521 -0.737 . . . . 0.0 110.561 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 59.8 mt 53.74 98.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.198 -0.939 . . . . 0.0 110.287 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -62.4 156.03 23.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.288 -0.883 . . . . 0.0 109.953 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -131.01 131.07 44.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.168 -0.957 . . . . 0.0 110.449 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 226' ' ' GLN . 2.8 m -143.86 42.38 1.45 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.364 -0.835 . . . . 0.0 110.006 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.424 ' HG2' ' N ' ' A' ' 226' ' ' GLN . 38.4 tt0 54.49 -90.32 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.381 -0.825 . . . . 0.0 110.311 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.424 ' N ' ' HG2' ' A' ' 225' ' ' GLU . 0.0 OUTLIER 178.79 -63.73 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.858 -1.151 . . . . 0.0 110.035 179.931 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.4 m -71.55 88.54 0.94 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -0.88 . . . . 0.0 110.3 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.129 179.95 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.224 0.535 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -155.96 166.47 33.39 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.312 -0.867 . . . . 0.0 110.275 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.618 HG22 ' HA2' ' A' ' 168' ' ' GLY . 10.1 t -97.85 171.07 8.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.922 . . . . 0.0 110.353 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.3 m -111.68 111.9 23.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.91 . . . . 0.0 110.065 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.9 mt -94.64 130.39 33.51 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.173 -0.954 . . . . 0.0 110.068 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.439 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 43.5 Cg_endo -69.69 -53.09 0.29 Allowed 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.442 1.233 . . . . 0.0 111.015 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.4 ' HB2' ' OD1' ' A' ' 174' ' ' ASP . 1.4 p30 -146.65 -170.45 3.52 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.099 -1.001 . . . . 0.0 111.184 -179.673 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -57.31 -39.91 91.05 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.715 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -49.62 -25.29 2.71 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.268 -1.137 . . . . 0.0 110.714 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.439 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -90.07 -35.31 15.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.138 -0.976 . . . . 0.0 110.067 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.409 ' O ' HG23 ' A' ' 133' ' ' VAL . . . -56.23 -24.68 43.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.359 -0.838 . . . . 0.0 110.177 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -84.53 -54.37 4.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.227 -0.921 . . . . 0.0 110.248 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.7 t -52.65 -26.49 13.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.256 -0.903 . . . . 0.0 110.324 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.1 tp -70.07 -46.04 65.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.291 -0.88 . . . . 0.0 110.398 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.667 HG13 ' HB3' ' A' ' 189' ' ' PHE . 40.5 t -56.88 -38.64 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.267 -0.896 . . . . 0.0 110.583 -179.629 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -85.29 -15.97 41.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.281 -0.887 . . . . 0.0 110.761 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.2 m -56.68 -45.81 81.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.025 -1.047 . . . . 0.0 110.288 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 92.3 p -133.35 -175.59 3.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.342 -0.849 . . . . 0.0 110.215 -179.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.59 -35.22 62.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.318 -0.864 . . . . 0.0 110.249 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 87.6 t -129.33 147.27 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.064 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.42 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -173.76 134.13 0.47 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.244 -0.91 . . . . 0.0 110.048 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 187' ' ' VAL . 9.4 p -120.46 147.33 24.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.097 -1.002 . . . . 0.0 110.371 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.628 HD12 ' CD2' ' A' ' 189' ' ' PHE . 7.4 mt -125.76 113.83 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.361 -0.837 . . . . 0.0 109.912 179.726 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -80.81 120.96 5.28 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.542 ' CE2' HG12 ' A' ' 175' ' ' VAL . 46.5 m-85 -91.22 80.86 5.56 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.193 -1.181 . . . . 0.0 109.753 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -100.06 140.39 34.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.079 -1.013 . . . . 0.0 111.033 -179.317 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.12 -27.83 18.3 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.671 0.748 . . . . 0.0 109.473 179.028 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.26 69.03 1.48 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.024 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.504 ' HA ' ' CB ' ' A' ' 152' ' ' ALA . 4.6 p -48.25 -24.0 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.717 -0.614 . . . . 0.0 111.327 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -78.91 3.45 16.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.102 -0.999 . . . . 0.0 110.873 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 94.5 p -85.56 -163.16 0.81 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.843 -1.161 . . . . 0.0 110.23 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.19 -49.65 6.44 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.327 -0.858 . . . . 0.0 110.353 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.21 -28.85 8.23 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.299 -0.876 . . . . 0.0 110.448 -179.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.504 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . . . -88.5 -29.25 20.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.346 -0.846 . . . . 0.0 110.136 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.82 -36.11 78.23 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.215 -0.928 . . . . 0.0 109.639 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -59.26 -49.09 79.19 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.103 -0.998 . . . . 0.0 108.607 178.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -50.96 -47.77 61.13 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.538 -0.726 . . . . 0.0 110.04 178.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.7 mt -47.4 -59.51 3.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.512 -0.743 . . . . 0.0 110.375 179.655 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -58.21 -50.53 73.21 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.424 -0.797 . . . . 0.0 110.057 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -53.82 -43.74 69.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.333 -0.854 . . . . 0.0 109.948 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.95 -24.41 63.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.86 . . . . 0.0 110.074 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -77.76 -40.58 40.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.871 . . . . 0.0 110.303 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.8 -39.9 68.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 0.0 110.334 -179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.449 HG21 ' CE1' ' A' ' 167' ' ' PHE . 0.7 OUTLIER -89.81 144.76 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.296 -0.877 . . . . 0.0 110.262 -179.862 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -132.29 18.6 4.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.215 -0.928 . . . . 0.0 110.394 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.461 ' O ' HD13 ' A' ' 165' ' ' ILE . 6.0 p-10 -125.51 21.36 7.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -0.959 . . . . 0.0 110.266 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.461 HD13 ' O ' ' A' ' 164' ' ' ASP . 45.0 mm -136.43 134.05 19.61 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.172 -0.955 . . . . 0.0 110.175 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.42 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 48.2 Cg_endo -74.67 75.2 3.61 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 O-C-N 123.542 1.285 . . . . 0.0 110.474 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.449 ' CE1' HG21 ' A' ' 162' ' ' ILE . 5.7 m-85 -67.9 134.0 50.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.303 -0.873 . . . . 0.0 110.323 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.618 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -124.72 149.23 16.93 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.54 ' O ' HG23 ' A' ' 169' ' ' ILE . 9.2 tt -148.27 125.03 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.206 -1.173 . . . . 0.0 110.29 -179.82 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.626 ' CG2' HG11 ' A' ' 175' ' ' VAL . 2.3 t -141.5 157.14 45.52 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 122.196 0.998 . . . . 0.0 110.933 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 94.9 p -124.77 3.41 8.17 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.47 178.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 124' ' ' PRO . 64.1 t30 -63.5 127.66 32.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.194 -0.941 . . . . 0.0 110.32 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.27 -32.78 11.47 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.241 -0.912 . . . . 0.0 110.597 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.4 ' OD1' ' HB2' ' A' ' 125' ' ' ASP . 0.8 OUTLIER -54.22 -31.82 54.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.098 -1.001 . . . . 0.0 109.88 179.84 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.626 HG11 ' CG2' ' A' ' 170' ' ' THR . 39.8 t -79.08 -27.02 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 109.692 179.593 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -84.32 -39.81 18.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 109.14 179.328 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 46.5 t -72.89 -4.78 34.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.464 -0.772 . . . . 0.0 110.231 178.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.67 -52.19 5.13 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.067 -1.021 . . . . 0.0 109.171 179.609 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -89.84 4.5 49.65 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.749 -0.595 . . . . 0.0 110.532 179.769 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 53.56 59.99 3.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.078 -1.014 . . . . 0.0 110.451 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 60.0 mt -102.82 102.77 12.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 110.13 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -53.47 -26.76 21.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.194 -0.941 . . . . 0.0 109.992 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -141.54 -175.44 4.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.406 -0.808 . . . . 0.0 109.839 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.409 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 11.8 p-10 -72.25 165.09 25.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.093 -1.004 . . . . 0.0 110.131 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -172.18 160.19 31.57 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 186' ' ' VAL . 34.2 m -123.91 97.25 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -1.18 . . . . 0.0 110.158 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.68 ' O ' HG23 ' A' ' 140' ' ' VAL . 89.1 t -108.81 155.77 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 109.96 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.751 HD22 ' HB3' ' A' ' 215' ' ' ASN . 6.6 tt -107.96 159.47 16.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.023 -1.048 . . . . 0.0 109.709 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.667 ' HB3' HG13 ' A' ' 133' ' ' VAL . 45.0 m-85 -130.11 121.26 26.0 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.901 -1.124 . . . . 0.0 110.349 -179.313 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.432 ' HD3' HD23 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -132.86 164.05 27.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.381 -0.824 . . . . 0.0 110.163 179.876 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -82.63 -26.15 32.48 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.206 -0.933 . . . . 0.0 110.845 -179.624 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.429 ' CD1' ' HG3' ' A' ' 190' ' ' LYS . 1.6 p90 -90.86 -176.81 4.78 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.287 -0.883 . . . . 0.0 110.988 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 47.01 -159.67 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.632 0.729 . . . . 0.0 110.928 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.91 -29.48 60.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.667 -0.646 . . . . 0.0 110.4 -179.731 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.4 ' HA2' ' HG2' ' A' ' 190' ' ' LYS . . . 96.09 -16.92 60.23 Favored Glycine 0 N--CA 1.483 1.822 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.494 ' HG3' ' CE1' ' A' ' 189' ' ' PHE . 4.2 ttp180 -138.34 154.31 48.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.018 -1.283 . . . . 0.0 110.479 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . 0.455 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 1.5 m-80 -125.15 -153.91 0.59 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.312 -0.867 . . . . 0.0 110.038 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.574 ' HA ' HG22 ' A' ' 187' ' ' VAL . 18.1 p30 -178.77 78.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.511 -0.743 . . . . 0.0 109.998 179.61 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -46.21 142.68 2.74 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.367 -0.833 . . . . 0.0 111.062 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 198' ' ' ASN . 6.5 mt-10 -140.94 123.62 16.09 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.299 -0.876 . . . . 0.0 109.819 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 133.38 -121.64 2.89 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -120.04 104.61 10.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.203 -1.174 . . . . 0.0 110.213 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.637 ' O ' HG13 ' A' ' 203' ' ' VAL . 6.5 p -58.84 91.38 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.15 -0.968 . . . . 0.0 110.224 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 66.0 p -126.12 160.1 31.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 110.079 179.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.554 ' O ' HD12 ' A' ' 209' ' ' LEU . 0.2 OUTLIER -49.87 -47.46 51.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 0.0 110.648 -179.956 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -63.25 -41.63 99.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.283 -0.885 . . . . 0.0 110.652 -179.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -79.04 -26.61 43.12 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.159 -0.963 . . . . 0.0 110.474 -179.713 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.59 HD21 HG23 ' A' ' 203' ' ' VAL . 19.1 mt -73.52 -59.25 2.8 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.248 -0.908 . . . . 0.0 110.499 -179.622 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.554 HD12 ' O ' ' A' ' 205' ' ' LYS . 5.5 mt -49.13 -40.16 31.39 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.303 -0.873 . . . . 0.0 110.886 -179.635 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -67.83 -45.14 75.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.12 -0.987 . . . . 0.0 110.451 -179.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.406 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 16.6 t80 -58.57 -54.41 47.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.933 . . . . 0.0 110.8 -179.624 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.503 HD12 HD12 ' A' ' 188' ' ' LEU . 6.4 mm -58.09 -47.96 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.155 -0.966 . . . . 0.0 110.026 -179.624 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.408 ' HA ' ' NE2' ' A' ' 216' ' ' GLN . 0.3 OUTLIER -58.04 -21.92 47.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.507 -0.746 . . . . 0.0 110.429 -179.766 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -90.03 -25.36 20.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.098 -1.001 . . . . 0.0 110.57 -179.716 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.751 ' HB3' HD22 ' A' ' 188' ' ' LEU . 76.1 m-20 -90.61 -39.81 12.29 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.169 -0.957 . . . . 0.0 110.893 -179.361 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.415 ' HG3' ' N ' ' A' ' 217' ' ' LEU . 5.6 pt20 -58.47 -28.89 65.76 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.196 -0.94 . . . . 0.0 110.813 -179.512 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.415 ' N ' ' HG3' ' A' ' 216' ' ' GLN . 48.1 mt -136.17 94.6 13.98 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.091 -1.006 . . . . 0.0 110.753 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -74.33 111.65 3.36 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.725 1.381 . . . . 0.0 110.189 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 219' ' ' LEU . 4.2 mm? -94.43 56.45 2.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.155 -0.966 . . . . 0.0 110.192 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 220' ' ' VAL . 11.5 p -111.9 29.46 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 110.096 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 2.9 mp -127.94 -42.27 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.297 -0.877 . . . . 0.0 110.338 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.32 132.75 34.58 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.684 -0.635 . . . . 0.0 110.215 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -88.12 -45.48 10.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.193 -0.942 . . . . 0.0 110.283 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 224' ' ' THR . 10.2 t -57.44 134.92 56.48 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.267 -0.896 . . . . 0.0 110.237 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -116.29 73.48 0.85 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.942 . . . . 0.0 110.357 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -164.35 66.63 0.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.927 . . . . 0.0 110.193 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.6 m -117.13 130.01 56.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.904 . . . . 0.0 110.207 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.186 -179.97 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.24 0.543 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.98 161.44 23.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 110.183 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.674 HG22 ' HA2' ' A' ' 168' ' ' GLY . 9.9 t -85.8 169.39 13.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 110.249 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.7 m -108.66 104.41 13.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 110.342 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.999 HD21 HD12 ' A' ' 132' ' ' LEU . 67.3 mt -80.65 133.67 55.34 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.192 -0.942 . . . . 0.0 110.048 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.513 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 45.3 Cg_endo -71.23 -35.13 9.01 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.387 1.204 . . . . 0.0 110.556 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.421 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.3 OUTLIER -167.75 -170.76 1.45 Allowed 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.169 0.985 . . . . 0.0 111.487 -179.919 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -58.09 -31.77 65.91 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.421 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -54.63 -28.81 49.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -1.141 . . . . 0.0 110.295 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.653 ' HB1' HD22 ' A' ' 123' ' ' LEU . . . -84.08 -35.02 24.03 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.931 . . . . 0.0 110.103 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -53.46 -29.16 34.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 0.0 109.98 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -90.15 -29.98 17.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.426 -0.796 . . . . 0.0 110.22 179.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.56 -35.19 30.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.195 -0.94 . . . . 0.0 110.263 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.999 HD12 HD21 ' A' ' 123' ' ' LEU . 3.2 tt -59.9 -58.26 9.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.316 -0.865 . . . . 0.0 109.739 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 97.9 t -51.98 -24.61 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.45 -0.781 . . . . 0.0 110.212 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -82.38 -21.81 35.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.311 -0.868 . . . . 0.0 110.262 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.8 m -53.14 -58.85 5.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.221 -0.924 . . . . 0.0 110.203 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 82.6 p -121.9 -179.03 4.0 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.288 -0.882 . . . . 0.0 110.296 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -69.56 -39.96 77.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.287 -0.883 . . . . 0.0 110.179 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.6 t -117.94 143.44 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.389 -0.82 . . . . 0.0 110.275 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.456 ' CB ' ' HG2' ' A' ' 166' ' ' PRO . . . -165.95 147.54 6.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.241 -0.912 . . . . 0.0 109.957 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.498 HG11 ' CZ ' ' A' ' 167' ' ' PHE . 7.3 p -127.11 150.09 32.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 O-C-N 121.103 -0.998 . . . . 0.0 110.205 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.433 HD11 ' HB3' ' A' ' 132' ' ' LEU . 75.5 mt -143.48 120.19 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.41 -0.806 . . . . 0.0 109.647 179.599 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.411 ' C ' ' CD1' ' A' ' 143' ' ' PHE . . . -85.89 166.68 39.37 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.507 ' CE2' HG12 ' A' ' 175' ' ' VAL . 26.5 m-85 -129.86 76.56 1.73 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.405 -1.056 . . . . 0.0 109.85 179.833 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.73 ' HZ ' HG21 ' A' ' 203' ' ' VAL . 19.6 m-85 -104.1 145.82 29.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.99 -1.069 . . . . 0.0 111.099 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.26 -27.75 19.26 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.786 0.803 . . . . 0.0 109.464 179.523 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.407 ' HB3' ' HB3' ' A' ' 149' ' ' SER . 0.3 OUTLIER -131.0 73.0 1.52 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.687 -0.633 . . . . 0.0 109.511 179.014 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.522 ' O ' ' HB3' ' A' ' 152' ' ' ALA . 18.4 m -48.36 -24.54 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.262 -0.899 . . . . 0.0 110.869 -179.543 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -83.95 5.53 25.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.063 -1.023 . . . . 0.0 110.844 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.407 ' HB3' ' HB3' ' A' ' 146' ' ' ASP . 33.5 p -75.19 -166.29 0.49 Allowed 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.905 -1.122 . . . . 0.0 110.34 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -90.45 -19.95 23.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.537 -0.727 . . . . 0.0 110.159 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 10.5 t -81.93 -31.62 31.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.163 -0.961 . . . . 0.0 110.078 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 147' ' ' VAL . . . -80.67 -20.05 43.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 110.2 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -61.45 -39.16 89.86 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.221 -0.924 . . . . 0.0 109.751 179.471 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -67.09 -41.18 86.74 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.358 -0.839 . . . . 0.0 109.619 179.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -48.96 -57.09 7.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.397 -0.814 . . . . 0.0 110.607 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 156' ' ' LEU . 52.8 mt -53.87 -54.76 34.07 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.449 -0.782 . . . . 0.0 110.289 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -54.2 -46.67 72.51 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.42 -0.8 . . . . 0.0 110.347 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.09 -45.36 85.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.148 -0.97 . . . . 0.0 110.379 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.82 -31.11 72.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.939 . . . . 0.0 110.435 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -63.69 -29.59 70.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.183 -0.948 . . . . 0.0 110.232 -179.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -57.33 -48.38 79.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.907 . . . . 0.0 110.227 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.401 HG13 ' OD1' ' A' ' 164' ' ' ASP . 8.9 tt -90.85 158.27 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.175 -0.953 . . . . 0.0 110.01 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.11 19.16 1.24 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.033 -1.042 . . . . 0.0 110.609 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.524 ' O ' HD13 ' A' ' 165' ' ' ILE . 5.9 p-10 -116.25 16.3 15.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.141 -0.974 . . . . 0.0 110.495 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.524 HD13 ' O ' ' A' ' 164' ' ' ASP . 49.7 mm -134.41 140.35 35.49 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.126 -0.984 . . . . 0.0 110.11 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.456 ' HG2' ' CB ' ' A' ' 139' ' ' ALA . 48.0 Cg_endo -74.77 79.5 2.58 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.618 1.325 . . . . 0.0 110.508 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.498 ' CZ ' HG11 ' A' ' 140' ' ' VAL . 3.6 m-85 -68.79 135.64 51.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.33 -0.856 . . . . 0.0 109.933 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.674 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -131.35 151.99 19.88 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.564 -1.303 . . . . 0.0 109.942 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 169' ' ' ILE . 11.7 tt -150.19 140.34 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -1.105 . . . . 0.0 109.979 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.568 HG21 HG21 ' A' ' 175' ' ' VAL . 2.9 t -153.77 158.05 40.35 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.118 0.961 . . . . 0.0 111.069 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.1 m -119.97 0.97 10.9 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.44 178.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.402 ' ND2' ' HB2' ' A' ' 174' ' ' ASP . 56.2 t30 -60.53 145.97 46.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.138 -0.976 . . . . 0.0 110.174 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 37.8 t -70.41 -30.91 67.91 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.167 -0.958 . . . . 0.0 110.471 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.402 ' HB2' ' ND2' ' A' ' 172' ' ' ASN . 1.2 t70 -54.56 -40.88 69.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.073 -1.017 . . . . 0.0 109.955 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.568 HG21 HG21 ' A' ' 170' ' ' THR . 58.8 t -69.82 -30.69 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 0.0 109.546 179.481 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 176' ' ' PHE . 10.6 m-85 -80.34 -41.17 25.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.445 -0.784 . . . . 0.0 109.751 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.87 -6.34 37.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.416 -0.802 . . . . 0.0 110.551 179.531 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 15.0 tttp -90.03 -45.39 9.2 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.014 -1.054 . . . . 0.0 109.382 179.7 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -91.5 0.78 57.47 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.562 -0.711 . . . . 0.0 110.642 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 53.97 66.47 1.22 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.985 -1.072 . . . . 0.0 110.728 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 55.3 mt -107.97 114.34 28.19 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.236 -0.915 . . . . 0.0 109.945 179.62 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.423 ' O ' ' CG ' ' A' ' 183' ' ' LYS . 45.2 m-20 -61.81 -17.26 55.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.936 . . . . 0.0 110.33 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 182' ' ' ASP . 22.6 mtmt -157.75 -166.39 1.98 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.206 -0.934 . . . . 0.0 110.012 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 3.5 p30 -63.9 162.98 12.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.184 -0.947 . . . . 0.0 110.049 179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -176.32 152.28 12.52 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 70.4 t -118.75 133.97 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.383 -1.069 . . . . 0.0 109.697 179.629 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.739 HG22 ' HA ' ' A' ' 198' ' ' ASN . 77.3 t -141.92 145.06 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.223 -0.923 . . . . 0.0 110.468 -179.738 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.513 HD13 ' CB ' ' A' ' 215' ' ' ASN . 7.1 tt -105.03 146.85 28.51 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -118.81 127.18 53.28 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.722 -1.236 . . . . 0.0 110.834 -178.689 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.509 ' HB2' ' CE1' ' A' ' 192' ' ' PHE . 0.0 OUTLIER -138.47 158.06 44.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.389 -0.819 . . . . 0.0 110.222 179.827 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.1 mmmm -84.3 -21.3 31.06 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.244 -0.91 . . . . 0.0 110.433 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.509 ' CE1' ' HB2' ' A' ' 190' ' ' LYS . 1.7 p90 -90.55 -176.23 4.68 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.244 -0.91 . . . . 0.0 110.883 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 46.79 -158.76 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.684 0.754 . . . . 0.0 110.74 -179.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.46 -54.0 49.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.634 -0.666 . . . . 0.0 110.313 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 137.81 -31.11 2.51 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.82 173.88 10.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.172 -1.193 . . . . 0.0 110.156 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . 0.451 ' N ' ' ND2' ' A' ' 197' ' ' ASN . 1.3 m-80 -134.14 -40.36 0.83 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.121 -0.987 . . . . 0.0 110.811 -179.181 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.739 ' HA ' HG22 ' A' ' 187' ' ' VAL . 0.6 OUTLIER 63.98 94.23 0.05 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.248 -0.907 . . . . 0.0 110.202 -179.273 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.506 ' HB2' ' CZ ' ' A' ' 211' ' ' PHE . 41.0 t80 -88.96 136.73 32.86 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.338 -0.851 . . . . 0.0 110.201 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.477 ' O ' ' CE1' ' A' ' 199' ' ' PHE . 5.1 mt-10 -121.0 -147.38 0.39 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.209 -0.932 . . . . 0.0 109.678 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 58.15 -128.27 47.14 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.03 130.39 53.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.316 -1.108 . . . . 0.0 110.35 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.73 HG21 ' HZ ' ' A' ' 144' ' ' PHE . 28.2 m -77.49 59.13 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.383 -0.823 . . . . 0.0 110.073 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.403 ' OG1' ' ND2' ' A' ' 207' ' ' ASN . 7.6 p -93.76 156.18 16.82 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.587 -0.695 . . . . 0.0 110.354 -179.826 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.471 ' O ' HD12 ' A' ' 209' ' ' LEU . 9.6 tttt -48.64 -48.24 39.73 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.24 -0.913 . . . . 0.0 110.532 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . 0.423 ' HG3' ' N ' ' A' ' 207' ' ' ASN . 14.2 pt-20 -54.34 -41.15 68.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.941 . . . . 0.0 110.42 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.423 ' N ' ' HG3' ' A' ' 206' ' ' GLU . 79.9 m-20 -83.21 -28.41 29.28 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.287 -0.883 . . . . 0.0 110.149 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 208' ' ' LEU . 19.9 mt -72.16 -48.58 42.36 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.267 -0.896 . . . . 0.0 110.264 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.471 HD12 ' O ' ' A' ' 205' ' ' LYS . 9.1 mt -53.56 -38.92 64.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 109.899 179.719 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -74.17 -49.11 25.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.84 . . . . 0.0 109.925 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.506 ' CZ ' ' HB2' ' A' ' 199' ' ' PHE . 23.8 t80 -47.94 -58.14 4.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 110.79 179.752 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 21.6 mt -52.83 -47.61 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -0.867 . . . . 0.0 110.212 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.55 -41.37 88.78 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.24 -0.912 . . . . 0.0 109.939 179.722 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -62.03 -19.87 63.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.383 -0.823 . . . . 0.0 109.945 179.649 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.513 ' CB ' HD13 ' A' ' 188' ' ' LEU . 2.3 m-80 -89.23 -60.71 1.88 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.253 -0.905 . . . . 0.0 109.553 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.55 156.1 0.2 Allowed 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.395 -0.816 . . . . 0.0 111.18 179.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 8.0 mt 54.94 92.7 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.524 -0.735 . . . . 0.0 110.01 179.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.74 73.35 2.39 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.607 1.32 . . . . 0.0 110.414 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 87.2 mt -125.72 67.89 1.17 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 110.191 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.667 ' O ' HG13 ' A' ' 220' ' ' VAL . 7.8 p -120.84 77.9 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.955 . . . . 0.0 110.333 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.506 ' O ' HG23 ' A' ' 221' ' ' ILE . 7.4 tt -160.05 123.88 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -0.914 . . . . 0.0 110.155 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.33 -57.6 0.2 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.28 -0.888 . . . . 0.0 110.18 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -128.08 -52.58 1.31 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 110.098 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.2 p -93.52 152.24 19.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 110.231 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -116.88 33.53 5.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 110.29 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 53.42 69.26 0.72 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.289 -0.882 . . . . 0.0 110.198 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.5 m -60.7 -27.59 67.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 110.216 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.195 -179.918 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.307 0.575 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -79.86 167.01 21.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.218 -0.926 . . . . 0.0 110.366 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.616 HG22 ' HA2' ' A' ' 168' ' ' GLY . 10.1 t -96.31 169.69 9.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.119 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.6 m -109.15 107.89 18.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 110.249 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 24.8 mt -85.43 128.86 57.59 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.361 -0.837 . . . . 0.0 109.98 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.419 ' HD2' ' CB ' ' A' ' 128' ' ' ALA . 46.6 Cg_endo -72.05 -43.61 1.12 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.425 1.223 . . . . 0.0 110.431 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.425 ' OD1' ' HB3' ' A' ' 127' ' ' ALA . 0.3 OUTLIER -158.2 -170.42 3.12 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 122.108 0.956 . . . . 0.0 111.242 179.936 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -58.5 -27.97 61.7 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.425 ' HB3' ' OD1' ' A' ' 125' ' ' ASP . . . -54.04 -32.27 53.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -1.129 . . . . 0.0 110.096 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.419 ' CB ' ' HD2' ' A' ' 124' ' ' PRO . . . -87.11 -34.93 18.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 110.016 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.0 -22.75 61.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.349 -0.844 . . . . 0.0 110.033 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -84.69 -57.88 2.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 110.134 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.5 p -61.06 -18.2 56.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.312 -0.867 . . . . 0.0 110.377 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.55 HD23 HD11 ' A' ' 141' ' ' ILE . 17.2 tp -71.05 -49.44 44.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.151 -0.968 . . . . 0.0 109.891 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.619 HG22 ' HB3' ' A' ' 189' ' ' PHE . 59.1 t -64.83 -28.59 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.478 -0.764 . . . . 0.0 110.262 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -90.0 -0.74 57.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.276 -0.89 . . . . 0.0 110.96 -179.836 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 46.9 t -86.44 -23.19 26.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.915 -1.115 . . . . 0.0 110.31 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.401 ' OG ' ' HG3' ' A' ' 166' ' ' PRO . 0.6 OUTLIER -148.44 160.0 43.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.236 -0.915 . . . . 0.0 110.495 -179.94 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.77 -22.85 59.06 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.401 -0.812 . . . . 0.0 109.592 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.8 m -138.43 152.22 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.315 -0.866 . . . . 0.0 110.377 -179.773 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -173.41 134.48 0.52 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 0.0 109.862 179.799 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.89 149.8 23.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 120.994 -1.067 . . . . 0.0 110.271 -179.685 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.55 HD11 HD23 ' A' ' 132' ' ' LEU . 2.8 mp -134.9 117.26 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.342 -0.849 . . . . 0.0 110.139 179.733 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.21 126.12 7.34 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.649 ' CE2' HG12 ' A' ' 175' ' ' VAL . 65.7 m-85 -100.74 78.77 2.0 Allowed 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.102 -1.234 . . . . 0.0 110.206 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -104.52 146.32 29.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.061 -1.024 . . . . 0.0 110.835 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.43 -27.89 21.25 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.575 -0.703 . . . . 0.0 109.827 179.375 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.422 ' HB3' ' HB3' ' A' ' 149' ' ' SER . 0.5 OUTLIER -130.15 74.35 1.59 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.502 -0.749 . . . . 0.0 109.525 179.506 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.596 ' O ' ' HB3' ' A' ' 152' ' ' ALA . 23.5 m -52.82 -21.4 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.367 -0.833 . . . . 0.0 110.846 -179.542 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -82.65 8.41 12.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.125 -0.984 . . . . 0.0 110.838 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.422 ' HB3' ' HB3' ' A' ' 146' ' ' ASP . 7.5 p -84.67 -161.71 0.6 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.869 -1.144 . . . . 0.0 110.37 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -90.74 -21.31 21.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 0.0 110.269 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.36 -37.13 68.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.214 -0.929 . . . . 0.0 110.255 -179.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 147' ' ' VAL . . . -74.04 -26.85 60.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.207 -0.933 . . . . 0.0 109.722 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 149' ' ' SER . 25.1 mmtt -54.05 -49.83 68.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.887 . . . . 0.0 109.858 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -64.42 -39.71 94.36 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.343 -0.848 . . . . 0.0 109.782 179.511 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -52.07 -55.7 19.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.356 -0.84 . . . . 0.0 110.161 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.43 -56.66 16.46 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.382 -0.824 . . . . 0.0 110.169 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -49.38 -57.97 5.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.33 -0.856 . . . . 0.0 110.489 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.582 ' HB2' ' HA ' ' A' ' 205' ' ' LYS . . . -57.72 -36.34 71.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.806 179.652 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.9 -32.63 73.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.993 179.655 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -67.63 -31.77 72.02 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.224 -0.923 . . . . 0.0 110.098 179.683 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.77 -32.54 63.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 109.961 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.464 HG21 ' CG1' ' A' ' 165' ' ' ILE . 58.1 mt -102.76 139.41 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.33 -0.856 . . . . 0.0 110.111 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.81 15.61 8.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.921 . . . . 0.0 110.539 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -119.86 -10.21 9.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.194 -0.941 . . . . 0.0 110.549 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.464 ' CG1' HG21 ' A' ' 162' ' ' ILE . 39.7 mm -101.51 146.06 31.54 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.045 -1.034 . . . . 0.0 110.249 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.45 ' HD2' ' CG2' ' A' ' 165' ' ' ILE . 47.6 Cg_endo -85.53 72.86 4.16 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 O-C-N 123.722 1.38 . . . . 0.0 110.458 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.609 ' HZ ' HD13 ' A' ' 212' ' ' ILE . 5.6 m-85 -65.61 124.69 23.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.303 -0.873 . . . . 0.0 110.19 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.616 ' HA2' HG22 ' A' ' 121' ' ' THR . . . -121.09 153.05 16.68 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 8.1 tt -150.16 137.69 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -1.12 . . . . 0.0 110.159 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.6 HG21 HG11 ' A' ' 175' ' ' VAL . 2.5 t -154.17 156.89 37.99 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.116 0.96 . . . . 0.0 110.884 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 13.7 m -115.09 -2.08 12.87 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.506 178.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -59.19 118.72 6.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.182 -0.949 . . . . 0.0 110.252 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.4 m -50.46 -33.09 19.86 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.153 -0.967 . . . . 0.0 110.458 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.32 -35.81 60.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.208 -0.932 . . . . 0.0 110.076 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.649 HG12 ' CE2' ' A' ' 143' ' ' PHE . 40.6 t -79.25 -24.91 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.338 -0.851 . . . . 0.0 109.734 179.66 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 176' ' ' PHE . 12.2 m-85 -80.97 -45.87 15.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.37 -0.831 . . . . 0.0 109.704 179.75 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 41.4 t -67.74 -22.76 65.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.353 -0.842 . . . . 0.0 110.066 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.5 tttm -52.68 -57.49 9.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.247 -0.908 . . . . 0.0 110.207 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -89.7 13.97 12.9 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.266 -0.896 . . . . 0.0 110.565 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 51.99 61.0 3.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.132 -0.98 . . . . 0.0 110.423 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 68.0 mt -96.85 -26.65 15.02 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.125 -0.984 . . . . 0.0 110.417 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 52.71 21.1 1.76 Allowed 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.896 -0.503 . . . . 0.0 110.684 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.403 ' HD3' ' O ' ' A' ' 184' ' ' ASP . 0.3 OUTLIER -178.6 -163.37 0.06 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.208 -0.932 . . . . 0.0 109.764 179.888 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 4.1 m-20 -90.57 152.6 20.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.12 -0.987 . . . . 0.0 109.838 179.468 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -164.93 149.52 16.29 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.46 -1.352 . . . . 0.0 109.917 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 199' ' ' PHE . 82.3 t -117.55 94.46 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.403 -1.057 . . . . 0.0 109.484 179.561 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 84.9 t -113.71 156.39 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.141 -0.974 . . . . 0.0 110.682 -179.294 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.656 HD13 ' CB ' ' A' ' 215' ' ' ASN . 8.2 tt -108.91 157.73 18.35 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.195 -0.941 . . . . 0.0 109.275 179.674 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.619 ' HB3' HG22 ' A' ' 133' ' ' VAL . 46.7 m-85 -129.9 124.85 34.15 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.924 -1.11 . . . . 0.0 110.733 -179.099 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.33 179.11 6.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.369 -0.832 . . . . 0.0 109.964 179.475 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -95.96 -29.7 14.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.131 -0.98 . . . . 0.0 110.74 -179.36 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.11 -172.01 3.17 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.964 0.888 . . . . 0.0 111.211 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 47.89 -155.42 0.07 Allowed 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.733 0.777 . . . . 0.0 110.654 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.61 -26.12 68.54 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.668 -0.645 . . . . 0.0 110.214 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 100.42 -34.93 5.16 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.63 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.36 172.31 8.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.072 -1.252 . . . . 0.0 110.743 -179.716 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . 0.458 ' ND2' ' HB3' ' A' ' 188' ' ' LEU . 0.9 OUTLIER -139.45 -148.16 0.25 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.6 -0.688 . . . . 0.0 109.494 -179.44 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -175.54 84.27 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.189 -0.944 . . . . 0.0 110.259 179.397 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 186' ' ' VAL . 83.4 t80 -51.28 119.73 4.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.196 -0.94 . . . . 0.0 110.535 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -117.45 95.98 5.2 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.299 -0.875 . . . . 0.0 110.31 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 156.11 -178.41 32.65 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.8 119.73 16.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -1.15 . . . . 0.0 110.137 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 80.0 t -60.06 108.25 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.195 -0.94 . . . . 0.0 110.137 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.415 ' OG1' ' ND2' ' A' ' 207' ' ' ASN . 10.6 p -147.68 157.67 43.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.365 -0.835 . . . . 0.0 110.11 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.582 ' HA ' ' HB2' ' A' ' 158' ' ' ALA . 27.0 tttt -52.16 -48.15 65.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.282 -0.886 . . . . 0.0 110.587 -179.752 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -63.87 -24.85 67.91 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.184 -0.947 . . . . 0.0 110.483 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.415 ' ND2' ' OG1' ' A' ' 204' ' ' THR . 75.9 m-20 -90.31 -44.65 9.56 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.184 -0.948 . . . . 0.0 110.333 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' A' ' 208' ' ' LEU . 46.4 mt -58.96 -55.83 30.09 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.224 -0.923 . . . . 0.0 110.277 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 205' ' ' LYS . 0.9 OUTLIER -54.74 -23.69 18.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 0.0 110.094 179.899 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -80.81 -57.98 3.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 110.048 179.91 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -54.98 -54.04 48.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.898 . . . . 0.0 109.974 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.609 HD13 ' HZ ' ' A' ' 167' ' ' PHE . 82.0 mt -49.15 -55.64 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.274 -0.891 . . . . 0.0 110.284 179.676 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.06 -30.48 6.37 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.432 -0.792 . . . . 0.0 110.352 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.448 ' CD2' ' N ' ' A' ' 214' ' ' HIS . 29.2 m170 -87.78 -7.12 57.72 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.202 -0.936 . . . . 0.0 110.626 179.765 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.656 ' CB ' HD13 ' A' ' 188' ' ' LEU . 2.1 m-80 -89.31 -70.41 0.66 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.029 -1.044 . . . . 0.0 109.935 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -59.25 161.44 5.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.18 -0.95 . . . . 0.0 109.68 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 19.2 mt 53.59 99.34 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.29 -0.881 . . . . 0.0 110.368 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.6 111.85 2.89 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.578 1.304 . . . . 0.0 110.38 179.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.1 mt -94.42 115.93 28.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 0.0 110.383 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.482 ' O ' HG12 ' A' ' 220' ' ' VAL . 54.9 t -102.16 60.16 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.25 -0.906 . . . . 0.0 109.967 179.751 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.401 ' O ' ' CG1' ' A' ' 221' ' ' ILE . 1.3 tt -90.3 17.86 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.247 -0.908 . . . . 0.0 110.606 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -149.69 26.02 0.84 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.061 -1.024 . . . . 0.0 110.183 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 59.22 157.4 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.448 -0.783 . . . . 0.0 110.434 -180.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 4.1 m -136.87 106.25 6.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 0.0 110.144 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -56.61 126.93 28.88 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.317 -0.864 . . . . 0.0 110.249 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -145.23 126.79 15.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.285 -0.884 . . . . 0.0 110.133 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 6.1 t -144.74 151.97 39.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.246 -0.909 . . . . 0.0 110.263 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.185 179.921 . . . . . . . . 0 0 . 1 stop_ save_